
<html lang="en"     class="pb-page"  data-request-id="6ffd3148-fe09-422e-aa2c-963fd133bce3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm501512b;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2015.58.issue-14"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis" /></meta><meta name="dc.Creator" content="Thomas M.  Keck" /></meta><meta name="dc.Creator" content="William S.  John" /></meta><meta name="dc.Creator" content="Paul W.  Czoty" /></meta><meta name="dc.Creator" content="Michael A.  Nader" /></meta><meta name="dc.Creator" content="Amy Hauck  Newman" /></meta><meta name="dc.Description" content="The dopamine D3 receptor (D3R) is a target for developing medications to treat substance use disorders. D3R-selective compounds with high affinity and varying efficacies have been discovered, provi..." /></meta><meta name="Description" content="The dopamine D3 receptor (D3R) is a target for developing medications to treat substance use disorders. D3R-selective compounds with high affinity and varying efficacies have been discovered, provi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 31, 2015" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm501512b" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm501512b" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm501512b" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm501512b" /></link>
        
    
    

<title>Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm501512b" /></meta><meta property="og:title" content="Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0010.jpeg" /></meta><meta property="og:description" content="The dopamine D3 receptor (D3R) is a target for developing medications to treat substance use disorders. D3R-selective compounds with high affinity and varying efficacies have been discovered, providing critical research tools for cell-based studies that have been translated to in vivo models of drug abuse. D3R antagonists and partial agonists have shown especially promising results in rodent models of relapse-like behavior, including stress-, drug-, and cue-induced reinstatement of drug seeking. However, to date, translation to human studies has been limited. Herein, we present an overview and illustrate some of the pitfalls and challenges of developing novel D3R-selective compounds toward clinical utility, especially for treatment of cocaine abuse. Future research and development of D3R-selective antagonists and partial agonists for substance abuse remains critically important but will also require further evaluation and development of translational animal models to determine the best time in the addiction cycle to target D3Rs for optimal therapeutic efficacy." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm501512b"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm501512b">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm501512b&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm501512b&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm501512b&amp;href=/doi/10.1021/jm501512b" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 5361-5380</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm501155f" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+M.++Keck">Thomas M. Keck</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+S.++John">William S. John</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+W.++Czoty">Paul W. Czoty</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+A.++Nader">Michael A. Nader</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amy+Hauck++Newman">Amy Hauck Newman</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse—Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Chemistry & Biochemistry, College of Science and Mathematics; Department of Biomedical & Translational Sciences, School of Biomedical Science & Health Professions, Rowan University, 201 Mullica Hill Road, Glassboro, New Jersey 08028, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157-1083, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: (443)-740-2887. Fax: (443)-740-2111. E-mail: <a href="/cdn-cgi/l/email-protection#a7c6c9c2d0cac6c9e7cec9d3d5c689c9cec3c689c9cecf89c0c8d1"><span class="__cf_email__" data-cfemail="5c3d32392b313d321c3532282e3d723235383d72323534723b332a">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm501512b&amp;href=/doi/10.1021%2Fjm501512b" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 5361–5380</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 31, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 October 2014</li><li><span class="item_label"><b>Published</b> online</span>31 March 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 July 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm501512b" title="DOI URL">https://doi.org/10.1021/jm501512b</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm501512b"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4161</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">66</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm501512b" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;M. Keck&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;S. John&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;W. Czoty&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;A. Nader&quot;},{&quot;first_name&quot;:&quot;Amy&quot;,&quot;last_name&quot;:&quot;Hauck Newman&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;31&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;5361-5380&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm501512b&quot;},&quot;abstract&quot;:&quot;The dopamine D3 receptor (D3R) is a target for developing medications to treat substance use disorders. D3R-selective compounds with high affinity and varying efficacies have been discovered, providing critical research tools for cell-based studies that have been translated to in vivo models of drug abuse. D3R antagonists and partial agonists have shown especially promising results in rodent models of relapse-like behavior, including stress-, drug-, and cue-induced reinstatement of drug seeking. However, to date, translation to human studies has been limited. Herein, we present an overview and illustrate some of the pitfalls and challenges of developing novel D3R-selective compounds toward clinical utility, especially for treatment of cocaine abuse. Future research and development of D3R-selective antagonists and partial agonists for substance abuse remains critically important but will also require further evaluation and development of translational animal models to determine the best time in the addiction c&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501512b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501512b" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501512b&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501512b" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501512b&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501512b" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm501512b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501512b&amp;href=/doi/10.1021/jm501512b" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm501512b" /></input><a href="/doi/pdf/10.1021/jm501512b" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm501512b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm501512b%26sid%3Dliteratum%253Aachs%26pmid%3D25826710%26genre%3Darticle%26aulast%3DKeck%26date%3D2015%26atitle%3DIdentifying%2BMedication%2BTargets%2Bfor%2BPsychostimulant%2BAddiction%253A%2BUnraveling%2Bthe%2BDopamine%2BD3%2BReceptor%2BHypothesis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D14%26spage%3D5361%26epage%3D5380%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jmcmar.2015.58.issue-14/20150723/jmcmar.2015.58.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/medium/jm-2014-01512b_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The dopamine D3 receptor (D3R) is a target for developing medications to treat substance use disorders. D3R-selective compounds with high affinity and varying efficacies have been discovered, providing critical research tools for cell-based studies that have been translated to in vivo models of drug abuse. D3R antagonists and partial agonists have shown especially promising results in rodent models of relapse-like behavior, including stress-, drug-, and cue-induced reinstatement of drug seeking. However, to date, translation to human studies has been limited. Herein, we present an overview and illustrate some of the pitfalls and challenges of developing novel D3R-selective compounds toward clinical utility, especially for treatment of cocaine abuse. Future research and development of D3R-selective antagonists and partial agonists for substance abuse remains critically important but will also require further evaluation and development of translational animal models to determine the best time in the addiction cycle to target D3Rs for optimal therapeutic efficacy.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40430" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40430" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A decade ago, we (A.H.N. and M.A.N.) wrote a Perspective entitled <i>Dopamine D3 Receptor Partial Agonists and Antagonists as Potential Drug Abuse Therapeutics.</i><a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> We posited that, as all drugs of abuse either directly or indirectly increase dopamine (DA) levels in the mesolimbic region of the brain, DA receptors were one obvious target for medication development. We highlighted the supporting literature up to that time, focusing on the DA D3 receptor (D3R), and further emphasized that despite tremendous progress in identifying mechanistic underpinnings of the psychoactive actions of addictive drugs, particularly for the psychostimulants such as cocaine and methamphetamine (METH), not a single pharmacological treatment had been approved by the FDA. As millions of people in the United States and worldwide suffer from psychostimulant abuse and addiction, the public health need to develop medications to treat these substance use disorders was and remains significant. Since 2005, more than 6000 papers have been published on basic, preclinical, and clinical cocaine abuse research in an effort to develop effective treatments. Nonetheless, despite our best efforts with hypothesis-driven investigations producing promising results in animal models of psychostimulant addiction, we have not yet succeeded in identifying a single medication that can meet FDA safety and efficacy requirements in this population of patients. The broader question is why have we failed? A narrower question, and the focus of this Perspective, relates directly to the development of medications that target the D3R. In this review, we once again set the stage for the D3R as a lead target for medication discovery for psychostimulant addiction and highlight the application of small molecule structure–activity relationships (SAR), with the aid of structure-based design using the D3R crystal structure,<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2-4)</a> toward novel drug-like molecules. We then illustrate some of the challenges of moving our basic hypotheses through the rigors of drug development using our lead molecule <b>1</b> (PG648, Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>)<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> as an example.</div><div class="NLM_p">All known addictive drugs enhance DA signaling within key corticolimbic circuits of the brain that control reward, emotion, cognition, and motivation. Although the molecular targets of addictive drugs vary widely,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> they all appear to directly or indirectly enhance DA signaling in the ventral striatum, particularly the nucleus accumbens,<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> and activate neural circuitry that normally mediates reward responses to natural stimuli such as food and sex. Other dopaminergic pathways that project into the dorsal striatum and frontal cortex have also been identified as contributing to drug reward and may be especially affected in the progression to addiction.<a onclick="showRef(event, 'ref7 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref9">(7, 9)</a> Specifically, psychostimulant drugs directly increase synaptic DA by altering the function of the DA transporter (DAT). DAT blockers (e.g., cocaine, methylphenidate) inhibit DA removal from the synaptic cleft; DAT substrates (e.g., amphetamines) have more complex actions and can induce nonvesicular DA release into the synapse.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The commonality between these mechanistically distinct drugs of abuse is that rapid and profound increases in synaptic DA lead to stimulation of DA receptors, producing the stimulant and rewarding euphoric effects that can lead to abuse and addiction. What makes cocaine unique, though, is the rapid reversal of elevated DA, leading to compulsive drug taking.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> For example, cocaine and methylphenidate have similar regional distributions in the striatum, but the rapid pharmacokinetics of cocaine likely lead to its higher abuse potential.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">DA signaling is mediated by a family of G protein-coupled receptors (GPCRs). The five known DA receptors (D1R–D5R) are classified into two families on the basis of sequence similarity and second messenger activity. D1-like receptors (D1R and D5R) signal through G<sub>αs</sub> and enhance the production of intracellular cyclic AMP (cAMP); D2-like receptors (D2R, D3R, and D4R) signal through G<sub>αi/o</sub> and inhibit the production of intracellular cAMP.</div><div class="NLM_p">In comparison to D2R pharmacology, D3R pharmacology has been historically more enigmatic. D3Rs have relatively small shifts in agonist binding affinity in response to guanyl nucleotides, which may indicate relatively poor receptor coupling to G proteins or, alternatively, that the receptor structure is relatively rigid and only modestly affected by G protein association; relatedly, D3R receptor high- and low-affinity states are reported to differ only 5–10-fold in heterologous systems.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> D3Rs <i>do</i> couple to G proteins in heterologous systems, but not exclusively to G<sub>αi/o</sub> (some signaling through G<sub>αq</sub> has been reported), and the adenylate cyclase V isozyme is required for agonist-mediated inhibition of cAMP production.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> Furthermore, recent evidence indicates that D3Rs likely form functional heteromers with D1Rs in the striatum.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> The functional consequences of this interaction in vivo have yet to be elucidated, but it may play an important role in a variety of neuropsychiatric disorders.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">The D3R has long been a target of interest in addiction pharmacotherapy due to its relatively focal localization within the ventral striatum and its enhanced expression in drug-exposed brains.<a onclick="showRef(event, 'ref1 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref1 ref18 ref19">(1, 18, 19)</a> Several research groups have discovered highly selective D3R antagonists, partial agonists, and full agonists using small molecule SAR (for recent reviews, see refs <a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">20−22</a>) and more recently using the D3R crystal structure, computational methods, and molecular pharmacology.<a onclick="showRef(event, 'ref2 ref3 ref18 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref18 ref23 ref24">(-2, 3, 18, 23, 24)</a> Many of these D3R-selective ligands have served as essential research tools for pharmacological investigations at the molecular, cellular, and behavioral levels.</div><div class="NLM_p">Herein, we briefly discuss the history of D3R as a target for addiction treatment, including a preview of limited clinical studies. We discuss the viability of identifying a novel translational candidate for psychostimulant addiction, practical concerns for future development of D3R-targeted pharmacotherapies, and general obstacles to medication development for addiction. Translation of hypotheses based on preclinical findings has proven to be challenging due to the lack of clinically available, D3R-preferential compounds. One concern is that failure in the clinic of a single lead molecule could prematurely eliminate the D3R as a medication target for addiction pharmacotherapy.</div><div class="NLM_p">Over the past decade, we have discovered many D3R-selective ligands with varying efficacies as research tools that have high affinity (<i>K</i><sub>i</sub> < 10 nM) and D3R selectivity (>100-fold over D2R).<a onclick="showRef(event, 'ref5 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref5 ref25 ref26">(5, 25, 26)</a> One of our lead compounds, <i>N</i>-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)-3-hydroxybutyl)-1<i>H</i>-indole-2-carboxamide (<b>1</b>), is a high-affinity D3R-selective antagonist first reported in 2009.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Computational studies following the publication of the D3R crystal structure identified key interactions within the orthosteric (DA) binding site and the 2,3-diCl-phenylpiperazine moiety of <b>1</b>, as well as a secondary binding pocket that together likely contribute to the 4-phenylpiperazine class of compounds’ affinity, subtype selectivity, and efficacy.<a onclick="showRef(event, 'ref2 ref27'); return false;" href="javascript:void(0);" class="ref ref2 ref27">(2, 27)</a> Further studies determined that D2R–D3R subtype selectivity of <b>1</b> and related compounds depended critically on a divergent glycine residue in extracellular loop 1.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Given the success of earlier and structurally related compounds <b>2</b> (NGB2904),<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a><b>3</b> (PG01037),<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and <b>4</b> (SB277011A)<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> in animal models of addiction, compound <b>1</b>’s favorable receptor selectivity profile made it an enticing preclinical candidate. Hence, we highlight the development and preclinical evaluation of <b>1</b> as an instructive example of a D3R-selective antagonist that ultimately will not make it to the clinic; identifying pitfalls in the medications development process and areas of need in behavioral models of addiction.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/medium/jm-2014-01512b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Chemical Structures of Highlighted D3R-Selective Partial Agonists and Antagonists</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2 Rationale: D3R as a Pharmacotherapeutic Target for Psychostimulant Addiction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12641" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12641" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As a substantial cause of morbidity and mortality, drug addiction exerts major sociological and financial costs on individuals and society at large. A recent estimate of $500 billion in economic costs to the U.S. alone has been used to inspire further support and development of Addiction Medicine Programs.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> However, while there are presently pharmacotherapeutic options to treat dependence on nicotine,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> alcohol,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and opiates,<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> there are currently no FDA-approved medications for psychostimulant addiction. This deficit in our medical armamentarium significantly reduces what clinicians can do for psychostimulant abusers, which underscores the public health need to develop medications for treatment.</div><div class="NLM_p">It is well-established that prolonged exposure to psychostimulant drugs leads to adaptive neurobiological changes.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Key observations that encouraged the development of D3R-specific compounds for psychostimulant addiction treatment came from human postmortem studies showing elevated expression of D3Rs following acute or chronic exposure to cocaine.<a onclick="showRef(event, 'ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40">(38-40)</a> The phenomenon of increased D3R expression has been confirmed and extended to other drugs, including METH and alcohol, via animal and human studies using various molecular biology techniques and PET imaging.<a onclick="showRef(event, 'ref41 ref42 ref43 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43 ref44 ref45 ref46">(41-46)</a> As the focus of this Perspective is targeting D3R for psychostimulant addiction treatment, we encourage interested readers to consult other excellent reviews for discussions of the pharmacotherapeutic potential of D3R-selective compounds for substance use disorders associated with other classes of addictive drugs, including ethanol and opiates.<a onclick="showRef(event, 'ref41 ref47 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref41 ref47 ref48 ref49 ref50">(41, 47-50)</a></div><div class="NLM_p">Since the cloning of the D3R gene in 1990,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> several key differences have been identified between D3R and the closely related D2R (sharing 78% sequence identity in the transmembrane and binding domains). D2R expression in the human brain is widespread but most prominent in the dorsal striatum;<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> D3R expression is overall lower than D2R, and the distribution of striatal D3R is more limited to ventral regions, particularly the nucleus accumbens.<a onclick="showRef(event, 'ref48 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref48 ref52 ref53">(48, 52, 53)</a> A recent autoradiography study in postmortem human brain tissue reported that D3R expression is greater and more widespread than has previously been appreciated, including moderate dorsal striatal expression (although still lower density than D2R) and appreciable expression in extrastriatal regions such as the thalamus.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The recent development of newer radioligands, such as <b>5</b> ([<sup>3</sup>H]LS-3-134 in Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>), with greater D3R selectivity over D2R may further resolve the longstanding difficulty in differentiating D2R and D3R receptor densities in neuronal tissues.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div><div class="NLM_p">The localization of D3Rs within the ventral striatum suggests the receptor may play an important role in the rewarding effects of drugs and control of motivational behaviors. The relatively low D3R density in the dorsal striatum, compared to D2R, suggests that ligands sufficiently selective for D3R over D2R may also avoid the undesirable motor coordination and extrapyramidal side effects associated with nonselective D2-like antagonists (e.g., antipsychotics), commonly attributed to D2R blockade.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56, 57)</a> Moreover, a recent meta-analysis of randomized placebo-controlled trials with a variety of neuroleptics showed that these clinically available D2R/D3R antagonists were no more efficacious than placebo in improving abstinence or reducing craving for cocaine or METH, further suggesting that nonselective D2-like antagonists do not have clinical utility in this patient population.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> However, cariprazine (<b>6</b>, RGH-188, Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>), a partial agonist approximately 10-fold D3R-preferential, is in clinical development as an antipsychotic agent (for review, see ref <a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">59</a>) and has shown potential utility in preclinical models of cocaine abuse.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div><div class="NLM_p">While the major goal of addiction pharmacotherapy development is to block drug seeking, there has been recent interest in also focusing on cognitive deficits induced by long-term drug abuse.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> In one of the earlier studies, Laszy et al.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> used a water labyrinth test to assess spatial memory in rats and found that cognitive impairments induced by scopolamine were reversed by D3R antagonists. More recently, Mugnaini et al.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> reported that the D3R antagonist <b>7</b> (GSK598,809 in Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) partially attenuated an attentional bias, as assessed with a Stroop Task, in abstinent smokers. In a review on D3R and cognition, Nakajima et al.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> concluded that D3R blockade enhances cognitive function, whereas agonists at D3R appear to impair cognition. Recent preclinical studies suggest that the mechanism by which D3R blockade improves cognition involves the facilitation of both cholinergic and DA transmission in the frontal cortex.<a onclick="showRef(event, 'ref62 ref65 ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref62 ref65 ref66 ref67">(62, 65-67)</a> D3R may also influence cognition by modulating CREB signaling in the hippocampus<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> as well as through glutamatergic–D3R interactions.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> The relationship between D3R and cognition is an area of research that requires much additional work. While Nakajima et al.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> reported reversal in “compromised” animals, it remains to be determined whether selective D3R antagonists and/or partial agonists can improve cognition in subjects with cocaine- or METH-induced cognitive disruptions.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.1 Designing D3R-Selective Antagonists and Partial Agonists</h3><div class="NLM_p">The initial success of the partial agonist <b>8</b> (BP897 in Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) in a rodent model of cocaine addiction<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> spurred many laboratories in both academia and pharma to develop new drug-like molecules with D3R selectivity. SAR studies published by a number of research groups have been reviewed previously.<a onclick="showRef(event, 'ref1 ref3 ref21 ref71 ref72 ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref1 ref3 ref21 ref71 ref72 ref73 ref74">(1, 3, 21, 71-74)</a> Recently reported analogues in the 4-phenylpiperazine template include functionalization of the butyl linking chain<a onclick="showRef(event, 'ref5 ref25 ref26 ref75 ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref5 ref25 ref26 ref75 ref76 ref77">(5, 25, 26, 75-77)</a> and elaboration of both the terminal aryl amide and phenylpiperazine or head group.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Recently reported D3R-selective compounds can be seen in Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>. These compounds typically follow and expand upon the SAR already established for D3R-selective antagonists or partial agonists and, for those that have been tested in vivo, have similar behavioral profiles in animal models of psychostimulant abuse. A novel approach that inserted a cyclobutyl group in the linking chain and replaced the phenylpiperazine head group with tranylcypromine resulted in a recently reported novel series of D3R-selective antagonists.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></div><div class="NLM_p">Many of the newer analogues have capitalized on variations of the 4-phenylpiperazine template, but some interesting and diverse molecules have also been discovered. Notably, the evolution of SAR in the Glaxo program, led by Micheli and colleagues, abandoned the arylamide terminus for a heteroaryltriazole, as seen in <b>7</b>.<a onclick="showRef(event, 'ref20 ref79'); return false;" href="javascript:void(0);" class="ref ref20 ref79">(20, 79)</a> This modification resulted in high affinity and selectivity for the D3R target but also metabolic stability and low hERG channel activity, predicting that this compound would be bioavailable and safe in humans. Other groups have replaced the 4-phenylpiperazine with the tetrahydrobenzothiazole of pramipexole to give full<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> or partial<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> D3R agonists with both high affinity and subtype selectivity. Of note, the groups led by Dutta and Reith have also reported tetrahydrobenzothiazole analogues, but they have replaced the arylamide of the more classic D3R ligands with this functional group and retained an arylpiperazine or an arylamide piperazine to give a novel set of D3R-selective agonists.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> In this series, it is interesting to contemplate which end of these molecules binds to the orthosteric (DA) binding site and whether the other end binds to the secondary binding pocket believed to be occupied by the aryl amide of (<i>R</i>)-<b>1</b><a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> or a different site within the D3R protein to produce a full agonist profile. A similar hybridization approach that replaced the 4-phenylpiperazine with a 5-aminohydropyrazolopyridine group also resulted in a very interesting series of highly potent D3R agonists that were reported to demonstrate functional bias,<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> a hot topic in the D2-like receptor drug discovery arena (for review, see refs <a onclick="showRef(event, 'ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref84 ref85">84 and 85</a>) but beyond the scope of the present review. Gmeiner and colleagues are avidly following these leads and discovering other templates that display functionally biased profiles.<a onclick="showRef(event, 'ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref86 ref87">(86, 87)</a> The field is still in its infancy in terms of understanding the pharmacological and behavioral consequences of D3R-mediated biased agonism. Nevertheless, the combination of small molecule SAR and the D3R crystal structure with computational modeling will undoubtedly produce structurally and pharmacologically variant tools in the near future with which to probe these questions.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><figure id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/medium/jm-2014-01512b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Recently Reported D3R-Preferential Ligands with Novel Structural Templates</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">2.2 Translating D3R-Selective Antagonists and Partial Agonists to the Clinic</h3><div class="NLM_p">To date, very few D3R-selective or preferential antagonists or partial agonists have been tested in clinical trials for substance use disorders. Thus far, <b>7</b> appears to be the most clinically investigated compound based on publications in the literature and perusal of <a href="http://clinicaltrials.gov" class="extLink">clinicaltrials.gov</a> (e.g., ClinicalTrials.gov identifiers NCT00437632, NCT01188967, NCT00793468, NCT00605241, and NCT01039454).</div><div class="NLM_p">Briefly, after validating D3R occupancy in a PET study using [<sup>11</sup>C]PHNO<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> and evaluating its pharmacokinetics,<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a><b>7</b> was tested in several clinical studies. In overweight and obese subjects, <b>7</b> reduced approach bias<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> and attentional bias to palatable food cues<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> but did not alter fMRI brain responses to food images.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> In tobacco smokers, <b>7</b> transiently alleviated craving in smokers after overnight abstinence, although smoking increased.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Although <b>7</b> had some qualified successes in these clinical populations, and many other D3R-selective antagonists and partial agonists have been successful in preclinical models of cocaine or METH abuse, it is unclear at this time whether or not <b>7</b> will be evaluated in this patient population.</div><div class="NLM_p last">One concern that has emerged is the potential for <b>7</b> and other D3R antagonists to increase blood pressure, especially if taken in combination with stimulants (Nate Appel and Jane Acri, National Institute on Drug Abuse, personal communication), as D3Rs reside in the kidney and contribute to DA-mediated regulation of blood pressure.<a onclick="showRef(event, 'ref92 ref93 ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref92 ref93 ref94 ref95">(92-95)</a> Cocaine’s cardiovascular effects have been investigated, and increases in both blood pressure and heart rate have been well-documented.<a onclick="showRef(event, 'ref96 ref97'); return false;" href="javascript:void(0);" class="ref ref96 ref97">(96, 97)</a> Indeed, cardiovascular toxicity is likely the main contributor to medical complications and overdose. Both central and peripheral mediation of increased blood pressure upon acute and chronic administration of cocaine have been investigated with varying results depending on species, dose of cocaine, and acute versus chronic administration.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> The concern, of course, is that if subjects relapse to cocaine taking, blood pressure elevations due to cocaine exposure could be exacerbated in the presence of a D3R antagonist. Human studies investigating the effects of the D2R/D3R partial agonist aripiprazole on cocaine self-administration, drug discrimination, and cardiovascular effects reported a small, acute increase in blood pressure that was not sustained after repeated cocaine administration.<a onclick="showRef(event, 'ref98 ref99'); return false;" href="javascript:void(0);" class="ref ref98 ref99">(98, 99)</a> Further investigation with D3R-selective drugs is required in order to clearly determine whether D3R-selective partial agonists or antagonists are likely to exhibit this potential side effect. For example, in ongoing preclinical studies using nonhuman primates implanted with indwelling telemetry devices, administration of cocaine increases blood pressure and heart rate; these effects are either unaltered or enhanced by D3R antagonists, but they appear to be attenuated by D3R partial agonists (M.A. Nader, A.H. Newman, unpublished results). Also, it is critically important to determine whether this potential cardiovascular risk is mediated via D3R or is an off-target effect of the drug molecule: the latter might be addressed with appropriate structural modifications of the lead compound(s). Hence, continued evaluation of structurally diverse molecules with differing off-target profiles remains a priority to further validate the D3R as a target for medication development, especially for psychostimulant abuse. Of course, substance use disorders that by themselves do not alter blood pressure or heart rate may be completely treatable with D3R antagonists or partial agonists, without concern for cardiovascular safety. In addition, increases in blood pressure can be monitored and treated, if necessary, with clinically available drugs.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.3 Repurposing Buspirone for Treatment of Cocaine Abuse</h3><div class="NLM_p">In response to the interest in investigating D3R antagonists as potential pharmacotherapies for cocaine abuse, the clinically available anxiolytic buspirone was evaluated in several preclinical addiction models and in a clinical trial with cocaine abusers. While by no means D3R-selective, Bergman et al.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> reported that buspirone had higher affinity at the D3R compared to the D2R. When tested in monkeys self-administering cocaine, they found that buspirone decreased cocaine-maintained behavior to a larger degree than food-reinforced behavior. Mello et al.,<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> using rhesus monkeys that self-administered cocaine 4 times per day, found that continuous infusions of buspirone also decreased cocaine self-administration to a greater degree than food-reinforced responding. These findings supported the use of buspirone as a pharmacotherapy for cocaine addiction. Unfortunately, the positive results from these preclinical studies did not extend to clinical trials. Winhusen et al.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> reported negative effects of buspirone in cocaine abusers and, in fact, found that buspirone increased cocaine use in women. However, it should be noted that this study had a remarkable placebo effect: subjects that were not administered buspirone dramatically reduced their cocaine use. Further, it is not clear that the single tested dose (60 mg) of buspirone was adequate to achieve high occupancy of D3R for a sufficient duration of time to be effective.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Supporting this assumption is a recent study in primates measuring D3/D2R occupancy of buspirone using PET imaging.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> It was found that the low dose of oral buspirone (1.0 mg/kg) tested, approximately the same dose tested in the Winhusen et al. study, exhibited minimal D3R occupancy (<20%). In contrast, 80% sustained D3R occupancy was achieved by a dose that was 3-fold higher (3.0 mg/kg) and was well-tolerated. These data indicate the importance of using receptor occupancy as a guideline for therapeutic efficacy in that high and sustained levels are most likely needed for the successful treatment of addiction.</div><div class="NLM_p">On the basis of these clinical findings with buspirone, one may (prematurely) conclude that the D3R and, more specifically, D3R antagonists are not viable targets for psychostimulant addiction. We would caution against such conclusions for two reasons: First, buspirone has very complex pharmacology, with known effects at 5-HT<sub>1A</sub>, D2R, D3R, and D4Rs, as well as active metabolites that interact with α2-adrenergic receptors.<a onclick="showRef(event, 'ref100 ref104 ref105'); return false;" href="javascript:void(0);" class="ref ref100 ref104 ref105">(100, 104, 105)</a> Second, the choice of drug reinforcement schedules used in the preclinical evaluations of buspirone may not have been ideal to detect D3R-mediated antiaddiction effects.</div><div class="NLM_p last">One of the interesting aspects of the behavioral pharmacology of D3R compounds is the importance of the schedules of reinforcement used in self-administration studies (see refs <a onclick="showRef(event, 'ref1 ref48'); return false;" href="javascript:void(0);" class="ref ref1 ref48">1 and 48</a> for review). In the preclinical models used by Bergman et al.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> and Mello et al.,<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> there were no competing reinforcers when cocaine self-administration was studied, and this may be critical to understanding how medications, such as buspirone, can decrease one type of behavior (in their case, food-maintained responding) to a smaller degree than cocaine self-administration. More complex models, such as food–drug choice paradigms, measure reinforcing strength (efficacy) with the goal of examining treatments that decrease cocaine self-administration <i>and</i> reallocate responding from cocaine to food. In a recent study, John et al.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> found that 5 day treatment with buspirone increased cocaine choice, a finding consistent with the Winhusen et al.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> clinical study. Clearly, the animal models used to evaluate D3R compounds on cocaine self-administration need to be more thoughtfully analyzed in order to achieve translation of preclinical findings to clinical success. For example, in a study using socially housed monkeys, acute buspirone administration decreased cocaine choice relative to food in dominant monkeys but not subordinate animals, suggesting a possible interaction between environmental variables and efficacy of buspirone.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Importantly, though, it is our premise that using food–drug choice paradigms and the study of a range of D3R compounds (see below) will allow for (1) a better understanding of the role of D3Rs in cocaine abuse and (2) the identification of potential pharmacotherapies based on the D3R. Thus, buspirone should not be considered a representative D3R antagonist, and it is our perspective that this single clinical trial should not deter further research toward developing a D3R-selective antagonist or partial agonist for substance use disorders. It should, however, be noted that treatment-emergent adverse events reported in this study did not include increases in blood pressure in the subjects receiving buspirone.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">3 Recent Development of Novel D3R-Selective Compounds as in Vivo Tools</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18181" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18181" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">On the basis of the preclinical promise of early leads, our group and others have focused efforts on optimizing D3R affinity and selectivity as well as physical properties (e.g., cLogP, tPSA, metabolic stability, etc.) to improve their utility as in vivo tools. As drug abuse is a human behavior, we ultimately must develop tools that are stable in vivo, penetrate the blood–brain barrier, and selectively engage D3R. We must also be able to readily scale up the synthesis of these molecules for behavioral studies in rodent and nonhuman primate models, the most translational of which require chronic dosing. Like other medicinal chemists, we have optimized lead compounds, using structure–activity relationships and, more recently, the D3R crystal structure, to design novel molecules. These efforts have led to the identification of several new lead molecules, including (±)-, <i>R</i>-, and <i>S</i>-<b>1</b>, <b>3</b>, and others including <b>17</b> (CJB090),<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a><b>18</b> (PG619),<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a><b>19</b> (GCC3-09),<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and <b>20</b> (BAK2-66),<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> to highlight a few (Chart <a class="ref internalNav" href="#cht3" aria-label="3">3</a>). These compounds have been evaluated in cell-based binding assays along with compounds reported in the literature to obtain side-by-side data comparisons across the D2-like family of receptors.</div><figure id="cht3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/medium/jm-2014-01512b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. Behaviorally Tested D3R-Preferential Ligands</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">3.1 Relative Binding Affinity and D2-Like Receptor Subtype Selectivity of Dopaminergic Compounds</h3><div class="NLM_p">The binding affinities of representative D2-like compounds, in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, were obtained from human D2Rs, D3Rs, and D4Rs expressed in HEK293 cells. Using membranes from these cells and the antagonist radioligand [<sup>3</sup>H]<i>N</i>-methylspiperone, direct comparisons can be made of these structurally divergent compounds under identical experimental conditions (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for methods).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. D2-Like Binding Affinity and Subtype Selectivity of Selected Ligands Using [<sup>3</sup>H]<i>N</i>-Methylspiperone</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center">D2R</th><th class="rowsep1 colsep0" align="center">D3R</th><th class="rowsep1 colsep0" align="center">D4R</th><th class="rowsep1 colsep0" colspan="2" align="center">subtype selectivity</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub>  ±  SEM (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub>  ±  SEM (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub>  ±  SEM (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">D2/D3</th><th class="colsep0 rowsep0" align="center">D4/D3</th><th class="colsep0 rowsep0" align="center" char=".">cLogP</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>N</i>-methylspiperone<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></td><td class="colsep0 rowsep0" align="left">0.133 ± 0.00885</td><td class="colsep0 rowsep0" align="left">0.265 ± 0.00752</td><td class="colsep0 rowsep0" align="left">0.461 ± 0.00789</td><td class="colsep0 rowsep0" align="left">0.50</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">eticlopride<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></td><td class="colsep0 rowsep0" align="left">0.0860 ± 0.000951</td><td class="colsep0 rowsep0" align="left">0.134 ± 0.00437</td><td class="colsep0 rowsep0" align="left">46.4 ± 6.94</td><td class="colsep0 rowsep0" align="left">0.64</td><td class="colsep0 rowsep0" align="left">346</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">raclopride<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></td><td class="colsep0 rowsep0" align="left">12.7 ± 1.21</td><td class="colsep0 rowsep0" align="left">13.4 ± 0.695</td><td class="colsep0 rowsep0" align="left">14 700 ± 357</td><td class="colsep0 rowsep0" align="left">0.95</td><td class="colsep0 rowsep0" align="left">1100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">butaclamol<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></td><td class="colsep0 rowsep0" align="left">2.58 ± 0.473</td><td class="colsep0 rowsep0" align="left">6.39 ± 0.584</td><td class="colsep0 rowsep0" align="left">229 ± 57.0</td><td class="colsep0 rowsep0" align="left">0.40</td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">aripiprazole</td><td class="colsep0 rowsep0" align="left">0.343 ± 0.0899</td><td class="colsep0 rowsep0" align="left">1.00 ± 0.0250</td><td class="colsep0 rowsep0" align="left">57.1 ± 16.2</td><td class="colsep0 rowsep0" align="left">0.34</td><td class="colsep0 rowsep0" align="left">57</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>1</b> (PG648)<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></td><td class="colsep0 rowsep0" align="left">746 ± 123</td><td class="colsep0 rowsep0" align="left">1.88 ± 0.112</td><td class="colsep0 rowsep0" align="left">2600 ± 660</td><td class="colsep0 rowsep0" align="left">397</td><td class="colsep0 rowsep0" align="left">1380</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>1</b><a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></td><td class="colsep0 rowsep0" align="left">295 ± 65.0</td><td class="colsep0 rowsep0" align="left">0.528 ± 0.0910</td><td class="colsep0 rowsep0" align="left">3980 ± 882</td><td class="colsep0 rowsep0" align="left">559</td><td class="colsep0 rowsep0" align="left">7540</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>1</b><a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></td><td class="colsep0 rowsep0" align="left">786 ± 160</td><td class="colsep0 rowsep0" align="left">3.89 ± 0.365</td><td class="colsep0 rowsep0" align="left">1900 ± 491</td><td class="colsep0 rowsep0" align="left">202</td><td class="colsep0 rowsep0" align="left">489</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b> (NGB2904)</td><td class="colsep0 rowsep0" align="left">54.7 ± 5.20</td><td class="colsep0 rowsep0" align="left">0.233 ± 0.0089</td><td class="colsep0 rowsep0" align="left">3670 ± 626</td><td class="colsep0 rowsep0" align="left">235</td><td class="colsep0 rowsep0" align="left">15 800</td><td class="colsep0 rowsep0" align="char" char=".">6.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b> (PG01037)</td><td class="colsep0 rowsep0" align="left">74.0 ± 16.6</td><td class="colsep0 rowsep0" align="left">0.316 ± 0.0284</td><td class="colsep0 rowsep0" align="left">550 ± 28.3</td><td class="colsep0 rowsep0" align="left">234</td><td class="colsep0 rowsep0" align="left">1740</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b> (GSK598,809)</td><td class="colsep0 rowsep0" align="left">2110 ± 485</td><td class="colsep0 rowsep0" align="left">3.15 ± 0.335</td><td class="colsep0 rowsep0" align="left">35 600 ± 8,880</td><td class="colsep0 rowsep0" align="left">670</td><td class="colsep0 rowsep0" align="left">11 300</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b> (PG619)<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></td><td class="colsep0 rowsep0" align="left">1090 ± 20.6</td><td class="colsep0 rowsep0" align="left">6.70 ± 0.768</td><td class="colsep0 rowsep0" align="left">4470 ± 993</td><td class="colsep0 rowsep0" align="left">163</td><td class="colsep0 rowsep0" align="left">667</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b> (GCC3-09)</td><td class="colsep0 rowsep0" align="left">217 ± 35.6</td><td class="colsep0 rowsep0" align="left">0.920 ± 0.102</td><td class="colsep0 rowsep0" align="left">2040 ± 677</td><td class="colsep0 rowsep0" align="left">236</td><td class="colsep0 rowsep0" align="left">2210</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b> (BAK2-66)<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></td><td class="colsep0 rowsep0" align="left">956 ± 273</td><td class="colsep0 rowsep0" align="left">10.3 ± 1.98</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">93</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">5.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b> (YQA14)</td><td class="colsep0 rowsep0" align="left">46.9 ± 7.36</td><td class="colsep0 rowsep0" align="left">3.04 ± 0.369</td><td class="colsep0 rowsep0" align="left">2370 ± 223</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">780</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub> values determined by competitive inhibition of [<sup>3</sup>H]<i>N</i>-methylpsiperone binding in membranes harvested from HEK 293 cells stably expressing hD2R, hD3R, or hD4R. Detailed methods have been described previously<a onclick="showRef(event, 'ref76 ref78'); return false;" href="javascript:void(0);" class="ref ref76 ref78">(76, 78)</a> and are in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. NT, not tested. References indicate previously published binding data using identical methods.</p></div></div></div><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> shows the experimentally derived binding dissociation constants (<i>K</i><sub>i</sub>) for a number of dopaminergic compounds with varying selectivities for D3R over D2R and D4R. Of note, <i>N</i>-methylspiperone, eticlopride, raclopride, and butaclamol are well-known D2-like antagonists, demonstrating high binding affinities across the D2-family of receptors, with the notable exceptions of butaclamol and especially raclopride at D4R. Aripiprazole is a clinically available D2-like partial agonist, marketed as Abilify, used in the treatment of schizophrenia and mood disorders. It binds with high affinity to both D2R and D3R and has been shown to decrease cocaine self-administration and attenuate reinstatement in laboratory animals.<a onclick="showRef(event, 'ref109 ref110 ref111 ref112'); return false;" href="javascript:void(0);" class="ref ref109 ref110 ref111 ref112">(109-112)</a> Although mixed results have emerged from human studies,<a onclick="showRef(event, 'ref98 ref99 ref113'); return false;" href="javascript:void(0);" class="ref ref98 ref99 ref113">(98, 99, 113)</a> a recent phase II study using chronic treatment with lower doses reported that aripiprazole decreased cocaine craving.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a></div><div class="NLM_p">Because identical binding conditions were used, the data presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> permit direct binding affinity comparisons across compound classes. Compound <b>7</b> was the most subtype-selective compound in this set, with 670-fold D3R selectivity over D2R. Notably, binding for <b>21</b> (YQA14) in this system did not show two-site binding kinetics at D3R as reported previously.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> The <i>K</i><sub>i</sub> determined in this analysis (3.04 nM) is consistent with the <i>K</i><sub>i-Low</sub> reported previously (2.11 nM); coupled with a higher D2R affinity in this analysis than in the previous report (46.9 vs 335 nM),<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> compound <b>21</b> appears to be only moderately preferential for D3R binding over D2R when compared to others in this class of D3R ligands and points to the limitations of using cell-based binding affinities to predict D3R selectivities and potencies in vivo. Nevertheless, radioligand binding is the first line of testing in most drug discovery programs and is useful as long as compounds are evaluated side-by side under the same assay conditions. As noted in our previous Perspective, cell-based functional assay data remain difficult to interpret from an SAR standpoint;<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> hence, binding data remain our primary source of SAR, despite these limitations.</div><div class="NLM_p">Compound <b>2</b> is one of the first D3R-selective antagonists to be reported<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> and has served as an important preclinical tool. Early reports demonstrated that <b>2</b> significantly lowered the break point in rats trained to self-administer cocaine under a progressive-ratio (PR) schedule of reinforcement.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> PR schedules require an increase in number of responses following injections of cocaine and the last ratio completed (the break point) is thought to be a measure of reinforcing strength.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Compound <b>2</b> also inhibited cocaine-induced enhancement of brain stimulation reward threshold while neither maintaining self-administration nor altering brain-reward thresholds on its own. In addition, <b>2</b> blocked both cue- and cocaine-induced reinstatement of cocaine seeking, a preclinical model of relapse.<a onclick="showRef(event, 'ref28 ref29 ref118'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref118">(28, 29, 118)</a> Compound <b>2</b>, along with <b>4</b> and <b>8</b>, was also evaluated in METH-enhanced brain stimulation reward in rats. Notably, the two antagonists (<b>2</b> and <b>4</b>) effectively attenuated METH-enhanced brain stimulation reward and did not affect brain stimulation reward on their own; the partial agonist <b>8</b> attenuated METH-enhanced brain stimulation reward, but a high dose inhibited brain stimulation reward itself.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Hence, <b>2</b>, along with <b>4</b> and <b>8</b>, demonstrated potential for this class of ligands to be developed toward medications to treat cocaine and METH abuse. Although none of these agents would be translated to the clinic, all of them served as templates for the design of new analogues. While <b>4</b> was the precursor to <b>7</b>,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a><b>2</b> served as the starting point from which our early lead compounds <b>3</b> and <b>17</b> were derived.<a onclick="showRef(event, 'ref25 ref108 ref120'); return false;" href="javascript:void(0);" class="ref ref25 ref108 ref120">(25, 108, 120)</a> Compound <b>17</b> was the first partial agonist in our series that was evaluated in nonhuman primates and compared to <b>2</b> in two models of cocaine abuse.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> Interestingly, <b>17</b>, but not <b>2</b>, attenuated cocaine’s discriminative stimulus effects and decreased both cocaine- and food-maintained responding in monkeys that were trained on a second-order schedule of reinforcement.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> However, in a separate study with squirrel monkeys, <b>17</b> failed to attenuate cocaine self-administration or cocaine-induced reinstatement of extinguished cocaine-seeking behavior.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> As elaborated by Achat-Mendes et al.,<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> there are several possible reasons for these discrepant results including the different schedule parameters, the different frequencies of cocaine injection per session (maximally 10 in the Achat-Mendes et al. study<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> and 2 in the Martelle et al. study<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a>), and the different species used (squirrel monkeys vs rhesus monkeys). Another possible explanation could be the cocaine history of the subjects, which has been shown to influence the behavioral effects of D3R compounds.<a onclick="showRef(event, 'ref123 ref124 ref125'); return false;" href="javascript:void(0);" class="ref ref123 ref124 ref125">(123-125)</a></div><div class="NLM_p">Both <b>17</b> and the structurally related but more D3R-selective antagonist <b>3</b> reduced PR METH self-administration in rats with a history of long access (6 h per day, 6 days per week) to METH.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a><b>17</b>, in contrast to <b>3</b>, also reduced PR METH self-administration in rats with a history of short-access to METH (1 h per day, 3 days per week).<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> It is unclear at this time whether or not differences in pharmacokinetics or pharmacodynamics can explain these subtle differences in efficacy across species and models, although pharmacokinetic and metabolism data suggested that <b>3</b>, like <b>2</b>, had suboptimal bioavailability.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Overall, coupled with many other reports in the literature of similar findings with compounds such as <b>4</b>, <b>7</b>, and newer generation analogues, these data supported further optimization and development of D3R-selective antagonists or partial agonists. Recent reports from the Neisewander lab highlight novel 4-phenylpiperazines, exemplified by <b>22</b> (Chart <a class="ref internalNav" href="#cht3" aria-label="3">3</a>), each varying in their subtype selectivity and degree of partial agonism at D3R, that reduce cocaine self-administration.<a onclick="showRef(event, 'ref128 ref129 ref130'); return false;" href="javascript:void(0);" class="ref ref128 ref129 ref130">(128-130)</a></div><div class="NLM_p">Compound <b>17</b> and a newer-generation partial agonist, <b>18</b>,<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> exhibited interesting effects in rhesus monkeys with a history of cocaine self-administration in comparison to their drug-naïve counterparts.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> As part of our efforts to identify D3R-based behaviors in vivo, a model of D3R-induced yawning in rats<a onclick="showRef(event, 'ref131 ref132'); return false;" href="javascript:void(0);" class="ref ref131 ref132">(131, 132)</a> was modified, in which yawning could be produced in rhesus monkeys upon administration of the D3/D2R agonist quinpirole. In cocaine-naïve animals, quinpirole induces robust yawning, but the partial agonists <b>17</b> and <b>18</b> failed to do so.<a onclick="showRef(event, 'ref121 ref123'); return false;" href="javascript:void(0);" class="ref ref121 ref123">(121, 123)</a> However, in monkeys with a history of cocaine self-administration, both <b>17</b> and <b>18</b> induced yawning similar in magnitude to quinpirole.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> We reasoned that increased sensitivity to yawning might occur in the monkeys with a cocaine history, as increases in D3R densities had been reported in both human cocaine fatalities<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> as well as in cocaine-exposed rodents.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Nevertheless, in that study, <b>18</b> was unable to attenuate cocaine self-administration under a fixed-ratio (FR) 30 schedule of reinforcement. Unlike quinpirole, however, <b>18</b> did not reinstate cocaine seeking in these monkeys but rather attenuated cocaine-induced reinstatement.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a></div><div class="NLM_p">In an effort to continue to optimize D3R affinity, selectivity, and bioavailability, modifications of these lead molecules have led to newer generation compounds such as <b>19</b> and <b>1</b> (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Both of these compounds have high affinity (<i>K</i><sub>i</sub> 1–2 nM) for D3R and are highly selective over D2R and other off-target receptors.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Of note, (±)-<b>1</b> was evaluated in 64 radioligand/enzyme assays through the NIDA Addiction Treatment Discovery Program. Other than the reported binding affinities at D1R (<i>K</i><sub>i</sub> = 4630 nM) and 5-HT<sub>1A</sub> receptors (<i>K</i><sub>i</sub> = 104 nM),<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> (±)-<b>1</b> did not produce >50% inhibition of binding at any of the receptors evaluated at a concentration of 100 nM and only “hit” a few at 10 μM [e.g., α1 adrenergic, α2 adrenergic, histamine H1, sodium channel site 2, cholecystokinin 1 (CCK1), and neurokinin 2 (NK2)]. In addition, the IC<sub>50</sub> for (<i>R</i>)-<b>1</b> at the hERG channel was 0.38 μM, as determined using the PatchXpress assay<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> through the NIMH Psychoactive Drug Screening Program (PDSP; <a href="http://pdsp.med.unc.edu" class="extLink">http://pdsp.med.unc.edu</a>). Considering its <i>K</i><sub>i</sub> at D3R is ∼2 nM, (±)-<b>1</b> was considered to be highly selective for the D3R, and, despite its marginally acceptable cLogP value of 4.8, we chose it as our lead candidate for further development.</div><div class="NLM_p last">The addition of a 3-OH group in the linking chain of these molecules creates a chiral center; therefore, we synthesized the <i>R</i>- and <i>S</i>-enantiomers of <b>1</b>. In radioligand binding competition studies, we observed a small but significant enantioselectivity at D3R, but not at D2R, with the <i>R</i>-enantiomer having higher D3R affinity.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> From a structural point of view, this was significant and gave insight on differential binding interactions at the receptor protein level that were further explored.<a onclick="showRef(event, 'ref5 ref27'); return false;" href="javascript:void(0);" class="ref ref5 ref27">(5, 27)</a> To determine if behavioral effects were also enantioselective, we improved the enantioselective synthesis,<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> evaluated the microsomal metabolism and pharmacokinetics of the racemate, and then tested the racemate and the <i>R</i>- and <i>S</i>-enantiomers in behavioral models of cocaine and METH abuse.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">3.2 Further Development of Lead Compound <b>1</b></h3><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13">3.2.1 Pharmacokinetics and Metabolism Studies of (±)-<b>1</b> in Mice</h4><div class="NLM_p">Pharmacokinetic and metabolism studies were performed in mice. The plasma concentration–time profile of (±)-<b>1</b> after i.v. and p.o. dosing of 10 mg/kg is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. A summary of the plasma pharmacokinetic parameters is listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. Absorption for oral (±)-<b>1</b> was slightly delayed, peaking 2 h after administration. The peak plasma concentration (<i>C</i><sub>max</sub>) for (±)-<b>1</b> was 7369 ng/mL following i.v. dosing compared to 522 ng/mL following p.o. dosing; comparing oral versus intravenous AUC parameters gives a low/moderate average absolute bioavailability fraction (F%) of 16.2%. The plasma half-life (<i>t</i><sub>1/2</sub>) of i.v. (±)-<b>1</b> was approximately 75 min. (±)-<b>1</b> showed excellent brain penetrability following both p.o. and i.v. dosing, as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. The brain-to-plasma ratio ranged from 6- to 20-fold for (±)-<b>1</b>.</div><div class="NLM_p">We investigated the metabolism of (±)-<b>1</b>, and these data are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. (±)-<b>1</b> was found to be very stable in mouse plasma over a period of 60 min, with 90% of the parent compound remaining. (±)-<b>1</b> was, however, susceptible to phase I and phase II hepatic metabolism. In mouse liver microsomal incubations in the presence of NADPH, which measures phase I metabolism, 21% of the parent (±)-<b>1</b> remained after 60 min. Notably, microsomal stability in rats was increased to 37% of the parent (±)-<b>1</b> remaining after 60 min, under the same assay conditions, suggesting higher stability in this species. In mouse microsomes fortified with UDPGA, which measures phase II metabolism, 55% of the parent (±)-<b>1</b> remained after 60 min of incubation. No metabolism was observed in microsomes without the cofactors, showing their specificity to CYP- and UGT-dependent instability, respectively.</div><figure id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/medium/jm-2014-01512b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Concentration profiles for 10 mg/kg (±)-<b>1</b> in mouse plasma following i.v. (○) or p.o. (■) administration. Data are presented as mean ± SEM; <i>n</i> = 3 mice per time point.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Noncompartmental PK Parameters for 10 mg/kg (±)-<b>1</b> in Mouse Plasma Following i.v. or p.o. Administration</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" rowspan="2" align="center"> </th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">AUC<sub>last</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">(AUC<sub>inf</sub>)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>e</sub></th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">F%</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">(ng/mL)</th><th class="colsep0 rowsep0" align="center">(h)</th><th class="colsep0 rowsep0" align="center">(h·ng/mL)</th><th class="colsep0 rowsep0" align="center">(h·μg/mL)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">(h)</th><th class="colsep0 rowsep0" align="center"> </th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma (i.v.)</td><td class="colsep0 rowsep0" align="left">7369</td><td class="colsep0 rowsep0" align="left">0.08</td><td class="colsep0 rowsep0" align="left">7971</td><td class="colsep0 rowsep0" align="left">8895</td><td class="colsep0 rowsep0" align="left">0.55</td><td class="colsep0 rowsep0" align="left">1.241</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma (p.o.)</td><td class="colsep0 rowsep0" align="left">522</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">1299</td><td class="colsep0 rowsep0" align="left">NC<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NC<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">NC<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">16.2%</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Data are presented as mean; <i>n</i> = 3 mice per time point.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">NC, not calculated.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Brain Concentrations of (±)-<b>1</b> in Mouse Following i.v. or p.o. Dosing at 10 mg/kg</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="3" align="center">(±)-<b>1</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">time (h)</th><th class="colsep0 rowsep0" align="center">i.v. conc. ng/g (SD)</th><th class="colsep0 rowsep0" align="center">p.o. conc. ng/g (SD)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">28 928 (3716)</td><td class="colsep0 rowsep0" align="left">2979 (893)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">17 798 (3292)</td><td class="colsep0 rowsep0" align="left">9231 (3478)</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Metabolic Stability Results for (±)-<b>1</b> in Mouse Plasma and Liver Microsomes Compared to Positive Control Compounds Procaine (Plasma), Testosterone (Phase I), and 4-Methyl Umbelliferone (Phase II)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="5" align="center">(±)-<b>1</b></th><th class="rowsep1 colsep0" colspan="3" align="center">positive control compounds</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">time</th><th class="colsep0 rowsep0" align="center">plasma</th><th class="colsep0 rowsep0" align="center">phase I</th><th class="colsep0 rowsep0" align="center">phase II</th><th class="colsep0 rowsep0" align="center">negative control</th><th class="colsep0 rowsep0" align="center">procaine</th><th class="colsep0 rowsep0" align="center">testosterone</th><th class="colsep0 rowsep0" align="center">4-methyl umbelliferone</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">100%</td><td class="colsep0 rowsep0" align="left">100%</td><td class="colsep0 rowsep0" align="left">100%</td><td class="colsep0 rowsep0" align="left">100%</td><td class="colsep0 rowsep0" align="left">100%</td><td class="colsep0 rowsep0" align="left">100%</td><td class="colsep0 rowsep0" align="left">100%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">108%</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">97%</td><td class="colsep0 rowsep0" align="left">108%</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">103%</td><td class="colsep0 rowsep0" align="left">34%</td><td class="colsep0 rowsep0" align="left">64%</td><td class="colsep0 rowsep0" align="left">103%</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">90%</td><td class="colsep0 rowsep0" align="left">21%</td><td class="colsep0 rowsep0" align="left">55%</td><td class="colsep0 rowsep0" align="left">90%</td><td class="colsep0 rowsep0" align="left">9.70%</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">3.10%</td></tr></tbody></table></div></div></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17">3.2.2 Effects of i.p. (±)-, (<i>R</i>)-, and (<i>S</i>)-<b>1</b> on PR Responding for METH in Rats</h4><div class="NLM_p">Concurrent with the pharmacokinetic studies described above, (±)-, (<i>R</i>)-, and (<i>S</i>)-<b>1</b> were evaluated in a rat yawning model<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> to verify target engagement and determine an effective dose range for further behavioral evaluation. Although mouse yawning studies were initially attempted, it was discovered that D3R agonists do not induce yawning in mice, so that approach was abandoned. (±)-, (<i>R</i>)-, and (<i>S</i>)-<b>1</b> each attenuated 7-OH DPAT-induced yawning in rats, as demonstrated by a rightward shift in the ascending limb of the dose–response curve; however, no clear evidence of enantioselectivity was observed (J.L. Katz and A.H. Newman, unpublished results). Further, this model proved to be difficult to use as an in vivo screen for numerous reasons, including tolerance to the D3R-agonist effect on yawning and significant variation across subjects. It also required a large quantity of test drug to obtain full dose–response curves. Hence, we discontinued testing compounds in the rat yawning model as an in vivo diagnostic and instead used binding affinities as a guide to dose ranges evaluated in the subsequent rodent studies.</div><div class="NLM_p">Using methods described previously,<a onclick="showRef(event, 'ref135 ref136'); return false;" href="javascript:void(0);" class="ref ref135 ref136">(135, 136)</a><b>1</b> was evaluated for its effects in two rat models of drug-taking and drug-seeking behavior. Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A shows METH self-administration in rats responding under a PR schedule of reinforcement, comparing baseline performance against pretreatments with vehicle or the enantiomers of <b>1</b>; Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B presents these data normalized to each individual animal’s baseline performance. Separate one-way repeated-measures ANOVAs were conducted on number of injections, which represents PR break points (i.e., the final ratio completed). Compound <b>1</b> significantly and dose-dependently reduced METH injections [(±)-<b>1</b>: <i>F</i><sub>2,18</sub>: 19.36, <i>p</i> < 0.0001, Dunnett’s test: vehicle vs 3.0 mg/kg <i>p</i> > 0.05, vehicle vs 10 mg/kg <i>p</i> < 0.001; (<i>R</i>)-<b>1</b>: <i>F</i><sub>2,18</sub>: 11.15, <i>p</i> < 0.001, Dunnett’s test: vehicle vs 3.0 mg/kg <i>p</i> < 0.01, vehicle vs 10 mg/kg <i>p</i> < 0.01; (<i>S</i>)-<b>1</b>: <i>F</i><sub>2,18</sub>: 15.19, <i>p</i> < 0.0001, Dunnett’s test: vehicle vs 3.0 mg/kg <i>p</i> > 0.05, vehicle vs 10 mg/kg <i>p</i> < 0.001]. Similarly, one-way repeated-measures ANOVA revealed that <b>1</b> significantly reduced PR break points when normalized to baseline responding [(±)-<b>1</b>: <i>F</i><sub>2,18</sub>: 16.67, <i>p</i> < 0.001, Dunnett’s test: vehicle vs 3.0 mg/kg <i>p</i> > 0.05, vehicle vs 10 mg/kg <i>p</i> < 0.001; (<i>R</i>)-<b>1</b>: <i>F</i><sub>2,18</sub>: 13.16, <i>p</i> = 0.003, Dunnett’s test: vehicle vs 3.0 mg/kg <i>p</i> < 0.001, vehicle vs 10 mg/kg <i>p</i> < 0.001; (<i>S</i>)-<b>1</b>: <i>F</i><sub>2,18</sub>: 25.16, <i>p</i> < 0.001, Dunnett’s test: vehicle vs 3.0 mg/kg <i>p</i> < 0.01, vehicle vs 10 mg/kg <i>p</i> < 0.001]. Although (<i>R</i>)-<b>1</b> and (<i>S</i>)-<b>1</b> vary in their in vitro affinity and selectivity for D3R (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), the doses studied did not indicate a clear differential in vivo potency between enantiomers. Hence, only (±)-<b>1</b> was tested further.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/medium/jm-2014-01512b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effects of i.p. vehicle or <b>1</b> (racemic and enantiomers) on PR self-administration of METH. Data are presented as mean ± SEM; * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001. Statistics in panel A refer to number of METH injections (right axis) compared to vehicle; statistics in panel B refer to break point values (last ratio completed), normalized to baseline responding, compared to vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">PR drug self-administration paradigms are often used to evaluate the reinforcing efficacy of drugs of abuse.<a onclick="showRef(event, 'ref137 ref138 ref139'); return false;" href="javascript:void(0);" class="ref ref137 ref138 ref139">(137-139)</a> Because the response requirement to receive the next injection increases continuously, the break point (the last completed ratio) becomes a repeatable measure of the relative reinforcing value of a particular commodity (including drug dose). The PR procedure has been used in a variety of human research efforts, including some clinical populations, but has not been well-evaluated in measuring the therapeutic outcomes of pharmacological interventions in applied settings.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> However, recent findings that intranasal cocaine or intravenous opioids are effective reinforcers under PR schedules in humans<a onclick="showRef(event, 'ref141 ref142 ref143'); return false;" href="javascript:void(0);" class="ref ref141 ref142 ref143">(141-143)</a> suggest potential future translational utility in measuring the therapeutic efficacy of novel antiaddiction medications. Consistent with the results of other D3R antagonists, <b>1</b> effectively reduced the number of METH injections and the break points of treated rats. These findings suggest that <b>1</b> lowered the reinforcing efficacy of METH, providing further evidence that D3R signaling contributes to the rewarding value of psychostimulant drugs.</div></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18">3.2.3 Effects of i.p. (±)-<b>1</b> on Drug-Primed Reinstatement Responding for METH in Rats</h4><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A illustrates the acquisition and extinction of METH self-administration. Acquisition of self-administration began with a high dose (0.1 mg/kg/inj) of METH using an FR 1 schedule of reinforcement over five daily training sessions, followed by seven daily training sessions with a lower dose (0.05 mg/kg/inj) using an FR 2 schedule. This format allowed rapid acquisition of drug taking with robust levels of lever pressing. Following seven daily extinction-training sessions, in which lever presses resulted in no drug delivery or cue presentation, the effect of (±)-<b>1</b> on METH-primed reinstatement was tested (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B). One-way ANOVA revealed that (±)-<b>1</b> significantly reduced METH-primed reinstatement responding on the active lever [<i>F</i><sub>2,31</sub>: 3.817, <i>p</i> = 0.033, Dunnett’s test: vehicle vs 3.0 mg/kg <i>p</i> > 0.05, vehicle vs 10 mg/kg <i>p</i> < 0.05] but did not significantly alter inactive lever responding [<i>F</i><sub>2,31</sub>: 2.12, <i>p</i> > 0.13, Dunnett’s test: vehicle vs 3.0 mg/kg <i>p</i> > 0.05, vehicle vs 10 mg/kg <i>p</i> > 0.05].</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/medium/jm-2014-01512b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Acquisition of METH self-administration and extinction of self-administration. (B) Effects of i.p. vehicle or (±)-<b>1</b> on METH-primed reinstatement of METH-seeking behavior. Data are presented as mean ± SEM; * <i>p</i> < 0.05 compared to vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Reinstatement of drug-seeking behavior, via stressors, drug-associated cues or contexts, or acute exposure to the self-administered drug or related drugs, is a widely used model of drug craving and relapse (for review, see refs <a onclick="showRef(event, 'ref144 ref145 ref146'); return false;" href="javascript:void(0);" class="ref ref144 ref145 ref146">144−146</a>; see also ref <a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">147</a>). As with previous D3R-selective antagonists and partial agonists (e.g., <b>2</b>,<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a><b>3</b>,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and <b>4</b><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a>), (±)-<b>1</b> showed a dose-dependent reduction in METH-primed reinstatement responding. These results add to the growing evidence that D3R signaling plays an important role in the neurocircuitry that drives relapse to drug taking and that D3R-selective compounds could be useful therapeutics in the prevention of relapse. However, it should be noted here that assessing a medication that may prevent relapse requires that the subject abstain from drug taking for a period of time. If the D3R antagonists do not curb drug taking, then abstinence may be very difficult to achieve and hence clinical assessment for this therapeutic benefit will be challenging. It has been proposed that a “Rosetta Stone approach” be taken to developing drugs for addiction, wherein the addiction cycle is taken into account for a pharmacological strategy.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> In the case of D3R antagonists, additional treatment strategies may need to be in place to help subjects attain abstinence before administering D3R-selective therapeutics to prevent relapse.</div></div><div id="sec3_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19">3.2.4 Effects of Acute Intravenous (±)-<b>1</b> on Food–Cocaine Choice in Cynomolgus Monkeys</h4><div class="NLM_p">In addition to the rodent model studies, male cynomolgus monkeys were trained to self-administer cocaine under a concurrent schedule in which food was the alternative reinforcer. Under these experimental conditions, complete cocaine self-administration dose–response curves were determined each session (see ref <a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">112</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for methods). As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, in all but one monkey, (±)-<b>1</b> either shifted the cocaine choice curve to the left (4 subjects) or had no effect (2 subjects). In one monkey (C-6529), a decrease in choice of the highest cocaine dose was observed. When group data were analyzed, there was a main effect of cocaine dose (<i>F</i><sub>4,30</sub> = 81.8, <i>p</i> < 0.0001) but no main effect of drug pretreatment and no interaction. Posthoc multiple comparisons indicated a significant increase in cocaine choice when 0.01 mg/kg cocaine was available as the alternative to food. There were no significant effects of the highest dose tested (5.6 mg/kg) (±)-<b>1</b> on any of the dependent variables of secondary interest (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).</div><div class="NLM_p">Although (±)-<b>1</b> failed to reduce cocaine choice and increase food choice, which would be a result more congruent with a potential therapeutic, there are several testable hypotheses generated from these results. Both concurrent food–drug choice and PR responding are considered to be models of reinforcing strength.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> However, the effects of <b>1</b> are different in these two models, suggesting that they are measuring different aspects of self-administration (see ref <a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">150</a> for an example). One could hypothesize that drugs that share discriminative stimulus effects with cocaine would shift the cocaine choice dose–response curve to the left, as seen with <b>1</b>. However, in preliminary findings from monkeys trained to discriminate cocaine, <b>1</b> does not substitute for cocaine (M.A. Nader and A.H. Newman, unpublished results). Several investigators have shown that D2/D3R antagonists can shift the cocaine choice dose–response curve to the left (e.g., refs <a onclick="showRef(event, 'ref112 ref151 ref152'); return false;" href="javascript:void(0);" class="ref ref112 ref151 ref152">112, 151, and 152</a>). It is also possible that the differences noted are due to drug and/or species differences (see ref <a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">153</a>) or to differences in drug histories between the rat PR study and the monkey food–cocaine choice study. On the basis of our experience and the literature, D3R antagonists are most effective in models of relapse, and perhaps this is the clinical end point that should be singly targeted with this class of drugs. Nevertheless, from a basic research standpoint, additional behavioral models of addiction must be explored to fully elucidate the role of D3R in the development of addiction. Further, as described previously, neurobiological changes that occur upon chronic exposure to psychostimulant drugs and also during abstinence must also be quantified to better ascertain optimal timing of administration of D3R antagonists or partial agonists for potential therapeutic benefit. One obvious limitation to the present study is that 5.6 mg/kg was the highest dose that could be solubilized and administered intravenously to these subjects. It is certainly possible that the level of D3R occupancy required to observe behavioral effects was not achieved or sustained and future D3R occupancy determination, potentially using PET imaging or another biomarker, will need to be assessed.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/medium/jm-2014-01512b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of i.v. vehicle or (±)-<b>1</b> on cocaine choice in seven monkeys individually and as a group (lower right panel). Ordinates, percent of total reinforcers earned that resulted in cocaine injections. Abscissae, dose of cocaine (mg/kg) available as an alternative to a food pellet. Data in lower right panel represent mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20">3.2.5 Effects of Acute or Repeated Intravenous (±)-<b>1</b> on Food–METH Choice in Rhesus Monkeys</h4><div class="NLM_p">In order to more fully model the clinical situation in which chronic drug treatments are likely to be employed, a follow-up study was conducted in rhesus monkeys that self-administered METH in which (±)-<b>1</b> was administered for 5 consecutive days. In two of three monkeys, 5 day treatment with 3.0 mg/kg (±)-<b>1</b> (i.v.) produced a leftward shift of the METH choice curve (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Effects of acute treatment had a more pronounced effect in one monkey (R-1690), suggesting tolerance developed in this subject. When grouped data were analyzed, there were no statistically significant effects of 3.0 mg/kg (±)-<b>1</b> on any of the dependent variables of secondary interest (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). In addition to the possibility of suboptimal D3R occupancy, pharmacokinetic studies were conducted only in mice. Clearly, the pharmacokinetics and metabolism of <b>1</b> in monkeys may differ. These experimental sessions are approximately 2 h in duration, and drug self-administration doses are presented in ascending order. If the half-life of <b>1</b> is short in monkeys, then it is possible that there is insufficient drug blocking D3Rs later in the session when higher cocaine doses are available.</div><div class="NLM_p">An additional possibility is that the elevated DA from cocaine or METH is displacing <b>1</b> and that D3R antagonists are less effective in models of self-administration compared to reinstatement models or under conditions in which treatment occurs in the absence of psychostimulant availability. Indeed, a PET imaging study in rhesus monkeys with [<sup>18</sup>F]LS-3-134 suggested a high level of competition between this D3R-selective PET imaging agent and endogenous dopamine in the absence of a psychostimulant drugs.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> Thus, in the presence of psychostimulants, competing DA levels may render D3R antagonists ineffective. Future research is clearly needed to better understand the conditions under which D3R-selective compounds are effective in nonhuman primate models of psychostimulant addiction and which of these models is reliably translatable to human psychostimulant abusers.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/medium/jm-2014-01512b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of acute and chronic administration of (±)-<b>1</b> (i.v.) on METH choice in three rhesus monkeys (mean ± SEM of days 3–5 of daily treatment). Ordinates, percent of total reinforcers earned that resulted in METH injections. Abscissae, dose of METH (mg/kg) available as an alternative to a food pellet.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Secondary Dependent Variables in Food–Drug Choice Studies after Administration of Vehicle or (±)<b>1</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="3" align="center">cynomolgus monkeys</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±">vehicle</th><th class="colsep0 rowsep0" align="center" char="±">5.6 mg/kg (±)-<b>1</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">food reinforcers</td><td class="colsep0 rowsep0" align="char" char="±">30.0 ± 1.9</td><td class="colsep0 rowsep0" align="char" char="±">25.5 ± 2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cocaine injections</td><td class="colsep0 rowsep0" align="char" char="±">13.4 ± 1.3</td><td class="colsep0 rowsep0" align="char" char="±">15.5 ± 2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">total reinforcers</td><td class="colsep0 rowsep0" align="char" char="±">43.4 ± 2.0</td><td class="colsep0 rowsep0" align="char" char="±">40.3 ± 1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">intake (mg/kg)</td><td class="colsep0 rowsep0" align="char" char="±">0.77 ± 0.11</td><td class="colsep0 rowsep0" align="char" char="±">0.63 ± 0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">choice ED<sub>50</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.023 ± 0.006</td><td class="colsep0 rowsep0" align="char" char="±">0.012 ± 0.002</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="3" align="center">rhesus monkeys</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±">baseline</th><th class="colsep0 rowsep0" align="center" char="±">3.0 mg/kg (±)-<b>1</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">food reinforcers</td><td class="colsep0 rowsep0" align="char" char="±">19.9 ± 2.3</td><td class="colsep0 rowsep0" align="char" char="±">14.4 ± 2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">METH injections</td><td class="colsep0 rowsep0" align="char" char="±">14.8 ± 2.8</td><td class="colsep0 rowsep0" align="char" char="±">15.2 ± 1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">total reinforcers</td><td class="colsep0 rowsep0" align="char" char="±">34.7 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">29.7 ± 4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">intake (mg/kg)</td><td class="colsep0 rowsep0" align="char" char="±">1.08 ± 0.11</td><td class="colsep0 rowsep0" align="char" char="±">1.08 ± 0.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">choice ED<sub>50</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.024 ± 0.011</td><td class="colsep0 rowsep0" align="char" char="±">0.011 ± 0.003</td></tr></tbody></table></div></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">4 Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76681" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76681" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In radioligand competition binding experiments using [<sup>3</sup>H]<i>N</i>-methylspiperone and membranes from HEK293 cells expressing hD2R, hD3R, or hD4R, (±)-<b>1</b> exhibits nearly 400- and 1300-fold D3R selectivity over D2R and D4R, respectively. This is more pronounced when considering the enantioselectivity of D3R for the <i>R</i>-enantiomer.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The in vitro D3R selectivity of <b>1</b>, particularly (<i>R</i>)-<b>1</b>, was an improvement over previous generations of 2,3-dichlorophenylpiperazinebutylarylcarboxamides (e.g., <b>3</b>).<a onclick="showRef(event, 'ref25 ref75'); return false;" href="javascript:void(0);" class="ref ref25 ref75">(-25, 75)</a> As such, <b>1</b> and its enantiomers were some of the most D3R-selective ligands in our library and thus the tools we chose to test in vivo.</div><div class="NLM_p">To evaluate the in vivo stability of <b>1</b>, plasma pharmacokinetics (PK) was studied in mice, revealing plasma stability 0–1.5 h following i.v. administration of <b>1</b>. Additionally, <b>1</b> was orally bioavailable with good brain penetration. Compound <b>1</b> was actively metabolized by liver microsomes, but it showed a terminal half-life of approximately 1–1.5 h following i.v. administration. It should be noted that metabolism and PK studies were done in mice and thus these parameters may be different across species. Clearly, PK studies need to be extended to nonhuman primates and brain imaging needs to be utilized to study pharmacodynamics of these compounds entering the brain and occupying D3R. Nevertheless, these pharmacokinetic parameters appeared to be promising for a translational candidate, justifying further exploration in both rat and nonhuman primate models of drug addiction.</div><div class="NLM_p">Previous studies have demonstrated a trend in which D3R antagonists and partial agonists typically do not affect psychostimulant self-administration with low FR response requirements but attenuate drug taking in paradigms that increase the response requirement (e.g., high FR or PR models) or second-order schedules,<a onclick="showRef(event, 'ref29 ref30 ref31 ref126 ref155 ref156 ref157'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31 ref126 ref155 ref156 ref157">(29-31, 126, 155-157)</a> suggesting that D3R antagonism does not affect the primary reinforcing effects of drugs but reduces the motivation to self-administer drugs.<a onclick="showRef(event, 'ref48 ref158'); return false;" href="javascript:void(0);" class="ref ref48 ref158">(48, 158)</a> Consistent with that view is the success of D3R antagonists in rodent models of relapse, such as drug-, cue- and stress-induced reinstatement.<a onclick="showRef(event, 'ref28 ref29 ref30 ref31 ref157 ref159'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30 ref31 ref157 ref159">(28-31, 157, 159)</a> Compound <b>1</b> significantly reduced PR responding for METH, as measured by break point. There was no clear difference in potency seen between the (<i>R</i>)- and (<i>S</i>)-enantiomers; however, this study did not test a sufficient range of doses to reliably determine whether one enantiomer was more potent than the other in reducing PR break point in rats. Racemic <b>1</b> significantly attenuated METH-primed reinstatement as well. Overall, (±)-<b>1</b> (3.0–10 mg/kg, i.p.) was efficacious in two rat models of drug self-administration and drug seeking (i.e., reinstatement).</div><div class="NLM_p">In the food–cocaine choice model, cynomolgus monkeys were allowed to choose either a food reward or an i.v. cocaine infusion, with the cocaine dose varied across trials. Overall, <b>1</b> had inconsistent effects; when all data were combined, the general effect that emerged was that <b>1</b> shifted the dose–response curve of cocaine to the left, i.e., it potentiated cocaine choice over food. In the food–METH choice model using rhesus monkeys, the result was similar: <b>1</b> tended to shift the METH dose–response to the left or have no effect. One subject (R-1691) appeared to develop tolerance to the effect of <b>1</b>. The results of these studies may not appear to support further investigation. However, it must be noted that the food–drug choice model is not directed toward relapse, which the rodent studies with <b>1</b> and other D3R antagonists most support. Further evaluation of <b>1</b> and newer generation D3R antagonists and partial agonists are underway in nonhuman primate reinstatement to drug seeking models to determine if the rodent studies can be replicated with these agents in primates with a history of chronic drug taking. Chronic dosing with the treatment agent can also be evaluated in the nonhuman primates, which will also inform human studies.</div><div class="NLM_p last">In contrast to D3R antagonists such as (±)-<b>1</b> and <b>7</b>, D3R partial agonists pose several interesting questions. For example, it is known that chronic administration of receptor agonists commonly results in receptor downregulation, whereas chronic administration of receptor antagonists commonly results in receptor upregulation. With regard to partial agonists, a recent PET imaging study in cynomolgus monkeys found that chronic aripiprazole, a D2R partial agonist, produced different effects on D2R binding potential: it appeared to increase binding when the subject had, on average, low D2R availability and decreased binding potential in monkeys with higher average D2R availability.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> Thus, depending on the long-term consequences of cocaine or METH abuse on receptor availability, the effects of receptor partial agonists may be different than antagonists. There are behavioral nuances as well. Recently, it was reported that the effects of aripiprazole on cocaine–food choice varied depending on whether monkeys were given access to cocaine during aripiprazole treatment.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Thus, it remains possible that in nonhuman primates and humans D3R partial agonists would be more effective in a setting in which cocaine or METH were not available (e.g., residential treatment facility), at least in the early stages of treatment. Finally, there are ongoing studies to evaluate the effects of antagonists and partial agonists on peripheral D3Rs, particularly in regard to potential synergistic effects in combination with cocaine- and METH-induced elevations in heart rate and blood pressure, a key treatment risk that must be thoroughly evaluated and thoughtfully considered when describing potential treatment compounds.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">5 Overall Conclusions and Our Perspective</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71063" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71063" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The D3R remains an enigmatic target for addiction pharmacotherapy. The translation between rodent and nonhuman primate addiction models and again between nonhuman primate addiction models and humans in a clinical setting is fraught with pitfalls. Predecessors of <b>1</b> and <b>7</b> have failed to successfully clear the hurdles that lead to successful clinical trials. The partial agonist <b>8</b> was efficacious in rodent and primate models of addiction, but it failed in clinical trials for cocaine abuse.<a onclick="showRef(event, 'ref118 ref161 ref162'); return false;" href="javascript:void(0);" class="ref ref118 ref161 ref162">(118, 161, 162)</a> Compound <b>4</b> looked promising in rodent models of drug taking and drug seeking, but poor bioavailability and short half-life in primates led GlaxoSmithKline to halt further development of the compound.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> The recent failure of buspirone, as described above, may also bode poorly for continuing to pursue this target.</div><div class="NLM_p">Compound <b>1</b> will likely remain a research tool for basic and preclinical studies. Its inconsistent behavioral profile in nonhuman primates thus far may be directly related to a poor pharmacokinetic profile, lack of target engagement at the doses and time points tested, or simply lack of efficacy in these models. Future studies to parse out the contributing factors to its demise, before reaching the clinic, will be used for the next generation of drug design and choice of behavioral models. Nevertheless, newer generation agents in our laboratory and others are already making their way forward in development and will soon be evaluated in these and other models of drug abuse and neuropsychiatric disorders. Only continued drug design using structure–activity relationships and in vivo data will ultimately lead us to successfully identify D3R-selective compounds that have appropriate drug-like properties. So far, this goal remains to be achieved.</div><div class="NLM_p">A key concern in the field of addiction medicine and indeed all neuropsychiatric drug discovery is the effectiveness of animal models to evaluate preclinical candidates.<a onclick="showRef(event, 'ref163 ref164'); return false;" href="javascript:void(0);" class="ref ref163 ref164">(163, 164)</a> In one of the first studies using D3R partial agonists, it was reported that the effects of <b>8</b> were different in models of drug seeking compared to drug self-administration.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> The study of D3R compounds has provided a better understanding of the importance of models that incorporate long-term cocaine and METH self-administration and a clearer perception of the importance of behavioral phenotype. For example, it appears that the behavioral pharmacology of D3R partial agonists are different depending on whether the subjects are drug-naïve or have a drug history<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> and, for D3R agonists, whether the drug is cocaine or METH.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Moreover, individual differences in the efficacy of D3R antagonists to reduce drug self-administration have been found involving acute vs chronic treatment,<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> drug history,<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> and social rank.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> These findings are reflected in human imaging studies involving the D3R-preferential PET ligand [<sup>11</sup>C]PHNO<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> in cocaine and METH abusers.<a onclick="showRef(event, 'ref42 ref43 ref44 ref167'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44 ref167">(42-44, 167)</a></div><div class="NLM_p">There are important temporal differences in psychostimulant-induced D3R dysregulation that should be taken into account for the D3R’s therapeutic potential. For instance, studies designed to examine the time course of changes in D3R binding and sensitivity observe D3R upregulation after prolonged abstinence (30–45 days after the last cocaine administration) but not during self-administration or within 7 days of abstinence.<a onclick="showRef(event, 'ref133 ref168 ref169'); return false;" href="javascript:void(0);" class="ref ref133 ref168 ref169">(133, 168, 169)</a> Furthermore, the subjects in some of the recent human imaging studies demonstrating D3R upregulation following chronic cocaine or METH use were scanned on average 18.5 ± 20.5<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and 50.1 ± 64.4<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> days, respectively, after their most recent drug use, which appear to reflect substantial periods of abstinence. Therefore, although it is clear that D3R expression is significantly altered in drug abusers, perhaps there is a specific window of time in the addiction cycle in which the therapeutic potential of D3R antagonists and partial agonists could be maximally beneficial.</div><div class="NLM_p">The difficulties of treating drug addiction are compounded by the high incidence of comorbid neuropsychiatric disorders with substance use disorders, including depression, anxiety, ADHD, and schizophrenia.<a onclick="showRef(event, 'ref170 ref171 ref172 ref173'); return false;" href="javascript:void(0);" class="ref ref170 ref171 ref172 ref173">(170-173)</a> Further complicating the search for translational medications for addiction is the complexity of D3R receptor signaling and genetics. There is not yet a clear understanding of the role of D1R–D3R heteromers in the striatum or whether receptor heteromers are a viable target for drug development. We have recently speculated on the possible role of the D1R–D3R heteromer in drug memory reconsolidation, and future studies in this area are of great interest.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> Additionally, there are a number of studies linking various D3R gene polymorphisms with neuropsychiatric disorders. In particular, rs6280, which encodes the functional missense mutation Ser9Gly, may enhance reward-related DA release.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> This particular polymorphism has been associated with nicotine dependence,<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> alcohol dependence,<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a> and early onset heroin dependence.<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> Further study will be necessary to determine the significance of receptor heteromerization and genetic variation at D3R in the development of substance use disorders or in the response to an antiaddiction pharmacotherapeutic.</div><div class="NLM_p">Given these considerations, it is important that the preclinical and clinical studies showing negative results with D3R antagonists and partial agonists thus far not be used to prematurely rule out the utilization of these pharmacotherapies for addiction. Instead, these studies should be used to guide future efforts in designing more appropriate behavioral models to evaluate D3R compounds and determining the subsets of individuals in which D3R pharmacotherapies can be most effective. To reiterate, assessing a medication that may have its greatest utility in the prevention of relapse, as may be the case for D3R pharmacotherapy, requires that clinical subjects abstain from drug taking for a period of time. On the basis of preclinical results thus far, D3R antagonists do not effectively reduce active drug taking, but they do reduce relapse-like behavior. Therefore, if D3R antagonists are best suited for a role as a relapse-prevention treatment, then they will likely only be successful in the framework of a larger treatment program in which subjects have already attained abstinence. Trials designed to test D3R antagonists in patients actively using drugs may not see any attenuation in drug taking and would not be well-suited to evaluate the abstinence-maintaining therapeutic potential of this compound class. Hence, lessons learned from the buspirone case described in Section <a class="ref internalNav" href="#sec2_3" aria-label="2.3">2.3</a> should be used in future psychostimulant medication development.</div><div class="NLM_p last">This Perspective highlights the importance of developing selective compounds to better understand the role of D3R in addiction. It is our opinion that repurposing drugs that are clinically available has utility in guiding future research. However, the use of drugs with D3R affinity, but also many other targets (e.g., buspirone), should not be used to exemplify the pharmacology, biology, and physiology related to this important target. Recently, a new D3R-preferential partial agonist, <b>23</b> (BP1.4979 in Chart <a class="ref internalNav" href="#cht3" aria-label="3">3</a>, communicated by Jean-Charles Schwartz, Dopamine 2013 meeting), was introduced by Bioprojet, and a clinical trial on smoking cessation has begun (<a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> identifier NCT01785147). Although data remain unpublished, presumably this compound has been vetted through all of the in vitro and in vivo assays that Pharma has at its disposal (as compared to academic drug discovery programs such as ours) to be considered for translation to human studies. The fact that <b>23</b> is a partial agonist is of further interest and will provide answers to some of the questions regarding D3R efficacy posed above. Results of these clinical investigations will be of great interest to our community of addiction researchers and will very likely determine if the D3R remains a target to pursue for smoking cessation as well as other substance use disorders. One final thought is that D3R antagonists and partial agonists may not prove to be efficacious or safe for treatment of cocaine or METH addiction but may still hold promise for addictions to other substances, such as nicotine, opiates (including prescription pain killers, e.g., oxycodone), alcohol, food and Δ<sup>9</sup>-tetrahydrocannabinol (THC), the active ingredient in marijuana. Hence, it is our perspective that the development of selective D3R ligands, with varying efficacies, as research tools that are active and metabolically stable in vivo, can help to elucidate underpinnings of addiction and other neuropsychiatric disorders. Hence, future research and development of these agents toward these therapeutic end points remains vitally important. Further, developing animal models that can translate preclinical research is challenging and yet key to finding pharmacotherapeutic treatments for this underserved patient population.</div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24"><a href="/doi/suppl/10.1021/jm501512b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04803" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04803" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Detailed methods.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm501512b/suppl_file/jm501512b_si_001.pdf">jm501512b_si_001.pdf (362.25 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm501512b" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40367" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40367" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amy Hauck Newman</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Section, Molecular Targets and Medications Discovery Branch,
National Institute on Drug Abuse—Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#89e8e7ecfee4e8e7c9e0e7fdfbe8a7e7e0ede8a7e7e0e1a7eee6ff"><span class="__cf_email__" data-cfemail="dfbeb1baa8b2beb19fb6b1abadbef1b1b6bbbef1b1b6b7f1b8b0a9">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas M. Keck</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Section, Molecular Targets and Medications Discovery Branch,
National Institute on Drug Abuse—Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry & Biochemistry, College of Science and Mathematics;
Department of Biomedical & Translational Sciences, School of Biomedical
Science & Health Professions, Rowan
University, 201 Mullica
Hill Road, Glassboro, New
Jersey 08028, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William S. John</span> - <span class="hlFld-Affiliation affiliation">Department
of Physiology and Pharmacology, Wake Forest
School of Medicine, Winston-Salem, North Carolina 27157-1083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul W. Czoty</span> - <span class="hlFld-Affiliation affiliation">Department
of Physiology and Pharmacology, Wake Forest
School of Medicine, Winston-Salem, North Carolina 27157-1083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael A. Nader</span> - <span class="hlFld-Affiliation affiliation">Department
of Physiology and Pharmacology, Wake Forest
School of Medicine, Winston-Salem, North Carolina 27157-1083, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51863" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51863" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Thomas M. Keck</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=BIO-d299e2773-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Thomas M. Keck</b> received his doctorate in Physiology and Pharmacology in 2009 from Oregon Health & Science University in Portland, Oregon. He did his postdoctoral studies at the National Institute on Drug Abuse (NIDA-IRP), NIH, in the Medicinal Chemistry Section, Molecular Targets and Medications Discovery Research Branch, under the mentorship of Dr. Newman. In 2014, he became an Assistant Professor at Rowan University in Glassboro, New Jersey, with joint appointments in the Department of Chemistry & Biochemistry and the Department of Biomedical & Translational Sciences. His research focuses on the evaluation of novel ligands in preclinical models of neuropsychiatric disorders.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">William S. John</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=BIO-d299e2778-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>William S. John</b> received his B.S. in Biology at the University of North Carolina at Greensboro in 2010. He is currently a doctoral student in the Department of Physiology & Pharmacology at Wake Forest School of Medicine under the mentorship of Dr. Nader. His dissertation research focuses on the role of DA D3 receptors in mediating the behavioral effects of substance abuse in nonhuman primate models of cocaine and METH self-administration, with the goal of identifying novel treatment strategies.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Paul W. Czoty</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=BIO-d299e2783-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Paul W. Czoty</b> received his doctorate in Neuroscience from Emory University in Atlanta, Georgia, in 2000. After his postdoctoral work at Harvard Medical School’s McLean Hospital in Belmont, Massachusetts, he went to the Wake Forest School of Medicine, where he is an Associate Professor of Physiology & Pharmacology. He has written over 50 journal articles describing research using nonhuman primate models of substance abuse.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Michael A. Nader</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=BIO-d299e2788-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Michael A. Nader</b> received his doctorate in Experimental Psychology from the University of Minnesota, Minneapolis, Minnesota, in 1985. After his postdoctoral work at Uniformed Services University of the Health Sciences in Bethesda, Maryland, he went to the University of Chicago, where he was a member of the Research Faculty. He has been at Wake Forest University School of Medicine since 1992, where he is a Professor of Physiology & Pharmacology and Radiology. He has over 140 journal articles describing preclinical models of drug abuse.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Amy Hauck Newman</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=BIO-d299e2793-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Amy Hauck Newman</b> received her doctorate in Medicinal Chemistry from the Medical College of Virginia, Virginia Commonwealth University. After postdoctoral studies at the National Institute on Diabetes, Digestive and Kidney Diseases, National Institutes of Health (NIH), and a brief time at Walter Reed Army Institute of Research, she joined the Intramural Research Program of the National Institute on Drug Abuse (NIDA-IRP), NIH. She is currently a Senior Investigator, Deputy Scientific Director, and Chief of the Molecular Targets and Medications Discovery Research Branch and the Medicinal Chemistry Section. She has coauthored more than 230 original articles and reviews on the design, synthesis, and pharmacological evaluation of CNS active agents, with an emphasis on selective ligands for the dopaminergic system, as leads toward potential treatment medications for psychostimulant abuse.</p></figure></div><div class="ack" id="ACK-d299e2807-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31660" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31660" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We acknowledge Jianjing Cao and Drs. Peter Grundt, Ashwini K. Banala, and Vivek Kumar for synthetic contributions to this project. We acknowledge Catherine Schweppe and Caitlin Burzynski for assistance in obtaining binding data. We acknowledge Drs. Barbara Slusher and Rana Rais for the pharmacokinetic analyses and Michael Coller and Michelle Bell for excellent assistance in collecting data from monkeys. This work was funded by the NIDA-IRP and grants DA012460 and DA010584. W.S.J. is supported by T32 AA-007565.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i31" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i31"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i32" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i32"> Abbreviations Used</h2><tr><td class="NLM_term">D3R</td><td class="NLM_def"><p class="first last">dopamine D3 receptor</p></td></tr><tr><td class="NLM_term">DA</td><td class="NLM_def"><p class="first last">dopamine</p></td></tr><tr><td class="NLM_term">METH</td><td class="NLM_def"><p class="first last">methamphetamine</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationships</p></td></tr><tr><td class="NLM_term">DAT</td><td class="NLM_def"><p class="first last">dopamine transporter</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G protein-coupled receptors</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic AMP</p></td></tr><tr><td class="NLM_term">PR</td><td class="NLM_def"><p class="first last">progressive ratio</p></td></tr><tr><td class="NLM_term">FR</td><td class="NLM_def"><p class="first last">fixed ratio</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">peak plasma concentration</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">plasma half-life</p></td></tr><tr><td class="NLM_term">F%</td><td class="NLM_def"><p class="first last">bioavailability fraction</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06685" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06685" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 178 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3663</span><span class="NLM_x">–</span> <span class="NLM_lpage">3679</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040190e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtl2nur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3663-3679&author=A.+H.+Newmanauthor=P.+Grundtauthor=M.+A.+Nader&title=Dopamine+D3+receptor+partial+agonists+and+antagonists+as+potential+drug+abuse+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D3 Receptor Partial Agonists and Antagonists as Potential Drug Abuse Therapeutic Agents</span></div><div class="casAuthors">Newman, Amy Hauck; Grundt, Peter; Nader, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3663-3679</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This report is limited to discussions of potential dopamine D3 receptor agents, currently being developed as medications for drug abuse and other neuropsychiatric disorders, to partial agonists and antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqHXSFV83KfLVg90H21EOLACvtfcHk0ljWT3iLxW4Gvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtl2nur0%253D&md5=4244539d9e8038e2027dba1e21497cdd</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm040190e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040190e%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DDopamine%2520D3%2520receptor%2520partial%2520agonists%2520and%2520antagonists%2520as%2520potential%2520drug%2520abuse%2520therapeutic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3663%26epage%3D3679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Chien, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">1091</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1126%2Fscience.1197410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=21097933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVahurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1091-1095&author=E.+Y.+Chienauthor=W.+Liuauthor=Q.+Zhaoauthor=V.+Katritchauthor=G.+W.+Hanauthor=M.+A.+Hansonauthor=L.+Shiauthor=A.+H.+Newmanauthor=J.+A.+Javitchauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+human+dopamine+D3+receptor+in+complex+with+a+D2%2FD3+selective+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist</span></div><div class="casAuthors">Chien, Ellen Y. T.; Liu, Wei; Zhao, Qiang; Katritch, Vsevolod; Won Han, Gye; Hanson, Michael A.; Shi, Lei; Newman, Amy Hauck; Javitch, Jonathan A.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6007</span>),
    <span class="NLM_cas:pages">1091-1095</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Dopamine modulates movement, cognition, and emotion through activation of dopamine G protein-coupled receptors in the brain.  The crystal structure of the human dopamine D3 receptor (D3R) in complex with the small mol. D2R/D3R-specific antagonist eticlopride reveals important features of the ligand binding pocket and extracellular loops.  On the intracellular side of the receptor, a locked conformation of the ionic lock and two distinctly different conformations of intracellular loop 2 are obsd.  Docking of R-22, a D3R-selective antagonist, reveals an extracellular extension of the eticlopride binding site that comprises a second binding pocket for the aryl amide of R-22, which differs between the highly homologous D2R and D3R.  This difference provides direction to the design of D3R-selective agents for treating drug abuse and other neuropsychiatric indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOEcfSdjMm-7Vg90H21EOLACvtfcHk0ljWT3iLxW4Gvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVahurvM&md5=12c6f343daea9fb14ca605a092f28533</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1197410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1197410%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DE.%2BY.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520human%2520dopamine%2520D3%2520receptor%2520in%2520complex%2520with%2520a%2520D2%252FD3%2520selective%2520antagonist%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D1091%26epage%3D1095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Keck, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burzynski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Beyond small-molecule SAR: using the dopamine D3 receptor crystal structure to guide drug design</span> <span class="citation_source-journal">Adv. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2FB978-0-12-420118-7.00007-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24484980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsFCitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=267-300&author=T.+M.+Keckauthor=C.+Burzynskiauthor=L.+Shiauthor=A.+H.+Newman&title=Beyond+small-molecule+SAR%3A+using+the+dopamine+D3+receptor+crystal+structure+to+guide+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond small-molecule SAR: using the dopamine D3 receptor crystal structure to guide drug design</span></div><div class="casAuthors">Keck, Thomas M.; Burzynski, Caitlin; Shi, Lei; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Pharmacology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse</span>),
    <span class="NLM_cas:pages">267-300</span>CODEN:
                <span class="NLM_cas:coden">ADPHEL</span>;
        ISSN:<span class="NLM_cas:issn">1054-3589</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The dopamine D3 receptor is a target of pharmacotherapeutic interest in a variety of neurol. disorders including schizophrenia, restless leg syndrome, and drug addiction.  The high protein sequence homol. between the D3 and D2 receptors has posed a challenge to developing D3 receptor-selective ligands whose behavioral actions can be attributed to D3 receptor engagement, in vivo.  However, through primarily small-mol. structure-activity relationship (SAR) studies, a variety of chem. scaffolds have been discovered over the past two decades that have resulted in several D3 receptor-selective ligands with high affinity and in vivo activity.  Nevertheless, viable clin. candidates remain limited.  The recent detn. of the high-resoln. crystal structure of the D3 receptor has invigorated structure-based drug design, providing refinements to the mol. dynamic models and testable predictions about receptor-ligand interactions.  This chapter will highlight recent preclin. and clin. studies demonstrating potential utility of D3 receptor-selective ligands in the treatment of addiction.  In addn., new structure-based rational drug design strategies for D3 receptor-selective ligands that complement traditional small-mol. SAR to improve the selectivity and directed efficacy profiles are examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbH7VLMIagF7Vg90H21EOLACvtfcHk0ljWT3iLxW4Gvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsFCitb8%253D&md5=d266814a068e4528c70e200a860fab64</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-420118-7.00007-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-420118-7.00007-X%26sid%3Dliteratum%253Aachs%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DBurzynski%26aufirst%3DC.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DBeyond%2520small-molecule%2520SAR%253A%2520using%2520the%2520dopamine%2520D3%2520receptor%2520crystal%2520structure%2520to%2520guide%2520drug%2520design%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2014%26volume%3D69%26spage%3D267%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span> </span><span class="NLM_article-title">Structure-based drug design for dopamine D3 receptor</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.2174%2F138620712803901135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=22931309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvV2quw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=775-791&author=Z.+Fengauthor=T.+Houauthor=Y.+Li&title=Structure-based+drug+design+for+dopamine+D3+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based drug design for dopamine D3 receptor</span></div><div class="casAuthors">Feng, Zhiwei; Hou, Tingjun; Li, Youyong</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">775-791</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  D2-like receptors are members of dopamine receptors, including dopamine D2 receptor (D2R), dopamine D3 receptor (D3R), and dopamine D4 receptor (D4R), which modulate behavior, cognition, and emotion.  D2-like receptors are crit. targets for drug development.  Particularly, D3R has been identified as a therapeutic target for antipsychotic and anti-parkinsonian drugs.  Recently, the crystal structure of D3R was reported.  Here we summarize the available active compds. for D3R and the structure-activity relationships (SAR) studies of them.  This provides lead templates for further chem. modification.  We describe the structure features of the recent crystal structure of D3R and its difference from other G protein-coupled receptors (GPCRs).  We provide the recognition mechanism of the inhibitors of D3R (mol. docking results and mol. dynamics results), which illustrates the interaction between the inhibitors and crit. residues of D3R.  Finally, we summarize the outlook of drug development for D3R.  Our study provides useful information for developing high selective, high potent antagonists and agonists of D3R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrytYUzWYZN3bVg90H21EOLACvtfcHk0ljf9GbAvaXTkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvV2quw%253D%253D&md5=7d50a2de5c7865751e63a37850127e1b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F138620712803901135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138620712803901135%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DHou%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DStructure-based%2520drug%2520design%2520for%2520dopamine%2520D3%2520receptor%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2012%26volume%3D15%26spage%3D775%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyriac, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span> </span><span class="NLM_article-title"><i>N</i>-(4-(4-(2,3-Dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D3 receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2559</span><span class="NLM_x">–</span> <span class="NLM_lpage">2570</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900095y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2559-2570&author=A.+H.+Newmanauthor=P.+Grundtauthor=G.+Cyriacauthor=J.+R.+Deschampsauthor=M.+Taylorauthor=R.+Kumarauthor=D.+Hoauthor=R.+R.+Luedtke&title=N-%284-%284-%282%2C3-Dichloro-+or+2-methoxyphenyl%29piperazin-1-yl%29butyl%29heterobiarylcarboxamides+with+functionalized+linking+chains+as+high+affinity+and+enantioselective+D3+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm900095y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900095y%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DCyriac%26aufirst%3DG.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DHo%26aufirst%3DD.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26atitle%3DN-%25284-%25284-%25282%252C3-Dichloro-%2520or%25202-methoxyphenyl%2529piperazin-1-yl%2529butyl%2529heterobiarylcarboxamides%2520with%2520functionalized%2520linking%2520chains%2520as%2520high%2520affinity%2520and%2520enantioselective%2520D3%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2559%26epage%3D2570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Ikemoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, R. A.</span><span> </span><span class="NLM_article-title">Mapping of chemical trigger zones for reward</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=190-201&author=S.+Ikemotoauthor=R.+A.+Wise&title=Mapping+of+chemical+trigger+zones+for+reward"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIkemoto%26aufirst%3DS.%26aulast%3DWise%26aufirst%3DR.%2BA.%26atitle%3DMapping%2520of%2520chemical%2520trigger%2520zones%2520for%2520reward%26jtitle%3DNeuropharmacology%26date%3D2004%26volume%3D47%26spage%3D190%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Koob, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkow, N. D.</span><span> </span><span class="NLM_article-title">Neurocircuitry of addiction</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1038%2Fnpp.2009.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=19710631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BD1MfivVWgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=217-238&author=G.+F.+Koobauthor=N.+D.+Volkow&title=Neurocircuitry+of+addiction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Neurocircuitry of addiction</span></div><div class="casAuthors">Koob George F; Volkow Nora D</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">217-38</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Drug addiction is a chronically relapsing disorder that has been characterized by (1) compulsion to seek and take the drug, (2) loss of control in limiting intake, and (3) emergence of a negative emotional state (eg, dysphoria, anxiety, irritability) reflecting a motivational withdrawal syndrome when access to the drug is prevented.  Drug addiction has been conceptualized as a disorder that involves elements of both impulsivity and compulsivity that yield a composite addiction cycle composed of three stages: 'binge/intoxication', 'withdrawal/negative affect', and 'preoccupation/anticipation' (craving).  Animal and human imaging studies have revealed discrete circuits that mediate the three stages of the addiction cycle with key elements of the ventral tegmental area and ventral striatum as a focal point for the binge/intoxication stage, a key role for the extended amygdala in the withdrawal/negative affect stage, and a key role in the preoccupation/anticipation stage for a widely distributed network involving the orbitofrontal cortex-dorsal striatum, prefrontal cortex, basolateral amygdala, hippocampus, and insula involved in craving and the cingulate gyrus, dorsolateral prefrontal, and inferior frontal cortices in disrupted inhibitory control.  The transition to addiction involves neuroplasticity in all of these structures that may begin with changes in the mesolimbic dopamine system and a cascade of neuroadaptations from the ventral striatum to dorsal striatum and orbitofrontal cortex and eventually dysregulation of the prefrontal cortex, cingulate gyrus, and extended amygdala.  The delineation of the neurocircuitry of the evolving stages of the addiction syndrome forms a heuristic basis for the search for the molecular, genetic, and neuropharmacological neuroadaptations that are key to vulnerability for developing and maintaining addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRm5_6_UKyiWwqdek-gHSrIfW6udTcc2ear0WQhPY3t2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MfivVWgtA%253D%253D&md5=f6b4f491d6a4e9ea48fc89d18cebc022</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2009.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2009.110%26sid%3Dliteratum%253Aachs%26aulast%3DKoob%26aufirst%3DG.%2BF.%26aulast%3DVolkow%26aufirst%3DN.%2BD.%26atitle%3DNeurocircuitry%2520of%2520addiction%26jtitle%3DNeuropsychopharmacology%26date%3D2010%26volume%3D35%26spage%3D217%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Russo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nestler, E. J.</span><span> </span><span class="NLM_article-title">The brain reward circuitry in mood disorders</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1038%2Fnrn3381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=23942470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1KgtrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=609-625&author=S.+J.+Russoauthor=E.+J.+Nestler&title=The+brain+reward+circuitry+in+mood+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The brain reward circuitry in mood disorders</span></div><div class="casAuthors">Russo, Scott J.; Nestler, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">609-625</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mood disorders are common and debilitating conditions characterized in part by profound deficits in reward-related behavioral domains.  A recent literature has identified important structural and functional alterations within the brain's reward circuitry - particularly in the ventral tegmental area-nucleus accumbens pathway - that are assocd. with symptoms such as anhedonia and aberrant reward-assocd. perception and memory.  This Review synthesizes recent data from human and rodent studies from which emerges a circuit-level framework for understanding reward deficits in depression.  We also discuss some of the mol. and cellular underpinnings of this framework, ranging from adaptations in glutamatergic synapses and neurotrophic factors to transcriptional and epigenetic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOLF5CC3Y-dLVg90H21EOLACvtfcHk0ljf9GbAvaXTkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1KgtrfP&md5=a4df74d29daa78ad13a56700d45cb4b7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrn3381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3381%26sid%3Dliteratum%253Aachs%26aulast%3DRusso%26aufirst%3DS.%2BJ.%26aulast%3DNestler%26aufirst%3DE.%2BJ.%26atitle%3DThe%2520brain%2520reward%2520circuitry%2520in%2520mood%2520disorders%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D609%26epage%3D625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Volkow, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telang, F.</span><span> </span><span class="NLM_article-title">Addiction: beyond dopamine reward circuitry</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">15037</span><span class="NLM_x">–</span> <span class="NLM_lpage">15042</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=15037-15042&author=N.+D.+Volkowauthor=G.+J.+Wangauthor=J.+S.+Fowlerauthor=D.+Tomasiauthor=F.+Telang&title=Addiction%3A+beyond+dopamine+reward+circuitry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVolkow%26aufirst%3DN.%2BD.%26aulast%3DWang%26aufirst%3DG.%2BJ.%26aulast%3DFowler%26aufirst%3DJ.%2BS.%26aulast%3DTomasi%26aufirst%3DD.%26aulast%3DTelang%26aufirst%3DF.%26atitle%3DAddiction%253A%2520beyond%2520dopamine%2520reward%2520circuitry%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D15037%26epage%3D15042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Schmitt, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span> </span><span class="NLM_article-title">Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1187</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1187&publication_year=2010&pages=316-340&author=K.+C.+Schmittauthor=M.+E.+Reith&title=Regulation+of+the+dopamine+transporter%3A+aspects+relevant+to+psychostimulant+drugs+of+abuse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DK.%2BC.%26aulast%3DReith%26aufirst%3DM.%2BE.%26atitle%3DRegulation%2520of%2520the%2520dopamine%2520transporter%253A%2520aspects%2520relevant%2520to%2520psychostimulant%2520drugs%2520of%2520abuse%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2010%26volume%3D1187%26spage%3D316%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Volkow, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatley, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewey, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitzemann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gifford, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pappas, N. R.</span><span> </span><span class="NLM_article-title">Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of “high”</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=9862747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaK1MXisVylsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=1999&pages=14-20&author=N.+D.+Volkowauthor=G.+J.+Wangauthor=J.+S.+Fowlerauthor=S.+J.+Gatleyauthor=J.+Loganauthor=Y.+S.+Dingauthor=S.+L.+Deweyauthor=R.+Hitzemannauthor=A.+N.+Giffordauthor=N.+R.+Pappas&title=Blockade+of+striatal+dopamine+transporters+by+intravenous+methylphenidate+is+not+sufficient+to+induce+self-reports+of+%E2%80%9Chigh%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high"</span></div><div class="casAuthors">Volkow, Nora D.; Wang, Gene-Jack; Fowler, Joanna S.; Gatley, S. John; Logan, Jean; Ding, Yu-Shin; Dewey, Stephen L.; Hitzemann, Robert; Gifford, Andrew N.; Pappas, Naomi R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-20</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The reinforcing effects of cocaine and methylphenidate have been linked to their ability to block dopamine transporters (DAT).  Using positron emission tomog. (PET), the authors previously showed that i.v. cocaine induced a significant level of DAT blockade, which was assocd. with the intensity for self-reports of high in cocaine abusers.  In this study, the authors measured DAT occupancies after i.v. methylphenidate and assessed whether they also were assocd. with the high.  Occupation of DAT by i.v. MP was measured with PET using [11C]cocaine, as a DAT ligand, in 8 normal control subjects tested with different methylphenidate doses.  The ratio of the distribution vol. of [11C]cocaine in striatum to that in cerebellum, which corresponds to Bmax/Kd + 1, was used as a measure of DAT availability.  In parallel, self-reports of high were measured.  Methylphenidate produced a dose-dependent blockade of DAT with an estd. ED50 of 0.075 mg/kg.  DAT occupancies were significantly correlated with the high (p < .03).  However, 4 of the 8 subjects, despite having significant levels of DAT blockade, did not perceive the high.  Methylphenidate is as effective as cocaine in blocking DAT in the human brain (cocaine ED50 = 0.13 mg/kg), and DAT blockade, as for cocaine, was also assocd. with the high.  However, the fact that there were subjects who despite significant DAT blockade did not experience the high suggests that DAT blockade, although necessary, is not sufficient to produce the high.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsfc6EeBfQXrVg90H21EOLACvtfcHk0liSgB5ejv8KOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisVylsg%253D%253D&md5=00e1c470cdce78abd15dfd2d0c1bca2e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVolkow%26aufirst%3DN.%2BD.%26aulast%3DWang%26aufirst%3DG.%2BJ.%26aulast%3DFowler%26aufirst%3DJ.%2BS.%26aulast%3DGatley%26aufirst%3DS.%2BJ.%26aulast%3DLogan%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DY.%2BS.%26aulast%3DDewey%26aufirst%3DS.%2BL.%26aulast%3DHitzemann%26aufirst%3DR.%26aulast%3DGifford%26aufirst%3DA.%2BN.%26aulast%3DPappas%26aufirst%3DN.%2BR.%26atitle%3DBlockade%2520of%2520striatal%2520dopamine%2520transporters%2520by%2520intravenous%2520methylphenidate%2520is%2520not%2520sufficient%2520to%2520induce%2520self-reports%2520of%2520%25E2%2580%259Chigh%25E2%2580%259D%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D288%26spage%3D14%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Volkow, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatley, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitzemann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, A. P.</span><span> </span><span class="NLM_article-title">Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1001%2Farchpsyc.1995.03950180042006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=7771915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaK2MXmvFCnsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1995&pages=456-463&author=N.+D.+Volkowauthor=Y.+S.+Dingauthor=J.+S.+Fowlerauthor=G.+J.+Wangauthor=J.+Loganauthor=J.+S.+Gatleyauthor=S.+Deweyauthor=C.+Ashbyauthor=J.+Liebermannauthor=R.+Hitzemannauthor=A.+P.+Wolf&title=Is+methylphenidate+like+cocaine%3F+Studies+on+their+pharmacokinetics+and+distribution+in+the+human+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Is methylphenidate like cocaine? studies on their pharmacokinetics and distribution in the human brain</span></div><div class="casAuthors">Volkow, Nora D.; Ding, Yu-Shin; Fowler, Joanna S.; Wang, Gene-Jack; Logan, Jean; Gatley, John S.; Dewey, Stephen; Ashby, Charles; Liebermann, Jeffrey; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">456-63</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">The purposes of this study were to investigate the pharmacokinetics of methylphenidate hydrochloride (Ritalin) in the human brain, to compare them with those of cocaine, and to evaluate whether cocaine and methylphenidate compete for the same binding sites.  We used positron emission tomog. to measure the temporal and spatial distribution of carbon 11 (11C)-labeled methylphenidate.  These results were compared with those obtained previously for [11C]cocaine.  Eight healthy male subjects, 20 to 51 yr of age, were scanned with [11C] methylphenidate.  Three were tested twice to assess test-retest variability, four were tested at baseline and after administration of methylphenidate, and one was tested with [11C]methylphenidate and [11C]cocaine.  Two baboons were scanned to evaluate whether there was competition between cocaine and methylphenidate for the same binding sites in the brain.  The uptake of [11C]methylphenidate in the brain was high (mean±SD, 7.5%±1.5%), and the maximal concn. occurred in striatum.  Pretreatment with methylphenidate decreased binding only in striatum (40%).  Although the regional distribution of [11C]methylphenidate was identical to that of [11C]cocaine and they competed with each other for the same binding sites, these two drugs differed markedly in their pharmacokinetics.  Clearance of [11C]methylphenidate from striatum (90 min) was significantly slower than that of [11C]cocaine (20 min).  For both drugs, their fast uptake in striatum paralleled the experience of the "high.".  For methylphenidate, the high decreased very rapidly despite significant binding of the drug in the brain.  In contrast, for cocaine, the decline in the high paralleled its fast rate of clearance from the brain.  We speculate that because the experience of the high is assocd. with the fast uptake of cocaine and methylphenidate in the brain, the slow clearance of methylphenidate from the brain may serve as a limiting factor in promoting its frequent self-administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLZTzkKHqGebVg90H21EOLACvtfcHk0liSgB5ejv8KOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvFCnsLg%253D&md5=87024caf77fea8f8656fcd15d67487d0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1995.03950180042006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1995.03950180042006%26sid%3Dliteratum%253Aachs%26aulast%3DVolkow%26aufirst%3DN.%2BD.%26aulast%3DDing%26aufirst%3DY.%2BS.%26aulast%3DFowler%26aufirst%3DJ.%2BS.%26aulast%3DWang%26aufirst%3DG.%2BJ.%26aulast%3DLogan%26aufirst%3DJ.%26aulast%3DGatley%26aufirst%3DJ.%2BS.%26aulast%3DDewey%26aufirst%3DS.%26aulast%3DAshby%26aufirst%3DC.%26aulast%3DLiebermann%26aufirst%3DJ.%26aulast%3DHitzemann%26aufirst%3DR.%26aulast%3DWolf%26aufirst%3DA.%2BP.%26atitle%3DIs%2520methylphenidate%2520like%2520cocaine%253F%2520Studies%2520on%2520their%2520pharmacokinetics%2520and%2520distribution%2520in%2520the%2520human%2520brain%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1995%26volume%3D52%26spage%3D456%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Ahlgren-Beckendorf, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levant, B.</span><span> </span><span class="NLM_article-title">Signaling mechanisms of the D3 dopamine receptor</span> <span class="citation_source-journal">J. Recept. Signal Transduction Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1081%2FRRS-200029953" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=15521358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVKhs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=117-130&author=J.+A.+Ahlgren-Beckendorfauthor=B.+Levant&title=Signaling+mechanisms+of+the+D3+dopamine+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Signaling Mechanisms of the D3 Dopamine Receptor</span></div><div class="casAuthors">Ahlgren-Beckendorf, Joy A.; Levant, Beth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Receptors and Signal Transduction</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">117-130</span>CODEN:
                <span class="NLM_cas:coden">JRSTCT</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review.  A substantial body of evidence shows the capacity of the dopamine D3 receptor to couple functionally to G proteins when expressed in an appropriate milieu in heterologous expression systems.  In these systems, activation of D3 receptors inhibits adenylate cyclase, modulates ion flow through potassium and calcium channels, and activates kinases, most notably mitogen-activated protein kinase.  Coupling to Gi/Go is implicated in many of these effects, but other G proteins may contribute.  Studies with chimeric receptors implicate the 3rd intracellular loop in the mediation of agonist-induced signal transduction.  Finally, D3-preferring drugs modulate expression of c-fos in neuronal cultures and brain.  Signaling mechanisms of the D3 receptor in brain, however, remain to be definitively detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOl-65wNzGh7Vg90H21EOLACvtfcHk0liSgB5ejv8KOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVKhs7w%253D&md5=30ff8f18d95ab96ae90c078458ff4dc6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1081%2FRRS-200029953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FRRS-200029953%26sid%3Dliteratum%253Aachs%26aulast%3DAhlgren-Beckendorf%26aufirst%3DJ.%2BA.%26aulast%3DLevant%26aufirst%3DB.%26atitle%3DSignaling%2520mechanisms%2520of%2520the%2520D3%2520dopamine%2520receptor%26jtitle%3DJ.%2520Recept.%2520Signal%2520Transduction%2520Res.%26date%3D2004%26volume%3D24%26spage%3D117%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Sidhu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niznik, H. B.</span><span> </span><span class="NLM_article-title">Coupling of dopamine receptor subtypes to multiple and diverse G proteins</span> <span class="citation_source-journal">Int. J. Dev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2000&pages=669-677&author=A.+Sidhuauthor=H.+B.+Niznik&title=Coupling+of+dopamine+receptor+subtypes+to+multiple+and+diverse+G+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSidhu%26aufirst%3DA.%26aulast%3DNiznik%26aufirst%3DH.%2BB.%26atitle%3DCoupling%2520of%2520dopamine%2520receptor%2520subtypes%2520to%2520multiple%2520and%2520diverse%2520G%2520proteins%26jtitle%3DInt.%2520J.%2520Dev.%2520Neurosci.%26date%3D2000%26volume%3D18%26spage%3D669%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Marcellino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casado, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Foll, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drago, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saur, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lluis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuxe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span> </span><span class="NLM_article-title">Identification of dopamine D1–D3 receptor heteromers. Indications for a role of synergistic D1–D3 receptor interactions in the striatum</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">26016</span><span class="NLM_x">–</span> <span class="NLM_lpage">26025</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=26016-26025&author=D.+Marcellinoauthor=S.+Ferreauthor=V.+Casadoauthor=A.+Cortesauthor=B.+Le+Follauthor=C.+Mazzolaauthor=F.+Dragoauthor=O.+Saurauthor=H.+Starkauthor=A.+Sorianoauthor=C.+Barnesauthor=S.+R.+Goldbergauthor=C.+Lluisauthor=K.+Fuxeauthor=R.+Franco&title=Identification+of+dopamine+D1%E2%80%93D3+receptor+heteromers.+Indications+for+a+role+of+synergistic+D1%E2%80%93D3+receptor+interactions+in+the+striatum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarcellino%26aufirst%3DD.%26aulast%3DFerre%26aufirst%3DS.%26aulast%3DCasado%26aufirst%3DV.%26aulast%3DCortes%26aufirst%3DA.%26aulast%3DLe%2BFoll%26aufirst%3DB.%26aulast%3DMazzola%26aufirst%3DC.%26aulast%3DDrago%26aufirst%3DF.%26aulast%3DSaur%26aufirst%3DO.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DSoriano%26aufirst%3DA.%26aulast%3DBarnes%26aufirst%3DC.%26aulast%3DGoldberg%26aufirst%3DS.%2BR.%26aulast%3DLluis%26aufirst%3DC.%26aulast%3DFuxe%26aufirst%3DK.%26aulast%3DFranco%26aufirst%3DR.%26atitle%3DIdentification%2520of%2520dopamine%2520D1%25E2%2580%2593D3%2520receptor%2520heteromers.%2520Indications%2520for%2520a%2520role%2520of%2520synergistic%2520D1%25E2%2580%2593D3%2520receptor%2520interactions%2520in%2520the%2520striatum%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D26016%26epage%3D26025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Guitart, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Soto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar-Barodia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naidu, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallol, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lluis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canela, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casado, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferre, S.</span><span> </span><span class="NLM_article-title">Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1–D3 receptor heterotetramer</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=417-429&author=X.+Guitartauthor=G.+Navarroauthor=E.+Morenoauthor=H.+Yanoauthor=N.+S.+Caiauthor=M.+Sanchez-Sotoauthor=S.+Kumar-Barodiaauthor=Y.+T.+Naiduauthor=J.+Mallolauthor=A.+Cortesauthor=C.+Lluisauthor=E.+I.+Canelaauthor=V.+Casadoauthor=P.+J.+McCormickauthor=S.+Ferre&title=Functional+selectivity+of+allosteric+interactions+within+G+protein-coupled+receptor+oligomers%3A+the+dopamine+D1%E2%80%93D3+receptor+heterotetramer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuitart%26aufirst%3DX.%26aulast%3DNavarro%26aufirst%3DG.%26aulast%3DMoreno%26aufirst%3DE.%26aulast%3DYano%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DN.%2BS.%26aulast%3DSanchez-Soto%26aufirst%3DM.%26aulast%3DKumar-Barodia%26aufirst%3DS.%26aulast%3DNaidu%26aufirst%3DY.%2BT.%26aulast%3DMallol%26aufirst%3DJ.%26aulast%3DCortes%26aufirst%3DA.%26aulast%3DLluis%26aufirst%3DC.%26aulast%3DCanela%26aufirst%3DE.%2BI.%26aulast%3DCasado%26aufirst%3DV.%26aulast%3DMcCormick%26aufirst%3DP.%2BJ.%26aulast%3DFerre%26aufirst%3DS.%26atitle%3DFunctional%2520selectivity%2520of%2520allosteric%2520interactions%2520within%2520G%2520protein-coupled%2520receptor%2520oligomers%253A%2520the%2520dopamine%2520D1%25E2%2580%2593D3%2520receptor%2520heterotetramer%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D86%26spage%3D417%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Fiorentini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savoia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bono, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallarico, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Missale, C.</span><span> </span><span class="NLM_article-title">The D3 dopamine receptor: From structural interactions to function</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1016/j.euroneuro.2014.1011.1021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.euroneuro.2014.1011.1021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=25532864" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+Fiorentiniauthor=P.+Savoiaauthor=F.+Bonoauthor=P.+Tallaricoauthor=C.+Missale&title=The+D3+dopamine+receptor%3A+From+structural+interactions+to+function&doi=10.1016%2Fj.euroneuro.2014.1011.1021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2014.1011.1021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2014.1011.1021%26sid%3Dliteratum%253Aachs%26aulast%3DFiorentini%26aufirst%3DC.%26aulast%3DSavoia%26aufirst%3DP.%26aulast%3DBono%26aufirst%3DF.%26aulast%3DTallarico%26aufirst%3DP.%26aulast%3DMissale%26aufirst%3DC.%26atitle%3DThe%2520D3%2520dopamine%2520receptor%253A%2520From%2520structural%2520interactions%2520to%2520function%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2014%26doi%3D10.1016%2Fj.euroneuro.2014.1011.1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaylock, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skolnick, P.</span><span> </span><span class="NLM_article-title">Medication discovery for addiction: translating the dopamine D3 receptor hypothesis</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">882</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.bcp.2012.06.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=22781742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOqu73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=882-890&author=A.+H.+Newmanauthor=B.+L.+Blaylockauthor=M.+A.+Naderauthor=J.+Bergmanauthor=D.+R.+Sibleyauthor=P.+Skolnick&title=Medication+discovery+for+addiction%3A+translating+the+dopamine+D3+receptor+hypothesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Medication discovery for addiction: Translating the dopamine D3 receptor hypothesis</span></div><div class="casAuthors">Newman, Amy Hauck; Blaylock, Brandi L.; Nader, Michael A.; Bergman, Jack; Sibley, David R.; Skolnick, Phil</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">882-890</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The dopamine D3 receptor (D3R) has been investigated as a potential target for medication development to treat substance use disorders (SUDs) with a particular focus on cocaine and methamphetamine.  Currently, there are no approved medications to treat cocaine and methamphetamine addiction and thus developing pharmacotherapeutics to complement existing behavioral strategies is a fundamental goal.  Novel compds. with high affinity and D3R selectivity have been evaluated in numerous animal models of drug abuse and favorable outcomes in nonhuman primate models of self-administration and relapse have provided compelling evidence to advance these agents into the clinic.  One approach is to repurpose drugs that share the D3R mechanism and already have clin. utility, and to this end buspirone has been identified as a viable candidate for clin. trials.  A second, but substantially more resource intensive and risky approach involves the development of compds. that exclusively target D3R, such as GSK598809 and PG 619.  Clin. investigation of these drugs or other novel D3R-selective agents will provide a better understanding of the role D3R plays in addiction and whether or not antagonists or partial agonists that are D3R selective are effective in achieving abstinence in this patient population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_waGudfGt4LVg90H21EOLACvtfcHk0liA9XVux4lYMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOqu73O&md5=820f1ddd46c9888c687bc0cc8cd3aa96</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.06.023%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DBlaylock%26aufirst%3DB.%2BL.%26aulast%3DNader%26aufirst%3DM.%2BA.%26aulast%3DBergman%26aufirst%3DJ.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DSkolnick%26aufirst%3DP.%26atitle%3DMedication%2520discovery%2520for%2520addiction%253A%2520translating%2520the%2520dopamine%2520D3%2520receptor%2520hypothesis%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26spage%3D882%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Heidbreder, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1187</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1111%2Fj.1749-6632.2009.05149.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=20201845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXks1Snurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1187&publication_year=2010&pages=4-34&author=C.+A.+Heidbrederauthor=A.+H.+Newman&title=Current+perspectives+on+selective+dopamine+D%283%29+receptor+antagonists+as+pharmacotherapeutics+for+addictions+and+related+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders</span></div><div class="casAuthors">Heidbreder, Christian A.; Newman, Amy H.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1187</span>
        (<span class="NLM_cas:issue">Addiction Reviews 2</span>),
    <span class="NLM_cas:pages">4-34</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Repeated exposure to drugs of abuse produces long-term mol. and neurochem. changes that may explain the core features of addiction, such as the compulsive seeking and taking of the drug, as well as the risk of relapse.  A growing no. of new mol. and cellular targets of addictive drugs have been identified, and rapid advances are being made in relating those targets to specific behavioral phenotypes in animal models of addiction.  In this context, the pattern of expression of the dopamine (DA) D3 receptor in the rodent and human brain and changes in this pattern in response to drugs of abuse have contributed primarily to direct research efforts toward the development of selective DA D3 receptor antagonists.  Growing preclin. evidence indicates that these compds. may actually regulate the motivation to self-administer drugs and disrupt drug-assocd. cue-induced craving.  This report will be divided into three parts.  First, preclin. evidence in support of the efficacy of selective DA D3 receptor antagonists in animal models of drug addiction will be reviewed.  The effects of mixed DA D2/D3 receptor antagonists will not be discussed here because most of these compds. have low selectivity at the D3 vs. D2 receptor, and their efficacy profile is related primarily to functional antagonism at D2 receptors and possibly interactions with other neurotransmitter systems.  Second, major advances in medicinal chem. for the identification and optimization of selective DA D3 receptor antagonists and partial agonists will be analyzed.  Third, translational research from preclin. efficacy studies to so-called proof-of-concept studies for drug addiction indications will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqarcQYm33s6LVg90H21EOLACvtfcHk0lgC59hYz24vDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXks1Snurc%253D&md5=48ded12d27f36b8d77717b118ccfa869</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2009.05149.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2009.05149.x%26sid%3Dliteratum%253Aachs%26aulast%3DHeidbreder%26aufirst%3DC.%2BA.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DCurrent%2520perspectives%2520on%2520selective%2520dopamine%2520D%25283%2529%2520receptor%2520antagonists%2520as%2520pharmacotherapeutics%2520for%2520addictions%2520and%2520related%2520disorders%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2010%26volume%3D1187%26spage%3D4%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Micheli, F.</span><span> </span><span class="NLM_article-title">Recent advances in the development of dopamine D3 receptor antagonists: a medicinal chemistry perspective</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1152</span><span class="NLM_x">–</span> <span class="NLM_lpage">1162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1002%2Fcmdc.201000538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=21425240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVCntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1152-1162&author=F.+Micheli&title=Recent+advances+in+the+development+of+dopamine+D3+receptor+antagonists%3A+a+medicinal+chemistry+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Development of Dopamine D3 Receptor Antagonists: a Medicinal Chemistry Perspective</span></div><div class="casAuthors">Micheli, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1152-1162</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Dopamine (DA) D3 receptor antagonism might play a significant role in different therapeutic areas.  A high no. of preclin. studies on DA D3 receptor antagonists have shown efficacy in animal models of Parkinson's disease, schizophrenia and drug dependence.  This Review covers the activities of medicinal chemists in this field over the last ten years towards the identification of truly selective compds.  Both primary and patent literature is reviewed here.  Since the original discoveries, a clear trend towards the optimization of the developability properties of the new scaffold has clearly emerged with time, from both academic and industrial researchers.  Examples of advanced leads from academia and industry are described.  The latest potential therapeutic applications are reported too.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofhYCeq4b9EbVg90H21EOLACvtfcHk0lgC59hYz24vDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVCntbk%253D&md5=61c2b60b5e69df3517421e922b7aa73a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000538%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520dopamine%2520D3%2520receptor%2520antagonists%253A%2520a%2520medicinal%2520chemistry%2520perspective%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1152%26epage%3D1162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Micheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C.</span><span> </span><span class="NLM_article-title">Dopamine D3 receptor antagonists: a patent review (2007–2012)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1517%2F13543776.2013.757593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=23282131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1Sqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=363-381&author=F.+Micheliauthor=C.+Heidbreder&title=Dopamine+D3+receptor+antagonists%3A+a+patent+review+%282007%E2%80%932012%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D3 receptor antagonists: a patent review (2007 - 2012)</span></div><div class="casAuthors">Micheli, Fabrizio; Heidbreder, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">363-381</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The synthesis and characterization of new highly potent and selective dopamine (DA) D3 receptor antagonists has permitted to characterize the role of the DA D3 receptor in the control of drug-seeking behavior and in the pathophysiol. of impulse control disorders and schizophrenia.Areas covered: In the present review, the authors will first describe most recent classes of DA D3 receptor antagonists by reviewing about 43 patent applications during the 2007 - 2012 period; they will then outline the biol. rationale in support of the use of selective DA D3 receptor antagonists in the treatment of drug addiction, impulse control disorders and schizophrenia.Expert opinion: The strongest clin. application and potential for selective DA D3 receptor antagonists lies in the redn. of drug-induced incentive motivation, the attenuation of drug's rewarding efficacy and the redn. in reinstatement of drug-seeking behavior triggered either by re-exposure to the drug itself, re-exposure to environmental cues that had been previously assocd. with drug-taking behavior or stress.  The selectivity of these antagonists together with reduced lipophilicity (minimizing unspecific binding), increased brain penetration and improved physico-chem. profile are all key factors for clin. efficacy and safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz7CcUwWNKXrVg90H21EOLACvtfcHk0lgC59hYz24vDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1Sqsrk%253D&md5=cbf7c42a3a88693f44b1adea64f6caf3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.757593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.757593%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3DDopamine%2520D3%2520receptor%2520antagonists%253A%2520a%2520patent%2520review%2520%25282007%25E2%2580%25932012%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D363%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Ye, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumeyer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldessarini, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A.</span><span> </span><span class="NLM_article-title">Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">PR123</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr300113a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2013&pages=PR123-178&author=N.+Yeauthor=J.+L.+Neumeyerauthor=R.+J.+Baldessariniauthor=X.+Zhenauthor=A.+Zhang&title=Update+1+of%3A+Recent+progress+in+development+of+dopamine+receptor+subtype-selective+agents%3A+potential+therapeutics+for+neurological+and+psychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fcr300113a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr300113a%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DN.%26aulast%3DNeumeyer%26aufirst%3DJ.%2BL.%26aulast%3DBaldessarini%26aufirst%3DR.%2BJ.%26aulast%3DZhen%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DA.%26atitle%3DUpdate%25201%2520of%253A%2520Recent%2520progress%2520in%2520development%2520of%2520dopamine%2520receptor%2520subtype-selective%2520agents%253A%2520potential%2520therapeutics%2520for%2520neurological%2520and%2520psychiatric%2520disorders%26jtitle%3DChem.%2520Rev.%26date%3D2013%26volume%3D113%26spage%3DPR123%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Michino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donthamsetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beuming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banala, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinquet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span> </span><span class="NLM_article-title">A single glycine in extracellular loop 1 is the critical determinant for pharmacological specificity of dopamine D2 and D3 receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">854</span><span class="NLM_x">–</span> <span class="NLM_lpage">864</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1124%2Fmol.113.087833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24061855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVyitLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=854-864&author=M.+Michinoauthor=P.+Donthamsettiauthor=T.+Beumingauthor=A.+Banalaauthor=L.+Duanauthor=T.+Rouxauthor=Y.+Hanauthor=E.+Trinquetauthor=A.+H.+Newmanauthor=J.+A.+Javitchauthor=L.+Shi&title=A+single+glycine+in+extracellular+loop+1+is+the+critical+determinant+for+pharmacological+specificity+of+dopamine+D2+and+D3+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A single glycine in extracellular loop 1 is the critical determinant for pharmacological specificity of dopamine D2 and D3 receptors</span></div><div class="casAuthors">Michino, Mayako; Donthamsetti, Prashant; Beuming, Thijs; Banala, Ashwini; Duan, Lihua; Roux, Thomas; Han, Yang; Trinquet, Eric; Newman, Amy Hauck; Javitch, Jonathan A.; Shi, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">854-864</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Subtype-selective agents for the dopamine D3 receptor (D3R) have been considered as potential medications for drug addiction and other neuropsychiatric disorders.  Medicinal chem. efforts have led to the discovery of 4-phenylpiperazine derivs. that are >100-fold selective for the dopamine D3 receptor over dopamine D2 receptor (D2R), despite high sequence identity (78% in the transmembrane domain).  Based on the recent crystal structure of D3R, we demonstrated that the 4-phenylpiperazine moiety in this class of D3R-selective compds. binds to the conserved orthosteric binding site, whereas the extended aryl amide moiety is oriented toward a divergent secondary binding pocket (SBP).  In an effort to further characterize mol. determinants of the selectivity of these compds., we modeled their binding modes in D3R and D2R by comparative ligand docking and mol. dynamics simulations.  We found that the aryl amide moiety in the SBP differentially induces conformational changes in transmembrane segment 2 and extracellular loop 1 (EL1), which amplify the divergence of the SBP in D3R and D2R.  Receptor chimera and site-directed mutagenesis studies were used to validate these binding modes and to identify a divergent glycine in EL1 as crit. to D3R over D2R subtype selectivity.  A better understanding of drug-dependent receptor conformations such as these is key to the rational design of compds. targeting a specific receptor among closely related homologs, and may also lead to discovery of novel chemotypes that exploit subtle differences in protein conformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTHm99ZIZbabVg90H21EOLACvtfcHk0lgC59hYz24vDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVyitLvK&md5=225a4cfc272ec9897eeb010dd551c3b9</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.087833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.087833%26sid%3Dliteratum%253Aachs%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DBanala%26aufirst%3DA.%26aulast%3DDuan%26aufirst%3DL.%26aulast%3DRoux%26aufirst%3DT.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DTrinquet%26aufirst%3DE.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DL.%26atitle%3DA%2520single%2520glycine%2520in%2520extracellular%2520loop%25201%2520is%2520the%2520critical%2520determinant%2520for%2520pharmacological%2520specificity%2520of%2520dopamine%2520D2%2520and%2520D3%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26spage%3D854%26epage%3D864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Ananthan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saini, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobrath, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padmalayam, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bostwick, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAleer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span> </span><span class="NLM_article-title">Design, synthesis, and structure–activity relationship studies of a series of [4-(4-carboxamidobutyl)]-1-arylpiperazines: insights into structural features contributing to dopamine D3 versus D2 receptor subtype selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">7042</span><span class="NLM_x">–</span> <span class="NLM_lpage">7060</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500801r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7042-7060&author=S.+Ananthanauthor=S.+K.+Sainiauthor=G.+Zhouauthor=J.+V.+Hobrathauthor=I.+Padmalayamauthor=L.+Zhaiauthor=J.+R.+Bostwickauthor=T.+Antonioauthor=M.+E.+Reithauthor=S.+McDowellauthor=E.+Choauthor=L.+McAleerauthor=M.+Taylorauthor=R.+R.+Luedtke&title=Design%2C+synthesis%2C+and+structure%E2%80%93activity+relationship+studies+of+a+series+of+%5B4-%284-carboxamidobutyl%29%5D-1-arylpiperazines%3A+insights+into+structural+features+contributing+to+dopamine+D3+versus+D2+receptor+subtype+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm500801r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500801r%26sid%3Dliteratum%253Aachs%26aulast%3DAnanthan%26aufirst%3DS.%26aulast%3DSaini%26aufirst%3DS.%2BK.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DHobrath%26aufirst%3DJ.%2BV.%26aulast%3DPadmalayam%26aufirst%3DI.%26aulast%3DZhai%26aufirst%3DL.%26aulast%3DBostwick%26aufirst%3DJ.%2BR.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DMcDowell%26aufirst%3DS.%26aulast%3DCho%26aufirst%3DE.%26aulast%3DMcAleer%26aufirst%3DL.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520studies%2520of%2520a%2520series%2520of%2520%255B4-%25284-carboxamidobutyl%2529%255D-1-arylpiperazines%253A%2520insights%2520into%2520structural%2520features%2520contributing%2520to%2520dopamine%2520D3%2520versus%2520D2%2520receptor%2520subtype%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7042%26epage%3D7060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElveen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Novel heterocyclic trans olefin analogues of <i>N</i>-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049465g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=839-848&author=P.+Grundtauthor=E.+E.+Carlsonauthor=J.+Caoauthor=C.+J.+Bennettauthor=E.+McElveenauthor=M.+Taylorauthor=R.+R.+Luedtkeauthor=A.+H.+Newman&title=Novel+heterocyclic+trans+olefin+analogues+of+N-%7B4-%5B4-%282%2C3-dichlorophenyl%29piperazin-1-yl%5Dbutyl%7Darylcarboxamides+as+selective+probes+with+high+affinity+for+the+dopamine+D3+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm049465g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049465g%26sid%3Dliteratum%253Aachs%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DCarlson%26aufirst%3DE.%2BE.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DC.%2BJ.%26aulast%3DMcElveen%26aufirst%3DE.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DNovel%2520heterocyclic%2520trans%2520olefin%2520analogues%2520of%2520N-%257B4-%255B4-%25282%252C3-dichlorophenyl%2529piperazin-1-yl%255Dbutyl%257Darylcarboxamides%2520as%2520selective%2520probes%2520with%2520high%2520affinity%2520for%2520the%2520dopamine%2520D3%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D839%26epage%3D848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Banala, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatri, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roof, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title"><i>N</i>-(3-Fluoro-4-(4-(2-methoxy or 2,3-dichlorophenyl)piperazine-1-yl)butyl)arylcarboxamides as selective dopamine D3 receptor ligands: critical role of the carboxamide linker for D3 receptor selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3581</span><span class="NLM_x">–</span> <span class="NLM_lpage">3594</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200288r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3581-3594&author=A.+K.+Banalaauthor=B.+A.+Levyauthor=S.+S.+Khatriauthor=C.+A.+Furmanauthor=R.+A.+Roofauthor=Y.+Mishraauthor=S.+A.+Griffinauthor=D.+R.+Sibleyauthor=R.+R.+Luedtkeauthor=A.+H.+Newman&title=N-%283-Fluoro-4-%284-%282-methoxy+or+2%2C3-dichlorophenyl%29piperazine-1-yl%29butyl%29arylcarboxamides+as+selective+dopamine+D3+receptor+ligands%3A+critical+role+of+the+carboxamide+linker+for+D3+receptor+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm200288r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200288r%26sid%3Dliteratum%253Aachs%26aulast%3DBanala%26aufirst%3DA.%2BK.%26aulast%3DLevy%26aufirst%3DB.%2BA.%26aulast%3DKhatri%26aufirst%3DS.%2BS.%26aulast%3DFurman%26aufirst%3DC.%2BA.%26aulast%3DRoof%26aufirst%3DR.%2BA.%26aulast%3DMishra%26aufirst%3DY.%26aulast%3DGriffin%26aufirst%3DS.%2BA.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DN-%25283-Fluoro-4-%25284-%25282-methoxy%2520or%25202%252C3-dichlorophenyl%2529piperazine-1-yl%2529butyl%2529arylcarboxamides%2520as%2520selective%2520dopamine%2520D3%2520receptor%2520ligands%253A%2520critical%2520role%2520of%2520the%2520carboxamide%2520linker%2520for%2520D3%2520receptor%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3581%26epage%3D3594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beuming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banala, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donthamsetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongetti, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBounty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span> </span><span class="NLM_article-title">Molecular determinants of selectivity and efficacy at the dopamine D3 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6689</span><span class="NLM_x">–</span> <span class="NLM_lpage">6699</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300482h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsFCkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6689-6699&author=A.+H.+Newmanauthor=T.+Beumingauthor=A.+K.+Banalaauthor=P.+Donthamsettiauthor=K.+Pongettiauthor=A.+LaBountyauthor=B.+Levyauthor=J.+Caoauthor=M.+Michinoauthor=R.+R.+Luedtkeauthor=J.+A.+Javitchauthor=L.+Shi&title=Molecular+determinants+of+selectivity+and+efficacy+at+the+dopamine+D3+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Determinants of Selectivity and Efficacy at the Dopamine D3 Receptor</span></div><div class="casAuthors">Newman, Amy Hauck; Beuming, Thijs; Banala, Ashwini K.; Donthamsetti, Prashant; Pongetti, Katherine; LaBounty, Alex; Levy, Benjamin; Cao, Jianjing; Michino, Mayako; Luedtke, Robert R.; Javitch, Jonathan A.; Shi, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6689-6699</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dopamine D3 receptor (D3R) has been implicated in substance abuse and other neuropsychiatric disorders.  The high sequence homol. between the D3R and D2R, esp. within the orthosteric binding site (OBS) that binds dopamine, has made the development of D3R-selective compds. challenging.  Here, we deconstruct into pharmacophoric elements a series of D3R-selective substituted-4-phenylpiperazine compds. and use computational simulations and binding and activation studies to dissect the structural bases for D3R selectivity and efficacy.  We find that selectivity arises from divergent interactions within a second binding pocket (SBP) sep. from the OBS, whereas efficacy depends on the binding mode in the OBS.  Our findings reveal structural features of the receptor that are crit. to selectivity and efficacy that can be used to design highly D3R-selective ligands with targeted efficacies.  These findings are generalizable to other GPCRs in which the SBP can be targeted by bitopic or allosteric ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmBJU7uyvVg7Vg90H21EOLACvtfcHk0lhCUQUOzRwugA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsFCkt7c%253D&md5=033dd49282723650828a3ec0a31211e5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm300482h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300482h%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DBanala%26aufirst%3DA.%2BK.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DPongetti%26aufirst%3DK.%26aulast%3DLaBounty%26aufirst%3DA.%26aulast%3DLevy%26aufirst%3DB.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DL.%26atitle%3DMolecular%2520determinants%2520of%2520selectivity%2520and%2520efficacy%2520at%2520the%2520dopamine%2520D3%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6689%26epage%3D6699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Gilbert, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z. X.</span><span> </span><span class="NLM_article-title">Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=17-28&author=J.+G.+Gilbertauthor=A.+H.+Newmanauthor=E.+L.+Gardnerauthor=C.+R.+Ashbyauthor=C.+A.+Heidbrederauthor=A.+C.+Pakauthor=X.+Q.+Pengauthor=Z.+X.+Xi&title=Acute+administration+of+SB-277011A%2C+NGB+2904%2C+or+BP+897+inhibits+cocaine+cue-induced+reinstatement+of+drug-seeking+behavior+in+rats%3A+role+of+dopamine+D3+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGilbert%26aufirst%3DJ.%2BG.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DHeidbreder%26aufirst%3DC.%2BA.%26aulast%3DPak%26aufirst%3DA.%2BC.%26aulast%3DPeng%26aufirst%3DX.%2BQ.%26aulast%3DXi%26aufirst%3DZ.%2BX.%26atitle%3DAcute%2520administration%2520of%2520SB-277011A%252C%2520NGB%25202904%252C%2520or%2520BP%2520897%2520inhibits%2520cocaine%2520cue-induced%2520reinstatement%2520of%2520drug-seeking%2520behavior%2520in%2520rats%253A%2520role%2520of%2520dopamine%2520D3%2520receptors%26jtitle%3DSynapse%26date%3D2005%26volume%3D57%26spage%3D17%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Xi, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gitajn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span> </span><span class="NLM_article-title">The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine’s rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1393</span><span class="NLM_x">–</span> <span class="NLM_lpage">1405</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=1393-1405&author=Z.+X.+Xiauthor=A.+H.+Newmanauthor=J.+G.+Gilbertauthor=A.+C.+Pakauthor=X.+Q.+Pengauthor=C.+R.+Ashbyauthor=L.+Gitajnauthor=E.+L.+Gardner&title=The+novel+dopamine+D3+receptor+antagonist+NGB+2904+inhibits+cocaine%E2%80%99s+rewarding+effects+and+cocaine-induced+reinstatement+of+drug-seeking+behavior+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DZ.%2BX.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DGilbert%26aufirst%3DJ.%2BG.%26aulast%3DPak%26aufirst%3DA.%2BC.%26aulast%3DPeng%26aufirst%3DX.%2BQ.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DGitajn%26aufirst%3DL.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26atitle%3DThe%2520novel%2520dopamine%2520D3%2520receptor%2520antagonist%2520NGB%25202904%2520inhibits%2520cocaine%25E2%2580%2599s%2520rewarding%2520effects%2520and%2520cocaine-induced%2520reinstatement%2520of%2520drug-seeking%2520behavior%2520in%2520rats%26jtitle%3DNeuropsychopharmacology%26date%3D2006%26volume%3D31%26spage%3D1393%26epage%3D1405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Higley, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span> </span><span class="NLM_article-title">PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1177%2F0269881109358201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=20142301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFSju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=263-273&author=A.+E.+Higleyauthor=K.+Spillerauthor=P.+Grundtauthor=A.+H.+Newmanauthor=S.+W.+Kieferauthor=Z.+X.+Xiauthor=E.+L.+Gardner&title=PG01037%2C+a+novel+dopamine+D3+receptor+antagonist%2C+inhibits+the+effects+of+methamphetamine+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats</span></div><div class="casAuthors">Higley, Amanda E.; Spiller, Krista; Grundt, Peter; Newman, Amy Hauck; Kiefer, Stephen W.; Xi, Zheng-Xiong; Gardner, Eliot L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">263-273</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Our previous studies have shown that the selective dopamine D3 receptor antagonists SB-277011A or NGB 2904 significantly attenuate cocaine self-administration under a progressive-ratio reinforcement schedule and cocaine-, methamphetamine- or nicotine-enhanced brain stimulation reward.  However, the poor bioavailability of SB-277011A has limited its potential use in humans.  In the present study, we investigated the effects of the novel D3 receptor antagonist PG01037 on methamphetamine self-administration, methamphetamine-assocd. cue-induced reinstatement of drug seeking and methamphetamine-enhanced brain stimulation reward.  Rats were allowed to i.v. self-administer methamphetamine under fixed-ratio 2 and progressive-ratio reinforcement conditions, and then the effects of PG01037 on methamphetamine self-administration and cue-induced reinstatement were assessed.  Addnl. groups of rats were trained for intracranial elec. brain stimulation reward and the effects of PG01037 and methamphetamine on brain stimulation reward were assessed.  Acute i.p. administration of PG01037 (3, 10, 30 mg/kg) failed to alter methamphetamine or sucrose self-administration under fixed-ratio 2 reinforcement, but significantly lowered the break-point levels for methamphetamine or sucrose self-administration under progressive-ratio reinforcement.  In addn., PG01037 significantly inhibited methamphetamine-assocd. cue-triggered reinstatement of drug-seeking behavior and methamphetamine-enhanced brain stimulation reward.  These data suggest that the novel D3 antagonist PG01037 significantly attenuates the rewarding effects as assessed by progressive-ratio self-administration and brain stimulation reward, and inhibits methamphetamine-assocd. cue-induced reinstatement of drug-seeking behavior.  These findings support the potential use of PG01037 or other selective D3 antagonists in the treatment of methamphetamine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5j7BtWdpNV7Vg90H21EOLACvtfcHk0li1OlmZ4kxqsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFSju7Y%253D&md5=904e609c8a3549b42af4c1f2bf670684</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1177%2F0269881109358201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0269881109358201%26sid%3Dliteratum%253Aachs%26aulast%3DHigley%26aufirst%3DA.%2BE.%26aulast%3DSpiller%26aufirst%3DK.%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DKiefer%26aufirst%3DS.%2BW.%26aulast%3DXi%26aufirst%3DZ.%2BX.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26atitle%3DPG01037%252C%2520a%2520novel%2520dopamine%2520D3%2520receptor%2520antagonist%252C%2520inhibits%2520the%2520effects%2520of%2520methamphetamine%2520in%2520rats%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2011%26volume%3D25%26spage%3D263%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Higley, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span> </span><span class="NLM_article-title">Dopamine D(3) receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">659</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.ejphar.2011.02.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=21466803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFGntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=659&publication_year=2011&pages=187-192&author=A.+E.+Higleyauthor=S.+W.+Kieferauthor=X.+Liauthor=J.+Gaalauthor=Z.+X.+Xiauthor=E.+L.+Gardner&title=Dopamine+D%283%29+receptor+antagonist+SB-277011A+inhibits+methamphetamine+self-administration+and+methamphetamine-induced+reinstatement+of+drug-seeking+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D3 receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats</span></div><div class="casAuthors">Higley, Amanda E.; Kiefer, Stephen W.; Li, Xia; Gaal, Jozsef; Xi, Zheng-Xiong; Gardner, Eliot L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">659</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">187-192</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have previously reported that selective blockade of brain dopamine D3 receptors by SB-277011A significantly attenuates cocaine self-administration and cocaine-induced reinstatement of drug-seeking behavior.  In the present study, we investigated whether SB-277011A similarly inhibits methamphetamine self-administration and methamphetamine-induced reinstatement to drug-seeking behavior.  Male Long-Evans rats were allowed to i.v. self-administer methamphetamine (0.05 mg/kg/infusion) under fixed-ratio 2 (FR2) or progressive-ratio (PR) reinforcement conditions, and some rats were tested for methamphetamine-induced reinstatement of drug-seeking behavior after extinction of self-administration.  The effects of SB-277011A on each of these methamphetamine-supported behaviors were then tested.  Acute i.p. administration of SB-277011A failed to alter methamphetamine self-administration under FR2 reinforcement, but significantly lowered the break-point for methamphetamine self-administration under PR reinforcement.  SB-277011A also significantly inhibited methamphetamine-triggered reinstatement of extinguished drug-seeking behavior.  Overall, these data show that blockade of dopamine D3 receptors by SB-277011A attenuates the rewarding and incentive motivational effects of methamphetamine in rats, supporting the development of selective dopamine D3 antagonists for the treatment of methamphetamine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7xl1sYrL3L7Vg90H21EOLACvtfcHk0li1OlmZ4kxqsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFGntLg%253D&md5=aff782e2174c94f5fffbeae4e7f98e85</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2011.02.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2011.02.046%26sid%3Dliteratum%253Aachs%26aulast%3DHigley%26aufirst%3DA.%2BE.%26aulast%3DKiefer%26aufirst%3DS.%2BW.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGaal%26aufirst%3DJ.%26aulast%3DXi%26aufirst%3DZ.%2BX.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26atitle%3DDopamine%2520D%25283%2529%2520receptor%2520antagonist%2520SB-277011A%2520inhibits%2520methamphetamine%2520self-administration%2520and%2520methamphetamine-induced%2520reinstatement%2520of%2520drug-seeking%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D659%26spage%3D187%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">O’Connor, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokol, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Onofrio, G.</span><span> </span><span class="NLM_article-title">Addiction medicine: the birth of a new discipline</span> <span class="citation_source-journal">JAMA Int. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">174</span><span class="NLM_x">, </span> <span class="NLM_fpage">1717</span><span class="NLM_x">–</span> <span class="NLM_lpage">1718</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1001%2Fjamainternmed.2014.4211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=25201642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FptlersQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2014&pages=1717-1718&author=P.+G.+O%E2%80%99Connorauthor=R.+J.+Sokolauthor=G.+D%E2%80%99Onofrio&title=Addiction+medicine%3A+the+birth+of+a+new+discipline"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Addiction medicine: the birth of a new discipline</span></div><div class="casAuthors">O'Connor Patrick G; Sokol Robert J; D'Onofrio Gail</div><div class="citationInfo"><span class="NLM_cas:title">JAMA internal medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1717-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSWNdmGTHu_4srRqEXsZufAfW6udTcc2eagdzRpCQzafLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FptlersQ%253D%253D&md5=8d0023a5dde450ec466e910be2a53e46</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1001%2Fjamainternmed.2014.4211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamainternmed.2014.4211%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%2BG.%26aulast%3DSokol%26aufirst%3DR.%2BJ.%26aulast%3DD%25E2%2580%2599Onofrio%26aufirst%3DG.%26atitle%3DAddiction%2520medicine%253A%2520the%2520birth%2520of%2520a%2520new%2520discipline%26jtitle%3DJAMA%2520Int.%2520Med.%26date%3D2014%26volume%3D174%26spage%3D1717%26epage%3D1718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Le Houezec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubin, H. J.</span><span> </span><span class="NLM_article-title">Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1959</span><span class="NLM_x">–</span> <span class="NLM_lpage">1967</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1517%2F14656566.2013.818978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=23978314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVektr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=1959-1967&author=J.+Le+Houezecauthor=H.+J.+Aubin&title=Pharmacotherapies+and+harm-reduction+options+for+the+treatment+of+tobacco+dependence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence</span></div><div class="casAuthors">Le Houezec, Jacques; Aubin, Henri-Jean</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1959-1967</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Tobacco dependence, a chronic relapsing condition, requires repeated interventions and multiple attempts to quit.  Areas covered: Strategies for assisting smoking cessation include behavioral counselling and pharmacotherapy.  Three drugs are currently used as first-line pharmacotherapy: nicotine replacement therapy (NRT), bupropion and varenicline.  Compared to placebo, the drug effect varies from RR = 2.27 for varenicline, to 1.69 for bupropion, and 1.60 for any form of NRT.  Cytisine (similar to varenicline) has a RR = 3.98 compared to placebo (two trials).  Second-line pharmacotherapies include nortriptyline and clonidine.  This review also offers an overview of pipeline developments.  Expert opinion: Effective medications exist, and clinicians should encourage and offer treatment to every smoker.  However, most smokers try to quit by themselves, with only about 3% quitting successfully each year.  Alternative interventions are needed.  Harm redn. has not received much support to date.  Safer alternative to tobacco smoking (smoke-free products, long-term use of cessation drugs, or electronic cigarettes) could save lives and reduce the burden of tobacco-related deaths and diseases.  Despite some encouragement to develop a research agenda for e-cigarettes, particularly on the safety issues, too little attention has been brought to this area of research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpALcCZ0674V7Vg90H21EOLACvtfcHk0lg5ycmViYqhhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVektr%252FN&md5=6c5822860388ce77c15deae3da3f7789</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1517%2F14656566.2013.818978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2013.818978%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BHouezec%26aufirst%3DJ.%26aulast%3DAubin%26aufirst%3DH.%2BJ.%26atitle%3DPharmacotherapies%2520and%2520harm-reduction%2520options%2520for%2520the%2520treatment%2520of%2520tobacco%2520dependence%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2013%26volume%3D14%26spage%3D1959%26epage%3D1967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Jonas, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amick, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobashev, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wines, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanahan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gass, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbutt, J. C.</span><span> </span><span class="NLM_article-title">Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis</span> <span class="citation_source-journal">JAMA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">1889</span><span class="NLM_x">–</span> <span class="NLM_lpage">1900</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2014&pages=1889-1900&author=D.+E.+Jonasauthor=H.+R.+Amickauthor=C.+Feltnerauthor=G.+Bobashevauthor=K.+Thomasauthor=R.+Winesauthor=M.+M.+Kimauthor=E.+Shanahanauthor=C.+E.+Gassauthor=C.+J.+Roweauthor=J.+C.+Garbutt&title=Pharmacotherapy+for+adults+with+alcohol+use+disorders+in+outpatient+settings%3A+a+systematic+review+and+meta-analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJonas%26aufirst%3DD.%2BE.%26aulast%3DAmick%26aufirst%3DH.%2BR.%26aulast%3DFeltner%26aufirst%3DC.%26aulast%3DBobashev%26aufirst%3DG.%26aulast%3DThomas%26aufirst%3DK.%26aulast%3DWines%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DM.%2BM.%26aulast%3DShanahan%26aufirst%3DE.%26aulast%3DGass%26aufirst%3DC.%2BE.%26aulast%3DRowe%26aufirst%3DC.%2BJ.%26aulast%3DGarbutt%26aufirst%3DJ.%2BC.%26atitle%3DPharmacotherapy%2520for%2520adults%2520with%2520alcohol%2520use%2520disorders%2520in%2520outpatient%2520settings%253A%2520a%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DJAMA%26date%3D2014%26volume%3D311%26spage%3D1889%26epage%3D1900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Raisch, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fye, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boardman, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, M. R.</span><span> </span><span class="NLM_article-title">Opioid dependence treatment, including buprenorphine/naloxone</span> <span class="citation_source-journal">Ann. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">312</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=312-321&author=D.+W.+Raischauthor=C.+L.+Fyeauthor=K.+D.+Boardmanauthor=M.+R.+Sather&title=Opioid+dependence+treatment%2C+including+buprenorphine%2Fnaloxone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaisch%26aufirst%3DD.%2BW.%26aulast%3DFye%26aufirst%3DC.%2BL.%26aulast%3DBoardman%26aufirst%3DK.%2BD.%26aulast%3DSather%26aufirst%3DM.%2BR.%26atitle%3DOpioid%2520dependence%2520treatment%252C%2520including%2520buprenorphine%252Fnaloxone%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2002%26volume%3D36%26spage%3D312%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Fudala, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridge, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williford, W. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raisch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casadonte, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malkerneker, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tusel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buprenorphine/Naloxone Collaborative Study Group</span><span> </span><span class="NLM_article-title">Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">349</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">958</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1056%2FNEJMoa022164" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=12954743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntFeitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2003&pages=949-958&author=P.+J.+Fudalaauthor=T.+P.+Bridgeauthor=S.+Herbertauthor=W.+O.+Willifordauthor=C.+N.+Chiangauthor=K.+Jonesauthor=J.+Collinsauthor=D.+Raischauthor=P.+Casadonteauthor=R.+J.+Goldsmithauthor=W.+Lingauthor=U.+Malkernekerauthor=L.+McNicholasauthor=J.+Rennerauthor=S.+Stineauthor=D.+Tuselauthor=Buprenorphine%2FNaloxone+Collaborative+Study+Group&title=Office-based+treatment+of+opiate+addiction+with+a+sublingual-tablet+formulation+of+buprenorphine+and+naloxone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone</span></div><div class="casAuthors">Fudala, Paul J.; Bridge, T. Peter; Herbert, Susan; Williford, William O.; Chiang, C. Nora; Jones, Karen; Collins, Joseph; Raisch, Dennis; Casadonte, Paul; Goldsmith, R. Jeffrey; Ling, Walter; Malkerneker, Usha; McNicholas, Laura; Renner, John; Stine, Susan; Tusel, Donald</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">949-958</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone has been proposed, but its efficacy and safety have not been well studied.  We conducted a multicenter, randomized, placebo-controlled trial involving 326 opiate-addicted persons who were assigned to office-based treatment with sublingual tablets consisting of buprenorphine (16 mg) in combination with naloxone (4 mg), buprenorphine alone (16 mg), or placebo given daily for four weeks.  The primary outcome measures were the percentage of urine samples neg. for opiates and the subjects' self-reported craving for opiates.  Safety data were obtained on 461 opiate-addicted persons who participated in an open-label study of buprenorphine and naloxone (at daily doses of up to 24 mg and 6 mg, resp.) and another 11 persons who received this combination only during the trial.  The double-blind trial was terminated early because buprenorphine and naloxone in combination and buprenorphine alone were found to have greater efficacy than placebo.  The proportion of urine samples that were neg. for opiates was greater in the combined-treatment and buprenorphine groups (17.8 percent and 20.7 percent, resp.) than in the placebo group (5.8 percent, P<0.001 for both comparisons); the active-treatment groups also reported less opiate craving (P<0.001 for both comparisons with placebo).  Rates of adverse events were similar in the active-treatment and placebo groups.  During the open-label phase, the percentage of urine samples neg. for opiates ranged from 35.2 percent to 67.4 percent.  Results from the open-label follow-up study indicated that the combined treatment was safe and well tolerated.  Buprenorphine and naloxone in combination and buprenorphine alone are safe and reduce the use of opiates and the craving for opiates among opiate-addicted persons who receive these medications in an office-based setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-0okugtFPhLVg90H21EOLACvtfcHk0lh2dPCA-PXi0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntFeitrw%253D&md5=35ff9ab1748dba9036f4ff27d7433bd6</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa022164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa022164%26sid%3Dliteratum%253Aachs%26aulast%3DFudala%26aufirst%3DP.%2BJ.%26aulast%3DBridge%26aufirst%3DT.%2BP.%26aulast%3DHerbert%26aufirst%3DS.%26aulast%3DWilliford%26aufirst%3DW.%2BO.%26aulast%3DChiang%26aufirst%3DC.%2BN.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DCollins%26aufirst%3DJ.%26aulast%3DRaisch%26aufirst%3DD.%26aulast%3DCasadonte%26aufirst%3DP.%26aulast%3DGoldsmith%26aufirst%3DR.%2BJ.%26aulast%3DLing%26aufirst%3DW.%26aulast%3DMalkerneker%26aufirst%3DU.%26aulast%3DMcNicholas%26aufirst%3DL.%26aulast%3DRenner%26aufirst%3DJ.%26aulast%3DStine%26aufirst%3DS.%26aulast%3DTusel%26aufirst%3DD.%26aulast%3D%26atitle%3DOffice-based%2520treatment%2520of%2520opiate%2520addiction%2520with%2520a%2520sublingual-tablet%2520formulation%2520of%2520buprenorphine%2520and%2520naloxone%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D349%26spage%3D949%26epage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Koob, G. F.</span><span> </span><span class="NLM_article-title">The neurobiology of addiction: a neuroadaptational view relevant for diagnosis</span> <span class="citation_source-journal">Addiction</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2006&pages=23-30&author=G.+F.+Koob&title=The+neurobiology+of+addiction%3A+a+neuroadaptational+view+relevant+for+diagnosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoob%26aufirst%3DG.%2BF.%26atitle%3DThe%2520neurobiology%2520of%2520addiction%253A%2520a%2520neuroadaptational%2520view%2520relevant%2520for%2520diagnosis%26jtitle%3DAddiction%26date%3D2006%26volume%3D101%26spage%3D23%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Staley, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mash, D. C.</span><span> </span><span class="NLM_article-title">Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">6100</span><span class="NLM_x">–</span> <span class="NLM_lpage">6106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=8815892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaK28Xntleisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=6100-6106&author=J.+K.+Staleyauthor=D.+C.+Mash&title=Adaptive+increase+in+D3+dopamine+receptors+in+the+brain+reward+circuits+of+human+cocaine+fatalities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities</span></div><div class="casAuthors">Staley, Julie K.; Mash, Deborah C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6100-6106</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Recent studies have suggested that the D3 dopamine receptor subtype plays a pivotal role in the reinforcing effects of cocaine.  The D3 receptor-preferring agonist 7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT) is a reinforcer in rhesus monkeys trained to self-administer cocaine, but not in cocaine-naive monkeys.  In this work, in vitro autoradiog. localization of [3H]-(+)-7-OH-DPAT binding in the human brain demonstrated that D3 receptors were prevalent and highly localized over the ventromedial sectors of the striatum.  Pharmacol. characterization of [3H]-(+)-7-OH-DPAT binding to the human nucleus accumbens demonstrated a rank order of potency similar to that obsd. for binding to the cloned D3 receptor expressed in transfected cell lines.  Region-of-interest anal. of [3H]-(+)-7-OH-DPAT binding to the D3 receptor demonstrated a 1-3-fold elevation in the no. of binding sites over particular sectors of the striatum and substantia nigra in cocaine overdose victims as compared with age-matched and drug-free control subjects.  The elevated no. of [3H]-(+)-7-OH-DPAT binding sites demonstrates that adaptive changes in the D3 receptor in the reward circuitry of the brain are assocd. with chronic cocaine abuse.  The D3 receptor may be a useful target for development of anticocaine drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppMNXOozUcmrVg90H21EOLACvtfcHk0lh2dPCA-PXi0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xntleisbk%253D&md5=5b503d0e1c8e7d621ebc63be126f8079</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStaley%26aufirst%3DJ.%2BK.%26aulast%3DMash%26aufirst%3DD.%2BC.%26atitle%3DAdaptive%2520increase%2520in%2520D3%2520dopamine%2520receptors%2520in%2520the%2520brain%2520reward%2520circuits%2520of%2520human%2520cocaine%2520fatalities%26jtitle%3DJ.%2520Neurosci.%26date%3D1996%26volume%3D16%26spage%3D6100%26epage%3D6106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Segal, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraes, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mash, D. C.</span><span> </span><span class="NLM_article-title">Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities</span> <span class="citation_source-journal">Brain Res. Mol. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">339</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2FS0169-328X%2897%2900025-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=9149110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaK2sXitVKqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1997&pages=335-339&author=D.+M.+Segalauthor=C.+T.+Moraesauthor=D.+C.+Mash&title=Up-regulation+of+D3+dopamine+receptor+mRNA+in+the+nucleus+accumbens+of+human+cocaine+fatalities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities</span></div><div class="casAuthors">Segal, David M.; Moraes, Carlos T.; Mash, Deborah C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">335-339</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The effects of chronic cocaine use on D3 receptor mRNA expression in the human nucleus accumbens was assessed by reverse transcription-polymerase chain reaction.  D3 receptor/cyclophilin mRNA ratios in the nucleus accumbens were increased 6-fold in cocaine overdose victims as compared to age-matched and drug-free control subjects.  This finding demonstrates that chronic cocaine exposure leads to adaptive increases in the expression of D3 receptor gene in a crit. reward center in brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofVqjSgzm08rVg90H21EOLACvtfcHk0lh2dPCA-PXi0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitVKqsbc%253D&md5=96519c2f514430320ea40320a9072414</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0169-328X%2897%2900025-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-328X%252897%252900025-9%26sid%3Dliteratum%253Aachs%26aulast%3DSegal%26aufirst%3DD.%2BM.%26aulast%3DMoraes%26aufirst%3DC.%2BT.%26aulast%3DMash%26aufirst%3DD.%2BC.%26atitle%3DUp-regulation%2520of%2520D3%2520dopamine%2520receptor%2520mRNA%2520in%2520the%2520nucleus%2520accumbens%2520of%2520human%2520cocaine%2520fatalities%26jtitle%3DBrain%2520Res.%2520Mol.%2520Brain%2520Res.%26date%3D1997%26volume%3D45%26spage%3D335%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Mash, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staley, J. K.</span><span> </span><span class="NLM_article-title">D3 dopamine and kappa opioid receptor alterations in human brain of cocaine-overdose victims</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">877</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=877&publication_year=1999&pages=507-522&author=D.+C.+Mashauthor=J.+K.+Staley&title=D3+dopamine+and+kappa+opioid+receptor+alterations+in+human+brain+of+cocaine-overdose+victims"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMash%26aufirst%3DD.%2BC.%26aulast%3DStaley%26aufirst%3DJ.%2BK.%26atitle%3DD3%2520dopamine%2520and%2520kappa%2520opioid%2520receptor%2520alterations%2520in%2520human%2520brain%2520of%2520cocaine-overdose%2520victims%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D1999%26volume%3D877%26spage%3D507%26epage%3D522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Le Foll, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabiner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boileau, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo Pich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokoloff, P.</span><span> </span><span class="NLM_article-title">Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">211</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2FB978-0-444-63425-2.00011-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24968784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1SqtLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2014&pages=255-275&author=B.+Le+Follauthor=G.+Colloauthor=E.+A.+Rabinerauthor=I.+Boileauauthor=E.+Merlo+Pichauthor=P.+Sokoloff&title=Dopamine+D3+receptor+ligands+for+drug+addiction+treatment%3A+update+on+recent+findings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D3 receptor ligands for drug addiction treatment, update on recent findings</span></div><div class="casAuthors">Le Foll, Bernard; Collo, Ginetta; Rabiner, Eugenii A.; Boileau, Isabelle; Pich, Emilio Merlo; Sokoloff, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue">Dopamine</span>),
    <span class="NLM_cas:pages">255-275</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The dopamine D3 receptor is located in the limbic area and apparently mediates selective effects on motivation to take drugs and drug-seeking behaviors, so that there has been considerable interest on the possible use of D3 receptor ligands to treat drug addiction.  However, only recently selective tools allowing studying this receptor have been developed.  This chapter presents an overview of findings that were presented at a symposium on the conference Dopamine 2013 in Sardinia in May 2013.  Novel neurobiol. findings indicate that drugs of abuse can lead to significant structural plasticity in rodent brain and that this is dependent on the availability of functional dopamine D3 autoreceptor, whose activation increased phosphorylation in the ERK pathway and in the Akt/mTORC1 pathway indicating the parallel engagement of a series of intracellular signaling pathways all involved in cell growth and survival.  Preclin. findings using animal models of drug-seeking behaviors confirm that D3 antagonists have a promising profile to treat drug addiction across drugs of abuse type.  Imaging the D3 is now feasible in human subjects.  Notably, the development of (+)-4-propyl-9-hydroxynaphthoxazine ligand used in positron emission tomog. (PET) studies in humans allows to measure D3 and D2 receptors based on the area of the brain under study.  This PET ligand has been used to confirm up-regulation of D3 sites in psychostimulant users and to reveal that tobacco smoking produces elevation of dopamine at the level of D3 sites.  There are now novel antagonists being developed, but also old drugs such as buspirone, that are available to test the D3 hypothesis in humans.  The first results of clin. investigations are now being provided.  Overall, those recent findings support further exploration of D3 ligands to treat drug addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxIQ6SUa_NcrVg90H21EOLACvtfcHk0ljnrKSfCSvsbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1SqtLzP&md5=e997ab74bf84de9d62b9b734a585b949</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FB978-0-444-63425-2.00011-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-444-63425-2.00011-8%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BFoll%26aufirst%3DB.%26aulast%3DCollo%26aufirst%3DG.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DBoileau%26aufirst%3DI.%26aulast%3DMerlo%2BPich%26aufirst%3DE.%26aulast%3DSokoloff%26aufirst%3DP.%26atitle%3DDopamine%2520D3%2520receptor%2520ligands%2520for%2520drug%2520addiction%2520treatment%253A%2520update%2520on%2520recent%2520findings%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2014%26volume%3D211%26spage%3D255%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Boileau, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behzadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusjan, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selby, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zack, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCluskey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, S. J.</span><span> </span><span class="NLM_article-title">Higher binding of the dopamine D3 receptor-preferring ligand [<sup>11</sup>C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1353</span><span class="NLM_x">–</span> <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1523%2FJNEUROSCI.4371-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=22279219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1Cmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=1353-1359&author=I.+Boileauauthor=D.+Payerauthor=S.+Houleauthor=A.+Behzadiauthor=P.+M.+Rusjanauthor=J.+Tongauthor=D.+Wilkinsauthor=P.+Selbyauthor=T.+P.+Georgeauthor=M.+Zackauthor=Y.+Furukawaauthor=T.+McCluskeyauthor=A.+A.+Wilsonauthor=S.+J.+Kish&title=Higher+binding+of+the+dopamine+D3+receptor-preferring+ligand+%5B11C%5D-%28%2B%29-propyl-hexahydro-naphtho-oxazin+in+methamphetamine+polydrug+users%3A+a+positron+emission+tomography+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study</span></div><div class="casAuthors">Boileau, Isabelle; Payer, Doris; Houle, Sylvain; Behzadi, Arian; Rusjan, Pablo M.; Tong, Junchao; Wilkins, Diana; Selby, Peter; George, Tony P.; Zack, Martin; Furukawa, Yoshiaki; McCluskey, Tina; Wilson, Alan A.; Kish, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1353-1359</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Positron emission tomog. (PET) findings suggesting lower D2-type dopamine receptors and dopamine concn. in brains of stimulant users have prompted speculation that increasing dopamine signaling might help in drug treatment.  However, this strategy needs to consider the possibility, based on animal and postmortem human data, that dopaminergic activity at the related D3 receptor might, in contrast, be elevated and thereby contribute to drug-taking behavior.  We tested the hypothesis that D3 receptor binding is above normal in methamphetamine (MA) polydrug users, using PET and the D3-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin ([11C]-(+)-PHNO).  Sixteen control subjects and 16 polydrug users reporting MA as their primary drug of abuse underwent PET scanning after [11C]-(+)-PHNO.  Compared with control subjects, drug users had higher [11C]-(+)-PHNO binding in the D3-rich midbrain substantia nigra (SN; +46%; p < 0.02) and in the globus pallidus (+9%; p = 0.06) and ventral pallidum (+11%; p = 0.1), whereas binding was slightly lower in the D2-rich dorsal striatum (approx. -4%, NS; -12% in heavy users, p = 0.01) and related to drug-use severity.  The [11C]-(+)-PHNO binding ratio in D3-rich SN vs. D2-rich dorsal striatum was 55% higher in MA users (p = 0.004), with heavy but not moderate users having ratios significantly different from controls.  [11C]-(+)-PHNO binding in SN was related to self-reported "drug wanting.".  We conclude that the dopamine D3 receptor, unlike the D2 receptor, might be upregulated in brains of MA polydrug users, although lower dopamine levels in MA users could have contributed to the finding.  Pharmacol. studies are needed to establish whether normalization of D3 receptor function could reduce vulnerability to relapse in stimulant abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrI6mw4uiDYbVg90H21EOLACvtfcHk0ljnrKSfCSvsbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1Cmt7g%253D&md5=9db9d298d4931a88f0fe81928022575f</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4371-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4371-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DBoileau%26aufirst%3DI.%26aulast%3DPayer%26aufirst%3DD.%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DBehzadi%26aufirst%3DA.%26aulast%3DRusjan%26aufirst%3DP.%2BM.%26aulast%3DTong%26aufirst%3DJ.%26aulast%3DWilkins%26aufirst%3DD.%26aulast%3DSelby%26aufirst%3DP.%26aulast%3DGeorge%26aufirst%3DT.%2BP.%26aulast%3DZack%26aufirst%3DM.%26aulast%3DFurukawa%26aufirst%3DY.%26aulast%3DMcCluskey%26aufirst%3DT.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DKish%26aufirst%3DS.%2BJ.%26atitle%3DHigher%2520binding%2520of%2520the%2520dopamine%2520D3%2520receptor-preferring%2520ligand%2520%255B11C%255D-%2528%252B%2529-propyl-hexahydro-naphtho-oxazin%2520in%2520methamphetamine%2520polydrug%2520users%253A%2520a%2520positron%2520emission%2520tomography%2520study%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D1353%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Payer, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behzadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusjan, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selby, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCluskey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boileau, I.</span><span> </span><span class="NLM_article-title">Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [<sup>11</sup>C]-+-PHNO</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=311-318&author=D.+E.+Payerauthor=A.+Behzadiauthor=S.+J.+Kishauthor=S.+Houleauthor=A.+A.+Wilsonauthor=P.+M.+Rusjanauthor=J.+Tongauthor=P.+Selbyauthor=T.+P.+Georgeauthor=T.+McCluskeyauthor=I.+Boileau&title=Heightened+D3+dopamine+receptor+levels+in+cocaine+dependence+and+contributions+to+the+addiction+behavioral+phenotype%3A+a+positron+emission+tomography+study+with+%5B11C%5D-%2B-PHNO"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPayer%26aufirst%3DD.%2BE.%26aulast%3DBehzadi%26aufirst%3DA.%26aulast%3DKish%26aufirst%3DS.%2BJ.%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DRusjan%26aufirst%3DP.%2BM.%26aulast%3DTong%26aufirst%3DJ.%26aulast%3DSelby%26aufirst%3DP.%26aulast%3DGeorge%26aufirst%3DT.%2BP.%26aulast%3DMcCluskey%26aufirst%3DT.%26aulast%3DBoileau%26aufirst%3DI.%26atitle%3DHeightened%2520D3%2520dopamine%2520receptor%2520levels%2520in%2520cocaine%2520dependence%2520and%2520contributions%2520to%2520the%2520addiction%2520behavioral%2520phenotype%253A%2520a%2520positron%2520emission%2520tomography%2520study%2520with%2520%255B11C%255D-%252B-PHNO%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D311%26epage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Payer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramaniam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boileau, I.</span><span> </span><span class="NLM_article-title">What is the role of the D3 receptor in addiction? A mini review of PET studies with [<sup>11</sup>C]-(+)-PHNO</span> <span class="citation_source-journal">Prog. Neuropsychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.pnpbp.2013.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=23999545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BC3sbkslCktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2014&pages=4-8&author=D.+Payerauthor=G.+Balasubramaniamauthor=I.+Boileau&title=What+is+the+role+of+the+D3+receptor+in+addiction%3F+A+mini+review+of+PET+studies+with+%5B11C%5D-%28%2B%29-PHNO"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">What is the role of the D3 receptor in addiction? A mini review of PET studies with [(11)C]-(+)-PHNO</span></div><div class="casAuthors">Payer Doris; Balasubramaniam Gayathiri; Boileau Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">Progress in neuro-psychopharmacology & biological psychiatry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The chronic use of drugs, including psychostimulants such as cocaine and amphetamine, has been associated with low D2/3 dopamine receptor availability, which in turn has been linked to poor clinical outcome.  In contrast, recent studies focused on the D3 receptor (a member of the D2-like receptor family) suggest that chronic exposure to stimulant drugs can up-regulate this receptor subtype, which, in preclinical models, is linked to dopamine system sensitization - a process hypothesized to contribute to relapse in addiction.  In this mini review we present recent human data suggesting that the D3 receptor may contribute to core features of addiction, and discuss the usefulness of the PET imaging probe [(11)C]-(+)-PHNO in investigating this question.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXKVTprS8g18kU0YCbOU3EfW6udTcc2eajkaFKyk-u_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbkslCktQ%253D%253D&md5=54c63263f9c6897a5219b3a85e5fe841</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2013.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2013.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DPayer%26aufirst%3DD.%26aulast%3DBalasubramaniam%26aufirst%3DG.%26aulast%3DBoileau%26aufirst%3DI.%26atitle%3DWhat%2520is%2520the%2520role%2520of%2520the%2520D3%2520receptor%2520in%2520addiction%253F%2520A%2520mini%2520review%2520of%2520PET%2520studies%2520with%2520%255B11C%255D-%2528%252B%2529-PHNO%26jtitle%3DProg.%2520Neuropsychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2014%26volume%3D52%26spage%3D4%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Erritzoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tziortzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bargiela, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colasanti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Searle, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaver, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nutt, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo-Pich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabiner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingford-Hughes, A.</span><span> </span><span class="NLM_article-title">In vivo imaging of cerebral dopamine D3 receptors in alcoholism</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1703</span><span class="NLM_x">–</span> <span class="NLM_lpage">1712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=1703-1712&author=D.+Erritzoeauthor=A.+Tziortziauthor=D.+Bargielaauthor=A.+Colasantiauthor=G.+E.+Searleauthor=R.+N.+Gunnauthor=J.+D.+Beaverauthor=A.+Waldmanauthor=D.+J.+Nuttauthor=M.+Baniauthor=E.+Merlo-Pichauthor=E.+A.+Rabinerauthor=A.+Lingford-Hughes&title=In+vivo+imaging+of+cerebral+dopamine+D3+receptors+in+alcoholism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DErritzoe%26aufirst%3DD.%26aulast%3DTziortzi%26aufirst%3DA.%26aulast%3DBargiela%26aufirst%3DD.%26aulast%3DColasanti%26aufirst%3DA.%26aulast%3DSearle%26aufirst%3DG.%2BE.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DBeaver%26aufirst%3DJ.%2BD.%26aulast%3DWaldman%26aufirst%3DA.%26aulast%3DNutt%26aufirst%3DD.%2BJ.%26aulast%3DBani%26aufirst%3DM.%26aulast%3DMerlo-Pich%26aufirst%3DE.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DLingford-Hughes%26aufirst%3DA.%26atitle%3DIn%2520vivo%2520imaging%2520of%2520cerebral%2520dopamine%2520D3%2520receptors%2520in%2520alcoholism%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D1703%26epage%3D1712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Le Foll, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boileau, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Ciano, P.</span><span> </span><span class="NLM_article-title">Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.3389%2Ffphar.2014.00161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=25071579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BC2cbmvFOksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=161&author=B.+Le+Follauthor=A.+A.+Wilsonauthor=A.+Graffauthor=I.+Boileauauthor=P.+Di+Ciano&title=Recent+methods+for+measuring+dopamine+D3+receptor+occupancy+in+vivo%3A+importance+for+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development</span></div><div class="casAuthors">Le Foll Bernard; Wilson Alan A; Graff Ariel; Boileau Isabelle; Di Ciano Patricia</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">161</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">There is considerable interest in developing highly selective dopamine (DA) D3 receptor ligands for a variety of mental health disorders.  DA D3 receptors have been implicated in Parkinson's disease, schizophrenia, anxiety, depression, and substance use disorders.  The most concrete evidence suggests a role for the D3 receptor in drug-seeking behaviors.  D3 receptors are a subtype of D2 receptors, and traditionally the functional role of these two receptors has been difficult to differentiate.  Over the past 10-15 years a number of compounds selective for D3 over D2 receptors have been developed.  However, translating these findings into clinical research has been difficult as many of these compounds cannot be used in humans.  Therefore, the functional data involving the D3 receptor in drug addiction mostly comes from pre-clinical studies.  Recently, with the advent of [(11)C]-(+)-PHNO, it has become possible to image D3 receptors in the human brain with increased selectivity and sensitivity.  This is a significant innovation over traditional methods such as [(11)C]-raclopride that cannot differentiate between D2 and D3 receptors.  The use of [(11)C]-(+)-PHNO will allow for further delineation of the role of D3 receptors.  Here, we review recent evidence that the role of the D3 receptor has functional importance and is distinct from the role of the D2 receptor.  We then introduce the utility of analyzing [(11)C]-(+)-PHNO binding by region of interest.  This novel methodology can be used in pre-clinical and clinical approaches for the measurement of occupancy of both D3 and D2 receptors.  Evidence that [(11)C]-(+)-PHNO can provide insights into the function of D3 receptors in addiction is also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9_NOconUSPCCEBeYuoi7AfW6udTcc2eamSJ8XeH-thrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbmvFOksQ%253D%253D&md5=aa051596b978c380a5eaeeb2eb15f81d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2014.00161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2014.00161%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BFoll%26aufirst%3DB.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DGraff%26aufirst%3DA.%26aulast%3DBoileau%26aufirst%3DI.%26aulast%3DDi%2BCiano%26aufirst%3DP.%26atitle%3DRecent%2520methods%2520for%2520measuring%2520dopamine%2520D3%2520receptor%2520occupancy%2520in%2520vivo%253A%2520importance%2520for%2520drug%2520development%26jtitle%3DFront.%2520Pharmacol.%26date%3D2014%26volume%3D5%26spage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Heidbreder, C.</span><span> </span><span class="NLM_article-title">Rationale in support of the use of selective dopamine D(3) receptor antagonists for the pharmacotherapeutic management of substance use disorders</span> <span class="citation_source-journal">Naunyn-Schmiedeberg’s Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">386</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1007%2Fs00210-012-0803-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=23104235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ejur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=386&publication_year=2013&pages=167-176&author=C.+Heidbreder&title=Rationale+in+support+of+the+use+of+selective+dopamine+D%283%29+receptor+antagonists+for+the+pharmacotherapeutic+management+of+substance+use+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Rationale in support of the use of selective dopamine D3 receptor antagonists for the pharmacotherapeutic management of substance use disorders</span></div><div class="casAuthors">Heidbreder, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">386</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-176</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Growing evidence indicates that dopamine (DA) D3 receptors are involved in the control of drug-seeking behavior and may play an important role in the pathophysiol. of substance use disorders.  First, DA D3 receptors are distributed in strategic areas belonging to the mesolimbic DA system such as the ventral striatum, midbrain, and pallidum, which have been assocd. with behaviors controlled by the presentation of drug-assocd. cues.  Second, repeated exposure to drugs of abuse has been shown to produce neuroadaptations in the DA D3 system.  Third, the synthesis and characterization of highly potent and selective DA D3 receptor antagonists has permitted to further define the role of the DA D3 receptor in drug addiction.  Provided that the available preclin. and preliminary clin. evidence can be translated into clin. proof of concept in human, selective DA D3 receptor antagonists show promise for the treatment of substance use disorders as reflected by their potential to (1) regulate the motivation to self-administered drugs under schedules of reinforcement that require an increase in work demand and (2) disrupt the responsiveness to drug-assocd. stimuli that play a key role in the reinstatement of drug-seeking behavior triggered by re-exposure to the drug itself, re-exposure to environmental cues that had been previously assocd. with drug-taking behavior, or stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJryekGxZ_AbVg90H21EOLACvtfcHk0lilIg0C3T8JQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ejur0%253D&md5=4b196deebddce4d802a3dcef465d1dac</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs00210-012-0803-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-012-0803-6%26sid%3Dliteratum%253Aachs%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3DRationale%2520in%2520support%2520of%2520the%2520use%2520of%2520selective%2520dopamine%2520D%25283%2529%2520receptor%2520antagonists%2520for%2520the%2520pharmacotherapeutic%2520management%2520of%2520substance%2520use%2520disorders%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D2013%26volume%3D386%26spage%3D167%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Heidbreder, C.</span><span> </span><span class="NLM_article-title">Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.2174%2F187152708786927822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=19128200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFansA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=410-421&author=C.+Heidbreder&title=Selective+antagonism+at+dopamine+D3+receptors+as+a+target+for+drug+addiction+pharmacotherapy%3A+a+review+of+preclinical+evidence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence</span></div><div class="casAuthors">Heidbreder, Christian</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">410-421</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The focal distribution of the dopamine (DA) D3 receptor in brain regions implicated in emotional and cognitive functions has made this target a main focus of drug discovery efforts.  This paper will review the most recent lines of research in support of the use of selective DA D3 receptor antagonists for the pharmacotherapeutic management of drug addiction: (1) expression of the DA D3 receptor in the rodent and human brain; (2) changes in expression of the DA D3 receptor following exposure to drugs of abuse, and (3) efficacy of selective DA D3 receptor antagonists in preclin. paradigms assessing the behavioral effects of drugs such as cocaine, nicotine, alc., methamphetamine, and heroin.  This manuscript, however, will not review the effects of nonselective DA D2/D3 receptor antagonists or partial D3 receptor agonists.  Growing evidence suggests that selective DA D3 receptor antagonists do not affect the primary reinforcing effects of drugs of abuse, but rather seem to regulate the motivation to self-administer drugs under schedules of reinforcement that require an increase in work demand.  In addn., selective antagonism at DA D3 receptors appears to disrupt significantly the responsiveness to drug-assocd. stimuli that play a key role in reinstatement of drug-seeking behavior.  These preclin. findings will be discussed in the context of translational research relevant to the design of early clin. trials and hypothesis testing in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcM0jWAd6GHrVg90H21EOLACvtfcHk0lilIg0C3T8JQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFansA%253D%253D&md5=8f187ba70d486dc49f745562fe3f9408</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.2174%2F187152708786927822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152708786927822%26sid%3Dliteratum%253Aachs%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3DSelective%2520antagonism%2520at%2520dopamine%2520D3%2520receptors%2520as%2520a%2520target%2520for%2520drug%2520addiction%2520pharmacotherapy%253A%2520a%2520review%2520of%2520preclinical%2520evidence%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2008%26volume%3D7%26spage%3D410%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Heidbreder, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thanos, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span> </span><span class="NLM_article-title">Role of dopamine D3 receptors in the addictive properties of ethanol</span> <span class="citation_source-journal">Drugs Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1358%2Fdot.2004.40.4.820081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsVCktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2004&pages=355-365&author=C.+A.+Heidbrederauthor=M.+Andreoliauthor=C.+Marconauthor=P.+K.+Thanosauthor=C.+R.+Ashbyauthor=E.+L.+Gardner&title=Role+of+dopamine+D3+receptors+in+the+addictive+properties+of+ethanol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Role of dopamine D3 receptors in the addictive properties of ethanol</span></div><div class="casAuthors">Heidbreder, Christian A.; Andreoli, Michela; Marcon, Clara; Thanos, Panayotis K.; Ashby, Charles R., Jr.; Gardner, Eliot L.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-365</span>CODEN:
                <span class="NLM_cas:coden">MDACAP</span>;
        ISSN:<span class="NLM_cas:issn">0025-7656</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  After the cloning of the dopamine D1 and D2 receptors (1-3), several addnl. dopamine receptors were identified.  These new subtypes included the D3 and D4 receptors, which are similar to D2, and the D5 receptor, which is similar to D1 (4-6).  Although most studies have focused on the role of dopamine D1 and D2 receptors in mediating the addictive liability of drugs, the lack of selective pharmacol. tools has significantly hampered this particular field of research.  In contrast, recent studies using selective competitive antagonists have shown that the dopamine D3 receptor is involved in drug-seeking behavior.  The present review is intended to highlight a new, promising area in alc. research that focuses on the role of the dopamine D3 receptor in the addictive properties of ethanol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBovpsxBZkP7Vg90H21EOLACvtfcHk0lgkz4na7eZa7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsVCktb4%253D&md5=6b64fde1da825766872b1bece0f577af</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1358%2Fdot.2004.40.4.820081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdot.2004.40.4.820081%26sid%3Dliteratum%253Aachs%26aulast%3DHeidbreder%26aufirst%3DC.%2BA.%26aulast%3DAndreoli%26aufirst%3DM.%26aulast%3DMarcon%26aufirst%3DC.%26aulast%3DThanos%26aufirst%3DP.%2BK.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26atitle%3DRole%2520of%2520dopamine%2520D3%2520receptors%2520in%2520the%2520addictive%2520properties%2520of%2520ethanol%26jtitle%3DDrugs%2520Today%26date%3D2004%26volume%3D40%26spage%3D355%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Le Foll, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokoloff, P.</span><span> </span><span class="NLM_article-title">The dopamine D3 receptor and drug dependence: effects on reward or beyond?</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">541</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=525-541&author=B.+Le+Follauthor=S.+R.+Goldbergauthor=P.+Sokoloff&title=The+dopamine+D3+receptor+and+drug+dependence%3A+effects+on+reward+or+beyond%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BFoll%26aufirst%3DB.%26aulast%3DGoldberg%26aufirst%3DS.%2BR.%26aulast%3DSokoloff%26aufirst%3DP.%26atitle%3DThe%2520dopamine%2520D3%2520receptor%2520and%2520drug%2520dependence%253A%2520effects%2520on%2520reward%2520or%2520beyond%253F%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D49%26spage%3D525%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Sokoloff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giros, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martres, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouthenet, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J. C.</span><span> </span><span class="NLM_article-title">Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1038%2F347146a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=1975644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaK3MXhsFyjtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=1990&pages=146-151&author=P.+Sokoloffauthor=B.+Girosauthor=M.+P.+Martresauthor=M.+L.+Bouthenetauthor=J.+C.+Schwartz&title=Molecular+cloning+and+characterization+of+a+novel+dopamine+receptor+%28D3%29+as+a+target+for+neuroleptics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics</span></div><div class="casAuthors">Sokoloff, Pierre; Giros, Bruno; Martres, Marie Pascale; Bouthenet, Marie Louise; Schwartz, Jean Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6289</span>),
    <span class="NLM_cas:pages">146-51</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">A dopamine receptor has been characterized which differs in its pharmacol. and signalling system from the D1 or D2 receptor and represents both an autoreceptor and a postsynaptic receptor.  The D3 receptor is localized to limbic areas of the brain, which are assocd. with cognitive, emotional, and endocrine functions.  It seems to mediate some of the effects of antipsychotic drugs and drugs used against Parkinson's disease, that were previously thought to interact only with D2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYcwXGdNb1ILVg90H21EOLACvtfcHk0lgRh9GlKaq86g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhsFyjtrg%253D&md5=0ea4d33964b478c51de32e96345811f6</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2F347146a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F347146a0%26sid%3Dliteratum%253Aachs%26aulast%3DSokoloff%26aufirst%3DP.%26aulast%3DGiros%26aufirst%3DB.%26aulast%3DMartres%26aufirst%3DM.%2BP.%26aulast%3DBouthenet%26aufirst%3DM.%2BL.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26atitle%3DMolecular%2520cloning%2520and%2520characterization%2520of%2520a%2520novel%2520dopamine%2520receptor%2520%2528D3%2529%2520as%2520a%2520target%2520for%2520neuroleptics%26jtitle%3DNature%26date%3D1990%26volume%3D347%26spage%3D146%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Gurevich, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyce, J. N.</span><span> </span><span class="NLM_article-title">Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">60</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=60-80&author=E.+V.+Gurevichauthor=J.+N.+Joyce&title=Distribution+of+dopamine+D3+receptor+expressing+neurons+in+the+human+forebrain%3A+comparison+with+D2+receptor+expressing+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGurevich%26aufirst%3DE.%2BV.%26aulast%3DJoyce%26aufirst%3DJ.%2BN.%26atitle%3DDistribution%2520of%2520dopamine%2520D3%2520receptor%2520expressing%2520neurons%2520in%2520the%2520human%2520forebrain%253A%2520comparison%2520with%2520D2%2520receptor%2520expressing%2520neurons%26jtitle%3DNeuropsychopharmacology%26date%3D1999%26volume%3D20%26spage%3D60%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Searle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaver, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comley, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tziortzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mugnaini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffante, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo-Pich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabiner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laruelle, M.</span><span> </span><span class="NLM_article-title">Imaging dopamine D3 receptors in the human brain with positron emission tomography, [<sup>11</sup>C]PHNO, and a selective D3 receptor antagonist</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.biopsych.2010.04.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=20599188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1eitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2010&pages=392-399&author=G.+Searleauthor=J.+D.+Beaverauthor=R.+A.+Comleyauthor=M.+Baniauthor=A.+Tziortziauthor=M.+Slifsteinauthor=M.+Mugnainiauthor=C.+Griffanteauthor=A.+A.+Wilsonauthor=E.+Merlo-Pichauthor=S.+Houleauthor=R.+Gunnauthor=E.+A.+Rabinerauthor=M.+Laruelle&title=Imaging+dopamine+D3+receptors+in+the+human+brain+with+positron+emission+tomography%2C+%5B11C%5DPHNO%2C+and+a+selective+D3+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist</span></div><div class="casAuthors">Searle, Graham; Beaver, John D.; Comley, Robert A.; Bani, Massimo; Tziortzi, Andri; Slifstein, Mark; Mugnaini, Manolo; Griffante, Cristiana; Wilson, Alan A.; Merlo-Pich, Emilio; Houle, Sylvain; Gunn, Roger; Rabiner, Eugenii A.; Laruelle, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">392-399</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Dopamine D3 receptors are involved in the pathophysiol. of several neuropsychiatric conditions. [11C]-(+)-PHNO is a radiolabeled D2 and D3 agonist, suitable for imaging the agonist binding sites (denoted D2HIGH and D3) of these receptors with positron emission tomog. (PET).  PET studies in nonhuman primates documented that, in vivo, [11C]-(+)-PHNO displays a relative selectivity for D3 compared with D2HIGH receptor sites and that the [11C]-(+)-PHNO signal is enriched in D3 contribution compared with conventional ligands such as [11C] raclopride.  To define the D3 contribution (fPHNOD3) to [11C]-(+)-PHNO binding potential (BPND) in healthy humans, 52 PET scans were obtained in 19 healthy volunteers at baseline and following oral administration of various doses of the selective D3 receptor antagonist, GSK598809.  The impact of GSK598809 on [11C]-(+)-PHNO was regionally selective.  In dorsal regions of the striatum, GSK598809 did not significantly affect [11C]-(+)-PHNO BPND (fPHNOD3 ≈ 0%).  Conversely, in the substantia nigra, GSK598809 dose-dependently reduced [11C]-(+)-PHNO binding to nonspecific level (fPHNOD3 ≈ 100%).  In ventral striatum (VST), globus pallidus and thalamus (THA), [11C]-(+)-PHNO BPND was attributable to a combination of D2HIGH and D3 receptor sites, with fPHNOD3 of 26%, 67% and 46%, resp.  D3 receptor binding potential (BPNDD3) was highest in globus pallidus (1.90) and substantial nigra (1.39), with lower levels in VST (.77) and THA (.18) and negligible levels in dorsal striatum.  This study elucidated the pharmacol. nature of the [11C]-(+)-PHNO signal in healthy subjects and provided the first quantification of D3 receptor availability with PET in the living human brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEJHz3sXsWDrVg90H21EOLACvtfcHk0lgRh9GlKaq86g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1eitrc%253D&md5=dbb2800b668a23be61f9b0c90f2725c3</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2010.04.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2010.04.038%26sid%3Dliteratum%253Aachs%26aulast%3DSearle%26aufirst%3DG.%26aulast%3DBeaver%26aufirst%3DJ.%2BD.%26aulast%3DComley%26aufirst%3DR.%2BA.%26aulast%3DBani%26aufirst%3DM.%26aulast%3DTziortzi%26aufirst%3DA.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DMugnaini%26aufirst%3DM.%26aulast%3DGriffante%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DMerlo-Pich%26aufirst%3DE.%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DGunn%26aufirst%3DR.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DLaruelle%26aufirst%3DM.%26atitle%3DImaging%2520dopamine%2520D3%2520receptors%2520in%2520the%2520human%2520brain%2520with%2520positron%2520emission%2520tomography%252C%2520%255B11C%255DPHNO%252C%2520and%2520a%2520selective%2520D3%2520receptor%2520antagonist%26jtitle%3DBiol.%2520Psychiatry%26date%3D2010%26volume%3D68%26spage%3D392%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e49483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e49483&author=J.+Sunauthor=J.+Xuauthor=N.+J.+Cairnsauthor=J.+S.+Perlmutterauthor=R.+H.+Mach&title=Dopamine+D1%2C+D2%2C+D3+receptors%2C+vesicular+monoamine+transporter+type-2+%28VMAT2%29+and+dopamine+transporter+%28DAT%29+densities+in+aged+human+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DCairns%26aufirst%3DN.%2BJ.%26aulast%3DPerlmutter%26aufirst%3DJ.%2BS.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DDopamine%2520D1%252C%2520D2%252C%2520D3%2520receptors%252C%2520vesicular%2520monoamine%2520transporter%2520type-2%2520%2528VMAT2%2529%2520and%2520dopamine%2520transporter%2520%2528DAT%2529%2520densities%2520in%2520aged%2520human%2520brain%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De49483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Rangel-Barajas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span> </span><span class="NLM_article-title">Characterization of [<sup>3</sup>H]LS-3-134, a novel arylamide phenylpiperazine D3 dopamine receptor selective radioligand</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">418</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1111%2Fjnc.12825" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=25041389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGltr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2014&pages=418-431&author=C.+Rangel-Barajasauthor=M.+Malikauthor=M.+Taylorauthor=K.+A.+Neveauthor=R.+H.+Machauthor=R.+R.+Luedtke&title=Characterization+of+%5B3H%5DLS-3-134%2C+a+novel+arylamide+phenylpiperazine+D3+dopamine+receptor+selective+radioligand"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of [3H]LS-3-134, a novel arylamide phenylpiperazine D3 dopamine receptor selective radioligand</span></div><div class="casAuthors">Rangel-Barajas, Claudia; Malik, Maninder; Taylor, Michelle; Neve, Kim A.; Mach, Robert H.; Luedtke, Robert R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">418-431</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">LS-3-134 is a substituted N-phenylpiperazine deriv. that has been reported to exhibit: (i) high-affinity binding (Ki value 0.2 nM) at human D3 dopamine receptors, (ii) > 100-fold D3 vs. D2 dopamine receptor subtype binding selectivity, and (iii) low-affinity binding (Ki > 5000 nM) at sigma 1 and sigma 2 receptors.  Based upon a forskolin-dependent activation of the adenylyl cyclase inhibition assay, LS-3-134 is a weak partial agonist at both D2 and D3 dopamine receptor subtypes (29% and 35% of full agonist activity, resp.).  In this study, [3H]-labeled LS-3-134 was prepd. and evaluated to further characterize its use as a D3 dopamine receptor selective radioligand.  Kinetic and equil. radioligand binding studies were performed.  This radioligand rapidly reaches equil. (10-15 min at 37°C) and binds with high affinity to both human (Kd = 0.06 ± 0.01 nM) and rat (Kd = 0.2 ± 0.02 nM) D3 receptors expressed in HEK293 cells.  Direct and competitive radioligand binding studies using rat caudate and nucleus accumbens tissue indicate that [3H]LS-3-134 selectively binds a homogeneous population of binding sites with a dopamine D3 receptor pharmacol. profile.  Based upon these studies, we propose that [3H]LS-3-134 represents a novel D3 dopamine receptor selective radioligand that can be used for studying the expression and regulation of the D3 dopamine receptor subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoceMK9Cvq0h7Vg90H21EOLACvtfcHk0lgRh9GlKaq86g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGltr7E&md5=178cc8bbf98e42db09940bcea3d5a02e</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12825%26sid%3Dliteratum%253Aachs%26aulast%3DRangel-Barajas%26aufirst%3DC.%26aulast%3DMalik%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DNeve%26aufirst%3DK.%2BA.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26atitle%3DCharacterization%2520of%2520%255B3H%255DLS-3-134%252C%2520a%2520novel%2520arylamide%2520phenylpiperazine%2520D3%2520dopamine%2520receptor%2520selective%2520radioligand%26jtitle%3DJ.%2520Neurochem.%26date%3D2014%26volume%3D131%26spage%3D418%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Millan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peglion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivet, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dacquet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bervoets, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girardon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaput, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audinot, V.</span><span> </span><span class="NLM_article-title">Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297:1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">885</span><span class="NLM_x">–</span> <span class="NLM_lpage">898</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=7473180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaK2MXpsF2gs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1995&pages=885-898&author=M.+J.+Millanauthor=J.+L.+Peglionauthor=J.+Vianauthor=J.+M.+Rivetauthor=M.+Broccoauthor=A.+Gobertauthor=A.+Newman-Tancrediauthor=C.+Dacquetauthor=K.+Bervoetsauthor=S.+Girardonauthor=V.+Jacquesauthor=C.+Chaputauthor=V.+Audinot&title=Functional+correlates+of+dopamine+D3+receptor+activation+in+the+rat+in+vivo+and+their+modulation+by+the+selective+antagonist%2C+%28%2B%29-S+14297%3A1.+Activation+of+postsynaptic+D3+receptors+mediates+hypothermia%2C+whereas+blockade+of+D2+receptors+elicits+prolactin+secretion+and+catalepsy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: I. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy</span></div><div class="casAuthors">Millan, Mark J.; Peglion, Jean-Louis; Vian, Joeel; Rivet, Jean-Michel; Brocco, Mauricette; Gobert, Alain; Newman-Tancredi, Adrian; Dacquet, Catherine; Bervoets, Karin; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">885-98</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Using [125I]-iodosulpride as a radioligand, the novel naphthofurane (±)-S 11566 {(±)-[7-(N,N-dipropylamino)-5,6,7,8-tetrahydro-naphtho(2,3b)dihydro,2,3-furane]} showed a marked preference for human, recombinant D3 as compared with D2 receptors stably transfected into Chinese hamster ovary cells (Kis = 24/529 nM).  This activity resided in its (+)-eutomer, (+)-S 14297 (13/297 nM) as compared with its (-)-distomer, (-)-S 17777 (405/3544 nM).  In contrast, (+)-AJ 76 manifested only a mild 2-fold preference for D3 sites (70/154 nM), whereas haloperidol and six addnl. antagonists showed a mild (2-7-fold) preference for D2 sites.  As concerns agonists, (+)-7-OH-DPAT, (±)-CGS 15855A, quinerolane, (-)-quinpirole and N-0434 displayed a preference (6-40-fold) for D3 receptors, whereas piribedil showed a slight, 2-fold, preference for D2 sites (243/126 nM).  (+)-S 14297 showed low (> 1.0 μM) affinity at rat D1 and D2 sites and at cloned, human D4 and D5 receptors and only low affinity (145 to > 10,000 nM) at all other sites examd.  In vivo, administered s.c., (+)-7-OH-DPAT, CGS 15855A, quinelorane, (-)-quinpirole and N-0434 potently evoked hypothermia.  Across all (8) agonists tested, potency correlated significantly with affinity at D3 sites (r =.84) but not D2 sites (r =.50, P >.05).  (+)-S 14297 (0.16-1.25 mg/kg, s.c.) blocked the induction of hypothermia by (+)-7-OH-DPAT, CGS 15855A and (-)-quinpirole, but not by the α2-adrenergic agonist, clonidine, without influencing core temp. alone.  In contrast, (-)-S 1777 (10.0 mg/kg, s.c.) was only partially active.  Across all (9) antagonists, potency for inhibition of (+)-7-OH-DPAT-induced hypothermia correlated more strongly with affinity at D3 (r =.96) than D2 (r =.75) sites.  Whereas haloperidol and the other antagonists provoked prolactin secretion and elicited catalepsy, (+)-S 14297 and (±)-S 11566 at doses of ≤10.0 and 40.0 mg/kg, s.c., resp., were not significantly effective.  Across all antagonists, potency for eliciting prolactin secretion and catalepsy correlated better with affinity at D2 (r =.95 and.06) than D3 (r =.76 and.91) sites.  In conclusion, these data demonstrate that the novel naphthofurane, (+)-S 14297, is a selective ligand (antagonist) at dopamine D3 receptors and suggest that their activation mediates hypothermia in the rat.  In distinction, (+)-S 14297 elicits neither prolactin secretion nor catalepsy, actions that appear to reflect blockade of dopamine D2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7ba6fbWzpObVg90H21EOLACvtfcHk0lgDjp_boY-U-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpsF2gs7o%253D&md5=9ea0a49e623b6f2f07f54363ccbe85d8</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DPeglion%26aufirst%3DJ.%2BL.%26aulast%3DVian%26aufirst%3DJ.%26aulast%3DRivet%26aufirst%3DJ.%2BM.%26aulast%3DBrocco%26aufirst%3DM.%26aulast%3DGobert%26aufirst%3DA.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26aulast%3DDacquet%26aufirst%3DC.%26aulast%3DBervoets%26aufirst%3DK.%26aulast%3DGirardon%26aufirst%3DS.%26aulast%3DJacques%26aufirst%3DV.%26aulast%3DChaput%26aufirst%3DC.%26aulast%3DAudinot%26aufirst%3DV.%26atitle%3DFunctional%2520correlates%2520of%2520dopamine%2520D3%2520receptor%2520activation%2520in%2520the%2520rat%2520in%2520vivo%2520and%2520their%2520modulation%2520by%2520the%2520selective%2520antagonist%252C%2520%2528%252B%2529-S%252014297%253A1.%2520Activation%2520of%2520postsynaptic%2520D3%2520receptors%2520mediates%2520hypothermia%252C%2520whereas%2520blockade%2520of%2520D2%2520receptors%2520elicits%2520prolactin%2520secretion%2520and%2520catalepsy%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1995%26volume%3D275%26spage%3D885%26epage%3D898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Cho, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. M.</span><span> </span><span class="NLM_article-title">Current perspectives on the selective regulation of dopamine D(2) and D(3) receptors</span> <span class="citation_source-journal">Arch. Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1521</span><span class="NLM_x">–</span> <span class="NLM_lpage">1538</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1007%2Fs12272-010-1005-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=21052931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlOqtr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=1521-1538&author=D.+I.+Choauthor=M.+Zhengauthor=K.+M.+Kim&title=Current+perspectives+on+the+selective+regulation+of+dopamine+D%282%29+and+D%283%29+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Current perspectives on the selective regulation of dopamine D2 and D3 receptors</span></div><div class="casAuthors">Cho, Dong Im; Zheng, Mei; Kim, Kyeong-Man</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1521-1538</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">A review.  Among the characterized dopamine receptor subtypes, D2 receptor (D2R) and D3 receptor (D3R) are the main targets of neuroleptics that are currently in use.  In particular, D3R is closely related to the etiol. of schizophrenia and drug addiction.  The spatial expression patterns of D2R and D3R are distinct in certain areas of the brain.  D2R are heavily expressed in the regions responsible for motor functions, whereas D3R are more selectively expressed in the limbic regions, which are assocd. with cognitive and emotional functions.  Therefore, disturbances in the motor and endocrine functions, which are the most serious problems caused by the current neuroleptics, are likely to result from the non-selective blockade of D2R.  Selective regulation of D3R is needed to sep. the desired therapeutic activities from unwanted side effects that result from promiscuous blockade of other receptors.  D2R and D3R possess high sequence homol. and employ similar signaling pathways, and it is difficult to selectively regulate them.  In this review, we discuss the signaling mechanisms, intracellular trafficking, and desensitization properties of D2R and D3R.  In addn., the proteins interacting with D2R or D3R are discussed in relation to their roles in the regulation of receptor functions, followed by the current status of the development of selective D3R ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4cCMB-iwXjLVg90H21EOLACvtfcHk0lgDjp_boY-U-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlOqtr3K&md5=7dd5bae45a4c7f356f33523f999dafe6</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1007%2Fs12272-010-1005-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-010-1005-8%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DD.%2BI.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DK.%2BM.%26atitle%3DCurrent%2520perspectives%2520on%2520the%2520selective%2520regulation%2520of%2520dopamine%2520D%25282%2529%2520and%2520D%25283%2529%2520receptors%26jtitle%3DArch.%2520Pharm.%2520Res.%26date%3D2010%26volume%3D33%26spage%3D1521%26epage%3D1538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Kishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correll, C. U.</span><span> </span><span class="NLM_article-title">Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1169</span><span class="NLM_x">–</span> <span class="NLM_lpage">1180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2013&pages=e1169-1180&author=T.+Kishiauthor=Y.+Matsudaauthor=N.+Iwataauthor=C.+U.+Correll&title=Antipsychotics+for+cocaine+or+psychostimulant+dependence%3A+systematic+review+and+meta-analysis+of+randomized%2C+placebo-controlled+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKishi%26aufirst%3DT.%26aulast%3DMatsuda%26aufirst%3DY.%26aulast%3DIwata%26aufirst%3DN.%26aulast%3DCorrell%26aufirst%3DC.%2BU.%26atitle%3DAntipsychotics%2520for%2520cocaine%2520or%2520psychostimulant%2520dependence%253A%2520systematic%2520review%2520and%2520meta-analysis%2520of%2520randomized%252C%2520placebo-controlled%2520trials%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2013%26volume%3D74%26spage%3De1169%26epage%3D1180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Veselinovic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulzen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunder, G.</span><span> </span><span class="NLM_article-title">Cariprazine, a new, orally active dopamine D2/3 receptor partial agonist for the treatment of schizophrenia, bipolar mania and depression</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1141</span><span class="NLM_x">–</span> <span class="NLM_lpage">1159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1586%2F14737175.2013.853448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24175719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWjsLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1141-1159&author=T.+Veselinovicauthor=M.+Paulzenauthor=G.+Grunder&title=Cariprazine%2C+a+new%2C+orally+active+dopamine+D2%2F3+receptor+partial+agonist+for+the+treatment+of+schizophrenia%2C+bipolar+mania+and+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Cariprazine, a new, orally active dopamine D2/3 receptor partial agonist for the treatment of schizophrenia, bipolar mania and depression</span></div><div class="casAuthors">Veselinovic, Tanja; Paulzen, Michael; Gruender, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1141-1159</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Cariprazine is a novel drug with partial agonist activity at dopamine D2/3 receptors and six- to eightfold higher affinity for human dopamine D3 over D2 receptors.  Results from several placebo-controlled Phase II/III trials in patients with a The Diagnostic and Statistical Manual of Mental Disorders IV diagnosis of schizophrenia or bipolar I disorder suggest that cariprazine is superior to placebo with respect to antipsychotic and antimanic activity.  Reports concerning safety and tolerability of cariprazine are mainly favorable, although the rates of treatment-assocd. adverse events, which most commonly included akathisia and extrapyramidal symptom, are rather high.  However, only minor alterations of clin. lab. values, prolactin concns. and ECG parameters are reported in cariprazine-treated patients.  A new drug application to the U.S. F DA for cariprazine for the treatment of both schizophrenia and manic or mixed episodes assocd. with bipolar I disorder was submitted in Nov. 2012.  A more precise assessment of the clin. properties of this new drug will require addnl. studies, aimed to compare and contrast cariprazine with other antipsychotic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPsIaMWyuixrVg90H21EOLACvtfcHk0lgZjAsjzP8ttg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWjsLjF&md5=b30e0bf57bb1004c626be6913c0393f9</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1586%2F14737175.2013.853448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.2013.853448%26sid%3Dliteratum%253Aachs%26aulast%3DVeselinovic%26aufirst%3DT.%26aulast%3DPaulzen%26aufirst%3DM.%26aulast%3DGrunder%26aufirst%3DG.%26atitle%3DCariprazine%252C%2520a%2520new%252C%2520orally%2520active%2520dopamine%2520D2%252F3%2520receptor%2520partial%2520agonist%2520for%2520the%2520treatment%2520of%2520schizophrenia%252C%2520bipolar%2520mania%2520and%2520depression%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2013%26volume%3D13%26spage%3D1141%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Roman, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gyertyan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szombathelyi, Z.</span><span> </span><span class="NLM_article-title">Cariprazine (RGH-188), a D(3)-preferring dopamine D(3)/D(2) receptor partial agonist antipsychotic candidate demonstrates anti-abuse potential in rats</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">226</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=2013&pages=285-293&author=V.+Romanauthor=I.+Gyertyanauthor=K.+Saghyauthor=B.+Kissauthor=Z.+Szombathelyi&title=Cariprazine+%28RGH-188%29%2C+a+D%283%29-preferring+dopamine+D%283%29%2FD%282%29+receptor+partial+agonist+antipsychotic+candidate+demonstrates+anti-abuse+potential+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoman%26aufirst%3DV.%26aulast%3DGyertyan%26aufirst%3DI.%26aulast%3DSaghy%26aufirst%3DK.%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DSzombathelyi%26aufirst%3DZ.%26atitle%3DCariprazine%2520%2528RGH-188%2529%252C%2520a%2520D%25283%2529-preferring%2520dopamine%2520D%25283%2529%252FD%25282%2529%2520receptor%2520partial%2520agonist%2520antipsychotic%2520candidate%2520demonstrates%2520anti-abuse%2520potential%2520in%2520rats%26jtitle%3DPsychopharmacology%26date%3D2013%26volume%3D226%26spage%3D285%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Gould, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duke, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=138-151&author=R.+W.+Gouldauthor=A.+N.+Dukeauthor=M.+A.+Nader&title=PET+studies+in+nonhuman+primate+models+of+cocaine+abuse%3A+translational+research+related+to+vulnerability+and+neuroadaptations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGould%26aufirst%3DR.%2BW.%26aulast%3DDuke%26aufirst%3DA.%2BN.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DPET%2520studies%2520in%2520nonhuman%2520primate%2520models%2520of%2520cocaine%2520abuse%253A%2520translational%2520research%2520related%2520to%2520vulnerability%2520and%2520neuroadaptations%26jtitle%3DNeuropharmacology%26date%3D2014%26volume%3D84%26spage%3D138%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Laszy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laszlovszky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gyertyan, I.</span><span> </span><span class="NLM_article-title">Dopamine D3 receptor antagonists improve the learning performance in memory-impaired rats</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">575</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2005&pages=567-575&author=J.+Laszyauthor=I.+Laszlovszkyauthor=I.+Gyertyan&title=Dopamine+D3+receptor+antagonists+improve+the+learning+performance+in+memory-impaired+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaszy%26aufirst%3DJ.%26aulast%3DLaszlovszky%26aufirst%3DI.%26aulast%3DGyertyan%26aufirst%3DI.%26atitle%3DDopamine%2520D3%2520receptor%2520antagonists%2520improve%2520the%2520learning%2520performance%2520in%2520memory-impaired%2520rats%26jtitle%3DPsychopharmacology%26date%3D2005%26volume%3D179%26spage%3D567%26epage%3D575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Mugnaini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iavarone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavallini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffante, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliosi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savoia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaver, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabiner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo Pich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bani, M.</span><span> </span><span class="NLM_article-title">Occupancy of brain dopamine D3 receptors and drug craving: a translational approach</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=302-312&author=M.+Mugnainiauthor=L.+Iavaroneauthor=P.+Cavalliniauthor=C.+Griffanteauthor=B.+Oliosiauthor=C.+Savoiaauthor=J.+Beaverauthor=E.+A.+Rabinerauthor=F.+Micheliauthor=C.+Heidbrederauthor=A.+Andornauthor=E.+Merlo+Pichauthor=M.+Bani&title=Occupancy+of+brain+dopamine+D3+receptors+and+drug+craving%3A+a+translational+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMugnaini%26aufirst%3DM.%26aulast%3DIavarone%26aufirst%3DL.%26aulast%3DCavallini%26aufirst%3DP.%26aulast%3DGriffante%26aufirst%3DC.%26aulast%3DOliosi%26aufirst%3DB.%26aulast%3DSavoia%26aufirst%3DC.%26aulast%3DBeaver%26aufirst%3DJ.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DHeidbreder%26aufirst%3DC.%26aulast%3DAndorn%26aufirst%3DA.%26aulast%3DMerlo%2BPich%26aufirst%3DE.%26aulast%3DBani%26aufirst%3DM.%26atitle%3DOccupancy%2520of%2520brain%2520dopamine%2520D3%2520receptors%2520and%2520drug%2520craving%253A%2520a%2520translational%2520approach%26jtitle%3DNeuropsychopharmacology%26date%3D2013%26volume%3D38%26spage%3D302%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Nakajima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerretsen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caravaggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Foll, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulsant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graff-Guerrero, A.</span><span> </span><span class="NLM_article-title">The potential role of dopamine D(3) receptor neurotransmission in cognition</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.euroneuro.2013.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=23791072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVyrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=799-813&author=S.+Nakajimaauthor=P.+Gerretsenauthor=H.+Takeuchiauthor=F.+Caravaggioauthor=T.+Chowauthor=B.+Le+Follauthor=B.+Mulsantauthor=B.+Pollockauthor=A.+Graff-Guerrero&title=The+potential+role+of+dopamine+D%283%29+receptor+neurotransmission+in+cognition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The potential role of dopamine D3 receptor neurotransmission in cognition</span></div><div class="casAuthors">Nakajima, Shinichiro; Gerretsen, Philip; Takeuchi, Hiroyoshi; Caravaggio, Fernando; Chow, Tiffany; Le Foll, Bernard; Mulsant, Benoit; Pollock, Bruce; Graff-Guerrero, Ariel</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">799-813</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Currently available treatments have limited pro-cognitive effects for neuropsychiatric disorders, such as schizophrenia, Parkinson's disease and Alzheimer's disease.  The primary objective of this work is to review the literature on the role of dopamine D3 receptors in cognition, and propose dopamine D3 receptor antagonists as possible cognitive enhancers for neuropsychiatric disorders.  A literature search was performed to identify animal and human studies on D3 receptors and cognition using PubMed, MEDLINE and EMBASE.  The search terms included "dopamine D3 receptor" and "cognition".  The literature search identified 164 articles.  The results revealed: (1) D3 receptors are assocd. with cognitive functioning in both healthy individuals and those with neuropsychiatric disorders; (2) D3 receptor blockade appears to enhance while D3 receptor agonism seems to impair cognitive function, including memory, attention, learning, processing speed, social recognition and executive function independent of age; and (3) D3 receptor antagonists may exert their pro-cognitive effect by enhancing the release of acetylcholine in the prefrontal cortex, disinhibiting the activity of dopamine neurons projecting to the nucleus accumbens or prefrontal cortex, or activating CREB signaling in the hippocampus.  These findings suggest that D3 receptor blockade may enhance cognitive performance in healthy individuals and treat cognitive dysfunction in individuals with a neuropsychiatric disorder.  Clin. trials are needed to confirm these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSUxqVZeIzYLVg90H21EOLACvtfcHk0lgZjAsjzP8ttg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVyrtLc%253D&md5=3d42c98b759d0d27039345dbee2ae73e</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2013.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2013.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DNakajima%26aufirst%3DS.%26aulast%3DGerretsen%26aufirst%3DP.%26aulast%3DTakeuchi%26aufirst%3DH.%26aulast%3DCaravaggio%26aufirst%3DF.%26aulast%3DChow%26aufirst%3DT.%26aulast%3DLe%2BFoll%26aufirst%3DB.%26aulast%3DMulsant%26aufirst%3DB.%26aulast%3DPollock%26aufirst%3DB.%26aulast%3DGraff-Guerrero%26aufirst%3DA.%26atitle%3DThe%2520potential%2520role%2520of%2520dopamine%2520D%25283%2529%2520receptor%2520neurotransmission%2520in%2520cognition%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2013%26volume%3D23%26spage%3D799%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Lacroix, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hows, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C. A.</span><span> </span><span class="NLM_article-title">Selective antagonism at dopamine D3 receptors enhances monoaminergic and cholinergic neurotransmission in the rat anterior cingulate cortex</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">849</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=839-849&author=L.+P.+Lacroixauthor=M.+E.+Howsauthor=A.+J.+Shahauthor=J.+J.+Haganauthor=C.+A.+Heidbreder&title=Selective+antagonism+at+dopamine+D3+receptors+enhances+monoaminergic+and+cholinergic+neurotransmission+in+the+rat+anterior+cingulate+cortex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLacroix%26aufirst%3DL.%2BP.%26aulast%3DHows%26aufirst%3DM.%2BE.%26aulast%3DShah%26aufirst%3DA.%2BJ.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DHeidbreder%26aufirst%3DC.%2BA.%26atitle%3DSelective%2520antagonism%2520at%2520dopamine%2520D3%2520receptors%2520enhances%2520monoaminergic%2520and%2520cholinergic%2520neurotransmission%2520in%2520the%2520rat%2520anterior%2520cingulate%2520cortex%26jtitle%3DNeuropsychopharmacology%26date%3D2003%26volume%3D28%26spage%3D839%26epage%3D849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Millan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cara, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dekeyne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panayi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Groote, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cistarelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billiras, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobert, A.</span><span> </span><span class="NLM_article-title">Selective blockade of dopamine D(3) versus D(2) receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysis</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">1047</span><span class="NLM_x">–</span> <span class="NLM_lpage">1061</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1111%2Fj.1471-4159.2006.04262.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=17266737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisFGnu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2007&pages=1047-1061&author=M.+J.+Millanauthor=B.+Di+Caraauthor=A.+Dekeyneauthor=F.+Panayiauthor=L.+De+Grooteauthor=D.+Sicardauthor=L.+Cistarelliauthor=R.+Billirasauthor=A.+Gobert&title=Selective+blockade+of+dopamine+D%283%29+versus+D%282%29+receptors+enhances+frontocortical+cholinergic+transmission+and+social+memory+in+rats%3A+a+parallel+neurochemical+and+behavioural+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Selective blockade of dopamine D3 versus D2 receptors enhances frontal cortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioral analysis</span></div><div class="casAuthors">Millan, Mark J.; Di Cara, Benjamin; Dekeyne, Anne; Panayi, Fany; De Groote, Lotte; Sicard, Dorothee; Cistarelli, Laetitia; Billiras, Rodolphe; Gobert, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1047-1061</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Though dopaminergic mechanisms modulate cholinergic transmission and cognitive function, the significance of specific receptor subtypes remains uncertain.  Here, we examd. the roles of dopamine D3 vs. D2 receptors.  By analogy with tacrine (0.16-2.5 mg/kg, s.c.), the selective D3 receptor antagonists, S33084 (0.01-0.63) and SB277,011 (0.63-40.0), elicited dose-dependent, pronounced and sustained elevations in dialysis levels of acetylcholine (ACh) in the frontal cortex, but not the hippocampus, of freely-moving rats.  The actions of these antagonists were stereospecifically mimicked by (+)S14297 (1.25), whereas its inactive distomer, (-)S17777, was ineffective.  The preferential D2 receptor antagonist, L741,626 (10.0), failed to modify levels of ACh.  S33084 (0.01-0.63) and SB277,011 (0.16-2.5) also mimicked tacrine (0.04-0.63) by dose-dependently attenuating the deleterious influence of scopolamine (1.25) upon social memory (recognition by an adult rat of a juvenile conspecific).  Further, (+)S14297 (1.25) vs. (-)S17777 stereospecifically blocked the action of scopolamine.  Using an intersession interval of 120 min (spontaneous loss of recognition), S33084 (0.04-0.63), SB277,011 (0.16-10.0) and (+)S14297 (0.63-10.0) likewise mimicked tacrine (0.16-2.5) in enhancing social memory.  In contrast, L741,626 (0.16-10.0) displayed amnesic properties.  In conclusion, selective blockade of D3 receptors facilitates frontal cortical cholinergic transmission and improves social memory in rats.  These data support the pertinence of D3 receptors as a target for treatment of disorders in which cognitive function is compromised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdxC_Nsga5b7Vg90H21EOLACvtfcHk0lhUbNz-MUZLUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisFGnu7g%253D&md5=e40dfd968d9f0a5ba2554511d84cd01e</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04262.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04262.x%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DDi%2BCara%26aufirst%3DB.%26aulast%3DDekeyne%26aufirst%3DA.%26aulast%3DPanayi%26aufirst%3DF.%26aulast%3DDe%2BGroote%26aufirst%3DL.%26aulast%3DSicard%26aufirst%3DD.%26aulast%3DCistarelli%26aufirst%3DL.%26aulast%3DBilliras%26aufirst%3DR.%26aulast%3DGobert%26aufirst%3DA.%26atitle%3DSelective%2520blockade%2520of%2520dopamine%2520D%25283%2529%2520versus%2520D%25282%2529%2520receptors%2520enhances%2520frontocortical%2520cholinergic%2520transmission%2520and%2520social%2520memory%2520in%2520rats%253A%2520a%2520parallel%2520neurochemical%2520and%2520behavioural%2520analysis%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D100%26spage%3D1047%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Loiseau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">Blockade of dopamine D(3) receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: similar actions of D(1) receptor agonists, but not of D(2) antagonists</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.euroneuro.2008.07.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=18793829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKrsb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=23-33&author=F.+Loiseauauthor=M.+J.+Millan&title=Blockade+of+dopamine+D%283%29+receptors+in+frontal+cortex%2C+but+not+in+sub-cortical+structures%2C+enhances+social+recognition+in+rats%3A+similar+actions+of+D%281%29+receptor+agonists%2C+but+not+of+D%282%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of dopamine D3 receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: Similar actions of D1 receptor agonists, but not of D2 antagonists</span></div><div class="casAuthors">Loiseau, Florence; Millan, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-33</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Though D3 receptor antagonists can enhance cognitive function, their sites of action remain unexplored.  This issue was addressed employing a model of social recognition in rats, and the actions of D3 antagonists were compared to D1 agonists that likewise possess pro-cognitive properties.  Infusion of the highly selective D3 antagonists, S33084 and SB277,011 (0.04-2.5 μg/side), into the frontal cortex (FCX) dose-dependently reversed the deficit in recognition induced by a delay.  By contrast, the preferential D2 antagonist, L741,626 (0.63-5.0) had no effect.  The action of S33084 was regionally specific inasmuch as its injection into the nucleus accumbens or striatum was ineffective.  A similar increase of recognition was obtained upon injection of the D1 agonist, SKF81297 (0.04-0.63), into the FCX though it was also active (0.63) in the nucleus accumbens.  These data suggest that D3 receptors modulating social recognition are localized in FCX, and underpin their pertinence as targets for antipsychotic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhPiGFm02p5LVg90H21EOLACvtfcHk0lhUbNz-MUZLUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKrsb7M&md5=fefba41f9316430bd0311e4a13aa6a17</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2008.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2008.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DLoiseau%26aufirst%3DF.%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3DBlockade%2520of%2520dopamine%2520D%25283%2529%2520receptors%2520in%2520frontal%2520cortex%252C%2520but%2520not%2520in%2520sub-cortical%2520structures%252C%2520enhances%2520social%2520recognition%2520in%2520rats%253A%2520similar%2520actions%2520of%2520D%25281%2529%2520receptor%2520agonists%252C%2520but%2520not%2520of%2520D%25282%2529%2520antagonists%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2009%26volume%3D19%26spage%3D23%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Xing, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span> </span><span class="NLM_article-title">Influence of dopamine D3 receptor knockout on age-related decline of spatial memory</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">481</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=481&publication_year=2010&pages=149-153&author=B.+Xingauthor=X.+Mengauthor=S.+Weiauthor=S.+Li&title=Influence+of+dopamine+D3+receptor+knockout+on+age-related+decline+of+spatial+memory"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DB.%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DS.%26atitle%3DInfluence%2520of%2520dopamine%2520D3%2520receptor%2520knockout%2520on%2520age-related%2520decline%2520of%2520spatial%2520memory%26jtitle%3DNeurosci.%2520Lett.%26date%3D2010%26volume%3D481%26spage%3D149%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Sokoloff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leriche, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louvel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pumain, R.</span><span> </span><span class="NLM_article-title">Direct and indirect interactions of the dopamine D(3) receptor with glutamate pathways: implications for the treatment of schizophrenia</span> <span class="citation_source-journal">Naunyn-Schmiedeberg’s Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">386</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1007%2Fs00210-012-0797-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=23001156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ejtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=386&publication_year=2013&pages=107-124&author=P.+Sokoloffauthor=L.+Lericheauthor=J.+Diazauthor=J.+Louvelauthor=R.+Pumain&title=Direct+and+indirect+interactions+of+the+dopamine+D%283%29+receptor+with+glutamate+pathways%3A+implications+for+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Direct and indirect interactions of the dopamine D3 receptor with glutamate pathways: implications for the treatment of schizophrenia</span></div><div class="casAuthors">Sokoloff, Pierre; Leriche, Ludovic; Diaz, Jorge; Louvel, Jacques; Pumain, Rene</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">386</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-124</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">This article, based on original data as well as on previously reported preclin. and clin. data that are reviewed, describes direct and indirect interactions of the D3 receptor with N-methyl-d-aspartate receptor (NMDA) signaling and their functional consequences and therapeutic implications for schizophrenia.  D3 receptor immunoreactivity at ultrastructural level with electron microscopy was identified at presumably glutamatergic, asym. synapses of the medium-sized spiny neurons of the nucleus accumbens.  This finding supports the existence of a direct interaction of the D3 receptor with glutamate, in line with previously described interactions with NMDA signaling involving Ca2+/calmodulin-dependent protein kinase II at post-synaptic densities (Liu et al. 2009).  Indirect interactions of the D3 receptor with glutamate could involve a neg. control exerted by the D3 receptor on mesocortical dopamine neurons and the complex regulation of the glutamatergic pyramidal cells by dopamine in the prefrontal cortex.  This could be exemplified here by the regulation of pyramidal cell activity in conditions of chronic NMDA receptor blockade with dizocilpine (MK-801).  BP897, a D3 receptor-selective partial agonist, reversed the dysregulation of cortical c-fos mRNA expression and pyramidal cell hyperexcitability, as measured by paired-pulse electrophysiol.  At the behavioral level, blockade of the D3 receptor, by known D3 receptor antagonists or the novel D3 receptor-selective antagonist F17141, produces antipsychotic-like effects in reversing hyperactivity and social interaction deficits induced by NMDA receptor blockade by MK-801 in mice.  The glutamate-D3 receptor interactions described here offer a conceptual framework for developing new D3 receptor-selective drugs, which may appear as an original, efficacious, and safe way to potentially indirectly target glutamate in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmIL4lHJC_r7Vg90H21EOLACvtfcHk0lhUbNz-MUZLUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ejtbs%253D&md5=a6317c4c802a0f07c9dfa12e7ef63b34</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1007%2Fs00210-012-0797-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-012-0797-0%26sid%3Dliteratum%253Aachs%26aulast%3DSokoloff%26aufirst%3DP.%26aulast%3DLeriche%26aufirst%3DL.%26aulast%3DDiaz%26aufirst%3DJ.%26aulast%3DLouvel%26aufirst%3DJ.%26aulast%3DPumain%26aufirst%3DR.%26atitle%3DDirect%2520and%2520indirect%2520interactions%2520of%2520the%2520dopamine%2520D%25283%2529%2520receptor%2520with%2520glutamate%2520pathways%253A%2520implications%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D2013%26volume%3D386%26spage%3D107%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Pilla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perachon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermuth, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everitt, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokoloff, P.</span><span> </span><span class="NLM_article-title">Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">400</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1038%2F22560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=10432116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaK1MXkvFOntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=1999&pages=371-375&author=M.+Pillaauthor=S.+Perachonauthor=F.+Sautelauthor=F.+Garridoauthor=A.+Mannauthor=C.+G.+Wermuthauthor=J.+C.+Schwartzauthor=B.+J.+Everittauthor=P.+Sokoloff&title=Selective+inhibition+of+cocaine-seeking+behaviour+by+a+partial+dopamine+D3+receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of cocaine-seeking behavior by a partial dopamine D3 receptor agonist</span></div><div class="casAuthors">Pilla, Maria; Perachon, Sylvie; Sautel, Francois; Garrido, Fabrice; Mann, Andre; Wermuth, Camille G.; Schwartz, Jean-Charles; Everitt, Barry J.; Sokoloff, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">6742</span>),
    <span class="NLM_cas:pages">371-375</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Environmental stimuli that are reliably assocd. with the effects of many abused drugs, esp. stimulants such as cocaine, can produce craving and relapse in abstinent human substance abusers.  In animals, such cues can induce and maintain drug-seeking behavior and also reinstate drug-seeking after extinction.  Reducing the motivational effects of drug-related cues might therefore be useful in the treatment of addiction.  Converging pharmacol., human post-mortem and genetic studies implicate the dopamine D3 receptor in drug addiction.  Here we have designed BP 897, the first D3-receptor-selective agonist, as assessed in vitro with recombinant receptors and in vivo with mice bearing disrupted D3-receptor genes.  BP 897 is a partial agonist in vitro and acts in vivo as either an agonist or an antagonist.  We show that BP 897 inhibits cocaine-seeking behavior that depends upon the presentation of drug-assocd. cues, without having any intrinsic, primary rewarding effects.  Our data indicate that compds. like BP 897 could be used for reducing the drug craving and vulnerability to relapse that are elicited by drug-assocd. environmental stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6SwJsmcTSCLVg90H21EOLACvtfcHk0liEg0cBCx6kSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvFOntr0%253D&md5=3f4055a4cd1b6cee7e890ff1b96b21b6</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2F22560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F22560%26sid%3Dliteratum%253Aachs%26aulast%3DPilla%26aufirst%3DM.%26aulast%3DPerachon%26aufirst%3DS.%26aulast%3DSautel%26aufirst%3DF.%26aulast%3DGarrido%26aufirst%3DF.%26aulast%3DMann%26aufirst%3DA.%26aulast%3DWermuth%26aufirst%3DC.%2BG.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26aulast%3DEveritt%26aufirst%3DB.%2BJ.%26aulast%3DSokoloff%26aufirst%3DP.%26atitle%3DSelective%2520inhibition%2520of%2520cocaine-seeking%2520behaviour%2520by%2520a%2520partial%2520dopamine%2520D3%2520receptor%2520agonist%26jtitle%3DNature%26date%3D1999%26volume%3D400%26spage%3D371%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Hackling, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, H.</span><span> </span><span class="NLM_article-title">Dopamine D3 receptor ligands with antagonist properties</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">946</span><span class="NLM_x">–</span> <span class="NLM_lpage">961</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=946-961&author=A.+E.+Hacklingauthor=H.+Stark&title=Dopamine+D3+receptor+ligands+with+antagonist+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHackling%26aufirst%3DA.%2BE.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DDopamine%2520D3%2520receptor%2520ligands%2520with%2520antagonist%2520properties%26jtitle%3DChemBioChem%26date%3D2002%26volume%3D3%26spage%3D946%26epage%3D961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Boeckler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Dopamine D3 receptor ligands: recent advances in the control of subtype selectivity and intrinsic activity</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1768</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">887</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1768&publication_year=2007&pages=871-887&author=F.+Boecklerauthor=P.+Gmeiner&title=Dopamine+D3+receptor+ligands%3A+recent+advances+in+the+control+of+subtype+selectivity+and+intrinsic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoeckler%26aufirst%3DF.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DDopamine%2520D3%2520receptor%2520ligands%253A%2520recent%2520advances%2520in%2520the%2520control%2520of%2520subtype%2520selectivity%2520and%2520intrinsic%2520activity%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2007%26volume%3D1768%26spage%3D871%26epage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Micheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C.</span><span> </span><span class="NLM_article-title">Selective dopamine D3 receptor antagonists: a review 2001–2005</span> <span class="citation_source-journal">Recent Pat. CNS Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=271-288&author=F.+Micheliauthor=C.+Heidbreder&title=Selective+dopamine+D3+receptor+antagonists%3A+a+review+2001%E2%80%932005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3DSelective%2520dopamine%2520D3%2520receptor%2520antagonists%253A%2520a%2520review%25202001%25E2%2580%25932005%26jtitle%3DRecent%2520Pat.%2520CNS%2520Drug%2520Discovery%26date%3D2006%26volume%3D1%26spage%3D271%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Boeckler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">The structural evolution of dopamine D3 receptor ligands: structure–activity relationships and selected neuropharmacological aspects</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.pharmthera.2006.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=16905195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFCit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2006&pages=281-333&author=F.+Boecklerauthor=P.+Gmeiner&title=The+structural+evolution+of+dopamine+D3+receptor+ligands%3A+structure%E2%80%93activity+relationships+and+selected+neuropharmacological+aspects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">The structural evolution of dopamine D3 receptor ligands: Structure-activity relationships and selected neuropharmacological aspects</span></div><div class="casAuthors">Boeckler, Frank; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-333</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Evolution consists largely of mol. tinkering.  Following the famous concept of the mol. geneticist and medicine Nobel laureate Francois Jacob, in this review we describe the structural evolution of dopamine D3 receptor ligands from the natural agonist dopamine (DA) to highly potent and subtype selective new agents by bioisosteric tinkering with well-established and privileged or novel and fancy chem. functionalities and scaffolds.  Some of the more than 200 ligands presented herein have already achieved therapeutic or scientific value up to now, some will most likely achieve it in the future.  Hence, great importance is not only attached to the relationship between structure and activity of the ligands, but also to their utility as pharmacol. tools in animal models or as therapeutics in patients with neurol. diseases or other disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq4e4fi-6e0bVg90H21EOLACvtfcHk0liEg0cBCx6kSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFCit70%253D&md5=732805be028ec7c4f62d0b1cccb3a3fd</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2006.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2006.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DBoeckler%26aufirst%3DF.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DThe%2520structural%2520evolution%2520of%2520dopamine%2520D3%2520receptor%2520ligands%253A%2520structure%25E2%2580%2593activity%2520relationships%2520and%2520selected%2520neuropharmacological%2520aspects%26jtitle%3DPharmacol.%2520Ther.%26date%3D2006%26volume%3D112%26spage%3D281%26epage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prevatt, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floresca, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Heterocyclic analogues of <i>N</i>-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4135</span><span class="NLM_x">–</span> <span class="NLM_lpage">4146</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0704200" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosVWitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4135-4146&author=P.+Grundtauthor=K.+M.+Prevattauthor=J.+Caoauthor=M.+Taylorauthor=C.+Z.+Florescaauthor=J.+K.+Choiauthor=B.+G.+Jenkinsauthor=R.+R.+Luedtkeauthor=A.+H.+Newman&title=Heterocyclic+analogues+of+N-%284-%284-%282%2C3-dichlorophenyl%29piperazin-1-yl%29butyl%29arylcarboxamides+with+functionalized+linking+chains+as+novel+dopamine+D3+receptor+ligands%3A+potential+substance+abuse+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Heterocyclic Analogues of N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with Functionalized Linking Chains as Novel Dopamine D3 Receptor Ligands: Potential Substance Abuse Therapeutic Agents</span></div><div class="casAuthors">Grundt, Peter; Prevatt, Katherine M.; Cao, Jianjing; Taylor, Michelle; Floresca, Christina Z.; Choi, Ji-Kyung; Jenkins, Bruce G.; Luedtke, Robert R.; Hauck Newman, Amy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4135-4146</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dopamine D3 receptor antagonists and partial agonists have been shown to modulate drug-seeking effects induced by cocaine and other abused substances.  Compd. 6 [PG01037, (N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)-trans-but-2-enyl)-4-pyridine-2-ylbenzamide)] and related analogs are currently being evaluated in animal models of drug addiction.  In these studies, a discrepancy between in vitro binding affinity, in vivo occupancy, and behavioral potency has been obsd.  The purpose of this study was to examine (1) modifications of the 2-pyridylphenyl moiety of 6 and (2) hydroxyl, acetyl, and cyclopropyl substitutions on the butylamide linking chain systematically coupled with 2-fluorenylamide or 2-pyridylphenylamide and 2-methoxy- or 2,3-dichloro-substituted phenylpiperazines to measure the impact on binding affinity, D2/D3 selectivity, lipophilicity, and function.  In general, these modifications were well tolerated at the human dopamine D3 (hD3) receptor (Ki = 1-5 nM) as measured in competition binding assays.  Several analogs showed >100-fold selectivity for dopamine D3 over D2 and D4 receptors.  In addn., while all the derivs. with an olefinic linker were antagonists, in quinpirole-stimulated mitogenesis at hD3 receptors, several of the hydroxybutyl-linked analogs (16, 17, 21) showed partial agonist activity.  Finally, several structural modifications reduced lipophilicities while retaining the desired binding profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVBkV6gsuYUrVg90H21EOLACvtfcHk0lgweC7ZgO8zqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosVWitLY%253D&md5=594bd5ab15004fbdf521ddaee4698b96</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm0704200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0704200%26sid%3Dliteratum%253Aachs%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DPrevatt%26aufirst%3DK.%2BM.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DFloresca%26aufirst%3DC.%2BZ.%26aulast%3DChoi%26aufirst%3DJ.%2BK.%26aulast%3DJenkins%26aufirst%3DB.%2BG.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DHeterocyclic%2520analogues%2520of%2520N-%25284-%25284-%25282%252C3-dichlorophenyl%2529piperazin-1-yl%2529butyl%2529arylcarboxamides%2520with%2520functionalized%2520linking%2520chains%2520as%2520novel%2520dopamine%2520D3%2520receptor%2520ligands%253A%2520potential%2520substance%2520abuse%2520therapeutic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4135%26epage%3D4146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Kumar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banala, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keck, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Chiral resolution and serendipitous fluorination reaction for the selective dopamine D3 receptor antagonist BAK2-66</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml500006v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslamuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=647-651&author=V.+Kumarauthor=A.+K.+Banalaauthor=E.+G.+Garciaauthor=J.+Caoauthor=T.+M.+Keckauthor=A.+Bonifaziauthor=J.+R.+Deschampsauthor=A.+H.+Newman&title=Chiral+resolution+and+serendipitous+fluorination+reaction+for+the+selective+dopamine+D3+receptor+antagonist+BAK2-66"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Chiral Resolution and Serendipitous Fluorination Reaction for the Selective Dopamine D3 Receptor Antagonist BAK2-66</span></div><div class="casAuthors">Kumar, Vivek; Banala, Ashwini K.; Garcia, Erick G.; Cao, Jianjing; Keck, Thomas M.; Bonifazi, Alessandro; Deschamps, Jeffery R.; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">647-651</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The improved chiral synthesis of the selective dopamine D3 receptor (D3R) antagonist (R)-N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)-3-hydroxybutyl)1H-indole-2-carboxamide ((R)-PG648) is described.  The same chiral secondary alc. intermediate was used to prep. the enantiomers of a 3-F-benzofuranyl analog, BAK 2-66 (I).  The abs. configurations of the 3-F enantiomers were assigned from their X-ray crystal structures that confirmed retention of configuration during fluorination with N,N-diethylaminosulfur trifluoride (DAST).  (R)-I showed higher D3R affinity and selectivity than its (S)-enantiomer; however, it had lower D3R affinity and enantioselectivity than (R)-PG648.  Further, importance of the 4-atom linker length between the aryl amide and 4-phenylpiperazine was demonstrated with the 4-fluorobutyl-product (II).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTRVSlrPS4ybVg90H21EOLACvtfcHk0lgweC7ZgO8zqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslamuro%253D&md5=17ddfb3b45b6630f53c917281d76b620</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fml500006v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500006v%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DBanala%26aufirst%3DA.%2BK.%26aulast%3DGarcia%26aufirst%3DE.%2BG.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DChiral%2520resolution%2520and%2520serendipitous%2520fluorination%2520reaction%2520for%2520the%2520selective%2520dopamine%2520D3%2520receptor%2520antagonist%2520BAK2-66%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D647%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of fluorine-containing D(3) dopamine receptor ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1555</span><span class="NLM_x">–</span> <span class="NLM_lpage">1564</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101323b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1555-1564&author=Z.+Tuauthor=S.+Liauthor=J.+Cuiauthor=J.+Xuauthor=M.+Taylorauthor=D.+Hoauthor=R.+R.+Luedtkeauthor=R.+H.+Mach&title=Synthesis+and+pharmacological+evaluation+of+fluorine-containing+D%283%29+dopamine+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm101323b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101323b%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DHo%26aufirst%3DD.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520fluorine-containing%2520D%25283%2529%2520dopamine%2520receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1555%26epage%3D1564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keck, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Tranylcypromine substituted cis-hydroxycyclobutylnaphthamides as potent and selective dopamine D(3) receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4962</span><span class="NLM_x">–</span> <span class="NLM_lpage">4968</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401798r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosVOnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4962-4968&author=J.+Chenauthor=B.+Levantauthor=C.+Jiangauthor=T.+M.+Keckauthor=A.+H.+Newmanauthor=S.+Wang&title=Tranylcypromine+substituted+cis-hydroxycyclobutylnaphthamides+as+potent+and+selective+dopamine+D%283%29+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Tranylcypromine Substituted cis-Hydroxycyclobutylnaphthamides as Potent and Selective Dopamine D3 Receptor Antagonists</span></div><div class="casAuthors">Chen, Jianyong; Levant, Beth; Jiang, Cheng; Keck, Thomas M.; Newman, Amy Hauck; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4962-4968</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report a class of potent and selective dopamine D3 receptor antagonists based upon tranylcypromine.  Although tranylcypromine has a low affinity for the rat D3 receptor (Ki = 12.8 μM), our efforts have yielded (1R,2S)-11 (CJ-1882), which has Ki values of 2.7 and 2.8 nM at the rat and human dopamine D3 receptors, resp., and displays resp. selectivities of >10000-fold and 223-fold over the rat and human D2 receptors.  Evaluation in a β-arrestin functional assay showed that (1R,2S)-11 is a potent and competitive antagonist at the human D3 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowWudWdAfWgLVg90H21EOLACvtfcHk0lgweC7ZgO8zqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosVOnurg%253D&md5=e2ddf0711d00103be281cb043b19ec3a</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm401798r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401798r%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLevant%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DTranylcypromine%2520substituted%2520cis-hydroxycyclobutylnaphthamides%2520as%2520potent%2520and%2520selective%2520dopamine%2520D%25283%2529%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4962%26epage%3D4968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Micheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arista, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonanomi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braggio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelli, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Checchia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di-Fabio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffante, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamprecht, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchioro, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mugnaini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedesco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarsi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terreni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C.</span><span> </span><span class="NLM_article-title">1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">374</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901319p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=374-391&author=F.+Micheliauthor=L.+Aristaauthor=G.+Bonanomiauthor=F.+E.+Blaneyauthor=S.+Braggioauthor=A.+M.+Capelliauthor=A.+Checchiaauthor=F.+Damianiauthor=R.+Di-Fabioauthor=S.+Fontanaauthor=G.+Gentileauthor=C.+Griffanteauthor=D.+Hamprechtauthor=C.+Marchioroauthor=M.+Mugnainiauthor=J.+Pinerauthor=E.+Rattiauthor=G.+Tedescoauthor=L.+Tarsiauthor=S.+Terreniauthor=A.+Worbyauthor=C.+R.+Ashbyauthor=C.+Heidbreder&title=1%2C2%2C4-Triazolyl+azabicyclo%5B3.1.0%5Dhexanes%3A+a+new+series+of+potent+and+selective+dopamine+D%283%29+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjm901319p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901319p%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DArista%26aufirst%3DL.%26aulast%3DBonanomi%26aufirst%3DG.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DBraggio%26aufirst%3DS.%26aulast%3DCapelli%26aufirst%3DA.%2BM.%26aulast%3DChecchia%26aufirst%3DA.%26aulast%3DDamiani%26aufirst%3DF.%26aulast%3DDi-Fabio%26aufirst%3DR.%26aulast%3DFontana%26aufirst%3DS.%26aulast%3DGentile%26aufirst%3DG.%26aulast%3DGriffante%26aufirst%3DC.%26aulast%3DHamprecht%26aufirst%3DD.%26aulast%3DMarchioro%26aufirst%3DC.%26aulast%3DMugnaini%26aufirst%3DM.%26aulast%3DPiner%26aufirst%3DJ.%26aulast%3DRatti%26aufirst%3DE.%26aulast%3DTedesco%26aufirst%3DG.%26aulast%3DTarsi%26aufirst%3DL.%26aulast%3DTerreni%26aufirst%3DS.%26aulast%3DWorby%26aufirst%3DA.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3D1%252C2%252C4-Triazolyl%2520azabicyclo%255B3.1.0%255Dhexanes%253A%2520a%2520new%2520series%2520of%2520potent%2520and%2520selective%2520dopamine%2520D%25283%2529%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D374%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Biswas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuzhikandathil, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Further structure--activity relationships study of hybrid 7-{[2-(4-phenylpiperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol analogues: identification of a high-affinity D3-preferring agonist with potent in vivo activity with long duration of action</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070860r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=101-117&author=S.+Biswasauthor=S.+Zhangauthor=F.+Fernandezauthor=B.+Ghoshauthor=J.+Zhenauthor=E.+Kuzhikandathilauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Further+structure%2D%2Dactivity+relationships+study+of+hybrid+7-%7B%5B2-%284-phenylpiperazin-1-yl%29ethyl%5Dpropylamino%7D-5%2C6%2C7%2C8-tetrahydronaphthalen-2-ol+analogues%3A+identification+of+a+high-affinity+D3-preferring+agonist+with+potent+in+vivo+activity+with+long+duration+of+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm070860r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070860r%26sid%3Dliteratum%253Aachs%26aulast%3DBiswas%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DFernandez%26aufirst%3DF.%26aulast%3DGhosh%26aufirst%3DB.%26aulast%3DZhen%26aufirst%3DJ.%26aulast%3DKuzhikandathil%26aufirst%3DE.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DFurther%2520structure--activity%2520relationships%2520study%2520of%2520hybrid%25207-%257B%255B2-%25284-phenylpiperazin-1-yl%2529ethyl%255Dpropylamino%257D-5%252C6%252C7%252C8-tetrahydronaphthalen-2-ol%2520analogues%253A%2520identification%2520of%2520a%2520high-affinity%2520D3-preferring%2520agonist%2520with%2520potent%2520in%2520vivo%2520activity%2520with%2520long%2520duration%2520of%2520action%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D101%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of potent and selective ligands for the dopamine 3 (D3) receptor with a novel in vivo behavioral profile</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5905</span><span class="NLM_x">–</span> <span class="NLM_lpage">5908</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800471h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5905-5908&author=J.+Chenauthor=G.+T.+Collinsauthor=J.+Zhangauthor=C.+Y.+Yangauthor=B.+Levantauthor=J.+Woodsauthor=S.+Wang&title=Design%2C+synthesis%2C+and+evaluation+of+potent+and+selective+ligands+for+the+dopamine+3+%28D3%29+receptor+with+a+novel+in+vivo+behavioral+profile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fjm800471h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800471h%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DG.%2BT.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DLevant%26aufirst%3DB.%26aulast%3DWoods%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520potent%2520and%2520selective%2520ligands%2520for%2520the%2520dopamine%25203%2520%2528D3%2529%2520receptor%2520with%2520a%2520novel%2520in%2520vivo%2520behavioral%2520profile%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5905%26epage%3D5908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Structure–activity relationship study of <i>N</i><sup>6</sup>-(2-(4-(1<i>H</i>-indol-5-yl)piperazin-1-yl)ethyl)-<i>N</i><sup>6</sup>-propyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-2,6-diamine analogues: development of highly selective D3 dopamine receptor agonists along with a highly potent D2/D3 agonist and their pharmacological characterization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5826</span><span class="NLM_x">–</span> <span class="NLM_lpage">5840</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300268s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5826-5840&author=M.+Johnsonauthor=T.+Antonioauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Structure%E2%80%93activity+relationship+study+of+N6-%282-%284-%281H-indol-5-yl%29piperazin-1-yl%29ethyl%29-N6-propyl-4%2C5%2C6%2C7-tetrahydrobenzo%5Bd%5Dthiazole-2%2C6-diamine+analogues%3A+development+of+highly+selective+D3+dopamine+receptor+agonists+along+with+a+highly+potent+D2%2FD3+agonist+and+their+pharmacological+characterization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fjm300268s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300268s%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520study%2520of%2520N6-%25282-%25284-%25281H-indol-5-yl%2529piperazin-1-yl%2529ethyl%2529-N6-propyl-4%252C5%252C6%252C7-tetrahydrobenzo%255Bd%255Dthiazole-2%252C6-diamine%2520analogues%253A%2520development%2520of%2520highly%2520selective%2520D3%2520dopamine%2520receptor%2520agonists%2520along%2520with%2520a%2520highly%2520potent%2520D2%252FD3%2520agonist%2520and%2520their%2520pharmacological%2520characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5826%26epage%3D5840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Tschammer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elsner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrlich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuster, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhhorn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whistler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Highly potent 5-aminotetrahydropyrazolopyridines: enantioselective dopamine D3 receptor binding, functional selectivity, and analysis of receptor–ligand interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2477</span><span class="NLM_x">–</span> <span class="NLM_lpage">2491</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101639t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2477-2491&author=N.+Tschammerauthor=J.+Elsnerauthor=A.+Goetzauthor=K.+Ehrlichauthor=S.+Schusterauthor=M.+Rubergauthor=J.+Kuhhornauthor=D.+Thompsonauthor=J.+Whistlerauthor=H.+Hubnerauthor=P.+Gmeiner&title=Highly+potent+5-aminotetrahydropyrazolopyridines%3A+enantioselective+dopamine+D3+receptor+binding%2C+functional+selectivity%2C+and+analysis+of+receptor%E2%80%93ligand+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm101639t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101639t%26sid%3Dliteratum%253Aachs%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DElsner%26aufirst%3DJ.%26aulast%3DGoetz%26aufirst%3DA.%26aulast%3DEhrlich%26aufirst%3DK.%26aulast%3DSchuster%26aufirst%3DS.%26aulast%3DRuberg%26aufirst%3DM.%26aulast%3DKuhhorn%26aufirst%3DJ.%26aulast%3DThompson%26aufirst%3DD.%26aulast%3DWhistler%26aufirst%3DJ.%26aulast%3DHubner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DHighly%2520potent%25205-aminotetrahydropyrazolopyridines%253A%2520enantioselective%2520dopamine%2520D3%2520receptor%2520binding%252C%2520functional%2520selectivity%252C%2520and%2520analysis%2520of%2520receptor%25E2%2580%2593ligand%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2477%26epage%3D2491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Correll, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span> </span><span class="NLM_article-title">Biased ligand modulation of seven transmembrane receptors (7TMRs): functional implications for drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">6887</span><span class="NLM_x">–</span> <span class="NLM_lpage">6896</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401677g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6887-6896&author=C.+C.+Correllauthor=B.+A.+McKittrick&title=Biased+ligand+modulation+of+seven+transmembrane+receptors+%287TMRs%29%3A+functional+implications+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjm401677g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401677g%26sid%3Dliteratum%253Aachs%26aulast%3DCorrell%26aufirst%3DC.%2BC.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26atitle%3DBiased%2520ligand%2520modulation%2520of%2520seven%2520transmembrane%2520receptors%2520%25287TMRs%2529%253A%2520functional%2520implications%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6887%26epage%3D6896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Shonberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span> </span><span class="NLM_article-title">Biased agonism at G protein-coupled receptors: the promise and the challenges—a medicinal chemistry perspective</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1286</span><span class="NLM_x">–</span> <span class="NLM_lpage">1330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1002%2Fmed.21318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24796277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslalu7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=1286-1330&author=J.+Shonbergauthor=L.+Lopezauthor=P.+J.+Scammellsauthor=A.+Christopoulosauthor=B.+Capuanoauthor=J.+R.+Lane&title=Biased+agonism+at+G+protein-coupled+receptors%3A+the+promise+and+the+challenges%E2%80%94a+medicinal+chemistry+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Biased Agonism at G Protein-Coupled Receptors: The Promise and the Challenges-A Medicinal Chemistry Perspective</span></div><div class="casAuthors">Shonberg, Jeremy; Lopez, Laura; Scammells, Peter J.; Christopoulos, Arthur; Capuano, Ben; Lane, J. Robert</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1286-1330</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Historically, detn. of G protein-coupled receptor (GPCR) ligand efficacy has often been restricted to identifying the ligand as an agonist or antagonist at a given signaling pathway.  This classification was deemed sufficient to predict compd. efficacy at all signaling endpoints, including the therapeutically relevant one(s).  However, it is now apparent that ligands acting at the same GPCR can stabilize multiple, distinct, receptor conformations linked to different functional outcomes.  This phenomenon, known as biased agonism, stimulus bias, or functional selectivity offers the opportunity to sep. on-target therapeutic effects from side effects through the design of drugs that show pathway selectivity.  However, the medicinal chemist faces numerous challenges to develop biased ligands, including the detection and quantification of biased agonism.  This review summarizes the current state of the field of research into biased agonism at GPCRs, with a particular focus on efforts to relate biased agonism to ligand structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg-egFZpSKvbVg90H21EOLACvtfcHk0liqc8J4ZMFydw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslalu7rJ&md5=85a5b385750d21856ae044391c46ee75</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1002%2Fmed.21318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21318%26sid%3Dliteratum%253Aachs%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26atitle%3DBiased%2520agonism%2520at%2520G%2520protein-coupled%2520receptors%253A%2520the%2520promise%2520and%2520the%2520challenges%25E2%2580%2594a%2520medicinal%2520chemistry%2520perspective%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2014%26volume%3D34%26spage%3D1286%26epage%3D1330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Hiller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinemann, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Functionally selective dopamine D2/D3 receptor agonists comprising an enyne moiety</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5130</span><span class="NLM_x">–</span> <span class="NLM_lpage">5141</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400520c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslSqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5130-5141&author=C.+Hillerauthor=R.+C.+Klingauthor=F.+W.+Heinemannauthor=K.+Meyerauthor=H.+Hubnerauthor=P.+Gmeiner&title=Functionally+selective+dopamine+D2%2FD3+receptor+agonists+comprising+an+enyne+moiety"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Functionally Selective Dopamine D2/D3 Receptor Agonists Comprising an Enyne Moiety</span></div><div class="casAuthors">Hiller, Christine; Kling, Ralf C.; Heinemann, Frank W.; Meyer, Karsten; Huebner, Harald; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5130-5141</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nonracemic ethynylcyclohexynylamines I and ent-I {R = 1,1'-biphenyl-4-yl, pyrazolo[1,5-a]pyridin-2-yl, pyrazolo[1,5-a]pyridin-3-yl, 4-[3-(1-butyl-1,2,3-triazol-4-yloxy)propoxy]-3-methoxyphenyl, benzo[b]thiophene-2-yl, ferrocenyl} were prepd. as dopamine receptor agonists with atypical catechol isosteres; their selectivities for dopamine receptors and for activating receptors through G-protein subunits Go and Gi and the metabolic stability of rac-I (R = 4-PhC6H4) were detd.  The ethynylcyclohexynylamines bound to D2-like receptors with high affinities.  Ent-I (R = pyrazolo[1,5-a]pyridin-2-yl) selectively activated D2slow-promoted Go activation over Gi coupling; the most significant functional bias obsd. was for ent-I {R = 4-[3-(1-butyl-1,2,3-triazol-4-yloxy)propoxy]-3-methoxyphenyl} which selectively activated Go over Gi coupling at D2long receptors.  Functional selectivity for β-arrestin recruitment over Gi activation was obsd. for I (R = 1,1'-biphenyl-4-yl) and ent-I (R = benzothiophene-2-yl), while ent-I (R = pyrazolo[1,5-a]pyridin-2-yl) preferred β-arrestin recruitment compared to Go coupling.  The structure of a nonracemic N-(ethynylcyclohexenyl)dinitrobenzamide was detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXn2SrS-IBCrVg90H21EOLACvtfcHk0liqc8J4ZMFydw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslSqtr4%253D&md5=3855de949f505a83ed3aa561ca182e75</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm400520c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400520c%26sid%3Dliteratum%253Aachs%26aulast%3DHiller%26aufirst%3DC.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DHeinemann%26aufirst%3DF.%2BW.%26aulast%3DMeyer%26aufirst%3DK.%26aulast%3DHubner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DFunctionally%2520selective%2520dopamine%2520D2%252FD3%2520receptor%2520agonists%2520comprising%2520an%2520enyne%2520moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5130%26epage%3D5141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Möller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skultety, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leuner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Functionally selective dopamine D(2), D(3) receptor partial agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4861</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5004039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4861-4875&author=D.+M%C3%B6llerauthor=R.+C.+Klingauthor=M.+Skultetyauthor=K.+Leunerauthor=H.+Hubnerauthor=P.+Gmeiner&title=Functionally+selective+dopamine+D%282%29%2C+D%283%29+receptor+partial+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fjm5004039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5004039%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DSkultety%26aufirst%3DM.%26aulast%3DLeuner%26aufirst%3DK.%26aulast%3DHubner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DFunctionally%2520selective%2520dopamine%2520D%25282%2529%252C%2520D%25283%2529%2520receptor%2520partial%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4861%26epage%3D4875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">te Beek, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoethout, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bani, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iavarone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaassen, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fina, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Gerven, J. M.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and central nervous system effects of the novel dopamine D3 receptor antagonist GSK598809 and intravenous alcohol infusion at pseudo-steady state</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1177%2F0269881111431750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=22219221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFyntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=303-314&author=E.+T.+te+Beekauthor=R.+W.+Zoethoutauthor=M.+S.+Baniauthor=A.+Andornauthor=L.+Iavaroneauthor=E.+S.+Klaassenauthor=P.+Finaauthor=J.+M.+van+Gerven&title=Pharmacokinetics+and+central+nervous+system+effects+of+the+novel+dopamine+D3+receptor+antagonist+GSK598809+and+intravenous+alcohol+infusion+at+pseudo-steady+state"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and central nervous system effects of the novel dopamine D3 receptor antagonist GSK598809 and intravenous alcohol infusion at pseudo-steady state</span></div><div class="casAuthors">te Beek, E. T.; Zoethout, R. W. M.; Bani, M. S. G.; Andorn, A.; Iavarone, L.; Klaassen, E. S.; Fina, P.; van Gerven, J. M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">303-314</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">GSK598809 is a novel selective dopamine D3 receptor antagonist, currently in development for the treatment of substance abuse and addiction.  In a blinded, randomized, placebo-controlled study, effects of single oral doses of 175 mg GSK598809 were evaluated in healthy volunteers.  Pharmacokinetics, central nervous system (CNS) effects and potential for interactions with alc. were evaluated, using an alc. infusion paradigm and anal. of eye movements, adaptive tracking, visual analog scales, body sway, serum prolactin and verbal visual learning test.  Adverse effects of GSK598809 included headache, dizziness and somnolence.  Plasma concn. of GSK598809 was maximal 2-3 h postdose and decreased with a half-life of roughly 20 h.  CNS effects were limited to prolactin elevation and decreased adaptive tracking.  Co-administration of GSK598809 and alc. did not affect alc. pharmacokinetics, but caused a 9% decrease of Cmax and a 15% increase of AUC of GSK598809.  CNS effects of co-administration were mainly additive, except a small supra-additive increase in saccadic reaction time and decrease in delayed word recall.  In conclusion, GSK598809 causes elevation of serum prolactin and a small decrease in adaptive tracking performance.  After co-administration with alc., effects of GSK598809 are mainly additive and the combination is well tolerated in healthy volunteers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_wePB6PIRp7Vg90H21EOLACvtfcHk0liqc8J4ZMFydw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFyntrY%253D&md5=6f4c518348fda9985d56dfd5977ddc51</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1177%2F0269881111431750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0269881111431750%26sid%3Dliteratum%253Aachs%26aulast%3Dte%2BBeek%26aufirst%3DE.%2BT.%26aulast%3DZoethout%26aufirst%3DR.%2BW.%26aulast%3DBani%26aufirst%3DM.%2BS.%26aulast%3DAndorn%26aufirst%3DA.%26aulast%3DIavarone%26aufirst%3DL.%26aulast%3DKlaassen%26aufirst%3DE.%2BS.%26aulast%3DFina%26aufirst%3DP.%26aulast%3Dvan%2BGerven%26aufirst%3DJ.%2BM.%26atitle%3DPharmacokinetics%2520and%2520central%2520nervous%2520system%2520effects%2520of%2520the%2520novel%2520dopamine%2520D3%2520receptor%2520antagonist%2520GSK598809%2520and%2520intravenous%2520alcohol%2520infusion%2520at%2520pseudo-steady%2520state%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2012%26volume%3D26%26spage%3D303%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Mogg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo-Pich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullmore, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathan, P. J.</span><span> </span><span class="NLM_article-title">Effect of dopamine D(3) receptor antagonism on approach responses to food cues in overweight and obese individuals</span> <span class="citation_source-journal">Behav. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=603-608&author=K.+Moggauthor=B.+P.+Bradleyauthor=B.+O%E2%80%99Neillauthor=M.+Baniauthor=E.+Merlo-Pichauthor=A.+Kochauthor=E.+T.+Bullmoreauthor=P.+J.+Nathan&title=Effect+of+dopamine+D%283%29+receptor+antagonism+on+approach+responses+to+food+cues+in+overweight+and+obese+individuals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMogg%26aufirst%3DK.%26aulast%3DBradley%26aufirst%3DB.%2BP.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%26aulast%3DBani%26aufirst%3DM.%26aulast%3DMerlo-Pich%26aufirst%3DE.%26aulast%3DKoch%26aufirst%3DA.%26aulast%3DBullmore%26aufirst%3DE.%2BT.%26aulast%3DNathan%26aufirst%3DP.%2BJ.%26atitle%3DEffect%2520of%2520dopamine%2520D%25283%2529%2520receptor%2520antagonism%2520on%2520approach%2520responses%2520to%2520food%2520cues%2520in%2520overweight%2520and%2520obese%2520individuals%26jtitle%3DBehav.%2520Pharmacol.%26date%3D2012%26volume%3D23%26spage%3D603%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Nathan, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mogg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaver, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo-Pich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swirski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodds, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullmore, E. T.</span><span> </span><span class="NLM_article-title">The effects of the dopamine D(3) receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1017%2FS1461145711001052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=21745436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis1ejtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=149-161&author=P.+J.+Nathanauthor=B.+V.+O%E2%80%99Neillauthor=K.+Moggauthor=B.+P.+Bradleyauthor=J.+Beaverauthor=M.+Baniauthor=E.+Merlo-Pichauthor=P.+C.+Fletcherauthor=B.+Swirskiauthor=A.+Kochauthor=C.+M.+Doddsauthor=E.+T.+Bullmore&title=The+effects+of+the+dopamine+D%283%29+receptor+antagonist+GSK598809+on+attentional+bias+to+palatable+food+cues+in+overweight+and+obese+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of the dopamine D3 receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects</span></div><div class="casAuthors">Nathan, Pradeep J.; O'Neill, Barry V.; Mogg, Karin; Bradley, Brendan P.; Beaver, John; Bani, Massimo; Merlo-Pich, Emilio; Fletcher, Paul C.; Swirski, Bridget; Koch, Annelize; Dodds, Chris M.; Bullmore, Edward T.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-161</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">The mesolimbic dopamine system plays a crit. role in the reinforcing effects of rewards.  Evidence from pre-clin. studies suggests that D3 receptor antagonists may attenuate the motivational impact of rewarding cues.  In this study we examd. the acute effects of the D3 receptor antagonist GSK598809 on attentional bias to rewarding food cues in overweight to obese individuals (n=26, BMI mean=32.7±3.7, range 27-40 kg/m2) who reported binge and emotional eating.  We also detd. whether individual differences in restrained eating style modulated the effects of GSK598809 on attentional bias.  The study utilized a randomized, double-blind, placebo-controlled cross-over design with each participant tested following acute administration of placebo and GSK598809 (175 mg).  Attentional bias was assessed by the visual probe task and modified Stroop task using food-related words.  Overall GSK598809 had no effects on attentional bias in either the visual probe or food Stroop tasks.  However, the effect of GSK598809 on both visual probe and food Stroop attentional bias scores was inversely correlated with a measure of eating restraint allowing the identification of two subpopulations, low- and high-restrained eaters.  Low-restrained eaters had a significant attentional bias towards food cues in both tasks under placebo, and this was attenuated by GSK598809.  In contrast, high-restrained eaters showed no attentional bias to food cues following either placebo or GSK598809.  These findings suggest that excessive attentional bias to food cues generated by individual differences in eating traits can be modulated by D3 receptor antagonists, warranting further investigation with measures of eating behavior and wt. loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_bx5ouR9_W7Vg90H21EOLACvtfcHk0lhy_1leF-zpkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis1ejtrg%253D&md5=2bbf9cb07a39ef8a896ef5d72711fa54</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1017%2FS1461145711001052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145711001052%26sid%3Dliteratum%253Aachs%26aulast%3DNathan%26aufirst%3DP.%2BJ.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BV.%26aulast%3DMogg%26aufirst%3DK.%26aulast%3DBradley%26aufirst%3DB.%2BP.%26aulast%3DBeaver%26aufirst%3DJ.%26aulast%3DBani%26aufirst%3DM.%26aulast%3DMerlo-Pich%26aufirst%3DE.%26aulast%3DFletcher%26aufirst%3DP.%2BC.%26aulast%3DSwirski%26aufirst%3DB.%26aulast%3DKoch%26aufirst%3DA.%26aulast%3DDodds%26aufirst%3DC.%2BM.%26aulast%3DBullmore%26aufirst%3DE.%2BT.%26atitle%3DThe%2520effects%2520of%2520the%2520dopamine%2520D%25283%2529%2520receptor%2520antagonist%2520GSK598809%2520on%2520attentional%2520bias%2520to%2520palatable%2520food%2520cues%2520in%2520overweight%2520and%2520obese%2520subjects%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2012%26volume%3D15%26spage%3D149%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Dodds, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaver, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makwana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo-Pich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullmore, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathan, P. J.</span><span> </span><span class="NLM_article-title">Effect of the dopamine D3 receptor antagonist GSK598809 on brain responses to rewarding food images in overweight and obese binge eaters</span> <span class="citation_source-journal">Appetite</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2012&pages=27-33&author=C.+M.+Doddsauthor=B.+O%E2%80%99Neillauthor=J.+Beaverauthor=A.+Makwanaauthor=M.+Baniauthor=E.+Merlo-Pichauthor=P.+C.+Fletcherauthor=A.+Kochauthor=E.+T.+Bullmoreauthor=P.+J.+Nathan&title=Effect+of+the+dopamine+D3+receptor+antagonist+GSK598809+on+brain+responses+to+rewarding+food+images+in+overweight+and+obese+binge+eaters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDodds%26aufirst%3DC.%2BM.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%26aulast%3DBeaver%26aufirst%3DJ.%26aulast%3DMakwana%26aufirst%3DA.%26aulast%3DBani%26aufirst%3DM.%26aulast%3DMerlo-Pich%26aufirst%3DE.%26aulast%3DFletcher%26aufirst%3DP.%2BC.%26aulast%3DKoch%26aufirst%3DA.%26aulast%3DBullmore%26aufirst%3DE.%2BT.%26aulast%3DNathan%26aufirst%3DP.%2BJ.%26atitle%3DEffect%2520of%2520the%2520dopamine%2520D3%2520receptor%2520antagonist%2520GSK598809%2520on%2520brain%2520responses%2520to%2520rewarding%2520food%2520images%2520in%2520overweight%2520and%2520obese%2520binge%2520eaters%26jtitle%3DAppetite%26date%3D2012%26volume%3D59%26spage%3D27%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">O’Connell, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughan, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botkin, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, R. M.</span><span> </span><span class="NLM_article-title">Expression of the dopamine D3 receptor protein in the rat kidney</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">886</span><span class="NLM_x">–</span> <span class="NLM_lpage">895</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1998&pages=886-895&author=D.+P.+O%E2%80%99Connellauthor=C.+J.+Vaughanauthor=A.+M.+Aherneauthor=S.+J.+Botkinauthor=Z.+Q.+Wangauthor=R.+A.+Felderauthor=R.+M.+Carey&title=Expression+of+the+dopamine+D3+receptor+protein+in+the+rat+kidney"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DD.%2BP.%26aulast%3DVaughan%26aufirst%3DC.%2BJ.%26aulast%3DAherne%26aufirst%3DA.%2BM.%26aulast%3DBotkin%26aufirst%3DS.%2BJ.%26aulast%3DWang%26aufirst%3DZ.%2BQ.%26aulast%3DFelder%26aufirst%3DR.%2BA.%26aulast%3DCarey%26aufirst%3DR.%2BM.%26atitle%3DExpression%2520of%2520the%2520dopamine%2520D3%2520receptor%2520protein%2520in%2520the%2520rat%2520kidney%26jtitle%3DHypertension%26date%3D1998%26volume%3D32%26spage%3D886%26epage%3D895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Hussain, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lokhandwala, M. F.</span><span> </span><span class="NLM_article-title">Renal dopamine receptors and hypertension</span> <span class="citation_source-journal">Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1amtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2003&pages=134-142&author=T.+Hussainauthor=M.+F.+Lokhandwala&title=Renal+dopamine+receptors+and+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Renal dopamine receptors and hypertension</span></div><div class="casAuthors">Hussain, Tahir; Lokhandwala, Mustafa F.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Biology and Medicine (Maywood, NJ, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">134-142</span>CODEN:
                <span class="NLM_cas:coden">EBMMBE</span>;
        ISSN:<span class="NLM_cas:issn">1535-3702</span>.
    
            (<span class="NLM_cas:orgname">Society for Experimental Biology and Medicine</span>)
        </div><div class="casAbstract">A review.  Dopamine has been recognized as an important modulator of central as well as peripheral physiol. functions in both humans and animals.  Dopamine receptors have been identified in a no. of organs and tissues, which include several regions within the central nervous system, sympathetic ganglia and postganglionic nerve terminals, various vascular beds, the heart, the gastrointestinal tract, and the kidney.  The peripheral dopamine receptors influence cardiovascular and renal function by decreasing afterload and vascular resistance and promoting sodium excretion.  Within the kidney, dopamine receptors are present along the nephron, with highest d. on proximal tubule epithelial cells.  It has been reported that there is a defective dopamine receptor, esp. D1 receptor function, in the proximal tubule of various animal models of hypertension as well as in humans with essential hypertension.  Recent reports have revealed the site of and the mol. mechanisms responsible for the defect in D1 receptors in hypertension.  Moreover, recent studies have also demonstrated that the disruption of various dopamine receptor subtypes and their function produces hypertension in rodents.  In this review, we present evidence that dopamine and dopamine receptors play an important role in regulating renal sodium excretion and that defective renal dopamine prodn. and/or dopamine receptor function may contribute to the development of various forms of hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorQTmyiNsVoLVg90H21EOLACvtfcHk0li7ejl5wu71hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1amtbc%253D&md5=63c7a17aaefeaa835fb9c3e482c948cf</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DT.%26aulast%3DLokhandwala%26aufirst%3DM.%2BF.%26atitle%3DRenal%2520dopamine%2520receptors%2520and%2520hypertension%26jtitle%3DExp.%2520Biol.%2520Med.%26date%3D2003%26volume%3D228%26spage%3D134%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Zeng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jose, P. A.</span><span> </span><span class="NLM_article-title">Dopamine receptors: important antihypertensive counterbalance against hypertensive factors</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2011&pages=11-17&author=C.+Zengauthor=P.+A.+Jose&title=Dopamine+receptors%3A+important+antihypertensive+counterbalance+against+hypertensive+factors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DC.%26aulast%3DJose%26aufirst%3DP.%2BA.%26atitle%3DDopamine%2520receptors%253A%2520important%2520antihypertensive%2520counterbalance%2520against%2520hypertensive%2520factors%26jtitle%3DHypertension%26date%3D2011%26volume%3D57%26spage%3D11%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Armando, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villar, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jose, P. A.</span><span> </span><span class="NLM_article-title">Dopamine and renal function and blood pressure regulation</span> <span class="citation_source-journal">Compr. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1075</span><span class="NLM_x">–</span> <span class="NLM_lpage">1117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=23733636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BC3snpsVentw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=1075-1117&author=I.+Armandoauthor=V.+A.+Villarauthor=P.+A.+Jose&title=Dopamine+and+renal+function+and+blood+pressure+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine and renal function and blood pressure regulation</span></div><div class="casAuthors">Armando Ines; Villar Van Anthony M; Jose Pedro A</div><div class="citationInfo"><span class="NLM_cas:title">Comprehensive Physiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1075-117</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dopamine is an important regulator of systemic blood pressure via multiple mechanisms.  It affects fluid and electrolyte balance by its actions on renal hemodynamics and epithelial ion and water transport and by regulation of hormones and humoral agents.  The kidney synthesizes dopamine from circulating or filtered L-DOPA independently from innervation.  The major determinants of the renal tubular synthesis/release of dopamine are probably sodium intake and intracellular sodium.  Dopamine exerts its actions via two families of cell surface receptors, D1-like receptors comprising D1R and D5R, and D2-like receptors comprising D2R, D3R, and D4R, and by interactions with other G protein-coupled receptors.  D1-like receptors are linked to vasodilation, while the effect of D2-like receptors on the vasculature is variable and probably dependent upon the state of nerve activity.  Dopamine secreted into the tubular lumen acts mainly via D1-like receptors in an autocrine/paracrine manner to regulate ion transport in the proximal and distal nephron.  These effects are mediated mainly by tubular mechanisms and augmented by hemodynamic mechanisms.  The natriuretic effect of D1-like receptors is caused by inhibition of ion transport in the apical and basolateral membranes.  D2-like receptors participate in the inhibition of ion transport during conditions of euvolemia and moderate volume expansion.  Dopamine also controls ion transport and blood pressure by regulating the production of reactive oxygen species and the inflammatory response.  Essential hypertension is associated with abnormalities in dopamine production, receptor number, and/or posttranslational modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRUksfu_AqPfJagfuraLLzSfW6udTcc2eb_cSs1K-z53bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snpsVentw%253D%253D&md5=38b8410fb3e439148eaa83c519137051</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArmando%26aufirst%3DI.%26aulast%3DVillar%26aufirst%3DV.%2BA.%26aulast%3DJose%26aufirst%3DP.%2BA.%26atitle%3DDopamine%2520and%2520renal%2520function%2520and%2520blood%2520pressure%2520regulation%26jtitle%3DCompr.%2520Physiol.%26date%3D2011%26volume%3D1%26spage%3D1075%26epage%3D1117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Schindler, C. W.</span><span> </span><span class="NLM_article-title">Cocaine and cardiovascular toxicity</span> <span class="citation_source-journal">Addict. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1080%2F1355621961000124676" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=12893485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaK28XntVOjt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1996&pages=31-47&author=C.+W.+Schindler&title=Cocaine+and+cardiovascular+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Cocaine and cardiovascular toxicity</span></div><div class="casAuthors">Schindler, Charles W.</div><div class="citationInfo"><span class="NLM_cas:title">Addiction Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-47</span>CODEN:
                <span class="NLM_cas:coden">ADBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1355-6215</span>.
    
            (<span class="NLM_cas:orgname">Carfax</span>)
        </div><div class="casAbstract">A review, with ∼125 refs.  Over the past 10 yr a great deal has been learned about the cardiovascular effects of cocaine.  In particular, the acute effects of cocaine have been studied extensively.  Upon acute administration cocaine increases blood pressure and heart rate, primarily through an action on the sympathetic nervous system.  Cocaine also suppresses the baroreflex response and vagal tone, further contributing to its effects on heart rate.  At the same time cocaine is increasing the work-load on the heart it induces coronary artery vasoconstriction, potentially leading to cardiac ischemia.  At higher doses cocaine can depress ventricular function and slow elec. conduction in the heart.  Both these effects appear to be mediated by cocaine's local anesthetic action.  The effects of cocaine mediated by the sympathetic nervous system are greatly reduced in anesthetized animals.  Further, when cocaine is administered repeatedly over a short period of time, acute tolerance can develop to the sympathomimetic effects of cocaine.  In contrast, the effects of cocaine mediated by its local anesthetic action do not appear blunted by anesthesia or susceptible to acute tolerance.  With chronic administration, higher doses appear to induce tolerance while lower doses may induce sensitization to cocaine's sympathomimetic effects.  Cocaine also induces a variety of pathol. changes in the heart, including myocardial contraction band necrosis and ventricular hypertrophy.  These effects of cocaine on the heart can all contribute to potentially lethal cardiovascular events.  In addn. to the effects of cocaine alone, the metabolites of cocaine may also contribute to cocaine's cardiovascular toxicity, and both licit and illicit drugs used in combination with cocaine might potentially alter its cardiovascular effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom0YH3xdifa7Vg90H21EOLACvtfcHk0ljhxb8suRXbiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntVOjt7k%253D&md5=dc35d5ad5e7b133f268fc32cf1322afb</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1080%2F1355621961000124676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F1355621961000124676%26sid%3Dliteratum%253Aachs%26aulast%3DSchindler%26aufirst%3DC.%2BW.%26atitle%3DCocaine%2520and%2520cardiovascular%2520toxicity%26jtitle%3DAddict.%2520Biol.%26date%3D1996%26volume%3D1%26spage%3D31%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Brecklin, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J. L.</span><span> </span><span class="NLM_article-title">Cardiovascular effects of cocaine: focus on hypertension</span> <span class="citation_source-journal">J. Clin. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtlCntLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=212-217&author=C.+S.+Brecklinauthor=J.+L.+Bauman&title=Cardiovascular+effects+of+cocaine%3A+focus+on+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular effects of cocaine: focus on hypertension</span></div><div class="casAuthors">Brecklin, Carolyn S.; Bauman, Jerry L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Hypertension (Greenwich, Connecticut)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">212-217</span>CODEN:
                <span class="NLM_cas:coden">JCHYFN</span>;
        ISSN:<span class="NLM_cas:issn">1524-6175</span>.
    
            (<span class="NLM_cas:orgname">Le Jacq Communications, Inc.</span>)
        </div><div class="casAbstract">A review with 42 refs.  Cocaine, a naturally occurring alkaloid, has increasingly been implicated in a myriad of medical complications.  The majority of these relate to cardiovascular effects of the drug, a potent sympathomimetic.  In addn., cocaine has effects on endothelin-1, the sodium channel, and nitric oxide which further enhance its untoward cardiovascular effects.  The cardiovascular effects of cocaine include myocardial ischemia or infarction, ventricular arrhythmias and sudden death, cardiomyopathy, cerebral infarction or hemorrhage, and acute hypertension.  Although hypertension has been described in the offspring of cocaine using mothers, two recent studies have not found an increased prevalence of chronic hypertension in adults.  Nonetheless, long term abuse of cocaine can lead to the various forms of target organ damage usually assocd. with untreated essential hypertension, presumably due to frequent intermittent and severe elevations in blood pressure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEEvupb6UCrLVg90H21EOLACvtfcHk0ljhxb8suRXbiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtlCntLk%253D&md5=19bbb0265a915eb2723a4b57036949c3</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrecklin%26aufirst%3DC.%2BS.%26aulast%3DBauman%26aufirst%3DJ.%2BL.%26atitle%3DCardiovascular%2520effects%2520of%2520cocaine%253A%2520focus%2520on%2520hypertension%26jtitle%3DJ.%2520Clin.%2520Hypertens.%26date%3D1999%26volume%3D1%26spage%3D212%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Haney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foltin, R. W.</span><span> </span><span class="NLM_article-title">Aripiprazole maintenance increases smoked cocaine self-administration in humans</span> <span class="citation_source-journal">Psychopharmacology </span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">216</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=2011&pages=379-387&author=M.+Haneyauthor=E.+Rubinauthor=R.+W.+Foltin&title=Aripiprazole+maintenance+increases+smoked+cocaine+self-administration+in+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaney%26aufirst%3DM.%26aulast%3DRubin%26aufirst%3DE.%26aulast%3DFoltin%26aufirst%3DR.%2BW.%26atitle%3DAripiprazole%2520maintenance%2520increases%2520smoked%2520cocaine%2520self-administration%2520in%2520humans%26jtitle%3DPsychopharmacology%2520%26date%3D2011%26volume%3D216%26spage%3D379%26epage%3D387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Lile, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoops, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hays, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, C. R.</span><span> </span><span class="NLM_article-title">Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1469</span><span class="NLM_x">–</span> <span class="NLM_lpage">1479</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1177%2F0269881110385597" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=20952456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFGgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=1469-1479&author=J.+A.+Lileauthor=W.+W.+Stoopsauthor=P.+E.+Glaserauthor=L.+R.+Haysauthor=C.+R.+Rush&title=Discriminative+stimulus%2C+subject-rated+and+cardiovascular+effects+of+cocaine+alone+and+in+combination+with+aripiprazole+in+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans</span></div><div class="casAuthors">Lile, Joshua A.; Stoops, William W.; Glaser, Paul E. A.; Hays, Lon R.; Rush, Craig R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1469-1479</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Aripiprazole is a dopamine D2 receptor partial agonist undergoing evaluation as a pharmacotherapy for stimulant-use disorders.  Acutely administered aripiprazole attenuates the discriminative stimulus and other behavioral effects of d-amphetamine in humans; however, whether aripiprazole attenuates the effects of more commonly abused stimulants is unknown.  The aim of this expt. was to assess the discriminative stimulus, subject-rated and cardiovascular effects of oral cocaine alone and following acute administration of aripiprazole in humans.  Eight cocaine-dependent subjects learned to discriminate 150 mg cocaine from placebo.  After acquiring the discrimination, the effects of cocaine (0, 25, 50, 100 and 200 mg) administered alone and in combination with aripiprazole (15 mg) were detd.  Significant effects of cocaine were obsd. for the drug discrimination task, stimulant-like subject-rated effects and heart rate.  Limited effects of aripiprazole were revealed.  However, for most measures, fewer doses of cocaine were significantly greater than placebo when combined with aripiprazole, suggesting a redn. in the discriminative stimulus, self-reported and cardiovascular effects of cocaine.  These data are consistent with previous studies that have tested acutely administered aripiprazole in combination with d-amphetamine and suggest that the ability of aripiprazole to modify stimulant effects is a function of the duration of treatment (acute vs. chronic).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlSaJkRIPntrVg90H21EOLACvtfcHk0ljhxb8suRXbiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFGgtQ%253D%253D&md5=6276629ea5c3c83c037875d728dcc866</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1177%2F0269881110385597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0269881110385597%26sid%3Dliteratum%253Aachs%26aulast%3DLile%26aufirst%3DJ.%2BA.%26aulast%3DStoops%26aufirst%3DW.%2BW.%26aulast%3DGlaser%26aufirst%3DP.%2BE.%26aulast%3DHays%26aufirst%3DL.%2BR.%26aulast%3DRush%26aufirst%3DC.%2BR.%26atitle%3DDiscriminative%2520stimulus%252C%2520subject-rated%2520and%2520cardiovascular%2520effects%2520of%2520cocaine%2520alone%2520and%2520in%2520combination%2520with%2520aripiprazole%2520in%2520humans%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2011%26volume%3D25%26spage%3D1469%26epage%3D1479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Bergman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roof, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conroy, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mello, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skolnick, P.</span><span> </span><span class="NLM_article-title">Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">458</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1017%2FS1461145712000661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=22827916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFKktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2013&pages=445-458&author=J.+Bergmanauthor=R.+A.+Roofauthor=C.+A.+Furmanauthor=J.+L.+Conroyauthor=N.+K.+Melloauthor=D.+R.+Sibleyauthor=P.+Skolnick&title=Modification+of+cocaine+self-administration+by+buspirone+%28buspar%C2%AE%29%3A+potential+involvement+of+D3+and+D4+dopamine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Modification of cocaine self-administration by buspirone (buspar): potential involvement of D3 and D4 dopamine receptors</span></div><div class="casAuthors">Bergman, Jack; Roof, Rebecca A.; Furman, Cheryse A.; Conroy, Jennie L.; Mello, Nancy K.; Sibley, David R.; Skolnick, Phil</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">445-458</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Converging lines of evidence indicate that elevations in synaptic dopamine levels play a pivotal role in the reinforcing effects of cocaine, which are assocd. with its abuse liability.  This evidence has led to the exploration of dopamine receptor blockers as pharmacotherapy for cocaine addiction.  While neither D1 nor D2 receptor antagonists have proven effective, medications acting at two other potential targets, D3 and D4 receptors, have yet to be explored for this indication in the clinic.  Buspirone, a 5-HT1A partial agonist approved for the treatment of anxiety, has been reported to also bind with high affinity to D3 and D4 receptors.  In view of this biochem. profile, the present research was conducted to examine both the functional effects of buspirone on these receptors and, in non-human primates, its ability to modify the reinforcing effects of i.v. cocaine in a behaviorally selective manner.  Radioligand binding studies confirmed that buspirone binds with high affinity to recombinant human D3 and D4 receptors (∼98 and ∼29 nm resp.).  Live cell functional assays also revealed that buspirone, and its metabolites, function as antagonists at both D3 and D4 receptors.  In behavioral studies, doses of buspirone that had inconsistent effects on food-maintained responding (0.1 or 0.3 mg/kg i.m.) produced a marked downward shift in the dose-effect function for cocaine-maintained behavior, reflecting substantial decreases in self-administration of one or more unit doses of i.v. cocaine in each subject.  These results support the further evaluation of buspirone as a candidate medication for the management of cocaine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq69I6VSGbSerVg90H21EOLACvtfcHk0ljhxb8suRXbiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFKktL4%253D&md5=977dd2218df7db5300b1e4c1865dafd9</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1017%2FS1461145712000661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145712000661%26sid%3Dliteratum%253Aachs%26aulast%3DBergman%26aufirst%3DJ.%26aulast%3DRoof%26aufirst%3DR.%2BA.%26aulast%3DFurman%26aufirst%3DC.%2BA.%26aulast%3DConroy%26aufirst%3DJ.%2BL.%26aulast%3DMello%26aufirst%3DN.%2BK.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DSkolnick%26aufirst%3DP.%26atitle%3DModification%2520of%2520cocaine%2520self-administration%2520by%2520buspirone%2520%2528buspar%25C2%25AE%2529%253A%2520potential%2520involvement%2520of%2520D3%2520and%2520D4%2520dopamine%2520receptors%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2013%26volume%3D16%26spage%3D445%26epage%3D458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Mello, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fivel, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohut, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergman, J.</span><span> </span><span class="NLM_article-title">Effects of chronic buspirone treatment on cocaine self-administration</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=455-467&author=N.+K.+Melloauthor=P.+A.+Fivelauthor=S.+J.+Kohutauthor=J.+Bergman&title=Effects+of+chronic+buspirone+treatment+on+cocaine+self-administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMello%26aufirst%3DN.%2BK.%26aulast%3DFivel%26aufirst%3DP.%2BA.%26aulast%3DKohut%26aufirst%3DS.%2BJ.%26aulast%3DBergman%26aufirst%3DJ.%26atitle%3DEffects%2520of%2520chronic%2520buspirone%2520treatment%2520on%2520cocaine%2520self-administration%26jtitle%3DNeuropsychopharmacology%26date%3D2013%26volume%3D38%26spage%3D455%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Winhusen, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kropp, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindblad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douaihy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgkins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chartier, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kampman, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanVeldhuisen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigham, G. S.</span><span> </span><span class="NLM_article-title">Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">757</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.4088%2FJCP.13m08862" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24911028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsl2mtLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2014&pages=757-764&author=T.+M.+Winhusenauthor=F.+Kroppauthor=R.+Lindbladauthor=A.+Douaihyauthor=L.+Haynesauthor=C.+Hodgkinsauthor=K.+Chartierauthor=K.+M.+Kampmanauthor=G.+Sharmaauthor=D.+F.+Lewisauthor=P.+VanVeldhuisenauthor=J.+Theobaldauthor=J.+Mayauthor=G.+S.+Brigham&title=Multisite%2C+randomized%2C+double-blind%2C+placebo-controlled+pilot+clinical+trial+to+evaluate+the+efficacy+of+buspirone+as+a+relapse-prevention+treatment+for+cocaine+dependence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence</span></div><div class="casAuthors">Winhusen, Theresa M.; Kropp, Frankie; Lindblad, Robert; Douaihy, Antoine; Haynes, Louise; Hodgkins, Candace; Chartier, Karen; Kampman, Kyle M.; Sharma, Gaurav; Lewis, Daniel F.; VanVeldhuisen, Paul; Theobald, Jeff; May, Jeanine; Brigham, Gregory S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry (Memphis, TN, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">757-764</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">Objective: To evaluate the potential efficacy of buspirone as a relapse-prevention treatment for cocaine dependence.  Method: A randomized, double-blind, placebo-controlled, 16-wk pilot trial was conducted at 6 clin. sites between August 2012 and June 2013.  Adult crack cocaine users meeting DSM-IV-TR criteria for current cocaine dependence who were scheduled to be in inpatient/residential substance use disorder (SUD) treatment for 12-19 days when randomized and planning to enroll in local outpatient treatment through the end of the active treatment phase were randomized to buspirone titrated to 60 mg/d (n = 35) or placebo (n = 27).  All participants received psychosocial treatment as usually provided by the SUD treatment programs in which they were enrolled.  Outcome measures included max. days of continuous cocaine abstinence (primary), proportion of cocaine use days, and days to first cocaine use during the outpatient treatment phase (study weeks 4-15) as assessed by self-report and urine drug screens.  Results: There were no significant treatment effects on max. continuous days of cocaine abstinence or days to first cocaine use.  In the female participants (n = 23), there was a significant treatment-by-time interaction effect (χ21 = 15.26, P < .0001), reflecting an increase in cocaine use by those receiving buspirone, relative to placebo, early in the outpatient treatment phase.  A similar effect was not detected in the male participants (n = 39; χ21 = 0.14, P = .70).  Conclusions: The results suggest that buspirone is unlikely to have a beneficial effect on preventing relapse to cocaine use and that buspirone for cocaine-dependent women may worsen their cocaine use outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDJDG0_9x3XbVg90H21EOLACvtfcHk0liiTWuF6EIt5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsl2mtLrJ&md5=468e3f0c922354e767b0b40c53caa066</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.4088%2FJCP.13m08862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4088%252FJCP.13m08862%26sid%3Dliteratum%253Aachs%26aulast%3DWinhusen%26aufirst%3DT.%2BM.%26aulast%3DKropp%26aufirst%3DF.%26aulast%3DLindblad%26aufirst%3DR.%26aulast%3DDouaihy%26aufirst%3DA.%26aulast%3DHaynes%26aufirst%3DL.%26aulast%3DHodgkins%26aufirst%3DC.%26aulast%3DChartier%26aufirst%3DK.%26aulast%3DKampman%26aufirst%3DK.%2BM.%26aulast%3DSharma%26aufirst%3DG.%26aulast%3DLewis%26aufirst%3DD.%2BF.%26aulast%3DVanVeldhuisen%26aufirst%3DP.%26aulast%3DTheobald%26aufirst%3DJ.%26aulast%3DMay%26aufirst%3DJ.%26aulast%3DBrigham%26aufirst%3DG.%2BS.%26atitle%3DMultisite%252C%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520pilot%2520clinical%2520trial%2520to%2520evaluate%2520the%2520efficacy%2520of%2520buspirone%2520as%2520a%2520relapse-prevention%2520treatment%2520for%2520cocaine%2520dependence%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2014%26volume%3D75%26spage%3D757%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Kim, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skolnick, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muench, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shea, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexoff, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkow, N. D.</span><span> </span><span class="NLM_article-title">Therapeutic doses of buspirone block D3 receptors in the living primate brain</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1257</span><span class="NLM_x">–</span> <span class="NLM_lpage">1267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1017%2FS1461145714000194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24679922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVKlurbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2014&pages=1257-1267&author=S.+W.+Kimauthor=J.+S.+Fowlerauthor=P.+Skolnickauthor=L.+Muenchauthor=Y.+Kangauthor=C.+Sheaauthor=J.+Loganauthor=D.+Kimauthor=P.+Carterauthor=P.+Kingauthor=D.+Alexoffauthor=N.+D.+Volkow&title=Therapeutic+doses+of+buspirone+block+D3+receptors+in+the+living+primate+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic doses of buspirone block D3 receptors in the living primate brain</span></div><div class="casAuthors">Kim, Sung Won; Fowler, Joanna S.; Skolnick, Phil; Muench, Lisa; Kang, Yeona; Shea, Colleen; Logan, Jean; Kim, Dohyun; Carter, Pauline; King, Payton; Alexoff, David; Volkow, Nora D.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1257-1267</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Dopamine D3 receptor (D3R) antagonists may be effective medications for multiple substance use disorders (SUDs).  However, no selective D3R antagonists are currently available for clin. testing.  Buspirone, originally characterized as a 5-HT1A partial agonist and used as an anxiolytic, also binds to D3R and D4R with high affinity, with lower affinity to D2R, and interferes with cocaine reward.  Here we used PET with [11C]PHNO (D3R-preferring radioligand), [11C]raclopride (D2R/D3R radioligand) and [11C]NNC-112 (D1R radioligand) to measure occupancy of oral and parenteral buspirone in the primate brain.  I.m. buspirone (0.19 and 0.5 mg/kg) blocked both [11C]PHNO and [11C]raclopride binding to striatum, exhibiting high occupancy (50-85%) at 15 min and rapid wash-out over 2-6 h.  In contrast, oral buspirone (3 mg/kg) significantly blocked [11C]PHNO binding in D3-rich regions (globus pallidum and midbrain) at 3 h, but had minimal effects on [11C]raclopride binding (28-37% at 1 h and 10% at 3 h).  Buspirone did not block [11C]NNC-112.  Our findings provide evidence that i.m. buspirone blocks D3R and D2R, whereas oral buspirone is more selective towards D3R blockade in vivo, consistent with extensive first pass metab. and supporting the hypothesis that its metabolites (5- and 6'-hydroxybuspirone) merit evaluation for treating SUDs.  They also indicate that for oral buspirone to achieve greater than 80% sustained D3R occupancy, as might be needed to treat addiction, higher doses (at least three-fold) than those used to treat anxiety (maximal 60 mg) will be required.  Nonetheless, based on previous clin. studies, these doses would be safe and well tolerated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9nEJ4ovtHrLVg90H21EOLACvtfcHk0liiTWuF6EIt5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVKlurbL&md5=0f25e50e1b5854c5892b686af8d61631</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1017%2FS1461145714000194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145714000194%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DFowler%26aufirst%3DJ.%2BS.%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DMuench%26aufirst%3DL.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DShea%26aufirst%3DC.%26aulast%3DLogan%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DCarter%26aufirst%3DP.%26aulast%3DKing%26aufirst%3DP.%26aulast%3DAlexoff%26aufirst%3DD.%26aulast%3DVolkow%26aufirst%3DN.%2BD.%26atitle%3DTherapeutic%2520doses%2520of%2520buspirone%2520block%2520D3%2520receptors%2520in%2520the%2520living%2520primate%2520brain%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2014%26volume%3D17%26spage%3D1257%26epage%3D1267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Gobert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivet, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cistarelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1999&pages=1251-1262&author=A.+Gobertauthor=J.+M.+Rivetauthor=L.+Cistarelliauthor=C.+Melonauthor=M.+J.+Millan&title=Buspirone+modulates+basal+and+fluoxetine-stimulated+dialysate+levels+of+dopamine%2C+noradrenaline+and+serotonin+in+the+frontal+cortex+of+freely+moving+rats%3A+activation+of+serotonin1A+receptors+and+blockade+of+alpha2-adrenergic+receptors+underlie+its+actions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGobert%26aufirst%3DA.%26aulast%3DRivet%26aufirst%3DJ.%2BM.%26aulast%3DCistarelli%26aufirst%3DL.%26aulast%3DMelon%26aufirst%3DC.%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3DBuspirone%2520modulates%2520basal%2520and%2520fluoxetine-stimulated%2520dialysate%2520levels%2520of%2520dopamine%252C%2520noradrenaline%2520and%2520serotonin%2520in%2520the%2520frontal%2520cortex%2520of%2520freely%2520moving%2520rats%253A%2520activation%2520of%2520serotonin1A%2520receptors%2520and%2520blockade%2520of%2520alpha2-adrenergic%2520receptors%2520underlie%2520its%2520actions%26jtitle%3DNeuroscience%26date%3D1999%26volume%3D93%26spage%3D1251%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Algeri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Luigi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simoni, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imeri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perego, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchetti, G.</span><span> </span><span class="NLM_article-title">Multiple and complex effects of buspirone on central dopaminergic system</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">823</span><span class="NLM_x">–</span> <span class="NLM_lpage">826</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1988&pages=823-826&author=S.+Algeriauthor=A.+De+Luigiauthor=M.+G.+De+Simoniauthor=L.+Imeriauthor=M.+Marconiauthor=S.+Navaauthor=C.+Peregoauthor=G.+Sacchetti&title=Multiple+and+complex+effects+of+buspirone+on+central+dopaminergic+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlgeri%26aufirst%3DS.%26aulast%3DDe%2BLuigi%26aufirst%3DA.%26aulast%3DDe%2BSimoni%26aufirst%3DM.%2BG.%26aulast%3DImeri%26aufirst%3DL.%26aulast%3DMarconi%26aufirst%3DM.%26aulast%3DNava%26aufirst%3DS.%26aulast%3DPerego%26aufirst%3DC.%26aulast%3DSacchetti%26aufirst%3DG.%26atitle%3DMultiple%2520and%2520complex%2520effects%2520of%2520buspirone%2520on%2520central%2520dopaminergic%2520system%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1988%26volume%3D29%26spage%3D823%26epage%3D826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">John, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banala, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">Effects of buspirone and the dopamine D3 receptor compound PG619 on cocaine and methamphetamine self-administration in rhesus monkeys using a food-drug choice paradigm</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">232</span><span class="NLM_x">, </span> <span class="NLM_fpage">1279</span><span class="NLM_x">–</span> <span class="NLM_lpage">1289</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2014&pages=1279-1289&author=W.+S.+Johnauthor=A.+K.+Banalaauthor=A.+H.+Newmanauthor=M.+A.+Nader&title=Effects+of+buspirone+and+the+dopamine+D3+receptor+compound+PG619+on+cocaine+and+methamphetamine+self-administration+in+rhesus+monkeys+using+a+food-drug+choice+paradigm"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohn%26aufirst%3DW.%2BS.%26aulast%3DBanala%26aufirst%3DA.%2BK.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DEffects%2520of%2520buspirone%2520and%2520the%2520dopamine%2520D3%2520receptor%2520compound%2520PG619%2520on%2520cocaine%2520and%2520methamphetamine%2520self-administration%2520in%2520rhesus%2520monkeys%2520using%2520a%2520food-drug%2520choice%2520paradigm%26jtitle%3DPsychopharmacology%26date%3D2014%26volume%3D232%26spage%3D1279%26epage%3D1289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Czoty, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">Effects of oral and intravenous administration of buspirone on food-cocaine choice in socially housed male cynomolgus monkeys</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1072</span><span class="NLM_x">–</span> <span class="NLM_lpage">1083</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2014&pages=1072-1083&author=P.+W.+Czotyauthor=M.+A.+Nader&title=Effects+of+oral+and+intravenous+administration+of+buspirone+on+food-cocaine+choice+in+socially+housed+male+cynomolgus+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCzoty%26aufirst%3DP.%2BW.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DEffects%2520of%2520oral%2520and%2520intravenous%2520administration%2520of%2520buspirone%2520on%2520food-cocaine%2520choice%2520in%2520socially%2520housed%2520male%2520cynomolgus%2520monkeys%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D40%26spage%3D1072%26epage%3D1083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robarge, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span> </span><span class="NLM_article-title"><i>N</i>-(4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2179</span><span class="NLM_x">–</span> <span class="NLM_lpage">2183</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2179-2183&author=A.+H.+Newmanauthor=J.+Caoauthor=C.+J.+Bennettauthor=M.+J.+Robargeauthor=R.+A.+Freemanauthor=R.+R.+Luedtke&title=N-%284-%5B4-%282%2C3-Dichlorophenyl%29piperazin-1-yl%5Dbutyl%2C+butenyl+and+butynyl%29arylcarboxamides+as+novel+dopamine+D%283%29+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DC.%2BJ.%26aulast%3DRobarge%26aufirst%3DM.%2BJ.%26aulast%3DFreeman%26aufirst%3DR.%2BA.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26atitle%3DN-%25284-%255B4-%25282%252C3-Dichlorophenyl%2529piperazin-1-yl%255Dbutyl%252C%2520butenyl%2520and%2520butynyl%2529arylcarboxamides%2520as%2520novel%2520dopamine%2520D%25283%2529%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2179%26epage%3D2183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Sorensen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sager, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennum, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thogersen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hee Bengtsen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wortwein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink-Jensen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woldbye, D. P.</span><span> </span><span class="NLM_article-title">Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">199</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=199&publication_year=2008&pages=37-46&author=G.+Sorensenauthor=T.+N.+Sagerauthor=J.+H.+Petersenauthor=L.+T.+Brennumauthor=P.+Thogersenauthor=C.+Hee+Bengtsenauthor=M.+Thomsenauthor=G.+Wortweinauthor=A.+Fink-Jensenauthor=D.+P.+Woldbye&title=Aripiprazole+blocks+acute+self-administration+of+cocaine+and+is+not+self-administered+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSorensen%26aufirst%3DG.%26aulast%3DSager%26aufirst%3DT.%2BN.%26aulast%3DPetersen%26aufirst%3DJ.%2BH.%26aulast%3DBrennum%26aufirst%3DL.%2BT.%26aulast%3DThogersen%26aufirst%3DP.%26aulast%3DHee%2BBengtsen%26aufirst%3DC.%26aulast%3DThomsen%26aufirst%3DM.%26aulast%3DWortwein%26aufirst%3DG.%26aulast%3DFink-Jensen%26aufirst%3DA.%26aulast%3DWoldbye%26aufirst%3DD.%2BP.%26atitle%3DAripiprazole%2520blocks%2520acute%2520self-administration%2520of%2520cocaine%2520and%2520is%2520not%2520self-administered%2520in%2520mice%26jtitle%3DPsychopharmacology%26date%3D2008%26volume%3D199%26spage%3D37%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Thomsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink-Jensen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woldbye, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wortwein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sager, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepe, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caine, S. B.</span><span> </span><span class="NLM_article-title">Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">201</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=201&publication_year=2008&pages=43-53&author=M.+Thomsenauthor=A.+Fink-Jensenauthor=D.+P.+Woldbyeauthor=G.+Wortweinauthor=T.+N.+Sagerauthor=R.+Holmauthor=L.+M.+Pepeauthor=S.+B.+Caine&title=Effects+of+acute+and+chronic+aripiprazole+treatment+on+choice+between+cocaine+self-administration+and+food+under+a+concurrent+schedule+of+reinforcement+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomsen%26aufirst%3DM.%26aulast%3DFink-Jensen%26aufirst%3DA.%26aulast%3DWoldbye%26aufirst%3DD.%2BP.%26aulast%3DWortwein%26aufirst%3DG.%26aulast%3DSager%26aufirst%3DT.%2BN.%26aulast%3DHolm%26aufirst%3DR.%26aulast%3DPepe%26aufirst%3DL.%2BM.%26aulast%3DCaine%26aufirst%3DS.%2BB.%26atitle%3DEffects%2520of%2520acute%2520and%2520chronic%2520aripiprazole%2520treatment%2520on%2520choice%2520between%2520cocaine%2520self-administration%2520and%2520food%2520under%2520a%2520concurrent%2520schedule%2520of%2520reinforcement%2520in%2520rats%26jtitle%3DPsychopharmacology%26date%3D2008%26volume%3D201%26spage%3D43%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Feltenstein, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">See, R. E.</span><span> </span><span class="NLM_article-title">Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapse</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">207</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2009&pages=401-411&author=M.+W.+Feltensteinauthor=P.+H.+Doauthor=R.+E.+See&title=Repeated+aripiprazole+administration+attenuates+cocaine+seeking+in+a+rat+model+of+relapse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeltenstein%26aufirst%3DM.%2BW.%26aulast%3DDo%26aufirst%3DP.%2BH.%26aulast%3DSee%26aufirst%3DR.%2BE.%26atitle%3DRepeated%2520aripiprazole%2520administration%2520attenuates%2520cocaine%2520seeking%2520in%2520a%2520rat%2520model%2520of%2520relapse%26jtitle%3DPsychopharmacology%26date%3D2009%26volume%3D207%26spage%3D401%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Czoty, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">Effects of dopamine D2/D3 receptor ligands on food-cocaine choice in socially housed male cynomolgus monkeys</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1124%2Fjpet.112.201012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=23211363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2013&pages=329-338&author=P.+W.+Czotyauthor=M.+A.+Nader&title=Effects+of+dopamine+D2%2FD3+receptor+ligands+on+food-cocaine+choice+in+socially+housed+male+cynomolgus+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of dopamine D2/D3 receptor ligands on food-cocaine choice in socially housed male cynomolgus monkeys</span></div><div class="casAuthors">Czoty, Paul W.; Nader, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">329-338</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dopamine D2/D3 receptor partial agonists have been suggested as medications for cocaine dependence.  The present expts. examd. the effect of acute and repeated administration of drugs with varying intrinsic efficacy at D2/D3 receptors on the relative reinforcing strength of cocaine.  Use of socially housed cynomolgus monkeys permitted the assessment of whether social status, known to alter D2/D3 receptor availability, influenced the behavioral effects of D2/D3 receptor compds.  The high-efficacy agonist R(-)-norpropylapomorphine [(-)-NPA], low-efficacy agonist aripiprazole (ARI), and antagonist eticlopride (ETIC) were administered acutely to monkeys self-administering cocaine under a food-cocaine choice procedure in which a cocaine self-administration dose-effect curve was detd. daily.  The effects of 5-day treatment with ARI and (-)-NPA were characterized under conditions in which monkeys did (ARI) or did not [ARI and (-)-NPA] self-administer cocaine during treatment.  When administered acutely, ARI and ETIC increased the choice of low cocaine doses, and only (-)-NPA decreased the choice of higher cocaine doses and cocaine intake; effects were similar across social ranks.  When administered repeatedly while self administration occurred only on days 1 and 5 of treatment, ARI, but not (-)-NPA, decreased cocaine choice in dominant monkeys, whereas (-)-NPA, but not ARI, did so in subordinates.  When dominant monkeys self-administered cocaine on all five days of ARI treatment, however, these effects were not obsd.  The results indicate that the behavioral effects of D2/D3 receptor agonists can differ according to intrinsic efficacy and subject characteristics.  Moreover, these results suggest that exposure to cocaine during treatment can counteract treatment-induced redns. in the reinforcing effects of cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppeV0UkXGrs7Vg90H21EOLACvtfcHk0lhRjFrWGZOw0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKiurs%253D&md5=78a3670a4381c977853571466322ae5e</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.201012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.201012%26sid%3Dliteratum%253Aachs%26aulast%3DCzoty%26aufirst%3DP.%2BW.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DEffects%2520of%2520dopamine%2520D2%252FD3%2520receptor%2520ligands%2520on%2520food-cocaine%2520choice%2520in%2520socially%2520housed%2520male%2520cynomolgus%2520monkeys%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D344%26spage%3D329%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Stoops, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lofwall, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, C. R.</span><span> </span><span class="NLM_article-title">The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance</span> <span class="citation_source-journal">Am. J. Drug Alcohol Abuse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1080%2F00952990701651556" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=17994473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BD2snntFCgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2007&pages=769-776&author=W.+W.+Stoopsauthor=J.+A.+Lileauthor=M.+R.+Lofwallauthor=C.+R.+Rush&title=The+safety%2C+tolerability%2C+and+subject-rated+effects+of+acute+intranasal+cocaine+administration+during+aripiprazole+maintenance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance</span></div><div class="casAuthors">Stoops William W; Lile Joshua A; Lofwall Michelle R; Rush Craig R</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of drug and alcohol abuse</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">769-76</span>
        ISSN:<span class="NLM_cas:issn">0095-2990</span>.
    </div><div class="casAbstract">Although cocaine dependence remains a significant public health concern, efforts to identify a pharmacotherapy have been unsuccessful.  The purpose of this study was to assess the safety, tolerability, and subject-rated effects of intranasal cocaine during maintenance on aripiprazole, a novel antipsychotic with partial agonist activity at monoamine receptors implicated in the effects of cocaine.  To this end, eight cocaine dependent subjects were maintained on 10 mg oral aripiprazole and placebo in counterbalanced order prior to assessing the physiological and subject-rated effects of intranasal cocaine (4, 20, 40, and 60 mg).  Aripiprazole was generally devoid of effects, but did alter temperature-increasing and subject-rated effects of cocaine as a function of cocaine dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkDJF9x7XUmoJKJbLTgsvCfW6udTcc2eZp9-T50fv6bLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snntFCgtQ%253D%253D&md5=164a2d369dd4bed35d0f8f4113c09597</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1080%2F00952990701651556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00952990701651556%26sid%3Dliteratum%253Aachs%26aulast%3DStoops%26aufirst%3DW.%2BW.%26aulast%3DLile%26aufirst%3DJ.%2BA.%26aulast%3DLofwall%26aufirst%3DM.%2BR.%26aulast%3DRush%26aufirst%3DC.%2BR.%26atitle%3DThe%2520safety%252C%2520tolerability%252C%2520and%2520subject-rated%2520effects%2520of%2520acute%2520intranasal%2520cocaine%2520administration%2520during%2520aripiprazole%2520maintenance%26jtitle%3DAm.%2520J.%2520Drug%2520Alcohol%2520Abuse%26date%3D2007%26volume%3D33%26spage%3D769%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Meini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecconi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellesi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biasci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ameglio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellegrini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forgione, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rucci, P.</span><span> </span><span class="NLM_article-title">Aripiprazole and ropinirole treatment for cocaine dependence: evidence from a pilot study</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1376</span><span class="NLM_x">–</span> <span class="NLM_lpage">1383</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.2174%2F138161211796150783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=21524261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosVSktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=1376-1383&author=M.+Meiniauthor=M.+Monciniauthor=D.+Cecconiauthor=V.+Cellesiauthor=L.+Biasciauthor=G.+Simoniauthor=M.+Ameglioauthor=M.+Pellegriniauthor=R.+N.+Forgioneauthor=P.+Rucci&title=Aripiprazole+and+ropinirole+treatment+for+cocaine+dependence%3A+evidence+from+a+pilot+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Aripiprazole and ropinirole treatment for cocaine dependence: evidence from a pilot study</span></div><div class="casAuthors">Meini, M.; Moncini, M.; Cecconi, D.; Cellesi, V.; Biasci, L.; Simoni, G.; Ameglio, M.; Pellegrini, M.; Forgione, R. N.; Rucci, P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1376-1383</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Currently, there is no specific pharmacol. therapy with established efficacy for the treatment of cocaine dependence.  The aim of this study was to det. the safety, tolerability and the effects of aripiprazole and ropinirole in patients with cocaine dependence.  This randomized clin. trial of 12-wk duration was carried out on 28 consecutive patients with cocaine dependence presenting for treatment.  The diagnostic assessment was performed using ICD-9-CM criteria and Mini International Neuropsychiatric Interview.  The Clin. Global Impression Scale, a Visual Analog Scale to assess craving and a self-report questionnaire on the use of cocaine were administered at baseline and then weekly throughout the study.  Urinalyses were carried out 3 times per wk to search for benzoylecgonine.  Of the 28 study participants, 14 completed the protocol.  Treatment discontinuation was unrelated with side effects.  One patient required a dosage redn. of ropinirole because of sleepiness and one patient assigned to aripiprazole who reported moderate akathysia had the dosage reduced to 5 mg/day.  Routine blood works did not show significant changes from baseline and the overall proportion of pos. urinalyses for benzoylecgonine did not differ significantly between treatments.  Using linear mixed-effect models a significant decrease in craving was found in the overall sample.  The mean no. of cocaine administrations exhibited a faster decrease with aripiprazole compared with ropinirole.  Our pilot study indicates that cocaine craving decreases with both aripiprazole and ropinirole treatment but aripiprazole is more efficacious in reducing cocaine use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDB3WEs3uXJLVg90H21EOLACvtfcHk0liZHkENx_4U8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosVSktL4%253D&md5=32eb351997e0369e91d71bda4eb33149</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.2174%2F138161211796150783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161211796150783%26sid%3Dliteratum%253Aachs%26aulast%3DMeini%26aufirst%3DM.%26aulast%3DMoncini%26aufirst%3DM.%26aulast%3DCecconi%26aufirst%3DD.%26aulast%3DCellesi%26aufirst%3DV.%26aulast%3DBiasci%26aufirst%3DL.%26aulast%3DSimoni%26aufirst%3DG.%26aulast%3DAmeglio%26aufirst%3DM.%26aulast%3DPellegrini%26aufirst%3DM.%26aulast%3DForgione%26aufirst%3DR.%2BN.%26aulast%3DRucci%26aufirst%3DP.%26atitle%3DAripiprazole%2520and%2520ropinirole%2520treatment%2520for%2520cocaine%2520dependence%253A%2520evidence%2520from%2520a%2520pilot%2520study%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2011%26volume%3D17%26spage%3D1376%26epage%3D1383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Song, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span> </span><span class="NLM_article-title">YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice</span> <span class="citation_source-journal">Addict. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1111%2Fj.1369-1600.2011.00317.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=21507153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC38XltV2kt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=259-273&author=R.+Songauthor=R.+F.+Yangauthor=N.+Wuauthor=R.+B.+Suauthor=J.+Liauthor=X.+Q.+Pengauthor=X.+Liauthor=J.+Gaalauthor=Z.+X.+Xiauthor=E.+L.+Gardner&title=YQA14%3A+a+novel+dopamine+D3+receptor+antagonist+that+inhibits+cocaine+self-administration+in+rats+and+mice%2C+but+not+in+D3+receptor-knockout+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice</span></div><div class="casAuthors">Song, Rui; Yang, Ri-Fang; Wu, Ning; Su, Rui-Bin; Li, Jin; Peng, Xiao-Qing; Li, Xia; Gaal, Jozsef; Xi, Zheng-Xiong; Gardner, Eliot L.</div><div class="citationInfo"><span class="NLM_cas:title">Addiction Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">259-273</span>CODEN:
                <span class="NLM_cas:coden">ADBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1369-1600</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The dopamine (DA) D3 receptor is posited to be importantly involved in drug reward and addiction, and D3 receptor antagonists have shown extraordinary promise as potential anti-addiction pharmacotherapeutic agents in animal models of drug addiction.  SB-277011A is the best characterized D3 receptor antagonist in such models.  However, the potential use of SB-277011A in humans is precluded by pharmacokinetic and toxicity problems.  We here report a novel D3 receptor antagonist YQA14 that shows similar pharmacol. properties as SB-277011A.  In vitro receptor binding assays suggest that YQA14 has two binding sites on human cloned D3 receptors with Kl-High (0.68 × 10-4 nM) and Kl-Low (2.11 nM), and displays > 150-fold selectivity for D3 over D2 receptors and > 1000-fold selectivity for D3 over other DA receptors.  Systemic administration of YQA14 (6.25-25 mg/kg) or SB-277011A (12.5-25 mg/kg) significantly and dose-dependently reduced i.v. cocaine self-administration under both low fixed-ratio and progressive-ratio reinforcement conditions in rats, while failing to alter oral sucrose self-administration and locomotor activity, suggesting a selective inhibition of drug reward.  However, when the drug dose was increased to 50 mg/kg, YQA14 and SB-277011A significantly inhibited basal and cocaine-enhanced locomotion in rats.  Finally, both D3 antagonists dose-dependently inhibited i.v. cocaine self-administration in wild-type mice, but not in D3 receptor-knockout mice, suggesting that their action is mediated by D3 receptor blockade.  These findings suggest that YQA14 has a similar anti-addiction profile as SB-277011A, and deserves further study and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoutvbaR_4-rVg90H21EOLACvtfcHk0liZHkENx_4U8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltV2kt7c%253D&md5=3bc010bc1b0031dc7a23398dc4764b6f</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1111%2Fj.1369-1600.2011.00317.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1369-1600.2011.00317.x%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DR.%2BF.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DSu%26aufirst%3DR.%2BB.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DX.%2BQ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGaal%26aufirst%3DJ.%26aulast%3DXi%26aufirst%3DZ.%2BX.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26atitle%3DYQA14%253A%2520a%2520novel%2520dopamine%2520D3%2520receptor%2520antagonist%2520that%2520inhibits%2520cocaine%2520self-administration%2520in%2520rats%2520and%2520mice%252C%2520but%2520not%2520in%2520D3%2520receptor-knockout%2520mice%26jtitle%3DAddict.%2520Biol.%26date%3D2012%26volume%3D17%26spage%3D259%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodbeck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Primus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasley, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurkauf, A.</span><span> </span><span class="NLM_article-title">NGB 2904 and NGB 2849: two highly selective dopamine D3 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2715</span><span class="NLM_x">–</span> <span class="NLM_lpage">2718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=2715-2718&author=J.+Yuanauthor=X.+Chenauthor=R.+Brodbeckauthor=R.+Primusauthor=J.+Braunauthor=J.+W.+Wasleyauthor=A.+Thurkauf&title=NGB+2904+and+NGB+2849%3A+two+highly+selective+dopamine+D3+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DBrodbeck%26aufirst%3DR.%26aulast%3DPrimus%26aufirst%3DR.%26aulast%3DBraun%26aufirst%3DJ.%26aulast%3DWasley%26aufirst%3DJ.%2BW.%26aulast%3DThurkauf%26aufirst%3DA.%26atitle%3DNGB%25202904%2520and%2520NGB%25202849%253A%2520two%2520highly%2520selective%2520dopamine%2520D3%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26spage%3D2715%26epage%3D2718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Stafford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeSage, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glowa, J. R.</span><span> </span><span class="NLM_article-title">Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=1998&pages=169-184&author=D.+Staffordauthor=M.+G.+LeSageauthor=J.+R.+Glowa&title=Progressive-ratio+schedules+of+drug+delivery+in+the+analysis+of+drug+self-administration%3A+a+review"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStafford%26aufirst%3DD.%26aulast%3DLeSage%26aufirst%3DM.%2BG.%26aulast%3DGlowa%26aufirst%3DJ.%2BR.%26atitle%3DProgressive-ratio%2520schedules%2520of%2520drug%2520delivery%2520in%2520the%2520analysis%2520of%2520drug%2520self-administration%253A%2520a%2520review%26jtitle%3DPsychopharmacology%26date%3D1998%26volume%3D139%26spage%3D169%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Xi, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span> </span><span class="NLM_article-title">Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=240-259&author=Z.+X.+Xiauthor=E.+L.+Gardner&title=Pharmacological+actions+of+NGB+2904%2C+a+selective+dopamine+D3+receptor+antagonist%2C+in+animal+models+of+drug+addiction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DZ.%2BX.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26atitle%3DPharmacological%2520actions%2520of%2520NGB%25202904%252C%2520a%2520selective%2520dopamine%2520D3%2520receptor%2520antagonist%252C%2520in%2520animal%2520models%2520of%2520drug%2520addiction%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2007%26volume%3D13%26spage%3D240%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Spiller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span> </span><span class="NLM_article-title">The selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">196</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2008&pages=533-542&author=K.+Spillerauthor=Z.+X.+Xiauthor=X.+Q.+Pengauthor=A.+H.+Newmanauthor=C.+R.+Ashbyauthor=C.+Heidbrederauthor=J.+Gaalauthor=E.+L.+Gardner&title=The+selective+dopamine+D3+receptor+antagonists+SB-277011A+and+NGB+2904+and+the+putative+partial+D3+receptor+agonist+BP-897+attenuate+methamphetamine-enhanced+brain+stimulation+reward+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpiller%26aufirst%3DK.%26aulast%3DXi%26aufirst%3DZ.%2BX.%26aulast%3DPeng%26aufirst%3DX.%2BQ.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DHeidbreder%26aufirst%3DC.%26aulast%3DGaal%26aufirst%3DJ.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26atitle%3DThe%2520selective%2520dopamine%2520D3%2520receptor%2520antagonists%2520SB-277011A%2520and%2520NGB%25202904%2520and%2520the%2520putative%2520partial%2520D3%2520receptor%2520agonist%2520BP-897%2520attenuate%2520methamphetamine-enhanced%2520brain%2520stimulation%2520reward%2520in%2520rats%26jtitle%3DPsychopharmacology%26date%3D2008%26volume%3D196%26spage%3D533%26epage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Robarge, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husbands, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieltyka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodbeck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurkauf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Design and synthesis of [(2,3-dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as novel ligands selective for the dopamine D3 receptor subtype</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3175</span><span class="NLM_x">–</span> <span class="NLM_lpage">3186</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010146o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3175-3186&author=M.+J.+Robargeauthor=S.+M.+Husbandsauthor=A.+Kieltykaauthor=R.+Brodbeckauthor=A.+Thurkaufauthor=A.+H.+Newman&title=Design+and+synthesis+of+%5B%282%2C3-dichlorophenyl%29piperazin-1-yl%5Dalkylfluorenylcarboxamides+as+novel+ligands+selective+for+the+dopamine+D3+receptor+subtype"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Fjm010146o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010146o%26sid%3Dliteratum%253Aachs%26aulast%3DRobarge%26aufirst%3DM.%2BJ.%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26aulast%3DKieltyka%26aufirst%3DA.%26aulast%3DBrodbeck%26aufirst%3DR.%26aulast%3DThurkauf%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%255B%25282%252C3-dichlorophenyl%2529piperazin-1-yl%255Dalkylfluorenylcarboxamides%2520as%2520novel%2520ligands%2520selective%2520for%2520the%2520dopamine%2520D3%2520receptor%2520subtype%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3175%26epage%3D3186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Martelle, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claytor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reboussin, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">Effects of two novel D3-selective compounds, NGB 2904 [<i>N</i>-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9<i>H</i>-fluorene-2-carboxamide] and CJB 090 [<i>N</i>-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide], on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1124%2Fjpet.106.113571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=17272677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFehtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=573-582&author=J.+L.+Martelleauthor=R.+Claytorauthor=J.+T.+Rossauthor=B.+A.+Reboussinauthor=A.+H.+Newmanauthor=M.+A.+Nader&title=Effects+of+two+novel+D3-selective+compounds%2C+NGB+2904+%5BN-%284-%284-%282%2C3-dichlorophenyl%29piperazin-1-yl%29butyl%29-9H-fluorene-2-carboxamide%5D+and+CJB+090+%5BN-%284-%284-%282%2C3-dichlorophenyl%29piperazin-1-yl%29butyl%29-4-%28pyridin-2-yl%29benzamide%5D%2C+on+the+reinforcing+and+discriminative+stimulus+effects+of+cocaine+in+rhesus+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of two novel D3-selective compounds, NGB 2904 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide] and CJB 090 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide], on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys</span></div><div class="casAuthors">Martelle, Jennifer L.; Claytor, Renee; Ross, Jason T.; Reboussin, Beth A.; Newman, Amy Hauck; Nader, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">573-582</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The present study examd. the effects of two novel dopamine D3 receptor compds., NGB 2904 and CJB 090, a partial agonist, in two models of cocaine abuse in rhesus monkeys.  To establish a dose range and time course of effects, both compds. were shown to block quinpirole-induced yawning when administered i.m. 15, 30, or 120 min before quinpirole.  Next, rhesus monkeys were trained to discriminate i.m. injections of saline (0.5 mL) and cocaine (0.3 mg/kg).  Neither D3 compd. (0.03-3.0 mg/kg; n = 3) substituted for cocaine in any monkey.  When given in combination with cocaine, CJB 090 but not NGB 2904 attenuated the discriminative stimulus effects of cocaine, shifting the cocaine dose-response curve to the right.  In a sep. group of monkeys, responding was maintained under a second-order schedule of either food (1.0-g pellets; n = 3) or cocaine (0.1 mg/kg/injection; n = 4) presentation.  When responding was stable, a dose of NGB 2904 (1.0-5.6 mg/kg i.v.) or CJB 090 (0.3-3.0 mg/kg i.v.) was administered for 5 consecutive days, immediately before the session.  CJB 090, but not NGB 2904, decreased cocaine- and food-maintained responding.  These data indicate that compds. with relatively high affinity and selectivity for the D3 receptor can attenuate the discriminative and reinforcing stimulus effects of cocaine while not producing cocaine-like effects.  The present findings support the continued examn. of D3 compds. as pharmacol. tools for better understanding the role of this receptor subtype in cocaine addiction and as potential lead compds. for novel therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0LWJO0jjxa7Vg90H21EOLACvtfcHk0lid8uAFFIdI4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFehtbs%253D&md5=9d2f1428cf5af16bc70e18fb9a530f18</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.113571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.113571%26sid%3Dliteratum%253Aachs%26aulast%3DMartelle%26aufirst%3DJ.%2BL.%26aulast%3DClaytor%26aufirst%3DR.%26aulast%3DRoss%26aufirst%3DJ.%2BT.%26aulast%3DReboussin%26aufirst%3DB.%2BA.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DEffects%2520of%2520two%2520novel%2520D3-selective%2520compounds%252C%2520NGB%25202904%2520%255BN-%25284-%25284-%25282%252C3-dichlorophenyl%2529piperazin-1-yl%2529butyl%2529-9H-fluorene-2-carboxamide%255D%2520and%2520CJB%2520090%2520%255BN-%25284-%25284-%25282%252C3-dichlorophenyl%2529piperazin-1-yl%2529butyl%2529-4-%2528pyridin-2-yl%2529benzamide%255D%252C%2520on%2520the%2520reinforcing%2520and%2520discriminative%2520stimulus%2520effects%2520of%2520cocaine%2520in%2520rhesus%2520monkeys%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26spage%3D573%26epage%3D582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Achat-Mendes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platt, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spealman, R. D.</span><span> </span><span class="NLM_article-title">The dopamine D3 receptor partial agonist CJB 090 inhibits the discriminative stimulus but not the reinforcing or priming effects of cocaine in squirrel monkeys</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">206</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2009&pages=73-84&author=C.+Achat-Mendesauthor=D.+M.+Plattauthor=A.+H.+Newmanauthor=R.+D.+Spealman&title=The+dopamine+D3+receptor+partial+agonist+CJB+090+inhibits+the+discriminative+stimulus+but+not+the+reinforcing+or+priming+effects+of+cocaine+in+squirrel+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAchat-Mendes%26aufirst%3DC.%26aulast%3DPlatt%26aufirst%3DD.%2BM.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DSpealman%26aufirst%3DR.%2BD.%26atitle%3DThe%2520dopamine%2520D3%2520receptor%2520partial%2520agonist%2520CJB%2520090%2520inhibits%2520the%2520discriminative%2520stimulus%2520but%2520not%2520the%2520reinforcing%2520or%2520priming%2520effects%2520of%2520cocaine%2520in%2520squirrel%2520monkeys%26jtitle%3DPsychopharmacology%26date%3D2009%26volume%3D206%26spage%3D73%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Blaylock, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banala, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">Influence of cocaine history on the behavioral effects of dopamine D(3) receptor-selective compounds in monkeys</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1104</span><span class="NLM_x">–</span> <span class="NLM_lpage">1113</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=1104-1113&author=B.+L.+Blaylockauthor=R.+W.+Gouldauthor=A.+Banalaauthor=P.+Grundtauthor=R.+R.+Luedtkeauthor=A.+H.+Newmanauthor=M.+A.+Nader&title=Influence+of+cocaine+history+on+the+behavioral+effects+of+dopamine+D%283%29+receptor-selective+compounds+in+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlaylock%26aufirst%3DB.%2BL.%26aulast%3DGould%26aufirst%3DR.%2BW.%26aulast%3DBanala%26aufirst%3DA.%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DInfluence%2520of%2520cocaine%2520history%2520on%2520the%2520behavioral%2520effects%2520of%2520dopamine%2520D%25283%2529%2520receptor-selective%2520compounds%2520in%2520monkeys%26jtitle%3DNeuropsychopharmacology%26date%3D2011%26volume%3D36%26spage%3D1104%26epage%3D1113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Martelle, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czoty, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duke, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">Further characterization of quinpirole-elicited yawning as a model of dopamine D3 receptor activation in male and female monkeys</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1124%2Fjpet.114.214833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24876234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVKis7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2014&pages=205-211&author=S.+E.+Martelleauthor=S.+H.+Naderauthor=P.+W.+Czotyauthor=W.+S.+Johnauthor=A.+N.+Dukeauthor=P.+K.+Gargauthor=S.+Gargauthor=A.+H.+Newmanauthor=M.+A.+Nader&title=Further+characterization+of+quinpirole-elicited+yawning+as+a+model+of+dopamine+D3+receptor+activation+in+male+and+female+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Further characterization of quinpirole-elicited yawning as a model of dopamine D3 receptor activation in male and female monkeys</span></div><div class="casAuthors">Martelle, Susan E.; Nader, Susan H.; Czoty, Paul W.; John, William S.; Duke, Angela N.; Garg, Pradeep K.; Garg, Sudha; Newman, Amy H.; Nader, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-211, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The dopamine (DA) D3 receptor (D3R) has been assocd. with impulsivity, pathol. gambling and drug addiction, making it a potential target for pharmacotherapy development.  Positron emission tomog. studies using the D3R-preferring radioligand [11C]PHNO ([11C](+)-propyl-hexahydro-naphtho-oxazin) have shown higher binding potentials in drug abusers compared with control subjects.  Preclin. studies have examd. D3R receptor activation using the DA agonist quinpirole and the unconditioned behavior of yawning.  However, the relationship between quinpirole-elicited yawning and D3R receptor availability has not been detd.  In Expt. 1, eight drug-naive male rhesus monkeys were scanned with [11C]PHNO and the ability of quinpirole (0.01-0.3 mg/kg i.m.) to elicit yawning was examd.  Significant pos. (globus pallidus) and neg. (caudate nucleus, putamen, ventral pallidum and hippocampus) relationships between D3R receptor availability and quinpirole-induced yawns were noted.  Expt. 2 replicated earlier findings that a history of cocaine self-administration (n = 11) did not affect quinpirole-induced yawning and extended this to examine monkeys (n = 3) with a history of methamphetamine (MA) self-administration and found that monkeys with experience self-administering MA showed greater potency and significantly higher quinpirole-elicited yawning compared with controls.  Finally, quinpirole-elicited yawning was studied in drug-naive female monkeys (n = 6) and compared with drug-naive male monkeys (n = 8).  Sex differences were noted, with quinpirole being more potent and eliciting significantly more yawns in males compared with females.  Taken together these findings support the use of quinpirole-elicited yawning as a behavioral tool for examg. D3R activation in monkeys and that both drug history and sex may influence individual sensitivity to the behavioral effects of D3R compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3uRUbNFUsj7Vg90H21EOLACvtfcHk0lidQdBJoZqwRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVKis7vK&md5=1cc38ae0f4cc38f036327175417d2ca1</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.214833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.214833%26sid%3Dliteratum%253Aachs%26aulast%3DMartelle%26aufirst%3DS.%2BE.%26aulast%3DNader%26aufirst%3DS.%2BH.%26aulast%3DCzoty%26aufirst%3DP.%2BW.%26aulast%3DJohn%26aufirst%3DW.%2BS.%26aulast%3DDuke%26aufirst%3DA.%2BN.%26aulast%3DGarg%26aufirst%3DP.%2BK.%26aulast%3DGarg%26aufirst%3DS.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DFurther%2520characterization%2520of%2520quinpirole-elicited%2520yawning%2520as%2520a%2520model%2520of%2520dopamine%2520D3%2520receptor%2520activation%2520in%2520male%2520and%2520female%2520monkeys%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D350%26spage%3D205%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Hamilton, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czoty, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">Characterization of the dopamine receptor system in adult rhesus monkeys exposed to cocaine throughout gestation</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2010&pages=481-488&author=L.+R.+Hamiltonauthor=P.+W.+Czotyauthor=H.+D.+Gageauthor=M.+A.+Nader&title=Characterization+of+the+dopamine+receptor+system+in+adult+rhesus+monkeys+exposed+to+cocaine+throughout+gestation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DL.%2BR.%26aulast%3DCzoty%26aufirst%3DP.%2BW.%26aulast%3DGage%26aufirst%3DH.%2BD.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DCharacterization%2520of%2520the%2520dopamine%2520receptor%2520system%2520in%2520adult%2520rhesus%2520monkeys%2520exposed%2520to%2520cocaine%2520throughout%2520gestation%26jtitle%3DPsychopharmacology%26date%3D2010%26volume%3D210%26spage%3D481%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Orio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulvirenti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koob, G. F.</span><span> </span><span class="NLM_article-title">The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access</span> <span class="citation_source-journal">Addict. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">312</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1111%2Fj.1369-1600.2010.00211.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=20456290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1ahu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=312-323&author=L.+Orioauthor=S.+Weeauthor=A.+H.+Newmanauthor=L.+Pulvirentiauthor=G.+F.+Koob&title=The+dopamine+D3+receptor+partial+agonist+CJB090+and+antagonist+PG01037+decrease+progressive+ratio+responding+for+methamphetamine+in+rats+with+extended-access"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access</span></div><div class="casAuthors">Orio, Laura; Wee, Sunmee; Newman, Amy H.; Pulvirenti, Luigi; Koob, George F.</div><div class="citationInfo"><span class="NLM_cas:title">Addiction Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">312-323</span>CODEN:
                <span class="NLM_cas:coden">ADBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1355-6215</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Previous work suggests a role for dopamine D3-like receptors in psychostimulant reinforcement.  The development of new compds. acting selectively at dopamine D3 receptors has opened new possibilities to explore the role of these receptors in animal models of psychostimulant dependence.  Here we investigated whether the dopamine D3 partial agonist CJB090 (1-10 mg/kg, i.v) and the D3 antagonist PG01037 (8-32 mg/kg, s.c.) modified methamphetamine (0.05 mg/kg/injection) i.v. self-administration under fixed-(FR) and progressive-(PR) ratio schedules in rats allowed limited (short access, ShA; 1 h sessions 3 days/wk) or extended access (long access, LgA; 6 h sessions 6 days/wk).  Under a FR1 schedule, the highest dose of the D3 partial agonist CJB090 selectively reduced methamphetamine self-administration in LgA but not in ShA rats, whereas the full D3 antagonist PG01037 produced no effect in either group.  Under a PR schedule of reinforcement, the D3 partial agonist CJB090 reduced the max. no. of responses performed ('breakpoint') for methamphetamine in LgA rats at the doses of 5 and 10 mg/kg, and also it produced a significant redn. in the ShA group at the highest dose.  However, the D3 full antagonist PG01037 only reduced PR methamphetamine self-administration in LgA rats at the highest dose of 32 mg/kg with no effect in the ShA group.  The results suggest that rats might be more sensitive to pharmacol. modulation of dopamine D3 receptors following extended access to methamphetamine self-administration, opening the possibility that D3 receptors play a role in excessive methamphetamine intake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps0PzhJXFJG7Vg90H21EOLACvtfcHk0lidQdBJoZqwRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1ahu7k%253D&md5=9cb4523db1f4dcde0260117a6ad5e7c7</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1111%2Fj.1369-1600.2010.00211.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1369-1600.2010.00211.x%26sid%3Dliteratum%253Aachs%26aulast%3DOrio%26aufirst%3DL.%26aulast%3DWee%26aufirst%3DS.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DPulvirenti%26aufirst%3DL.%26aulast%3DKoob%26aufirst%3DG.%2BF.%26atitle%3DThe%2520dopamine%2520D3%2520receptor%2520partial%2520agonist%2520CJB090%2520and%2520antagonist%2520PG01037%2520decrease%2520progressive%2520ratio%2520responding%2520for%2520methamphetamine%2520in%2520rats%2520with%2520extended-access%26jtitle%3DAddict.%2520Biol.%26date%3D2010%26volume%3D15%26spage%3D312%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Mason, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddington, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voulalas, P. J.</span><span> </span><span class="NLM_article-title">Characterization of the transport, metabolism, and pharmacokinetics of the dopamine D3 receptor-selective fluorenyl- and 2-pyridylphenyl amides developed for treatment of psychostimulant abuse</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">854</span><span class="NLM_x">–</span> <span class="NLM_lpage">864</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1124%2Fjpet.109.165084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=20228156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvFClsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=854-864&author=C.+W.+Masonauthor=H.+E.+Hassanauthor=K.+P.+Kimauthor=J.+Caoauthor=N.+D.+Eddingtonauthor=A.+H.+Newmanauthor=P.+J.+Voulalas&title=Characterization+of+the+transport%2C+metabolism%2C+and+pharmacokinetics+of+the+dopamine+D3+receptor-selective+fluorenyl-+and+2-pyridylphenyl+amides+developed+for+treatment+of+psychostimulant+abuse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the transport, metabolism, and pharmacokinetics of the dopamine D3 receptor-selective fluorenyl- and 2-pyridylphenyl amides developed for treatment of psychostimulant abuse</span></div><div class="casAuthors">Mason, Clifford W.; Hassan, Hazem E.; Kim, Kang-Pil; Cao, Jianjing; Eddington, Natalie D.; Newman, Amy Hauck; Voulalas, Pamela J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">854-864</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The recent discovery of novel high-affinity and selective dopamine D3 receptor (DA D3R) antagonists and partial agonists has provided tools with which to further elucidate the role DA D3R plays in substance abuse.  The present study was conducted to evaluate the transport, metab., pharmacokinetics, and brain uptake of the DA D3R-selective fluorenyl amides, NGB 2904 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide] fumarate and JJC 4-077 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)-3-hydroxybutyl)-9H-fluorene-2-carboxamide hydrochloride], and the 2-pyridylphenyl amides, CJB 090 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridine-2-yl)benzamide hydrochloride] and PG 01037 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)-trans-but-2-enyl)-4-(pyridine-2-yl)benzamide hydrochloride], all of which have been studied in animal models of psychostimulant abuse.  Addnl. screening with a panel of human and rat Supersomes was performed for NGB 2904 and PG 01037.  Drug-stimulated ATPase activation assays and bidirectional transport and efflux assays were used to test for substrate specificity of NGB 2904 and PG 01037 for human and rat efflux transporters.  All compds. exhibited moderate elimination half-lives, ranging from 1.49 to 3.27 h, and large vols. of distribution (5.95-14.19 l/kg).  The brain-to-plasma ratios ranged from 2.93 to 11.81 and were higher than those previously reported for cocaine.  Brain exposure levels of NGB 2904 and PG 01037 were significantly reduced after i.p. administration compared with i.v. administration.  The metab. of these compds. was mediated primarily by CYP3A subfamilies.  PG 01037 was a P-glycoprotein-transported substrate.  Higher doses of these compds. are often required for in vivo action, suggesting decreased bioavailability via extravascular administration that may be attributed to high drug efflux and hepatic metab.  These studies provide important preclin. information for optimization of next-generation D3R selective agents for the treatment of drug addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFm2tdQWBlXbVg90H21EOLACvtfcHk0ljcPAUeQAwUsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvFClsbw%253D&md5=626b181940c176ecaccb3e8b5273f4a8</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.165084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.165084%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DC.%2BW.%26aulast%3DHassan%26aufirst%3DH.%2BE.%26aulast%3DKim%26aufirst%3DK.%2BP.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DEddington%26aufirst%3DN.%2BD.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DVoulalas%26aufirst%3DP.%2BJ.%26atitle%3DCharacterization%2520of%2520the%2520transport%252C%2520metabolism%252C%2520and%2520pharmacokinetics%2520of%2520the%2520dopamine%2520D3%2520receptor-selective%2520fluorenyl-%2520and%25202-pyridylphenyl%2520amides%2520developed%2520for%2520treatment%2520of%2520psychostimulant%2520abuse%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D854%26epage%3D864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Cheung, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammerslag, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durbin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peartree, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neisewander, J. L.</span><span> </span><span class="NLM_article-title">Phenylpiperazine derivatives with selectivity for dopamine D3 receptors modulate cocaine self-administration in rats</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">1346</span><span class="NLM_x">–</span> <span class="NLM_lpage">1359</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2012&pages=1346-1359&author=T.+H.+Cheungauthor=B.+C.+Nolanauthor=L.+R.+Hammerslagauthor=S.+M.+Weberauthor=J.+P.+Durbinauthor=N.+A.+Peartreeauthor=R.+H.+Machauthor=R.+R.+Luedtkeauthor=J.+L.+Neisewander&title=Phenylpiperazine+derivatives+with+selectivity+for+dopamine+D3+receptors+modulate+cocaine+self-administration+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DT.%2BH.%26aulast%3DNolan%26aufirst%3DB.%2BC.%26aulast%3DHammerslag%26aufirst%3DL.%2BR.%26aulast%3DWeber%26aufirst%3DS.%2BM.%26aulast%3DDurbin%26aufirst%3DJ.%2BP.%26aulast%3DPeartree%26aufirst%3DN.%2BA.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DNeisewander%26aufirst%3DJ.%2BL.%26atitle%3DPhenylpiperazine%2520derivatives%2520with%2520selectivity%2520for%2520dopamine%2520D3%2520receptors%2520modulate%2520cocaine%2520self-administration%2520in%2520rats%26jtitle%3DNeuropharmacology%26date%3D2012%26volume%3D63%26spage%3D1346%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Cheung, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriaux, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandler, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaan, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neisewander, J. L.</span><span> </span><span class="NLM_article-title">Reduction of cocaine self-administration and D3 receptor-mediated behavior by two novel dopamine D3 receptor-selective partial agonists, OS-3-106 and WW-III-55</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1124%2Fjpet.112.202911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24018640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSqsLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2013&pages=410-423&author=T.+H.+Cheungauthor=A.+L.+Loriauxauthor=S.+M.+Weberauthor=K.+N.+Chandlerauthor=J.+D.+Lenzauthor=R.+F.+Schaanauthor=R.+H.+Machauthor=R.+R.+Luedtkeauthor=J.+L.+Neisewander&title=Reduction+of+cocaine+self-administration+and+D3+receptor-mediated+behavior+by+two+novel+dopamine+D3+receptor-selective+partial+agonists%2C+OS-3-106+and+WW-III-55"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of cocaine self-administration and D3 receptor-mediated behavior by two novel dopamine D3 receptor-selective partial agonists, OS-3-106 and WW-III-55</span></div><div class="casAuthors">Cheung, Timothy H. C.; Loriaux, Amy L.; Weber, Suzanne M.; Chandler, Kayla N.; Lenz, Jeffrey D.; Schaan, Romina F.; Mach, Robert H.; Luedtke, Robert R.; Neisewander, Janet L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">410-423</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dopamine D3 receptor (D3R)-selective compds. may be useful medications for cocaine dependence.  In this study, we identified two novel arylamide phenylpiperazines, OS-3-106 and WW-III-55, as partial agonists at the D3R in the adenylyl cyclase inhibition assay.  OS-3-106 and WW-III-55 have 115- and 862-fold D3R:D2 receptor (D2R) binding selectivity, resp.  We investigated their effects (0, 3, 5.6, or 10 mg/kg) on operant responding by using a multiple variable-interval (VI) 60-s schedule that alternated components with sucrose reinforcement and components with i.v. cocaine reinforcement (0.375 mg/kg).  Addnl., we evaluated the effect of OS-3-106 (10 mg/kg) on the dose-response function of cocaine self-administration and the effect of WW-III-55 (0-5.6 mg/kg) on a progressive ratio schedule with either cocaine or sucrose reinforcement.  Both compds. were also examd. for effects on locomotion and yawning induced by a D3R agonist.  OS-3-106 decreased cocaine and sucrose reinforcement rates, increased latency to first response for cocaine but not sucrose, and down-shifted the cocaine self-administration dose-response function.  WW-III-55 did not affect cocaine self-administration on the multiple-variable interval schedule, but it reduced cocaine and sucrose intake on the progressive ratio schedule.  Both compds. reduced locomotion at doses that reduced responding, and both compds. attenuated yawning induced by low doses of 7-OH-DPAT (a D3R-mediated behavior), but neither affected yawning on the descending limb of the 7-OH-DPAT dose-response function (a D2R-mediated behavior).  Therefore, both compds. blocked a D3R-mediated behavior.  However, OS-3-106 was more effective in reducing cocaine self-administration.  These findings support D3Rs, and possibly D2Rs, as targets for medications aimed at reducing the motivation to seek cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohpmGpI3Ejz7Vg90H21EOLACvtfcHk0ljcPAUeQAwUsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSqsLrN&md5=643b08be291f9e831fc3abc5567ec9ec</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.202911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.202911%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DT.%2BH.%26aulast%3DLoriaux%26aufirst%3DA.%2BL.%26aulast%3DWeber%26aufirst%3DS.%2BM.%26aulast%3DChandler%26aufirst%3DK.%2BN.%26aulast%3DLenz%26aufirst%3DJ.%2BD.%26aulast%3DSchaan%26aufirst%3DR.%2BF.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DNeisewander%26aufirst%3DJ.%2BL.%26atitle%3DReduction%2520of%2520cocaine%2520self-administration%2520and%2520D3%2520receptor-mediated%2520behavior%2520by%2520two%2520novel%2520dopamine%2520D3%2520receptor-selective%2520partial%2520agonists%252C%2520OS-3-106%2520and%2520WW-III-55%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D347%26spage%3D410%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Weber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durbin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swerdlow, N. R.</span><span> </span><span class="NLM_article-title">Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2009&pages=141-147&author=M.+Weberauthor=W.+L.+Changauthor=J.+P.+Durbinauthor=P.+E.+Parkauthor=R.+R.+Luedtkeauthor=R.+H.+Machauthor=N.+R.+Swerdlow&title=Using+prepulse+inhibition+to+detect+functional+D3+receptor+antagonism%3A+effects+of+WC10+and+WC44"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeber%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DW.%2BL.%26aulast%3DDurbin%26aufirst%3DJ.%2BP.%26aulast%3DPark%26aufirst%3DP.%2BE.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DSwerdlow%26aufirst%3DN.%2BR.%26atitle%3DUsing%2520prepulse%2520inhibition%2520to%2520detect%2520functional%2520D3%2520receptor%2520antagonism%253A%2520effects%2520of%2520WC10%2520and%2520WC44%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2009%26volume%3D93%26spage%3D141%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Collins, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J. H.</span><span> </span><span class="NLM_article-title">Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">310</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1124%2Fjpet.105.085472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=15833897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtVeju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2005&pages=310-319&author=G.+T.+Collinsauthor=J.+M.+Witkinauthor=A.+H.+Newmanauthor=K.+A.+Svenssonauthor=P.+Grundtauthor=J.+Caoauthor=J.+H.+Woods&title=Dopamine+agonist-induced+yawning+in+rats%3A+a+dopamine+D3+receptor-mediated+behavior"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine agonist-induced yawning in rats: A dopamine D3 receptor-mediated behavior</span></div><div class="casAuthors">Collins, Gregory T.; Witkin, Jeffrey M.; Newman, Amy H.; Svensson, Kjell A.; Grundt, Peter; Cao, Jianjing; Woods, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">310-319</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A specific role for the dopamine D3 receptor in behavior has yet to be elucidated.  We now report that dopamine D2/D3 agonists elicit dose-dependent yawning behavior in rats, resulting in an inverted U-shaped dose-response curve.  A series of expts. was directed toward the hypothesis that the induction of yawning is a D3 receptor-mediated effect, whereas the inhibition of the yawning obsd. at higher doses is due to competing D2 receptor activity.  We compared several dopaminergic agonists with a range of in vitro D3 selectivity, including PD-128907, PD-128908, quinelorane, pramipexole, 7-hydroxy-2-dipropylaminotetralin HBr, quinpirole, bromocriptine, and apomorphine, with respect to their ability to induce yawning in rats.  A series of D2/D3 antagonists differing in selectivity for D3 over D2 receptors were evaluated for their ability to alter the effects of the dopamine agonists.  The antagonists L-741626, haloperidol, nafadotride, U 99194, SB-277011A, and PG 01037 were used to det. effects on dose-response curves for D2/D3 agonist-induced yawning.  In addn., the potential contribution of cholinergic and/or serotonergic mechanisms to the yawning response was investigated using a series of pharmacol. tools including scopolamine, mianserin, and the D3-preferring antagonists nafadotride, U 99194, SB-277011A, and PG 01037 to differentially modulate yawning induced by PD-128907, physostigmine, and N-[3-(trifluoromethyl)phenyl]piperazine HCl.  The results of these expts. provide convergent evidence that dopamine D2/D3 agonist-induced yawning is a D3 agonist-mediated behavior, with subsequent inhibition of yawning being driven by competing D2 agonist activity.  Thus, dopamine agonist-induced yawning may represent an in vivo method for selectively identifying D3 and D2 receptor-mediated activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzU9dti9p8tbVg90H21EOLACvtfcHk0lizPDEAV2tqKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtVeju7Y%253D&md5=e772eb780c6646b92523d814a1494e73</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.085472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.085472%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DG.%2BT.%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DWoods%26aufirst%3DJ.%2BH.%26atitle%3DDopamine%2520agonist-induced%2520yawning%2520in%2520rats%253A%2520a%2520dopamine%2520D3%2520receptor-mediated%2520behavior%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D314%26spage%3D310%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Collins, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husbands, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauvignac, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J. H.</span><span> </span><span class="NLM_article-title">Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2007&pages=159-170&author=G.+T.+Collinsauthor=A.+H.+Newmanauthor=P.+Grundtauthor=K.+C.+Riceauthor=S.+M.+Husbandsauthor=C.+Chauvignacauthor=J.+Chenauthor=S.+Wangauthor=J.+H.+Woods&title=Yawning+and+hypothermia+in+rats%3A+effects+of+dopamine+D3+and+D2+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DG.%2BT.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26aulast%3DChauvignac%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWoods%26aufirst%3DJ.%2BH.%26atitle%3DYawning%2520and%2520hypothermia%2520in%2520rats%253A%2520effects%2520of%2520dopamine%2520D3%2520and%2520D2%2520agonists%2520and%2520antagonists%26jtitle%3DPsychopharmacology%26date%3D2007%26volume%3D193%26spage%3D159%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Neisewander, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran-Nguyen, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffey, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyce, J. N.</span><span> </span><span class="NLM_article-title">Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1479</span><span class="NLM_x">–</span> <span class="NLM_lpage">1487</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=1479-1487&author=J.+L.+Neisewanderauthor=R.+A.+Fuchsauthor=L.+T.+Tran-Nguyenauthor=S.+M.+Weberauthor=G.+P.+Coffeyauthor=J.+N.+Joyce&title=Increases+in+dopamine+D3+receptor+binding+in+rats+receiving+a+cocaine+challenge+at+various+time+points+after+cocaine+self-administration%3A+implications+for+cocaine-seeking+behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeisewander%26aufirst%3DJ.%2BL.%26aulast%3DFuchs%26aufirst%3DR.%2BA.%26aulast%3DTran-Nguyen%26aufirst%3DL.%2BT.%26aulast%3DWeber%26aufirst%3DS.%2BM.%26aulast%3DCoffey%26aufirst%3DG.%2BP.%26aulast%3DJoyce%26aufirst%3DJ.%2BN.%26atitle%3DIncreases%2520in%2520dopamine%2520D3%2520receptor%2520binding%2520in%2520rats%2520receiving%2520a%2520cocaine%2520challenge%2520at%2520various%2520time%2520points%2520after%2520cocaine%2520self-administration%253A%2520implications%2520for%2520cocaine-seeking%2520behavior%26jtitle%3DNeuropsychopharmacology%26date%3D2004%26volume%3D29%26spage%3D1479%26epage%3D1487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Huang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hufeisen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Identification of human Ether-a-go-go related gene modulators by three screening platforms in an academic drug-discovery setting</span> <span class="citation_source-journal">Assay Drug Dev. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">742</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=727-742&author=X.+P.+Huangauthor=T.+Manganoauthor=S.+Hufeisenauthor=V.+Setolaauthor=B.+L.+Roth&title=Identification+of+human+Ether-a-go-go+related+gene+modulators+by+three+screening+platforms+in+an+academic+drug-discovery+setting"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DMangano%26aufirst%3DT.%26aulast%3DHufeisen%26aufirst%3DS.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DIdentification%2520of%2520human%2520Ether-a-go-go%2520related%2520gene%2520modulators%2520by%2520three%2520screening%2520platforms%2520in%2520an%2520academic%2520drug-discovery%2520setting%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2010%26volume%3D8%26spage%3D727%26epage%3D742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Keck, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z. X.</span><span> </span><span class="NLM_article-title">Fenobam sulfate inhibits cocaine-taking and cocaine-seeking behavior in rats: implications for addiction treatment in humans</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">229</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=2013&pages=253-265&author=T.+M.+Keckauthor=H.+J.+Yangauthor=G.+H.+Biauthor=Y.+Huangauthor=H.+Y.+Zhangauthor=R.+Srivastavaauthor=E.+L.+Gardnerauthor=A.+H.+Newmanauthor=Z.+X.+Xi&title=Fenobam+sulfate+inhibits+cocaine-taking+and+cocaine-seeking+behavior+in+rats%3A+implications+for+addiction+treatment+in+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DYang%26aufirst%3DH.%2BJ.%26aulast%3DBi%26aufirst%3DG.%2BH.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%2BY.%26aulast%3DSrivastava%26aufirst%3DR.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DXi%26aufirst%3DZ.%2BX.%26atitle%3DFenobam%2520sulfate%2520inhibits%2520cocaine-taking%2520and%2520cocaine-seeking%2520behavior%2520in%2520rats%253A%2520implications%2520for%2520addiction%2520treatment%2520in%2520humans%26jtitle%3DPsychopharmacology%26date%3D2013%26volume%3D229%26spage%3D253%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Keck, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats</span> <span class="citation_source-journal">Addict. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1111%2Fadb.12086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24001208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjt1Slu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=195-209&author=T.+M.+Keckauthor=M.+F.+Zouauthor=G.+H.+Biauthor=H.+Y.+Zhangauthor=X.+F.+Wangauthor=H.+J.+Yangauthor=R.+Srivastavaauthor=E.+L.+Gardnerauthor=Z.+X.+Xiauthor=A.+H.+Newman&title=A+novel+mGluR5+antagonist%2C+MFZ+10-7%2C+inhibits+cocaine-taking+and+cocaine-seeking+behavior+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats</span></div><div class="casAuthors">Keck, Thomas M.; Zou, Mu-Fa; Bi, Guo-Hua; Zhang, Hai-Ying; Wang, Xiao-Fei; Yang, Hong-Ju; Srivastava, Ratika; Gardner, Eliot L.; Xi, Zheng-Xiong; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Addiction Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-209</span>CODEN:
                <span class="NLM_cas:coden">ADBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1369-1600</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Pre-clin. studies suggest that neg. allosteric modulators (NAMs) of the metabotropic glutamate receptor subtype 5 (mGluR5), including 2-methyl-6-(phenylethynyl)pyridine (MPEP), 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) and fenobam are highly effective in attenuating drug-taking and drug-seeking behaviors.  However, both MPEP and MTEP have no translational potential for use in humans because of their off-target effects and short half-lives.  Here, we report that 3-fluoro-5-[(6-methylpyridin-2-yl)ethynyl]benzonitrile (MFZ 10-7), a novel mGluR5 NAM, is more potent and selective than MPEP, MTEP and fenobam in both in vitro binding and functional assays.  Similar to MTEP, i.p. administration of MFZ 10-7 inhibited i.v. cocaine self-administration, cocaine-induced reinstatement of drug-seeking behavior and cocaine-assocd. cue-induced cocaine-seeking behavior in rats.  Although MFZ 10-7 and MTEP lowered the rate of oral sucrose self-administration, they did not alter total sucrose intake.  Further, MFZ 10-7 appeared to be more potent than MTEP in inducing downward shifts in the cocaine dose-response curve, but less effective than MTEP in attenuating sucrose-induced reinstatement of sucrose-seeking behavior.  MFZ 10-7 and MTEP had no effect on basal locomotor behavior.  These findings not only provide addnl. evidence supporting an important role for mGluR5 in cocaine reward and addiction, but also introduce a new tool for both in vitro and in vivo investigations with which to further characterize this role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZjsn6PiPda7Vg90H21EOLACvtfcHk0lizPDEAV2tqKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjt1Slu7w%253D&md5=660cc3bc341aff74ec5c8e89d1ddb23d</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1111%2Fadb.12086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fadb.12086%26sid%3Dliteratum%253Aachs%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DZou%26aufirst%3DM.%2BF.%26aulast%3DBi%26aufirst%3DG.%2BH.%26aulast%3DZhang%26aufirst%3DH.%2BY.%26aulast%3DWang%26aufirst%3DX.%2BF.%26aulast%3DYang%26aufirst%3DH.%2BJ.%26aulast%3DSrivastava%26aufirst%3DR.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26aulast%3DXi%26aufirst%3DZ.%2BX.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DA%2520novel%2520mGluR5%2520antagonist%252C%2520MFZ%252010-7%252C%2520inhibits%2520cocaine-taking%2520and%2520cocaine-seeking%2520behavior%2520in%2520rats%26jtitle%3DAddict.%2520Biol.%26date%3D2014%26volume%3D19%26spage%3D195%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Richardson, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, D. C.</span><span> </span><span class="NLM_article-title">Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2F0165-0270%2895%2900153-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=8794935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaK28Xkt1Olsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1996&pages=1-11&author=N.+R.+Richardsonauthor=D.+C.+Roberts&title=Progressive+ratio+schedules+in+drug+self-administration+studies+in+rats%3A+a+method+to+evaluate+reinforcing+efficacy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy</span></div><div class="casAuthors">Richardson, Nicole R.; Roberts, David C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 71 refs. Drug self-administration studies have recently employed progressive ratio (PR) schedules to examine psychostimulant and opiate reinforcement.  This review addresses the tech., statistical, and theor. issues related to the use of the PR schedule in self-administration studies in rats.  Session parameters adopted for use in in the authors' lab. and the considerations relevant to them are described.  The strengths and weaknesses of the PR schedule are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVG8KHfw02R7Vg90H21EOLACvtfcHk0ljJOmFZEAu3ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xkt1Olsb4%253D&md5=e60158742a40dd8bf90046e9b56a0a69</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2F0165-0270%2895%2900153-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-0270%252895%252900153-0%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DN.%2BR.%26aulast%3DRoberts%26aufirst%3DD.%2BC.%26atitle%3DProgressive%2520ratio%2520schedules%2520in%2520drug%2520self-administration%2520studies%2520in%2520rats%253A%2520a%2520method%2520to%2520evaluate%2520reinforcing%2520efficacy%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D1996%26volume%3D66%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Arnold, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, D. C.</span><span> </span><span class="NLM_article-title">A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=441-447&author=J.+M.+Arnoldauthor=D.+C.+Roberts&title=A+critique+of+fixed+and+progressive+ratio+schedules+used+to+examine+the+neural+substrates+of+drug+reinforcement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DJ.%2BM.%26aulast%3DRoberts%26aufirst%3DD.%2BC.%26atitle%3DA%2520critique%2520of%2520fixed%2520and%2520progressive%2520ratio%2520schedules%2520used%2520to%2520examine%2520the%2520neural%2520substrates%2520of%2520drug%2520reinforcement%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1997%26volume%3D57%26spage%3D441%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Roberts, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span> </span><span class="NLM_article-title">How to make a rat addicted to cocaine</span> <span class="citation_source-journal">Prog. Neuropsychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1614</span><span class="NLM_x">–</span> <span class="NLM_lpage">1624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.pnpbp.2007.08.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=17888555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BD2snktFKgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2007&pages=1614-1624&author=D.+C.+Robertsauthor=D.+Morganauthor=Y.+Liu&title=How+to+make+a+rat+addicted+to+cocaine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">How to make a rat addicted to cocaine</span></div><div class="casAuthors">Roberts David C S; Morgan Drake; Liu Yu</div><div class="citationInfo"><span class="NLM_cas:title">Progress in neuro-psychopharmacology & biological psychiatry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1614-24</span>
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    </div><div class="casAbstract">Procedures have been developed which provide extremely stable patterns of cocaine self-administration in rats and these have been useful in lesion and drug pretreatment studies aimed at understanding the neurobiology of cocaine reinforcement.  The issue now is whether studying the neurobiology of reinforcement is the same as studying the neurobiology of addiction.  If the goal is to understand a progressive and deteriorating disorder, then the self-administration procedures should model specific aspects of the progressive stages of the addiction process.  Here we review theoretical strategies for modeling the addiction process and present data from a series of experiments from our laboratory showing conditions which produce a progressive change in the motivation to self-administer cocaine in rats.  This phenomenon is revealed by an escalation in breakpoints on a progressive ratio schedule.  The effect, which is robust and persistent, depends on dose and speed of injection.  Interestingly, high drug intake can retard the development of this effect, which we argue indicates that the addiction process has a developmental sequence.  Finally, we suggest that specific parameters (dose, price and availability) can be used to examine the transition from recreational use to binge-like intake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRUN2-8jIzYQG52AMpI4GK2fW6udTcc2eacEkUM1vy5n7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snktFKgtw%253D%253D&md5=2a277388b2a0ec836ef0ce8e4bc681f7</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2007.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2007.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DD.%2BC.%26aulast%3DMorgan%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DHow%2520to%2520make%2520a%2520rat%2520addicted%2520to%2520cocaine%26jtitle%3DProg.%2520Neuropsychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2007%26volume%3D31%26spage%3D1614%26epage%3D1624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Roane, H. S.</span><span> </span><span class="NLM_article-title">On the applied use of progressive-ratio schedules of reinforcement</span> <span class="citation_source-journal">J. Appl. Behav. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1901%2Fjaba.2008.41-155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=18595280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BD1cvislSmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=155-161&author=H.+S.+Roane&title=On+the+applied+use+of+progressive-ratio+schedules+of+reinforcement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">On the applied use of progressive-ratio schedules of reinforcement</span></div><div class="casAuthors">Roane Henry S</div><div class="citationInfo"><span class="NLM_cas:title">Journal of applied behavior analysis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-61</span>
        ISSN:<span class="NLM_cas:issn">0021-8855</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTiWpqJRewCZpQHPYJuLg8TfW6udTcc2eacEkUM1vy5n7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvislSmsg%253D%253D&md5=59222e2eeb65da771fcb5b7648a8f562</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1901%2Fjaba.2008.41-155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1901%252Fjaba.2008.41-155%26sid%3Dliteratum%253Aachs%26aulast%3DRoane%26aufirst%3DH.%2BS.%26atitle%3DOn%2520the%2520applied%2520use%2520of%2520progressive-ratio%2520schedules%2520of%2520reinforcement%26jtitle%3DJ.%2520Appl.%2520Behav.%2520Anal.%26date%3D2008%26volume%3D41%26spage%3D155%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Comer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vosburg, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalczyk, W. J.</span><span> </span><span class="NLM_article-title">Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1179</span><span class="NLM_x">–</span> <span class="NLM_lpage">1191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=1179-1191&author=S.+D.+Comerauthor=M.+A.+Sullivanauthor=R.+A.+Whittingtonauthor=S.+K.+Vosburgauthor=W.+J.+Kowalczyk&title=Abuse+liability+of+prescription+opioids+compared+to+heroin+in+morphine-maintained+heroin+abusers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DComer%26aufirst%3DS.%2BD.%26aulast%3DSullivan%26aufirst%3DM.%2BA.%26aulast%3DWhittington%26aufirst%3DR.%2BA.%26aulast%3DVosburg%26aufirst%3DS.%2BK.%26aulast%3DKowalczyk%26aufirst%3DW.%2BJ.%26atitle%3DAbuse%2520liability%2520of%2520prescription%2520opioids%2520compared%2520to%2520heroin%2520in%2520morphine-maintained%2520heroin%2520abusers%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26spage%3D1179%26epage%3D1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Jones, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, S. D.</span><span> </span><span class="NLM_article-title">A review of human drug self-administration procedures</span> <span class="citation_source-journal">Behav. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=384-395&author=J.+D.+Jonesauthor=S.+D.+Comer&title=A+review+of+human+drug+self-administration+procedures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DJ.%2BD.%26aulast%3DComer%26aufirst%3DS.%2BD.%26atitle%3DA%2520review%2520of%2520human%2520drug%2520self-administration%2520procedures%26jtitle%3DBehav.%2520Pharmacol.%26date%3D2013%26volume%3D24%26spage%3D384%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Stoops, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hays, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, C. R.</span><span> </span><span class="NLM_article-title">Intranasal cocaine functions as reinforcer on a progressive ratio schedule in humans</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">644</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.ejphar.2010.06.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=20638380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVejs7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=644&publication_year=2010&pages=101-105&author=W.+W.+Stoopsauthor=J.+A.+Lileauthor=P.+E.+Glaserauthor=L.+R.+Haysauthor=C.+R.+Rush&title=Intranasal+cocaine+functions+as+reinforcer+on+a+progressive+ratio+schedule+in+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Intranasal cocaine functions as reinforcer on a progressive ratio schedule in humans</span></div><div class="casAuthors">Stoops, William W.; Lile, Joshua A.; Glaser, Paul E. A.; Hays, Lon R.; Rush, Craig R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">644</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">101-105</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cocaine dependence continues to be a worldwide public health concern.  Although the majority of individuals reporting cocaine use do so via the intranasal route, relatively few lab. expts. have examd. the reinforcing effects of cocaine administered intranasally.  The purpose of this expt. was to measure the reinforcing effects of intranasal cocaine using a progressive ratio schedule in which eight cocaine-using subjects chose between doses of cocaine (4 [placebo], 15, 30 and 45 mg) and an alternative reinforcer (0.25).  During each session, subjects first sampled the dose of cocaine available that day and then made six choices between that dose and money, which were available on concurrent progressive ratio schedules of responding.  Break points for active cocaine doses were higher than those for placebo but no statistically significant active vs. placebo dose effects were obsd. on subject-rated or physiol. measures.  These data demonstrate that intranasal cocaine functions as a reinforcer under a progressive ratio schedule in humans.  Future research should test higher cocaine doses and larger values of the alternative reinforcer.  These procedures may be useful for examg. the influence of putative pharmacol. and behavioral interventions on intranasal cocaine self-administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxjRMUo-XoG7Vg90H21EOLACvtfcHk0ljm3y0PkSuOHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVejs7jJ&md5=21ab997b2f5267a094990ef341b01a6a</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2010.06.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2010.06.055%26sid%3Dliteratum%253Aachs%26aulast%3DStoops%26aufirst%3DW.%2BW.%26aulast%3DLile%26aufirst%3DJ.%2BA.%26aulast%3DGlaser%26aufirst%3DP.%2BE.%26aulast%3DHays%26aufirst%3DL.%2BR.%26aulast%3DRush%26aufirst%3DC.%2BR.%26atitle%3DIntranasal%2520cocaine%2520functions%2520as%2520reinforcer%2520on%2520a%2520progressive%2520ratio%2520schedule%2520in%2520humans%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D644%26spage%3D101%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Epstein, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preston, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaham, Y.</span><span> </span><span class="NLM_article-title">Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">189</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2006&pages=1-16&author=D.+H.+Epsteinauthor=K.+L.+Prestonauthor=J.+Stewartauthor=Y.+Shaham&title=Toward+a+model+of+drug+relapse%3A+an+assessment+of+the+validity+of+the+reinstatement+procedure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEpstein%26aufirst%3DD.%2BH.%26aulast%3DPreston%26aufirst%3DK.%2BL.%26aulast%3DStewart%26aufirst%3DJ.%26aulast%3DShaham%26aufirst%3DY.%26atitle%3DToward%2520a%2520model%2520of%2520drug%2520relapse%253A%2520an%2520assessment%2520of%2520the%2520validity%2520of%2520the%2520reinstatement%2520procedure%26jtitle%3DPsychopharmacology%26date%3D2006%26volume%3D189%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Shaham, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalev, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Wit, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, J.</span><span> </span><span class="NLM_article-title">The reinstatement model of drug relapse: history, methodology and major findings</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2003&pages=3-20&author=Y.+Shahamauthor=U.+Shalevauthor=L.+Luauthor=H.+De+Witauthor=J.+Stewart&title=The+reinstatement+model+of+drug+relapse%3A+history%2C+methodology+and+major+findings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaham%26aufirst%3DY.%26aulast%3DShalev%26aufirst%3DU.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DDe%2BWit%26aufirst%3DH.%26aulast%3DStewart%26aufirst%3DJ.%26atitle%3DThe%2520reinstatement%2520model%2520of%2520drug%2520relapse%253A%2520history%252C%2520methodology%2520and%2520major%2520findings%26jtitle%3DPsychopharmacology%26date%3D2003%26volume%3D168%26spage%3D3%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Bossert, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchant, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calu, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaham, Y.</span><span> </span><span class="NLM_article-title">The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">229</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=2013&pages=453-476&author=J.+M.+Bossertauthor=N.+J.+Marchantauthor=D.+J.+Caluauthor=Y.+Shaham&title=The+reinstatement+model+of+drug+relapse%3A+recent+neurobiological+findings%2C+emerging+research+topics%2C+and+translational+research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBossert%26aufirst%3DJ.%2BM.%26aulast%3DMarchant%26aufirst%3DN.%2BJ.%26aulast%3DCalu%26aufirst%3DD.%2BJ.%26aulast%3DShaham%26aufirst%3DY.%26atitle%3DThe%2520reinstatement%2520model%2520of%2520drug%2520relapse%253A%2520recent%2520neurobiological%2520findings%252C%2520emerging%2520research%2520topics%252C%2520and%2520translational%2520research%26jtitle%3DPsychopharmacology%26date%3D2013%26volume%3D229%26spage%3D453%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, S. T.</span><span> </span><span class="NLM_article-title">The validity of the reinstatement model of craving and relapse to drug use</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2003&pages=21-30&author=J.+L.+Katzauthor=S.+T.+Higgins&title=The+validity+of+the+reinstatement+model+of+craving+and+relapse+to+drug+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DHiggins%26aufirst%3DS.%2BT.%26atitle%3DThe%2520validity%2520of%2520the%2520reinstatement%2520model%2520of%2520craving%2520and%2520relapse%2520to%2520drug%2520use%26jtitle%3DPsychopharmacology%26date%3D2003%26volume%3D168%26spage%3D21%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Koob, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenneth Lloyd, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, B. J.</span><span> </span><span class="NLM_article-title">Development of pharmacotherapies for drug addiction: a Rosetta stone approach</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="NLM_x">–</span> <span class="NLM_lpage">515</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=500-515&author=G.+F.+Koobauthor=G.+Kenneth+Lloydauthor=B.+J.+Mason&title=Development+of+pharmacotherapies+for+drug+addiction%3A+a+Rosetta+stone+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoob%26aufirst%3DG.%2BF.%26aulast%3DKenneth%2BLloyd%26aufirst%3DG.%26aulast%3DMason%26aufirst%3DB.%2BJ.%26atitle%3DDevelopment%2520of%2520pharmacotherapies%2520for%2520drug%2520addiction%253A%2520a%2520Rosetta%2520stone%2520approach%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D500%26epage%3D515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Woolverton, W. L.; Nader, M. A.</span><span> </span><span class="NLM_article-title">Experimental evaluation of the reinforcing effects of drugs</span>. In  <span class="citation_source-book">Testing and Evaluation of Drugs of Abuse</span>; <span class="NLM_contrib-group">Adler, M. W.; Cowan, A.</span>, Eds.; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">Oxford, England</span>,<span class="NLM_x"> </span><span class="NLM_year">1990</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&pages=165-192&author=W.+L.+Woolverton&author=M.+A.+Naderauthor=M.+W.+Adler&author=A.+Cowan&title=Testing+and+Evaluation+of+Drugs+of+Abuse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWoolverton%26aufirst%3DW.%2BL.%26atitle%3DExperimental%2520evaluation%2520of%2520the%2520reinforcing%2520effects%2520of%2520drugs%26btitle%3DTesting%2520and%2520Evaluation%2520of%2520Drugs%2520of%2520Abuse%26aulast%3DAdler%26aufirst%3DM.%2BW.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D1990%26spage%3D165%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Lile, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birmingham, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolverton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">The reinforcing efficacy of the dopamine reuptake inhibitor 2beta-propanoyl-3beta-(4-tolyl)-tropane (PTT) as measured by a progressive-ratio schedule and a choice procedure in rhesus monkeys</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">640</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1124%2Fjpet.102.039180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=12388646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD38XotlCnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=640-648&author=J.+A.+Lileauthor=D.+Morganauthor=A.+M.+Birminghamauthor=Z.+Wangauthor=W.+L.+Woolvertonauthor=H.+M.+Daviesauthor=M.+A.+Nader&title=The+reinforcing+efficacy+of+the+dopamine+reuptake+inhibitor+2beta-propanoyl-3beta-%284-tolyl%29-tropane+%28PTT%29+as+measured+by+a+progressive-ratio+schedule+and+a+choice+procedure+in+rhesus+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">The reinforcing efficacy of the dopamine reuptake inhibitor 2β-propanoyl-3β-(4-tolyl)-tropane (PTT) as measured by a progressive-ratio schedule and a choice procedure in rhesus monkeys</span></div><div class="casAuthors">Lile, Joshua A.; Morgan, Drake; Birmingham, Anne M.; Wang, Zhixia; Woolverton, William L.; Davies, Huw M. L.; Nader, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">640-648</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The present series of expts. was undertaken to investigate the variables that influence the reinforcing efficacy of psychostimulants.  The time of onset for dopamine transporter (DAT) occupancy of the long-acting, high-affinity DAT blocker 2β-propanoyl-3β-(4-tolyl)-tropane (PTT) was measured using an ex vivo binding assay in rodents and was detd. to be significantly longer than for cocaine (30 min vs. 2 min).  To assess the reinforcing efficacy of PTT relative to cocaine, a discrete-trials drug-drug choice procedure (n = 3) and a progressive-ratio (PR) schedule (n = 4) were used in rhesus monkeys.  Cocaine (0.003-0.56 mg/kg/injection) and PTT (0.003 - 0.03 mg/kg/injection) maintained responding greater than saline under the PR schedule.  Maximal breaking points were significantly higher for cocaine compared with PTT.  A sep. group of monkeys prepd. with double-lumen catheters was allowed to choose between cocaine (saline and 0.03 - 0.3 mg/kg/injection) and PTT (saline, and 0.01 and 0.03 mg/kg/injection).  Under these conditions, PTT was not preferred over saline.  When saline or 0.01 mg/kg/injection PTT was available as alternatives to cocaine, the highest dose of cocaine maintained greater than 80% choice.  When 0.03 mg/kg/injection PTT was the alternative to cocaine, cocaine choice declined to approx. 50%, and total cocaine intake was decreased by ∼70% at the highest cocaine dose.  These results suggest that the reinforcing efficacy of PTT is less than cocaine in nonhuman primates.  Data from studies with PTT indicate that slow-onset, long-acting DAT inhibitors can decrease cocaine self-administration while not functioning robustly as reinforcers, and support the further investigation of these drugs as treatment for cocaine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz98P3Fox5TrVg90H21EOLACvtfcHk0lgPkZd5084cVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotlCnsr8%253D&md5=08f152ed0aa6c2973cf1a0cab12a9a2e</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.039180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.039180%26sid%3Dliteratum%253Aachs%26aulast%3DLile%26aufirst%3DJ.%2BA.%26aulast%3DMorgan%26aufirst%3DD.%26aulast%3DBirmingham%26aufirst%3DA.%2BM.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWoolverton%26aufirst%3DW.%2BL.%26aulast%3DDavies%26aufirst%3DH.%2BM.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DThe%2520reinforcing%2520efficacy%2520of%2520the%2520dopamine%2520reuptake%2520inhibitor%25202beta-propanoyl-3beta-%25284-tolyl%2529-tropane%2520%2528PTT%2529%2520as%2520measured%2520by%2520a%2520progressive-ratio%2520schedule%2520and%2520a%2520choice%2520procedure%2520in%2520rhesus%2520monkeys%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D640%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Woolverton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balster, R. L.</span><span> </span><span class="NLM_article-title">Effects of antipsychotic compounds in rhesus monkeys given a choice between cocaine and food</span> <span class="citation_source-journal">Drug Alcohol Depend.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2F0376-8716%2881%2990088-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=7297414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaL3MXmtFGisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1981&pages=69-78&author=W.+L.+Woolvertonauthor=R.+L.+Balster&title=Effects+of+antipsychotic+compounds+in+rhesus+monkeys+given+a+choice+between+cocaine+and+food"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of antipsychotic compounds in rhesus monkeys given a choice between cocaine and food</span></div><div class="casAuthors">Woolverton, William L.; Balster, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-78</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    </div><div class="casAbstract">Rhesus monkeys were trained in a preference procedure to choose between i.v. injections of cocaine  [50-36-2] or food presentation.  Frequency of cocaine choice increased as unit dose of cocaine was increased.  Continuous infusions of low or intermediate doses of chlorpromazine (CPZ)  [50-53-3] or haloperidol (H)  [52-86-8] either did not affect or increased the frequency of cocaine choice.  Higher doses of CPZ or H completely suppressed responding for both reinforcers.  Although there appears to be a mutual antagonism of some of the effects of cocaine and these antipsychotic compds., the results of the present expt. fail to support the hypothesis that the reinforcing effects of cocaine can be antagonized with CPZ or H.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnEw82QKhCZ7Vg90H21EOLACvtfcHk0lgPkZd5084cVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXmtFGisL0%253D&md5=4297ae04eb320bfce8ad634372f5da34</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1016%2F0376-8716%2881%2990088-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0376-8716%252881%252990088-0%26sid%3Dliteratum%253Aachs%26aulast%3DWoolverton%26aufirst%3DW.%2BL.%26aulast%3DBalster%26aufirst%3DR.%2BL.%26atitle%3DEffects%2520of%2520antipsychotic%2520compounds%2520in%2520rhesus%2520monkeys%2520given%2520a%2520choice%2520between%2520cocaine%2520and%2520food%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D1981%26volume%3D8%26spage%3D69%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Negus, S. S.</span><span> </span><span class="NLM_article-title">Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with <i>d</i>-amphetamine and flupenthixol</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">919</span><span class="NLM_x">–</span> <span class="NLM_lpage">931</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=919-931&author=S.+S.+Negus&title=Rapid+assessment+of+choice+between+cocaine+and+food+in+rhesus+monkeys%3A+effects+of+environmental+manipulations+and+treatment+with+d-amphetamine+and+flupenthixol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNegus%26aufirst%3DS.%2BS.%26atitle%3DRapid%2520assessment%2520of%2520choice%2520between%2520cocaine%2520and%2520food%2520in%2520rhesus%2520monkeys%253A%2520effects%2520of%2520environmental%2520manipulations%2520and%2520treatment%2520with%2520d-amphetamine%2520and%2520flupenthixol%26jtitle%3DNeuropsychopharmacology%26date%3D2003%26volume%3D28%26spage%3D919%26epage%3D931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Levant, B.</span><span> </span><span class="NLM_article-title">Differential distribution of D3 dopamine receptors in the brains of several mammalian species</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">800</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2FS0006-8993%2898%2900529-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=9685676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaK1cXks1KrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=800&publication_year=1998&pages=269-274&author=B.+Levant&title=Differential+distribution+of+D3+dopamine+receptors+in+the+brains+of+several+mammalian+species"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Differential distribution of D3 dopamine receptors in the brains of several mammalian species</span></div><div class="casAuthors">Levant, Beth</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">800</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-274</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The D3 dopamine receptor has been proposed as a potential target for the treatment of schizophrenia and drug abuse.  This study compares the distribution of D3 sites in mouse, rat, guinea pig, and rabbit brain, and dog and human cerebellum using quant. autoradiog. with the putatively selective D3 receptor radioligand [3H]PD 128907.  In the mouse, rat, guinea pig, and rabbit, specific [3H]PD 128907 binding was heterogeneously distributed with highest densities obsd. in the islands of Calleja, followed by the nucleus accumbens.  Moderate densities of [3H]PD 128907 binding were obsd. in the anteroventral and dorsomedial caudate nucleus.  Dense [3H]PD 128907-labeled sites were obsd. in the dorsal thalamus, posterior mammillary nucleus, and dorsomedial interpeduncular nucleus of the rabbit that were not detected in the other species studied.  Moderately dense [3H]PD 128907 binding was also obsd. in the mol. layer of cerebellar lobule X of the rat but not in the mouse, guinea pig, rabbit, dog, or human.  These observations indicate significant inter-species differences in the distribution of D3 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf6KxmvddebLVg90H21EOLACvtfcHk0lgPkZd5084cVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXks1KrtLs%253D&md5=4a37b801934dd04773d416e9dd63545e</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2898%2900529-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252898%252900529-0%26sid%3Dliteratum%253Aachs%26aulast%3DLevant%26aufirst%3DB.%26atitle%3DDifferential%2520distribution%2520of%2520D3%2520dopamine%2520receptors%2520in%2520the%2520brains%2520of%2520several%2520mammalian%2520species%26jtitle%3DBrain%2520Res.%26date%3D1998%26volume%3D800%26spage%3D269%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derdeyn, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintun, M. A.</span><span> </span><span class="NLM_article-title">Endogenous dopamine (DA) competes with the binding of a radiolabeled D(3) receptor partial agonist in vivo: a positron emission tomography study</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">724</span><span class="NLM_x">–</span> <span class="NLM_lpage">732</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2011&pages=724-732&author=R.+H.+Machauthor=Z.+Tuauthor=J.+Xuauthor=S.+Liauthor=L.+A.+Jonesauthor=M.+Taylorauthor=R.+R.+Luedtkeauthor=C.+P.+Derdeynauthor=J.+S.+Perlmutterauthor=M.+A.+Mintun&title=Endogenous+dopamine+%28DA%29+competes+with+the+binding+of+a+radiolabeled+D%283%29+receptor+partial+agonist+in+vivo%3A+a+positron+emission+tomography+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DL.%2BA.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DDerdeyn%26aufirst%3DC.%2BP.%26aulast%3DPerlmutter%26aufirst%3DJ.%2BS.%26aulast%3DMintun%26aufirst%3DM.%2BA.%26atitle%3DEndogenous%2520dopamine%2520%2528DA%2529%2520competes%2520with%2520the%2520binding%2520of%2520a%2520radiolabeled%2520D%25283%2529%2520receptor%2520partial%2520agonist%2520in%2520vivo%253A%2520a%2520positron%2520emission%2520tomography%2520study%26jtitle%3DSynapse%26date%3D2011%26volume%3D65%26spage%3D724%26epage%3D732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Di Ciano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underwood, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everitt, B. J.</span><span> </span><span class="NLM_article-title">Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=329-338&author=P.+Di+Cianoauthor=R.+J.+Underwoodauthor=J.+J.+Haganauthor=B.+J.+Everitt&title=Attenuation+of+cue-controlled+cocaine-seeking+by+a+selective+D3+dopamine+receptor+antagonist+SB-277011-A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BCiano%26aufirst%3DP.%26aulast%3DUnderwood%26aufirst%3DR.%2BJ.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DEveritt%26aufirst%3DB.%2BJ.%26atitle%3DAttenuation%2520of%2520cue-controlled%2520cocaine-seeking%2520by%2520a%2520selective%2520D3%2520dopamine%2520receptor%2520antagonist%2520SB-277011-A%26jtitle%3DNeuropsychopharmacology%26date%3D2003%26volume%3D28%26spage%3D329%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Xi, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span> </span><span class="NLM_article-title">Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3427</span><span class="NLM_x">–</span> <span class="NLM_lpage">3438</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1111%2Fj.1460-9568.2005.04159.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=16026480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BD2MzmvFKgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2005&pages=3427-3438&author=Z.+X.+Xiauthor=J.+G.+Gilbertauthor=A.+C.+Pakauthor=C.+R.+Ashbyauthor=C.+A.+Heidbrederauthor=E.+L.+Gardner&title=Selective+dopamine+D3+receptor+antagonism+by+SB-277011A+attenuates+cocaine+reinforcement+as+assessed+by+progressive-ratio+and+variable-cost-variable-payoff+fixed-ratio+cocaine+self-administration+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats</span></div><div class="casAuthors">Xi Zheng-Xiong; Gilbert Jeremy G; Pak Arlene C; Ashby Charles R Jr; Heidbreder Christian A; Gardner Eliot L</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3427-38</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">In rats, acute administration of SB-277011A, a highly selective dopamine (DA) D(3) receptor antagonist, blocks cocaine-enhanced brain stimulation reward, cocaine-seeking behaviour and reinstatement of cocaine-seeking behaviour.  Here, we investigated whether SB-277011A attenuates cocaine reinforcement as assessed by cocaine self-administration under variable-cost-variable-payoff fixed-ratio (FR) and progressive-ratio (PR) reinforcement schedules.  Acute i.p. administration of SB-277011A (3-24 mg/kg) did not significantly alter cocaine (0.75 mg/kg/infusion) self-administration reinforced under FR1 (one lever press for one cocaine infusion) conditions.  However, acute administration of SB-277011A (24 mg/kg, i.p.) progressively attenuated cocaine self-administration when: (a) the unit dose of self-administered cocaine was lowered from 0.75 to 0.125-0.5 mg/kg, and (b) the work demand for cocaine reinforcement was increased from FR1 to FR10.  Under PR (increasing number of lever presses for each successive cocaine infusion) cocaine reinforcement, acute administration of SB-277011A (6-24 mg/kg i.p.) lowered the PR break point for cocaine self-administration in a dose-dependent manner.  The reduction in the cocaine (0.25-1.0 mg/kg) dose-response break-point curve produced by 24 mg/kg SB-277011A is consistent with a reduction in cocaine's reinforcing efficacy.  When substituted for cocaine, SB-277011A alone did not sustain self-administration behaviour.  In contrast with the mixed DA D(2)/D(3) receptor antagonist haloperidol (1 mg/kg), SB-277011A (3, 12 or 24 mg/kg) failed to impede locomotor activity, failed to impair rearing behaviour, failed to produce catalepsy and failed to impair rotarod performance.  These results show that SB-277011A significantly inhibits acute cocaine-induced reinforcement except at high cocaine doses and low work requirement for cocaine.  If these results extrapolate to humans, SB-277011A or similar selective DA D(3) receptor antagonists may be useful in the treatment of cocaine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSGuXqkPgxMy252AMpI4GK2fW6udTcc2eZ-w9xlCrk4QLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzmvFKgtw%253D%253D&md5=5cd50cb9043a38f7739e04f1996af73e</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.2005.04159.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.2005.04159.x%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DZ.%2BX.%26aulast%3DGilbert%26aufirst%3DJ.%2BG.%26aulast%3DPak%26aufirst%3DA.%2BC.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DHeidbreder%26aufirst%3DC.%2BA.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26atitle%3DSelective%2520dopamine%2520D3%2520receptor%2520antagonism%2520by%2520SB-277011A%2520attenuates%2520cocaine%2520reinforcement%2520as%2520assessed%2520by%2520progressive-ratio%2520and%2520variable-cost-variable-payoff%2520fixed-ratio%2520cocaine%2520self-administration%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2005%26volume%3D21%26spage%3D3427%26epage%3D3438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Gyertyan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laszlovszky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gemesi, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasztor, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Csongor, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domany, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tihanyi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szombathelyi, Z.</span><span> </span><span class="NLM_article-title">Effects of RGH-237 [<i>N</i>-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D(3) receptor partial agonist in animal models of cocaine abuse</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">1268</span><span class="NLM_x">–</span> <span class="NLM_lpage">1278</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1124%2Fjpet.106.107920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=17170312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1Wgu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=1268-1278&author=I.+Gyertyanauthor=B.+Kissauthor=K.+Galauthor=I.+Laszlovszkyauthor=A.+Horvathauthor=L.+I.+Gemesiauthor=K.+Saghyauthor=G.+Pasztorauthor=M.+Zajerauthor=M.+Kapasauthor=E.+A.+Csongorauthor=G.+Domanyauthor=K.+Tihanyiauthor=Z.+Szombathelyi&title=Effects+of+RGH-237+%5BN-%7B4-%5B4-%283-aminocarbonyl-phenyl%29-piperazin-1-yl%5D-butyl%7D-4-bromo-benzamide%5D%2C+an+orally+active%2C+selective+dopamine+D%283%29+receptor+partial+agonist+in+animal+models+of+cocaine+abuse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D3 receptor partial agonist in animal models of cocaine abuse</span></div><div class="casAuthors">Gyertyan, Istvan; Kiss, Bela; Gal, Krisztina; Laszlovszky, Istvan; Horvath, Attila; Gemesi, Larisza I.; Saghy, Katalin; Pasztor, Gabriella; Zajer, Maria; Kapas, Margit; Csongor, Eva Agai; Domany, Gyorgy; Tihanyi, Karoly; Szombathelyi, Zsolt</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1268-1278</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dopamine D3 receptor partial agonism has been suggested as a potential therapeutic intervention in cocaine addiction.  RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide] was identified as a novel selective dopamine D3 receptor partial agonist and used for testing this hypothesis in animal models.  The compd. showed nanomolar affinity to human (Ki = 6.7 nM) and rat (Ki = 1.6 nM) D3 receptors with an intrinsic activity of approx. 50%.  It possessed several hundredfold selectivity over the D2 receptor.  The mol. bound with moderate (100-250 nM) affinity to 5-hydroxytryptamine 1A (5-HT1A) and nonselectively labeled opiate receptors.  RGH-237 proved to be practically inactive on more than 40 other targets, including monoaminergic, cholinergic, GABAergic, and glutamatergic receptors.  In rats orally administered RGH-237 was well and rapidly absorbed yielding 41% oral bioavailability.  At its pharmacol. active dose (10 mg/kg p.o.), the brain concn. of RGH-237 reached 110 ng/g.  Its blood and brain levels were sustained for 3 h.  RGH-237 at the oral dose of 10 mg/kg moderately but significantly inhibited the acquisition of cocaine-induced place preference, although by itself, it had no place-conditioning effect.  The compd. did not affect fixed ratio 1 cocaine self-administration.  In a reinstatement paradigm of cocaine self-administration, the compd. potently and dose-dependently blocked the cue-induced cocaine-seeking behavior of rats at 10 and 30 mg/kg oral doses.  RGH-237 did not affect seeking activity for natural rewards, such as sucrose and water.  It did not exert notable effect on spontaneous motor activity of rats.  Our results demonstrate that selective D3 partial agonists may be an effective therapeutic means in the treatment of cocaine abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfWOX5gEQ1DbVg90H21EOLACvtfcHk0lg1bFPo2IR-LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1Wgu74%253D&md5=a670d6e9d14b24332cc31f8a36708cd0</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.107920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.107920%26sid%3Dliteratum%253Aachs%26aulast%3DGyertyan%26aufirst%3DI.%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DGal%26aufirst%3DK.%26aulast%3DLaszlovszky%26aufirst%3DI.%26aulast%3DHorvath%26aufirst%3DA.%26aulast%3DGemesi%26aufirst%3DL.%2BI.%26aulast%3DSaghy%26aufirst%3DK.%26aulast%3DPasztor%26aufirst%3DG.%26aulast%3DZajer%26aufirst%3DM.%26aulast%3DKapas%26aufirst%3DM.%26aulast%3DCsongor%26aufirst%3DE.%2BA.%26aulast%3DDomany%26aufirst%3DG.%26aulast%3DTihanyi%26aufirst%3DK.%26aulast%3DSzombathelyi%26aufirst%3DZ.%26atitle%3DEffects%2520of%2520RGH-237%2520%255BN-%257B4-%255B4-%25283-aminocarbonyl-phenyl%2529-piperazin-1-yl%255D-butyl%257D-4-bromo-benzamide%255D%252C%2520an%2520orally%2520active%252C%2520selective%2520dopamine%2520D%25283%2529%2520receptor%2520partial%2520agonist%2520in%2520animal%2520models%2520of%2520cocaine%2520abuse%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D1268%26epage%3D1278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Di Ciano, P.</span><span> </span><span class="NLM_article-title">Drug seeking under a second-order schedule of reinforcement depends on dopamine D3 receptors in the basolateral amygdala</span> <span class="citation_source-journal">Behav. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2008&pages=129-139&author=P.+Di+Ciano&title=Drug+seeking+under+a+second-order+schedule+of+reinforcement+depends+on+dopamine+D3+receptors+in+the+basolateral+amygdala"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BCiano%26aufirst%3DP.%26atitle%3DDrug%2520seeking%2520under%2520a%2520second-order%2520schedule%2520of%2520reinforcement%2520depends%2520on%2520dopamine%2520D3%2520receptors%2520in%2520the%2520basolateral%2520amygdala%26jtitle%3DBehav.%2520Neurosci.%26date%3D2008%26volume%3D122%26spage%3D129%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Vorel, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span> </span><span class="NLM_article-title">Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">9595</span><span class="NLM_x">–</span> <span class="NLM_lpage">9603</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1523%2FJNEUROSCI.22-21-09595.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=12417684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVGmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=9595-9603&author=S.+R.+Vorelauthor=C.+R.+Ashbyauthor=M.+Paulauthor=X.+Liuauthor=R.+Hayesauthor=J.+J.+Haganauthor=D.+N.+Middlemissauthor=G.+Stempauthor=E.+L.+Gardner&title=Dopamine+D3+receptor+antagonism+inhibits+cocaine-seeking+and+cocaine-enhanced+brain+reward+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats</span></div><div class="casAuthors">Vorel, Stanislav R.; Ashby, Charles R., Jr.; Paul, Mousumi; Liu, Xinhe; Hayes, Robert; Hagan, Jim J.; Middlemiss, Derek N.; Stemp, Geoffrey; Gardner, Eliot L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9595-9603</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The dopamine D3 receptor is preferentially localized to the mesocorticolimbic dopaminergic system and has been hypothesized to play a role in cocaine addiction.  To study the involvement of the D3 receptor in brain mechanisms and behaviors commonly assumed to be involved in the addicting properties of cocaine, the potent and selective D3 receptor antagonist SB-277011-A was administered to lab. rats, and the following measures were assessed: (1) cocaine-enhanced elec. brain-stimulation reward, (2) cocaine-induced conditioned place preference, and (3) cocaine-triggered reinstatement of cocaine seeking behavior.  Systemic injections of SB-277011-A were found to (1) block enhancement of elec. brain stimulation reward by cocaine, (2) dose-dependently attenuate cocaine-induced conditioned place preference, and (3) dose-dependently attenuate cocaine-triggered reinstatement of cocaine seeking behavior.  Thus, D3 receptor blockade attenuates both the rewarding effects of cocaine and cocaine-induced drug-seeking behavior.  These data suggest an important role for D3 receptors in mediating the addictive properties of cocaine and suggest that blockade of dopamine D3 receptors may constitute a new and useful target for prospective pharmacotherapies for cocaine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbTQ6RyNaVH7Vg90H21EOLACvtfcHk0lg1bFPo2IR-LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVGmtr8%253D&md5=fafad91654fc4c174b1f0fe431b206cc</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.22-21-09595.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.22-21-09595.2002%26sid%3Dliteratum%253Aachs%26aulast%3DVorel%26aufirst%3DS.%2BR.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DPaul%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DHayes%26aufirst%3DR.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26atitle%3DDopamine%2520D3%2520receptor%2520antagonism%2520inhibits%2520cocaine-seeking%2520and%2520cocaine-enhanced%2520brain%2520reward%2520in%2520rats%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D9595%26epage%3D9603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Czoty, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">Effects of repeated treatment with the dopamine D2/D3 receptor partial agonist aripiprazole on striatal D2/D3 receptor availability in monkeys</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=2014&pages=613-619&author=P.+W.+Czotyauthor=H.+D.+Gageauthor=P.+K.+Gargauthor=S.+Gargauthor=M.+A.+Nader&title=Effects+of+repeated+treatment+with+the+dopamine+D2%2FD3+receptor+partial+agonist+aripiprazole+on+striatal+D2%2FD3+receptor+availability+in+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCzoty%26aufirst%3DP.%2BW.%26aulast%3DGage%26aufirst%3DH.%2BD.%26aulast%3DGarg%26aufirst%3DP.%2BK.%26aulast%3DGarg%26aufirst%3DS.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DEffects%2520of%2520repeated%2520treatment%2520with%2520the%2520dopamine%2520D2%252FD3%2520receptor%2520partial%2520agonist%2520aripiprazole%2520on%2520striatal%2520D2%252FD3%2520receptor%2520availability%2520in%2520monkeys%26jtitle%3DPsychopharmacology%26date%3D2014%26volume%3D231%26spage%3D613%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Garcia-Ladona, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B. F.</span><span> </span><span class="NLM_article-title">BP 897, a selective dopamine D3 receptor ligand with therapeutic potential for the treatment of cocaine-addiction</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=141-158&author=F.+J.+Garcia-Ladonaauthor=B.+F.+Cox&title=BP+897%2C+a+selective+dopamine+D3+receptor+ligand+with+therapeutic+potential+for+the+treatment+of+cocaine-addiction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Ladona%26aufirst%3DF.%2BJ.%26aulast%3DCox%26aufirst%3DB.%2BF.%26atitle%3DBP%2520897%252C%2520a%2520selective%2520dopamine%2520D3%2520receptor%2520ligand%2520with%2520therapeutic%2520potential%2520for%2520the%2520treatment%2520of%2520cocaine-addiction%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2003%26volume%3D9%26spage%3D141%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Preti, A.</span><span> </span><span class="NLM_article-title">New developments in the pharmacotherapy of cocaine abuse</span> <span class="citation_source-journal">Addict. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1111%2Fj.1369-1600.2007.00061.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=17508985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOqur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=133-151&author=A.+Preti&title=New+developments+in+the+pharmacotherapy+of+cocaine+abuse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">New developments in the pharmacotherapy of cocaine abuse</span></div><div class="casAuthors">Preti, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Addiction Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-151</span>CODEN:
                <span class="NLM_cas:coden">ADBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1355-6215</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite huge advances in the neuroscience of substance abuse and dependence in the past 20 years, no approved pharmacol. treatment exists for cocaine abuse.  The available drugs for the treatment of cocaine abuse are poorly effective, hence the need for new compds. to be screened and tested for efficacy: targeting symptoms might improve the effectiveness of the treatment of cocaine abuse and dependence.  On the basis of the known neurochem. of cocaine, some target compds. have been studied: among others.  BP-897, a D3 partial agonist: vanoxerine, a highly selective inhibitor of dopamine uptake: aripiprazole, a partial mixed-action agonist approved for the treatment of schizophrenia.  Recently modafinil, approved for the treatment of narcolepsy, proved effective in favoring cocaine abstinence in cocaine-abusing people.  Some placebo-controlled studies also reported the effectiveness of topiramate, a licensed antiepileptic drug, and of tiagabine, a gamma-aminobutyric acid (GABA) re-uptake inhibitor also approved as an anticonvulsant: both compds. increased cocaine abstinence with no serious adverse events.  Promising results came from two more compds. acting on the GABA circuits, baclofen and valproic acid.  Finally disulfiram, prescribed with active psychosocial therapy, was found to favor higher retention rates and longer abstinence periods from both alc. and cocaine in polydrug-abusing patients.  An alternative approach rests on the use of vaccines, to date in the exptl. stage still.  Psychosocial treatments are a useful companion in the pharmacotherapy of cocaine abuse, with group therapy and contingency management therapies improving motivation and social functioning, particularly in patients abusing alc. as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBg9wU-hybkLVg90H21EOLACvtfcHk0liCB3BnTou05g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOqur3N&md5=93b4725efc304ddaee04534fa1ecfa8c</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1111%2Fj.1369-1600.2007.00061.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1369-1600.2007.00061.x%26sid%3Dliteratum%253Aachs%26aulast%3DPreti%26aufirst%3DA.%26atitle%3DNew%2520developments%2520in%2520the%2520pharmacotherapy%2520of%2520cocaine%2520abuse%26jtitle%3DAddict.%2520Biol.%26date%3D2007%26volume%3D12%26spage%3D133%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Pierce, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderschuren, L. J.</span><span> </span><span class="NLM_article-title">Rational development of addiction pharmacotherapies: successes, failures, and prospects</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">a012880</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=a012880&author=R.+C.+Pierceauthor=C.+P.+O%E2%80%99Brienauthor=P.+J.+Kennyauthor=L.+J.+Vanderschuren&title=Rational+development+of+addiction+pharmacotherapies%3A+successes%2C+failures%2C+and+prospects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DR.%2BC.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DC.%2BP.%26aulast%3DKenny%26aufirst%3DP.%2BJ.%26aulast%3DVanderschuren%26aufirst%3DL.%2BJ.%26atitle%3DRational%2520development%2520of%2520addiction%2520pharmacotherapies%253A%2520successes%252C%2520failures%252C%2520and%2520prospects%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2012%26volume%3D2%26spage%3Da012880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Ahmed, S. H.</span><span> </span><span class="NLM_article-title">Validation crisis in animal models of drug addiction: beyond non-disordered drug use toward drug addiction</span> <span class="citation_source-journal">Neurosci. Biobehav. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=172-184&author=S.+H.+Ahmed&title=Validation+crisis+in+animal+models+of+drug+addiction%3A+beyond+non-disordered+drug+use+toward+drug+addiction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DS.%2BH.%26atitle%3DValidation%2520crisis%2520in%2520animal%2520models%2520of%2520drug%2520addiction%253A%2520beyond%2520non-disordered%2520drug%2520use%2520toward%2520drug%2520addiction%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2010%26volume%3D35%26spage%3D172%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">John, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">Differential effects of the dopamine D3 receptor antagonist PG01037 on cocaine and methamphetamine self-administration in rhesus monkeys</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2015&pages=34-43&author=W.+S.+Johnauthor=A.+H.+Newmanauthor=M.+A.+Nader&title=Differential+effects+of+the+dopamine+D3+receptor+antagonist+PG01037+on+cocaine+and+methamphetamine+self-administration+in+rhesus+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohn%26aufirst%3DW.%2BS.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DDifferential%2520effects%2520of%2520the%2520dopamine%2520D3%2520receptor%2520antagonist%2520PG01037%2520on%2520cocaine%2520and%2520methamphetamine%2520self-administration%2520in%2520rhesus%2520monkeys%26jtitle%3DNeuropharmacology%26date%3D2015%26volume%3D92%26spage%3D34%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">Searle, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaver, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tziortzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comley, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghibellini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo-Pich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabiner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R. N.</span><span> </span><span class="NLM_article-title">Mathematical modelling of [<sup>11</sup>C]-(+)-PHNO human competition studies</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=119-132&author=G.+E.+Searleauthor=J.+D.+Beaverauthor=A.+Tziortziauthor=R.+A.+Comleyauthor=M.+Baniauthor=G.+Ghibelliniauthor=E.+Merlo-Pichauthor=E.+A.+Rabinerauthor=M.+Laruelleauthor=R.+N.+Gunn&title=Mathematical+modelling+of+%5B11C%5D-%28%2B%29-PHNO+human+competition+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSearle%26aufirst%3DG.%2BE.%26aulast%3DBeaver%26aufirst%3DJ.%2BD.%26aulast%3DTziortzi%26aufirst%3DA.%26aulast%3DComley%26aufirst%3DR.%2BA.%26aulast%3DBani%26aufirst%3DM.%26aulast%3DGhibellini%26aufirst%3DG.%26aulast%3DMerlo-Pich%26aufirst%3DE.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26atitle%3DMathematical%2520modelling%2520of%2520%255B11C%255D-%2528%252B%2529-PHNO%2520human%2520competition%2520studies%26jtitle%3DNeuroImage%26date%3D2013%26volume%3D68%26spage%3D119%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Matuskey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallezot, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pittman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanyiri, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaiser, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannestad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, M. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labaree, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potenza, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malison, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y. S.</span><span> </span><span class="NLM_article-title">Dopamine D(3) receptor alterations in cocaine-dependent humans imaged with [<sup>11</sup>C](+)PHNO</span> <span class="citation_source-journal">Drug Alcohol Depend.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.drugalcdep.2014.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24717909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1Onur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2014&pages=100-105&author=D.+Matuskeyauthor=J.+D.+Gallezotauthor=B.+Pittmanauthor=W.+Williamsauthor=J.+Wanyiriauthor=E.+Gaiserauthor=D.+E.+Leeauthor=J.+Hannestadauthor=K.+Limauthor=M.+Q.+Zhengauthor=S.+F.+Linauthor=D.+Labareeauthor=M.+N.+Potenzaauthor=R.+E.+Carsonauthor=R.+T.+Malisonauthor=Y.+S.+Ding&title=Dopamine+D%283%29+receptor+alterations+in+cocaine-dependent+humans+imaged+with+%5B11C%5D%28%2B%29PHNO"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D3 receptor alterations in cocaine-dependent humans imaged with [11C](+)PHNO</span></div><div class="casAuthors">Matuskey, David; Gallezot, Jean-Dominique; Pittman, Brian; Williams, Wendol; Wanyiri, Jane; Gaiser, Edward; Lee, Dianne E.; Hannestad, Jonas; Lim, Keunpoong; Zheng, Minq-Qiang; Lin, Shu-fei; Labaree, David; Potenza, Marc N.; Carson, Richard E.; Malison, Robert T.; Ding, Yu-Shin</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">100-105</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Evidence from animal models and postmortem human studies points to the importance of the dopamine D3 receptor (D3R) in cocaine dependence (CD).  The objective of this pilot study was to use the D3R-preferring radioligand [11C](+)PHNO to compare receptor availability in groups with and without CD.  Ten medically healthy, non-treatment seeking CD subjects (mean age 41 ± 8) in early abstinence were compared to 10 healthy control (HC) subjects (mean age 41 ± 6) with no history of cocaine or illicit substance abuse.  Binding potential (BPND), a measure of available receptors, was detd. with parametric images, computed using the simplified ref. tissue model (SRTM2) with the cerebellum as the ref. region.  BPND in CD subjects was higher in D3R-rich areas including the substantia nigra ((SN) 29%; P = 0.03), hypothalamus (28%; P = 0.02) and amygdala (35%; P = 0.03).  No between-group differences were obsd. in the striatum or pallidum.  BPND values in the SN (r = +0.83; P = 0.008) and pallidum (r = +0.67; P = 0.03) correlated with years of cocaine use.  Between-group differences suggest an important role for dopaminergic transmission in the SN, hypothalamus and amygdala in CD.  Such findings also highlight the potential relevance of D3R as a medication development target in CD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLL7Wj9mkgx7Vg90H21EOLACvtfcHk0lhL-ReValqLEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1Onur0%253D&md5=017147b027fee82196209cdaff86829d</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1016%2Fj.drugalcdep.2014.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drugalcdep.2014.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DMatuskey%26aufirst%3DD.%26aulast%3DGallezot%26aufirst%3DJ.%2BD.%26aulast%3DPittman%26aufirst%3DB.%26aulast%3DWilliams%26aufirst%3DW.%26aulast%3DWanyiri%26aufirst%3DJ.%26aulast%3DGaiser%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DD.%2BE.%26aulast%3DHannestad%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DK.%26aulast%3DZheng%26aufirst%3DM.%2BQ.%26aulast%3DLin%26aufirst%3DS.%2BF.%26aulast%3DLabaree%26aufirst%3DD.%26aulast%3DPotenza%26aufirst%3DM.%2BN.%26aulast%3DCarson%26aufirst%3DR.%2BE.%26aulast%3DMalison%26aufirst%3DR.%2BT.%26aulast%3DDing%26aufirst%3DY.%2BS.%26atitle%3DDopamine%2520D%25283%2529%2520receptor%2520alterations%2520in%2520cocaine-dependent%2520humans%2520imaged%2520with%2520%255B11C%255D%2528%252B%2529PHNO%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D2014%26volume%3D139%26spage%3D100%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Collins, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J. H.</span><span> </span><span class="NLM_article-title">Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">215</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2011&pages=609-620&author=G.+T.+Collinsauthor=Y.+N.+Truongauthor=B.+Levantauthor=J.+Chenauthor=S.+Wangauthor=J.+H.+Woods&title=Behavioral+sensitization+to+cocaine+in+rats%3A+evidence+for+temporal+differences+in+dopamine+D3+and+D2+receptor+sensitivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DG.%2BT.%26aulast%3DTruong%26aufirst%3DY.%2BN.%26aulast%3DLevant%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWoods%26aufirst%3DJ.%2BH.%26atitle%3DBehavioral%2520sensitization%2520to%2520cocaine%2520in%2520rats%253A%2520evidence%2520for%2520temporal%2520differences%2520in%2520dopamine%2520D3%2520and%2520D2%2520receptor%2520sensitivity%26jtitle%3DPsychopharmacology%26date%3D2011%26volume%3D215%26spage%3D609%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group">Conrad, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, M. E.</span><span> </span><span class="NLM_article-title">Dopamine receptor expression and distribution dynamically change in the rat nucleus accumbens after withdrawal from cocaine self-administration</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2010&pages=182-194&author=K.+L.+Conradauthor=K.+Fordauthor=M.+Marinelliauthor=M.+E.+Wolf&title=Dopamine+receptor+expression+and+distribution+dynamically+change+in+the+rat+nucleus+accumbens+after+withdrawal+from+cocaine+self-administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConrad%26aufirst%3DK.%2BL.%26aulast%3DFord%26aufirst%3DK.%26aulast%3DMarinelli%26aufirst%3DM.%26aulast%3DWolf%26aufirst%3DM.%2BE.%26atitle%3DDopamine%2520receptor%2520expression%2520and%2520distribution%2520dynamically%2520change%2520in%2520the%2520rat%2520nucleus%2520accumbens%2520after%2520withdrawal%2520from%2520cocaine%2520self-administration%26jtitle%3DNeuroscience%26date%3D2010%26volume%3D169%26spage%3D182%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group">Brady, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verduin, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolliver, B. K.</span><span> </span><span class="NLM_article-title">Treatment of patients comorbid for addiction and other psychiatric disorders</span> <span class="citation_source-journal">Curr. Psychiatry Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">374</span><span class="NLM_x">–</span> <span class="NLM_lpage">380</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1007%2Fs11920-007-0048-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=17915076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BD2srptlaktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=374-380&author=K.+T.+Bradyauthor=M.+L.+Verduinauthor=B.+K.+Tolliver&title=Treatment+of+patients+comorbid+for+addiction+and+other+psychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of patients comorbid for addiction and other psychiatric disorders</span></div><div class="casAuthors">Brady Kathleen T; Verduin Marcia L; Tolliver Bryan K</div><div class="citationInfo"><span class="NLM_cas:title">Current psychiatry reports</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">374-80</span>
        ISSN:<span class="NLM_cas:issn">1523-3812</span>.
    </div><div class="casAbstract">Psychiatric disorders and drug and alcohol use disorders commonly co-occur.  A growing literature has documented the epidemiology and effects on the course of illness of comorbid psychiatric and substance use disorders (SUDs).  Advances in treatment of co-occurring illnesses have progressed more slowly.  The current article reviews recent developments in the diagnosis and treatment of co-occurring psychiatric disorders and SUDs with particular focus on psychotic disorders, affective disorders, anxiety disorders, personality disorders, and attention-deficit/hyperactivity disorder.  Current treatment options and implications for future research are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOGdJ16j6YIEBuFdjgVNKSfW6udTcc2eb2Zkp17rwa7rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srptlaktA%253D%253D&md5=255a95cfc2dcd68d07426314387df70f</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1007%2Fs11920-007-0048-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11920-007-0048-0%26sid%3Dliteratum%253Aachs%26aulast%3DBrady%26aufirst%3DK.%2BT.%26aulast%3DVerduin%26aufirst%3DM.%2BL.%26aulast%3DTolliver%26aufirst%3DB.%2BK.%26atitle%3DTreatment%2520of%2520patients%2520comorbid%2520for%2520addiction%2520and%2520other%2520psychiatric%2520disorders%26jtitle%3DCurr.%2520Psychiatry%2520Rep.%26date%3D2007%26volume%3D9%26spage%3D374%26epage%3D380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">Schuckit, M. A.</span><span> </span><span class="NLM_article-title">Comorbidity between substance use disorders and psychiatric conditions</span> <span class="citation_source-journal">Addiction</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2006&pages=76-88&author=M.+A.+Schuckit&title=Comorbidity+between+substance+use+disorders+and+psychiatric+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchuckit%26aufirst%3DM.%2BA.%26atitle%3DComorbidity%2520between%2520substance%2520use%2520disorders%2520and%2520psychiatric%2520conditions%26jtitle%3DAddiction%26date%3D2006%26volume%3D101%26spage%3D76%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group">Urbanoski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenaszchuk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veldhuizen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, B.</span><span> </span><span class="NLM_article-title">The clustering of psychopathology among adults seeking treatment for alcohol and drug addiction</span> <span class="citation_source-journal">J. Subst. Abuse Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.jsat.2014.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=25124260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FhslCqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2015&pages=21-26&author=K.+Urbanoskiauthor=C.+Kenaszchukauthor=S.+Veldhuizenauthor=B.+Rush&title=The+clustering+of+psychopathology+among+adults+seeking+treatment+for+alcohol+and+drug+addiction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">The clustering of psychopathology among adults seeking treatment for alcohol and drug addiction</span></div><div class="casAuthors">Urbanoski Karen; Kenaszchuk Chris; Veldhuizen Scott; Rush Brian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of substance abuse treatment</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Beyond the high prevalence of co-occurring mental and substance use disorders, little is known about more complex patterns of psychopathology and multimorbidity, particularly in treatment populations.  We sought to identify a parsimonious set of latent classes to describe the structure of mental disorder comorbidity among adults entering outpatient addiction treatment, and explore differences in the structure and prevalence of classes across sociodemographic characteristics.  Participants (N=544) completed the Psychiatric Diagnostic Screening Questionnaire at treatment admission.  We used latent class analysis to identify classes of clients with specific patterns of co-occurring mental disorders.  The best-fitting solution identified 3 classes, characterized by no comorbidity (i.e., substance use disorders only), co-occurring major depression, and multimorbidity or a high degree of psychopathology.  Older age was associated with lower probability of being in the class with co-occurring major depression, women were more likely than men to be in the multimorbid class, and being married or partnered was associated with a lower probability of being in either of the comorbid classes.  These results are consistent with general population research on the patterning of psychiatric disorders, implying that while clients in addiction treatment may have extraordinarily high levels of psychopathology, the patterns of symptoms and the groups most affected are not markedly different than in other settings.  By capturing the complexity of interrelationships among the many factors that are known to influence prognosis and outcomes, latent class analysis offers a useful way to examine and represent case-mix in clinical populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ69rwS04o_OFQKX3ooHxWjfW6udTcc2eZs8lhIEVqBQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FhslCqtQ%253D%253D&md5=833d8cfa15751a2b3aae40940ead5144</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.jsat.2014.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsat.2014.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DUrbanoski%26aufirst%3DK.%26aulast%3DKenaszchuk%26aufirst%3DC.%26aulast%3DVeldhuizen%26aufirst%3DS.%26aulast%3DRush%26aufirst%3DB.%26atitle%3DThe%2520clustering%2520of%2520psychopathology%2520among%2520adults%2520seeking%2520treatment%2520for%2520alcohol%2520and%2520drug%2520addiction%26jtitle%3DJ.%2520Subst.%2520Abuse%2520Treat.%26date%3D2015%26volume%3D49%26spage%3D21%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group">Compton, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaslow, N. J.</span><span> </span><span class="NLM_article-title">The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems</span> <span class="citation_source-journal">Soc. Psychiatry Psychiatr. Epidemiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">939</span><span class="NLM_x">–</span> <span class="NLM_lpage">946</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1007%2Fs00127-005-0964-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=16247563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FivVensw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2005&pages=939-946&author=M.+T.+Comptonauthor=P.+S.+Weissauthor=J.+C.+Westauthor=N.+J.+Kaslow&title=The+associations+between+substance+use+disorders%2C+schizophrenia-spectrum+disorders%2C+and+Axis+IV+psychosocial+problems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems</span></div><div class="casAuthors">Compton Michael T; Weiss Paul S; West Joyce C; Kaslow Nadine J</div><div class="citationInfo"><span class="NLM_cas:title">Social psychiatry and psychiatric epidemiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">939-46</span>
        ISSN:<span class="NLM_cas:issn">0933-7954</span>.
    </div><div class="casAbstract">BACKGROUND:  Substance abuse among individuals with schizophrenia-spectrum disorders (SSDs) is associated with a range of adverse psychosocial outcomes in the areas of occupational functioning, housing stability, economic independence, access to health care, and involvement with the legal system.  The aim of this study was to estimate the effects of substance use disorders (SUDs), SSDS, and dual diagnosis with both disorders on the risk for six important Axis IV psychosocial problems.  This was accomplished using a large dataset of patients who are representative of individuals in routine US psychiatric practice.  METHOD:  Weighted data from the 1999 Study of Psychiatric Patients and Treatments from a practice-based research network of the American Psychiatric Institute for Research and Education were analyzed.  Some 615 US psychiatrists provided detailed clinical, psychosocial, and health services information on 1,843 patients, including 285 patients with one or more SUDs without an SSD, 180 patients with a diagnosis of an SSD without substance abuse comorbidity, and 68 dually diagnosed patients.  Logistic regression models were used to determine effect estimates (adjusted odds ratios), and corresponding 95% confidence intervals were calculated.  RESULTS:  After adjusting for sociodemographic variables and for SSD diagnosis, SUD diagnosis was independently associated with increased risk for five of the Axis IV psychosocial problems of interest (occupational problems, housing problems, economic problems, problems with access to health care services, and problems related to interaction with the legal system/crime) when compared to all other psychiatric patients (n=1,310).  After adjusting for the sociodemographic variables and for SUD diagnosis, SSD diagnosis (compared to all other psychiatric diagnoses) was associated with Axis IV economic problems, but not with the other five psychosocial problems of interest.  The presence of both an SUD and an SSD diagnosis (dual diagnosis) was associated with a greater risk for four of the six Axis IV psychosocial problems studied, compared to the risks associated with either diagnosis alone.  Limiting the substance of abuse to alcohol resulted in similar findings.  CONCLUSIONS:  Although SUDs are associated with increased risk for poor social adjustment, the comorbidity of SUDs and SSDs is associated with greatly compounded psychosocial burdens.  These findings, from a large sample of representative US psychiatric patients, demonstrate the ongoing need for improved services and policies for those specially burdened patients with the dual diagnosis of both an SSD and substance abuse or dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRm5th7kqzWsEQ0lWbKiCflfW6udTcc2eZs8lhIEVqBQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FivVensw%253D%253D&md5=764a38c70d8115475fbe8a287ba7d4a9</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1007%2Fs00127-005-0964-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00127-005-0964-4%26sid%3Dliteratum%253Aachs%26aulast%3DCompton%26aufirst%3DM.%2BT.%26aulast%3DWeiss%26aufirst%3DP.%2BS.%26aulast%3DWest%26aufirst%3DJ.%2BC.%26aulast%3DKaslow%26aufirst%3DN.%2BJ.%26atitle%3DThe%2520associations%2520between%2520substance%2520use%2520disorders%252C%2520schizophrenia-spectrum%2520disorders%252C%2520and%2520Axis%2520IV%2520psychosocial%2520problems%26jtitle%3DSoc.%2520Psychiatry%2520Psychiatr.%2520Epidemiol.%26date%3D2005%26volume%3D40%26spage%3D939%26epage%3D946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span> </span><span class="NLM_article-title">Dopamine D1 and D3 receptors mediate reconsolidation of cocaine memories in mouse models of drug self-administration</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2014&pages=154-164&author=Y.+Yanauthor=A.+H.+Newmanauthor=M.+Xu&title=Dopamine+D1+and+D3+receptors+mediate+reconsolidation+of+cocaine+memories+in+mouse+models+of+drug+self-administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DY.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DXu%26aufirst%3DM.%26atitle%3DDopamine%2520D1%2520and%2520D3%2520receptors%2520mediate%2520reconsolidation%2520of%2520cocaine%2520memories%2520in%2520mouse%2520models%2520of%2520drug%2520self-administration%26jtitle%3DNeuroscience%26date%3D2014%26volume%3D278%26spage%3D154%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group">Savitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgkinson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Soelch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szczepanik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nugent, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herscovitch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drevets, W. C.</span><span> </span><span class="NLM_article-title">The functional DRD3 Ser9Gly polymorphism (rs6280) is pleiotropic, affecting reward as well as movement</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e54108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e54108&author=J.+Savitzauthor=C.+A.+Hodgkinsonauthor=C.+Martin-Soelchauthor=P.+H.+Shenauthor=J.+Szczepanikauthor=A.+Nugentauthor=P.+Herscovitchauthor=A.+A.+Graceauthor=D.+Goldmanauthor=W.+C.+Drevets&title=The+functional+DRD3+Ser9Gly+polymorphism+%28rs6280%29+is+pleiotropic%2C+affecting+reward+as+well+as+movement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSavitz%26aufirst%3DJ.%26aulast%3DHodgkinson%26aufirst%3DC.%2BA.%26aulast%3DMartin-Soelch%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DP.%2BH.%26aulast%3DSzczepanik%26aufirst%3DJ.%26aulast%3DNugent%26aufirst%3DA.%26aulast%3DHerscovitch%26aufirst%3DP.%26aulast%3DGrace%26aufirst%3DA.%2BA.%26aulast%3DGoldman%26aufirst%3DD.%26aulast%3DDrevets%26aufirst%3DW.%2BC.%26atitle%3DThe%2520functional%2520DRD3%2520Ser9Gly%2520polymorphism%2520%2528rs6280%2529%2520is%2520pleiotropic%252C%2520affecting%2520reward%2520as%2520well%2520as%2520movement%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De54108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M. D.</span><span> </span><span class="NLM_article-title">A functional polymorphism, rs6280, in DRD3 is significantly associated with nicotine dependence in European-American smokers</span> <span class="citation_source-journal">Am. J. Med. Genet., Part B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">1109</span><span class="NLM_x">–</span> <span class="NLM_lpage">1115</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1002%2Fajmg.b.30731" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht12ru7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2008&pages=1109-1115&author=W.+Huangauthor=T.+J.+Payneauthor=J.+Z.+Maauthor=M.+D.+Li&title=A+functional+polymorphism%2C+rs6280%2C+in+DRD3+is+significantly+associated+with+nicotine+dependence+in+European-American+smokers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">A functional polymorphism, rs6280, in DRD3 is significantly associated with nicotine dependence in European-American smokers</span></div><div class="casAuthors">Huang, Weihua; Payne, Thomas J.; Ma, Jennie Z.; Li, Ming D.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">147B</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1109-1115</span>CODEN:
                <span class="NLM_cas:coden">AJMGC9</span>;
        ISSN:<span class="NLM_cas:issn">1552-4841</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Nicotine enhances reward functions in the mesocorticolimbic dopamine system in general and the nucleus accumbens in particular.  The genes encoding dopamine receptors are thus plausible candidates for involvement in nicotine dependence (ND).  We investigated 13 single nucleotide polymorphisms (SNPs) spanning a region of the dopamine D3 receptor gene (DRD3) to det. whether DRD3 is assocd. with ND.  We studied a set of 2,037 subjects in 602 nuclear families representing two distinct American populations using three ND measures, namely, smoking quantity (SQ), the Heaviness of Smoking Index (HSI), and the Fagerstrom Test for ND (FTND).  In the family based assocn. study, we found that SNP rs6280 showed a strong assocn. with ND in European-Americans (EAs) and the pooled sample, whereas SNPs rs1486012 and rs963468 had weak assocns. with ND in African-Americans (AAs) and the pooled sample.  Further haplotype anal. with all contiguous 3-SNP groups revealed relatively weak evidence for assocn. of DRD3 with ND in the EA and pooled samples.  The results indicate that DRD3 is significantly assocd. with ND in EAs, and that rs6280, a functional polymorphism causing an amino acid change of serine to glycine (Ser9Gly) in the N-terminal extracellular domain of the D3 receptor, likely is causative of the assocn. between DRD3 and ND.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQBxlbD4Lev7Vg90H21EOLACvtfcHk0liYvP6SffTg5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht12ru7rE&md5=7684e31a70946a544f14a575da99df63</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1002%2Fajmg.b.30731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fajmg.b.30731%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DPayne%26aufirst%3DT.%2BJ.%26aulast%3DMa%26aufirst%3DJ.%2BZ.%26aulast%3DLi%26aufirst%3DM.%2BD.%26atitle%3DA%2520functional%2520polymorphism%252C%2520rs6280%252C%2520in%2520DRD3%2520is%2520significantly%2520associated%2520with%2520nicotine%2520dependence%2520in%2520European-American%2520smokers%26jtitle%3DAm.%2520J.%2520Med.%2520Genet.%252C%2520Part%2520B%26date%3D2008%26volume%3D147%26spage%3D1109%26epage%3D1115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group">Kang, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, H. E.</span><span> </span><span class="NLM_article-title">DRD3 Gene rs6280 polymorphism may be associated with alcohol dependence overall and with Lesch type I alcohol dependence in Koreans</span> <span class="citation_source-journal">Neuropsychobiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=140-146&author=S.+G.+Kangauthor=B.+H.+Leeauthor=J.+S.+Leeauthor=Y.+G.+Chaiauthor=K.+P.+Koauthor=H.+J.+Leeauthor=D.+M.+Hanauthor=H.+Jiauthor=G.+H.+Jangauthor=H.+E.+Shin&title=DRD3+Gene+rs6280+polymorphism+may+be+associated+with+alcohol+dependence+overall+and+with+Lesch+type+I+alcohol+dependence+in+Koreans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DS.%2BG.%26aulast%3DLee%26aufirst%3DB.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DChai%26aufirst%3DY.%2BG.%26aulast%3DKo%26aufirst%3DK.%2BP.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DHan%26aufirst%3DD.%2BM.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DJang%26aufirst%3DG.%2BH.%26aulast%3DShin%26aufirst%3DH.%2BE.%26atitle%3DDRD3%2520Gene%2520rs6280%2520polymorphism%2520may%2520be%2520associated%2520with%2520alcohol%2520dependence%2520overall%2520and%2520with%2520Lesch%2520type%2520I%2520alcohol%2520dependence%2520in%2520Koreans%26jtitle%3DNeuropsychobiology%26date%3D2014%26volume%3D69%26spage%3D140%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. Y.</span><span> </span><span class="NLM_article-title">DRD3 variation associates with early-onset heroin dependence, but not specific personality traits</span> <span class="citation_source-journal">Prog. Neuropsychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.pnpbp.2013.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24398431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BC2czivF2gsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2014&pages=1-8&author=S.+C.+Kuoauthor=Y.+W.+Yehauthor=C.+Y.+Chenauthor=C.+C.+Huangauthor=H.+A.+Changauthor=C.+H.+Yenauthor=P.+S.+Hoauthor=C.+S.+Liangauthor=H.+W.+Chouauthor=R.+B.+Luauthor=S.+Y.+Huang&title=DRD3+variation+associates+with+early-onset+heroin+dependence%2C+but+not+specific+personality+traits"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">DRD3 variation associates with early-onset heroin dependence, but not specific personality traits</span></div><div class="casAuthors">Kuo Shin-Chang; Yeh Yi-Wei; Chen Chun-Yen; Huang Chang-Chih; Chang Hsin-An; Yen Che-Hung; Ho Pei-Shen; Chou Han-Wei; Liang Chih-Sung; Lu Ru-Band; Huang San-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">Progress in neuro-psychopharmacology & biological psychiatry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dopamine D3 receptor-mediated pathways are involved in the mechanism of addiction, and genetic factors play a role in the vulnerability to heroin dependence.  The aim of this study was to examine whether the corresponding gene, DRD3, is associated with the development of heroin dependence and specific personality traits in HD patients.  Eight polymorphisms in DRD3 were analyzed in 1067 unrelated Han Chinese subjects (566 heroin dependence patients and 501 controls).  All participants were screened using the same assessment tool and all patients met the criteria for heroin dependence.  A Tridimensional Personality Questionnaire was used to assess personality traits in 276 heroin dependence patients.  In addition, heroin dependence patients were divided into 4 clinical subgroups based on age-of-onset and family history of substance abuse, to reduce the clinical heterogeneity.  The rs6280 and rs9825563 variants showed association with the development of early-onset heroin dependence.  The GTA haplotype frequency in the block (rs324029, rs6280, rs9825563) was significantly associated with early-onset heroin dependence (p=0.003).  However, these significant associations were weaker after Bonferroni's correction.  In addition, these DRD3 polymorphisms did not influence novelty seeking and harm avoidance scores in HD patients.  DRD3 is possibly a genetic factor in the development of early-onset heroin dependence, but is not associated with specific personality traits in these patients among the Han Chinese population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_J0wMANoO-N1QT_1O5WBYfW6udTcc2eYfdtWrCzMiOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czivF2gsQ%253D%253D&md5=8308255d9f5b17e7dea50e21f26f9351</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2013.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2013.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DYeh%26aufirst%3DY.%2BW.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DChang%26aufirst%3DH.%2BA.%26aulast%3DYen%26aufirst%3DC.%2BH.%26aulast%3DHo%26aufirst%3DP.%2BS.%26aulast%3DLiang%26aufirst%3DC.%2BS.%26aulast%3DChou%26aufirst%3DH.%2BW.%26aulast%3DLu%26aufirst%3DR.%2BB.%26aulast%3DHuang%26aufirst%3DS.%2BY.%26atitle%3DDRD3%2520variation%2520associates%2520with%2520early-onset%2520heroin%2520dependence%252C%2520but%2520not%2520specific%2520personality%2520traits%26jtitle%3DProg.%2520Neuropsychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2014%26volume%3D51%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 66 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Hamed S. Hayatshahi, Robert R. Luedtke, Michelle Taylor, Peng-Jen Chen, Benjamin E. Blass, <span class="NLM_string-name hlFld-ContribAuthor">Jin Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Factors Governing Selectivity of Dopamine Receptor Binding Compounds for D2R and D3R Subtypes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2021,</strong> <em>61 </em>
                                    (6)
                                     , 2829-2843. <a href="https://doi.org/10.1021/acs.jcim.1c00036" title="DOI URL">https://doi.org/10.1021/acs.jcim.1c00036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.1c00036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.1c00036%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DFactors%252BGoverning%252BSelectivity%252Bof%252BDopamine%252BReceptor%252BBinding%252BCompounds%252Bfor%252BD2R%252Band%252BD3R%252BSubtypes%26aulast%3DHayatshahi%26aufirst%3DHamed%2BS.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D12012021%26date%3D14052021%26volume%3D61%26issue%3D6%26spage%3D2829%26epage%3D2843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alessandro Bonifazi, Francisco O. Battiti, Julie Sanchez, Saheem A. Zaidi, Eric Bow, Mariia Makarova, Jianjing Cao, Anver Basha Shaik, Agnieszka Sulima, Kenner C. Rice, Vsevolod Katritch, Meritxell Canals, J. Robert Lane, <span class="NLM_string-name hlFld-ContribAuthor">Amy Hauck Newman</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Dual-Target μ-Opioid Receptor and Dopamine D3 Receptor Ligands as Potential Nonaddictive Pharmacotherapeutics for Pain Management. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7778-7808. <a href="https://doi.org/10.1021/acs.jmedchem.1c00611" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00611</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00611%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BDual-Target%252B%2525CE%2525BC-Opioid%252BReceptor%252Band%252BDopamine%252BD3%252BReceptor%252BLigands%252Bas%252BPotential%252BNonaddictive%252BPharmacotherapeutics%252Bfor%252BPain%252BManagement%26aulast%3DBonifazi%26aufirst%3DAlessandro%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D02042021%26date%3D20052021%26volume%3D64%26issue%3D11%26spage%3D7778%26epage%3D7808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Francisco O. Battiti, Amy Hauck Newman, <span class="NLM_string-name hlFld-ContribAuthor">Alessandro Bonifazi</span>. </span><span class="cited-content_cbyCitation_article-title">Exception That Proves the Rule: Investigation of Privileged Stereochemistry in Designing Dopamine D3R Bitopic Agonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (10)
                                     , 1956-1964. <a href="https://doi.org/10.1021/acsmedchemlett.9b00660" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00660</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00660%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DException%252BThat%252BProves%252Bthe%252BRule%25253A%252BInvestigation%252Bof%252BPrivileged%252BStereochemistry%252Bin%252BDesigning%252BDopamine%252BD3R%252BBitopic%252BAgonists%26aulast%3DBattiti%26aufirst%3DFrancisco%2BO.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D30122019%26date%3D28022020%26date%3D03032020%26date%3D28022020%26volume%3D11%26issue%3D10%26spage%3D1956%26epage%3D1964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Liang Tan, Qingtong Zhou, Wenzhong Yan, Jian Sun, Alan P. Kozikowski, Suwen Zhao, Xi-Ping Huang, <span class="NLM_string-name hlFld-ContribAuthor">Jianjun Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Bitopic 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as Selective Dopamine D3 Receptor Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (9)
                                     , 4579-4602. <a href="https://doi.org/10.1021/acs.jmedchem.9b01835" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01835</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01835%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BBitopic%252B2-Phenylcyclopropylmethylamine%252B%252528PCPMA%252529%252BDerivatives%252Bas%252BSelective%252BDopamine%252BD3%252BReceptor%252BLigands%26aulast%3DTan%26aufirst%3DLiang%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D18112019%26date%3D23042020%26date%3D13042020%26volume%3D63%26issue%3D9%26spage%3D4579%26epage%3D4602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Amy Hauck Newman, Francisco O. Battiti, <span class="NLM_string-name hlFld-ContribAuthor">Alessandro Bonifazi</span>. </span><span class="cited-content_cbyCitation_article-title">2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 1779-1797. <a href="https://doi.org/10.1021/acs.jmedchem.9b01105" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01105</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01105%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2016%252BPhilip%252BS.%252BPortoghese%252BMedicinal%252BChemistry%252BLectureship%25253A%252BDesigning%252BBivalent%252Bor%252BBitopic%252BMolecules%252Bfor%252BG-Protein%252BCoupled%252BReceptors.%252BThe%252BWhole%252BIs%252BGreater%252BThan%252Bthe%252BSum%252Bof%252BIts%252BParts%26aulast%3DNewman%26aufirst%3DAmy%2BHauck%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D09072019%26date%3D24092019%26date%3D09092019%26volume%3D63%26issue%3D5%26spage%3D1779%26epage%3D1797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Anver
Basha Shaik, Vivek Kumar, Alessandro Bonifazi, Adrian M. Guerrero, Sophie L. Cemaj, Alexandra Gadiano, Jenny Lam, Zheng-Xiong Xi, Rana Rais, Barbara S. Slusher, <span class="NLM_string-name hlFld-ContribAuthor">Amy Hauck Newman</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of Novel Primary and Secondary Pharmacophores and 3-Substitution in the Linking Chain of a Series of Highly Selective and Bitopic Dopamine D3 Receptor Antagonists and Partial Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (20)
                                     , 9061-9077. <a href="https://doi.org/10.1021/acs.jmedchem.9b00607" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00607</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00607%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInvestigation%252Bof%252BNovel%252BPrimary%252Band%252BSecondary%252BPharmacophores%252Band%252B3-Substitution%252Bin%252Bthe%252BLinking%252BChain%252Bof%252Ba%252BSeries%252Bof%252BHighly%252BSelective%252Band%252BBitopic%252BDopamine%252BD3%252BReceptor%252BAntagonists%252Band%252BPartial%252BAgonists%26aulast%3DShaik%26aufirst%3DAnver%2BBasha%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D08042019%26date%3D15102019%26date%3D17092019%26volume%3D62%26issue%3D20%26spage%3D9061%26epage%3D9077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Francisco
O. Battiti, Sophie L. Cemaj, Adrian M. Guerrero, Anver Basha Shaik, Jenny Lam, Rana Rais, Barbara S. Slusher, Jeffery R. Deschamps, Greg H. Imler, Amy Hauck Newman, <span class="NLM_string-name hlFld-ContribAuthor">Alessandro Bonifazi</span>. </span><span class="cited-content_cbyCitation_article-title">The Significance of Chirality in Drug Design and Synthesis of Bitopic Ligands as D3 Receptor (D3R) Selective Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (13)
                                     , 6287-6314. <a href="https://doi.org/10.1021/acs.jmedchem.9b00702" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00702</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00702%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BSignificance%252Bof%252BChirality%252Bin%252BDrug%252BDesign%252Band%252BSynthesis%252Bof%252BBitopic%252BLigands%252Bas%252BD3%252BReceptor%252B%252528D3R%252529%252BSelective%252BAgonists%26aulast%3DBattiti%26aufirst%3DFrancisco%2BO.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D29042019%26date%3D01072019%26date%3D19062019%26volume%3D62%26issue%3D13%26spage%3D6287%26epage%3D6314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sean W. Reilly, Aladdin A. Riad, Chia-Ju Hsieh, Kristoffer Sahlholm, Daniel A. Jacome, Suzy Griffin, Michelle Taylor, Chi-Chang Weng, Kuiying Xu, Nathan Kirschner, Robert R. Luedtke, Christopher Parry, Shipra Malhotra, John Karanicolas, <span class="NLM_string-name hlFld-ContribAuthor">Robert H. Mach</span>. </span><span class="cited-content_cbyCitation_article-title">Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D3 Receptor (D3R) Ligand Promiscuity across Highly Conserved Aminergic G-Protein-Coupled Receptors (GPCRs). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (10)
                                     , 5132-5147. <a href="https://doi.org/10.1021/acs.jmedchem.9b00412" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00412</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00412%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLeveraging%252Ba%252BLow-Affinity%252BDiazaspiro%252BOrthosteric%252BFragment%252Bto%252BReduce%252BDopamine%252BD3%252BReceptor%252B%252528D3R%252529%252BLigand%252BPromiscuity%252Bacross%252BHighly%252BConserved%252BAminergic%252BG-Protein-Coupled%252BReceptors%252B%252528GPCRs%252529%26aulast%3DReilly%26aufirst%3DSean%2BW.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D12032019%26date%3D06052019%26date%3D25042019%26volume%3D62%26issue%3D10%26spage%3D5132%26epage%3D5147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Satishkumar Gadhiya, Pierpaolo Cordone, Rajat K. Pal, Emilio Gallicchio, Lauren Wickstrom, Tom Kurtzman, Steven Ramsey, <span class="NLM_string-name hlFld-ContribAuthor">Wayne W. Harding</span>. </span><span class="cited-content_cbyCitation_article-title">New Dopamine D3-Selective Receptor Ligands Containing a 6-Methoxy-1,2,3,4-tetrahydroisoquinolin-7-ol Motif. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (10)
                                     , 990-995. <a href="https://doi.org/10.1021/acsmedchemlett.8b00229" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00229%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNew%252BDopamine%252BD3-Selective%252BReceptor%252BLigands%252BContaining%252Ba%252B6-Methoxy-1%25252C2%25252C3%25252C4-tetrahydroisoquinolin-7-ol%252BMotif%26aulast%3DGadhiya%26aufirst%3DSatishkumar%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D17052018%26date%3D10092018%26date%3D11092018%26date%3D10092018%26volume%3D9%26issue%3D10%26spage%3D990%26epage%3D995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sean W.  Reilly</span>, <span class="hlFld-ContribAuthor ">Suzy  Griffin</span>, <span class="hlFld-ContribAuthor ">Michelle  Taylor</span>, <span class="hlFld-ContribAuthor ">Kristoffer  Sahlholm</span>, <span class="hlFld-ContribAuthor ">Chi-Chang  Weng</span>, <span class="hlFld-ContribAuthor ">Kuiying  Xu</span>, <span class="hlFld-ContribAuthor ">Daniel A.  Jacome</span>, <span class="hlFld-ContribAuthor ">Robert R.  Luedtke</span>, and <span class="hlFld-ContribAuthor ">Robert H.  Mach</span>  . </span><span class="cited-content_cbyCitation_article-title">Highly Selective Dopamine D3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (23)
                                     , 9905-9910. <a href="https://doi.org/10.1021/acs.jmedchem.7b01248" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01248</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01248%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHighly%252BSelective%252BDopamine%252BD3%252BReceptor%252BAntagonists%252Bwith%252BArylated%252BDiazaspiro%252BAlkane%252BCores%26aulast%3DReilly%26aufirst%3DSean%2BW.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23082017%26date%3D21112017%26date%3D14122017%26date%3D10112017%26volume%3D60%26issue%3D23%26spage%3D9905%26epage%3D9910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">Hideaki  Yano</span>, <span class="hlFld-ContribAuthor ">Michael P.  Ellenberger</span>, <span class="hlFld-ContribAuthor ">Ludovic  Muller</span>, <span class="hlFld-ContribAuthor ">Vivek  Kumar</span>, <span class="hlFld-ContribAuthor ">Mu-Fa  Zou</span>, <span class="hlFld-ContribAuthor ">Ning Sheng  Cai</span>, <span class="hlFld-ContribAuthor ">Adrian M.  Guerrero</span>, <span class="hlFld-ContribAuthor ">Amina S.  Woods</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>, and <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D2 Receptor (D2R) Biased Agonism. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (7)
                                     , 2890-2907. <a href="https://doi.org/10.1021/acs.jmedchem.6b01875" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01875%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BBivalent%252BLigands%252BBased%252Bon%252Bthe%252BSumanirole%252BPharmacophore%252BReveal%252BDopamine%252BD2%252BReceptor%252B%252528D2R%252529%252BBiased%252BAgonism%26aulast%3DBonifazi%26aufirst%3DAlessandro%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D20122016%26date%3D16032017%26date%3D13042017%26volume%3D60%26issue%3D7%26spage%3D2890%26epage%3D2907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessio  De Simone</span>, <span class="hlFld-ContribAuthor ">Debora  Russo</span>, <span class="hlFld-ContribAuthor ">Gian Filippo  Ruda</span>, <span class="hlFld-ContribAuthor ">Alessandra  Micoli</span>, <span class="hlFld-ContribAuthor ">Mariarosaria  Ferraro</span>, <span class="hlFld-ContribAuthor ">Rita Maria Concetta  Di Martino</span>, <span class="hlFld-ContribAuthor ">Giuliana  Ottonello</span>, <span class="hlFld-ContribAuthor ">Maria  Summa</span>, <span class="hlFld-ContribAuthor ">Andrea  Armirotti</span>, <span class="hlFld-ContribAuthor ">Tiziano  Bandiera</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>, and <span class="hlFld-ContribAuthor ">Giovanni  Bottegoni</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, Structure–Activity Relationship Studies, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) Modeling of a Series of O-Biphenyl Carbamates as Dual Modulators of Dopamine D3 Receptor and Fatty Acid Amide Hydrolase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (6)
                                     , 2287-2304. <a href="https://doi.org/10.1021/acs.jmedchem.6b01578" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01578</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01578%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252BStructure%2525E2%252580%252593Activity%252BRelationship%252BStudies%25252C%252Band%252BThree-Dimensional%252BQuantitative%252BStructure%2525E2%252580%252593Activity%252BRelationship%252B%2525283D-QSAR%252529%252BModeling%252Bof%252Ba%252BSeries%252Bof%252BO-Biphenyl%252BCarbamates%252Bas%252BDual%252BModulators%252Bof%252BDopamine%252BD3%252BReceptor%252Band%252BFatty%252BAcid%252BAmide%252BHydrolase%26aulast%3DDe%2BSimone%26aufirst%3DAlessio%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D24102016%26date%3D02032017%26date%3D23032017%26date%3D09022017%26volume%3D60%26issue%3D6%26spage%3D2287%26epage%3D2304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaozhao  Wang</span>, <span class="hlFld-ContribAuthor ">Aaron M.  Tocker</span>, <span class="hlFld-ContribAuthor ">Peng  Huang</span>, <span class="hlFld-ContribAuthor ">Maarten E. A.  Reith</span>, <span class="hlFld-ContribAuthor ">Lee-Yuan  Liu-Chen</span>, <span class="hlFld-ContribAuthor ">Amos B.  Smith, III</span>, and <span class="hlFld-ContribAuthor ">Sandhya  Kortagere</span>  . </span><span class="cited-content_cbyCitation_article-title">Functional Characterization of a Novel Series of Biased Signaling Dopamine D3 Receptor Agonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (3)
                                     , 486-500. <a href="https://doi.org/10.1021/acschemneuro.6b00221" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00221</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00221%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DFunctional%252BCharacterization%252Bof%252Ba%252BNovel%252BSeries%252Bof%252BBiased%252BSignaling%252BDopamine%252BD3%252BReceptor%252BAgonists%26aulast%3DXu%26aufirst%3DWei%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D29072016%26date%3D01112016%26date%3D23112016%26date%3D15032017%26date%3D01112016%26volume%3D8%26issue%3D3%26spage%3D486%26epage%3D500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vivek  Kumar</span>, <span class="hlFld-ContribAuthor ">Amy E.  Moritz</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Keck</span>, <span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">Michael P.  Ellenberger</span>, <span class="hlFld-ContribAuthor ">Christopher D.  Sibley</span>, <span class="hlFld-ContribAuthor ">R. Benjamin  Free</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>, <span class="hlFld-ContribAuthor ">J. Robert  Lane</span>, <span class="hlFld-ContribAuthor ">David R.  Sibley</span>, and <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D3 Receptor (D3R). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (4)
                                     , 1478-1494. <a href="https://doi.org/10.1021/acs.jmedchem.6b01688" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01688</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01688%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BPharmacological%252BCharacterization%252Bof%252BNovel%252Btrans-Cyclopropylmethyl-Linked%252BBivalent%252BLigands%252BThat%252BExhibit%252BSelectivity%252Band%252BAllosteric%252BPharmacology%252Bat%252Bthe%252BDopamine%252BD3%252BReceptor%252B%252528D3R%252529%26aulast%3DKumar%26aufirst%3DVivek%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D16112016%26date%3D10022017%26date%3D23022017%26volume%3D60%26issue%3D4%26spage%3D1478%26epage%3D1494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mayako  Michino</span>, <span class="hlFld-ContribAuthor ">Comfort A.  Boateng</span>, <span class="hlFld-ContribAuthor ">Prashant  Donthamsetti</span>, <span class="hlFld-ContribAuthor ">Hideaki  Yano</span>, <span class="hlFld-ContribAuthor ">Oluyomi M.  Bakare</span>, <span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">Michael P.  Ellenberger</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Keck</span>, <span class="hlFld-ContribAuthor ">Vivek  Kumar</span>, <span class="hlFld-ContribAuthor ">Clare  Zhu</span>, <span class="hlFld-ContribAuthor ">Ravi  Verma</span>, <span class="hlFld-ContribAuthor ">Jeffrey R.  Deschamps</span>, <span class="hlFld-ContribAuthor ">Jonathan A.  Javitch</span>, <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>, and <span class="hlFld-ContribAuthor ">Lei  Shi</span>  . </span><span class="cited-content_cbyCitation_article-title">Toward Understanding the Structural Basis of Partial Agonism at the Dopamine D3 Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (2)
                                     , 580-593. <a href="https://doi.org/10.1021/acs.jmedchem.6b01148" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01148%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DToward%252BUnderstanding%252Bthe%252BStructural%252BBasis%252Bof%252BPartial%252BAgonism%252Bat%252Bthe%252BDopamine%252BD3%252BReceptor%26aulast%3DMichino%26aufirst%3DMayako%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D05082016%26date%3D05012017%26date%3D26012017%26date%3D16122016%26volume%3D60%26issue%3D2%26spage%3D580%26epage%3D593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Travis T.  Wager</span>, <span class="hlFld-ContribAuthor ">Thomas  Chappie</span>, <span class="hlFld-ContribAuthor ">David  Horton</span>, <span class="hlFld-ContribAuthor ">Ramalakshmi Y.  Chandrasekaran</span>, <span class="hlFld-ContribAuthor ">Brian  Samas</span>, <span class="hlFld-ContribAuthor ">Elizabeth R.  Dunn-Sims</span>, <span class="hlFld-ContribAuthor ">Cathleen  Hsu</span>, <span class="hlFld-ContribAuthor ">Nawshaba  Nawreen</span>, <span class="hlFld-ContribAuthor ">Michelle A.  Vanase-Frawley</span>, <span class="hlFld-ContribAuthor ">Rebecca E.  O’Connor</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Keith  Dlugolenski</span>, <span class="hlFld-ContribAuthor ">Nancy C.  Stratman</span>, <span class="hlFld-ContribAuthor ">Mark J.  Majchrzak</span>, <span class="hlFld-ContribAuthor ">Bethany L.  Kormos</span>, <span class="hlFld-ContribAuthor ">David P.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Aarti  Sawant-Basak</span>, and <span class="hlFld-ContribAuthor ">Andy N.  Mead</span>  . </span><span class="cited-content_cbyCitation_article-title">Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side Effects. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (1)
                                     , 165-177. <a href="https://doi.org/10.1021/acschemneuro.6b00297" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00297</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00297%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDopamine%252BD3%25252FD2%252BReceptor%252BAntagonist%252BPF-4363467%252BAttenuates%252BOpioid%252BDrug-Seeking%252BBehavior%252Bwithout%252BConcomitant%252BD2%252BSide%252BEffects%26aulast%3DWager%26aufirst%3DTravis%2BT.%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D08092016%26date%3D07102016%26date%3D21102016%26date%3D18012017%26date%3D07102016%26volume%3D8%26issue%3D1%26spage%3D165%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianjing  Cao</span>, <span class="hlFld-ContribAuthor ">Rachel D.  Slack</span>, <span class="hlFld-ContribAuthor ">Oluyomi M.  Bakare</span>, <span class="hlFld-ContribAuthor ">Caitlin  Burzynski</span>, <span class="hlFld-ContribAuthor ">Rana  Rais</span>, <span class="hlFld-ContribAuthor ">Barbara S.  Slusher</span>, <span class="hlFld-ContribAuthor ">Theresa  Kopajtic</span>, <span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">Michael P.  Ellenberger</span>, <span class="hlFld-ContribAuthor ">Hideaki  Yano</span>, <span class="hlFld-ContribAuthor ">Yi  He</span>, <span class="hlFld-ContribAuthor ">Guo-Hua  Bi</span>, <span class="hlFld-ContribAuthor ">Zheng-Xiong  Xi</span>, <span class="hlFld-ContribAuthor ">Claus J.  Loland</span>, and <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (23)
                                     , 10676-10691. <a href="https://doi.org/10.1021/acs.jmedchem.6b01373" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01373</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01373%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Band%252BHigh%252BAffinity%252B2-%25255B%252528Diphenylmethyl%252529sulfinyl%25255Dacetamide%252B%252528Modafinil%252529%252BAnalogues%252Bas%252BAtypical%252BDopamine%252BTransporter%252BInhibitors%26aulast%3DCao%26aufirst%3DJianjing%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D19092016%26date%3D28112016%26date%3D08122016%26volume%3D59%26issue%3D23%26spage%3D10676%26epage%3D10691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrizio  Micheli</span>, <span class="hlFld-ContribAuthor ">Alessia  Bacchi</span>, <span class="hlFld-ContribAuthor ">Simone  Braggio</span>, <span class="hlFld-ContribAuthor ">Laura  Castelletti</span>, <span class="hlFld-ContribAuthor ">Palmina  Cavallini</span>, <span class="hlFld-ContribAuthor ">Paolo  Cavanni</span>, <span class="hlFld-ContribAuthor ">Susanna  Cremonesi</span>, <span class="hlFld-ContribAuthor ">Michele  Dal Cin</span>, <span class="hlFld-ContribAuthor ">Aldo  Feriani</span>, <span class="hlFld-ContribAuthor ">Sylvie  Gehanne</span>, <span class="hlFld-ContribAuthor ">Mahmud  Kajbaf</span>, <span class="hlFld-ContribAuthor ">Luciano  Marchió</span>, <span class="hlFld-ContribAuthor ">Selena  Nola</span>, <span class="hlFld-ContribAuthor ">Beatrice  Oliosi</span>, <span class="hlFld-ContribAuthor ">Annalisa  Pellacani</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Perdonà</span>, <span class="hlFld-ContribAuthor ">Anna  Sava</span>, <span class="hlFld-ContribAuthor ">Teresa  Semeraro</span>, <span class="hlFld-ContribAuthor ">Luca  Tarsi</span>, <span class="hlFld-ContribAuthor ">Silvia  Tomelleri</span>, <span class="hlFld-ContribAuthor ">Andrea  Wong</span>, <span class="hlFld-ContribAuthor ">Filippo  Visentini</span>, <span class="hlFld-ContribAuthor ">Laura  Zonzini</span>, and <span class="hlFld-ContribAuthor ">Christian  Heidbreder</span>  . </span><span class="cited-content_cbyCitation_article-title">1,2,4-Triazolyl 5-Azaspiro[2.4]heptanes: Lead Identification and Early Lead Optimization of a New Series of Potent and Selective Dopamine D3 Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (18)
                                     , 8549-8576. <a href="https://doi.org/10.1021/acs.jmedchem.6b00972" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00972</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00972%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1%25252C2%25252C4-Triazolyl%252B5-Azaspiro%25255B2.4%25255Dheptanes%25253A%252BLead%252BIdentification%252Band%252BEarly%252BLead%252BOptimization%252Bof%252Ba%252BNew%252BSeries%252Bof%252BPotent%252Band%252BSelective%252BDopamine%252BD3%252BReceptor%252BAntagonists%26aulast%3DMicheli%26aufirst%3DFabrizio%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D08072016%26date%3D09092016%26date%3D22092016%26date%3D26082016%26volume%3D59%26issue%3D18%26spage%3D8549%26epage%3D8576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vivek  Kumar</span>, <span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">Michael P.  Ellenberger</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Keck</span>, <span class="hlFld-ContribAuthor ">Elie  Pommier</span>, <span class="hlFld-ContribAuthor ">Rana  Rais</span>, <span class="hlFld-ContribAuthor ">Barbara S.  Slusher</span>, <span class="hlFld-ContribAuthor ">Eliot  Gardner</span>, <span class="hlFld-ContribAuthor ">Zhi-Bing  You</span>, <span class="hlFld-ContribAuthor ">Zheng-Xiong  Xi</span>, and <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>  . </span><span class="cited-content_cbyCitation_article-title">Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (16)
                                     , 7634-7650. <a href="https://doi.org/10.1021/acs.jmedchem.6b00860" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00860</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00860%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHighly%252BSelective%252BDopamine%252BD3%252BReceptor%252B%252528D3R%252529%252BAntagonists%252Band%252BPartial%252BAgonists%252BBased%252Bon%252BEticlopride%252Band%252Bthe%252BD3R%252BCrystal%252BStructure%25253A%252BNew%252BLeads%252Bfor%252BOpioid%252BDependence%252BTreatment%26aulast%3DKumar%26aufirst%3DVivek%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D07062016%26date%3D10082016%26date%3D25082016%26volume%3D59%26issue%3D16%26spage%3D7634%26epage%3D7650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mu-Fa  Zou</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Keck</span>, <span class="hlFld-ContribAuthor ">Vivek  Kumar</span>, <span class="hlFld-ContribAuthor ">Prashant  Donthamsetti</span>, <span class="hlFld-ContribAuthor ">Mayako  Michino</span>, <span class="hlFld-ContribAuthor ">Caitlin  Burzynski</span>, <span class="hlFld-ContribAuthor ">Catherine  Schweppe</span>, <span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">R. Benjamin  Free</span>, <span class="hlFld-ContribAuthor ">David R.  Sibley</span>, <span class="hlFld-ContribAuthor ">Aaron  Janowsky</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>, <span class="hlFld-ContribAuthor ">Jonathan A.  Javitch</span>, and <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Analogues of (R)-5-(Methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Sumanirole) Provide Clues to Dopamine D2/D3 Receptor Agonist Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (7)
                                     , 2973-2988. <a href="https://doi.org/10.1021/acs.jmedchem.5b01612" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01612</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01612%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BAnalogues%252Bof%252B%252528R%252529-5-%252528Methylamino%252529-5%25252C6-dihydro-4H-imidazo%25255B4%25252C5%25252C1-ij%25255Dquinolin-2%2525281H%252529-one%252B%252528Sumanirole%252529%252BProvide%252BClues%252Bto%252BDopamine%252BD2%25252FD3%252BReceptor%252BAgonist%252BSelectivity%26aulast%3DZou%26aufirst%3DMu-Fa%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D14102015%26date%3D01042016%26date%3D14042016%26volume%3D59%26issue%3D7%26spage%3D2973%26epage%3D2988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Comfort A.  Boateng</span>, <span class="hlFld-ContribAuthor ">Oluyomi M.  Bakare</span>, <span class="hlFld-ContribAuthor ">Jia  Zhan</span>, <span class="hlFld-ContribAuthor ">Ashwini K.  Banala</span>, <span class="hlFld-ContribAuthor ">Caitlin  Burzynski</span>, <span class="hlFld-ContribAuthor ">Elie  Pommier</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Keck</span>, <span class="hlFld-ContribAuthor ">Prashant  Donthamsetti</span>, <span class="hlFld-ContribAuthor ">Jonathan A.  Javitch</span>, <span class="hlFld-ContribAuthor ">Rana  Rais</span>, <span class="hlFld-ContribAuthor ">Barbara S.  Slusher</span>, <span class="hlFld-ContribAuthor ">Zheng-Xiong  Xi</span>, and <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>  . </span><span class="cited-content_cbyCitation_article-title">High Affinity Dopamine D3 Receptor (D3R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D3R Knockout Mice. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (15)
                                     , 6195-6213. <a href="https://doi.org/10.1021/acs.jmedchem.5b00776" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00776</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00776%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHigh%252BAffinity%252BDopamine%252BD3%252BReceptor%252B%252528D3R%252529-Selective%252BAntagonists%252BAttenuate%252BHeroin%252BSelf-Administration%252Bin%252BWild-Type%252Bbut%252Bnot%252BD3R%252BKnockout%252BMice%26aulast%3DBoateng%26aufirst%3DComfort%2BA.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D21052015%26date%3D23072015%26date%3D13082015%26volume%3D58%26issue%3D15%26spage%3D6195%26epage%3D6213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gustavo A.  Angarita</span>, <span class="hlFld-ContribAuthor ">Hasti  Hadizadeh</span>, <span class="hlFld-ContribAuthor ">Ignacio  Cerdena</span>, <span class="hlFld-ContribAuthor ">Marc N.  Potenza</span>. </span><span class="cited-content_cbyCitation_article-title">Can pharmacotherapy improve treatment outcomes in people with co-occurring major depressive and cocaine use disorders?. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Pharmacotherapy</span><span> <strong>2021,</strong> <em>67 </em>, 1-15. <a href="https://doi.org/10.1080/14656566.2021.1931684" title="DOI URL">https://doi.org/10.1080/14656566.2021.1931684</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14656566.2021.1931684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14656566.2021.1931684%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Pharmacotherapy%26atitle%3DCan%252Bpharmacotherapy%252Bimprove%252Btreatment%252Boutcomes%252Bin%252Bpeople%252Bwith%252Bco-occurring%252Bmajor%252Bdepressive%252Band%252Bcocaine%252Buse%252Bdisorders%25253F%26aulast%3DAngarita%26aufirst%3DGustavo%2BA.%26date%3D2021%26date%3D2021%26volume%3D67%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Boeun  Lee</span>, <span class="hlFld-ContribAuthor ">Michelle  Taylor</span>, <span class="hlFld-ContribAuthor ">Suzy A.  Griffin</span>, <span class="hlFld-ContribAuthor ">Tamara  McInnis</span>, <span class="hlFld-ContribAuthor ">Nathalie  Sumien</span>, <span class="hlFld-ContribAuthor ">Robert H.  Mach</span>, <span class="hlFld-ContribAuthor ">Robert R.  Luedtke</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of Substituted N-Phenylpiperazine Analogs as D3 vs. D2 Dopamine Receptor Subtype Selective Ligands. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (11)
                                     , 3182. <a href="https://doi.org/10.3390/molecules26113182" title="DOI URL">https://doi.org/10.3390/molecules26113182</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26113182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26113182%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DEvaluation%252Bof%252BSubstituted%252BN-Phenylpiperazine%252BAnalogs%252Bas%252BD3%252Bvs.%252BD2%252BDopamine%252BReceptor%252BSubtype%252BSelective%252BLigands%26aulast%3DLee%26aufirst%3DBoeun%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D11%26spage%3D3182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patrick  Appiah‐Kubi</span>, <span class="hlFld-ContribAuthor ">Fisayo Andrew  Olotu</span>, <span class="hlFld-ContribAuthor ">Mahmoud E. S.  Soliman</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the structural basis and atomistic binding mechanistic of the selective antagonist blockade at
              
                D
                3
              
              dopamine receptor over
              
                D
                2
              
              dopamine receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Recognition</span><span> <strong>2021,</strong> <em>34 </em>
                                    (5)
                                     <a href="https://doi.org/10.1002/jmr.2885" title="DOI URL">https://doi.org/10.1002/jmr.2885</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jmr.2885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjmr.2885%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Recognition%26atitle%3DExploring%252Bthe%252Bstructural%252Bbasis%252Band%252Batomistic%252Bbinding%252Bmechanistic%252Bof%252Bthe%252Bselective%252Bantagonist%252Bblockade%252Bat%252BD%252B3%252Bdopamine%252Breceptor%252Bover%252BD%252B2%252Bdopamine%252Breceptor%26aulast%3DAppiah%25E2%2580%2590Kubi%26aufirst%3DPatrick%26date%3D2021%26date%3D2021%26volume%3D34%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pramisha  Adhikari</span>, <span class="hlFld-ContribAuthor ">Bing  Xie</span>, <span class="hlFld-ContribAuthor ">Ana  Semeano</span>, <span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">Francisco O.  Battiti</span>, <span class="hlFld-ContribAuthor ">Amy H.  Newman</span>, <span class="hlFld-ContribAuthor ">Hideaki  Yano</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (4)
                                     , 570. <a href="https://doi.org/10.3390/biom11040570" title="DOI URL">https://doi.org/10.3390/biom11040570</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11040570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11040570%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DChirality%252Bof%252BNovel%252BBitopic%252BAgonists%252BDetermines%252BUnique%252BPharmacology%252Bat%252Bthe%252BDopamine%252BD3%252BReceptor%26aulast%3DAdhikari%26aufirst%3DPramisha%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D4%26spage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>, <span class="hlFld-ContribAuthor ">Therese  Ku</span>, <span class="hlFld-ContribAuthor ">Chloe J.  Jordan</span>, <span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">Zheng-Xiong  Xi</span>. </span><span class="cited-content_cbyCitation_article-title">New Drugs, Old Targets: Tweaking the Dopamine System to Treat Psychostimulant Use Disorders. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Pharmacology and Toxicology</span><span> <strong>2021,</strong> <em>61 </em>
                                    (1)
                                     , 609-628. <a href="https://doi.org/10.1146/annurev-pharmtox-030220-124205" title="DOI URL">https://doi.org/10.1146/annurev-pharmtox-030220-124205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-pharmtox-030220-124205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-pharmtox-030220-124205%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Pharmacology%2520and%2520Toxicology%26atitle%3DNew%252BDrugs%25252C%252BOld%252BTargets%25253A%252BTweaking%252Bthe%252BDopamine%252BSystem%252Bto%252BTreat%252BPsychostimulant%252BUse%252BDisorders%26aulast%3DNewman%26aufirst%3DAmy%2BHauck%26date%3D2021%26volume%3D61%26issue%3D1%26spage%3D609%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patrick D.  Worhunsky</span>, <span class="hlFld-ContribAuthor ">Gustavo A.  Angarita</span>, <span class="hlFld-ContribAuthor ">Zu Wei  Zhai</span>, <span class="hlFld-ContribAuthor ">David  Matuskey</span>, <span class="hlFld-ContribAuthor ">Jean-Dominique  Gallezot</span>, <span class="hlFld-ContribAuthor ">Robert T.  Malison</span>, <span class="hlFld-ContribAuthor ">Richard E.  Carson</span>, <span class="hlFld-ContribAuthor ">Marc N.  Potenza</span>. </span><span class="cited-content_cbyCitation_article-title">Multimodal investigation of dopamine D2/D3 receptors, default mode network suppression, and cognitive control in cocaine-use disorder. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2021,</strong> <em>46 </em>
                                    (2)
                                     , 316-324. <a href="https://doi.org/10.1038/s41386-020-00874-7" title="DOI URL">https://doi.org/10.1038/s41386-020-00874-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-020-00874-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-020-00874-7%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DMultimodal%252Binvestigation%252Bof%252Bdopamine%252BD2%25252FD3%252Breceptors%25252C%252Bdefault%252Bmode%252Bnetwork%252Bsuppression%25252C%252Band%252Bcognitive%252Bcontrol%252Bin%252Bcocaine-use%252Bdisorder%26aulast%3DWorhunsky%26aufirst%3DPatrick%2BD.%26date%3D2021%26date%3D2020%26volume%3D46%26issue%3D2%26spage%3D316%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tadele Mekuriya  Yadesa</span>, <span class="hlFld-ContribAuthor ">Patrick Engeu  Ogwang</span>, <span class="hlFld-ContribAuthor ">Casim Umba  Tolo</span>. </span><span class="cited-content_cbyCitation_article-title">Drugs in Clinical Practice from Toxic Plants and Phytochemicals. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 79-94. <a href="https://doi.org/10.1002/9781119650034.ch4" title="DOI URL">https://doi.org/10.1002/9781119650034.ch4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119650034.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119650034.ch4%26sid%3Dliteratum%253Aachs%26atitle%3DDrugs%252Bin%252BClinical%252BPractice%252Bfrom%252BToxic%252BPlants%252Band%252BPhytochemicals%26aulast%3DYadesa%26aufirst%3DTadele%2BMekuriya%26date%3D2020%26date%3D2020%26spage%3D79%26epage%3D94%26pub%3DWiley%26atitle%3DPoisonous%252BPlants%252Band%252BPhytochemicals%252Bin%252BDrug%252BDiscovery%26aulast%3DMtewa%26aufirst%3DAndrew%2BG.%26date%3D2020%26date%3D2020%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ewa  Galaj</span>, <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>, <span class="hlFld-ContribAuthor ">Zheng-Xiong  Xi</span>. </span><span class="cited-content_cbyCitation_article-title">Dopamine D3 receptor-based medication development for the treatment of opioid use disorder: Rationale, progress, and challenges. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience & Biobehavioral Reviews</span><span> <strong>2020,</strong> <em>114 </em>, 38-52. <a href="https://doi.org/10.1016/j.neubiorev.2020.04.024" title="DOI URL">https://doi.org/10.1016/j.neubiorev.2020.04.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neubiorev.2020.04.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neubiorev.2020.04.024%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%2520%2526%2520Biobehavioral%2520Reviews%26atitle%3DDopamine%252BD3%252Breceptor-based%252Bmedication%252Bdevelopment%252Bfor%252Bthe%252Btreatment%252Bof%252Bopioid%252Buse%252Bdisorder%25253A%252BRationale%25252C%252Bprogress%25252C%252Band%252Bchallenges%26aulast%3DGalaj%26aufirst%3DEwa%26date%3D2020%26volume%3D114%26spage%3D38%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gregory L.  Powell</span>, <span class="hlFld-ContribAuthor ">Mark D.  Namba</span>, <span class="hlFld-ContribAuthor ">Annika  Vannan</span>, <span class="hlFld-ContribAuthor ">John Paul  Bonadonna</span>, <span class="hlFld-ContribAuthor ">Andrew  Carlson</span>, <span class="hlFld-ContribAuthor ">Rachel  Mendoza</span>, <span class="hlFld-ContribAuthor ">Peng-Jen  Chen</span>, <span class="hlFld-ContribAuthor ">Robert R.  Luetdke</span>, <span class="hlFld-ContribAuthor ">Benjamin E.  Blass</span>, <span class="hlFld-ContribAuthor ">Janet L.  Neisewander</span>. </span><span class="cited-content_cbyCitation_article-title">The Long-Acting D3 Partial Agonist MC-25-41 Attenuates Motivation for Cocaine in Sprague-Dawley Rats. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (7)
                                     , 1076. <a href="https://doi.org/10.3390/biom10071076" title="DOI URL">https://doi.org/10.3390/biom10071076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10071076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10071076%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DThe%252BLong-Acting%252BD3%252BPartial%252BAgonist%252BMC-25-41%252BAttenuates%252BMotivation%252Bfor%252BCocaine%252Bin%252BSprague-Dawley%252BRats%26aulast%3DPowell%26aufirst%3DGregory%2BL.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D7%26spage%3D1076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana  Martinez</span>. </span><span class="cited-content_cbyCitation_article-title">Dopamine antagonists for the treatment of drug addiction: PF-4363467 and related compounds. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     , 84-90. <a href="https://doi.org/10.5155/eurjchem.11.1.84-90.1970" title="DOI URL">https://doi.org/10.5155/eurjchem.11.1.84-90.1970</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5155/eurjchem.11.1.84-90.1970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5155%2Feurjchem.11.1.84-90.1970%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Chemistry%26atitle%3DDopamine%252Bantagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Bdrug%252Baddiction%25253A%252BPF-4363467%252Band%252Brelated%252Bcompounds%26aulast%3DMartinez%26aufirst%3DAna%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1%26spage%3D84%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giordano  de Guglielmo</span>, <span class="hlFld-ContribAuthor ">Marsida  Kallupi</span>, <span class="hlFld-ContribAuthor ">Sharona  Sedighim</span>, <span class="hlFld-ContribAuthor ">Amy H.  Newman</span>, <span class="hlFld-ContribAuthor ">Olivier  George</span>. </span><span class="cited-content_cbyCitation_article-title">Dopamine D3 Receptor Antagonism Reverses the Escalation of Oxycodone Self-administration and Decreases Withdrawal-Induced Hyperalgesia and Irritability-Like Behavior in Oxycodone-Dependent Heterogeneous Stock Rats. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Behavioral Neuroscience</span><span> <strong>2020,</strong> <em>13 </em><a href="https://doi.org/10.3389/fnbeh.2019.00292" title="DOI URL">https://doi.org/10.3389/fnbeh.2019.00292</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnbeh.2019.00292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnbeh.2019.00292%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Behavioral%2520Neuroscience%26atitle%3DDopamine%252BD3%252BReceptor%252BAntagonism%252BReverses%252Bthe%252BEscalation%252Bof%252BOxycodone%252BSelf-administration%252Band%252BDecreases%252BWithdrawal-Induced%252BHyperalgesia%252Band%252BIrritability-Like%252BBehavior%252Bin%252BOxycodone-Dependent%252BHeterogeneous%252BStock%252BRats%26aulast%3Dde%2BGuglielmo%26aufirst%3DGiordano%26date%3D2020%26date%3D2020%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chloe J.  Jordan</span>, <span class="hlFld-ContribAuthor ">Bree A.  Humburg</span>, <span class="hlFld-ContribAuthor ">Eric B.  Thorndike</span>, <span class="hlFld-ContribAuthor ">Anver Basha  Shaik</span>, <span class="hlFld-ContribAuthor ">Zheng-Xiong  Xi</span>, <span class="hlFld-ContribAuthor ">Michael H.  Baumann</span>, <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>, <span class="hlFld-ContribAuthor ">Charles W.  Schindler</span>. </span><span class="cited-content_cbyCitation_article-title">Newly Developed Dopamine D
              3
              Receptor Antagonists,
              R
              -VK4-40 and
              R
              -VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2019,</strong> <em>371 </em>
                                    (3)
                                     , 602-614. <a href="https://doi.org/10.1124/jpet.119.259390" title="DOI URL">https://doi.org/10.1124/jpet.119.259390</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.119.259390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.119.259390%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DNewly%252BDeveloped%252BDopamine%252BD%252B3%252BReceptor%252BAntagonists%25252C%252BR%252B-VK4-40%252Band%252BR%252B-VK4-116%25252C%252BDo%252BNot%252BPotentiate%252BCardiovascular%252BEffects%252Bof%252BCocaine%252Bor%252BOxycodone%252Bin%252BRats%26aulast%3DJordan%26aufirst%3DChloe%2BJ.%26date%3D2019%26date%3D2019%26volume%3D371%26issue%3D3%26spage%3D602%26epage%3D614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chloe J.  Jordan</span>, <span class="hlFld-ContribAuthor ">Bree  Humburg</span>, <span class="hlFld-ContribAuthor ">Myra  Rice</span>, <span class="hlFld-ContribAuthor ">Guo-Hua  Bi</span>, <span class="hlFld-ContribAuthor ">Zhi-Bing  You</span>, <span class="hlFld-ContribAuthor ">Anver Basha  Shaik</span>, <span class="hlFld-ContribAuthor ">Jianjing  Cao</span>, <span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">Alexandra  Gadiano</span>, <span class="hlFld-ContribAuthor ">Rana  Rais</span>, <span class="hlFld-ContribAuthor ">Barbara  Slusher</span>, <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>, <span class="hlFld-ContribAuthor ">Zheng-Xiong  Xi</span>. </span><span class="cited-content_cbyCitation_article-title">The highly selective dopamine D R antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodents. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2019,</strong> <em>158 </em>, 107597. <a href="https://doi.org/10.1016/j.neuropharm.2019.04.003" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2019.04.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2019.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2019.04.003%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DThe%252Bhighly%252Bselective%252Bdopamine%252BD%252BR%252Bantagonist%25252C%252BR-VK4-40%252Battenuates%252Boxycodone%252Breward%252Band%252Baugments%252Banalgesia%252Bin%252Brodents%26aulast%3DJordan%26aufirst%3DChloe%2BJ.%26date%3D2019%26volume%3D158%26spage%3D107597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diana  Dow-Edwards</span>, <span class="hlFld-ContribAuthor ">Frank P.  MacMaster</span>, <span class="hlFld-ContribAuthor ">Bradley S.  Peterson</span>, <span class="hlFld-ContribAuthor ">Raymond  Niesink</span>, <span class="hlFld-ContribAuthor ">Susan  Andersen</span>, <span class="hlFld-ContribAuthor ">B.R.  Braams</span>. </span><span class="cited-content_cbyCitation_article-title">Experience during adolescence shapes brain development: From synapses and networks to normal and pathological behavior. </span><span class="cited-content_cbyCitation_journal-name">Neurotoxicology and Teratology</span><span> <strong>2019,</strong> <em>76 </em>, 106834. <a href="https://doi.org/10.1016/j.ntt.2019.106834" title="DOI URL">https://doi.org/10.1016/j.ntt.2019.106834</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ntt.2019.106834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ntt.2019.106834%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurotoxicology%2520and%2520Teratology%26atitle%3DExperience%252Bduring%252Badolescence%252Bshapes%252Bbrain%252Bdevelopment%25253A%252BFrom%252Bsynapses%252Band%252Bnetworks%252Bto%252Bnormal%252Band%252Bpathological%252Bbehavior%26aulast%3DDow-Edwards%26aufirst%3DDiana%26date%3D2019%26volume%3D76%26spage%3D106834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xavier  Guitart</span>, <span class="hlFld-ContribAuthor ">Estefanía  Moreno</span>, <span class="hlFld-ContribAuthor ">William  Rea</span>, <span class="hlFld-ContribAuthor ">Marta  Sánchez-Soto</span>, <span class="hlFld-ContribAuthor ">Ning-Sheng  Cai</span>, <span class="hlFld-ContribAuthor ">César  Quiroz</span>, <span class="hlFld-ContribAuthor ">Vivek  Kumar</span>, <span class="hlFld-ContribAuthor ">Liam  Bourque</span>, <span class="hlFld-ContribAuthor ">Antoni  Cortés</span>, <span class="hlFld-ContribAuthor ">Enric I.  Canela</span>, <span class="hlFld-ContribAuthor ">Christopher  Bishop</span>, <span class="hlFld-ContribAuthor ">Amy H.  Newman</span>, <span class="hlFld-ContribAuthor ">Vicent  Casadó</span>, <span class="hlFld-ContribAuthor ">Sergi  Ferré</span>. </span><span class="cited-content_cbyCitation_article-title">Biased G Protein-Independent Signaling of Dopamine D1-D3 Receptor Heteromers in the Nucleus Accumbens. </span><span class="cited-content_cbyCitation_journal-name">Molecular Neurobiology</span><span> <strong>2019,</strong> <em>56 </em>
                                    (10)
                                     , 6756-6769. <a href="https://doi.org/10.1007/s12035-019-1564-8" title="DOI URL">https://doi.org/10.1007/s12035-019-1564-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12035-019-1564-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12035-019-1564-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Neurobiology%26atitle%3DBiased%252BG%252BProtein-Independent%252BSignaling%252Bof%252BDopamine%252BD1-D3%252BReceptor%252BHeteromers%252Bin%252Bthe%252BNucleus%252BAccumbens%26aulast%3DGuitart%26aufirst%3DXavier%26date%3D2019%26date%3D2019%26volume%3D56%26issue%3D10%26spage%3D6756%26epage%3D6769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajat Kumar  Pal</span>, <span class="hlFld-ContribAuthor ">Satishkumar  Gadhiya</span>, <span class="hlFld-ContribAuthor ">Steven  Ramsey</span>, <span class="hlFld-ContribAuthor ">Pierpaolo  Cordone</span>, <span class="hlFld-ContribAuthor ">Lauren  Wickstrom</span>, <span class="hlFld-ContribAuthor ">Wayne W.  Harding</span>, <span class="hlFld-ContribAuthor ">Tom  Kurtzman</span>, <span class="hlFld-ContribAuthor ">Emilio  Gallicchio</span>, . </span><span class="cited-content_cbyCitation_article-title">Inclusion of enclosed hydration effects in the binding free energy estimation of dopamine D3 receptor complexes. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2019,</strong> <em>14 </em>
                                    (9)
                                     , e0222902. <a href="https://doi.org/10.1371/journal.pone.0222902" title="DOI URL">https://doi.org/10.1371/journal.pone.0222902</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0222902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0222902%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DInclusion%252Bof%252Benclosed%252Bhydration%252Beffects%252Bin%252Bthe%252Bbinding%252Bfree%252Benergy%252Bestimation%252Bof%252Bdopamine%252BD3%252Breceptor%252Bcomplexes%26aulast%3DPal%26aufirst%3DRajat%2BKumar%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D9%26spage%3De0222902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng-Jen  Chen</span>, <span class="hlFld-ContribAuthor ">Michelle  Taylor</span>, <span class="hlFld-ContribAuthor ">Suzy A.  Griffin</span>, <span class="hlFld-ContribAuthor ">Armaghan  Amani</span>, <span class="hlFld-ContribAuthor ">Hamed  Hayatshahi</span>, <span class="hlFld-ContribAuthor ">Kenneth  Korzekwa</span>, <span class="hlFld-ContribAuthor ">Min  Ye</span>, <span class="hlFld-ContribAuthor ">Robert H.  Mach</span>, <span class="hlFld-ContribAuthor ">Jin  Liu</span>, <span class="hlFld-ContribAuthor ">Robert R.  Luedtke</span>, <span class="hlFld-ContribAuthor ">John C.  Gordon</span>, <span class="hlFld-ContribAuthor ">Benjamin E.  Blass</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of N-(4-(4-phenyl piperazin-1-yl)butyl)-4-(thiophen-3-yl)benzamides as selective dopamine D3 receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (18)
                                     , 2690-2694. <a href="https://doi.org/10.1016/j.bmcl.2019.07.020" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.07.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.07.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.07.020%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252BN-%2525284-%2525284-phenyl%252Bpiperazin-1-yl%252529butyl%252529-4-%252528thiophen-3-yl%252529benzamides%252Bas%252Bselective%252Bdopamine%252BD3%252Breceptor%252Bligands%26aulast%3DChen%26aufirst%3DPeng-Jen%26date%3D2019%26volume%3D29%26issue%3D18%26spage%3D2690%26epage%3D2694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi-Bing  You</span>, <span class="hlFld-ContribAuthor ">Guo-Hua  Bi</span>, <span class="hlFld-ContribAuthor ">Ewa  Galaj</span>, <span class="hlFld-ContribAuthor ">Vivek  Kumar</span>, <span class="hlFld-ContribAuthor ">Jianjing  Cao</span>, <span class="hlFld-ContribAuthor ">Alexandra  Gadiano</span>, <span class="hlFld-ContribAuthor ">Rana  Rais</span>, <span class="hlFld-ContribAuthor ">Barbara S.  Slusher</span>, <span class="hlFld-ContribAuthor ">Eliot L.  Gardner</span>, <span class="hlFld-ContribAuthor ">Zheng-Xiong  Xi</span>, <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>. </span><span class="cited-content_cbyCitation_article-title">Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2019,</strong> <em>44 </em>
                                    (8)
                                     , 1415-1424. <a href="https://doi.org/10.1038/s41386-018-0284-5" title="DOI URL">https://doi.org/10.1038/s41386-018-0284-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-018-0284-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-018-0284-5%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DDopamine%252BD3R%252Bantagonist%252BVK4-116%252Battenuates%252Boxycodone%252Bself-administration%252Band%252Breinstatement%252Bwithout%252Bcompromising%252Bits%252Bantinociceptive%252Beffects%26aulast%3DYou%26aufirst%3DZhi-Bing%26date%3D2019%26date%3D2018%26volume%3D44%26issue%3D8%26spage%3D1415%26epage%3D1424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>, <span class="hlFld-ContribAuthor ">Jianjing  Cao</span>, <span class="hlFld-ContribAuthor ">Jacqueline D.  Keighron</span>, <span class="hlFld-ContribAuthor ">Chloe J.  Jordan</span>, <span class="hlFld-ContribAuthor ">Guo-Hua  Bi</span>, <span class="hlFld-ContribAuthor ">Ying  Liang</span>, <span class="hlFld-ContribAuthor ">Ara M.  Abramyan</span>, <span class="hlFld-ContribAuthor ">Alicia J.  Avelar</span>, <span class="hlFld-ContribAuthor ">Christopher W.  Tschumi</span>, <span class="hlFld-ContribAuthor ">Michael J.  Beckstead</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>, <span class="hlFld-ContribAuthor ">Gianluigi  Tanda</span>, <span class="hlFld-ContribAuthor ">Zheng-Xiong  Xi</span>. </span><span class="cited-content_cbyCitation_article-title">Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2019,</strong> <em>44 </em>
                                    (8)
                                     , 1435-1444. <a href="https://doi.org/10.1038/s41386-019-0366-z" title="DOI URL">https://doi.org/10.1038/s41386-019-0366-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-019-0366-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-019-0366-z%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DTranslating%252Bthe%252Batypical%252Bdopamine%252Buptake%252Binhibitor%252Bhypothesis%252Btoward%252Btherapeutics%252Bfor%252Btreatment%252Bof%252Bpsychostimulant%252Buse%252Bdisorders%26aulast%3DNewman%26aufirst%3DAmy%2BHauck%26date%3D2019%26date%3D2019%26volume%3D44%26issue%3D8%26spage%3D1435%26epage%3D1444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert K.  Doot</span>, <span class="hlFld-ContribAuthor ">Jacob G.  Dubroff</span>, <span class="hlFld-ContribAuthor ">Kyle J.  Labban</span>, <span class="hlFld-ContribAuthor ">Robert H.  Mach</span>. </span><span class="cited-content_cbyCitation_article-title">Selectivity of probes for PET imaging of dopamine D3 receptors. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience Letters</span><span> <strong>2019,</strong> <em>691 </em>, 18-25. <a href="https://doi.org/10.1016/j.neulet.2018.03.006" title="DOI URL">https://doi.org/10.1016/j.neulet.2018.03.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neulet.2018.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neulet.2018.03.006%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%2520Letters%26atitle%3DSelectivity%252Bof%252Bprobes%252Bfor%252BPET%252Bimaging%252Bof%252Bdopamine%252BD3%252Breceptors%26aulast%3DDoot%26aufirst%3DRobert%2BK.%26date%3D2019%26volume%3D691%26spage%3D18%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gregory L.  Powell</span>, <span class="hlFld-ContribAuthor ">John Paul  Bonadonna</span>, <span class="hlFld-ContribAuthor ">Annika  Vannan</span>, <span class="hlFld-ContribAuthor ">Kuiying  Xu</span>, <span class="hlFld-ContribAuthor ">Robert H.  Mach</span>, <span class="hlFld-ContribAuthor ">Robert R.  Luedtke</span>, <span class="hlFld-ContribAuthor ">Janet L.  Neisewander</span>. </span><span class="cited-content_cbyCitation_article-title">Dopamine D3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviors. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Biochemistry and Behavior</span><span> <strong>2018,</strong> <em>175 </em>, 123-129. <a href="https://doi.org/10.1016/j.pbb.2018.10.002" title="DOI URL">https://doi.org/10.1016/j.pbb.2018.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pbb.2018.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pbb.2018.10.002%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Biochemistry%2520and%2520Behavior%26atitle%3DDopamine%252BD3%252Breceptor%252Bpartial%252Bagonist%252BLS-3-134%252Battenuates%252Bcocaine-motivated%252Bbehaviors%26aulast%3DPowell%26aufirst%3DGregory%2BL.%26date%3D2018%26volume%3D175%26spage%3D123%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noelia  Ferruz</span>, <span class="hlFld-ContribAuthor ">Stefan  Doerr</span>, <span class="hlFld-ContribAuthor ">Michelle A.  Vanase-Frawley</span>, <span class="hlFld-ContribAuthor ">Yaozhong  Zou</span>, <span class="hlFld-ContribAuthor ">Xiaomin  Chen</span>, <span class="hlFld-ContribAuthor ">Eric S.  Marr</span>, <span class="hlFld-ContribAuthor ">Robin T.  Nelson</span>, <span class="hlFld-ContribAuthor ">Bethany L.  Kormos</span>, <span class="hlFld-ContribAuthor ">Travis T.  Wager</span>, <span class="hlFld-ContribAuthor ">Xinjun  Hou</span>, <span class="hlFld-ContribAuthor ">Anabella  Villalobos</span>, <span class="hlFld-ContribAuthor ">Simone  Sciabola</span>, <span class="hlFld-ContribAuthor ">Gianni  De Fabritiis</span>. </span><span class="cited-content_cbyCitation_article-title">Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-018-19345-7" title="DOI URL">https://doi.org/10.1038/s41598-018-19345-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-018-19345-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-018-19345-7%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDopamine%252BD3%252Breceptor%252Bantagonist%252Breveals%252Ba%252Bcryptic%252Bpocket%252Bin%252Baminergic%252BGPCRs%26aulast%3DFerruz%26aufirst%3DNoelia%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeih-San  Liow</span>, <span class="hlFld-ContribAuthor ">Cheryl  Morse</span>, <span class="hlFld-ContribAuthor ">Shuiyu  Lu</span>, <span class="hlFld-ContribAuthor ">Michael  Frankland</span>, <span class="hlFld-ContribAuthor ">George  Tye</span>, <span class="hlFld-ContribAuthor ">Sami  Zoghbi</span>, <span class="hlFld-ContribAuthor ">Robert  Gladding</span>, <span class="hlFld-ContribAuthor ">Anver  Shaik</span>, <span class="hlFld-ContribAuthor ">Robert  Innis</span>, <span class="hlFld-ContribAuthor ">Amy  Newman</span>, <span class="hlFld-ContribAuthor ">Victor  Pike</span>. </span><span class="cited-content_cbyCitation_article-title">[O-methyl-11C]N-(4-(4-(3-Chloro-2-methoxyphenyl)-piperazin-1-yl)butyl)-1H-indole-2-carboxamide ([11C]BAK4-51) Is an Efflux Transporter Substrate and Ineffective for PET Imaging of Brain D3 Receptors in Rodents and Monkey. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (11)
                                     , 2737. <a href="https://doi.org/10.3390/molecules23112737" title="DOI URL">https://doi.org/10.3390/molecules23112737</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23112737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23112737%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3D%25255BO-methyl-11C%25255DN-%2525284-%2525284-%2525283-Chloro-2-methoxyphenyl%252529-piperazin-1-yl%252529butyl%252529-1H-indole-2-carboxamide%252B%252528%25255B11C%25255DBAK4-51%252529%252BIs%252Ban%252BEfflux%252BTransporter%252BSubstrate%252Band%252BIneffective%252Bfor%252BPET%252BImaging%252Bof%252BBrain%252BD3%252BReceptors%252Bin%252BRodents%252Band%252BMonkey%26aulast%3DLiow%26aufirst%3DJeih-San%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D11%26spage%3D2737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gregory L.  Powell</span>, <span class="hlFld-ContribAuthor ">John Paul  Bonadonna</span>, <span class="hlFld-ContribAuthor ">Annika  Vannan</span>, <span class="hlFld-ContribAuthor ">Kuiying  Xu</span>, <span class="hlFld-ContribAuthor ">Robert H.  Mach</span>, <span class="hlFld-ContribAuthor ">Robert R.  Luedtke</span>, <span class="hlFld-ContribAuthor ">Janet L.  Neisewander</span>. </span><span class="cited-content_cbyCitation_article-title">RETRACTED: Dopamine D3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviors. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Biochemistry and Behavior</span><span> <strong>2018,</strong> <em>171 </em>, 46-53. <a href="https://doi.org/10.1016/j.pbb.2018.05.015" title="DOI URL">https://doi.org/10.1016/j.pbb.2018.05.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pbb.2018.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pbb.2018.05.015%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Biochemistry%2520and%2520Behavior%26atitle%3DRETRACTED%25253A%252BDopamine%252BD3%252Breceptor%252Bpartial%252Bagonist%252BLS-3-134%252Battenuates%252Bcocaine-motivated%252Bbehaviors%26aulast%3DPowell%26aufirst%3DGregory%2BL.%26date%3D2018%26volume%3D171%26spage%3D46%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Hui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR studies on 1,2,4-triazolyl 5-azaspiro [2.4]-heptanes as D 3 R antagonists. </span><span class="cited-content_cbyCitation_journal-name">Chemical Physics Letters</span><span> <strong>2018,</strong> <em>704 </em>, 11-20. <a href="https://doi.org/10.1016/j.cplett.2018.05.022" title="DOI URL">https://doi.org/10.1016/j.cplett.2018.05.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cplett.2018.05.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cplett.2018.05.022%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Physics%2520Letters%26atitle%3D3D-QSAR%252Bstudies%252Bon%252B1%25252C2%25252C4-triazolyl%252B5-azaspiro%252B%25255B2.4%25255D-heptanes%252Bas%252BD%252B3%252BR%252Bantagonists%26aulast%3DZhang%26aufirst%3DXin%26date%3D2018%26volume%3D704%26spage%3D11%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongkai  Cao</span>, <span class="hlFld-ContribAuthor ">Ningning  Sun</span>, <span class="hlFld-ContribAuthor ">Jiumei  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhiguo  Liu</span>, <span class="hlFld-ContribAuthor ">Yi-zhe  Tang</span>, <span class="hlFld-ContribAuthor ">Zhengzhi  Wu</span>, <span class="hlFld-ContribAuthor ">Kyeong-Man  Kim</span>, <span class="hlFld-ContribAuthor ">Seung Hoon  Cheon</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D
              3
              receptor agonists. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (9)
                                     , 1457-1465. <a href="https://doi.org/10.1039/C8MD00237A" title="DOI URL">https://doi.org/10.1039/C8MD00237A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00237A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00237A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252Bbitopic%252Barylpiperazine-phthalimides%252Bas%252Bselective%252Bdopamine%252BD%252B3%252Breceptor%252Bagonists%26aulast%3DCao%26aufirst%3DYongkai%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D9%26spage%3D1457%26epage%3D1465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Beresford</span>, <span class="hlFld-ContribAuthor ">Jennifer  Buchanan</span>, <span class="hlFld-ContribAuthor ">Elizabeth Brie  Thumm</span>, <span class="hlFld-ContribAuthor ">Chad  Emrick</span>, <span class="hlFld-ContribAuthor ">David  Weitzenkamp</span>, <span class="hlFld-ContribAuthor ">Patrick J.  Ronan</span>. </span><span class="cited-content_cbyCitation_article-title">Late Reduction of Cocaine Cravings in a Randomized, Double-Blind Trial of Aripiprazole vs Perphenazine in Schizophrenia and Comorbid Cocaine Dependence. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Psychopharmacology</span><span> <strong>2017,</strong> <em>37 </em>
                                    (6)
                                     , 657-663. <a href="https://doi.org/10.1097/JCP.0000000000000789" title="DOI URL">https://doi.org/10.1097/JCP.0000000000000789</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/JCP.0000000000000789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FJCP.0000000000000789%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Psychopharmacology%26atitle%3DLate%252BReduction%252Bof%252BCocaine%252BCravings%252Bin%252Ba%252BRandomized%25252C%252BDouble-Blind%252BTrial%252Bof%252BAripiprazole%252Bvs%252BPerphenazine%252Bin%252BSchizophrenia%252Band%252BComorbid%252BCocaine%252BDependence%26aulast%3DBeresford%26aufirst%3DThomas%26date%3D2017%26volume%3D37%26issue%3D6%26spage%3D657%26epage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi-Bing  You</span>, <span class="hlFld-ContribAuthor ">Jun-Tao  Gao</span>, <span class="hlFld-ContribAuthor ">Guo-Hua  Bi</span>, <span class="hlFld-ContribAuthor ">Yi  He</span>, <span class="hlFld-ContribAuthor ">Comfort  Boateng</span>, <span class="hlFld-ContribAuthor ">Jianjing  Cao</span>, <span class="hlFld-ContribAuthor ">Eliot L.  Gardner</span>, <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>, <span class="hlFld-ContribAuthor ">Zheng-Xiong  Xi</span>. </span><span class="cited-content_cbyCitation_article-title">The novel dopamine D3 receptor antagonists/partial agonists CAB2-015 and BAK4-54 inhibit oxycodone-taking and oxycodone-seeking behavior in rats. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2017,</strong> <em>126 </em>, 190-199. <a href="https://doi.org/10.1016/j.neuropharm.2017.09.007" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2017.09.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2017.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2017.09.007%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DThe%252Bnovel%252Bdopamine%252BD3%252Breceptor%252Bantagonists%25252Fpartial%252Bagonists%252BCAB2-015%252Band%252BBAK4-54%252Binhibit%252Boxycodone-taking%252Band%252Boxycodone-seeking%252Bbehavior%252Bin%252Brats%26aulast%3DYou%26aufirst%3DZhi-Bing%26date%3D2017%26volume%3D126%26spage%3D190%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrizio  Micheli</span>. </span><span class="cited-content_cbyCitation_article-title">Novel, Selective, and Developable Dopamine D
              3
              Antagonists with a Modified “Amino” Region. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (16)
                                     , 1254-1260. <a href="https://doi.org/10.1002/cmdc.201700148" title="DOI URL">https://doi.org/10.1002/cmdc.201700148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700148%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DNovel%25252C%252BSelective%25252C%252Band%252BDevelopable%252BDopamine%252BD%252B3%252BAntagonists%252Bwith%252Ba%252BModified%252B%2525E2%252580%25259CAmino%2525E2%252580%25259D%252BRegion%26aulast%3DMicheli%26aufirst%3DFabrizio%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D16%26spage%3D1254%26epage%3D1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anne  Stößel</span>, <span class="hlFld-ContribAuthor ">Regine  Brox</span>, <span class="hlFld-ContribAuthor ">Nirupam  Purkayastha</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, <span class="hlFld-ContribAuthor ">Carsten  Hocke</span>, <span class="hlFld-ContribAuthor ">Olaf  Prante</span>, <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>. </span><span class="cited-content_cbyCitation_article-title">Development of molecular tools based on the dopamine D 3 receptor ligand FAUC 329 showing inhibiting effects on drug and food maintained behavior. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (13)
                                     , 3491-3499. <a href="https://doi.org/10.1016/j.bmc.2017.04.036" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.04.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.04.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.04.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Bmolecular%252Btools%252Bbased%252Bon%252Bthe%252Bdopamine%252BD%252B3%252Breceptor%252Bligand%252BFAUC%252B329%252Bshowing%252Binhibiting%252Beffects%252Bon%252Bdrug%252Band%252Bfood%252Bmaintained%252Bbehavior%26aulast%3DSt%25C3%25B6%25C3%259Fel%26aufirst%3DAnne%26date%3D2017%26volume%3D25%26issue%3D13%26spage%3D3491%26epage%3D3499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Morgane  Thomsen</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Barrett</span>, <span class="hlFld-ContribAuthor ">Paul  Butler</span>, <span class="hlFld-ContribAuthor ">S. Stevens  Negus</span>, <span class="hlFld-ContribAuthor ">S. Barak  Caine</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of Acute and Chronic Treatments with Dopamine D
              2
              and D
              3
              Receptor Ligands on Cocaine versus Food Choice in Rats. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2017,</strong> <em>362 </em>
                                    (1)
                                     , 161-176. <a href="https://doi.org/10.1124/jpet.117.241141" title="DOI URL">https://doi.org/10.1124/jpet.117.241141</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.117.241141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.117.241141%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DEffects%252Bof%252BAcute%252Band%252BChronic%252BTreatments%252Bwith%252BDopamine%252BD%252B2%252Band%252BD%252B3%252BReceptor%252BLigands%252Bon%252BCocaine%252Bversus%252BFood%252BChoice%252Bin%252BRats%26aulast%3DThomsen%26aufirst%3DMorgane%26date%3D2017%26date%3D2017%26volume%3D362%26issue%3D1%26spage%3D161%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noor  Hussein</span>, <span class="hlFld-ContribAuthor ">Haneen  Amawi</span>, <span class="hlFld-ContribAuthor ">Chandrabose  Karthikeyan</span>, <span class="hlFld-ContribAuthor ">F. Scott  Hall</span>, <span class="hlFld-ContribAuthor ">Roopali  Mittal</span>, <span class="hlFld-ContribAuthor ">Piyush  Trivedi</span>, <span class="hlFld-ContribAuthor ">Charles R.  Ashby</span>, <span class="hlFld-ContribAuthor ">Amit K.  Tiwari</span>. </span><span class="cited-content_cbyCitation_article-title">The dopamine D 3 receptor antagonists PG01037, NGB2904, SB277011A, and U99194 reverse ABCG2 transporter-mediated drug resistance in cancer cell lines. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2017,</strong> <em>396 </em>, 167-180. <a href="https://doi.org/10.1016/j.canlet.2017.03.015" title="DOI URL">https://doi.org/10.1016/j.canlet.2017.03.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2017.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2017.03.015%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DThe%252Bdopamine%252BD%252B3%252Breceptor%252Bantagonists%252BPG01037%25252C%252BNGB2904%25252C%252BSB277011A%25252C%252Band%252BU99194%252Breverse%252BABCG2%252Btransporter-mediated%252Bdrug%2525C2%2525A0resistance%252Bin%252Bcancer%252Bcell%252Blines%26aulast%3DHussein%26aufirst%3DNoor%26date%3D2017%26volume%3D396%26spage%3D167%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stela Maris Kuze  Rates</span>, <span class="hlFld-ContribAuthor ">Andresa Heemann  Betti</span>, <span class="hlFld-ContribAuthor ">Liz Girardi  Müller</span>, <span class="hlFld-ContribAuthor ">Jéssica de Matos  Nunes</span>. </span><span class="cited-content_cbyCitation_article-title">Plant Toxins as Sources of Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 81-105. <a href="https://doi.org/10.1007/978-94-007-6464-4_5" title="DOI URL">https://doi.org/10.1007/978-94-007-6464-4_5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-94-007-6464-4_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-94-007-6464-4_5%26sid%3Dliteratum%253Aachs%26atitle%3DPlant%252BToxins%252Bas%252BSources%252Bof%252BDrugs%26aulast%3DRates%26aufirst%3DStela%2BMaris%2BKuze%26date%3D2017%26date%3D2017%26spage%3D81%26epage%3D105%26pub%3DSpringer%2520Netherlands%26atitle%3DPlant%252BToxins%26aulast%3DCarlini%26aufirst%3DC%25C3%25A9lia%2BRegina%26date%3D2017%26volume%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana  Weidenauer</span>, <span class="hlFld-ContribAuthor ">Martin  Bauer</span>, <span class="hlFld-ContribAuthor ">Ulrich  Sauerzopf</span>, <span class="hlFld-ContribAuthor ">Lucie  Bartova</span>, <span class="hlFld-ContribAuthor ">Nicole  Praschak-Rieder</span>, <span class="hlFld-ContribAuthor ">Harald H.  Sitte</span>, <span class="hlFld-ContribAuthor ">Siegfried  Kasper</span>, <span class="hlFld-ContribAuthor ">Matthäus  Willeit</span>. </span><span class="cited-content_cbyCitation_article-title">Making Sense of: Sensitization in Schizophrenia. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Neuropsychopharmacology</span><span> <strong>2017,</strong> <em>20 </em>
                                    (1)
                                     , 1-10. <a href="https://doi.org/10.1093/ijnp/pyw081" title="DOI URL">https://doi.org/10.1093/ijnp/pyw081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/ijnp/pyw081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fijnp%2Fpyw081%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Neuropsychopharmacology%26atitle%3DMaking%252BSense%252Bof%25253A%252BSensitization%252Bin%252BSchizophrenia%26aulast%3DWeidenauer%26aufirst%3DAna%26date%3D2017%26date%3D2016%26volume%3D20%26issue%3D1%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valerio  Mammoli</span>, <span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">Diego  Dal Ben</span>, <span class="hlFld-ContribAuthor ">Mario  Giannella</span>, <span class="hlFld-ContribAuthor ">Gianfabio  Giorgioni</span>, <span class="hlFld-ContribAuthor ">Alessandro  Piergentili</span>, <span class="hlFld-ContribAuthor ">Maria  Pigini</span>, <span class="hlFld-ContribAuthor ">Wilma  Quaglia</span>, <span class="hlFld-ContribAuthor ">Ajiroghene  Thomas</span>, <span class="hlFld-ContribAuthor ">Amy H.  Newman</span>, <span class="hlFld-ContribAuthor ">Sergi  Ferré</span>, <span class="hlFld-ContribAuthor ">Marta  Sanchez-Soto</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Keck</span>, <span class="hlFld-ContribAuthor ">Fabio  Del Bello</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Class of Dopamine D
              4
              Receptor Ligands Bearing an Imidazoline Nucleus. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (16)
                                     , 1819-1828. <a href="https://doi.org/10.1002/cmdc.201600022" title="DOI URL">https://doi.org/10.1002/cmdc.201600022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201600022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201600022%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DA%252BNovel%252BClass%252Bof%252BDopamine%252BD%252B4%252BReceptor%252BLigands%252BBearing%252Ban%252BImidazoline%252BNucleus%26aulast%3DMammoli%26aufirst%3DValerio%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D16%26spage%3D1819%26epage%3D1828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antoni  Cortés</span>, <span class="hlFld-ContribAuthor ">Estefanía  Moreno</span>, <span class="hlFld-ContribAuthor ">Mar  Rodríguez-Ruiz</span>, <span class="hlFld-ContribAuthor ">Enric I.  Canela</span>, <span class="hlFld-ContribAuthor ">Vicent  Casadó</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the dopamine D3 receptor: an overview of drug design strategies. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2016,</strong> <em>11 </em>
                                    (7)
                                     , 641-664. <a href="https://doi.org/10.1080/17460441.2016.1185413" title="DOI URL">https://doi.org/10.1080/17460441.2016.1185413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2016.1185413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2016.1185413%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DTargeting%252Bthe%252Bdopamine%252BD3%252Breceptor%25253A%252Ban%252Boverview%252Bof%252Bdrug%252Bdesign%252Bstrategies%26aulast%3DCort%25C3%25A9s%26aufirst%3DAntoni%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D7%26spage%3D641%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Butini</span>, <span class="hlFld-ContribAuthor ">K.  Nikolic</span>, <span class="hlFld-ContribAuthor ">S.  Kassel</span>, <span class="hlFld-ContribAuthor ">H.  Brückmann</span>, <span class="hlFld-ContribAuthor ">S.  Filipic</span>, <span class="hlFld-ContribAuthor ">D.  Agbaba</span>, <span class="hlFld-ContribAuthor ">S.  Gemma</span>, <span class="hlFld-ContribAuthor ">S.  Brogi</span>, <span class="hlFld-ContribAuthor ">M.  Brindisi</span>, <span class="hlFld-ContribAuthor ">G.  Campiani</span>, <span class="hlFld-ContribAuthor ">H.  Stark</span>. </span><span class="cited-content_cbyCitation_article-title">Polypharmacology of dopamine receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">Progress in Neurobiology</span><span> <strong>2016,</strong> <em>142 </em>, 68-103. <a href="https://doi.org/10.1016/j.pneurobio.2016.03.011" title="DOI URL">https://doi.org/10.1016/j.pneurobio.2016.03.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pneurobio.2016.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pneurobio.2016.03.011%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Neurobiology%26atitle%3DPolypharmacology%252Bof%252Bdopamine%252Breceptor%252Bligands%26aulast%3DButini%26aufirst%3DS.%26date%3D2016%26volume%3D142%26spage%3D68%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satishkumar  Gadhiya</span>, <span class="hlFld-ContribAuthor ">Sudharshan  Madapa</span>, <span class="hlFld-ContribAuthor ">Thomas  Kurtzman</span>, <span class="hlFld-ContribAuthor ">Ian L.  Alberts</span>, <span class="hlFld-ContribAuthor ">Steven  Ramsey</span>, <span class="hlFld-ContribAuthor ">Nagavara-Kishore  Pillarsetty</span>, <span class="hlFld-ContribAuthor ">Teja  Kalidindi</span>, <span class="hlFld-ContribAuthor ">Wayne W.  Harding</span>. </span><span class="cited-content_cbyCitation_article-title">Tetrahydroprotoberberine alkaloids with dopamine and σ receptor affinity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (9)
                                     , 2060-2071. <a href="https://doi.org/10.1016/j.bmc.2016.03.037" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.03.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.03.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.03.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DTetrahydroprotoberberine%252Balkaloids%252Bwith%252Bdopamine%252Band%252B%2525CF%252583%252Breceptor%252Baffinity%26aulast%3DGadhiya%26aufirst%3DSatishkumar%26date%3D2016%26volume%3D24%26issue%3D9%26spage%3D2060%26epage%3D2071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrizio  Micheli</span>, <span class="hlFld-ContribAuthor ">Andrea  Bernardelli</span>, <span class="hlFld-ContribAuthor ">Federica  Bianchi</span>, <span class="hlFld-ContribAuthor ">Simone  Braggio</span>, <span class="hlFld-ContribAuthor ">Laura  Castelletti</span>, <span class="hlFld-ContribAuthor ">Palmina  Cavallini</span>, <span class="hlFld-ContribAuthor ">Paolo  Cavanni</span>, <span class="hlFld-ContribAuthor ">Susanna  Cremonesi</span>, <span class="hlFld-ContribAuthor ">Michele Dal  Cin</span>, <span class="hlFld-ContribAuthor ">Aldo  Feriani</span>, <span class="hlFld-ContribAuthor ">Beatrice  Oliosi</span>, <span class="hlFld-ContribAuthor ">Teresa  Semeraro</span>, <span class="hlFld-ContribAuthor ">Luca  Tarsi</span>, <span class="hlFld-ContribAuthor ">Silvia  Tomelleri</span>, <span class="hlFld-ContribAuthor ">Andrea  Wong</span>, <span class="hlFld-ContribAuthor ">Filippo  Visentini</span>, <span class="hlFld-ContribAuthor ">Laura  Zonzini</span>, <span class="hlFld-ContribAuthor ">Christian  Heidbreder</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (8)
                                     , 1619-1636. <a href="https://doi.org/10.1016/j.bmc.2016.02.031" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.02.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.02.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.02.031%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3D1%25252C2%25252C4-Triazolyl%252Boctahydropyrrolo%25255B2%25252C3-b%25255Dpyrroles%25253A%252BA%252Bnew%252Bseries%252Bof%252Bpotent%252Band%252Bselective%252Bdopamine%252BD3%252Breceptor%252Bantagonists%26aulast%3DMicheli%26aufirst%3DFabrizio%26date%3D2016%26volume%3D24%26issue%3D8%26spage%3D1619%26epage%3D1636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Micoli</span>, <span class="hlFld-ContribAuthor ">A.  De Simone</span>, <span class="hlFld-ContribAuthor ">D.  Russo</span>, <span class="hlFld-ContribAuthor ">G.  Ottonello</span>, <span class="hlFld-ContribAuthor ">G.  Colombano</span>, <span class="hlFld-ContribAuthor ">G. F.  Ruda</span>, <span class="hlFld-ContribAuthor ">T.  Bandiera</span>, <span class="hlFld-ContribAuthor ">A.  Cavalli</span>, <span class="hlFld-ContribAuthor ">G.  Bottegoni</span>. </span><span class="cited-content_cbyCitation_article-title">Aryl and heteroaryl
              N
              -[4-[4-(2,3-substituted-phenyl)piperazine-1-yl]alkyl]carbamates with improved physico-chemical properties as dual modulators of dopamine D3 receptor and fatty acid amide hydrolase. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (3)
                                     , 537-541. <a href="https://doi.org/10.1039/C5MD00590F" title="DOI URL">https://doi.org/10.1039/C5MD00590F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00590F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00590F%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DAryl%252Band%252Bheteroaryl%252BN%252B-%25255B4-%25255B4-%2525282%25252C3-substituted-phenyl%252529piperazine-1-yl%25255Dalkyl%25255Dcarbamates%252Bwith%252Bimproved%252Bphysico-chemical%252Bproperties%252Bas%252Bdual%252Bmodulators%252Bof%252Bdopamine%252BD3%252Breceptor%252Band%252Bfatty%252Bacid%252Bamide%252Bhydrolase%26aulast%3DMicoli%26aufirst%3DA.%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D3%26spage%3D537%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christina B.  Shin</span>, <span class="hlFld-ContribAuthor ">Michela M.  Serchia</span>, <span class="hlFld-ContribAuthor ">John R.  Shahin</span>, <span class="hlFld-ContribAuthor ">Micaela A.  Ruppert-Majer</span>, <span class="hlFld-ContribAuthor ">Tod E.  Kippin</span>, <span class="hlFld-ContribAuthor ">Karen K.  Szumlinski</span>. </span><span class="cited-content_cbyCitation_article-title">Incubation of cocaine-craving relates to glutamate over-flow within ventromedial prefrontal cortex. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2016,</strong> <em>102 </em>, 103-110. <a href="https://doi.org/10.1016/j.neuropharm.2015.10.038" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2015.10.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2015.10.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2015.10.038%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DIncubation%252Bof%252Bcocaine-craving%252Brelates%252Bto%252Bglutamate%252Bover-flow%252Bwithin%252Bventromedial%252Bprefrontal%252Bcortex%26aulast%3DShin%26aufirst%3DChristina%2BB.%26date%3D2016%26volume%3D102%26spage%3D103%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan  Zhen</span>, <span class="hlFld-ContribAuthor ">Tamara  Antonio</span>, <span class="hlFld-ContribAuthor ">Joanna C.  Jacob</span>, <span class="hlFld-ContribAuthor ">David K.  Grandy</span>, <span class="hlFld-ContribAuthor ">Maarten E. A.  Reith</span>, <span class="hlFld-ContribAuthor ">Aloke K.  Dutta</span>, <span class="hlFld-ContribAuthor ">Dana E.  Selley</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy of Hybrid Tetrahydrobenzo[d]thiazole Based Aryl Piperazines D-264 and D-301 at D2 and D3 Receptors. </span><span class="cited-content_cbyCitation_journal-name">Neurochemical Research</span><span> <strong>2016,</strong> <em>41 </em>
                                    (1-2)
                                     , 328-339. <a href="https://doi.org/10.1007/s11064-015-1808-6" title="DOI URL">https://doi.org/10.1007/s11064-015-1808-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11064-015-1808-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11064-015-1808-6%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurochemical%2520Research%26atitle%3DEfficacy%252Bof%252BHybrid%252BTetrahydrobenzo%25255Bd%25255Dthiazole%252BBased%252BAryl%252BPiperazines%252BD-264%252Band%252BD-301%252Bat%252BD2%252Band%252BD3%252BReceptors%26aulast%3DZhen%26aufirst%3DJuan%26date%3D2016%26date%3D2015%26volume%3D41%26issue%3D1-2%26spage%3D328%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marc  Capet</span>, <span class="hlFld-ContribAuthor ">Thierry  Calmels</span>, <span class="hlFld-ContribAuthor ">Nicolas  Levoin</span>, <span class="hlFld-ContribAuthor ">Denis  Danvy</span>, <span class="hlFld-ContribAuthor ">Isabelle  Berrebi-Bertrand</span>, <span class="hlFld-ContribAuthor ">Holger  Stark</span>, <span class="hlFld-ContribAuthor ">Jean-Charles  Schwartz</span>, <span class="hlFld-ContribAuthor ">Jeanne-Marie  Lecomte</span>. </span><span class="cited-content_cbyCitation_article-title">Improving selectivity of dopamine D3 receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (3)
                                     , 885-888. <a href="https://doi.org/10.1016/j.bmcl.2015.12.068" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.12.068</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.12.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.12.068%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DImproving%252Bselectivity%252Bof%252Bdopamine%252BD3%252Breceptor%252Bligands%26aulast%3DCapet%26aufirst%3DMarc%26date%3D2016%26volume%3D26%26issue%3D3%26spage%3D885%26epage%3D888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongkai  Cao</span>, <span class="hlFld-ContribAuthor ">Chengchun  Min</span>, <span class="hlFld-ContribAuthor ">Srijan  Acharya</span>, <span class="hlFld-ContribAuthor ">Kyeong-Man  Kim</span>, <span class="hlFld-ContribAuthor ">Seung Hoon  Cheon</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of bitopic arylpiperazinephenyl-1,2,4-oxadiazoles as preferential dopamine D3 receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (2)
                                     , 191-200. <a href="https://doi.org/10.1016/j.bmc.2015.12.002" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.12.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.12.002%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bbitopic%252Barylpiperazinephenyl-1%25252C2%25252C4-oxadiazoles%252Bas%252Bpreferential%252Bdopamine%252BD3%252Breceptor%252Bligands%26aulast%3DCao%26aufirst%3DYongkai%26date%3D2016%26volume%3D24%26issue%3D2%26spage%3D191%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stela Maris Kuze  Rates</span>, <span class="hlFld-ContribAuthor ">Andresa Heemann  Betti</span>, <span class="hlFld-ContribAuthor ">Liz Girardi  Müller</span>, <span class="hlFld-ContribAuthor ">Jéssica de Matos  Nunes</span>. </span><span class="cited-content_cbyCitation_article-title">Plant Toxins as Sources of Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 1-21. <a href="https://doi.org/10.1007/978-94-007-6728-7_5-1" title="DOI URL">https://doi.org/10.1007/978-94-007-6728-7_5-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-94-007-6728-7_5-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-94-007-6728-7_5-1%26sid%3Dliteratum%253Aachs%26atitle%3DPlant%252BToxins%252Bas%252BSources%252Bof%252BDrugs%26aulast%3DRates%26aufirst%3DStela%2BMaris%2BKuze%26date%3D2015%26date%3D2015%26spage%3D1%26epage%3D21%26pub%3DSpringer%2520Netherlands%26atitle%3DPlant%252BToxins%26aulast%3DGopalakrishnakone%26aufirst%3DP.%26date%3D2015%26volume%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/medium/jm-2014-01512b_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/medium/jm-2014-01512b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Chemical Structures of Highlighted D3R-Selective Partial Agonists and Antagonists</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/medium/jm-2014-01512b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Recently Reported D3R-Preferential Ligands with Novel Structural Templates</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/medium/jm-2014-01512b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. Behaviorally Tested D3R-Preferential Ligands</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/medium/jm-2014-01512b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Concentration profiles for 10 mg/kg (±)-<b>1</b> in mouse plasma following i.v. (○) or p.o. (■) administration. Data are presented as mean ± SEM; <i>n</i> = 3 mice per time point.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/medium/jm-2014-01512b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effects of i.p. vehicle or <b>1</b> (racemic and enantiomers) on PR self-administration of METH. Data are presented as mean ± SEM; * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001. Statistics in panel A refer to number of METH injections (right axis) compared to vehicle; statistics in panel B refer to break point values (last ratio completed), normalized to baseline responding, compared to vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/medium/jm-2014-01512b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Acquisition of METH self-administration and extinction of self-administration. (B) Effects of i.p. vehicle or (±)-<b>1</b> on METH-primed reinstatement of METH-seeking behavior. Data are presented as mean ± SEM; * <i>p</i> < 0.05 compared to vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/medium/jm-2014-01512b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of i.v. vehicle or (±)-<b>1</b> on cocaine choice in seven monkeys individually and as a group (lower right panel). Ordinates, percent of total reinforcers earned that resulted in cocaine injections. Abscissae, dose of cocaine (mg/kg) available as an alternative to a food pellet. Data in lower right panel represent mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/medium/jm-2014-01512b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of acute and chronic administration of (±)-<b>1</b> (i.v.) on METH choice in three rhesus monkeys (mean ± SEM of days 3–5 of daily treatment). Ordinates, percent of total reinforcers earned that resulted in METH injections. Abscissae, dose of METH (mg/kg) available as an alternative to a food pellet.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jm501512b/20160331/images/large/jm-2014-01512b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501512b&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54475" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54475" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 178 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3663</span><span class="NLM_x">–</span> <span class="NLM_lpage">3679</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040190e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtl2nur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3663-3679&author=A.+H.+Newmanauthor=P.+Grundtauthor=M.+A.+Nader&title=Dopamine+D3+receptor+partial+agonists+and+antagonists+as+potential+drug+abuse+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D3 Receptor Partial Agonists and Antagonists as Potential Drug Abuse Therapeutic Agents</span></div><div class="casAuthors">Newman, Amy Hauck; Grundt, Peter; Nader, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3663-3679</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This report is limited to discussions of potential dopamine D3 receptor agents, currently being developed as medications for drug abuse and other neuropsychiatric disorders, to partial agonists and antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqHXSFV83KfLVg90H21EOLACvtfcHk0lgmHjlvmT9vuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtl2nur0%253D&md5=4244539d9e8038e2027dba1e21497cdd</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm040190e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040190e%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DDopamine%2520D3%2520receptor%2520partial%2520agonists%2520and%2520antagonists%2520as%2520potential%2520drug%2520abuse%2520therapeutic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3663%26epage%3D3679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Chien, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">1091</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1126%2Fscience.1197410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=21097933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVahurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1091-1095&author=E.+Y.+Chienauthor=W.+Liuauthor=Q.+Zhaoauthor=V.+Katritchauthor=G.+W.+Hanauthor=M.+A.+Hansonauthor=L.+Shiauthor=A.+H.+Newmanauthor=J.+A.+Javitchauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+human+dopamine+D3+receptor+in+complex+with+a+D2%2FD3+selective+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist</span></div><div class="casAuthors">Chien, Ellen Y. T.; Liu, Wei; Zhao, Qiang; Katritch, Vsevolod; Won Han, Gye; Hanson, Michael A.; Shi, Lei; Newman, Amy Hauck; Javitch, Jonathan A.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6007</span>),
    <span class="NLM_cas:pages">1091-1095</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Dopamine modulates movement, cognition, and emotion through activation of dopamine G protein-coupled receptors in the brain.  The crystal structure of the human dopamine D3 receptor (D3R) in complex with the small mol. D2R/D3R-specific antagonist eticlopride reveals important features of the ligand binding pocket and extracellular loops.  On the intracellular side of the receptor, a locked conformation of the ionic lock and two distinctly different conformations of intracellular loop 2 are obsd.  Docking of R-22, a D3R-selective antagonist, reveals an extracellular extension of the eticlopride binding site that comprises a second binding pocket for the aryl amide of R-22, which differs between the highly homologous D2R and D3R.  This difference provides direction to the design of D3R-selective agents for treating drug abuse and other neuropsychiatric indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOEcfSdjMm-7Vg90H21EOLACvtfcHk0lgmHjlvmT9vuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVahurvM&md5=12c6f343daea9fb14ca605a092f28533</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1197410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1197410%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DE.%2BY.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520human%2520dopamine%2520D3%2520receptor%2520in%2520complex%2520with%2520a%2520D2%252FD3%2520selective%2520antagonist%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D1091%26epage%3D1095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Keck, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burzynski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Beyond small-molecule SAR: using the dopamine D3 receptor crystal structure to guide drug design</span> <span class="citation_source-journal">Adv. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2FB978-0-12-420118-7.00007-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24484980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsFCitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=267-300&author=T.+M.+Keckauthor=C.+Burzynskiauthor=L.+Shiauthor=A.+H.+Newman&title=Beyond+small-molecule+SAR%3A+using+the+dopamine+D3+receptor+crystal+structure+to+guide+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond small-molecule SAR: using the dopamine D3 receptor crystal structure to guide drug design</span></div><div class="casAuthors">Keck, Thomas M.; Burzynski, Caitlin; Shi, Lei; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Pharmacology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse</span>),
    <span class="NLM_cas:pages">267-300</span>CODEN:
                <span class="NLM_cas:coden">ADPHEL</span>;
        ISSN:<span class="NLM_cas:issn">1054-3589</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The dopamine D3 receptor is a target of pharmacotherapeutic interest in a variety of neurol. disorders including schizophrenia, restless leg syndrome, and drug addiction.  The high protein sequence homol. between the D3 and D2 receptors has posed a challenge to developing D3 receptor-selective ligands whose behavioral actions can be attributed to D3 receptor engagement, in vivo.  However, through primarily small-mol. structure-activity relationship (SAR) studies, a variety of chem. scaffolds have been discovered over the past two decades that have resulted in several D3 receptor-selective ligands with high affinity and in vivo activity.  Nevertheless, viable clin. candidates remain limited.  The recent detn. of the high-resoln. crystal structure of the D3 receptor has invigorated structure-based drug design, providing refinements to the mol. dynamic models and testable predictions about receptor-ligand interactions.  This chapter will highlight recent preclin. and clin. studies demonstrating potential utility of D3 receptor-selective ligands in the treatment of addiction.  In addn., new structure-based rational drug design strategies for D3 receptor-selective ligands that complement traditional small-mol. SAR to improve the selectivity and directed efficacy profiles are examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbH7VLMIagF7Vg90H21EOLACvtfcHk0lgjpStFBSyFAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsFCitb8%253D&md5=d266814a068e4528c70e200a860fab64</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-420118-7.00007-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-420118-7.00007-X%26sid%3Dliteratum%253Aachs%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DBurzynski%26aufirst%3DC.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DBeyond%2520small-molecule%2520SAR%253A%2520using%2520the%2520dopamine%2520D3%2520receptor%2520crystal%2520structure%2520to%2520guide%2520drug%2520design%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2014%26volume%3D69%26spage%3D267%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span> </span><span class="NLM_article-title">Structure-based drug design for dopamine D3 receptor</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.2174%2F138620712803901135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=22931309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvV2quw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=775-791&author=Z.+Fengauthor=T.+Houauthor=Y.+Li&title=Structure-based+drug+design+for+dopamine+D3+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based drug design for dopamine D3 receptor</span></div><div class="casAuthors">Feng, Zhiwei; Hou, Tingjun; Li, Youyong</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">775-791</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  D2-like receptors are members of dopamine receptors, including dopamine D2 receptor (D2R), dopamine D3 receptor (D3R), and dopamine D4 receptor (D4R), which modulate behavior, cognition, and emotion.  D2-like receptors are crit. targets for drug development.  Particularly, D3R has been identified as a therapeutic target for antipsychotic and anti-parkinsonian drugs.  Recently, the crystal structure of D3R was reported.  Here we summarize the available active compds. for D3R and the structure-activity relationships (SAR) studies of them.  This provides lead templates for further chem. modification.  We describe the structure features of the recent crystal structure of D3R and its difference from other G protein-coupled receptors (GPCRs).  We provide the recognition mechanism of the inhibitors of D3R (mol. docking results and mol. dynamics results), which illustrates the interaction between the inhibitors and crit. residues of D3R.  Finally, we summarize the outlook of drug development for D3R.  Our study provides useful information for developing high selective, high potent antagonists and agonists of D3R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrytYUzWYZN3bVg90H21EOLACvtfcHk0lgjpStFBSyFAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvV2quw%253D%253D&md5=7d50a2de5c7865751e63a37850127e1b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F138620712803901135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138620712803901135%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DHou%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DStructure-based%2520drug%2520design%2520for%2520dopamine%2520D3%2520receptor%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2012%26volume%3D15%26spage%3D775%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyriac, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span> </span><span class="NLM_article-title"><i>N</i>-(4-(4-(2,3-Dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D3 receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2559</span><span class="NLM_x">–</span> <span class="NLM_lpage">2570</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900095y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2559-2570&author=A.+H.+Newmanauthor=P.+Grundtauthor=G.+Cyriacauthor=J.+R.+Deschampsauthor=M.+Taylorauthor=R.+Kumarauthor=D.+Hoauthor=R.+R.+Luedtke&title=N-%284-%284-%282%2C3-Dichloro-+or+2-methoxyphenyl%29piperazin-1-yl%29butyl%29heterobiarylcarboxamides+with+functionalized+linking+chains+as+high+affinity+and+enantioselective+D3+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm900095y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900095y%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DCyriac%26aufirst%3DG.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DHo%26aufirst%3DD.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26atitle%3DN-%25284-%25284-%25282%252C3-Dichloro-%2520or%25202-methoxyphenyl%2529piperazin-1-yl%2529butyl%2529heterobiarylcarboxamides%2520with%2520functionalized%2520linking%2520chains%2520as%2520high%2520affinity%2520and%2520enantioselective%2520D3%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2559%26epage%3D2570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Ikemoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, R. A.</span><span> </span><span class="NLM_article-title">Mapping of chemical trigger zones for reward</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=190-201&author=S.+Ikemotoauthor=R.+A.+Wise&title=Mapping+of+chemical+trigger+zones+for+reward"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIkemoto%26aufirst%3DS.%26aulast%3DWise%26aufirst%3DR.%2BA.%26atitle%3DMapping%2520of%2520chemical%2520trigger%2520zones%2520for%2520reward%26jtitle%3DNeuropharmacology%26date%3D2004%26volume%3D47%26spage%3D190%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Koob, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkow, N. D.</span><span> </span><span class="NLM_article-title">Neurocircuitry of addiction</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1038%2Fnpp.2009.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=19710631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BD1MfivVWgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=217-238&author=G.+F.+Koobauthor=N.+D.+Volkow&title=Neurocircuitry+of+addiction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Neurocircuitry of addiction</span></div><div class="casAuthors">Koob George F; Volkow Nora D</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">217-38</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Drug addiction is a chronically relapsing disorder that has been characterized by (1) compulsion to seek and take the drug, (2) loss of control in limiting intake, and (3) emergence of a negative emotional state (eg, dysphoria, anxiety, irritability) reflecting a motivational withdrawal syndrome when access to the drug is prevented.  Drug addiction has been conceptualized as a disorder that involves elements of both impulsivity and compulsivity that yield a composite addiction cycle composed of three stages: 'binge/intoxication', 'withdrawal/negative affect', and 'preoccupation/anticipation' (craving).  Animal and human imaging studies have revealed discrete circuits that mediate the three stages of the addiction cycle with key elements of the ventral tegmental area and ventral striatum as a focal point for the binge/intoxication stage, a key role for the extended amygdala in the withdrawal/negative affect stage, and a key role in the preoccupation/anticipation stage for a widely distributed network involving the orbitofrontal cortex-dorsal striatum, prefrontal cortex, basolateral amygdala, hippocampus, and insula involved in craving and the cingulate gyrus, dorsolateral prefrontal, and inferior frontal cortices in disrupted inhibitory control.  The transition to addiction involves neuroplasticity in all of these structures that may begin with changes in the mesolimbic dopamine system and a cascade of neuroadaptations from the ventral striatum to dorsal striatum and orbitofrontal cortex and eventually dysregulation of the prefrontal cortex, cingulate gyrus, and extended amygdala.  The delineation of the neurocircuitry of the evolving stages of the addiction syndrome forms a heuristic basis for the search for the molecular, genetic, and neuropharmacological neuroadaptations that are key to vulnerability for developing and maintaining addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRm5_6_UKyiWwqdek-gHSrIfW6udTcc2eYxcaXC91TNvLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MfivVWgtA%253D%253D&md5=f6b4f491d6a4e9ea48fc89d18cebc022</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2009.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2009.110%26sid%3Dliteratum%253Aachs%26aulast%3DKoob%26aufirst%3DG.%2BF.%26aulast%3DVolkow%26aufirst%3DN.%2BD.%26atitle%3DNeurocircuitry%2520of%2520addiction%26jtitle%3DNeuropsychopharmacology%26date%3D2010%26volume%3D35%26spage%3D217%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Russo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nestler, E. J.</span><span> </span><span class="NLM_article-title">The brain reward circuitry in mood disorders</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1038%2Fnrn3381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=23942470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1KgtrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=609-625&author=S.+J.+Russoauthor=E.+J.+Nestler&title=The+brain+reward+circuitry+in+mood+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The brain reward circuitry in mood disorders</span></div><div class="casAuthors">Russo, Scott J.; Nestler, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">609-625</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mood disorders are common and debilitating conditions characterized in part by profound deficits in reward-related behavioral domains.  A recent literature has identified important structural and functional alterations within the brain's reward circuitry - particularly in the ventral tegmental area-nucleus accumbens pathway - that are assocd. with symptoms such as anhedonia and aberrant reward-assocd. perception and memory.  This Review synthesizes recent data from human and rodent studies from which emerges a circuit-level framework for understanding reward deficits in depression.  We also discuss some of the mol. and cellular underpinnings of this framework, ranging from adaptations in glutamatergic synapses and neurotrophic factors to transcriptional and epigenetic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOLF5CC3Y-dLVg90H21EOLACvtfcHk0lh4QkLyVYcedg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1KgtrfP&md5=a4df74d29daa78ad13a56700d45cb4b7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrn3381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3381%26sid%3Dliteratum%253Aachs%26aulast%3DRusso%26aufirst%3DS.%2BJ.%26aulast%3DNestler%26aufirst%3DE.%2BJ.%26atitle%3DThe%2520brain%2520reward%2520circuitry%2520in%2520mood%2520disorders%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D609%26epage%3D625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Volkow, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telang, F.</span><span> </span><span class="NLM_article-title">Addiction: beyond dopamine reward circuitry</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">15037</span><span class="NLM_x">–</span> <span class="NLM_lpage">15042</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=15037-15042&author=N.+D.+Volkowauthor=G.+J.+Wangauthor=J.+S.+Fowlerauthor=D.+Tomasiauthor=F.+Telang&title=Addiction%3A+beyond+dopamine+reward+circuitry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVolkow%26aufirst%3DN.%2BD.%26aulast%3DWang%26aufirst%3DG.%2BJ.%26aulast%3DFowler%26aufirst%3DJ.%2BS.%26aulast%3DTomasi%26aufirst%3DD.%26aulast%3DTelang%26aufirst%3DF.%26atitle%3DAddiction%253A%2520beyond%2520dopamine%2520reward%2520circuitry%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D15037%26epage%3D15042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Schmitt, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span> </span><span class="NLM_article-title">Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1187</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1187&publication_year=2010&pages=316-340&author=K.+C.+Schmittauthor=M.+E.+Reith&title=Regulation+of+the+dopamine+transporter%3A+aspects+relevant+to+psychostimulant+drugs+of+abuse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DK.%2BC.%26aulast%3DReith%26aufirst%3DM.%2BE.%26atitle%3DRegulation%2520of%2520the%2520dopamine%2520transporter%253A%2520aspects%2520relevant%2520to%2520psychostimulant%2520drugs%2520of%2520abuse%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2010%26volume%3D1187%26spage%3D316%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Volkow, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatley, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewey, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitzemann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gifford, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pappas, N. R.</span><span> </span><span class="NLM_article-title">Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of “high”</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=9862747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaK1MXisVylsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=1999&pages=14-20&author=N.+D.+Volkowauthor=G.+J.+Wangauthor=J.+S.+Fowlerauthor=S.+J.+Gatleyauthor=J.+Loganauthor=Y.+S.+Dingauthor=S.+L.+Deweyauthor=R.+Hitzemannauthor=A.+N.+Giffordauthor=N.+R.+Pappas&title=Blockade+of+striatal+dopamine+transporters+by+intravenous+methylphenidate+is+not+sufficient+to+induce+self-reports+of+%E2%80%9Chigh%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high"</span></div><div class="casAuthors">Volkow, Nora D.; Wang, Gene-Jack; Fowler, Joanna S.; Gatley, S. John; Logan, Jean; Ding, Yu-Shin; Dewey, Stephen L.; Hitzemann, Robert; Gifford, Andrew N.; Pappas, Naomi R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-20</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The reinforcing effects of cocaine and methylphenidate have been linked to their ability to block dopamine transporters (DAT).  Using positron emission tomog. (PET), the authors previously showed that i.v. cocaine induced a significant level of DAT blockade, which was assocd. with the intensity for self-reports of high in cocaine abusers.  In this study, the authors measured DAT occupancies after i.v. methylphenidate and assessed whether they also were assocd. with the high.  Occupation of DAT by i.v. MP was measured with PET using [11C]cocaine, as a DAT ligand, in 8 normal control subjects tested with different methylphenidate doses.  The ratio of the distribution vol. of [11C]cocaine in striatum to that in cerebellum, which corresponds to Bmax/Kd + 1, was used as a measure of DAT availability.  In parallel, self-reports of high were measured.  Methylphenidate produced a dose-dependent blockade of DAT with an estd. ED50 of 0.075 mg/kg.  DAT occupancies were significantly correlated with the high (p < .03).  However, 4 of the 8 subjects, despite having significant levels of DAT blockade, did not perceive the high.  Methylphenidate is as effective as cocaine in blocking DAT in the human brain (cocaine ED50 = 0.13 mg/kg), and DAT blockade, as for cocaine, was also assocd. with the high.  However, the fact that there were subjects who despite significant DAT blockade did not experience the high suggests that DAT blockade, although necessary, is not sufficient to produce the high.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsfc6EeBfQXrVg90H21EOLACvtfcHk0lgIvc82lNzCqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisVylsg%253D%253D&md5=00e1c470cdce78abd15dfd2d0c1bca2e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVolkow%26aufirst%3DN.%2BD.%26aulast%3DWang%26aufirst%3DG.%2BJ.%26aulast%3DFowler%26aufirst%3DJ.%2BS.%26aulast%3DGatley%26aufirst%3DS.%2BJ.%26aulast%3DLogan%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DY.%2BS.%26aulast%3DDewey%26aufirst%3DS.%2BL.%26aulast%3DHitzemann%26aufirst%3DR.%26aulast%3DGifford%26aufirst%3DA.%2BN.%26aulast%3DPappas%26aufirst%3DN.%2BR.%26atitle%3DBlockade%2520of%2520striatal%2520dopamine%2520transporters%2520by%2520intravenous%2520methylphenidate%2520is%2520not%2520sufficient%2520to%2520induce%2520self-reports%2520of%2520%25E2%2580%259Chigh%25E2%2580%259D%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D288%26spage%3D14%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Volkow, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatley, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitzemann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, A. P.</span><span> </span><span class="NLM_article-title">Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1001%2Farchpsyc.1995.03950180042006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=7771915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaK2MXmvFCnsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1995&pages=456-463&author=N.+D.+Volkowauthor=Y.+S.+Dingauthor=J.+S.+Fowlerauthor=G.+J.+Wangauthor=J.+Loganauthor=J.+S.+Gatleyauthor=S.+Deweyauthor=C.+Ashbyauthor=J.+Liebermannauthor=R.+Hitzemannauthor=A.+P.+Wolf&title=Is+methylphenidate+like+cocaine%3F+Studies+on+their+pharmacokinetics+and+distribution+in+the+human+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Is methylphenidate like cocaine? studies on their pharmacokinetics and distribution in the human brain</span></div><div class="casAuthors">Volkow, Nora D.; Ding, Yu-Shin; Fowler, Joanna S.; Wang, Gene-Jack; Logan, Jean; Gatley, John S.; Dewey, Stephen; Ashby, Charles; Liebermann, Jeffrey; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">456-63</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">The purposes of this study were to investigate the pharmacokinetics of methylphenidate hydrochloride (Ritalin) in the human brain, to compare them with those of cocaine, and to evaluate whether cocaine and methylphenidate compete for the same binding sites.  We used positron emission tomog. to measure the temporal and spatial distribution of carbon 11 (11C)-labeled methylphenidate.  These results were compared with those obtained previously for [11C]cocaine.  Eight healthy male subjects, 20 to 51 yr of age, were scanned with [11C] methylphenidate.  Three were tested twice to assess test-retest variability, four were tested at baseline and after administration of methylphenidate, and one was tested with [11C]methylphenidate and [11C]cocaine.  Two baboons were scanned to evaluate whether there was competition between cocaine and methylphenidate for the same binding sites in the brain.  The uptake of [11C]methylphenidate in the brain was high (mean±SD, 7.5%±1.5%), and the maximal concn. occurred in striatum.  Pretreatment with methylphenidate decreased binding only in striatum (40%).  Although the regional distribution of [11C]methylphenidate was identical to that of [11C]cocaine and they competed with each other for the same binding sites, these two drugs differed markedly in their pharmacokinetics.  Clearance of [11C]methylphenidate from striatum (90 min) was significantly slower than that of [11C]cocaine (20 min).  For both drugs, their fast uptake in striatum paralleled the experience of the "high.".  For methylphenidate, the high decreased very rapidly despite significant binding of the drug in the brain.  In contrast, for cocaine, the decline in the high paralleled its fast rate of clearance from the brain.  We speculate that because the experience of the high is assocd. with the fast uptake of cocaine and methylphenidate in the brain, the slow clearance of methylphenidate from the brain may serve as a limiting factor in promoting its frequent self-administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLZTzkKHqGebVg90H21EOLACvtfcHk0lgIvc82lNzCqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvFCnsLg%253D&md5=87024caf77fea8f8656fcd15d67487d0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1995.03950180042006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1995.03950180042006%26sid%3Dliteratum%253Aachs%26aulast%3DVolkow%26aufirst%3DN.%2BD.%26aulast%3DDing%26aufirst%3DY.%2BS.%26aulast%3DFowler%26aufirst%3DJ.%2BS.%26aulast%3DWang%26aufirst%3DG.%2BJ.%26aulast%3DLogan%26aufirst%3DJ.%26aulast%3DGatley%26aufirst%3DJ.%2BS.%26aulast%3DDewey%26aufirst%3DS.%26aulast%3DAshby%26aufirst%3DC.%26aulast%3DLiebermann%26aufirst%3DJ.%26aulast%3DHitzemann%26aufirst%3DR.%26aulast%3DWolf%26aufirst%3DA.%2BP.%26atitle%3DIs%2520methylphenidate%2520like%2520cocaine%253F%2520Studies%2520on%2520their%2520pharmacokinetics%2520and%2520distribution%2520in%2520the%2520human%2520brain%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1995%26volume%3D52%26spage%3D456%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Ahlgren-Beckendorf, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levant, B.</span><span> </span><span class="NLM_article-title">Signaling mechanisms of the D3 dopamine receptor</span> <span class="citation_source-journal">J. Recept. Signal Transduction Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1081%2FRRS-200029953" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=15521358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVKhs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=117-130&author=J.+A.+Ahlgren-Beckendorfauthor=B.+Levant&title=Signaling+mechanisms+of+the+D3+dopamine+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Signaling Mechanisms of the D3 Dopamine Receptor</span></div><div class="casAuthors">Ahlgren-Beckendorf, Joy A.; Levant, Beth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Receptors and Signal Transduction</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">117-130</span>CODEN:
                <span class="NLM_cas:coden">JRSTCT</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review.  A substantial body of evidence shows the capacity of the dopamine D3 receptor to couple functionally to G proteins when expressed in an appropriate milieu in heterologous expression systems.  In these systems, activation of D3 receptors inhibits adenylate cyclase, modulates ion flow through potassium and calcium channels, and activates kinases, most notably mitogen-activated protein kinase.  Coupling to Gi/Go is implicated in many of these effects, but other G proteins may contribute.  Studies with chimeric receptors implicate the 3rd intracellular loop in the mediation of agonist-induced signal transduction.  Finally, D3-preferring drugs modulate expression of c-fos in neuronal cultures and brain.  Signaling mechanisms of the D3 receptor in brain, however, remain to be definitively detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOl-65wNzGh7Vg90H21EOLACvtfcHk0li17JURHEBR_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVKhs7w%253D&md5=30ff8f18d95ab96ae90c078458ff4dc6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1081%2FRRS-200029953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FRRS-200029953%26sid%3Dliteratum%253Aachs%26aulast%3DAhlgren-Beckendorf%26aufirst%3DJ.%2BA.%26aulast%3DLevant%26aufirst%3DB.%26atitle%3DSignaling%2520mechanisms%2520of%2520the%2520D3%2520dopamine%2520receptor%26jtitle%3DJ.%2520Recept.%2520Signal%2520Transduction%2520Res.%26date%3D2004%26volume%3D24%26spage%3D117%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Sidhu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niznik, H. B.</span><span> </span><span class="NLM_article-title">Coupling of dopamine receptor subtypes to multiple and diverse G proteins</span> <span class="citation_source-journal">Int. J. Dev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2000&pages=669-677&author=A.+Sidhuauthor=H.+B.+Niznik&title=Coupling+of+dopamine+receptor+subtypes+to+multiple+and+diverse+G+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSidhu%26aufirst%3DA.%26aulast%3DNiznik%26aufirst%3DH.%2BB.%26atitle%3DCoupling%2520of%2520dopamine%2520receptor%2520subtypes%2520to%2520multiple%2520and%2520diverse%2520G%2520proteins%26jtitle%3DInt.%2520J.%2520Dev.%2520Neurosci.%26date%3D2000%26volume%3D18%26spage%3D669%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Marcellino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casado, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Foll, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drago, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saur, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lluis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuxe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span> </span><span class="NLM_article-title">Identification of dopamine D1–D3 receptor heteromers. Indications for a role of synergistic D1–D3 receptor interactions in the striatum</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">26016</span><span class="NLM_x">–</span> <span class="NLM_lpage">26025</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=26016-26025&author=D.+Marcellinoauthor=S.+Ferreauthor=V.+Casadoauthor=A.+Cortesauthor=B.+Le+Follauthor=C.+Mazzolaauthor=F.+Dragoauthor=O.+Saurauthor=H.+Starkauthor=A.+Sorianoauthor=C.+Barnesauthor=S.+R.+Goldbergauthor=C.+Lluisauthor=K.+Fuxeauthor=R.+Franco&title=Identification+of+dopamine+D1%E2%80%93D3+receptor+heteromers.+Indications+for+a+role+of+synergistic+D1%E2%80%93D3+receptor+interactions+in+the+striatum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarcellino%26aufirst%3DD.%26aulast%3DFerre%26aufirst%3DS.%26aulast%3DCasado%26aufirst%3DV.%26aulast%3DCortes%26aufirst%3DA.%26aulast%3DLe%2BFoll%26aufirst%3DB.%26aulast%3DMazzola%26aufirst%3DC.%26aulast%3DDrago%26aufirst%3DF.%26aulast%3DSaur%26aufirst%3DO.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DSoriano%26aufirst%3DA.%26aulast%3DBarnes%26aufirst%3DC.%26aulast%3DGoldberg%26aufirst%3DS.%2BR.%26aulast%3DLluis%26aufirst%3DC.%26aulast%3DFuxe%26aufirst%3DK.%26aulast%3DFranco%26aufirst%3DR.%26atitle%3DIdentification%2520of%2520dopamine%2520D1%25E2%2580%2593D3%2520receptor%2520heteromers.%2520Indications%2520for%2520a%2520role%2520of%2520synergistic%2520D1%25E2%2580%2593D3%2520receptor%2520interactions%2520in%2520the%2520striatum%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D26016%26epage%3D26025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Guitart, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Soto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar-Barodia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naidu, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallol, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lluis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canela, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casado, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferre, S.</span><span> </span><span class="NLM_article-title">Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1–D3 receptor heterotetramer</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=417-429&author=X.+Guitartauthor=G.+Navarroauthor=E.+Morenoauthor=H.+Yanoauthor=N.+S.+Caiauthor=M.+Sanchez-Sotoauthor=S.+Kumar-Barodiaauthor=Y.+T.+Naiduauthor=J.+Mallolauthor=A.+Cortesauthor=C.+Lluisauthor=E.+I.+Canelaauthor=V.+Casadoauthor=P.+J.+McCormickauthor=S.+Ferre&title=Functional+selectivity+of+allosteric+interactions+within+G+protein-coupled+receptor+oligomers%3A+the+dopamine+D1%E2%80%93D3+receptor+heterotetramer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuitart%26aufirst%3DX.%26aulast%3DNavarro%26aufirst%3DG.%26aulast%3DMoreno%26aufirst%3DE.%26aulast%3DYano%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DN.%2BS.%26aulast%3DSanchez-Soto%26aufirst%3DM.%26aulast%3DKumar-Barodia%26aufirst%3DS.%26aulast%3DNaidu%26aufirst%3DY.%2BT.%26aulast%3DMallol%26aufirst%3DJ.%26aulast%3DCortes%26aufirst%3DA.%26aulast%3DLluis%26aufirst%3DC.%26aulast%3DCanela%26aufirst%3DE.%2BI.%26aulast%3DCasado%26aufirst%3DV.%26aulast%3DMcCormick%26aufirst%3DP.%2BJ.%26aulast%3DFerre%26aufirst%3DS.%26atitle%3DFunctional%2520selectivity%2520of%2520allosteric%2520interactions%2520within%2520G%2520protein-coupled%2520receptor%2520oligomers%253A%2520the%2520dopamine%2520D1%25E2%2580%2593D3%2520receptor%2520heterotetramer%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D86%26spage%3D417%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Fiorentini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savoia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bono, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallarico, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Missale, C.</span><span> </span><span class="NLM_article-title">The D3 dopamine receptor: From structural interactions to function</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1016/j.euroneuro.2014.1011.1021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.euroneuro.2014.1011.1021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=25532864" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+Fiorentiniauthor=P.+Savoiaauthor=F.+Bonoauthor=P.+Tallaricoauthor=C.+Missale&title=The+D3+dopamine+receptor%3A+From+structural+interactions+to+function&doi=10.1016%2Fj.euroneuro.2014.1011.1021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2014.1011.1021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2014.1011.1021%26sid%3Dliteratum%253Aachs%26aulast%3DFiorentini%26aufirst%3DC.%26aulast%3DSavoia%26aufirst%3DP.%26aulast%3DBono%26aufirst%3DF.%26aulast%3DTallarico%26aufirst%3DP.%26aulast%3DMissale%26aufirst%3DC.%26atitle%3DThe%2520D3%2520dopamine%2520receptor%253A%2520From%2520structural%2520interactions%2520to%2520function%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2014%26doi%3D10.1016%2Fj.euroneuro.2014.1011.1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaylock, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skolnick, P.</span><span> </span><span class="NLM_article-title">Medication discovery for addiction: translating the dopamine D3 receptor hypothesis</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">882</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.bcp.2012.06.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=22781742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOqu73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=882-890&author=A.+H.+Newmanauthor=B.+L.+Blaylockauthor=M.+A.+Naderauthor=J.+Bergmanauthor=D.+R.+Sibleyauthor=P.+Skolnick&title=Medication+discovery+for+addiction%3A+translating+the+dopamine+D3+receptor+hypothesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Medication discovery for addiction: Translating the dopamine D3 receptor hypothesis</span></div><div class="casAuthors">Newman, Amy Hauck; Blaylock, Brandi L.; Nader, Michael A.; Bergman, Jack; Sibley, David R.; Skolnick, Phil</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">882-890</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The dopamine D3 receptor (D3R) has been investigated as a potential target for medication development to treat substance use disorders (SUDs) with a particular focus on cocaine and methamphetamine.  Currently, there are no approved medications to treat cocaine and methamphetamine addiction and thus developing pharmacotherapeutics to complement existing behavioral strategies is a fundamental goal.  Novel compds. with high affinity and D3R selectivity have been evaluated in numerous animal models of drug abuse and favorable outcomes in nonhuman primate models of self-administration and relapse have provided compelling evidence to advance these agents into the clinic.  One approach is to repurpose drugs that share the D3R mechanism and already have clin. utility, and to this end buspirone has been identified as a viable candidate for clin. trials.  A second, but substantially more resource intensive and risky approach involves the development of compds. that exclusively target D3R, such as GSK598809 and PG 619.  Clin. investigation of these drugs or other novel D3R-selective agents will provide a better understanding of the role D3R plays in addiction and whether or not antagonists or partial agonists that are D3R selective are effective in achieving abstinence in this patient population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_waGudfGt4LVg90H21EOLACvtfcHk0ljq6r8PKL1N4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOqu73O&md5=820f1ddd46c9888c687bc0cc8cd3aa96</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.06.023%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DBlaylock%26aufirst%3DB.%2BL.%26aulast%3DNader%26aufirst%3DM.%2BA.%26aulast%3DBergman%26aufirst%3DJ.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DSkolnick%26aufirst%3DP.%26atitle%3DMedication%2520discovery%2520for%2520addiction%253A%2520translating%2520the%2520dopamine%2520D3%2520receptor%2520hypothesis%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26spage%3D882%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Heidbreder, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1187</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1111%2Fj.1749-6632.2009.05149.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=20201845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXks1Snurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1187&publication_year=2010&pages=4-34&author=C.+A.+Heidbrederauthor=A.+H.+Newman&title=Current+perspectives+on+selective+dopamine+D%283%29+receptor+antagonists+as+pharmacotherapeutics+for+addictions+and+related+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders</span></div><div class="casAuthors">Heidbreder, Christian A.; Newman, Amy H.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1187</span>
        (<span class="NLM_cas:issue">Addiction Reviews 2</span>),
    <span class="NLM_cas:pages">4-34</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Repeated exposure to drugs of abuse produces long-term mol. and neurochem. changes that may explain the core features of addiction, such as the compulsive seeking and taking of the drug, as well as the risk of relapse.  A growing no. of new mol. and cellular targets of addictive drugs have been identified, and rapid advances are being made in relating those targets to specific behavioral phenotypes in animal models of addiction.  In this context, the pattern of expression of the dopamine (DA) D3 receptor in the rodent and human brain and changes in this pattern in response to drugs of abuse have contributed primarily to direct research efforts toward the development of selective DA D3 receptor antagonists.  Growing preclin. evidence indicates that these compds. may actually regulate the motivation to self-administer drugs and disrupt drug-assocd. cue-induced craving.  This report will be divided into three parts.  First, preclin. evidence in support of the efficacy of selective DA D3 receptor antagonists in animal models of drug addiction will be reviewed.  The effects of mixed DA D2/D3 receptor antagonists will not be discussed here because most of these compds. have low selectivity at the D3 vs. D2 receptor, and their efficacy profile is related primarily to functional antagonism at D2 receptors and possibly interactions with other neurotransmitter systems.  Second, major advances in medicinal chem. for the identification and optimization of selective DA D3 receptor antagonists and partial agonists will be analyzed.  Third, translational research from preclin. efficacy studies to so-called proof-of-concept studies for drug addiction indications will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqarcQYm33s6LVg90H21EOLACvtfcHk0liZ4v85zqUqkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXks1Snurc%253D&md5=48ded12d27f36b8d77717b118ccfa869</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2009.05149.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2009.05149.x%26sid%3Dliteratum%253Aachs%26aulast%3DHeidbreder%26aufirst%3DC.%2BA.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DCurrent%2520perspectives%2520on%2520selective%2520dopamine%2520D%25283%2529%2520receptor%2520antagonists%2520as%2520pharmacotherapeutics%2520for%2520addictions%2520and%2520related%2520disorders%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2010%26volume%3D1187%26spage%3D4%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Micheli, F.</span><span> </span><span class="NLM_article-title">Recent advances in the development of dopamine D3 receptor antagonists: a medicinal chemistry perspective</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1152</span><span class="NLM_x">–</span> <span class="NLM_lpage">1162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1002%2Fcmdc.201000538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=21425240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVCntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1152-1162&author=F.+Micheli&title=Recent+advances+in+the+development+of+dopamine+D3+receptor+antagonists%3A+a+medicinal+chemistry+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Development of Dopamine D3 Receptor Antagonists: a Medicinal Chemistry Perspective</span></div><div class="casAuthors">Micheli, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1152-1162</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Dopamine (DA) D3 receptor antagonism might play a significant role in different therapeutic areas.  A high no. of preclin. studies on DA D3 receptor antagonists have shown efficacy in animal models of Parkinson's disease, schizophrenia and drug dependence.  This Review covers the activities of medicinal chemists in this field over the last ten years towards the identification of truly selective compds.  Both primary and patent literature is reviewed here.  Since the original discoveries, a clear trend towards the optimization of the developability properties of the new scaffold has clearly emerged with time, from both academic and industrial researchers.  Examples of advanced leads from academia and industry are described.  The latest potential therapeutic applications are reported too.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofhYCeq4b9EbVg90H21EOLACvtfcHk0liZ4v85zqUqkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVCntbk%253D&md5=61c2b60b5e69df3517421e922b7aa73a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000538%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520dopamine%2520D3%2520receptor%2520antagonists%253A%2520a%2520medicinal%2520chemistry%2520perspective%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1152%26epage%3D1162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Micheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C.</span><span> </span><span class="NLM_article-title">Dopamine D3 receptor antagonists: a patent review (2007–2012)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1517%2F13543776.2013.757593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=23282131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1Sqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=363-381&author=F.+Micheliauthor=C.+Heidbreder&title=Dopamine+D3+receptor+antagonists%3A+a+patent+review+%282007%E2%80%932012%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D3 receptor antagonists: a patent review (2007 - 2012)</span></div><div class="casAuthors">Micheli, Fabrizio; Heidbreder, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">363-381</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The synthesis and characterization of new highly potent and selective dopamine (DA) D3 receptor antagonists has permitted to characterize the role of the DA D3 receptor in the control of drug-seeking behavior and in the pathophysiol. of impulse control disorders and schizophrenia.Areas covered: In the present review, the authors will first describe most recent classes of DA D3 receptor antagonists by reviewing about 43 patent applications during the 2007 - 2012 period; they will then outline the biol. rationale in support of the use of selective DA D3 receptor antagonists in the treatment of drug addiction, impulse control disorders and schizophrenia.Expert opinion: The strongest clin. application and potential for selective DA D3 receptor antagonists lies in the redn. of drug-induced incentive motivation, the attenuation of drug's rewarding efficacy and the redn. in reinstatement of drug-seeking behavior triggered either by re-exposure to the drug itself, re-exposure to environmental cues that had been previously assocd. with drug-taking behavior or stress.  The selectivity of these antagonists together with reduced lipophilicity (minimizing unspecific binding), increased brain penetration and improved physico-chem. profile are all key factors for clin. efficacy and safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz7CcUwWNKXrVg90H21EOLACvtfcHk0liRyNkO5LX2Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1Sqsrk%253D&md5=cbf7c42a3a88693f44b1adea64f6caf3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.757593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.757593%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3DDopamine%2520D3%2520receptor%2520antagonists%253A%2520a%2520patent%2520review%2520%25282007%25E2%2580%25932012%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D363%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Ye, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumeyer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldessarini, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A.</span><span> </span><span class="NLM_article-title">Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">PR123</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr300113a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2013&pages=PR123-178&author=N.+Yeauthor=J.+L.+Neumeyerauthor=R.+J.+Baldessariniauthor=X.+Zhenauthor=A.+Zhang&title=Update+1+of%3A+Recent+progress+in+development+of+dopamine+receptor+subtype-selective+agents%3A+potential+therapeutics+for+neurological+and+psychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fcr300113a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr300113a%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DN.%26aulast%3DNeumeyer%26aufirst%3DJ.%2BL.%26aulast%3DBaldessarini%26aufirst%3DR.%2BJ.%26aulast%3DZhen%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DA.%26atitle%3DUpdate%25201%2520of%253A%2520Recent%2520progress%2520in%2520development%2520of%2520dopamine%2520receptor%2520subtype-selective%2520agents%253A%2520potential%2520therapeutics%2520for%2520neurological%2520and%2520psychiatric%2520disorders%26jtitle%3DChem.%2520Rev.%26date%3D2013%26volume%3D113%26spage%3DPR123%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Michino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donthamsetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beuming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banala, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinquet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span> </span><span class="NLM_article-title">A single glycine in extracellular loop 1 is the critical determinant for pharmacological specificity of dopamine D2 and D3 receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">854</span><span class="NLM_x">–</span> <span class="NLM_lpage">864</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1124%2Fmol.113.087833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24061855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVyitLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=854-864&author=M.+Michinoauthor=P.+Donthamsettiauthor=T.+Beumingauthor=A.+Banalaauthor=L.+Duanauthor=T.+Rouxauthor=Y.+Hanauthor=E.+Trinquetauthor=A.+H.+Newmanauthor=J.+A.+Javitchauthor=L.+Shi&title=A+single+glycine+in+extracellular+loop+1+is+the+critical+determinant+for+pharmacological+specificity+of+dopamine+D2+and+D3+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A single glycine in extracellular loop 1 is the critical determinant for pharmacological specificity of dopamine D2 and D3 receptors</span></div><div class="casAuthors">Michino, Mayako; Donthamsetti, Prashant; Beuming, Thijs; Banala, Ashwini; Duan, Lihua; Roux, Thomas; Han, Yang; Trinquet, Eric; Newman, Amy Hauck; Javitch, Jonathan A.; Shi, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">854-864</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Subtype-selective agents for the dopamine D3 receptor (D3R) have been considered as potential medications for drug addiction and other neuropsychiatric disorders.  Medicinal chem. efforts have led to the discovery of 4-phenylpiperazine derivs. that are >100-fold selective for the dopamine D3 receptor over dopamine D2 receptor (D2R), despite high sequence identity (78% in the transmembrane domain).  Based on the recent crystal structure of D3R, we demonstrated that the 4-phenylpiperazine moiety in this class of D3R-selective compds. binds to the conserved orthosteric binding site, whereas the extended aryl amide moiety is oriented toward a divergent secondary binding pocket (SBP).  In an effort to further characterize mol. determinants of the selectivity of these compds., we modeled their binding modes in D3R and D2R by comparative ligand docking and mol. dynamics simulations.  We found that the aryl amide moiety in the SBP differentially induces conformational changes in transmembrane segment 2 and extracellular loop 1 (EL1), which amplify the divergence of the SBP in D3R and D2R.  Receptor chimera and site-directed mutagenesis studies were used to validate these binding modes and to identify a divergent glycine in EL1 as crit. to D3R over D2R subtype selectivity.  A better understanding of drug-dependent receptor conformations such as these is key to the rational design of compds. targeting a specific receptor among closely related homologs, and may also lead to discovery of novel chemotypes that exploit subtle differences in protein conformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTHm99ZIZbabVg90H21EOLACvtfcHk0ljbPx0or3d_Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVyitLvK&md5=225a4cfc272ec9897eeb010dd551c3b9</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.087833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.087833%26sid%3Dliteratum%253Aachs%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DBanala%26aufirst%3DA.%26aulast%3DDuan%26aufirst%3DL.%26aulast%3DRoux%26aufirst%3DT.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DTrinquet%26aufirst%3DE.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DL.%26atitle%3DA%2520single%2520glycine%2520in%2520extracellular%2520loop%25201%2520is%2520the%2520critical%2520determinant%2520for%2520pharmacological%2520specificity%2520of%2520dopamine%2520D2%2520and%2520D3%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26spage%3D854%26epage%3D864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Ananthan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saini, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobrath, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padmalayam, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bostwick, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAleer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span> </span><span class="NLM_article-title">Design, synthesis, and structure–activity relationship studies of a series of [4-(4-carboxamidobutyl)]-1-arylpiperazines: insights into structural features contributing to dopamine D3 versus D2 receptor subtype selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">7042</span><span class="NLM_x">–</span> <span class="NLM_lpage">7060</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500801r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7042-7060&author=S.+Ananthanauthor=S.+K.+Sainiauthor=G.+Zhouauthor=J.+V.+Hobrathauthor=I.+Padmalayamauthor=L.+Zhaiauthor=J.+R.+Bostwickauthor=T.+Antonioauthor=M.+E.+Reithauthor=S.+McDowellauthor=E.+Choauthor=L.+McAleerauthor=M.+Taylorauthor=R.+R.+Luedtke&title=Design%2C+synthesis%2C+and+structure%E2%80%93activity+relationship+studies+of+a+series+of+%5B4-%284-carboxamidobutyl%29%5D-1-arylpiperazines%3A+insights+into+structural+features+contributing+to+dopamine+D3+versus+D2+receptor+subtype+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm500801r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500801r%26sid%3Dliteratum%253Aachs%26aulast%3DAnanthan%26aufirst%3DS.%26aulast%3DSaini%26aufirst%3DS.%2BK.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DHobrath%26aufirst%3DJ.%2BV.%26aulast%3DPadmalayam%26aufirst%3DI.%26aulast%3DZhai%26aufirst%3DL.%26aulast%3DBostwick%26aufirst%3DJ.%2BR.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DMcDowell%26aufirst%3DS.%26aulast%3DCho%26aufirst%3DE.%26aulast%3DMcAleer%26aufirst%3DL.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520studies%2520of%2520a%2520series%2520of%2520%255B4-%25284-carboxamidobutyl%2529%255D-1-arylpiperazines%253A%2520insights%2520into%2520structural%2520features%2520contributing%2520to%2520dopamine%2520D3%2520versus%2520D2%2520receptor%2520subtype%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7042%26epage%3D7060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElveen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Novel heterocyclic trans olefin analogues of <i>N</i>-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049465g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=839-848&author=P.+Grundtauthor=E.+E.+Carlsonauthor=J.+Caoauthor=C.+J.+Bennettauthor=E.+McElveenauthor=M.+Taylorauthor=R.+R.+Luedtkeauthor=A.+H.+Newman&title=Novel+heterocyclic+trans+olefin+analogues+of+N-%7B4-%5B4-%282%2C3-dichlorophenyl%29piperazin-1-yl%5Dbutyl%7Darylcarboxamides+as+selective+probes+with+high+affinity+for+the+dopamine+D3+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm049465g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049465g%26sid%3Dliteratum%253Aachs%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DCarlson%26aufirst%3DE.%2BE.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DC.%2BJ.%26aulast%3DMcElveen%26aufirst%3DE.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DNovel%2520heterocyclic%2520trans%2520olefin%2520analogues%2520of%2520N-%257B4-%255B4-%25282%252C3-dichlorophenyl%2529piperazin-1-yl%255Dbutyl%257Darylcarboxamides%2520as%2520selective%2520probes%2520with%2520high%2520affinity%2520for%2520the%2520dopamine%2520D3%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D839%26epage%3D848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Banala, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatri, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roof, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title"><i>N</i>-(3-Fluoro-4-(4-(2-methoxy or 2,3-dichlorophenyl)piperazine-1-yl)butyl)arylcarboxamides as selective dopamine D3 receptor ligands: critical role of the carboxamide linker for D3 receptor selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3581</span><span class="NLM_x">–</span> <span class="NLM_lpage">3594</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200288r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3581-3594&author=A.+K.+Banalaauthor=B.+A.+Levyauthor=S.+S.+Khatriauthor=C.+A.+Furmanauthor=R.+A.+Roofauthor=Y.+Mishraauthor=S.+A.+Griffinauthor=D.+R.+Sibleyauthor=R.+R.+Luedtkeauthor=A.+H.+Newman&title=N-%283-Fluoro-4-%284-%282-methoxy+or+2%2C3-dichlorophenyl%29piperazine-1-yl%29butyl%29arylcarboxamides+as+selective+dopamine+D3+receptor+ligands%3A+critical+role+of+the+carboxamide+linker+for+D3+receptor+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm200288r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200288r%26sid%3Dliteratum%253Aachs%26aulast%3DBanala%26aufirst%3DA.%2BK.%26aulast%3DLevy%26aufirst%3DB.%2BA.%26aulast%3DKhatri%26aufirst%3DS.%2BS.%26aulast%3DFurman%26aufirst%3DC.%2BA.%26aulast%3DRoof%26aufirst%3DR.%2BA.%26aulast%3DMishra%26aufirst%3DY.%26aulast%3DGriffin%26aufirst%3DS.%2BA.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DN-%25283-Fluoro-4-%25284-%25282-methoxy%2520or%25202%252C3-dichlorophenyl%2529piperazine-1-yl%2529butyl%2529arylcarboxamides%2520as%2520selective%2520dopamine%2520D3%2520receptor%2520ligands%253A%2520critical%2520role%2520of%2520the%2520carboxamide%2520linker%2520for%2520D3%2520receptor%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3581%26epage%3D3594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beuming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banala, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donthamsetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongetti, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBounty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span> </span><span class="NLM_article-title">Molecular determinants of selectivity and efficacy at the dopamine D3 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6689</span><span class="NLM_x">–</span> <span class="NLM_lpage">6699</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300482h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsFCkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6689-6699&author=A.+H.+Newmanauthor=T.+Beumingauthor=A.+K.+Banalaauthor=P.+Donthamsettiauthor=K.+Pongettiauthor=A.+LaBountyauthor=B.+Levyauthor=J.+Caoauthor=M.+Michinoauthor=R.+R.+Luedtkeauthor=J.+A.+Javitchauthor=L.+Shi&title=Molecular+determinants+of+selectivity+and+efficacy+at+the+dopamine+D3+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Determinants of Selectivity and Efficacy at the Dopamine D3 Receptor</span></div><div class="casAuthors">Newman, Amy Hauck; Beuming, Thijs; Banala, Ashwini K.; Donthamsetti, Prashant; Pongetti, Katherine; LaBounty, Alex; Levy, Benjamin; Cao, Jianjing; Michino, Mayako; Luedtke, Robert R.; Javitch, Jonathan A.; Shi, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6689-6699</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dopamine D3 receptor (D3R) has been implicated in substance abuse and other neuropsychiatric disorders.  The high sequence homol. between the D3R and D2R, esp. within the orthosteric binding site (OBS) that binds dopamine, has made the development of D3R-selective compds. challenging.  Here, we deconstruct into pharmacophoric elements a series of D3R-selective substituted-4-phenylpiperazine compds. and use computational simulations and binding and activation studies to dissect the structural bases for D3R selectivity and efficacy.  We find that selectivity arises from divergent interactions within a second binding pocket (SBP) sep. from the OBS, whereas efficacy depends on the binding mode in the OBS.  Our findings reveal structural features of the receptor that are crit. to selectivity and efficacy that can be used to design highly D3R-selective ligands with targeted efficacies.  These findings are generalizable to other GPCRs in which the SBP can be targeted by bitopic or allosteric ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmBJU7uyvVg7Vg90H21EOLACvtfcHk0lju4eEjqdgwjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsFCkt7c%253D&md5=033dd49282723650828a3ec0a31211e5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm300482h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300482h%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DBanala%26aufirst%3DA.%2BK.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DPongetti%26aufirst%3DK.%26aulast%3DLaBounty%26aufirst%3DA.%26aulast%3DLevy%26aufirst%3DB.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DL.%26atitle%3DMolecular%2520determinants%2520of%2520selectivity%2520and%2520efficacy%2520at%2520the%2520dopamine%2520D3%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6689%26epage%3D6699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Gilbert, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z. X.</span><span> </span><span class="NLM_article-title">Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=17-28&author=J.+G.+Gilbertauthor=A.+H.+Newmanauthor=E.+L.+Gardnerauthor=C.+R.+Ashbyauthor=C.+A.+Heidbrederauthor=A.+C.+Pakauthor=X.+Q.+Pengauthor=Z.+X.+Xi&title=Acute+administration+of+SB-277011A%2C+NGB+2904%2C+or+BP+897+inhibits+cocaine+cue-induced+reinstatement+of+drug-seeking+behavior+in+rats%3A+role+of+dopamine+D3+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGilbert%26aufirst%3DJ.%2BG.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DHeidbreder%26aufirst%3DC.%2BA.%26aulast%3DPak%26aufirst%3DA.%2BC.%26aulast%3DPeng%26aufirst%3DX.%2BQ.%26aulast%3DXi%26aufirst%3DZ.%2BX.%26atitle%3DAcute%2520administration%2520of%2520SB-277011A%252C%2520NGB%25202904%252C%2520or%2520BP%2520897%2520inhibits%2520cocaine%2520cue-induced%2520reinstatement%2520of%2520drug-seeking%2520behavior%2520in%2520rats%253A%2520role%2520of%2520dopamine%2520D3%2520receptors%26jtitle%3DSynapse%26date%3D2005%26volume%3D57%26spage%3D17%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Xi, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gitajn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span> </span><span class="NLM_article-title">The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine’s rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1393</span><span class="NLM_x">–</span> <span class="NLM_lpage">1405</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=1393-1405&author=Z.+X.+Xiauthor=A.+H.+Newmanauthor=J.+G.+Gilbertauthor=A.+C.+Pakauthor=X.+Q.+Pengauthor=C.+R.+Ashbyauthor=L.+Gitajnauthor=E.+L.+Gardner&title=The+novel+dopamine+D3+receptor+antagonist+NGB+2904+inhibits+cocaine%E2%80%99s+rewarding+effects+and+cocaine-induced+reinstatement+of+drug-seeking+behavior+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DZ.%2BX.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DGilbert%26aufirst%3DJ.%2BG.%26aulast%3DPak%26aufirst%3DA.%2BC.%26aulast%3DPeng%26aufirst%3DX.%2BQ.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DGitajn%26aufirst%3DL.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26atitle%3DThe%2520novel%2520dopamine%2520D3%2520receptor%2520antagonist%2520NGB%25202904%2520inhibits%2520cocaine%25E2%2580%2599s%2520rewarding%2520effects%2520and%2520cocaine-induced%2520reinstatement%2520of%2520drug-seeking%2520behavior%2520in%2520rats%26jtitle%3DNeuropsychopharmacology%26date%3D2006%26volume%3D31%26spage%3D1393%26epage%3D1405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Higley, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span> </span><span class="NLM_article-title">PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1177%2F0269881109358201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=20142301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFSju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=263-273&author=A.+E.+Higleyauthor=K.+Spillerauthor=P.+Grundtauthor=A.+H.+Newmanauthor=S.+W.+Kieferauthor=Z.+X.+Xiauthor=E.+L.+Gardner&title=PG01037%2C+a+novel+dopamine+D3+receptor+antagonist%2C+inhibits+the+effects+of+methamphetamine+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats</span></div><div class="casAuthors">Higley, Amanda E.; Spiller, Krista; Grundt, Peter; Newman, Amy Hauck; Kiefer, Stephen W.; Xi, Zheng-Xiong; Gardner, Eliot L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">263-273</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Our previous studies have shown that the selective dopamine D3 receptor antagonists SB-277011A or NGB 2904 significantly attenuate cocaine self-administration under a progressive-ratio reinforcement schedule and cocaine-, methamphetamine- or nicotine-enhanced brain stimulation reward.  However, the poor bioavailability of SB-277011A has limited its potential use in humans.  In the present study, we investigated the effects of the novel D3 receptor antagonist PG01037 on methamphetamine self-administration, methamphetamine-assocd. cue-induced reinstatement of drug seeking and methamphetamine-enhanced brain stimulation reward.  Rats were allowed to i.v. self-administer methamphetamine under fixed-ratio 2 and progressive-ratio reinforcement conditions, and then the effects of PG01037 on methamphetamine self-administration and cue-induced reinstatement were assessed.  Addnl. groups of rats were trained for intracranial elec. brain stimulation reward and the effects of PG01037 and methamphetamine on brain stimulation reward were assessed.  Acute i.p. administration of PG01037 (3, 10, 30 mg/kg) failed to alter methamphetamine or sucrose self-administration under fixed-ratio 2 reinforcement, but significantly lowered the break-point levels for methamphetamine or sucrose self-administration under progressive-ratio reinforcement.  In addn., PG01037 significantly inhibited methamphetamine-assocd. cue-triggered reinstatement of drug-seeking behavior and methamphetamine-enhanced brain stimulation reward.  These data suggest that the novel D3 antagonist PG01037 significantly attenuates the rewarding effects as assessed by progressive-ratio self-administration and brain stimulation reward, and inhibits methamphetamine-assocd. cue-induced reinstatement of drug-seeking behavior.  These findings support the potential use of PG01037 or other selective D3 antagonists in the treatment of methamphetamine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5j7BtWdpNV7Vg90H21EOLACvtfcHk0ljRPvZ9IQ_EYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFSju7Y%253D&md5=904e609c8a3549b42af4c1f2bf670684</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1177%2F0269881109358201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0269881109358201%26sid%3Dliteratum%253Aachs%26aulast%3DHigley%26aufirst%3DA.%2BE.%26aulast%3DSpiller%26aufirst%3DK.%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DKiefer%26aufirst%3DS.%2BW.%26aulast%3DXi%26aufirst%3DZ.%2BX.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26atitle%3DPG01037%252C%2520a%2520novel%2520dopamine%2520D3%2520receptor%2520antagonist%252C%2520inhibits%2520the%2520effects%2520of%2520methamphetamine%2520in%2520rats%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2011%26volume%3D25%26spage%3D263%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Higley, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span> </span><span class="NLM_article-title">Dopamine D(3) receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">659</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.ejphar.2011.02.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=21466803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFGntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=659&publication_year=2011&pages=187-192&author=A.+E.+Higleyauthor=S.+W.+Kieferauthor=X.+Liauthor=J.+Gaalauthor=Z.+X.+Xiauthor=E.+L.+Gardner&title=Dopamine+D%283%29+receptor+antagonist+SB-277011A+inhibits+methamphetamine+self-administration+and+methamphetamine-induced+reinstatement+of+drug-seeking+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D3 receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats</span></div><div class="casAuthors">Higley, Amanda E.; Kiefer, Stephen W.; Li, Xia; Gaal, Jozsef; Xi, Zheng-Xiong; Gardner, Eliot L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">659</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">187-192</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have previously reported that selective blockade of brain dopamine D3 receptors by SB-277011A significantly attenuates cocaine self-administration and cocaine-induced reinstatement of drug-seeking behavior.  In the present study, we investigated whether SB-277011A similarly inhibits methamphetamine self-administration and methamphetamine-induced reinstatement to drug-seeking behavior.  Male Long-Evans rats were allowed to i.v. self-administer methamphetamine (0.05 mg/kg/infusion) under fixed-ratio 2 (FR2) or progressive-ratio (PR) reinforcement conditions, and some rats were tested for methamphetamine-induced reinstatement of drug-seeking behavior after extinction of self-administration.  The effects of SB-277011A on each of these methamphetamine-supported behaviors were then tested.  Acute i.p. administration of SB-277011A failed to alter methamphetamine self-administration under FR2 reinforcement, but significantly lowered the break-point for methamphetamine self-administration under PR reinforcement.  SB-277011A also significantly inhibited methamphetamine-triggered reinstatement of extinguished drug-seeking behavior.  Overall, these data show that blockade of dopamine D3 receptors by SB-277011A attenuates the rewarding and incentive motivational effects of methamphetamine in rats, supporting the development of selective dopamine D3 antagonists for the treatment of methamphetamine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7xl1sYrL3L7Vg90H21EOLACvtfcHk0lhprEeZfQl4yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFGntLg%253D&md5=aff782e2174c94f5fffbeae4e7f98e85</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2011.02.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2011.02.046%26sid%3Dliteratum%253Aachs%26aulast%3DHigley%26aufirst%3DA.%2BE.%26aulast%3DKiefer%26aufirst%3DS.%2BW.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGaal%26aufirst%3DJ.%26aulast%3DXi%26aufirst%3DZ.%2BX.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26atitle%3DDopamine%2520D%25283%2529%2520receptor%2520antagonist%2520SB-277011A%2520inhibits%2520methamphetamine%2520self-administration%2520and%2520methamphetamine-induced%2520reinstatement%2520of%2520drug-seeking%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D659%26spage%3D187%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">O’Connor, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokol, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Onofrio, G.</span><span> </span><span class="NLM_article-title">Addiction medicine: the birth of a new discipline</span> <span class="citation_source-journal">JAMA Int. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">174</span><span class="NLM_x">, </span> <span class="NLM_fpage">1717</span><span class="NLM_x">–</span> <span class="NLM_lpage">1718</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1001%2Fjamainternmed.2014.4211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=25201642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FptlersQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2014&pages=1717-1718&author=P.+G.+O%E2%80%99Connorauthor=R.+J.+Sokolauthor=G.+D%E2%80%99Onofrio&title=Addiction+medicine%3A+the+birth+of+a+new+discipline"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Addiction medicine: the birth of a new discipline</span></div><div class="casAuthors">O'Connor Patrick G; Sokol Robert J; D'Onofrio Gail</div><div class="citationInfo"><span class="NLM_cas:title">JAMA internal medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1717-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSWNdmGTHu_4srRqEXsZufAfW6udTcc2ebjkQMFUiI1xbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FptlersQ%253D%253D&md5=8d0023a5dde450ec466e910be2a53e46</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1001%2Fjamainternmed.2014.4211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamainternmed.2014.4211%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%2BG.%26aulast%3DSokol%26aufirst%3DR.%2BJ.%26aulast%3DD%25E2%2580%2599Onofrio%26aufirst%3DG.%26atitle%3DAddiction%2520medicine%253A%2520the%2520birth%2520of%2520a%2520new%2520discipline%26jtitle%3DJAMA%2520Int.%2520Med.%26date%3D2014%26volume%3D174%26spage%3D1717%26epage%3D1718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Le Houezec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubin, H. J.</span><span> </span><span class="NLM_article-title">Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1959</span><span class="NLM_x">–</span> <span class="NLM_lpage">1967</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1517%2F14656566.2013.818978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=23978314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVektr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=1959-1967&author=J.+Le+Houezecauthor=H.+J.+Aubin&title=Pharmacotherapies+and+harm-reduction+options+for+the+treatment+of+tobacco+dependence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence</span></div><div class="casAuthors">Le Houezec, Jacques; Aubin, Henri-Jean</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1959-1967</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Tobacco dependence, a chronic relapsing condition, requires repeated interventions and multiple attempts to quit.  Areas covered: Strategies for assisting smoking cessation include behavioral counselling and pharmacotherapy.  Three drugs are currently used as first-line pharmacotherapy: nicotine replacement therapy (NRT), bupropion and varenicline.  Compared to placebo, the drug effect varies from RR = 2.27 for varenicline, to 1.69 for bupropion, and 1.60 for any form of NRT.  Cytisine (similar to varenicline) has a RR = 3.98 compared to placebo (two trials).  Second-line pharmacotherapies include nortriptyline and clonidine.  This review also offers an overview of pipeline developments.  Expert opinion: Effective medications exist, and clinicians should encourage and offer treatment to every smoker.  However, most smokers try to quit by themselves, with only about 3% quitting successfully each year.  Alternative interventions are needed.  Harm redn. has not received much support to date.  Safer alternative to tobacco smoking (smoke-free products, long-term use of cessation drugs, or electronic cigarettes) could save lives and reduce the burden of tobacco-related deaths and diseases.  Despite some encouragement to develop a research agenda for e-cigarettes, particularly on the safety issues, too little attention has been brought to this area of research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpALcCZ0674V7Vg90H21EOLACvtfcHk0lhprEeZfQl4yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVektr%252FN&md5=6c5822860388ce77c15deae3da3f7789</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1517%2F14656566.2013.818978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2013.818978%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BHouezec%26aufirst%3DJ.%26aulast%3DAubin%26aufirst%3DH.%2BJ.%26atitle%3DPharmacotherapies%2520and%2520harm-reduction%2520options%2520for%2520the%2520treatment%2520of%2520tobacco%2520dependence%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2013%26volume%3D14%26spage%3D1959%26epage%3D1967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Jonas, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amick, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobashev, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wines, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanahan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gass, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbutt, J. C.</span><span> </span><span class="NLM_article-title">Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis</span> <span class="citation_source-journal">JAMA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">1889</span><span class="NLM_x">–</span> <span class="NLM_lpage">1900</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2014&pages=1889-1900&author=D.+E.+Jonasauthor=H.+R.+Amickauthor=C.+Feltnerauthor=G.+Bobashevauthor=K.+Thomasauthor=R.+Winesauthor=M.+M.+Kimauthor=E.+Shanahanauthor=C.+E.+Gassauthor=C.+J.+Roweauthor=J.+C.+Garbutt&title=Pharmacotherapy+for+adults+with+alcohol+use+disorders+in+outpatient+settings%3A+a+systematic+review+and+meta-analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJonas%26aufirst%3DD.%2BE.%26aulast%3DAmick%26aufirst%3DH.%2BR.%26aulast%3DFeltner%26aufirst%3DC.%26aulast%3DBobashev%26aufirst%3DG.%26aulast%3DThomas%26aufirst%3DK.%26aulast%3DWines%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DM.%2BM.%26aulast%3DShanahan%26aufirst%3DE.%26aulast%3DGass%26aufirst%3DC.%2BE.%26aulast%3DRowe%26aufirst%3DC.%2BJ.%26aulast%3DGarbutt%26aufirst%3DJ.%2BC.%26atitle%3DPharmacotherapy%2520for%2520adults%2520with%2520alcohol%2520use%2520disorders%2520in%2520outpatient%2520settings%253A%2520a%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DJAMA%26date%3D2014%26volume%3D311%26spage%3D1889%26epage%3D1900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Raisch, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fye, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boardman, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, M. R.</span><span> </span><span class="NLM_article-title">Opioid dependence treatment, including buprenorphine/naloxone</span> <span class="citation_source-journal">Ann. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">312</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=312-321&author=D.+W.+Raischauthor=C.+L.+Fyeauthor=K.+D.+Boardmanauthor=M.+R.+Sather&title=Opioid+dependence+treatment%2C+including+buprenorphine%2Fnaloxone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaisch%26aufirst%3DD.%2BW.%26aulast%3DFye%26aufirst%3DC.%2BL.%26aulast%3DBoardman%26aufirst%3DK.%2BD.%26aulast%3DSather%26aufirst%3DM.%2BR.%26atitle%3DOpioid%2520dependence%2520treatment%252C%2520including%2520buprenorphine%252Fnaloxone%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2002%26volume%3D36%26spage%3D312%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Fudala, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridge, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williford, W. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raisch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casadonte, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malkerneker, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tusel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buprenorphine/Naloxone Collaborative Study Group</span><span> </span><span class="NLM_article-title">Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">349</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">958</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1056%2FNEJMoa022164" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=12954743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntFeitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2003&pages=949-958&author=P.+J.+Fudalaauthor=T.+P.+Bridgeauthor=S.+Herbertauthor=W.+O.+Willifordauthor=C.+N.+Chiangauthor=K.+Jonesauthor=J.+Collinsauthor=D.+Raischauthor=P.+Casadonteauthor=R.+J.+Goldsmithauthor=W.+Lingauthor=U.+Malkernekerauthor=L.+McNicholasauthor=J.+Rennerauthor=S.+Stineauthor=D.+Tuselauthor=Buprenorphine%2FNaloxone+Collaborative+Study+Group&title=Office-based+treatment+of+opiate+addiction+with+a+sublingual-tablet+formulation+of+buprenorphine+and+naloxone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone</span></div><div class="casAuthors">Fudala, Paul J.; Bridge, T. Peter; Herbert, Susan; Williford, William O.; Chiang, C. Nora; Jones, Karen; Collins, Joseph; Raisch, Dennis; Casadonte, Paul; Goldsmith, R. Jeffrey; Ling, Walter; Malkerneker, Usha; McNicholas, Laura; Renner, John; Stine, Susan; Tusel, Donald</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">949-958</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone has been proposed, but its efficacy and safety have not been well studied.  We conducted a multicenter, randomized, placebo-controlled trial involving 326 opiate-addicted persons who were assigned to office-based treatment with sublingual tablets consisting of buprenorphine (16 mg) in combination with naloxone (4 mg), buprenorphine alone (16 mg), or placebo given daily for four weeks.  The primary outcome measures were the percentage of urine samples neg. for opiates and the subjects' self-reported craving for opiates.  Safety data were obtained on 461 opiate-addicted persons who participated in an open-label study of buprenorphine and naloxone (at daily doses of up to 24 mg and 6 mg, resp.) and another 11 persons who received this combination only during the trial.  The double-blind trial was terminated early because buprenorphine and naloxone in combination and buprenorphine alone were found to have greater efficacy than placebo.  The proportion of urine samples that were neg. for opiates was greater in the combined-treatment and buprenorphine groups (17.8 percent and 20.7 percent, resp.) than in the placebo group (5.8 percent, P<0.001 for both comparisons); the active-treatment groups also reported less opiate craving (P<0.001 for both comparisons with placebo).  Rates of adverse events were similar in the active-treatment and placebo groups.  During the open-label phase, the percentage of urine samples neg. for opiates ranged from 35.2 percent to 67.4 percent.  Results from the open-label follow-up study indicated that the combined treatment was safe and well tolerated.  Buprenorphine and naloxone in combination and buprenorphine alone are safe and reduce the use of opiates and the craving for opiates among opiate-addicted persons who receive these medications in an office-based setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-0okugtFPhLVg90H21EOLACvtfcHk0ljNVtoN5V4oIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntFeitrw%253D&md5=35ff9ab1748dba9036f4ff27d7433bd6</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa022164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa022164%26sid%3Dliteratum%253Aachs%26aulast%3DFudala%26aufirst%3DP.%2BJ.%26aulast%3DBridge%26aufirst%3DT.%2BP.%26aulast%3DHerbert%26aufirst%3DS.%26aulast%3DWilliford%26aufirst%3DW.%2BO.%26aulast%3DChiang%26aufirst%3DC.%2BN.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DCollins%26aufirst%3DJ.%26aulast%3DRaisch%26aufirst%3DD.%26aulast%3DCasadonte%26aufirst%3DP.%26aulast%3DGoldsmith%26aufirst%3DR.%2BJ.%26aulast%3DLing%26aufirst%3DW.%26aulast%3DMalkerneker%26aufirst%3DU.%26aulast%3DMcNicholas%26aufirst%3DL.%26aulast%3DRenner%26aufirst%3DJ.%26aulast%3DStine%26aufirst%3DS.%26aulast%3DTusel%26aufirst%3DD.%26aulast%3D%26atitle%3DOffice-based%2520treatment%2520of%2520opiate%2520addiction%2520with%2520a%2520sublingual-tablet%2520formulation%2520of%2520buprenorphine%2520and%2520naloxone%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D349%26spage%3D949%26epage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Koob, G. F.</span><span> </span><span class="NLM_article-title">The neurobiology of addiction: a neuroadaptational view relevant for diagnosis</span> <span class="citation_source-journal">Addiction</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2006&pages=23-30&author=G.+F.+Koob&title=The+neurobiology+of+addiction%3A+a+neuroadaptational+view+relevant+for+diagnosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoob%26aufirst%3DG.%2BF.%26atitle%3DThe%2520neurobiology%2520of%2520addiction%253A%2520a%2520neuroadaptational%2520view%2520relevant%2520for%2520diagnosis%26jtitle%3DAddiction%26date%3D2006%26volume%3D101%26spage%3D23%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Staley, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mash, D. C.</span><span> </span><span class="NLM_article-title">Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">6100</span><span class="NLM_x">–</span> <span class="NLM_lpage">6106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=8815892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaK28Xntleisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=6100-6106&author=J.+K.+Staleyauthor=D.+C.+Mash&title=Adaptive+increase+in+D3+dopamine+receptors+in+the+brain+reward+circuits+of+human+cocaine+fatalities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities</span></div><div class="casAuthors">Staley, Julie K.; Mash, Deborah C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6100-6106</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Recent studies have suggested that the D3 dopamine receptor subtype plays a pivotal role in the reinforcing effects of cocaine.  The D3 receptor-preferring agonist 7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT) is a reinforcer in rhesus monkeys trained to self-administer cocaine, but not in cocaine-naive monkeys.  In this work, in vitro autoradiog. localization of [3H]-(+)-7-OH-DPAT binding in the human brain demonstrated that D3 receptors were prevalent and highly localized over the ventromedial sectors of the striatum.  Pharmacol. characterization of [3H]-(+)-7-OH-DPAT binding to the human nucleus accumbens demonstrated a rank order of potency similar to that obsd. for binding to the cloned D3 receptor expressed in transfected cell lines.  Region-of-interest anal. of [3H]-(+)-7-OH-DPAT binding to the D3 receptor demonstrated a 1-3-fold elevation in the no. of binding sites over particular sectors of the striatum and substantia nigra in cocaine overdose victims as compared with age-matched and drug-free control subjects.  The elevated no. of [3H]-(+)-7-OH-DPAT binding sites demonstrates that adaptive changes in the D3 receptor in the reward circuitry of the brain are assocd. with chronic cocaine abuse.  The D3 receptor may be a useful target for development of anticocaine drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppMNXOozUcmrVg90H21EOLACvtfcHk0ljNVtoN5V4oIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xntleisbk%253D&md5=5b503d0e1c8e7d621ebc63be126f8079</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStaley%26aufirst%3DJ.%2BK.%26aulast%3DMash%26aufirst%3DD.%2BC.%26atitle%3DAdaptive%2520increase%2520in%2520D3%2520dopamine%2520receptors%2520in%2520the%2520brain%2520reward%2520circuits%2520of%2520human%2520cocaine%2520fatalities%26jtitle%3DJ.%2520Neurosci.%26date%3D1996%26volume%3D16%26spage%3D6100%26epage%3D6106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Segal, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraes, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mash, D. C.</span><span> </span><span class="NLM_article-title">Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities</span> <span class="citation_source-journal">Brain Res. Mol. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">339</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2FS0169-328X%2897%2900025-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=9149110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaK2sXitVKqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1997&pages=335-339&author=D.+M.+Segalauthor=C.+T.+Moraesauthor=D.+C.+Mash&title=Up-regulation+of+D3+dopamine+receptor+mRNA+in+the+nucleus+accumbens+of+human+cocaine+fatalities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities</span></div><div class="casAuthors">Segal, David M.; Moraes, Carlos T.; Mash, Deborah C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">335-339</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The effects of chronic cocaine use on D3 receptor mRNA expression in the human nucleus accumbens was assessed by reverse transcription-polymerase chain reaction.  D3 receptor/cyclophilin mRNA ratios in the nucleus accumbens were increased 6-fold in cocaine overdose victims as compared to age-matched and drug-free control subjects.  This finding demonstrates that chronic cocaine exposure leads to adaptive increases in the expression of D3 receptor gene in a crit. reward center in brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofVqjSgzm08rVg90H21EOLACvtfcHk0lgqJr8dZnnzvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitVKqsbc%253D&md5=96519c2f514430320ea40320a9072414</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0169-328X%2897%2900025-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-328X%252897%252900025-9%26sid%3Dliteratum%253Aachs%26aulast%3DSegal%26aufirst%3DD.%2BM.%26aulast%3DMoraes%26aufirst%3DC.%2BT.%26aulast%3DMash%26aufirst%3DD.%2BC.%26atitle%3DUp-regulation%2520of%2520D3%2520dopamine%2520receptor%2520mRNA%2520in%2520the%2520nucleus%2520accumbens%2520of%2520human%2520cocaine%2520fatalities%26jtitle%3DBrain%2520Res.%2520Mol.%2520Brain%2520Res.%26date%3D1997%26volume%3D45%26spage%3D335%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Mash, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staley, J. K.</span><span> </span><span class="NLM_article-title">D3 dopamine and kappa opioid receptor alterations in human brain of cocaine-overdose victims</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">877</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=877&publication_year=1999&pages=507-522&author=D.+C.+Mashauthor=J.+K.+Staley&title=D3+dopamine+and+kappa+opioid+receptor+alterations+in+human+brain+of+cocaine-overdose+victims"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMash%26aufirst%3DD.%2BC.%26aulast%3DStaley%26aufirst%3DJ.%2BK.%26atitle%3DD3%2520dopamine%2520and%2520kappa%2520opioid%2520receptor%2520alterations%2520in%2520human%2520brain%2520of%2520cocaine-overdose%2520victims%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D1999%26volume%3D877%26spage%3D507%26epage%3D522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Le Foll, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabiner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boileau, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo Pich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokoloff, P.</span><span> </span><span class="NLM_article-title">Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">211</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2FB978-0-444-63425-2.00011-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24968784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1SqtLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2014&pages=255-275&author=B.+Le+Follauthor=G.+Colloauthor=E.+A.+Rabinerauthor=I.+Boileauauthor=E.+Merlo+Pichauthor=P.+Sokoloff&title=Dopamine+D3+receptor+ligands+for+drug+addiction+treatment%3A+update+on+recent+findings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D3 receptor ligands for drug addiction treatment, update on recent findings</span></div><div class="casAuthors">Le Foll, Bernard; Collo, Ginetta; Rabiner, Eugenii A.; Boileau, Isabelle; Pich, Emilio Merlo; Sokoloff, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue">Dopamine</span>),
    <span class="NLM_cas:pages">255-275</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The dopamine D3 receptor is located in the limbic area and apparently mediates selective effects on motivation to take drugs and drug-seeking behaviors, so that there has been considerable interest on the possible use of D3 receptor ligands to treat drug addiction.  However, only recently selective tools allowing studying this receptor have been developed.  This chapter presents an overview of findings that were presented at a symposium on the conference Dopamine 2013 in Sardinia in May 2013.  Novel neurobiol. findings indicate that drugs of abuse can lead to significant structural plasticity in rodent brain and that this is dependent on the availability of functional dopamine D3 autoreceptor, whose activation increased phosphorylation in the ERK pathway and in the Akt/mTORC1 pathway indicating the parallel engagement of a series of intracellular signaling pathways all involved in cell growth and survival.  Preclin. findings using animal models of drug-seeking behaviors confirm that D3 antagonists have a promising profile to treat drug addiction across drugs of abuse type.  Imaging the D3 is now feasible in human subjects.  Notably, the development of (+)-4-propyl-9-hydroxynaphthoxazine ligand used in positron emission tomog. (PET) studies in humans allows to measure D3 and D2 receptors based on the area of the brain under study.  This PET ligand has been used to confirm up-regulation of D3 sites in psychostimulant users and to reveal that tobacco smoking produces elevation of dopamine at the level of D3 sites.  There are now novel antagonists being developed, but also old drugs such as buspirone, that are available to test the D3 hypothesis in humans.  The first results of clin. investigations are now being provided.  Overall, those recent findings support further exploration of D3 ligands to treat drug addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxIQ6SUa_NcrVg90H21EOLACvtfcHk0lgqJr8dZnnzvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1SqtLzP&md5=e997ab74bf84de9d62b9b734a585b949</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FB978-0-444-63425-2.00011-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-444-63425-2.00011-8%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BFoll%26aufirst%3DB.%26aulast%3DCollo%26aufirst%3DG.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DBoileau%26aufirst%3DI.%26aulast%3DMerlo%2BPich%26aufirst%3DE.%26aulast%3DSokoloff%26aufirst%3DP.%26atitle%3DDopamine%2520D3%2520receptor%2520ligands%2520for%2520drug%2520addiction%2520treatment%253A%2520update%2520on%2520recent%2520findings%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2014%26volume%3D211%26spage%3D255%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Boileau, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behzadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusjan, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selby, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zack, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCluskey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, S. J.</span><span> </span><span class="NLM_article-title">Higher binding of the dopamine D3 receptor-preferring ligand [<sup>11</sup>C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1353</span><span class="NLM_x">–</span> <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1523%2FJNEUROSCI.4371-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=22279219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1Cmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=1353-1359&author=I.+Boileauauthor=D.+Payerauthor=S.+Houleauthor=A.+Behzadiauthor=P.+M.+Rusjanauthor=J.+Tongauthor=D.+Wilkinsauthor=P.+Selbyauthor=T.+P.+Georgeauthor=M.+Zackauthor=Y.+Furukawaauthor=T.+McCluskeyauthor=A.+A.+Wilsonauthor=S.+J.+Kish&title=Higher+binding+of+the+dopamine+D3+receptor-preferring+ligand+%5B11C%5D-%28%2B%29-propyl-hexahydro-naphtho-oxazin+in+methamphetamine+polydrug+users%3A+a+positron+emission+tomography+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study</span></div><div class="casAuthors">Boileau, Isabelle; Payer, Doris; Houle, Sylvain; Behzadi, Arian; Rusjan, Pablo M.; Tong, Junchao; Wilkins, Diana; Selby, Peter; George, Tony P.; Zack, Martin; Furukawa, Yoshiaki; McCluskey, Tina; Wilson, Alan A.; Kish, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1353-1359</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Positron emission tomog. (PET) findings suggesting lower D2-type dopamine receptors and dopamine concn. in brains of stimulant users have prompted speculation that increasing dopamine signaling might help in drug treatment.  However, this strategy needs to consider the possibility, based on animal and postmortem human data, that dopaminergic activity at the related D3 receptor might, in contrast, be elevated and thereby contribute to drug-taking behavior.  We tested the hypothesis that D3 receptor binding is above normal in methamphetamine (MA) polydrug users, using PET and the D3-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin ([11C]-(+)-PHNO).  Sixteen control subjects and 16 polydrug users reporting MA as their primary drug of abuse underwent PET scanning after [11C]-(+)-PHNO.  Compared with control subjects, drug users had higher [11C]-(+)-PHNO binding in the D3-rich midbrain substantia nigra (SN; +46%; p < 0.02) and in the globus pallidus (+9%; p = 0.06) and ventral pallidum (+11%; p = 0.1), whereas binding was slightly lower in the D2-rich dorsal striatum (approx. -4%, NS; -12% in heavy users, p = 0.01) and related to drug-use severity.  The [11C]-(+)-PHNO binding ratio in D3-rich SN vs. D2-rich dorsal striatum was 55% higher in MA users (p = 0.004), with heavy but not moderate users having ratios significantly different from controls.  [11C]-(+)-PHNO binding in SN was related to self-reported "drug wanting.".  We conclude that the dopamine D3 receptor, unlike the D2 receptor, might be upregulated in brains of MA polydrug users, although lower dopamine levels in MA users could have contributed to the finding.  Pharmacol. studies are needed to establish whether normalization of D3 receptor function could reduce vulnerability to relapse in stimulant abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrI6mw4uiDYbVg90H21EOLACvtfcHk0lgqJr8dZnnzvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1Cmt7g%253D&md5=9db9d298d4931a88f0fe81928022575f</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4371-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4371-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DBoileau%26aufirst%3DI.%26aulast%3DPayer%26aufirst%3DD.%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DBehzadi%26aufirst%3DA.%26aulast%3DRusjan%26aufirst%3DP.%2BM.%26aulast%3DTong%26aufirst%3DJ.%26aulast%3DWilkins%26aufirst%3DD.%26aulast%3DSelby%26aufirst%3DP.%26aulast%3DGeorge%26aufirst%3DT.%2BP.%26aulast%3DZack%26aufirst%3DM.%26aulast%3DFurukawa%26aufirst%3DY.%26aulast%3DMcCluskey%26aufirst%3DT.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DKish%26aufirst%3DS.%2BJ.%26atitle%3DHigher%2520binding%2520of%2520the%2520dopamine%2520D3%2520receptor-preferring%2520ligand%2520%255B11C%255D-%2528%252B%2529-propyl-hexahydro-naphtho-oxazin%2520in%2520methamphetamine%2520polydrug%2520users%253A%2520a%2520positron%2520emission%2520tomography%2520study%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D1353%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Payer, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behzadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusjan, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selby, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCluskey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boileau, I.</span><span> </span><span class="NLM_article-title">Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [<sup>11</sup>C]-+-PHNO</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=311-318&author=D.+E.+Payerauthor=A.+Behzadiauthor=S.+J.+Kishauthor=S.+Houleauthor=A.+A.+Wilsonauthor=P.+M.+Rusjanauthor=J.+Tongauthor=P.+Selbyauthor=T.+P.+Georgeauthor=T.+McCluskeyauthor=I.+Boileau&title=Heightened+D3+dopamine+receptor+levels+in+cocaine+dependence+and+contributions+to+the+addiction+behavioral+phenotype%3A+a+positron+emission+tomography+study+with+%5B11C%5D-%2B-PHNO"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPayer%26aufirst%3DD.%2BE.%26aulast%3DBehzadi%26aufirst%3DA.%26aulast%3DKish%26aufirst%3DS.%2BJ.%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DRusjan%26aufirst%3DP.%2BM.%26aulast%3DTong%26aufirst%3DJ.%26aulast%3DSelby%26aufirst%3DP.%26aulast%3DGeorge%26aufirst%3DT.%2BP.%26aulast%3DMcCluskey%26aufirst%3DT.%26aulast%3DBoileau%26aufirst%3DI.%26atitle%3DHeightened%2520D3%2520dopamine%2520receptor%2520levels%2520in%2520cocaine%2520dependence%2520and%2520contributions%2520to%2520the%2520addiction%2520behavioral%2520phenotype%253A%2520a%2520positron%2520emission%2520tomography%2520study%2520with%2520%255B11C%255D-%252B-PHNO%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D311%26epage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Payer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramaniam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boileau, I.</span><span> </span><span class="NLM_article-title">What is the role of the D3 receptor in addiction? A mini review of PET studies with [<sup>11</sup>C]-(+)-PHNO</span> <span class="citation_source-journal">Prog. Neuropsychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.pnpbp.2013.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=23999545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BC3sbkslCktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2014&pages=4-8&author=D.+Payerauthor=G.+Balasubramaniamauthor=I.+Boileau&title=What+is+the+role+of+the+D3+receptor+in+addiction%3F+A+mini+review+of+PET+studies+with+%5B11C%5D-%28%2B%29-PHNO"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">What is the role of the D3 receptor in addiction? A mini review of PET studies with [(11)C]-(+)-PHNO</span></div><div class="casAuthors">Payer Doris; Balasubramaniam Gayathiri; Boileau Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">Progress in neuro-psychopharmacology & biological psychiatry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The chronic use of drugs, including psychostimulants such as cocaine and amphetamine, has been associated with low D2/3 dopamine receptor availability, which in turn has been linked to poor clinical outcome.  In contrast, recent studies focused on the D3 receptor (a member of the D2-like receptor family) suggest that chronic exposure to stimulant drugs can up-regulate this receptor subtype, which, in preclinical models, is linked to dopamine system sensitization - a process hypothesized to contribute to relapse in addiction.  In this mini review we present recent human data suggesting that the D3 receptor may contribute to core features of addiction, and discuss the usefulness of the PET imaging probe [(11)C]-(+)-PHNO in investigating this question.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXKVTprS8g18kU0YCbOU3EfW6udTcc2eYXInkW_cVQLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbkslCktQ%253D%253D&md5=54c63263f9c6897a5219b3a85e5fe841</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2013.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2013.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DPayer%26aufirst%3DD.%26aulast%3DBalasubramaniam%26aufirst%3DG.%26aulast%3DBoileau%26aufirst%3DI.%26atitle%3DWhat%2520is%2520the%2520role%2520of%2520the%2520D3%2520receptor%2520in%2520addiction%253F%2520A%2520mini%2520review%2520of%2520PET%2520studies%2520with%2520%255B11C%255D-%2528%252B%2529-PHNO%26jtitle%3DProg.%2520Neuropsychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2014%26volume%3D52%26spage%3D4%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Erritzoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tziortzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bargiela, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colasanti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Searle, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaver, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nutt, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo-Pich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabiner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingford-Hughes, A.</span><span> </span><span class="NLM_article-title">In vivo imaging of cerebral dopamine D3 receptors in alcoholism</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1703</span><span class="NLM_x">–</span> <span class="NLM_lpage">1712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=1703-1712&author=D.+Erritzoeauthor=A.+Tziortziauthor=D.+Bargielaauthor=A.+Colasantiauthor=G.+E.+Searleauthor=R.+N.+Gunnauthor=J.+D.+Beaverauthor=A.+Waldmanauthor=D.+J.+Nuttauthor=M.+Baniauthor=E.+Merlo-Pichauthor=E.+A.+Rabinerauthor=A.+Lingford-Hughes&title=In+vivo+imaging+of+cerebral+dopamine+D3+receptors+in+alcoholism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DErritzoe%26aufirst%3DD.%26aulast%3DTziortzi%26aufirst%3DA.%26aulast%3DBargiela%26aufirst%3DD.%26aulast%3DColasanti%26aufirst%3DA.%26aulast%3DSearle%26aufirst%3DG.%2BE.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DBeaver%26aufirst%3DJ.%2BD.%26aulast%3DWaldman%26aufirst%3DA.%26aulast%3DNutt%26aufirst%3DD.%2BJ.%26aulast%3DBani%26aufirst%3DM.%26aulast%3DMerlo-Pich%26aufirst%3DE.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DLingford-Hughes%26aufirst%3DA.%26atitle%3DIn%2520vivo%2520imaging%2520of%2520cerebral%2520dopamine%2520D3%2520receptors%2520in%2520alcoholism%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D1703%26epage%3D1712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Le Foll, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boileau, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Ciano, P.</span><span> </span><span class="NLM_article-title">Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.3389%2Ffphar.2014.00161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=25071579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BC2cbmvFOksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=161&author=B.+Le+Follauthor=A.+A.+Wilsonauthor=A.+Graffauthor=I.+Boileauauthor=P.+Di+Ciano&title=Recent+methods+for+measuring+dopamine+D3+receptor+occupancy+in+vivo%3A+importance+for+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development</span></div><div class="casAuthors">Le Foll Bernard; Wilson Alan A; Graff Ariel; Boileau Isabelle; Di Ciano Patricia</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">161</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">There is considerable interest in developing highly selective dopamine (DA) D3 receptor ligands for a variety of mental health disorders.  DA D3 receptors have been implicated in Parkinson's disease, schizophrenia, anxiety, depression, and substance use disorders.  The most concrete evidence suggests a role for the D3 receptor in drug-seeking behaviors.  D3 receptors are a subtype of D2 receptors, and traditionally the functional role of these two receptors has been difficult to differentiate.  Over the past 10-15 years a number of compounds selective for D3 over D2 receptors have been developed.  However, translating these findings into clinical research has been difficult as many of these compounds cannot be used in humans.  Therefore, the functional data involving the D3 receptor in drug addiction mostly comes from pre-clinical studies.  Recently, with the advent of [(11)C]-(+)-PHNO, it has become possible to image D3 receptors in the human brain with increased selectivity and sensitivity.  This is a significant innovation over traditional methods such as [(11)C]-raclopride that cannot differentiate between D2 and D3 receptors.  The use of [(11)C]-(+)-PHNO will allow for further delineation of the role of D3 receptors.  Here, we review recent evidence that the role of the D3 receptor has functional importance and is distinct from the role of the D2 receptor.  We then introduce the utility of analyzing [(11)C]-(+)-PHNO binding by region of interest.  This novel methodology can be used in pre-clinical and clinical approaches for the measurement of occupancy of both D3 and D2 receptors.  Evidence that [(11)C]-(+)-PHNO can provide insights into the function of D3 receptors in addiction is also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9_NOconUSPCCEBeYuoi7AfW6udTcc2ebrGRIz7iOomLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbmvFOksQ%253D%253D&md5=aa051596b978c380a5eaeeb2eb15f81d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2014.00161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2014.00161%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BFoll%26aufirst%3DB.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DGraff%26aufirst%3DA.%26aulast%3DBoileau%26aufirst%3DI.%26aulast%3DDi%2BCiano%26aufirst%3DP.%26atitle%3DRecent%2520methods%2520for%2520measuring%2520dopamine%2520D3%2520receptor%2520occupancy%2520in%2520vivo%253A%2520importance%2520for%2520drug%2520development%26jtitle%3DFront.%2520Pharmacol.%26date%3D2014%26volume%3D5%26spage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Heidbreder, C.</span><span> </span><span class="NLM_article-title">Rationale in support of the use of selective dopamine D(3) receptor antagonists for the pharmacotherapeutic management of substance use disorders</span> <span class="citation_source-journal">Naunyn-Schmiedeberg’s Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">386</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1007%2Fs00210-012-0803-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=23104235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ejur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=386&publication_year=2013&pages=167-176&author=C.+Heidbreder&title=Rationale+in+support+of+the+use+of+selective+dopamine+D%283%29+receptor+antagonists+for+the+pharmacotherapeutic+management+of+substance+use+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Rationale in support of the use of selective dopamine D3 receptor antagonists for the pharmacotherapeutic management of substance use disorders</span></div><div class="casAuthors">Heidbreder, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">386</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-176</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Growing evidence indicates that dopamine (DA) D3 receptors are involved in the control of drug-seeking behavior and may play an important role in the pathophysiol. of substance use disorders.  First, DA D3 receptors are distributed in strategic areas belonging to the mesolimbic DA system such as the ventral striatum, midbrain, and pallidum, which have been assocd. with behaviors controlled by the presentation of drug-assocd. cues.  Second, repeated exposure to drugs of abuse has been shown to produce neuroadaptations in the DA D3 system.  Third, the synthesis and characterization of highly potent and selective DA D3 receptor antagonists has permitted to further define the role of the DA D3 receptor in drug addiction.  Provided that the available preclin. and preliminary clin. evidence can be translated into clin. proof of concept in human, selective DA D3 receptor antagonists show promise for the treatment of substance use disorders as reflected by their potential to (1) regulate the motivation to self-administered drugs under schedules of reinforcement that require an increase in work demand and (2) disrupt the responsiveness to drug-assocd. stimuli that play a key role in the reinstatement of drug-seeking behavior triggered by re-exposure to the drug itself, re-exposure to environmental cues that had been previously assocd. with drug-taking behavior, or stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJryekGxZ_AbVg90H21EOLACvtfcHk0lgeykWB-Zx7mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ejur0%253D&md5=4b196deebddce4d802a3dcef465d1dac</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs00210-012-0803-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-012-0803-6%26sid%3Dliteratum%253Aachs%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3DRationale%2520in%2520support%2520of%2520the%2520use%2520of%2520selective%2520dopamine%2520D%25283%2529%2520receptor%2520antagonists%2520for%2520the%2520pharmacotherapeutic%2520management%2520of%2520substance%2520use%2520disorders%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D2013%26volume%3D386%26spage%3D167%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Heidbreder, C.</span><span> </span><span class="NLM_article-title">Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.2174%2F187152708786927822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=19128200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFansA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=410-421&author=C.+Heidbreder&title=Selective+antagonism+at+dopamine+D3+receptors+as+a+target+for+drug+addiction+pharmacotherapy%3A+a+review+of+preclinical+evidence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence</span></div><div class="casAuthors">Heidbreder, Christian</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">410-421</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The focal distribution of the dopamine (DA) D3 receptor in brain regions implicated in emotional and cognitive functions has made this target a main focus of drug discovery efforts.  This paper will review the most recent lines of research in support of the use of selective DA D3 receptor antagonists for the pharmacotherapeutic management of drug addiction: (1) expression of the DA D3 receptor in the rodent and human brain; (2) changes in expression of the DA D3 receptor following exposure to drugs of abuse, and (3) efficacy of selective DA D3 receptor antagonists in preclin. paradigms assessing the behavioral effects of drugs such as cocaine, nicotine, alc., methamphetamine, and heroin.  This manuscript, however, will not review the effects of nonselective DA D2/D3 receptor antagonists or partial D3 receptor agonists.  Growing evidence suggests that selective DA D3 receptor antagonists do not affect the primary reinforcing effects of drugs of abuse, but rather seem to regulate the motivation to self-administer drugs under schedules of reinforcement that require an increase in work demand.  In addn., selective antagonism at DA D3 receptors appears to disrupt significantly the responsiveness to drug-assocd. stimuli that play a key role in reinstatement of drug-seeking behavior.  These preclin. findings will be discussed in the context of translational research relevant to the design of early clin. trials and hypothesis testing in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcM0jWAd6GHrVg90H21EOLACvtfcHk0lgeykWB-Zx7mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFansA%253D%253D&md5=8f187ba70d486dc49f745562fe3f9408</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.2174%2F187152708786927822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152708786927822%26sid%3Dliteratum%253Aachs%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3DSelective%2520antagonism%2520at%2520dopamine%2520D3%2520receptors%2520as%2520a%2520target%2520for%2520drug%2520addiction%2520pharmacotherapy%253A%2520a%2520review%2520of%2520preclinical%2520evidence%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2008%26volume%3D7%26spage%3D410%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Heidbreder, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thanos, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span> </span><span class="NLM_article-title">Role of dopamine D3 receptors in the addictive properties of ethanol</span> <span class="citation_source-journal">Drugs Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1358%2Fdot.2004.40.4.820081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsVCktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2004&pages=355-365&author=C.+A.+Heidbrederauthor=M.+Andreoliauthor=C.+Marconauthor=P.+K.+Thanosauthor=C.+R.+Ashbyauthor=E.+L.+Gardner&title=Role+of+dopamine+D3+receptors+in+the+addictive+properties+of+ethanol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Role of dopamine D3 receptors in the addictive properties of ethanol</span></div><div class="casAuthors">Heidbreder, Christian A.; Andreoli, Michela; Marcon, Clara; Thanos, Panayotis K.; Ashby, Charles R., Jr.; Gardner, Eliot L.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-365</span>CODEN:
                <span class="NLM_cas:coden">MDACAP</span>;
        ISSN:<span class="NLM_cas:issn">0025-7656</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  After the cloning of the dopamine D1 and D2 receptors (1-3), several addnl. dopamine receptors were identified.  These new subtypes included the D3 and D4 receptors, which are similar to D2, and the D5 receptor, which is similar to D1 (4-6).  Although most studies have focused on the role of dopamine D1 and D2 receptors in mediating the addictive liability of drugs, the lack of selective pharmacol. tools has significantly hampered this particular field of research.  In contrast, recent studies using selective competitive antagonists have shown that the dopamine D3 receptor is involved in drug-seeking behavior.  The present review is intended to highlight a new, promising area in alc. research that focuses on the role of the dopamine D3 receptor in the addictive properties of ethanol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBovpsxBZkP7Vg90H21EOLACvtfcHk0li_KPOa_7Qo-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsVCktb4%253D&md5=6b64fde1da825766872b1bece0f577af</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1358%2Fdot.2004.40.4.820081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdot.2004.40.4.820081%26sid%3Dliteratum%253Aachs%26aulast%3DHeidbreder%26aufirst%3DC.%2BA.%26aulast%3DAndreoli%26aufirst%3DM.%26aulast%3DMarcon%26aufirst%3DC.%26aulast%3DThanos%26aufirst%3DP.%2BK.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26atitle%3DRole%2520of%2520dopamine%2520D3%2520receptors%2520in%2520the%2520addictive%2520properties%2520of%2520ethanol%26jtitle%3DDrugs%2520Today%26date%3D2004%26volume%3D40%26spage%3D355%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Le Foll, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokoloff, P.</span><span> </span><span class="NLM_article-title">The dopamine D3 receptor and drug dependence: effects on reward or beyond?</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">541</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=525-541&author=B.+Le+Follauthor=S.+R.+Goldbergauthor=P.+Sokoloff&title=The+dopamine+D3+receptor+and+drug+dependence%3A+effects+on+reward+or+beyond%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BFoll%26aufirst%3DB.%26aulast%3DGoldberg%26aufirst%3DS.%2BR.%26aulast%3DSokoloff%26aufirst%3DP.%26atitle%3DThe%2520dopamine%2520D3%2520receptor%2520and%2520drug%2520dependence%253A%2520effects%2520on%2520reward%2520or%2520beyond%253F%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D49%26spage%3D525%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Sokoloff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giros, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martres, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouthenet, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J. C.</span><span> </span><span class="NLM_article-title">Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1038%2F347146a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=1975644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaK3MXhsFyjtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=1990&pages=146-151&author=P.+Sokoloffauthor=B.+Girosauthor=M.+P.+Martresauthor=M.+L.+Bouthenetauthor=J.+C.+Schwartz&title=Molecular+cloning+and+characterization+of+a+novel+dopamine+receptor+%28D3%29+as+a+target+for+neuroleptics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics</span></div><div class="casAuthors">Sokoloff, Pierre; Giros, Bruno; Martres, Marie Pascale; Bouthenet, Marie Louise; Schwartz, Jean Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6289</span>),
    <span class="NLM_cas:pages">146-51</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">A dopamine receptor has been characterized which differs in its pharmacol. and signalling system from the D1 or D2 receptor and represents both an autoreceptor and a postsynaptic receptor.  The D3 receptor is localized to limbic areas of the brain, which are assocd. with cognitive, emotional, and endocrine functions.  It seems to mediate some of the effects of antipsychotic drugs and drugs used against Parkinson's disease, that were previously thought to interact only with D2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYcwXGdNb1ILVg90H21EOLACvtfcHk0li_KPOa_7Qo-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhsFyjtrg%253D&md5=0ea4d33964b478c51de32e96345811f6</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2F347146a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F347146a0%26sid%3Dliteratum%253Aachs%26aulast%3DSokoloff%26aufirst%3DP.%26aulast%3DGiros%26aufirst%3DB.%26aulast%3DMartres%26aufirst%3DM.%2BP.%26aulast%3DBouthenet%26aufirst%3DM.%2BL.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26atitle%3DMolecular%2520cloning%2520and%2520characterization%2520of%2520a%2520novel%2520dopamine%2520receptor%2520%2528D3%2529%2520as%2520a%2520target%2520for%2520neuroleptics%26jtitle%3DNature%26date%3D1990%26volume%3D347%26spage%3D146%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Gurevich, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyce, J. N.</span><span> </span><span class="NLM_article-title">Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">60</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=60-80&author=E.+V.+Gurevichauthor=J.+N.+Joyce&title=Distribution+of+dopamine+D3+receptor+expressing+neurons+in+the+human+forebrain%3A+comparison+with+D2+receptor+expressing+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGurevich%26aufirst%3DE.%2BV.%26aulast%3DJoyce%26aufirst%3DJ.%2BN.%26atitle%3DDistribution%2520of%2520dopamine%2520D3%2520receptor%2520expressing%2520neurons%2520in%2520the%2520human%2520forebrain%253A%2520comparison%2520with%2520D2%2520receptor%2520expressing%2520neurons%26jtitle%3DNeuropsychopharmacology%26date%3D1999%26volume%3D20%26spage%3D60%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Searle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaver, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comley, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tziortzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mugnaini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffante, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo-Pich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabiner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laruelle, M.</span><span> </span><span class="NLM_article-title">Imaging dopamine D3 receptors in the human brain with positron emission tomography, [<sup>11</sup>C]PHNO, and a selective D3 receptor antagonist</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.biopsych.2010.04.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=20599188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1eitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2010&pages=392-399&author=G.+Searleauthor=J.+D.+Beaverauthor=R.+A.+Comleyauthor=M.+Baniauthor=A.+Tziortziauthor=M.+Slifsteinauthor=M.+Mugnainiauthor=C.+Griffanteauthor=A.+A.+Wilsonauthor=E.+Merlo-Pichauthor=S.+Houleauthor=R.+Gunnauthor=E.+A.+Rabinerauthor=M.+Laruelle&title=Imaging+dopamine+D3+receptors+in+the+human+brain+with+positron+emission+tomography%2C+%5B11C%5DPHNO%2C+and+a+selective+D3+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist</span></div><div class="casAuthors">Searle, Graham; Beaver, John D.; Comley, Robert A.; Bani, Massimo; Tziortzi, Andri; Slifstein, Mark; Mugnaini, Manolo; Griffante, Cristiana; Wilson, Alan A.; Merlo-Pich, Emilio; Houle, Sylvain; Gunn, Roger; Rabiner, Eugenii A.; Laruelle, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">392-399</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Dopamine D3 receptors are involved in the pathophysiol. of several neuropsychiatric conditions. [11C]-(+)-PHNO is a radiolabeled D2 and D3 agonist, suitable for imaging the agonist binding sites (denoted D2HIGH and D3) of these receptors with positron emission tomog. (PET).  PET studies in nonhuman primates documented that, in vivo, [11C]-(+)-PHNO displays a relative selectivity for D3 compared with D2HIGH receptor sites and that the [11C]-(+)-PHNO signal is enriched in D3 contribution compared with conventional ligands such as [11C] raclopride.  To define the D3 contribution (fPHNOD3) to [11C]-(+)-PHNO binding potential (BPND) in healthy humans, 52 PET scans were obtained in 19 healthy volunteers at baseline and following oral administration of various doses of the selective D3 receptor antagonist, GSK598809.  The impact of GSK598809 on [11C]-(+)-PHNO was regionally selective.  In dorsal regions of the striatum, GSK598809 did not significantly affect [11C]-(+)-PHNO BPND (fPHNOD3 ≈ 0%).  Conversely, in the substantia nigra, GSK598809 dose-dependently reduced [11C]-(+)-PHNO binding to nonspecific level (fPHNOD3 ≈ 100%).  In ventral striatum (VST), globus pallidus and thalamus (THA), [11C]-(+)-PHNO BPND was attributable to a combination of D2HIGH and D3 receptor sites, with fPHNOD3 of 26%, 67% and 46%, resp.  D3 receptor binding potential (BPNDD3) was highest in globus pallidus (1.90) and substantial nigra (1.39), with lower levels in VST (.77) and THA (.18) and negligible levels in dorsal striatum.  This study elucidated the pharmacol. nature of the [11C]-(+)-PHNO signal in healthy subjects and provided the first quantification of D3 receptor availability with PET in the living human brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEJHz3sXsWDrVg90H21EOLACvtfcHk0lgGsPMMllT2dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1eitrc%253D&md5=dbb2800b668a23be61f9b0c90f2725c3</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2010.04.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2010.04.038%26sid%3Dliteratum%253Aachs%26aulast%3DSearle%26aufirst%3DG.%26aulast%3DBeaver%26aufirst%3DJ.%2BD.%26aulast%3DComley%26aufirst%3DR.%2BA.%26aulast%3DBani%26aufirst%3DM.%26aulast%3DTziortzi%26aufirst%3DA.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DMugnaini%26aufirst%3DM.%26aulast%3DGriffante%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DMerlo-Pich%26aufirst%3DE.%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DGunn%26aufirst%3DR.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DLaruelle%26aufirst%3DM.%26atitle%3DImaging%2520dopamine%2520D3%2520receptors%2520in%2520the%2520human%2520brain%2520with%2520positron%2520emission%2520tomography%252C%2520%255B11C%255DPHNO%252C%2520and%2520a%2520selective%2520D3%2520receptor%2520antagonist%26jtitle%3DBiol.%2520Psychiatry%26date%3D2010%26volume%3D68%26spage%3D392%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e49483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e49483&author=J.+Sunauthor=J.+Xuauthor=N.+J.+Cairnsauthor=J.+S.+Perlmutterauthor=R.+H.+Mach&title=Dopamine+D1%2C+D2%2C+D3+receptors%2C+vesicular+monoamine+transporter+type-2+%28VMAT2%29+and+dopamine+transporter+%28DAT%29+densities+in+aged+human+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DCairns%26aufirst%3DN.%2BJ.%26aulast%3DPerlmutter%26aufirst%3DJ.%2BS.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DDopamine%2520D1%252C%2520D2%252C%2520D3%2520receptors%252C%2520vesicular%2520monoamine%2520transporter%2520type-2%2520%2528VMAT2%2529%2520and%2520dopamine%2520transporter%2520%2528DAT%2529%2520densities%2520in%2520aged%2520human%2520brain%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De49483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Rangel-Barajas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span> </span><span class="NLM_article-title">Characterization of [<sup>3</sup>H]LS-3-134, a novel arylamide phenylpiperazine D3 dopamine receptor selective radioligand</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">418</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1111%2Fjnc.12825" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=25041389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGltr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2014&pages=418-431&author=C.+Rangel-Barajasauthor=M.+Malikauthor=M.+Taylorauthor=K.+A.+Neveauthor=R.+H.+Machauthor=R.+R.+Luedtke&title=Characterization+of+%5B3H%5DLS-3-134%2C+a+novel+arylamide+phenylpiperazine+D3+dopamine+receptor+selective+radioligand"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of [3H]LS-3-134, a novel arylamide phenylpiperazine D3 dopamine receptor selective radioligand</span></div><div class="casAuthors">Rangel-Barajas, Claudia; Malik, Maninder; Taylor, Michelle; Neve, Kim A.; Mach, Robert H.; Luedtke, Robert R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">418-431</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">LS-3-134 is a substituted N-phenylpiperazine deriv. that has been reported to exhibit: (i) high-affinity binding (Ki value 0.2 nM) at human D3 dopamine receptors, (ii) > 100-fold D3 vs. D2 dopamine receptor subtype binding selectivity, and (iii) low-affinity binding (Ki > 5000 nM) at sigma 1 and sigma 2 receptors.  Based upon a forskolin-dependent activation of the adenylyl cyclase inhibition assay, LS-3-134 is a weak partial agonist at both D2 and D3 dopamine receptor subtypes (29% and 35% of full agonist activity, resp.).  In this study, [3H]-labeled LS-3-134 was prepd. and evaluated to further characterize its use as a D3 dopamine receptor selective radioligand.  Kinetic and equil. radioligand binding studies were performed.  This radioligand rapidly reaches equil. (10-15 min at 37°C) and binds with high affinity to both human (Kd = 0.06 ± 0.01 nM) and rat (Kd = 0.2 ± 0.02 nM) D3 receptors expressed in HEK293 cells.  Direct and competitive radioligand binding studies using rat caudate and nucleus accumbens tissue indicate that [3H]LS-3-134 selectively binds a homogeneous population of binding sites with a dopamine D3 receptor pharmacol. profile.  Based upon these studies, we propose that [3H]LS-3-134 represents a novel D3 dopamine receptor selective radioligand that can be used for studying the expression and regulation of the D3 dopamine receptor subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoceMK9Cvq0h7Vg90H21EOLACvtfcHk0lgGsPMMllT2dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGltr7E&md5=178cc8bbf98e42db09940bcea3d5a02e</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12825%26sid%3Dliteratum%253Aachs%26aulast%3DRangel-Barajas%26aufirst%3DC.%26aulast%3DMalik%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DNeve%26aufirst%3DK.%2BA.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26atitle%3DCharacterization%2520of%2520%255B3H%255DLS-3-134%252C%2520a%2520novel%2520arylamide%2520phenylpiperazine%2520D3%2520dopamine%2520receptor%2520selective%2520radioligand%26jtitle%3DJ.%2520Neurochem.%26date%3D2014%26volume%3D131%26spage%3D418%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Millan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peglion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivet, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dacquet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bervoets, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girardon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaput, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audinot, V.</span><span> </span><span class="NLM_article-title">Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297:1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">885</span><span class="NLM_x">–</span> <span class="NLM_lpage">898</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=7473180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaK2MXpsF2gs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1995&pages=885-898&author=M.+J.+Millanauthor=J.+L.+Peglionauthor=J.+Vianauthor=J.+M.+Rivetauthor=M.+Broccoauthor=A.+Gobertauthor=A.+Newman-Tancrediauthor=C.+Dacquetauthor=K.+Bervoetsauthor=S.+Girardonauthor=V.+Jacquesauthor=C.+Chaputauthor=V.+Audinot&title=Functional+correlates+of+dopamine+D3+receptor+activation+in+the+rat+in+vivo+and+their+modulation+by+the+selective+antagonist%2C+%28%2B%29-S+14297%3A1.+Activation+of+postsynaptic+D3+receptors+mediates+hypothermia%2C+whereas+blockade+of+D2+receptors+elicits+prolactin+secretion+and+catalepsy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: I. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy</span></div><div class="casAuthors">Millan, Mark J.; Peglion, Jean-Louis; Vian, Joeel; Rivet, Jean-Michel; Brocco, Mauricette; Gobert, Alain; Newman-Tancredi, Adrian; Dacquet, Catherine; Bervoets, Karin; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">885-98</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Using [125I]-iodosulpride as a radioligand, the novel naphthofurane (±)-S 11566 {(±)-[7-(N,N-dipropylamino)-5,6,7,8-tetrahydro-naphtho(2,3b)dihydro,2,3-furane]} showed a marked preference for human, recombinant D3 as compared with D2 receptors stably transfected into Chinese hamster ovary cells (Kis = 24/529 nM).  This activity resided in its (+)-eutomer, (+)-S 14297 (13/297 nM) as compared with its (-)-distomer, (-)-S 17777 (405/3544 nM).  In contrast, (+)-AJ 76 manifested only a mild 2-fold preference for D3 sites (70/154 nM), whereas haloperidol and six addnl. antagonists showed a mild (2-7-fold) preference for D2 sites.  As concerns agonists, (+)-7-OH-DPAT, (±)-CGS 15855A, quinerolane, (-)-quinpirole and N-0434 displayed a preference (6-40-fold) for D3 receptors, whereas piribedil showed a slight, 2-fold, preference for D2 sites (243/126 nM).  (+)-S 14297 showed low (> 1.0 μM) affinity at rat D1 and D2 sites and at cloned, human D4 and D5 receptors and only low affinity (145 to > 10,000 nM) at all other sites examd.  In vivo, administered s.c., (+)-7-OH-DPAT, CGS 15855A, quinelorane, (-)-quinpirole and N-0434 potently evoked hypothermia.  Across all (8) agonists tested, potency correlated significantly with affinity at D3 sites (r =.84) but not D2 sites (r =.50, P >.05).  (+)-S 14297 (0.16-1.25 mg/kg, s.c.) blocked the induction of hypothermia by (+)-7-OH-DPAT, CGS 15855A and (-)-quinpirole, but not by the α2-adrenergic agonist, clonidine, without influencing core temp. alone.  In contrast, (-)-S 1777 (10.0 mg/kg, s.c.) was only partially active.  Across all (9) antagonists, potency for inhibition of (+)-7-OH-DPAT-induced hypothermia correlated more strongly with affinity at D3 (r =.96) than D2 (r =.75) sites.  Whereas haloperidol and the other antagonists provoked prolactin secretion and elicited catalepsy, (+)-S 14297 and (±)-S 11566 at doses of ≤10.0 and 40.0 mg/kg, s.c., resp., were not significantly effective.  Across all antagonists, potency for eliciting prolactin secretion and catalepsy correlated better with affinity at D2 (r =.95 and.06) than D3 (r =.76 and.91) sites.  In conclusion, these data demonstrate that the novel naphthofurane, (+)-S 14297, is a selective ligand (antagonist) at dopamine D3 receptors and suggest that their activation mediates hypothermia in the rat.  In distinction, (+)-S 14297 elicits neither prolactin secretion nor catalepsy, actions that appear to reflect blockade of dopamine D2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7ba6fbWzpObVg90H21EOLACvtfcHk0ljBhl4KFNGFyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpsF2gs7o%253D&md5=9ea0a49e623b6f2f07f54363ccbe85d8</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DPeglion%26aufirst%3DJ.%2BL.%26aulast%3DVian%26aufirst%3DJ.%26aulast%3DRivet%26aufirst%3DJ.%2BM.%26aulast%3DBrocco%26aufirst%3DM.%26aulast%3DGobert%26aufirst%3DA.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26aulast%3DDacquet%26aufirst%3DC.%26aulast%3DBervoets%26aufirst%3DK.%26aulast%3DGirardon%26aufirst%3DS.%26aulast%3DJacques%26aufirst%3DV.%26aulast%3DChaput%26aufirst%3DC.%26aulast%3DAudinot%26aufirst%3DV.%26atitle%3DFunctional%2520correlates%2520of%2520dopamine%2520D3%2520receptor%2520activation%2520in%2520the%2520rat%2520in%2520vivo%2520and%2520their%2520modulation%2520by%2520the%2520selective%2520antagonist%252C%2520%2528%252B%2529-S%252014297%253A1.%2520Activation%2520of%2520postsynaptic%2520D3%2520receptors%2520mediates%2520hypothermia%252C%2520whereas%2520blockade%2520of%2520D2%2520receptors%2520elicits%2520prolactin%2520secretion%2520and%2520catalepsy%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1995%26volume%3D275%26spage%3D885%26epage%3D898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Cho, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. M.</span><span> </span><span class="NLM_article-title">Current perspectives on the selective regulation of dopamine D(2) and D(3) receptors</span> <span class="citation_source-journal">Arch. Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1521</span><span class="NLM_x">–</span> <span class="NLM_lpage">1538</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1007%2Fs12272-010-1005-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=21052931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlOqtr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=1521-1538&author=D.+I.+Choauthor=M.+Zhengauthor=K.+M.+Kim&title=Current+perspectives+on+the+selective+regulation+of+dopamine+D%282%29+and+D%283%29+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Current perspectives on the selective regulation of dopamine D2 and D3 receptors</span></div><div class="casAuthors">Cho, Dong Im; Zheng, Mei; Kim, Kyeong-Man</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1521-1538</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">A review.  Among the characterized dopamine receptor subtypes, D2 receptor (D2R) and D3 receptor (D3R) are the main targets of neuroleptics that are currently in use.  In particular, D3R is closely related to the etiol. of schizophrenia and drug addiction.  The spatial expression patterns of D2R and D3R are distinct in certain areas of the brain.  D2R are heavily expressed in the regions responsible for motor functions, whereas D3R are more selectively expressed in the limbic regions, which are assocd. with cognitive and emotional functions.  Therefore, disturbances in the motor and endocrine functions, which are the most serious problems caused by the current neuroleptics, are likely to result from the non-selective blockade of D2R.  Selective regulation of D3R is needed to sep. the desired therapeutic activities from unwanted side effects that result from promiscuous blockade of other receptors.  D2R and D3R possess high sequence homol. and employ similar signaling pathways, and it is difficult to selectively regulate them.  In this review, we discuss the signaling mechanisms, intracellular trafficking, and desensitization properties of D2R and D3R.  In addn., the proteins interacting with D2R or D3R are discussed in relation to their roles in the regulation of receptor functions, followed by the current status of the development of selective D3R ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4cCMB-iwXjLVg90H21EOLACvtfcHk0ljBhl4KFNGFyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlOqtr3K&md5=7dd5bae45a4c7f356f33523f999dafe6</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1007%2Fs12272-010-1005-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-010-1005-8%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DD.%2BI.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DK.%2BM.%26atitle%3DCurrent%2520perspectives%2520on%2520the%2520selective%2520regulation%2520of%2520dopamine%2520D%25282%2529%2520and%2520D%25283%2529%2520receptors%26jtitle%3DArch.%2520Pharm.%2520Res.%26date%3D2010%26volume%3D33%26spage%3D1521%26epage%3D1538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Kishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correll, C. U.</span><span> </span><span class="NLM_article-title">Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1169</span><span class="NLM_x">–</span> <span class="NLM_lpage">1180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2013&pages=e1169-1180&author=T.+Kishiauthor=Y.+Matsudaauthor=N.+Iwataauthor=C.+U.+Correll&title=Antipsychotics+for+cocaine+or+psychostimulant+dependence%3A+systematic+review+and+meta-analysis+of+randomized%2C+placebo-controlled+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKishi%26aufirst%3DT.%26aulast%3DMatsuda%26aufirst%3DY.%26aulast%3DIwata%26aufirst%3DN.%26aulast%3DCorrell%26aufirst%3DC.%2BU.%26atitle%3DAntipsychotics%2520for%2520cocaine%2520or%2520psychostimulant%2520dependence%253A%2520systematic%2520review%2520and%2520meta-analysis%2520of%2520randomized%252C%2520placebo-controlled%2520trials%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2013%26volume%3D74%26spage%3De1169%26epage%3D1180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Veselinovic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulzen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunder, G.</span><span> </span><span class="NLM_article-title">Cariprazine, a new, orally active dopamine D2/3 receptor partial agonist for the treatment of schizophrenia, bipolar mania and depression</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1141</span><span class="NLM_x">–</span> <span class="NLM_lpage">1159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1586%2F14737175.2013.853448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24175719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWjsLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1141-1159&author=T.+Veselinovicauthor=M.+Paulzenauthor=G.+Grunder&title=Cariprazine%2C+a+new%2C+orally+active+dopamine+D2%2F3+receptor+partial+agonist+for+the+treatment+of+schizophrenia%2C+bipolar+mania+and+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Cariprazine, a new, orally active dopamine D2/3 receptor partial agonist for the treatment of schizophrenia, bipolar mania and depression</span></div><div class="casAuthors">Veselinovic, Tanja; Paulzen, Michael; Gruender, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1141-1159</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Cariprazine is a novel drug with partial agonist activity at dopamine D2/3 receptors and six- to eightfold higher affinity for human dopamine D3 over D2 receptors.  Results from several placebo-controlled Phase II/III trials in patients with a The Diagnostic and Statistical Manual of Mental Disorders IV diagnosis of schizophrenia or bipolar I disorder suggest that cariprazine is superior to placebo with respect to antipsychotic and antimanic activity.  Reports concerning safety and tolerability of cariprazine are mainly favorable, although the rates of treatment-assocd. adverse events, which most commonly included akathisia and extrapyramidal symptom, are rather high.  However, only minor alterations of clin. lab. values, prolactin concns. and ECG parameters are reported in cariprazine-treated patients.  A new drug application to the U.S. F DA for cariprazine for the treatment of both schizophrenia and manic or mixed episodes assocd. with bipolar I disorder was submitted in Nov. 2012.  A more precise assessment of the clin. properties of this new drug will require addnl. studies, aimed to compare and contrast cariprazine with other antipsychotic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPsIaMWyuixrVg90H21EOLACvtfcHk0lgeD9ACcoTckw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWjsLjF&md5=b30e0bf57bb1004c626be6913c0393f9</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1586%2F14737175.2013.853448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.2013.853448%26sid%3Dliteratum%253Aachs%26aulast%3DVeselinovic%26aufirst%3DT.%26aulast%3DPaulzen%26aufirst%3DM.%26aulast%3DGrunder%26aufirst%3DG.%26atitle%3DCariprazine%252C%2520a%2520new%252C%2520orally%2520active%2520dopamine%2520D2%252F3%2520receptor%2520partial%2520agonist%2520for%2520the%2520treatment%2520of%2520schizophrenia%252C%2520bipolar%2520mania%2520and%2520depression%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2013%26volume%3D13%26spage%3D1141%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Roman, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gyertyan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szombathelyi, Z.</span><span> </span><span class="NLM_article-title">Cariprazine (RGH-188), a D(3)-preferring dopamine D(3)/D(2) receptor partial agonist antipsychotic candidate demonstrates anti-abuse potential in rats</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">226</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=2013&pages=285-293&author=V.+Romanauthor=I.+Gyertyanauthor=K.+Saghyauthor=B.+Kissauthor=Z.+Szombathelyi&title=Cariprazine+%28RGH-188%29%2C+a+D%283%29-preferring+dopamine+D%283%29%2FD%282%29+receptor+partial+agonist+antipsychotic+candidate+demonstrates+anti-abuse+potential+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoman%26aufirst%3DV.%26aulast%3DGyertyan%26aufirst%3DI.%26aulast%3DSaghy%26aufirst%3DK.%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DSzombathelyi%26aufirst%3DZ.%26atitle%3DCariprazine%2520%2528RGH-188%2529%252C%2520a%2520D%25283%2529-preferring%2520dopamine%2520D%25283%2529%252FD%25282%2529%2520receptor%2520partial%2520agonist%2520antipsychotic%2520candidate%2520demonstrates%2520anti-abuse%2520potential%2520in%2520rats%26jtitle%3DPsychopharmacology%26date%3D2013%26volume%3D226%26spage%3D285%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Gould, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duke, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=138-151&author=R.+W.+Gouldauthor=A.+N.+Dukeauthor=M.+A.+Nader&title=PET+studies+in+nonhuman+primate+models+of+cocaine+abuse%3A+translational+research+related+to+vulnerability+and+neuroadaptations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGould%26aufirst%3DR.%2BW.%26aulast%3DDuke%26aufirst%3DA.%2BN.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DPET%2520studies%2520in%2520nonhuman%2520primate%2520models%2520of%2520cocaine%2520abuse%253A%2520translational%2520research%2520related%2520to%2520vulnerability%2520and%2520neuroadaptations%26jtitle%3DNeuropharmacology%26date%3D2014%26volume%3D84%26spage%3D138%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Laszy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laszlovszky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gyertyan, I.</span><span> </span><span class="NLM_article-title">Dopamine D3 receptor antagonists improve the learning performance in memory-impaired rats</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">575</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2005&pages=567-575&author=J.+Laszyauthor=I.+Laszlovszkyauthor=I.+Gyertyan&title=Dopamine+D3+receptor+antagonists+improve+the+learning+performance+in+memory-impaired+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaszy%26aufirst%3DJ.%26aulast%3DLaszlovszky%26aufirst%3DI.%26aulast%3DGyertyan%26aufirst%3DI.%26atitle%3DDopamine%2520D3%2520receptor%2520antagonists%2520improve%2520the%2520learning%2520performance%2520in%2520memory-impaired%2520rats%26jtitle%3DPsychopharmacology%26date%3D2005%26volume%3D179%26spage%3D567%26epage%3D575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Mugnaini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iavarone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavallini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffante, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliosi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savoia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaver, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabiner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo Pich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bani, M.</span><span> </span><span class="NLM_article-title">Occupancy of brain dopamine D3 receptors and drug craving: a translational approach</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=302-312&author=M.+Mugnainiauthor=L.+Iavaroneauthor=P.+Cavalliniauthor=C.+Griffanteauthor=B.+Oliosiauthor=C.+Savoiaauthor=J.+Beaverauthor=E.+A.+Rabinerauthor=F.+Micheliauthor=C.+Heidbrederauthor=A.+Andornauthor=E.+Merlo+Pichauthor=M.+Bani&title=Occupancy+of+brain+dopamine+D3+receptors+and+drug+craving%3A+a+translational+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMugnaini%26aufirst%3DM.%26aulast%3DIavarone%26aufirst%3DL.%26aulast%3DCavallini%26aufirst%3DP.%26aulast%3DGriffante%26aufirst%3DC.%26aulast%3DOliosi%26aufirst%3DB.%26aulast%3DSavoia%26aufirst%3DC.%26aulast%3DBeaver%26aufirst%3DJ.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DHeidbreder%26aufirst%3DC.%26aulast%3DAndorn%26aufirst%3DA.%26aulast%3DMerlo%2BPich%26aufirst%3DE.%26aulast%3DBani%26aufirst%3DM.%26atitle%3DOccupancy%2520of%2520brain%2520dopamine%2520D3%2520receptors%2520and%2520drug%2520craving%253A%2520a%2520translational%2520approach%26jtitle%3DNeuropsychopharmacology%26date%3D2013%26volume%3D38%26spage%3D302%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Nakajima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerretsen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caravaggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Foll, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulsant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graff-Guerrero, A.</span><span> </span><span class="NLM_article-title">The potential role of dopamine D(3) receptor neurotransmission in cognition</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.euroneuro.2013.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=23791072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVyrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=799-813&author=S.+Nakajimaauthor=P.+Gerretsenauthor=H.+Takeuchiauthor=F.+Caravaggioauthor=T.+Chowauthor=B.+Le+Follauthor=B.+Mulsantauthor=B.+Pollockauthor=A.+Graff-Guerrero&title=The+potential+role+of+dopamine+D%283%29+receptor+neurotransmission+in+cognition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The potential role of dopamine D3 receptor neurotransmission in cognition</span></div><div class="casAuthors">Nakajima, Shinichiro; Gerretsen, Philip; Takeuchi, Hiroyoshi; Caravaggio, Fernando; Chow, Tiffany; Le Foll, Bernard; Mulsant, Benoit; Pollock, Bruce; Graff-Guerrero, Ariel</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">799-813</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Currently available treatments have limited pro-cognitive effects for neuropsychiatric disorders, such as schizophrenia, Parkinson's disease and Alzheimer's disease.  The primary objective of this work is to review the literature on the role of dopamine D3 receptors in cognition, and propose dopamine D3 receptor antagonists as possible cognitive enhancers for neuropsychiatric disorders.  A literature search was performed to identify animal and human studies on D3 receptors and cognition using PubMed, MEDLINE and EMBASE.  The search terms included "dopamine D3 receptor" and "cognition".  The literature search identified 164 articles.  The results revealed: (1) D3 receptors are assocd. with cognitive functioning in both healthy individuals and those with neuropsychiatric disorders; (2) D3 receptor blockade appears to enhance while D3 receptor agonism seems to impair cognitive function, including memory, attention, learning, processing speed, social recognition and executive function independent of age; and (3) D3 receptor antagonists may exert their pro-cognitive effect by enhancing the release of acetylcholine in the prefrontal cortex, disinhibiting the activity of dopamine neurons projecting to the nucleus accumbens or prefrontal cortex, or activating CREB signaling in the hippocampus.  These findings suggest that D3 receptor blockade may enhance cognitive performance in healthy individuals and treat cognitive dysfunction in individuals with a neuropsychiatric disorder.  Clin. trials are needed to confirm these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSUxqVZeIzYLVg90H21EOLACvtfcHk0liyzoqu5KoJgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVyrtLc%253D&md5=3d42c98b759d0d27039345dbee2ae73e</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2013.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2013.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DNakajima%26aufirst%3DS.%26aulast%3DGerretsen%26aufirst%3DP.%26aulast%3DTakeuchi%26aufirst%3DH.%26aulast%3DCaravaggio%26aufirst%3DF.%26aulast%3DChow%26aufirst%3DT.%26aulast%3DLe%2BFoll%26aufirst%3DB.%26aulast%3DMulsant%26aufirst%3DB.%26aulast%3DPollock%26aufirst%3DB.%26aulast%3DGraff-Guerrero%26aufirst%3DA.%26atitle%3DThe%2520potential%2520role%2520of%2520dopamine%2520D%25283%2529%2520receptor%2520neurotransmission%2520in%2520cognition%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2013%26volume%3D23%26spage%3D799%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Lacroix, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hows, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C. A.</span><span> </span><span class="NLM_article-title">Selective antagonism at dopamine D3 receptors enhances monoaminergic and cholinergic neurotransmission in the rat anterior cingulate cortex</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">849</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=839-849&author=L.+P.+Lacroixauthor=M.+E.+Howsauthor=A.+J.+Shahauthor=J.+J.+Haganauthor=C.+A.+Heidbreder&title=Selective+antagonism+at+dopamine+D3+receptors+enhances+monoaminergic+and+cholinergic+neurotransmission+in+the+rat+anterior+cingulate+cortex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLacroix%26aufirst%3DL.%2BP.%26aulast%3DHows%26aufirst%3DM.%2BE.%26aulast%3DShah%26aufirst%3DA.%2BJ.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DHeidbreder%26aufirst%3DC.%2BA.%26atitle%3DSelective%2520antagonism%2520at%2520dopamine%2520D3%2520receptors%2520enhances%2520monoaminergic%2520and%2520cholinergic%2520neurotransmission%2520in%2520the%2520rat%2520anterior%2520cingulate%2520cortex%26jtitle%3DNeuropsychopharmacology%26date%3D2003%26volume%3D28%26spage%3D839%26epage%3D849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Millan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cara, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dekeyne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panayi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Groote, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cistarelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billiras, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobert, A.</span><span> </span><span class="NLM_article-title">Selective blockade of dopamine D(3) versus D(2) receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysis</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">1047</span><span class="NLM_x">–</span> <span class="NLM_lpage">1061</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1111%2Fj.1471-4159.2006.04262.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=17266737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisFGnu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2007&pages=1047-1061&author=M.+J.+Millanauthor=B.+Di+Caraauthor=A.+Dekeyneauthor=F.+Panayiauthor=L.+De+Grooteauthor=D.+Sicardauthor=L.+Cistarelliauthor=R.+Billirasauthor=A.+Gobert&title=Selective+blockade+of+dopamine+D%283%29+versus+D%282%29+receptors+enhances+frontocortical+cholinergic+transmission+and+social+memory+in+rats%3A+a+parallel+neurochemical+and+behavioural+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Selective blockade of dopamine D3 versus D2 receptors enhances frontal cortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioral analysis</span></div><div class="casAuthors">Millan, Mark J.; Di Cara, Benjamin; Dekeyne, Anne; Panayi, Fany; De Groote, Lotte; Sicard, Dorothee; Cistarelli, Laetitia; Billiras, Rodolphe; Gobert, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1047-1061</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Though dopaminergic mechanisms modulate cholinergic transmission and cognitive function, the significance of specific receptor subtypes remains uncertain.  Here, we examd. the roles of dopamine D3 vs. D2 receptors.  By analogy with tacrine (0.16-2.5 mg/kg, s.c.), the selective D3 receptor antagonists, S33084 (0.01-0.63) and SB277,011 (0.63-40.0), elicited dose-dependent, pronounced and sustained elevations in dialysis levels of acetylcholine (ACh) in the frontal cortex, but not the hippocampus, of freely-moving rats.  The actions of these antagonists were stereospecifically mimicked by (+)S14297 (1.25), whereas its inactive distomer, (-)S17777, was ineffective.  The preferential D2 receptor antagonist, L741,626 (10.0), failed to modify levels of ACh.  S33084 (0.01-0.63) and SB277,011 (0.16-2.5) also mimicked tacrine (0.04-0.63) by dose-dependently attenuating the deleterious influence of scopolamine (1.25) upon social memory (recognition by an adult rat of a juvenile conspecific).  Further, (+)S14297 (1.25) vs. (-)S17777 stereospecifically blocked the action of scopolamine.  Using an intersession interval of 120 min (spontaneous loss of recognition), S33084 (0.04-0.63), SB277,011 (0.16-10.0) and (+)S14297 (0.63-10.0) likewise mimicked tacrine (0.16-2.5) in enhancing social memory.  In contrast, L741,626 (0.16-10.0) displayed amnesic properties.  In conclusion, selective blockade of D3 receptors facilitates frontal cortical cholinergic transmission and improves social memory in rats.  These data support the pertinence of D3 receptors as a target for treatment of disorders in which cognitive function is compromised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdxC_Nsga5b7Vg90H21EOLACvtfcHk0liyzoqu5KoJgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisFGnu7g%253D&md5=e40dfd968d9f0a5ba2554511d84cd01e</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04262.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04262.x%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DDi%2BCara%26aufirst%3DB.%26aulast%3DDekeyne%26aufirst%3DA.%26aulast%3DPanayi%26aufirst%3DF.%26aulast%3DDe%2BGroote%26aufirst%3DL.%26aulast%3DSicard%26aufirst%3DD.%26aulast%3DCistarelli%26aufirst%3DL.%26aulast%3DBilliras%26aufirst%3DR.%26aulast%3DGobert%26aufirst%3DA.%26atitle%3DSelective%2520blockade%2520of%2520dopamine%2520D%25283%2529%2520versus%2520D%25282%2529%2520receptors%2520enhances%2520frontocortical%2520cholinergic%2520transmission%2520and%2520social%2520memory%2520in%2520rats%253A%2520a%2520parallel%2520neurochemical%2520and%2520behavioural%2520analysis%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D100%26spage%3D1047%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Loiseau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">Blockade of dopamine D(3) receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: similar actions of D(1) receptor agonists, but not of D(2) antagonists</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.euroneuro.2008.07.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=18793829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKrsb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=23-33&author=F.+Loiseauauthor=M.+J.+Millan&title=Blockade+of+dopamine+D%283%29+receptors+in+frontal+cortex%2C+but+not+in+sub-cortical+structures%2C+enhances+social+recognition+in+rats%3A+similar+actions+of+D%281%29+receptor+agonists%2C+but+not+of+D%282%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of dopamine D3 receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: Similar actions of D1 receptor agonists, but not of D2 antagonists</span></div><div class="casAuthors">Loiseau, Florence; Millan, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-33</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Though D3 receptor antagonists can enhance cognitive function, their sites of action remain unexplored.  This issue was addressed employing a model of social recognition in rats, and the actions of D3 antagonists were compared to D1 agonists that likewise possess pro-cognitive properties.  Infusion of the highly selective D3 antagonists, S33084 and SB277,011 (0.04-2.5 μg/side), into the frontal cortex (FCX) dose-dependently reversed the deficit in recognition induced by a delay.  By contrast, the preferential D2 antagonist, L741,626 (0.63-5.0) had no effect.  The action of S33084 was regionally specific inasmuch as its injection into the nucleus accumbens or striatum was ineffective.  A similar increase of recognition was obtained upon injection of the D1 agonist, SKF81297 (0.04-0.63), into the FCX though it was also active (0.63) in the nucleus accumbens.  These data suggest that D3 receptors modulating social recognition are localized in FCX, and underpin their pertinence as targets for antipsychotic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhPiGFm02p5LVg90H21EOLACvtfcHk0lgQHHy7xNzEmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKrsb7M&md5=fefba41f9316430bd0311e4a13aa6a17</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2008.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2008.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DLoiseau%26aufirst%3DF.%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3DBlockade%2520of%2520dopamine%2520D%25283%2529%2520receptors%2520in%2520frontal%2520cortex%252C%2520but%2520not%2520in%2520sub-cortical%2520structures%252C%2520enhances%2520social%2520recognition%2520in%2520rats%253A%2520similar%2520actions%2520of%2520D%25281%2529%2520receptor%2520agonists%252C%2520but%2520not%2520of%2520D%25282%2529%2520antagonists%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2009%26volume%3D19%26spage%3D23%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Xing, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span> </span><span class="NLM_article-title">Influence of dopamine D3 receptor knockout on age-related decline of spatial memory</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">481</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=481&publication_year=2010&pages=149-153&author=B.+Xingauthor=X.+Mengauthor=S.+Weiauthor=S.+Li&title=Influence+of+dopamine+D3+receptor+knockout+on+age-related+decline+of+spatial+memory"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DB.%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DS.%26atitle%3DInfluence%2520of%2520dopamine%2520D3%2520receptor%2520knockout%2520on%2520age-related%2520decline%2520of%2520spatial%2520memory%26jtitle%3DNeurosci.%2520Lett.%26date%3D2010%26volume%3D481%26spage%3D149%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Sokoloff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leriche, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louvel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pumain, R.</span><span> </span><span class="NLM_article-title">Direct and indirect interactions of the dopamine D(3) receptor with glutamate pathways: implications for the treatment of schizophrenia</span> <span class="citation_source-journal">Naunyn-Schmiedeberg’s Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">386</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1007%2Fs00210-012-0797-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=23001156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ejtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=386&publication_year=2013&pages=107-124&author=P.+Sokoloffauthor=L.+Lericheauthor=J.+Diazauthor=J.+Louvelauthor=R.+Pumain&title=Direct+and+indirect+interactions+of+the+dopamine+D%283%29+receptor+with+glutamate+pathways%3A+implications+for+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Direct and indirect interactions of the dopamine D3 receptor with glutamate pathways: implications for the treatment of schizophrenia</span></div><div class="casAuthors">Sokoloff, Pierre; Leriche, Ludovic; Diaz, Jorge; Louvel, Jacques; Pumain, Rene</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">386</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-124</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">This article, based on original data as well as on previously reported preclin. and clin. data that are reviewed, describes direct and indirect interactions of the D3 receptor with N-methyl-d-aspartate receptor (NMDA) signaling and their functional consequences and therapeutic implications for schizophrenia.  D3 receptor immunoreactivity at ultrastructural level with electron microscopy was identified at presumably glutamatergic, asym. synapses of the medium-sized spiny neurons of the nucleus accumbens.  This finding supports the existence of a direct interaction of the D3 receptor with glutamate, in line with previously described interactions with NMDA signaling involving Ca2+/calmodulin-dependent protein kinase II at post-synaptic densities (Liu et al. 2009).  Indirect interactions of the D3 receptor with glutamate could involve a neg. control exerted by the D3 receptor on mesocortical dopamine neurons and the complex regulation of the glutamatergic pyramidal cells by dopamine in the prefrontal cortex.  This could be exemplified here by the regulation of pyramidal cell activity in conditions of chronic NMDA receptor blockade with dizocilpine (MK-801).  BP897, a D3 receptor-selective partial agonist, reversed the dysregulation of cortical c-fos mRNA expression and pyramidal cell hyperexcitability, as measured by paired-pulse electrophysiol.  At the behavioral level, blockade of the D3 receptor, by known D3 receptor antagonists or the novel D3 receptor-selective antagonist F17141, produces antipsychotic-like effects in reversing hyperactivity and social interaction deficits induced by NMDA receptor blockade by MK-801 in mice.  The glutamate-D3 receptor interactions described here offer a conceptual framework for developing new D3 receptor-selective drugs, which may appear as an original, efficacious, and safe way to potentially indirectly target glutamate in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmIL4lHJC_r7Vg90H21EOLACvtfcHk0lgQHHy7xNzEmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ejtbs%253D&md5=a6317c4c802a0f07c9dfa12e7ef63b34</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1007%2Fs00210-012-0797-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-012-0797-0%26sid%3Dliteratum%253Aachs%26aulast%3DSokoloff%26aufirst%3DP.%26aulast%3DLeriche%26aufirst%3DL.%26aulast%3DDiaz%26aufirst%3DJ.%26aulast%3DLouvel%26aufirst%3DJ.%26aulast%3DPumain%26aufirst%3DR.%26atitle%3DDirect%2520and%2520indirect%2520interactions%2520of%2520the%2520dopamine%2520D%25283%2529%2520receptor%2520with%2520glutamate%2520pathways%253A%2520implications%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D2013%26volume%3D386%26spage%3D107%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Pilla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perachon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermuth, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everitt, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokoloff, P.</span><span> </span><span class="NLM_article-title">Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">400</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1038%2F22560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=10432116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaK1MXkvFOntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=1999&pages=371-375&author=M.+Pillaauthor=S.+Perachonauthor=F.+Sautelauthor=F.+Garridoauthor=A.+Mannauthor=C.+G.+Wermuthauthor=J.+C.+Schwartzauthor=B.+J.+Everittauthor=P.+Sokoloff&title=Selective+inhibition+of+cocaine-seeking+behaviour+by+a+partial+dopamine+D3+receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of cocaine-seeking behavior by a partial dopamine D3 receptor agonist</span></div><div class="casAuthors">Pilla, Maria; Perachon, Sylvie; Sautel, Francois; Garrido, Fabrice; Mann, Andre; Wermuth, Camille G.; Schwartz, Jean-Charles; Everitt, Barry J.; Sokoloff, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">6742</span>),
    <span class="NLM_cas:pages">371-375</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Environmental stimuli that are reliably assocd. with the effects of many abused drugs, esp. stimulants such as cocaine, can produce craving and relapse in abstinent human substance abusers.  In animals, such cues can induce and maintain drug-seeking behavior and also reinstate drug-seeking after extinction.  Reducing the motivational effects of drug-related cues might therefore be useful in the treatment of addiction.  Converging pharmacol., human post-mortem and genetic studies implicate the dopamine D3 receptor in drug addiction.  Here we have designed BP 897, the first D3-receptor-selective agonist, as assessed in vitro with recombinant receptors and in vivo with mice bearing disrupted D3-receptor genes.  BP 897 is a partial agonist in vitro and acts in vivo as either an agonist or an antagonist.  We show that BP 897 inhibits cocaine-seeking behavior that depends upon the presentation of drug-assocd. cues, without having any intrinsic, primary rewarding effects.  Our data indicate that compds. like BP 897 could be used for reducing the drug craving and vulnerability to relapse that are elicited by drug-assocd. environmental stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6SwJsmcTSCLVg90H21EOLACvtfcHk0lgQHHy7xNzEmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvFOntr0%253D&md5=3f4055a4cd1b6cee7e890ff1b96b21b6</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2F22560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F22560%26sid%3Dliteratum%253Aachs%26aulast%3DPilla%26aufirst%3DM.%26aulast%3DPerachon%26aufirst%3DS.%26aulast%3DSautel%26aufirst%3DF.%26aulast%3DGarrido%26aufirst%3DF.%26aulast%3DMann%26aufirst%3DA.%26aulast%3DWermuth%26aufirst%3DC.%2BG.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26aulast%3DEveritt%26aufirst%3DB.%2BJ.%26aulast%3DSokoloff%26aufirst%3DP.%26atitle%3DSelective%2520inhibition%2520of%2520cocaine-seeking%2520behaviour%2520by%2520a%2520partial%2520dopamine%2520D3%2520receptor%2520agonist%26jtitle%3DNature%26date%3D1999%26volume%3D400%26spage%3D371%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Hackling, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, H.</span><span> </span><span class="NLM_article-title">Dopamine D3 receptor ligands with antagonist properties</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">946</span><span class="NLM_x">–</span> <span class="NLM_lpage">961</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=946-961&author=A.+E.+Hacklingauthor=H.+Stark&title=Dopamine+D3+receptor+ligands+with+antagonist+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHackling%26aufirst%3DA.%2BE.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DDopamine%2520D3%2520receptor%2520ligands%2520with%2520antagonist%2520properties%26jtitle%3DChemBioChem%26date%3D2002%26volume%3D3%26spage%3D946%26epage%3D961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Boeckler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Dopamine D3 receptor ligands: recent advances in the control of subtype selectivity and intrinsic activity</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1768</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">887</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1768&publication_year=2007&pages=871-887&author=F.+Boecklerauthor=P.+Gmeiner&title=Dopamine+D3+receptor+ligands%3A+recent+advances+in+the+control+of+subtype+selectivity+and+intrinsic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoeckler%26aufirst%3DF.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DDopamine%2520D3%2520receptor%2520ligands%253A%2520recent%2520advances%2520in%2520the%2520control%2520of%2520subtype%2520selectivity%2520and%2520intrinsic%2520activity%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2007%26volume%3D1768%26spage%3D871%26epage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Micheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C.</span><span> </span><span class="NLM_article-title">Selective dopamine D3 receptor antagonists: a review 2001–2005</span> <span class="citation_source-journal">Recent Pat. CNS Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=271-288&author=F.+Micheliauthor=C.+Heidbreder&title=Selective+dopamine+D3+receptor+antagonists%3A+a+review+2001%E2%80%932005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3DSelective%2520dopamine%2520D3%2520receptor%2520antagonists%253A%2520a%2520review%25202001%25E2%2580%25932005%26jtitle%3DRecent%2520Pat.%2520CNS%2520Drug%2520Discovery%26date%3D2006%26volume%3D1%26spage%3D271%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Boeckler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">The structural evolution of dopamine D3 receptor ligands: structure–activity relationships and selected neuropharmacological aspects</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.pharmthera.2006.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=16905195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFCit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2006&pages=281-333&author=F.+Boecklerauthor=P.+Gmeiner&title=The+structural+evolution+of+dopamine+D3+receptor+ligands%3A+structure%E2%80%93activity+relationships+and+selected+neuropharmacological+aspects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">The structural evolution of dopamine D3 receptor ligands: Structure-activity relationships and selected neuropharmacological aspects</span></div><div class="casAuthors">Boeckler, Frank; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-333</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Evolution consists largely of mol. tinkering.  Following the famous concept of the mol. geneticist and medicine Nobel laureate Francois Jacob, in this review we describe the structural evolution of dopamine D3 receptor ligands from the natural agonist dopamine (DA) to highly potent and subtype selective new agents by bioisosteric tinkering with well-established and privileged or novel and fancy chem. functionalities and scaffolds.  Some of the more than 200 ligands presented herein have already achieved therapeutic or scientific value up to now, some will most likely achieve it in the future.  Hence, great importance is not only attached to the relationship between structure and activity of the ligands, but also to their utility as pharmacol. tools in animal models or as therapeutics in patients with neurol. diseases or other disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq4e4fi-6e0bVg90H21EOLACvtfcHk0liZd3pstOInZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFCit70%253D&md5=732805be028ec7c4f62d0b1cccb3a3fd</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2006.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2006.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DBoeckler%26aufirst%3DF.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DThe%2520structural%2520evolution%2520of%2520dopamine%2520D3%2520receptor%2520ligands%253A%2520structure%25E2%2580%2593activity%2520relationships%2520and%2520selected%2520neuropharmacological%2520aspects%26jtitle%3DPharmacol.%2520Ther.%26date%3D2006%26volume%3D112%26spage%3D281%26epage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prevatt, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floresca, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Heterocyclic analogues of <i>N</i>-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4135</span><span class="NLM_x">–</span> <span class="NLM_lpage">4146</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0704200" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosVWitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4135-4146&author=P.+Grundtauthor=K.+M.+Prevattauthor=J.+Caoauthor=M.+Taylorauthor=C.+Z.+Florescaauthor=J.+K.+Choiauthor=B.+G.+Jenkinsauthor=R.+R.+Luedtkeauthor=A.+H.+Newman&title=Heterocyclic+analogues+of+N-%284-%284-%282%2C3-dichlorophenyl%29piperazin-1-yl%29butyl%29arylcarboxamides+with+functionalized+linking+chains+as+novel+dopamine+D3+receptor+ligands%3A+potential+substance+abuse+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Heterocyclic Analogues of N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with Functionalized Linking Chains as Novel Dopamine D3 Receptor Ligands: Potential Substance Abuse Therapeutic Agents</span></div><div class="casAuthors">Grundt, Peter; Prevatt, Katherine M.; Cao, Jianjing; Taylor, Michelle; Floresca, Christina Z.; Choi, Ji-Kyung; Jenkins, Bruce G.; Luedtke, Robert R.; Hauck Newman, Amy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4135-4146</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dopamine D3 receptor antagonists and partial agonists have been shown to modulate drug-seeking effects induced by cocaine and other abused substances.  Compd. 6 [PG01037, (N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)-trans-but-2-enyl)-4-pyridine-2-ylbenzamide)] and related analogs are currently being evaluated in animal models of drug addiction.  In these studies, a discrepancy between in vitro binding affinity, in vivo occupancy, and behavioral potency has been obsd.  The purpose of this study was to examine (1) modifications of the 2-pyridylphenyl moiety of 6 and (2) hydroxyl, acetyl, and cyclopropyl substitutions on the butylamide linking chain systematically coupled with 2-fluorenylamide or 2-pyridylphenylamide and 2-methoxy- or 2,3-dichloro-substituted phenylpiperazines to measure the impact on binding affinity, D2/D3 selectivity, lipophilicity, and function.  In general, these modifications were well tolerated at the human dopamine D3 (hD3) receptor (Ki = 1-5 nM) as measured in competition binding assays.  Several analogs showed >100-fold selectivity for dopamine D3 over D2 and D4 receptors.  In addn., while all the derivs. with an olefinic linker were antagonists, in quinpirole-stimulated mitogenesis at hD3 receptors, several of the hydroxybutyl-linked analogs (16, 17, 21) showed partial agonist activity.  Finally, several structural modifications reduced lipophilicities while retaining the desired binding profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVBkV6gsuYUrVg90H21EOLACvtfcHk0lhOZZf8aI7NAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosVWitLY%253D&md5=594bd5ab15004fbdf521ddaee4698b96</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm0704200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0704200%26sid%3Dliteratum%253Aachs%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DPrevatt%26aufirst%3DK.%2BM.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DFloresca%26aufirst%3DC.%2BZ.%26aulast%3DChoi%26aufirst%3DJ.%2BK.%26aulast%3DJenkins%26aufirst%3DB.%2BG.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DHeterocyclic%2520analogues%2520of%2520N-%25284-%25284-%25282%252C3-dichlorophenyl%2529piperazin-1-yl%2529butyl%2529arylcarboxamides%2520with%2520functionalized%2520linking%2520chains%2520as%2520novel%2520dopamine%2520D3%2520receptor%2520ligands%253A%2520potential%2520substance%2520abuse%2520therapeutic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4135%26epage%3D4146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Kumar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banala, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keck, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Chiral resolution and serendipitous fluorination reaction for the selective dopamine D3 receptor antagonist BAK2-66</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml500006v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslamuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=647-651&author=V.+Kumarauthor=A.+K.+Banalaauthor=E.+G.+Garciaauthor=J.+Caoauthor=T.+M.+Keckauthor=A.+Bonifaziauthor=J.+R.+Deschampsauthor=A.+H.+Newman&title=Chiral+resolution+and+serendipitous+fluorination+reaction+for+the+selective+dopamine+D3+receptor+antagonist+BAK2-66"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Chiral Resolution and Serendipitous Fluorination Reaction for the Selective Dopamine D3 Receptor Antagonist BAK2-66</span></div><div class="casAuthors">Kumar, Vivek; Banala, Ashwini K.; Garcia, Erick G.; Cao, Jianjing; Keck, Thomas M.; Bonifazi, Alessandro; Deschamps, Jeffery R.; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">647-651</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The improved chiral synthesis of the selective dopamine D3 receptor (D3R) antagonist (R)-N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)-3-hydroxybutyl)1H-indole-2-carboxamide ((R)-PG648) is described.  The same chiral secondary alc. intermediate was used to prep. the enantiomers of a 3-F-benzofuranyl analog, BAK 2-66 (I).  The abs. configurations of the 3-F enantiomers were assigned from their X-ray crystal structures that confirmed retention of configuration during fluorination with N,N-diethylaminosulfur trifluoride (DAST).  (R)-I showed higher D3R affinity and selectivity than its (S)-enantiomer; however, it had lower D3R affinity and enantioselectivity than (R)-PG648.  Further, importance of the 4-atom linker length between the aryl amide and 4-phenylpiperazine was demonstrated with the 4-fluorobutyl-product (II).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTRVSlrPS4ybVg90H21EOLACvtfcHk0lhOZZf8aI7NAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslamuro%253D&md5=17ddfb3b45b6630f53c917281d76b620</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fml500006v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500006v%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DBanala%26aufirst%3DA.%2BK.%26aulast%3DGarcia%26aufirst%3DE.%2BG.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DBonifazi%26aufirst%3DA.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DChiral%2520resolution%2520and%2520serendipitous%2520fluorination%2520reaction%2520for%2520the%2520selective%2520dopamine%2520D3%2520receptor%2520antagonist%2520BAK2-66%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D647%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of fluorine-containing D(3) dopamine receptor ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1555</span><span class="NLM_x">–</span> <span class="NLM_lpage">1564</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101323b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1555-1564&author=Z.+Tuauthor=S.+Liauthor=J.+Cuiauthor=J.+Xuauthor=M.+Taylorauthor=D.+Hoauthor=R.+R.+Luedtkeauthor=R.+H.+Mach&title=Synthesis+and+pharmacological+evaluation+of+fluorine-containing+D%283%29+dopamine+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm101323b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101323b%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DHo%26aufirst%3DD.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520fluorine-containing%2520D%25283%2529%2520dopamine%2520receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1555%26epage%3D1564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keck, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Tranylcypromine substituted cis-hydroxycyclobutylnaphthamides as potent and selective dopamine D(3) receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4962</span><span class="NLM_x">–</span> <span class="NLM_lpage">4968</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401798r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosVOnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4962-4968&author=J.+Chenauthor=B.+Levantauthor=C.+Jiangauthor=T.+M.+Keckauthor=A.+H.+Newmanauthor=S.+Wang&title=Tranylcypromine+substituted+cis-hydroxycyclobutylnaphthamides+as+potent+and+selective+dopamine+D%283%29+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Tranylcypromine Substituted cis-Hydroxycyclobutylnaphthamides as Potent and Selective Dopamine D3 Receptor Antagonists</span></div><div class="casAuthors">Chen, Jianyong; Levant, Beth; Jiang, Cheng; Keck, Thomas M.; Newman, Amy Hauck; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4962-4968</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report a class of potent and selective dopamine D3 receptor antagonists based upon tranylcypromine.  Although tranylcypromine has a low affinity for the rat D3 receptor (Ki = 12.8 μM), our efforts have yielded (1R,2S)-11 (CJ-1882), which has Ki values of 2.7 and 2.8 nM at the rat and human dopamine D3 receptors, resp., and displays resp. selectivities of >10000-fold and 223-fold over the rat and human D2 receptors.  Evaluation in a β-arrestin functional assay showed that (1R,2S)-11 is a potent and competitive antagonist at the human D3 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowWudWdAfWgLVg90H21EOLACvtfcHk0lhOZZf8aI7NAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosVOnurg%253D&md5=e2ddf0711d00103be281cb043b19ec3a</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm401798r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401798r%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLevant%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DTranylcypromine%2520substituted%2520cis-hydroxycyclobutylnaphthamides%2520as%2520potent%2520and%2520selective%2520dopamine%2520D%25283%2529%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4962%26epage%3D4968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Micheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arista, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonanomi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braggio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelli, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Checchia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di-Fabio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffante, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamprecht, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchioro, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mugnaini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedesco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarsi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terreni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C.</span><span> </span><span class="NLM_article-title">1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">374</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901319p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=374-391&author=F.+Micheliauthor=L.+Aristaauthor=G.+Bonanomiauthor=F.+E.+Blaneyauthor=S.+Braggioauthor=A.+M.+Capelliauthor=A.+Checchiaauthor=F.+Damianiauthor=R.+Di-Fabioauthor=S.+Fontanaauthor=G.+Gentileauthor=C.+Griffanteauthor=D.+Hamprechtauthor=C.+Marchioroauthor=M.+Mugnainiauthor=J.+Pinerauthor=E.+Rattiauthor=G.+Tedescoauthor=L.+Tarsiauthor=S.+Terreniauthor=A.+Worbyauthor=C.+R.+Ashbyauthor=C.+Heidbreder&title=1%2C2%2C4-Triazolyl+azabicyclo%5B3.1.0%5Dhexanes%3A+a+new+series+of+potent+and+selective+dopamine+D%283%29+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjm901319p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901319p%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DArista%26aufirst%3DL.%26aulast%3DBonanomi%26aufirst%3DG.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DBraggio%26aufirst%3DS.%26aulast%3DCapelli%26aufirst%3DA.%2BM.%26aulast%3DChecchia%26aufirst%3DA.%26aulast%3DDamiani%26aufirst%3DF.%26aulast%3DDi-Fabio%26aufirst%3DR.%26aulast%3DFontana%26aufirst%3DS.%26aulast%3DGentile%26aufirst%3DG.%26aulast%3DGriffante%26aufirst%3DC.%26aulast%3DHamprecht%26aufirst%3DD.%26aulast%3DMarchioro%26aufirst%3DC.%26aulast%3DMugnaini%26aufirst%3DM.%26aulast%3DPiner%26aufirst%3DJ.%26aulast%3DRatti%26aufirst%3DE.%26aulast%3DTedesco%26aufirst%3DG.%26aulast%3DTarsi%26aufirst%3DL.%26aulast%3DTerreni%26aufirst%3DS.%26aulast%3DWorby%26aufirst%3DA.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DHeidbreder%26aufirst%3DC.%26atitle%3D1%252C2%252C4-Triazolyl%2520azabicyclo%255B3.1.0%255Dhexanes%253A%2520a%2520new%2520series%2520of%2520potent%2520and%2520selective%2520dopamine%2520D%25283%2529%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D374%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Biswas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuzhikandathil, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Further structure--activity relationships study of hybrid 7-{[2-(4-phenylpiperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol analogues: identification of a high-affinity D3-preferring agonist with potent in vivo activity with long duration of action</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070860r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=101-117&author=S.+Biswasauthor=S.+Zhangauthor=F.+Fernandezauthor=B.+Ghoshauthor=J.+Zhenauthor=E.+Kuzhikandathilauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Further+structure%2D%2Dactivity+relationships+study+of+hybrid+7-%7B%5B2-%284-phenylpiperazin-1-yl%29ethyl%5Dpropylamino%7D-5%2C6%2C7%2C8-tetrahydronaphthalen-2-ol+analogues%3A+identification+of+a+high-affinity+D3-preferring+agonist+with+potent+in+vivo+activity+with+long+duration+of+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm070860r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070860r%26sid%3Dliteratum%253Aachs%26aulast%3DBiswas%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DFernandez%26aufirst%3DF.%26aulast%3DGhosh%26aufirst%3DB.%26aulast%3DZhen%26aufirst%3DJ.%26aulast%3DKuzhikandathil%26aufirst%3DE.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DFurther%2520structure--activity%2520relationships%2520study%2520of%2520hybrid%25207-%257B%255B2-%25284-phenylpiperazin-1-yl%2529ethyl%255Dpropylamino%257D-5%252C6%252C7%252C8-tetrahydronaphthalen-2-ol%2520analogues%253A%2520identification%2520of%2520a%2520high-affinity%2520D3-preferring%2520agonist%2520with%2520potent%2520in%2520vivo%2520activity%2520with%2520long%2520duration%2520of%2520action%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D101%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of potent and selective ligands for the dopamine 3 (D3) receptor with a novel in vivo behavioral profile</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5905</span><span class="NLM_x">–</span> <span class="NLM_lpage">5908</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800471h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5905-5908&author=J.+Chenauthor=G.+T.+Collinsauthor=J.+Zhangauthor=C.+Y.+Yangauthor=B.+Levantauthor=J.+Woodsauthor=S.+Wang&title=Design%2C+synthesis%2C+and+evaluation+of+potent+and+selective+ligands+for+the+dopamine+3+%28D3%29+receptor+with+a+novel+in+vivo+behavioral+profile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fjm800471h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800471h%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DG.%2BT.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DLevant%26aufirst%3DB.%26aulast%3DWoods%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520potent%2520and%2520selective%2520ligands%2520for%2520the%2520dopamine%25203%2520%2528D3%2529%2520receptor%2520with%2520a%2520novel%2520in%2520vivo%2520behavioral%2520profile%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5905%26epage%3D5908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, A. K.</span><span> </span><span class="NLM_article-title">Structure–activity relationship study of <i>N</i><sup>6</sup>-(2-(4-(1<i>H</i>-indol-5-yl)piperazin-1-yl)ethyl)-<i>N</i><sup>6</sup>-propyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-2,6-diamine analogues: development of highly selective D3 dopamine receptor agonists along with a highly potent D2/D3 agonist and their pharmacological characterization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5826</span><span class="NLM_x">–</span> <span class="NLM_lpage">5840</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300268s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5826-5840&author=M.+Johnsonauthor=T.+Antonioauthor=M.+E.+Reithauthor=A.+K.+Dutta&title=Structure%E2%80%93activity+relationship+study+of+N6-%282-%284-%281H-indol-5-yl%29piperazin-1-yl%29ethyl%29-N6-propyl-4%2C5%2C6%2C7-tetrahydrobenzo%5Bd%5Dthiazole-2%2C6-diamine+analogues%3A+development+of+highly+selective+D3+dopamine+receptor+agonists+along+with+a+highly+potent+D2%2FD3+agonist+and+their+pharmacological+characterization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fjm300268s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300268s%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DAntonio%26aufirst%3DT.%26aulast%3DReith%26aufirst%3DM.%2BE.%26aulast%3DDutta%26aufirst%3DA.%2BK.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520study%2520of%2520N6-%25282-%25284-%25281H-indol-5-yl%2529piperazin-1-yl%2529ethyl%2529-N6-propyl-4%252C5%252C6%252C7-tetrahydrobenzo%255Bd%255Dthiazole-2%252C6-diamine%2520analogues%253A%2520development%2520of%2520highly%2520selective%2520D3%2520dopamine%2520receptor%2520agonists%2520along%2520with%2520a%2520highly%2520potent%2520D2%252FD3%2520agonist%2520and%2520their%2520pharmacological%2520characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5826%26epage%3D5840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Tschammer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elsner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrlich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuster, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhhorn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whistler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Highly potent 5-aminotetrahydropyrazolopyridines: enantioselective dopamine D3 receptor binding, functional selectivity, and analysis of receptor–ligand interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2477</span><span class="NLM_x">–</span> <span class="NLM_lpage">2491</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101639t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2477-2491&author=N.+Tschammerauthor=J.+Elsnerauthor=A.+Goetzauthor=K.+Ehrlichauthor=S.+Schusterauthor=M.+Rubergauthor=J.+Kuhhornauthor=D.+Thompsonauthor=J.+Whistlerauthor=H.+Hubnerauthor=P.+Gmeiner&title=Highly+potent+5-aminotetrahydropyrazolopyridines%3A+enantioselective+dopamine+D3+receptor+binding%2C+functional+selectivity%2C+and+analysis+of+receptor%E2%80%93ligand+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm101639t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101639t%26sid%3Dliteratum%253Aachs%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DElsner%26aufirst%3DJ.%26aulast%3DGoetz%26aufirst%3DA.%26aulast%3DEhrlich%26aufirst%3DK.%26aulast%3DSchuster%26aufirst%3DS.%26aulast%3DRuberg%26aufirst%3DM.%26aulast%3DKuhhorn%26aufirst%3DJ.%26aulast%3DThompson%26aufirst%3DD.%26aulast%3DWhistler%26aufirst%3DJ.%26aulast%3DHubner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DHighly%2520potent%25205-aminotetrahydropyrazolopyridines%253A%2520enantioselective%2520dopamine%2520D3%2520receptor%2520binding%252C%2520functional%2520selectivity%252C%2520and%2520analysis%2520of%2520receptor%25E2%2580%2593ligand%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2477%26epage%3D2491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Correll, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span> </span><span class="NLM_article-title">Biased ligand modulation of seven transmembrane receptors (7TMRs): functional implications for drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">6887</span><span class="NLM_x">–</span> <span class="NLM_lpage">6896</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401677g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6887-6896&author=C.+C.+Correllauthor=B.+A.+McKittrick&title=Biased+ligand+modulation+of+seven+transmembrane+receptors+%287TMRs%29%3A+functional+implications+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjm401677g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401677g%26sid%3Dliteratum%253Aachs%26aulast%3DCorrell%26aufirst%3DC.%2BC.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26atitle%3DBiased%2520ligand%2520modulation%2520of%2520seven%2520transmembrane%2520receptors%2520%25287TMRs%2529%253A%2520functional%2520implications%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6887%26epage%3D6896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Shonberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span> </span><span class="NLM_article-title">Biased agonism at G protein-coupled receptors: the promise and the challenges—a medicinal chemistry perspective</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1286</span><span class="NLM_x">–</span> <span class="NLM_lpage">1330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1002%2Fmed.21318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24796277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslalu7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=1286-1330&author=J.+Shonbergauthor=L.+Lopezauthor=P.+J.+Scammellsauthor=A.+Christopoulosauthor=B.+Capuanoauthor=J.+R.+Lane&title=Biased+agonism+at+G+protein-coupled+receptors%3A+the+promise+and+the+challenges%E2%80%94a+medicinal+chemistry+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Biased Agonism at G Protein-Coupled Receptors: The Promise and the Challenges-A Medicinal Chemistry Perspective</span></div><div class="casAuthors">Shonberg, Jeremy; Lopez, Laura; Scammells, Peter J.; Christopoulos, Arthur; Capuano, Ben; Lane, J. Robert</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1286-1330</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Historically, detn. of G protein-coupled receptor (GPCR) ligand efficacy has often been restricted to identifying the ligand as an agonist or antagonist at a given signaling pathway.  This classification was deemed sufficient to predict compd. efficacy at all signaling endpoints, including the therapeutically relevant one(s).  However, it is now apparent that ligands acting at the same GPCR can stabilize multiple, distinct, receptor conformations linked to different functional outcomes.  This phenomenon, known as biased agonism, stimulus bias, or functional selectivity offers the opportunity to sep. on-target therapeutic effects from side effects through the design of drugs that show pathway selectivity.  However, the medicinal chemist faces numerous challenges to develop biased ligands, including the detection and quantification of biased agonism.  This review summarizes the current state of the field of research into biased agonism at GPCRs, with a particular focus on efforts to relate biased agonism to ligand structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg-egFZpSKvbVg90H21EOLACvtfcHk0liGTtAsAWvqmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslalu7rJ&md5=85a5b385750d21856ae044391c46ee75</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1002%2Fmed.21318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21318%26sid%3Dliteratum%253Aachs%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26atitle%3DBiased%2520agonism%2520at%2520G%2520protein-coupled%2520receptors%253A%2520the%2520promise%2520and%2520the%2520challenges%25E2%2580%2594a%2520medicinal%2520chemistry%2520perspective%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2014%26volume%3D34%26spage%3D1286%26epage%3D1330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Hiller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinemann, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Functionally selective dopamine D2/D3 receptor agonists comprising an enyne moiety</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5130</span><span class="NLM_x">–</span> <span class="NLM_lpage">5141</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400520c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslSqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5130-5141&author=C.+Hillerauthor=R.+C.+Klingauthor=F.+W.+Heinemannauthor=K.+Meyerauthor=H.+Hubnerauthor=P.+Gmeiner&title=Functionally+selective+dopamine+D2%2FD3+receptor+agonists+comprising+an+enyne+moiety"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Functionally Selective Dopamine D2/D3 Receptor Agonists Comprising an Enyne Moiety</span></div><div class="casAuthors">Hiller, Christine; Kling, Ralf C.; Heinemann, Frank W.; Meyer, Karsten; Huebner, Harald; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5130-5141</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nonracemic ethynylcyclohexynylamines I and ent-I {R = 1,1'-biphenyl-4-yl, pyrazolo[1,5-a]pyridin-2-yl, pyrazolo[1,5-a]pyridin-3-yl, 4-[3-(1-butyl-1,2,3-triazol-4-yloxy)propoxy]-3-methoxyphenyl, benzo[b]thiophene-2-yl, ferrocenyl} were prepd. as dopamine receptor agonists with atypical catechol isosteres; their selectivities for dopamine receptors and for activating receptors through G-protein subunits Go and Gi and the metabolic stability of rac-I (R = 4-PhC6H4) were detd.  The ethynylcyclohexynylamines bound to D2-like receptors with high affinities.  Ent-I (R = pyrazolo[1,5-a]pyridin-2-yl) selectively activated D2slow-promoted Go activation over Gi coupling; the most significant functional bias obsd. was for ent-I {R = 4-[3-(1-butyl-1,2,3-triazol-4-yloxy)propoxy]-3-methoxyphenyl} which selectively activated Go over Gi coupling at D2long receptors.  Functional selectivity for β-arrestin recruitment over Gi activation was obsd. for I (R = 1,1'-biphenyl-4-yl) and ent-I (R = benzothiophene-2-yl), while ent-I (R = pyrazolo[1,5-a]pyridin-2-yl) preferred β-arrestin recruitment compared to Go coupling.  The structure of a nonracemic N-(ethynylcyclohexenyl)dinitrobenzamide was detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXn2SrS-IBCrVg90H21EOLACvtfcHk0liGTtAsAWvqmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslSqtr4%253D&md5=3855de949f505a83ed3aa561ca182e75</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm400520c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400520c%26sid%3Dliteratum%253Aachs%26aulast%3DHiller%26aufirst%3DC.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DHeinemann%26aufirst%3DF.%2BW.%26aulast%3DMeyer%26aufirst%3DK.%26aulast%3DHubner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DFunctionally%2520selective%2520dopamine%2520D2%252FD3%2520receptor%2520agonists%2520comprising%2520an%2520enyne%2520moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5130%26epage%3D5141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Möller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skultety, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leuner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Functionally selective dopamine D(2), D(3) receptor partial agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4861</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5004039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4861-4875&author=D.+M%C3%B6llerauthor=R.+C.+Klingauthor=M.+Skultetyauthor=K.+Leunerauthor=H.+Hubnerauthor=P.+Gmeiner&title=Functionally+selective+dopamine+D%282%29%2C+D%283%29+receptor+partial+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fjm5004039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5004039%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ller%26aufirst%3DD.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DSkultety%26aufirst%3DM.%26aulast%3DLeuner%26aufirst%3DK.%26aulast%3DHubner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DFunctionally%2520selective%2520dopamine%2520D%25282%2529%252C%2520D%25283%2529%2520receptor%2520partial%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4861%26epage%3D4875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">te Beek, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoethout, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bani, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iavarone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaassen, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fina, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Gerven, J. M.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and central nervous system effects of the novel dopamine D3 receptor antagonist GSK598809 and intravenous alcohol infusion at pseudo-steady state</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1177%2F0269881111431750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=22219221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFyntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=303-314&author=E.+T.+te+Beekauthor=R.+W.+Zoethoutauthor=M.+S.+Baniauthor=A.+Andornauthor=L.+Iavaroneauthor=E.+S.+Klaassenauthor=P.+Finaauthor=J.+M.+van+Gerven&title=Pharmacokinetics+and+central+nervous+system+effects+of+the+novel+dopamine+D3+receptor+antagonist+GSK598809+and+intravenous+alcohol+infusion+at+pseudo-steady+state"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and central nervous system effects of the novel dopamine D3 receptor antagonist GSK598809 and intravenous alcohol infusion at pseudo-steady state</span></div><div class="casAuthors">te Beek, E. T.; Zoethout, R. W. M.; Bani, M. S. G.; Andorn, A.; Iavarone, L.; Klaassen, E. S.; Fina, P.; van Gerven, J. M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">303-314</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">GSK598809 is a novel selective dopamine D3 receptor antagonist, currently in development for the treatment of substance abuse and addiction.  In a blinded, randomized, placebo-controlled study, effects of single oral doses of 175 mg GSK598809 were evaluated in healthy volunteers.  Pharmacokinetics, central nervous system (CNS) effects and potential for interactions with alc. were evaluated, using an alc. infusion paradigm and anal. of eye movements, adaptive tracking, visual analog scales, body sway, serum prolactin and verbal visual learning test.  Adverse effects of GSK598809 included headache, dizziness and somnolence.  Plasma concn. of GSK598809 was maximal 2-3 h postdose and decreased with a half-life of roughly 20 h.  CNS effects were limited to prolactin elevation and decreased adaptive tracking.  Co-administration of GSK598809 and alc. did not affect alc. pharmacokinetics, but caused a 9% decrease of Cmax and a 15% increase of AUC of GSK598809.  CNS effects of co-administration were mainly additive, except a small supra-additive increase in saccadic reaction time and decrease in delayed word recall.  In conclusion, GSK598809 causes elevation of serum prolactin and a small decrease in adaptive tracking performance.  After co-administration with alc., effects of GSK598809 are mainly additive and the combination is well tolerated in healthy volunteers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_wePB6PIRp7Vg90H21EOLACvtfcHk0ljOSdrJeD1Y-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFyntrY%253D&md5=6f4c518348fda9985d56dfd5977ddc51</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1177%2F0269881111431750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0269881111431750%26sid%3Dliteratum%253Aachs%26aulast%3Dte%2BBeek%26aufirst%3DE.%2BT.%26aulast%3DZoethout%26aufirst%3DR.%2BW.%26aulast%3DBani%26aufirst%3DM.%2BS.%26aulast%3DAndorn%26aufirst%3DA.%26aulast%3DIavarone%26aufirst%3DL.%26aulast%3DKlaassen%26aufirst%3DE.%2BS.%26aulast%3DFina%26aufirst%3DP.%26aulast%3Dvan%2BGerven%26aufirst%3DJ.%2BM.%26atitle%3DPharmacokinetics%2520and%2520central%2520nervous%2520system%2520effects%2520of%2520the%2520novel%2520dopamine%2520D3%2520receptor%2520antagonist%2520GSK598809%2520and%2520intravenous%2520alcohol%2520infusion%2520at%2520pseudo-steady%2520state%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2012%26volume%3D26%26spage%3D303%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Mogg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo-Pich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullmore, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathan, P. J.</span><span> </span><span class="NLM_article-title">Effect of dopamine D(3) receptor antagonism on approach responses to food cues in overweight and obese individuals</span> <span class="citation_source-journal">Behav. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=603-608&author=K.+Moggauthor=B.+P.+Bradleyauthor=B.+O%E2%80%99Neillauthor=M.+Baniauthor=E.+Merlo-Pichauthor=A.+Kochauthor=E.+T.+Bullmoreauthor=P.+J.+Nathan&title=Effect+of+dopamine+D%283%29+receptor+antagonism+on+approach+responses+to+food+cues+in+overweight+and+obese+individuals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMogg%26aufirst%3DK.%26aulast%3DBradley%26aufirst%3DB.%2BP.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%26aulast%3DBani%26aufirst%3DM.%26aulast%3DMerlo-Pich%26aufirst%3DE.%26aulast%3DKoch%26aufirst%3DA.%26aulast%3DBullmore%26aufirst%3DE.%2BT.%26aulast%3DNathan%26aufirst%3DP.%2BJ.%26atitle%3DEffect%2520of%2520dopamine%2520D%25283%2529%2520receptor%2520antagonism%2520on%2520approach%2520responses%2520to%2520food%2520cues%2520in%2520overweight%2520and%2520obese%2520individuals%26jtitle%3DBehav.%2520Pharmacol.%26date%3D2012%26volume%3D23%26spage%3D603%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Nathan, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mogg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaver, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo-Pich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swirski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodds, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullmore, E. T.</span><span> </span><span class="NLM_article-title">The effects of the dopamine D(3) receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1017%2FS1461145711001052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=21745436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis1ejtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=149-161&author=P.+J.+Nathanauthor=B.+V.+O%E2%80%99Neillauthor=K.+Moggauthor=B.+P.+Bradleyauthor=J.+Beaverauthor=M.+Baniauthor=E.+Merlo-Pichauthor=P.+C.+Fletcherauthor=B.+Swirskiauthor=A.+Kochauthor=C.+M.+Doddsauthor=E.+T.+Bullmore&title=The+effects+of+the+dopamine+D%283%29+receptor+antagonist+GSK598809+on+attentional+bias+to+palatable+food+cues+in+overweight+and+obese+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of the dopamine D3 receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects</span></div><div class="casAuthors">Nathan, Pradeep J.; O'Neill, Barry V.; Mogg, Karin; Bradley, Brendan P.; Beaver, John; Bani, Massimo; Merlo-Pich, Emilio; Fletcher, Paul C.; Swirski, Bridget; Koch, Annelize; Dodds, Chris M.; Bullmore, Edward T.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-161</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">The mesolimbic dopamine system plays a crit. role in the reinforcing effects of rewards.  Evidence from pre-clin. studies suggests that D3 receptor antagonists may attenuate the motivational impact of rewarding cues.  In this study we examd. the acute effects of the D3 receptor antagonist GSK598809 on attentional bias to rewarding food cues in overweight to obese individuals (n=26, BMI mean=32.7±3.7, range 27-40 kg/m2) who reported binge and emotional eating.  We also detd. whether individual differences in restrained eating style modulated the effects of GSK598809 on attentional bias.  The study utilized a randomized, double-blind, placebo-controlled cross-over design with each participant tested following acute administration of placebo and GSK598809 (175 mg).  Attentional bias was assessed by the visual probe task and modified Stroop task using food-related words.  Overall GSK598809 had no effects on attentional bias in either the visual probe or food Stroop tasks.  However, the effect of GSK598809 on both visual probe and food Stroop attentional bias scores was inversely correlated with a measure of eating restraint allowing the identification of two subpopulations, low- and high-restrained eaters.  Low-restrained eaters had a significant attentional bias towards food cues in both tasks under placebo, and this was attenuated by GSK598809.  In contrast, high-restrained eaters showed no attentional bias to food cues following either placebo or GSK598809.  These findings suggest that excessive attentional bias to food cues generated by individual differences in eating traits can be modulated by D3 receptor antagonists, warranting further investigation with measures of eating behavior and wt. loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_bx5ouR9_W7Vg90H21EOLACvtfcHk0ljKN6TiPMv0HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis1ejtrg%253D&md5=2bbf9cb07a39ef8a896ef5d72711fa54</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1017%2FS1461145711001052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145711001052%26sid%3Dliteratum%253Aachs%26aulast%3DNathan%26aufirst%3DP.%2BJ.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BV.%26aulast%3DMogg%26aufirst%3DK.%26aulast%3DBradley%26aufirst%3DB.%2BP.%26aulast%3DBeaver%26aufirst%3DJ.%26aulast%3DBani%26aufirst%3DM.%26aulast%3DMerlo-Pich%26aufirst%3DE.%26aulast%3DFletcher%26aufirst%3DP.%2BC.%26aulast%3DSwirski%26aufirst%3DB.%26aulast%3DKoch%26aufirst%3DA.%26aulast%3DDodds%26aufirst%3DC.%2BM.%26aulast%3DBullmore%26aufirst%3DE.%2BT.%26atitle%3DThe%2520effects%2520of%2520the%2520dopamine%2520D%25283%2529%2520receptor%2520antagonist%2520GSK598809%2520on%2520attentional%2520bias%2520to%2520palatable%2520food%2520cues%2520in%2520overweight%2520and%2520obese%2520subjects%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2012%26volume%3D15%26spage%3D149%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Dodds, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaver, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makwana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo-Pich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullmore, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathan, P. J.</span><span> </span><span class="NLM_article-title">Effect of the dopamine D3 receptor antagonist GSK598809 on brain responses to rewarding food images in overweight and obese binge eaters</span> <span class="citation_source-journal">Appetite</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2012&pages=27-33&author=C.+M.+Doddsauthor=B.+O%E2%80%99Neillauthor=J.+Beaverauthor=A.+Makwanaauthor=M.+Baniauthor=E.+Merlo-Pichauthor=P.+C.+Fletcherauthor=A.+Kochauthor=E.+T.+Bullmoreauthor=P.+J.+Nathan&title=Effect+of+the+dopamine+D3+receptor+antagonist+GSK598809+on+brain+responses+to+rewarding+food+images+in+overweight+and+obese+binge+eaters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDodds%26aufirst%3DC.%2BM.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%26aulast%3DBeaver%26aufirst%3DJ.%26aulast%3DMakwana%26aufirst%3DA.%26aulast%3DBani%26aufirst%3DM.%26aulast%3DMerlo-Pich%26aufirst%3DE.%26aulast%3DFletcher%26aufirst%3DP.%2BC.%26aulast%3DKoch%26aufirst%3DA.%26aulast%3DBullmore%26aufirst%3DE.%2BT.%26aulast%3DNathan%26aufirst%3DP.%2BJ.%26atitle%3DEffect%2520of%2520the%2520dopamine%2520D3%2520receptor%2520antagonist%2520GSK598809%2520on%2520brain%2520responses%2520to%2520rewarding%2520food%2520images%2520in%2520overweight%2520and%2520obese%2520binge%2520eaters%26jtitle%3DAppetite%26date%3D2012%26volume%3D59%26spage%3D27%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">O’Connell, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughan, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botkin, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, R. M.</span><span> </span><span class="NLM_article-title">Expression of the dopamine D3 receptor protein in the rat kidney</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">886</span><span class="NLM_x">–</span> <span class="NLM_lpage">895</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1998&pages=886-895&author=D.+P.+O%E2%80%99Connellauthor=C.+J.+Vaughanauthor=A.+M.+Aherneauthor=S.+J.+Botkinauthor=Z.+Q.+Wangauthor=R.+A.+Felderauthor=R.+M.+Carey&title=Expression+of+the+dopamine+D3+receptor+protein+in+the+rat+kidney"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DD.%2BP.%26aulast%3DVaughan%26aufirst%3DC.%2BJ.%26aulast%3DAherne%26aufirst%3DA.%2BM.%26aulast%3DBotkin%26aufirst%3DS.%2BJ.%26aulast%3DWang%26aufirst%3DZ.%2BQ.%26aulast%3DFelder%26aufirst%3DR.%2BA.%26aulast%3DCarey%26aufirst%3DR.%2BM.%26atitle%3DExpression%2520of%2520the%2520dopamine%2520D3%2520receptor%2520protein%2520in%2520the%2520rat%2520kidney%26jtitle%3DHypertension%26date%3D1998%26volume%3D32%26spage%3D886%26epage%3D895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Hussain, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lokhandwala, M. F.</span><span> </span><span class="NLM_article-title">Renal dopamine receptors and hypertension</span> <span class="citation_source-journal">Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1amtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2003&pages=134-142&author=T.+Hussainauthor=M.+F.+Lokhandwala&title=Renal+dopamine+receptors+and+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Renal dopamine receptors and hypertension</span></div><div class="casAuthors">Hussain, Tahir; Lokhandwala, Mustafa F.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Biology and Medicine (Maywood, NJ, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">134-142</span>CODEN:
                <span class="NLM_cas:coden">EBMMBE</span>;
        ISSN:<span class="NLM_cas:issn">1535-3702</span>.
    
            (<span class="NLM_cas:orgname">Society for Experimental Biology and Medicine</span>)
        </div><div class="casAbstract">A review.  Dopamine has been recognized as an important modulator of central as well as peripheral physiol. functions in both humans and animals.  Dopamine receptors have been identified in a no. of organs and tissues, which include several regions within the central nervous system, sympathetic ganglia and postganglionic nerve terminals, various vascular beds, the heart, the gastrointestinal tract, and the kidney.  The peripheral dopamine receptors influence cardiovascular and renal function by decreasing afterload and vascular resistance and promoting sodium excretion.  Within the kidney, dopamine receptors are present along the nephron, with highest d. on proximal tubule epithelial cells.  It has been reported that there is a defective dopamine receptor, esp. D1 receptor function, in the proximal tubule of various animal models of hypertension as well as in humans with essential hypertension.  Recent reports have revealed the site of and the mol. mechanisms responsible for the defect in D1 receptors in hypertension.  Moreover, recent studies have also demonstrated that the disruption of various dopamine receptor subtypes and their function produces hypertension in rodents.  In this review, we present evidence that dopamine and dopamine receptors play an important role in regulating renal sodium excretion and that defective renal dopamine prodn. and/or dopamine receptor function may contribute to the development of various forms of hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorQTmyiNsVoLVg90H21EOLACvtfcHk0liYhfIDb5p2QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1amtbc%253D&md5=63c7a17aaefeaa835fb9c3e482c948cf</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DT.%26aulast%3DLokhandwala%26aufirst%3DM.%2BF.%26atitle%3DRenal%2520dopamine%2520receptors%2520and%2520hypertension%26jtitle%3DExp.%2520Biol.%2520Med.%26date%3D2003%26volume%3D228%26spage%3D134%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Zeng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jose, P. A.</span><span> </span><span class="NLM_article-title">Dopamine receptors: important antihypertensive counterbalance against hypertensive factors</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2011&pages=11-17&author=C.+Zengauthor=P.+A.+Jose&title=Dopamine+receptors%3A+important+antihypertensive+counterbalance+against+hypertensive+factors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DC.%26aulast%3DJose%26aufirst%3DP.%2BA.%26atitle%3DDopamine%2520receptors%253A%2520important%2520antihypertensive%2520counterbalance%2520against%2520hypertensive%2520factors%26jtitle%3DHypertension%26date%3D2011%26volume%3D57%26spage%3D11%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Armando, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villar, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jose, P. A.</span><span> </span><span class="NLM_article-title">Dopamine and renal function and blood pressure regulation</span> <span class="citation_source-journal">Compr. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1075</span><span class="NLM_x">–</span> <span class="NLM_lpage">1117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=23733636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BC3snpsVentw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=1075-1117&author=I.+Armandoauthor=V.+A.+Villarauthor=P.+A.+Jose&title=Dopamine+and+renal+function+and+blood+pressure+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine and renal function and blood pressure regulation</span></div><div class="casAuthors">Armando Ines; Villar Van Anthony M; Jose Pedro A</div><div class="citationInfo"><span class="NLM_cas:title">Comprehensive Physiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1075-117</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dopamine is an important regulator of systemic blood pressure via multiple mechanisms.  It affects fluid and electrolyte balance by its actions on renal hemodynamics and epithelial ion and water transport and by regulation of hormones and humoral agents.  The kidney synthesizes dopamine from circulating or filtered L-DOPA independently from innervation.  The major determinants of the renal tubular synthesis/release of dopamine are probably sodium intake and intracellular sodium.  Dopamine exerts its actions via two families of cell surface receptors, D1-like receptors comprising D1R and D5R, and D2-like receptors comprising D2R, D3R, and D4R, and by interactions with other G protein-coupled receptors.  D1-like receptors are linked to vasodilation, while the effect of D2-like receptors on the vasculature is variable and probably dependent upon the state of nerve activity.  Dopamine secreted into the tubular lumen acts mainly via D1-like receptors in an autocrine/paracrine manner to regulate ion transport in the proximal and distal nephron.  These effects are mediated mainly by tubular mechanisms and augmented by hemodynamic mechanisms.  The natriuretic effect of D1-like receptors is caused by inhibition of ion transport in the apical and basolateral membranes.  D2-like receptors participate in the inhibition of ion transport during conditions of euvolemia and moderate volume expansion.  Dopamine also controls ion transport and blood pressure by regulating the production of reactive oxygen species and the inflammatory response.  Essential hypertension is associated with abnormalities in dopamine production, receptor number, and/or posttranslational modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRUksfu_AqPfJagfuraLLzSfW6udTcc2eadSJMcAobgELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snpsVentw%253D%253D&md5=38b8410fb3e439148eaa83c519137051</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArmando%26aufirst%3DI.%26aulast%3DVillar%26aufirst%3DV.%2BA.%26aulast%3DJose%26aufirst%3DP.%2BA.%26atitle%3DDopamine%2520and%2520renal%2520function%2520and%2520blood%2520pressure%2520regulation%26jtitle%3DCompr.%2520Physiol.%26date%3D2011%26volume%3D1%26spage%3D1075%26epage%3D1117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Schindler, C. W.</span><span> </span><span class="NLM_article-title">Cocaine and cardiovascular toxicity</span> <span class="citation_source-journal">Addict. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1080%2F1355621961000124676" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=12893485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaK28XntVOjt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1996&pages=31-47&author=C.+W.+Schindler&title=Cocaine+and+cardiovascular+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Cocaine and cardiovascular toxicity</span></div><div class="casAuthors">Schindler, Charles W.</div><div class="citationInfo"><span class="NLM_cas:title">Addiction Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-47</span>CODEN:
                <span class="NLM_cas:coden">ADBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1355-6215</span>.
    
            (<span class="NLM_cas:orgname">Carfax</span>)
        </div><div class="casAbstract">A review, with ∼125 refs.  Over the past 10 yr a great deal has been learned about the cardiovascular effects of cocaine.  In particular, the acute effects of cocaine have been studied extensively.  Upon acute administration cocaine increases blood pressure and heart rate, primarily through an action on the sympathetic nervous system.  Cocaine also suppresses the baroreflex response and vagal tone, further contributing to its effects on heart rate.  At the same time cocaine is increasing the work-load on the heart it induces coronary artery vasoconstriction, potentially leading to cardiac ischemia.  At higher doses cocaine can depress ventricular function and slow elec. conduction in the heart.  Both these effects appear to be mediated by cocaine's local anesthetic action.  The effects of cocaine mediated by the sympathetic nervous system are greatly reduced in anesthetized animals.  Further, when cocaine is administered repeatedly over a short period of time, acute tolerance can develop to the sympathomimetic effects of cocaine.  In contrast, the effects of cocaine mediated by its local anesthetic action do not appear blunted by anesthesia or susceptible to acute tolerance.  With chronic administration, higher doses appear to induce tolerance while lower doses may induce sensitization to cocaine's sympathomimetic effects.  Cocaine also induces a variety of pathol. changes in the heart, including myocardial contraction band necrosis and ventricular hypertrophy.  These effects of cocaine on the heart can all contribute to potentially lethal cardiovascular events.  In addn. to the effects of cocaine alone, the metabolites of cocaine may also contribute to cocaine's cardiovascular toxicity, and both licit and illicit drugs used in combination with cocaine might potentially alter its cardiovascular effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom0YH3xdifa7Vg90H21EOLACvtfcHk0liYhfIDb5p2QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntVOjt7k%253D&md5=dc35d5ad5e7b133f268fc32cf1322afb</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1080%2F1355621961000124676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F1355621961000124676%26sid%3Dliteratum%253Aachs%26aulast%3DSchindler%26aufirst%3DC.%2BW.%26atitle%3DCocaine%2520and%2520cardiovascular%2520toxicity%26jtitle%3DAddict.%2520Biol.%26date%3D1996%26volume%3D1%26spage%3D31%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Brecklin, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J. L.</span><span> </span><span class="NLM_article-title">Cardiovascular effects of cocaine: focus on hypertension</span> <span class="citation_source-journal">J. Clin. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtlCntLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=212-217&author=C.+S.+Brecklinauthor=J.+L.+Bauman&title=Cardiovascular+effects+of+cocaine%3A+focus+on+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular effects of cocaine: focus on hypertension</span></div><div class="casAuthors">Brecklin, Carolyn S.; Bauman, Jerry L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Hypertension (Greenwich, Connecticut)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">212-217</span>CODEN:
                <span class="NLM_cas:coden">JCHYFN</span>;
        ISSN:<span class="NLM_cas:issn">1524-6175</span>.
    
            (<span class="NLM_cas:orgname">Le Jacq Communications, Inc.</span>)
        </div><div class="casAbstract">A review with 42 refs.  Cocaine, a naturally occurring alkaloid, has increasingly been implicated in a myriad of medical complications.  The majority of these relate to cardiovascular effects of the drug, a potent sympathomimetic.  In addn., cocaine has effects on endothelin-1, the sodium channel, and nitric oxide which further enhance its untoward cardiovascular effects.  The cardiovascular effects of cocaine include myocardial ischemia or infarction, ventricular arrhythmias and sudden death, cardiomyopathy, cerebral infarction or hemorrhage, and acute hypertension.  Although hypertension has been described in the offspring of cocaine using mothers, two recent studies have not found an increased prevalence of chronic hypertension in adults.  Nonetheless, long term abuse of cocaine can lead to the various forms of target organ damage usually assocd. with untreated essential hypertension, presumably due to frequent intermittent and severe elevations in blood pressure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEEvupb6UCrLVg90H21EOLACvtfcHk0lj5AnVEeugWRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtlCntLk%253D&md5=19bbb0265a915eb2723a4b57036949c3</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrecklin%26aufirst%3DC.%2BS.%26aulast%3DBauman%26aufirst%3DJ.%2BL.%26atitle%3DCardiovascular%2520effects%2520of%2520cocaine%253A%2520focus%2520on%2520hypertension%26jtitle%3DJ.%2520Clin.%2520Hypertens.%26date%3D1999%26volume%3D1%26spage%3D212%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Haney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foltin, R. W.</span><span> </span><span class="NLM_article-title">Aripiprazole maintenance increases smoked cocaine self-administration in humans</span> <span class="citation_source-journal">Psychopharmacology </span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">216</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=2011&pages=379-387&author=M.+Haneyauthor=E.+Rubinauthor=R.+W.+Foltin&title=Aripiprazole+maintenance+increases+smoked+cocaine+self-administration+in+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaney%26aufirst%3DM.%26aulast%3DRubin%26aufirst%3DE.%26aulast%3DFoltin%26aufirst%3DR.%2BW.%26atitle%3DAripiprazole%2520maintenance%2520increases%2520smoked%2520cocaine%2520self-administration%2520in%2520humans%26jtitle%3DPsychopharmacology%2520%26date%3D2011%26volume%3D216%26spage%3D379%26epage%3D387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Lile, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoops, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hays, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, C. R.</span><span> </span><span class="NLM_article-title">Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1469</span><span class="NLM_x">–</span> <span class="NLM_lpage">1479</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1177%2F0269881110385597" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=20952456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFGgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=1469-1479&author=J.+A.+Lileauthor=W.+W.+Stoopsauthor=P.+E.+Glaserauthor=L.+R.+Haysauthor=C.+R.+Rush&title=Discriminative+stimulus%2C+subject-rated+and+cardiovascular+effects+of+cocaine+alone+and+in+combination+with+aripiprazole+in+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans</span></div><div class="casAuthors">Lile, Joshua A.; Stoops, William W.; Glaser, Paul E. A.; Hays, Lon R.; Rush, Craig R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1469-1479</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Aripiprazole is a dopamine D2 receptor partial agonist undergoing evaluation as a pharmacotherapy for stimulant-use disorders.  Acutely administered aripiprazole attenuates the discriminative stimulus and other behavioral effects of d-amphetamine in humans; however, whether aripiprazole attenuates the effects of more commonly abused stimulants is unknown.  The aim of this expt. was to assess the discriminative stimulus, subject-rated and cardiovascular effects of oral cocaine alone and following acute administration of aripiprazole in humans.  Eight cocaine-dependent subjects learned to discriminate 150 mg cocaine from placebo.  After acquiring the discrimination, the effects of cocaine (0, 25, 50, 100 and 200 mg) administered alone and in combination with aripiprazole (15 mg) were detd.  Significant effects of cocaine were obsd. for the drug discrimination task, stimulant-like subject-rated effects and heart rate.  Limited effects of aripiprazole were revealed.  However, for most measures, fewer doses of cocaine were significantly greater than placebo when combined with aripiprazole, suggesting a redn. in the discriminative stimulus, self-reported and cardiovascular effects of cocaine.  These data are consistent with previous studies that have tested acutely administered aripiprazole in combination with d-amphetamine and suggest that the ability of aripiprazole to modify stimulant effects is a function of the duration of treatment (acute vs. chronic).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlSaJkRIPntrVg90H21EOLACvtfcHk0lj5AnVEeugWRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFGgtQ%253D%253D&md5=6276629ea5c3c83c037875d728dcc866</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1177%2F0269881110385597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0269881110385597%26sid%3Dliteratum%253Aachs%26aulast%3DLile%26aufirst%3DJ.%2BA.%26aulast%3DStoops%26aufirst%3DW.%2BW.%26aulast%3DGlaser%26aufirst%3DP.%2BE.%26aulast%3DHays%26aufirst%3DL.%2BR.%26aulast%3DRush%26aufirst%3DC.%2BR.%26atitle%3DDiscriminative%2520stimulus%252C%2520subject-rated%2520and%2520cardiovascular%2520effects%2520of%2520cocaine%2520alone%2520and%2520in%2520combination%2520with%2520aripiprazole%2520in%2520humans%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2011%26volume%3D25%26spage%3D1469%26epage%3D1479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Bergman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roof, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conroy, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mello, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skolnick, P.</span><span> </span><span class="NLM_article-title">Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">458</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1017%2FS1461145712000661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=22827916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFKktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2013&pages=445-458&author=J.+Bergmanauthor=R.+A.+Roofauthor=C.+A.+Furmanauthor=J.+L.+Conroyauthor=N.+K.+Melloauthor=D.+R.+Sibleyauthor=P.+Skolnick&title=Modification+of+cocaine+self-administration+by+buspirone+%28buspar%C2%AE%29%3A+potential+involvement+of+D3+and+D4+dopamine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Modification of cocaine self-administration by buspirone (buspar): potential involvement of D3 and D4 dopamine receptors</span></div><div class="casAuthors">Bergman, Jack; Roof, Rebecca A.; Furman, Cheryse A.; Conroy, Jennie L.; Mello, Nancy K.; Sibley, David R.; Skolnick, Phil</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">445-458</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Converging lines of evidence indicate that elevations in synaptic dopamine levels play a pivotal role in the reinforcing effects of cocaine, which are assocd. with its abuse liability.  This evidence has led to the exploration of dopamine receptor blockers as pharmacotherapy for cocaine addiction.  While neither D1 nor D2 receptor antagonists have proven effective, medications acting at two other potential targets, D3 and D4 receptors, have yet to be explored for this indication in the clinic.  Buspirone, a 5-HT1A partial agonist approved for the treatment of anxiety, has been reported to also bind with high affinity to D3 and D4 receptors.  In view of this biochem. profile, the present research was conducted to examine both the functional effects of buspirone on these receptors and, in non-human primates, its ability to modify the reinforcing effects of i.v. cocaine in a behaviorally selective manner.  Radioligand binding studies confirmed that buspirone binds with high affinity to recombinant human D3 and D4 receptors (∼98 and ∼29 nm resp.).  Live cell functional assays also revealed that buspirone, and its metabolites, function as antagonists at both D3 and D4 receptors.  In behavioral studies, doses of buspirone that had inconsistent effects on food-maintained responding (0.1 or 0.3 mg/kg i.m.) produced a marked downward shift in the dose-effect function for cocaine-maintained behavior, reflecting substantial decreases in self-administration of one or more unit doses of i.v. cocaine in each subject.  These results support the further evaluation of buspirone as a candidate medication for the management of cocaine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq69I6VSGbSerVg90H21EOLACvtfcHk0lj5AnVEeugWRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFKktL4%253D&md5=977dd2218df7db5300b1e4c1865dafd9</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1017%2FS1461145712000661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145712000661%26sid%3Dliteratum%253Aachs%26aulast%3DBergman%26aufirst%3DJ.%26aulast%3DRoof%26aufirst%3DR.%2BA.%26aulast%3DFurman%26aufirst%3DC.%2BA.%26aulast%3DConroy%26aufirst%3DJ.%2BL.%26aulast%3DMello%26aufirst%3DN.%2BK.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DSkolnick%26aufirst%3DP.%26atitle%3DModification%2520of%2520cocaine%2520self-administration%2520by%2520buspirone%2520%2528buspar%25C2%25AE%2529%253A%2520potential%2520involvement%2520of%2520D3%2520and%2520D4%2520dopamine%2520receptors%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2013%26volume%3D16%26spage%3D445%26epage%3D458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Mello, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fivel, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohut, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergman, J.</span><span> </span><span class="NLM_article-title">Effects of chronic buspirone treatment on cocaine self-administration</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=455-467&author=N.+K.+Melloauthor=P.+A.+Fivelauthor=S.+J.+Kohutauthor=J.+Bergman&title=Effects+of+chronic+buspirone+treatment+on+cocaine+self-administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMello%26aufirst%3DN.%2BK.%26aulast%3DFivel%26aufirst%3DP.%2BA.%26aulast%3DKohut%26aufirst%3DS.%2BJ.%26aulast%3DBergman%26aufirst%3DJ.%26atitle%3DEffects%2520of%2520chronic%2520buspirone%2520treatment%2520on%2520cocaine%2520self-administration%26jtitle%3DNeuropsychopharmacology%26date%3D2013%26volume%3D38%26spage%3D455%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Winhusen, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kropp, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindblad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douaihy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgkins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chartier, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kampman, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanVeldhuisen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigham, G. S.</span><span> </span><span class="NLM_article-title">Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">757</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.4088%2FJCP.13m08862" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24911028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsl2mtLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2014&pages=757-764&author=T.+M.+Winhusenauthor=F.+Kroppauthor=R.+Lindbladauthor=A.+Douaihyauthor=L.+Haynesauthor=C.+Hodgkinsauthor=K.+Chartierauthor=K.+M.+Kampmanauthor=G.+Sharmaauthor=D.+F.+Lewisauthor=P.+VanVeldhuisenauthor=J.+Theobaldauthor=J.+Mayauthor=G.+S.+Brigham&title=Multisite%2C+randomized%2C+double-blind%2C+placebo-controlled+pilot+clinical+trial+to+evaluate+the+efficacy+of+buspirone+as+a+relapse-prevention+treatment+for+cocaine+dependence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence</span></div><div class="casAuthors">Winhusen, Theresa M.; Kropp, Frankie; Lindblad, Robert; Douaihy, Antoine; Haynes, Louise; Hodgkins, Candace; Chartier, Karen; Kampman, Kyle M.; Sharma, Gaurav; Lewis, Daniel F.; VanVeldhuisen, Paul; Theobald, Jeff; May, Jeanine; Brigham, Gregory S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry (Memphis, TN, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">757-764</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">Objective: To evaluate the potential efficacy of buspirone as a relapse-prevention treatment for cocaine dependence.  Method: A randomized, double-blind, placebo-controlled, 16-wk pilot trial was conducted at 6 clin. sites between August 2012 and June 2013.  Adult crack cocaine users meeting DSM-IV-TR criteria for current cocaine dependence who were scheduled to be in inpatient/residential substance use disorder (SUD) treatment for 12-19 days when randomized and planning to enroll in local outpatient treatment through the end of the active treatment phase were randomized to buspirone titrated to 60 mg/d (n = 35) or placebo (n = 27).  All participants received psychosocial treatment as usually provided by the SUD treatment programs in which they were enrolled.  Outcome measures included max. days of continuous cocaine abstinence (primary), proportion of cocaine use days, and days to first cocaine use during the outpatient treatment phase (study weeks 4-15) as assessed by self-report and urine drug screens.  Results: There were no significant treatment effects on max. continuous days of cocaine abstinence or days to first cocaine use.  In the female participants (n = 23), there was a significant treatment-by-time interaction effect (χ21 = 15.26, P < .0001), reflecting an increase in cocaine use by those receiving buspirone, relative to placebo, early in the outpatient treatment phase.  A similar effect was not detected in the male participants (n = 39; χ21 = 0.14, P = .70).  Conclusions: The results suggest that buspirone is unlikely to have a beneficial effect on preventing relapse to cocaine use and that buspirone for cocaine-dependent women may worsen their cocaine use outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDJDG0_9x3XbVg90H21EOLACvtfcHk0ljvignErpDGOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsl2mtLrJ&md5=468e3f0c922354e767b0b40c53caa066</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.4088%2FJCP.13m08862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4088%252FJCP.13m08862%26sid%3Dliteratum%253Aachs%26aulast%3DWinhusen%26aufirst%3DT.%2BM.%26aulast%3DKropp%26aufirst%3DF.%26aulast%3DLindblad%26aufirst%3DR.%26aulast%3DDouaihy%26aufirst%3DA.%26aulast%3DHaynes%26aufirst%3DL.%26aulast%3DHodgkins%26aufirst%3DC.%26aulast%3DChartier%26aufirst%3DK.%26aulast%3DKampman%26aufirst%3DK.%2BM.%26aulast%3DSharma%26aufirst%3DG.%26aulast%3DLewis%26aufirst%3DD.%2BF.%26aulast%3DVanVeldhuisen%26aufirst%3DP.%26aulast%3DTheobald%26aufirst%3DJ.%26aulast%3DMay%26aufirst%3DJ.%26aulast%3DBrigham%26aufirst%3DG.%2BS.%26atitle%3DMultisite%252C%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520pilot%2520clinical%2520trial%2520to%2520evaluate%2520the%2520efficacy%2520of%2520buspirone%2520as%2520a%2520relapse-prevention%2520treatment%2520for%2520cocaine%2520dependence%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2014%26volume%3D75%26spage%3D757%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Kim, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skolnick, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muench, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shea, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexoff, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkow, N. D.</span><span> </span><span class="NLM_article-title">Therapeutic doses of buspirone block D3 receptors in the living primate brain</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1257</span><span class="NLM_x">–</span> <span class="NLM_lpage">1267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1017%2FS1461145714000194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24679922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVKlurbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2014&pages=1257-1267&author=S.+W.+Kimauthor=J.+S.+Fowlerauthor=P.+Skolnickauthor=L.+Muenchauthor=Y.+Kangauthor=C.+Sheaauthor=J.+Loganauthor=D.+Kimauthor=P.+Carterauthor=P.+Kingauthor=D.+Alexoffauthor=N.+D.+Volkow&title=Therapeutic+doses+of+buspirone+block+D3+receptors+in+the+living+primate+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic doses of buspirone block D3 receptors in the living primate brain</span></div><div class="casAuthors">Kim, Sung Won; Fowler, Joanna S.; Skolnick, Phil; Muench, Lisa; Kang, Yeona; Shea, Colleen; Logan, Jean; Kim, Dohyun; Carter, Pauline; King, Payton; Alexoff, David; Volkow, Nora D.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1257-1267</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Dopamine D3 receptor (D3R) antagonists may be effective medications for multiple substance use disorders (SUDs).  However, no selective D3R antagonists are currently available for clin. testing.  Buspirone, originally characterized as a 5-HT1A partial agonist and used as an anxiolytic, also binds to D3R and D4R with high affinity, with lower affinity to D2R, and interferes with cocaine reward.  Here we used PET with [11C]PHNO (D3R-preferring radioligand), [11C]raclopride (D2R/D3R radioligand) and [11C]NNC-112 (D1R radioligand) to measure occupancy of oral and parenteral buspirone in the primate brain.  I.m. buspirone (0.19 and 0.5 mg/kg) blocked both [11C]PHNO and [11C]raclopride binding to striatum, exhibiting high occupancy (50-85%) at 15 min and rapid wash-out over 2-6 h.  In contrast, oral buspirone (3 mg/kg) significantly blocked [11C]PHNO binding in D3-rich regions (globus pallidum and midbrain) at 3 h, but had minimal effects on [11C]raclopride binding (28-37% at 1 h and 10% at 3 h).  Buspirone did not block [11C]NNC-112.  Our findings provide evidence that i.m. buspirone blocks D3R and D2R, whereas oral buspirone is more selective towards D3R blockade in vivo, consistent with extensive first pass metab. and supporting the hypothesis that its metabolites (5- and 6'-hydroxybuspirone) merit evaluation for treating SUDs.  They also indicate that for oral buspirone to achieve greater than 80% sustained D3R occupancy, as might be needed to treat addiction, higher doses (at least three-fold) than those used to treat anxiety (maximal 60 mg) will be required.  Nonetheless, based on previous clin. studies, these doses would be safe and well tolerated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9nEJ4ovtHrLVg90H21EOLACvtfcHk0ljvignErpDGOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVKlurbL&md5=0f25e50e1b5854c5892b686af8d61631</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1017%2FS1461145714000194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145714000194%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DFowler%26aufirst%3DJ.%2BS.%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DMuench%26aufirst%3DL.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DShea%26aufirst%3DC.%26aulast%3DLogan%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DCarter%26aufirst%3DP.%26aulast%3DKing%26aufirst%3DP.%26aulast%3DAlexoff%26aufirst%3DD.%26aulast%3DVolkow%26aufirst%3DN.%2BD.%26atitle%3DTherapeutic%2520doses%2520of%2520buspirone%2520block%2520D3%2520receptors%2520in%2520the%2520living%2520primate%2520brain%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2014%26volume%3D17%26spage%3D1257%26epage%3D1267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Gobert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivet, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cistarelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1999&pages=1251-1262&author=A.+Gobertauthor=J.+M.+Rivetauthor=L.+Cistarelliauthor=C.+Melonauthor=M.+J.+Millan&title=Buspirone+modulates+basal+and+fluoxetine-stimulated+dialysate+levels+of+dopamine%2C+noradrenaline+and+serotonin+in+the+frontal+cortex+of+freely+moving+rats%3A+activation+of+serotonin1A+receptors+and+blockade+of+alpha2-adrenergic+receptors+underlie+its+actions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGobert%26aufirst%3DA.%26aulast%3DRivet%26aufirst%3DJ.%2BM.%26aulast%3DCistarelli%26aufirst%3DL.%26aulast%3DMelon%26aufirst%3DC.%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3DBuspirone%2520modulates%2520basal%2520and%2520fluoxetine-stimulated%2520dialysate%2520levels%2520of%2520dopamine%252C%2520noradrenaline%2520and%2520serotonin%2520in%2520the%2520frontal%2520cortex%2520of%2520freely%2520moving%2520rats%253A%2520activation%2520of%2520serotonin1A%2520receptors%2520and%2520blockade%2520of%2520alpha2-adrenergic%2520receptors%2520underlie%2520its%2520actions%26jtitle%3DNeuroscience%26date%3D1999%26volume%3D93%26spage%3D1251%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Algeri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Luigi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simoni, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imeri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perego, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchetti, G.</span><span> </span><span class="NLM_article-title">Multiple and complex effects of buspirone on central dopaminergic system</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">823</span><span class="NLM_x">–</span> <span class="NLM_lpage">826</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1988&pages=823-826&author=S.+Algeriauthor=A.+De+Luigiauthor=M.+G.+De+Simoniauthor=L.+Imeriauthor=M.+Marconiauthor=S.+Navaauthor=C.+Peregoauthor=G.+Sacchetti&title=Multiple+and+complex+effects+of+buspirone+on+central+dopaminergic+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlgeri%26aufirst%3DS.%26aulast%3DDe%2BLuigi%26aufirst%3DA.%26aulast%3DDe%2BSimoni%26aufirst%3DM.%2BG.%26aulast%3DImeri%26aufirst%3DL.%26aulast%3DMarconi%26aufirst%3DM.%26aulast%3DNava%26aufirst%3DS.%26aulast%3DPerego%26aufirst%3DC.%26aulast%3DSacchetti%26aufirst%3DG.%26atitle%3DMultiple%2520and%2520complex%2520effects%2520of%2520buspirone%2520on%2520central%2520dopaminergic%2520system%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1988%26volume%3D29%26spage%3D823%26epage%3D826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">John, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banala, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">Effects of buspirone and the dopamine D3 receptor compound PG619 on cocaine and methamphetamine self-administration in rhesus monkeys using a food-drug choice paradigm</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">232</span><span class="NLM_x">, </span> <span class="NLM_fpage">1279</span><span class="NLM_x">–</span> <span class="NLM_lpage">1289</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2014&pages=1279-1289&author=W.+S.+Johnauthor=A.+K.+Banalaauthor=A.+H.+Newmanauthor=M.+A.+Nader&title=Effects+of+buspirone+and+the+dopamine+D3+receptor+compound+PG619+on+cocaine+and+methamphetamine+self-administration+in+rhesus+monkeys+using+a+food-drug+choice+paradigm"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohn%26aufirst%3DW.%2BS.%26aulast%3DBanala%26aufirst%3DA.%2BK.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DEffects%2520of%2520buspirone%2520and%2520the%2520dopamine%2520D3%2520receptor%2520compound%2520PG619%2520on%2520cocaine%2520and%2520methamphetamine%2520self-administration%2520in%2520rhesus%2520monkeys%2520using%2520a%2520food-drug%2520choice%2520paradigm%26jtitle%3DPsychopharmacology%26date%3D2014%26volume%3D232%26spage%3D1279%26epage%3D1289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Czoty, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">Effects of oral and intravenous administration of buspirone on food-cocaine choice in socially housed male cynomolgus monkeys</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1072</span><span class="NLM_x">–</span> <span class="NLM_lpage">1083</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2014&pages=1072-1083&author=P.+W.+Czotyauthor=M.+A.+Nader&title=Effects+of+oral+and+intravenous+administration+of+buspirone+on+food-cocaine+choice+in+socially+housed+male+cynomolgus+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCzoty%26aufirst%3DP.%2BW.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DEffects%2520of%2520oral%2520and%2520intravenous%2520administration%2520of%2520buspirone%2520on%2520food-cocaine%2520choice%2520in%2520socially%2520housed%2520male%2520cynomolgus%2520monkeys%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D40%26spage%3D1072%26epage%3D1083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robarge, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span> </span><span class="NLM_article-title"><i>N</i>-(4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2179</span><span class="NLM_x">–</span> <span class="NLM_lpage">2183</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2179-2183&author=A.+H.+Newmanauthor=J.+Caoauthor=C.+J.+Bennettauthor=M.+J.+Robargeauthor=R.+A.+Freemanauthor=R.+R.+Luedtke&title=N-%284-%5B4-%282%2C3-Dichlorophenyl%29piperazin-1-yl%5Dbutyl%2C+butenyl+and+butynyl%29arylcarboxamides+as+novel+dopamine+D%283%29+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DC.%2BJ.%26aulast%3DRobarge%26aufirst%3DM.%2BJ.%26aulast%3DFreeman%26aufirst%3DR.%2BA.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26atitle%3DN-%25284-%255B4-%25282%252C3-Dichlorophenyl%2529piperazin-1-yl%255Dbutyl%252C%2520butenyl%2520and%2520butynyl%2529arylcarboxamides%2520as%2520novel%2520dopamine%2520D%25283%2529%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2179%26epage%3D2183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Sorensen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sager, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennum, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thogersen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hee Bengtsen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wortwein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink-Jensen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woldbye, D. P.</span><span> </span><span class="NLM_article-title">Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">199</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=199&publication_year=2008&pages=37-46&author=G.+Sorensenauthor=T.+N.+Sagerauthor=J.+H.+Petersenauthor=L.+T.+Brennumauthor=P.+Thogersenauthor=C.+Hee+Bengtsenauthor=M.+Thomsenauthor=G.+Wortweinauthor=A.+Fink-Jensenauthor=D.+P.+Woldbye&title=Aripiprazole+blocks+acute+self-administration+of+cocaine+and+is+not+self-administered+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSorensen%26aufirst%3DG.%26aulast%3DSager%26aufirst%3DT.%2BN.%26aulast%3DPetersen%26aufirst%3DJ.%2BH.%26aulast%3DBrennum%26aufirst%3DL.%2BT.%26aulast%3DThogersen%26aufirst%3DP.%26aulast%3DHee%2BBengtsen%26aufirst%3DC.%26aulast%3DThomsen%26aufirst%3DM.%26aulast%3DWortwein%26aufirst%3DG.%26aulast%3DFink-Jensen%26aufirst%3DA.%26aulast%3DWoldbye%26aufirst%3DD.%2BP.%26atitle%3DAripiprazole%2520blocks%2520acute%2520self-administration%2520of%2520cocaine%2520and%2520is%2520not%2520self-administered%2520in%2520mice%26jtitle%3DPsychopharmacology%26date%3D2008%26volume%3D199%26spage%3D37%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Thomsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink-Jensen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woldbye, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wortwein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sager, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepe, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caine, S. B.</span><span> </span><span class="NLM_article-title">Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">201</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=201&publication_year=2008&pages=43-53&author=M.+Thomsenauthor=A.+Fink-Jensenauthor=D.+P.+Woldbyeauthor=G.+Wortweinauthor=T.+N.+Sagerauthor=R.+Holmauthor=L.+M.+Pepeauthor=S.+B.+Caine&title=Effects+of+acute+and+chronic+aripiprazole+treatment+on+choice+between+cocaine+self-administration+and+food+under+a+concurrent+schedule+of+reinforcement+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomsen%26aufirst%3DM.%26aulast%3DFink-Jensen%26aufirst%3DA.%26aulast%3DWoldbye%26aufirst%3DD.%2BP.%26aulast%3DWortwein%26aufirst%3DG.%26aulast%3DSager%26aufirst%3DT.%2BN.%26aulast%3DHolm%26aufirst%3DR.%26aulast%3DPepe%26aufirst%3DL.%2BM.%26aulast%3DCaine%26aufirst%3DS.%2BB.%26atitle%3DEffects%2520of%2520acute%2520and%2520chronic%2520aripiprazole%2520treatment%2520on%2520choice%2520between%2520cocaine%2520self-administration%2520and%2520food%2520under%2520a%2520concurrent%2520schedule%2520of%2520reinforcement%2520in%2520rats%26jtitle%3DPsychopharmacology%26date%3D2008%26volume%3D201%26spage%3D43%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Feltenstein, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">See, R. E.</span><span> </span><span class="NLM_article-title">Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapse</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">207</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2009&pages=401-411&author=M.+W.+Feltensteinauthor=P.+H.+Doauthor=R.+E.+See&title=Repeated+aripiprazole+administration+attenuates+cocaine+seeking+in+a+rat+model+of+relapse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeltenstein%26aufirst%3DM.%2BW.%26aulast%3DDo%26aufirst%3DP.%2BH.%26aulast%3DSee%26aufirst%3DR.%2BE.%26atitle%3DRepeated%2520aripiprazole%2520administration%2520attenuates%2520cocaine%2520seeking%2520in%2520a%2520rat%2520model%2520of%2520relapse%26jtitle%3DPsychopharmacology%26date%3D2009%26volume%3D207%26spage%3D401%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Czoty, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">Effects of dopamine D2/D3 receptor ligands on food-cocaine choice in socially housed male cynomolgus monkeys</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1124%2Fjpet.112.201012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=23211363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2013&pages=329-338&author=P.+W.+Czotyauthor=M.+A.+Nader&title=Effects+of+dopamine+D2%2FD3+receptor+ligands+on+food-cocaine+choice+in+socially+housed+male+cynomolgus+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of dopamine D2/D3 receptor ligands on food-cocaine choice in socially housed male cynomolgus monkeys</span></div><div class="casAuthors">Czoty, Paul W.; Nader, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">329-338</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dopamine D2/D3 receptor partial agonists have been suggested as medications for cocaine dependence.  The present expts. examd. the effect of acute and repeated administration of drugs with varying intrinsic efficacy at D2/D3 receptors on the relative reinforcing strength of cocaine.  Use of socially housed cynomolgus monkeys permitted the assessment of whether social status, known to alter D2/D3 receptor availability, influenced the behavioral effects of D2/D3 receptor compds.  The high-efficacy agonist R(-)-norpropylapomorphine [(-)-NPA], low-efficacy agonist aripiprazole (ARI), and antagonist eticlopride (ETIC) were administered acutely to monkeys self-administering cocaine under a food-cocaine choice procedure in which a cocaine self-administration dose-effect curve was detd. daily.  The effects of 5-day treatment with ARI and (-)-NPA were characterized under conditions in which monkeys did (ARI) or did not [ARI and (-)-NPA] self-administer cocaine during treatment.  When administered acutely, ARI and ETIC increased the choice of low cocaine doses, and only (-)-NPA decreased the choice of higher cocaine doses and cocaine intake; effects were similar across social ranks.  When administered repeatedly while self administration occurred only on days 1 and 5 of treatment, ARI, but not (-)-NPA, decreased cocaine choice in dominant monkeys, whereas (-)-NPA, but not ARI, did so in subordinates.  When dominant monkeys self-administered cocaine on all five days of ARI treatment, however, these effects were not obsd.  The results indicate that the behavioral effects of D2/D3 receptor agonists can differ according to intrinsic efficacy and subject characteristics.  Moreover, these results suggest that exposure to cocaine during treatment can counteract treatment-induced redns. in the reinforcing effects of cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppeV0UkXGrs7Vg90H21EOLACvtfcHk0liJnhHEJ5vJ2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKiurs%253D&md5=78a3670a4381c977853571466322ae5e</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.201012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.201012%26sid%3Dliteratum%253Aachs%26aulast%3DCzoty%26aufirst%3DP.%2BW.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DEffects%2520of%2520dopamine%2520D2%252FD3%2520receptor%2520ligands%2520on%2520food-cocaine%2520choice%2520in%2520socially%2520housed%2520male%2520cynomolgus%2520monkeys%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D344%26spage%3D329%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Stoops, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lofwall, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, C. R.</span><span> </span><span class="NLM_article-title">The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance</span> <span class="citation_source-journal">Am. J. Drug Alcohol Abuse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1080%2F00952990701651556" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=17994473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BD2snntFCgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2007&pages=769-776&author=W.+W.+Stoopsauthor=J.+A.+Lileauthor=M.+R.+Lofwallauthor=C.+R.+Rush&title=The+safety%2C+tolerability%2C+and+subject-rated+effects+of+acute+intranasal+cocaine+administration+during+aripiprazole+maintenance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance</span></div><div class="casAuthors">Stoops William W; Lile Joshua A; Lofwall Michelle R; Rush Craig R</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of drug and alcohol abuse</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">769-76</span>
        ISSN:<span class="NLM_cas:issn">0095-2990</span>.
    </div><div class="casAbstract">Although cocaine dependence remains a significant public health concern, efforts to identify a pharmacotherapy have been unsuccessful.  The purpose of this study was to assess the safety, tolerability, and subject-rated effects of intranasal cocaine during maintenance on aripiprazole, a novel antipsychotic with partial agonist activity at monoamine receptors implicated in the effects of cocaine.  To this end, eight cocaine dependent subjects were maintained on 10 mg oral aripiprazole and placebo in counterbalanced order prior to assessing the physiological and subject-rated effects of intranasal cocaine (4, 20, 40, and 60 mg).  Aripiprazole was generally devoid of effects, but did alter temperature-increasing and subject-rated effects of cocaine as a function of cocaine dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkDJF9x7XUmoJKJbLTgsvCfW6udTcc2ebsgv5lxMK6yrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snntFCgtQ%253D%253D&md5=164a2d369dd4bed35d0f8f4113c09597</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1080%2F00952990701651556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00952990701651556%26sid%3Dliteratum%253Aachs%26aulast%3DStoops%26aufirst%3DW.%2BW.%26aulast%3DLile%26aufirst%3DJ.%2BA.%26aulast%3DLofwall%26aufirst%3DM.%2BR.%26aulast%3DRush%26aufirst%3DC.%2BR.%26atitle%3DThe%2520safety%252C%2520tolerability%252C%2520and%2520subject-rated%2520effects%2520of%2520acute%2520intranasal%2520cocaine%2520administration%2520during%2520aripiprazole%2520maintenance%26jtitle%3DAm.%2520J.%2520Drug%2520Alcohol%2520Abuse%26date%3D2007%26volume%3D33%26spage%3D769%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Meini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecconi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellesi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biasci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ameglio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellegrini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forgione, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rucci, P.</span><span> </span><span class="NLM_article-title">Aripiprazole and ropinirole treatment for cocaine dependence: evidence from a pilot study</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1376</span><span class="NLM_x">–</span> <span class="NLM_lpage">1383</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.2174%2F138161211796150783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=21524261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosVSktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=1376-1383&author=M.+Meiniauthor=M.+Monciniauthor=D.+Cecconiauthor=V.+Cellesiauthor=L.+Biasciauthor=G.+Simoniauthor=M.+Ameglioauthor=M.+Pellegriniauthor=R.+N.+Forgioneauthor=P.+Rucci&title=Aripiprazole+and+ropinirole+treatment+for+cocaine+dependence%3A+evidence+from+a+pilot+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Aripiprazole and ropinirole treatment for cocaine dependence: evidence from a pilot study</span></div><div class="casAuthors">Meini, M.; Moncini, M.; Cecconi, D.; Cellesi, V.; Biasci, L.; Simoni, G.; Ameglio, M.; Pellegrini, M.; Forgione, R. N.; Rucci, P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1376-1383</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Currently, there is no specific pharmacol. therapy with established efficacy for the treatment of cocaine dependence.  The aim of this study was to det. the safety, tolerability and the effects of aripiprazole and ropinirole in patients with cocaine dependence.  This randomized clin. trial of 12-wk duration was carried out on 28 consecutive patients with cocaine dependence presenting for treatment.  The diagnostic assessment was performed using ICD-9-CM criteria and Mini International Neuropsychiatric Interview.  The Clin. Global Impression Scale, a Visual Analog Scale to assess craving and a self-report questionnaire on the use of cocaine were administered at baseline and then weekly throughout the study.  Urinalyses were carried out 3 times per wk to search for benzoylecgonine.  Of the 28 study participants, 14 completed the protocol.  Treatment discontinuation was unrelated with side effects.  One patient required a dosage redn. of ropinirole because of sleepiness and one patient assigned to aripiprazole who reported moderate akathysia had the dosage reduced to 5 mg/day.  Routine blood works did not show significant changes from baseline and the overall proportion of pos. urinalyses for benzoylecgonine did not differ significantly between treatments.  Using linear mixed-effect models a significant decrease in craving was found in the overall sample.  The mean no. of cocaine administrations exhibited a faster decrease with aripiprazole compared with ropinirole.  Our pilot study indicates that cocaine craving decreases with both aripiprazole and ropinirole treatment but aripiprazole is more efficacious in reducing cocaine use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDB3WEs3uXJLVg90H21EOLACvtfcHk0liJnhHEJ5vJ2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosVSktL4%253D&md5=32eb351997e0369e91d71bda4eb33149</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.2174%2F138161211796150783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161211796150783%26sid%3Dliteratum%253Aachs%26aulast%3DMeini%26aufirst%3DM.%26aulast%3DMoncini%26aufirst%3DM.%26aulast%3DCecconi%26aufirst%3DD.%26aulast%3DCellesi%26aufirst%3DV.%26aulast%3DBiasci%26aufirst%3DL.%26aulast%3DSimoni%26aufirst%3DG.%26aulast%3DAmeglio%26aufirst%3DM.%26aulast%3DPellegrini%26aufirst%3DM.%26aulast%3DForgione%26aufirst%3DR.%2BN.%26aulast%3DRucci%26aufirst%3DP.%26atitle%3DAripiprazole%2520and%2520ropinirole%2520treatment%2520for%2520cocaine%2520dependence%253A%2520evidence%2520from%2520a%2520pilot%2520study%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2011%26volume%3D17%26spage%3D1376%26epage%3D1383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Song, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span> </span><span class="NLM_article-title">YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice</span> <span class="citation_source-journal">Addict. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1111%2Fj.1369-1600.2011.00317.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=21507153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC38XltV2kt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=259-273&author=R.+Songauthor=R.+F.+Yangauthor=N.+Wuauthor=R.+B.+Suauthor=J.+Liauthor=X.+Q.+Pengauthor=X.+Liauthor=J.+Gaalauthor=Z.+X.+Xiauthor=E.+L.+Gardner&title=YQA14%3A+a+novel+dopamine+D3+receptor+antagonist+that+inhibits+cocaine+self-administration+in+rats+and+mice%2C+but+not+in+D3+receptor-knockout+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice</span></div><div class="casAuthors">Song, Rui; Yang, Ri-Fang; Wu, Ning; Su, Rui-Bin; Li, Jin; Peng, Xiao-Qing; Li, Xia; Gaal, Jozsef; Xi, Zheng-Xiong; Gardner, Eliot L.</div><div class="citationInfo"><span class="NLM_cas:title">Addiction Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">259-273</span>CODEN:
                <span class="NLM_cas:coden">ADBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1369-1600</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The dopamine (DA) D3 receptor is posited to be importantly involved in drug reward and addiction, and D3 receptor antagonists have shown extraordinary promise as potential anti-addiction pharmacotherapeutic agents in animal models of drug addiction.  SB-277011A is the best characterized D3 receptor antagonist in such models.  However, the potential use of SB-277011A in humans is precluded by pharmacokinetic and toxicity problems.  We here report a novel D3 receptor antagonist YQA14 that shows similar pharmacol. properties as SB-277011A.  In vitro receptor binding assays suggest that YQA14 has two binding sites on human cloned D3 receptors with Kl-High (0.68 × 10-4 nM) and Kl-Low (2.11 nM), and displays > 150-fold selectivity for D3 over D2 receptors and > 1000-fold selectivity for D3 over other DA receptors.  Systemic administration of YQA14 (6.25-25 mg/kg) or SB-277011A (12.5-25 mg/kg) significantly and dose-dependently reduced i.v. cocaine self-administration under both low fixed-ratio and progressive-ratio reinforcement conditions in rats, while failing to alter oral sucrose self-administration and locomotor activity, suggesting a selective inhibition of drug reward.  However, when the drug dose was increased to 50 mg/kg, YQA14 and SB-277011A significantly inhibited basal and cocaine-enhanced locomotion in rats.  Finally, both D3 antagonists dose-dependently inhibited i.v. cocaine self-administration in wild-type mice, but not in D3 receptor-knockout mice, suggesting that their action is mediated by D3 receptor blockade.  These findings suggest that YQA14 has a similar anti-addiction profile as SB-277011A, and deserves further study and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoutvbaR_4-rVg90H21EOLACvtfcHk0lic6-xJbYfjYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltV2kt7c%253D&md5=3bc010bc1b0031dc7a23398dc4764b6f</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1111%2Fj.1369-1600.2011.00317.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1369-1600.2011.00317.x%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DR.%2BF.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DSu%26aufirst%3DR.%2BB.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DX.%2BQ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGaal%26aufirst%3DJ.%26aulast%3DXi%26aufirst%3DZ.%2BX.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26atitle%3DYQA14%253A%2520a%2520novel%2520dopamine%2520D3%2520receptor%2520antagonist%2520that%2520inhibits%2520cocaine%2520self-administration%2520in%2520rats%2520and%2520mice%252C%2520but%2520not%2520in%2520D3%2520receptor-knockout%2520mice%26jtitle%3DAddict.%2520Biol.%26date%3D2012%26volume%3D17%26spage%3D259%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodbeck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Primus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasley, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurkauf, A.</span><span> </span><span class="NLM_article-title">NGB 2904 and NGB 2849: two highly selective dopamine D3 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2715</span><span class="NLM_x">–</span> <span class="NLM_lpage">2718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=2715-2718&author=J.+Yuanauthor=X.+Chenauthor=R.+Brodbeckauthor=R.+Primusauthor=J.+Braunauthor=J.+W.+Wasleyauthor=A.+Thurkauf&title=NGB+2904+and+NGB+2849%3A+two+highly+selective+dopamine+D3+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DBrodbeck%26aufirst%3DR.%26aulast%3DPrimus%26aufirst%3DR.%26aulast%3DBraun%26aufirst%3DJ.%26aulast%3DWasley%26aufirst%3DJ.%2BW.%26aulast%3DThurkauf%26aufirst%3DA.%26atitle%3DNGB%25202904%2520and%2520NGB%25202849%253A%2520two%2520highly%2520selective%2520dopamine%2520D3%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26spage%3D2715%26epage%3D2718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Stafford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeSage, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glowa, J. R.</span><span> </span><span class="NLM_article-title">Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=1998&pages=169-184&author=D.+Staffordauthor=M.+G.+LeSageauthor=J.+R.+Glowa&title=Progressive-ratio+schedules+of+drug+delivery+in+the+analysis+of+drug+self-administration%3A+a+review"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStafford%26aufirst%3DD.%26aulast%3DLeSage%26aufirst%3DM.%2BG.%26aulast%3DGlowa%26aufirst%3DJ.%2BR.%26atitle%3DProgressive-ratio%2520schedules%2520of%2520drug%2520delivery%2520in%2520the%2520analysis%2520of%2520drug%2520self-administration%253A%2520a%2520review%26jtitle%3DPsychopharmacology%26date%3D1998%26volume%3D139%26spage%3D169%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Xi, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span> </span><span class="NLM_article-title">Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=240-259&author=Z.+X.+Xiauthor=E.+L.+Gardner&title=Pharmacological+actions+of+NGB+2904%2C+a+selective+dopamine+D3+receptor+antagonist%2C+in+animal+models+of+drug+addiction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DZ.%2BX.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26atitle%3DPharmacological%2520actions%2520of%2520NGB%25202904%252C%2520a%2520selective%2520dopamine%2520D3%2520receptor%2520antagonist%252C%2520in%2520animal%2520models%2520of%2520drug%2520addiction%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2007%26volume%3D13%26spage%3D240%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Spiller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span> </span><span class="NLM_article-title">The selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">196</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2008&pages=533-542&author=K.+Spillerauthor=Z.+X.+Xiauthor=X.+Q.+Pengauthor=A.+H.+Newmanauthor=C.+R.+Ashbyauthor=C.+Heidbrederauthor=J.+Gaalauthor=E.+L.+Gardner&title=The+selective+dopamine+D3+receptor+antagonists+SB-277011A+and+NGB+2904+and+the+putative+partial+D3+receptor+agonist+BP-897+attenuate+methamphetamine-enhanced+brain+stimulation+reward+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpiller%26aufirst%3DK.%26aulast%3DXi%26aufirst%3DZ.%2BX.%26aulast%3DPeng%26aufirst%3DX.%2BQ.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DHeidbreder%26aufirst%3DC.%26aulast%3DGaal%26aufirst%3DJ.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26atitle%3DThe%2520selective%2520dopamine%2520D3%2520receptor%2520antagonists%2520SB-277011A%2520and%2520NGB%25202904%2520and%2520the%2520putative%2520partial%2520D3%2520receptor%2520agonist%2520BP-897%2520attenuate%2520methamphetamine-enhanced%2520brain%2520stimulation%2520reward%2520in%2520rats%26jtitle%3DPsychopharmacology%26date%3D2008%26volume%3D196%26spage%3D533%26epage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Robarge, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husbands, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieltyka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodbeck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurkauf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Design and synthesis of [(2,3-dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as novel ligands selective for the dopamine D3 receptor subtype</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3175</span><span class="NLM_x">–</span> <span class="NLM_lpage">3186</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010146o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3175-3186&author=M.+J.+Robargeauthor=S.+M.+Husbandsauthor=A.+Kieltykaauthor=R.+Brodbeckauthor=A.+Thurkaufauthor=A.+H.+Newman&title=Design+and+synthesis+of+%5B%282%2C3-dichlorophenyl%29piperazin-1-yl%5Dalkylfluorenylcarboxamides+as+novel+ligands+selective+for+the+dopamine+D3+receptor+subtype"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Fjm010146o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010146o%26sid%3Dliteratum%253Aachs%26aulast%3DRobarge%26aufirst%3DM.%2BJ.%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26aulast%3DKieltyka%26aufirst%3DA.%26aulast%3DBrodbeck%26aufirst%3DR.%26aulast%3DThurkauf%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%255B%25282%252C3-dichlorophenyl%2529piperazin-1-yl%255Dalkylfluorenylcarboxamides%2520as%2520novel%2520ligands%2520selective%2520for%2520the%2520dopamine%2520D3%2520receptor%2520subtype%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3175%26epage%3D3186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Martelle, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claytor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reboussin, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">Effects of two novel D3-selective compounds, NGB 2904 [<i>N</i>-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9<i>H</i>-fluorene-2-carboxamide] and CJB 090 [<i>N</i>-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide], on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1124%2Fjpet.106.113571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=17272677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFehtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=573-582&author=J.+L.+Martelleauthor=R.+Claytorauthor=J.+T.+Rossauthor=B.+A.+Reboussinauthor=A.+H.+Newmanauthor=M.+A.+Nader&title=Effects+of+two+novel+D3-selective+compounds%2C+NGB+2904+%5BN-%284-%284-%282%2C3-dichlorophenyl%29piperazin-1-yl%29butyl%29-9H-fluorene-2-carboxamide%5D+and+CJB+090+%5BN-%284-%284-%282%2C3-dichlorophenyl%29piperazin-1-yl%29butyl%29-4-%28pyridin-2-yl%29benzamide%5D%2C+on+the+reinforcing+and+discriminative+stimulus+effects+of+cocaine+in+rhesus+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of two novel D3-selective compounds, NGB 2904 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide] and CJB 090 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide], on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys</span></div><div class="casAuthors">Martelle, Jennifer L.; Claytor, Renee; Ross, Jason T.; Reboussin, Beth A.; Newman, Amy Hauck; Nader, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">573-582</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The present study examd. the effects of two novel dopamine D3 receptor compds., NGB 2904 and CJB 090, a partial agonist, in two models of cocaine abuse in rhesus monkeys.  To establish a dose range and time course of effects, both compds. were shown to block quinpirole-induced yawning when administered i.m. 15, 30, or 120 min before quinpirole.  Next, rhesus monkeys were trained to discriminate i.m. injections of saline (0.5 mL) and cocaine (0.3 mg/kg).  Neither D3 compd. (0.03-3.0 mg/kg; n = 3) substituted for cocaine in any monkey.  When given in combination with cocaine, CJB 090 but not NGB 2904 attenuated the discriminative stimulus effects of cocaine, shifting the cocaine dose-response curve to the right.  In a sep. group of monkeys, responding was maintained under a second-order schedule of either food (1.0-g pellets; n = 3) or cocaine (0.1 mg/kg/injection; n = 4) presentation.  When responding was stable, a dose of NGB 2904 (1.0-5.6 mg/kg i.v.) or CJB 090 (0.3-3.0 mg/kg i.v.) was administered for 5 consecutive days, immediately before the session.  CJB 090, but not NGB 2904, decreased cocaine- and food-maintained responding.  These data indicate that compds. with relatively high affinity and selectivity for the D3 receptor can attenuate the discriminative and reinforcing stimulus effects of cocaine while not producing cocaine-like effects.  The present findings support the continued examn. of D3 compds. as pharmacol. tools for better understanding the role of this receptor subtype in cocaine addiction and as potential lead compds. for novel therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0LWJO0jjxa7Vg90H21EOLACvtfcHk0lhnFj6e3ei-zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFehtbs%253D&md5=9d2f1428cf5af16bc70e18fb9a530f18</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.113571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.113571%26sid%3Dliteratum%253Aachs%26aulast%3DMartelle%26aufirst%3DJ.%2BL.%26aulast%3DClaytor%26aufirst%3DR.%26aulast%3DRoss%26aufirst%3DJ.%2BT.%26aulast%3DReboussin%26aufirst%3DB.%2BA.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DEffects%2520of%2520two%2520novel%2520D3-selective%2520compounds%252C%2520NGB%25202904%2520%255BN-%25284-%25284-%25282%252C3-dichlorophenyl%2529piperazin-1-yl%2529butyl%2529-9H-fluorene-2-carboxamide%255D%2520and%2520CJB%2520090%2520%255BN-%25284-%25284-%25282%252C3-dichlorophenyl%2529piperazin-1-yl%2529butyl%2529-4-%2528pyridin-2-yl%2529benzamide%255D%252C%2520on%2520the%2520reinforcing%2520and%2520discriminative%2520stimulus%2520effects%2520of%2520cocaine%2520in%2520rhesus%2520monkeys%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26spage%3D573%26epage%3D582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Achat-Mendes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platt, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spealman, R. D.</span><span> </span><span class="NLM_article-title">The dopamine D3 receptor partial agonist CJB 090 inhibits the discriminative stimulus but not the reinforcing or priming effects of cocaine in squirrel monkeys</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">206</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2009&pages=73-84&author=C.+Achat-Mendesauthor=D.+M.+Plattauthor=A.+H.+Newmanauthor=R.+D.+Spealman&title=The+dopamine+D3+receptor+partial+agonist+CJB+090+inhibits+the+discriminative+stimulus+but+not+the+reinforcing+or+priming+effects+of+cocaine+in+squirrel+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAchat-Mendes%26aufirst%3DC.%26aulast%3DPlatt%26aufirst%3DD.%2BM.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DSpealman%26aufirst%3DR.%2BD.%26atitle%3DThe%2520dopamine%2520D3%2520receptor%2520partial%2520agonist%2520CJB%2520090%2520inhibits%2520the%2520discriminative%2520stimulus%2520but%2520not%2520the%2520reinforcing%2520or%2520priming%2520effects%2520of%2520cocaine%2520in%2520squirrel%2520monkeys%26jtitle%3DPsychopharmacology%26date%3D2009%26volume%3D206%26spage%3D73%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Blaylock, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banala, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">Influence of cocaine history on the behavioral effects of dopamine D(3) receptor-selective compounds in monkeys</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1104</span><span class="NLM_x">–</span> <span class="NLM_lpage">1113</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=1104-1113&author=B.+L.+Blaylockauthor=R.+W.+Gouldauthor=A.+Banalaauthor=P.+Grundtauthor=R.+R.+Luedtkeauthor=A.+H.+Newmanauthor=M.+A.+Nader&title=Influence+of+cocaine+history+on+the+behavioral+effects+of+dopamine+D%283%29+receptor-selective+compounds+in+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlaylock%26aufirst%3DB.%2BL.%26aulast%3DGould%26aufirst%3DR.%2BW.%26aulast%3DBanala%26aufirst%3DA.%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DInfluence%2520of%2520cocaine%2520history%2520on%2520the%2520behavioral%2520effects%2520of%2520dopamine%2520D%25283%2529%2520receptor-selective%2520compounds%2520in%2520monkeys%26jtitle%3DNeuropsychopharmacology%26date%3D2011%26volume%3D36%26spage%3D1104%26epage%3D1113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Martelle, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czoty, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duke, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">Further characterization of quinpirole-elicited yawning as a model of dopamine D3 receptor activation in male and female monkeys</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1124%2Fjpet.114.214833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24876234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVKis7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2014&pages=205-211&author=S.+E.+Martelleauthor=S.+H.+Naderauthor=P.+W.+Czotyauthor=W.+S.+Johnauthor=A.+N.+Dukeauthor=P.+K.+Gargauthor=S.+Gargauthor=A.+H.+Newmanauthor=M.+A.+Nader&title=Further+characterization+of+quinpirole-elicited+yawning+as+a+model+of+dopamine+D3+receptor+activation+in+male+and+female+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Further characterization of quinpirole-elicited yawning as a model of dopamine D3 receptor activation in male and female monkeys</span></div><div class="casAuthors">Martelle, Susan E.; Nader, Susan H.; Czoty, Paul W.; John, William S.; Duke, Angela N.; Garg, Pradeep K.; Garg, Sudha; Newman, Amy H.; Nader, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-211, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The dopamine (DA) D3 receptor (D3R) has been assocd. with impulsivity, pathol. gambling and drug addiction, making it a potential target for pharmacotherapy development.  Positron emission tomog. studies using the D3R-preferring radioligand [11C]PHNO ([11C](+)-propyl-hexahydro-naphtho-oxazin) have shown higher binding potentials in drug abusers compared with control subjects.  Preclin. studies have examd. D3R receptor activation using the DA agonist quinpirole and the unconditioned behavior of yawning.  However, the relationship between quinpirole-elicited yawning and D3R receptor availability has not been detd.  In Expt. 1, eight drug-naive male rhesus monkeys were scanned with [11C]PHNO and the ability of quinpirole (0.01-0.3 mg/kg i.m.) to elicit yawning was examd.  Significant pos. (globus pallidus) and neg. (caudate nucleus, putamen, ventral pallidum and hippocampus) relationships between D3R receptor availability and quinpirole-induced yawns were noted.  Expt. 2 replicated earlier findings that a history of cocaine self-administration (n = 11) did not affect quinpirole-induced yawning and extended this to examine monkeys (n = 3) with a history of methamphetamine (MA) self-administration and found that monkeys with experience self-administering MA showed greater potency and significantly higher quinpirole-elicited yawning compared with controls.  Finally, quinpirole-elicited yawning was studied in drug-naive female monkeys (n = 6) and compared with drug-naive male monkeys (n = 8).  Sex differences were noted, with quinpirole being more potent and eliciting significantly more yawns in males compared with females.  Taken together these findings support the use of quinpirole-elicited yawning as a behavioral tool for examg. D3R activation in monkeys and that both drug history and sex may influence individual sensitivity to the behavioral effects of D3R compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3uRUbNFUsj7Vg90H21EOLACvtfcHk0lg5Y2nuB68qLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVKis7vK&md5=1cc38ae0f4cc38f036327175417d2ca1</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.214833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.214833%26sid%3Dliteratum%253Aachs%26aulast%3DMartelle%26aufirst%3DS.%2BE.%26aulast%3DNader%26aufirst%3DS.%2BH.%26aulast%3DCzoty%26aufirst%3DP.%2BW.%26aulast%3DJohn%26aufirst%3DW.%2BS.%26aulast%3DDuke%26aufirst%3DA.%2BN.%26aulast%3DGarg%26aufirst%3DP.%2BK.%26aulast%3DGarg%26aufirst%3DS.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DFurther%2520characterization%2520of%2520quinpirole-elicited%2520yawning%2520as%2520a%2520model%2520of%2520dopamine%2520D3%2520receptor%2520activation%2520in%2520male%2520and%2520female%2520monkeys%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D350%26spage%3D205%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Hamilton, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czoty, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">Characterization of the dopamine receptor system in adult rhesus monkeys exposed to cocaine throughout gestation</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2010&pages=481-488&author=L.+R.+Hamiltonauthor=P.+W.+Czotyauthor=H.+D.+Gageauthor=M.+A.+Nader&title=Characterization+of+the+dopamine+receptor+system+in+adult+rhesus+monkeys+exposed+to+cocaine+throughout+gestation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DL.%2BR.%26aulast%3DCzoty%26aufirst%3DP.%2BW.%26aulast%3DGage%26aufirst%3DH.%2BD.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DCharacterization%2520of%2520the%2520dopamine%2520receptor%2520system%2520in%2520adult%2520rhesus%2520monkeys%2520exposed%2520to%2520cocaine%2520throughout%2520gestation%26jtitle%3DPsychopharmacology%26date%3D2010%26volume%3D210%26spage%3D481%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Orio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulvirenti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koob, G. F.</span><span> </span><span class="NLM_article-title">The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access</span> <span class="citation_source-journal">Addict. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">312</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1111%2Fj.1369-1600.2010.00211.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=20456290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1ahu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=312-323&author=L.+Orioauthor=S.+Weeauthor=A.+H.+Newmanauthor=L.+Pulvirentiauthor=G.+F.+Koob&title=The+dopamine+D3+receptor+partial+agonist+CJB090+and+antagonist+PG01037+decrease+progressive+ratio+responding+for+methamphetamine+in+rats+with+extended-access"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access</span></div><div class="casAuthors">Orio, Laura; Wee, Sunmee; Newman, Amy H.; Pulvirenti, Luigi; Koob, George F.</div><div class="citationInfo"><span class="NLM_cas:title">Addiction Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">312-323</span>CODEN:
                <span class="NLM_cas:coden">ADBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1355-6215</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Previous work suggests a role for dopamine D3-like receptors in psychostimulant reinforcement.  The development of new compds. acting selectively at dopamine D3 receptors has opened new possibilities to explore the role of these receptors in animal models of psychostimulant dependence.  Here we investigated whether the dopamine D3 partial agonist CJB090 (1-10 mg/kg, i.v) and the D3 antagonist PG01037 (8-32 mg/kg, s.c.) modified methamphetamine (0.05 mg/kg/injection) i.v. self-administration under fixed-(FR) and progressive-(PR) ratio schedules in rats allowed limited (short access, ShA; 1 h sessions 3 days/wk) or extended access (long access, LgA; 6 h sessions 6 days/wk).  Under a FR1 schedule, the highest dose of the D3 partial agonist CJB090 selectively reduced methamphetamine self-administration in LgA but not in ShA rats, whereas the full D3 antagonist PG01037 produced no effect in either group.  Under a PR schedule of reinforcement, the D3 partial agonist CJB090 reduced the max. no. of responses performed ('breakpoint') for methamphetamine in LgA rats at the doses of 5 and 10 mg/kg, and also it produced a significant redn. in the ShA group at the highest dose.  However, the D3 full antagonist PG01037 only reduced PR methamphetamine self-administration in LgA rats at the highest dose of 32 mg/kg with no effect in the ShA group.  The results suggest that rats might be more sensitive to pharmacol. modulation of dopamine D3 receptors following extended access to methamphetamine self-administration, opening the possibility that D3 receptors play a role in excessive methamphetamine intake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps0PzhJXFJG7Vg90H21EOLACvtfcHk0lg5Y2nuB68qLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1ahu7k%253D&md5=9cb4523db1f4dcde0260117a6ad5e7c7</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1111%2Fj.1369-1600.2010.00211.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1369-1600.2010.00211.x%26sid%3Dliteratum%253Aachs%26aulast%3DOrio%26aufirst%3DL.%26aulast%3DWee%26aufirst%3DS.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DPulvirenti%26aufirst%3DL.%26aulast%3DKoob%26aufirst%3DG.%2BF.%26atitle%3DThe%2520dopamine%2520D3%2520receptor%2520partial%2520agonist%2520CJB090%2520and%2520antagonist%2520PG01037%2520decrease%2520progressive%2520ratio%2520responding%2520for%2520methamphetamine%2520in%2520rats%2520with%2520extended-access%26jtitle%3DAddict.%2520Biol.%26date%3D2010%26volume%3D15%26spage%3D312%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Mason, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddington, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voulalas, P. J.</span><span> </span><span class="NLM_article-title">Characterization of the transport, metabolism, and pharmacokinetics of the dopamine D3 receptor-selective fluorenyl- and 2-pyridylphenyl amides developed for treatment of psychostimulant abuse</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">854</span><span class="NLM_x">–</span> <span class="NLM_lpage">864</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1124%2Fjpet.109.165084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=20228156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvFClsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=854-864&author=C.+W.+Masonauthor=H.+E.+Hassanauthor=K.+P.+Kimauthor=J.+Caoauthor=N.+D.+Eddingtonauthor=A.+H.+Newmanauthor=P.+J.+Voulalas&title=Characterization+of+the+transport%2C+metabolism%2C+and+pharmacokinetics+of+the+dopamine+D3+receptor-selective+fluorenyl-+and+2-pyridylphenyl+amides+developed+for+treatment+of+psychostimulant+abuse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the transport, metabolism, and pharmacokinetics of the dopamine D3 receptor-selective fluorenyl- and 2-pyridylphenyl amides developed for treatment of psychostimulant abuse</span></div><div class="casAuthors">Mason, Clifford W.; Hassan, Hazem E.; Kim, Kang-Pil; Cao, Jianjing; Eddington, Natalie D.; Newman, Amy Hauck; Voulalas, Pamela J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">854-864</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The recent discovery of novel high-affinity and selective dopamine D3 receptor (DA D3R) antagonists and partial agonists has provided tools with which to further elucidate the role DA D3R plays in substance abuse.  The present study was conducted to evaluate the transport, metab., pharmacokinetics, and brain uptake of the DA D3R-selective fluorenyl amides, NGB 2904 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide] fumarate and JJC 4-077 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)-3-hydroxybutyl)-9H-fluorene-2-carboxamide hydrochloride], and the 2-pyridylphenyl amides, CJB 090 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridine-2-yl)benzamide hydrochloride] and PG 01037 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)-trans-but-2-enyl)-4-(pyridine-2-yl)benzamide hydrochloride], all of which have been studied in animal models of psychostimulant abuse.  Addnl. screening with a panel of human and rat Supersomes was performed for NGB 2904 and PG 01037.  Drug-stimulated ATPase activation assays and bidirectional transport and efflux assays were used to test for substrate specificity of NGB 2904 and PG 01037 for human and rat efflux transporters.  All compds. exhibited moderate elimination half-lives, ranging from 1.49 to 3.27 h, and large vols. of distribution (5.95-14.19 l/kg).  The brain-to-plasma ratios ranged from 2.93 to 11.81 and were higher than those previously reported for cocaine.  Brain exposure levels of NGB 2904 and PG 01037 were significantly reduced after i.p. administration compared with i.v. administration.  The metab. of these compds. was mediated primarily by CYP3A subfamilies.  PG 01037 was a P-glycoprotein-transported substrate.  Higher doses of these compds. are often required for in vivo action, suggesting decreased bioavailability via extravascular administration that may be attributed to high drug efflux and hepatic metab.  These studies provide important preclin. information for optimization of next-generation D3R selective agents for the treatment of drug addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFm2tdQWBlXbVg90H21EOLACvtfcHk0lg5Y2nuB68qLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvFClsbw%253D&md5=626b181940c176ecaccb3e8b5273f4a8</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.165084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.165084%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DC.%2BW.%26aulast%3DHassan%26aufirst%3DH.%2BE.%26aulast%3DKim%26aufirst%3DK.%2BP.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DEddington%26aufirst%3DN.%2BD.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DVoulalas%26aufirst%3DP.%2BJ.%26atitle%3DCharacterization%2520of%2520the%2520transport%252C%2520metabolism%252C%2520and%2520pharmacokinetics%2520of%2520the%2520dopamine%2520D3%2520receptor-selective%2520fluorenyl-%2520and%25202-pyridylphenyl%2520amides%2520developed%2520for%2520treatment%2520of%2520psychostimulant%2520abuse%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D854%26epage%3D864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Cheung, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammerslag, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durbin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peartree, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neisewander, J. L.</span><span> </span><span class="NLM_article-title">Phenylpiperazine derivatives with selectivity for dopamine D3 receptors modulate cocaine self-administration in rats</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">1346</span><span class="NLM_x">–</span> <span class="NLM_lpage">1359</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2012&pages=1346-1359&author=T.+H.+Cheungauthor=B.+C.+Nolanauthor=L.+R.+Hammerslagauthor=S.+M.+Weberauthor=J.+P.+Durbinauthor=N.+A.+Peartreeauthor=R.+H.+Machauthor=R.+R.+Luedtkeauthor=J.+L.+Neisewander&title=Phenylpiperazine+derivatives+with+selectivity+for+dopamine+D3+receptors+modulate+cocaine+self-administration+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DT.%2BH.%26aulast%3DNolan%26aufirst%3DB.%2BC.%26aulast%3DHammerslag%26aufirst%3DL.%2BR.%26aulast%3DWeber%26aufirst%3DS.%2BM.%26aulast%3DDurbin%26aufirst%3DJ.%2BP.%26aulast%3DPeartree%26aufirst%3DN.%2BA.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DNeisewander%26aufirst%3DJ.%2BL.%26atitle%3DPhenylpiperazine%2520derivatives%2520with%2520selectivity%2520for%2520dopamine%2520D3%2520receptors%2520modulate%2520cocaine%2520self-administration%2520in%2520rats%26jtitle%3DNeuropharmacology%26date%3D2012%26volume%3D63%26spage%3D1346%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Cheung, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriaux, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandler, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaan, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neisewander, J. L.</span><span> </span><span class="NLM_article-title">Reduction of cocaine self-administration and D3 receptor-mediated behavior by two novel dopamine D3 receptor-selective partial agonists, OS-3-106 and WW-III-55</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1124%2Fjpet.112.202911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24018640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSqsLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2013&pages=410-423&author=T.+H.+Cheungauthor=A.+L.+Loriauxauthor=S.+M.+Weberauthor=K.+N.+Chandlerauthor=J.+D.+Lenzauthor=R.+F.+Schaanauthor=R.+H.+Machauthor=R.+R.+Luedtkeauthor=J.+L.+Neisewander&title=Reduction+of+cocaine+self-administration+and+D3+receptor-mediated+behavior+by+two+novel+dopamine+D3+receptor-selective+partial+agonists%2C+OS-3-106+and+WW-III-55"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of cocaine self-administration and D3 receptor-mediated behavior by two novel dopamine D3 receptor-selective partial agonists, OS-3-106 and WW-III-55</span></div><div class="casAuthors">Cheung, Timothy H. C.; Loriaux, Amy L.; Weber, Suzanne M.; Chandler, Kayla N.; Lenz, Jeffrey D.; Schaan, Romina F.; Mach, Robert H.; Luedtke, Robert R.; Neisewander, Janet L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">410-423</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dopamine D3 receptor (D3R)-selective compds. may be useful medications for cocaine dependence.  In this study, we identified two novel arylamide phenylpiperazines, OS-3-106 and WW-III-55, as partial agonists at the D3R in the adenylyl cyclase inhibition assay.  OS-3-106 and WW-III-55 have 115- and 862-fold D3R:D2 receptor (D2R) binding selectivity, resp.  We investigated their effects (0, 3, 5.6, or 10 mg/kg) on operant responding by using a multiple variable-interval (VI) 60-s schedule that alternated components with sucrose reinforcement and components with i.v. cocaine reinforcement (0.375 mg/kg).  Addnl., we evaluated the effect of OS-3-106 (10 mg/kg) on the dose-response function of cocaine self-administration and the effect of WW-III-55 (0-5.6 mg/kg) on a progressive ratio schedule with either cocaine or sucrose reinforcement.  Both compds. were also examd. for effects on locomotion and yawning induced by a D3R agonist.  OS-3-106 decreased cocaine and sucrose reinforcement rates, increased latency to first response for cocaine but not sucrose, and down-shifted the cocaine self-administration dose-response function.  WW-III-55 did not affect cocaine self-administration on the multiple-variable interval schedule, but it reduced cocaine and sucrose intake on the progressive ratio schedule.  Both compds. reduced locomotion at doses that reduced responding, and both compds. attenuated yawning induced by low doses of 7-OH-DPAT (a D3R-mediated behavior), but neither affected yawning on the descending limb of the 7-OH-DPAT dose-response function (a D2R-mediated behavior).  Therefore, both compds. blocked a D3R-mediated behavior.  However, OS-3-106 was more effective in reducing cocaine self-administration.  These findings support D3Rs, and possibly D2Rs, as targets for medications aimed at reducing the motivation to seek cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohpmGpI3Ejz7Vg90H21EOLACvtfcHk0lh_vBhw95Toug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSqsLrN&md5=643b08be291f9e831fc3abc5567ec9ec</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.202911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.202911%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DT.%2BH.%26aulast%3DLoriaux%26aufirst%3DA.%2BL.%26aulast%3DWeber%26aufirst%3DS.%2BM.%26aulast%3DChandler%26aufirst%3DK.%2BN.%26aulast%3DLenz%26aufirst%3DJ.%2BD.%26aulast%3DSchaan%26aufirst%3DR.%2BF.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DNeisewander%26aufirst%3DJ.%2BL.%26atitle%3DReduction%2520of%2520cocaine%2520self-administration%2520and%2520D3%2520receptor-mediated%2520behavior%2520by%2520two%2520novel%2520dopamine%2520D3%2520receptor-selective%2520partial%2520agonists%252C%2520OS-3-106%2520and%2520WW-III-55%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D347%26spage%3D410%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Weber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durbin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swerdlow, N. R.</span><span> </span><span class="NLM_article-title">Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2009&pages=141-147&author=M.+Weberauthor=W.+L.+Changauthor=J.+P.+Durbinauthor=P.+E.+Parkauthor=R.+R.+Luedtkeauthor=R.+H.+Machauthor=N.+R.+Swerdlow&title=Using+prepulse+inhibition+to+detect+functional+D3+receptor+antagonism%3A+effects+of+WC10+and+WC44"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeber%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DW.%2BL.%26aulast%3DDurbin%26aufirst%3DJ.%2BP.%26aulast%3DPark%26aufirst%3DP.%2BE.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DSwerdlow%26aufirst%3DN.%2BR.%26atitle%3DUsing%2520prepulse%2520inhibition%2520to%2520detect%2520functional%2520D3%2520receptor%2520antagonism%253A%2520effects%2520of%2520WC10%2520and%2520WC44%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2009%26volume%3D93%26spage%3D141%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Collins, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J. H.</span><span> </span><span class="NLM_article-title">Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">310</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1124%2Fjpet.105.085472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=15833897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtVeju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2005&pages=310-319&author=G.+T.+Collinsauthor=J.+M.+Witkinauthor=A.+H.+Newmanauthor=K.+A.+Svenssonauthor=P.+Grundtauthor=J.+Caoauthor=J.+H.+Woods&title=Dopamine+agonist-induced+yawning+in+rats%3A+a+dopamine+D3+receptor-mediated+behavior"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine agonist-induced yawning in rats: A dopamine D3 receptor-mediated behavior</span></div><div class="casAuthors">Collins, Gregory T.; Witkin, Jeffrey M.; Newman, Amy H.; Svensson, Kjell A.; Grundt, Peter; Cao, Jianjing; Woods, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">310-319</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A specific role for the dopamine D3 receptor in behavior has yet to be elucidated.  We now report that dopamine D2/D3 agonists elicit dose-dependent yawning behavior in rats, resulting in an inverted U-shaped dose-response curve.  A series of expts. was directed toward the hypothesis that the induction of yawning is a D3 receptor-mediated effect, whereas the inhibition of the yawning obsd. at higher doses is due to competing D2 receptor activity.  We compared several dopaminergic agonists with a range of in vitro D3 selectivity, including PD-128907, PD-128908, quinelorane, pramipexole, 7-hydroxy-2-dipropylaminotetralin HBr, quinpirole, bromocriptine, and apomorphine, with respect to their ability to induce yawning in rats.  A series of D2/D3 antagonists differing in selectivity for D3 over D2 receptors were evaluated for their ability to alter the effects of the dopamine agonists.  The antagonists L-741626, haloperidol, nafadotride, U 99194, SB-277011A, and PG 01037 were used to det. effects on dose-response curves for D2/D3 agonist-induced yawning.  In addn., the potential contribution of cholinergic and/or serotonergic mechanisms to the yawning response was investigated using a series of pharmacol. tools including scopolamine, mianserin, and the D3-preferring antagonists nafadotride, U 99194, SB-277011A, and PG 01037 to differentially modulate yawning induced by PD-128907, physostigmine, and N-[3-(trifluoromethyl)phenyl]piperazine HCl.  The results of these expts. provide convergent evidence that dopamine D2/D3 agonist-induced yawning is a D3 agonist-mediated behavior, with subsequent inhibition of yawning being driven by competing D2 agonist activity.  Thus, dopamine agonist-induced yawning may represent an in vivo method for selectively identifying D3 and D2 receptor-mediated activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzU9dti9p8tbVg90H21EOLACvtfcHk0lh_vBhw95Toug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtVeju7Y%253D&md5=e772eb780c6646b92523d814a1494e73</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.085472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.085472%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DG.%2BT.%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DWoods%26aufirst%3DJ.%2BH.%26atitle%3DDopamine%2520agonist-induced%2520yawning%2520in%2520rats%253A%2520a%2520dopamine%2520D3%2520receptor-mediated%2520behavior%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D314%26spage%3D310%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Collins, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husbands, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauvignac, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J. H.</span><span> </span><span class="NLM_article-title">Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2007&pages=159-170&author=G.+T.+Collinsauthor=A.+H.+Newmanauthor=P.+Grundtauthor=K.+C.+Riceauthor=S.+M.+Husbandsauthor=C.+Chauvignacauthor=J.+Chenauthor=S.+Wangauthor=J.+H.+Woods&title=Yawning+and+hypothermia+in+rats%3A+effects+of+dopamine+D3+and+D2+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DG.%2BT.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26aulast%3DChauvignac%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWoods%26aufirst%3DJ.%2BH.%26atitle%3DYawning%2520and%2520hypothermia%2520in%2520rats%253A%2520effects%2520of%2520dopamine%2520D3%2520and%2520D2%2520agonists%2520and%2520antagonists%26jtitle%3DPsychopharmacology%26date%3D2007%26volume%3D193%26spage%3D159%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Neisewander, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran-Nguyen, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffey, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyce, J. N.</span><span> </span><span class="NLM_article-title">Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1479</span><span class="NLM_x">–</span> <span class="NLM_lpage">1487</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=1479-1487&author=J.+L.+Neisewanderauthor=R.+A.+Fuchsauthor=L.+T.+Tran-Nguyenauthor=S.+M.+Weberauthor=G.+P.+Coffeyauthor=J.+N.+Joyce&title=Increases+in+dopamine+D3+receptor+binding+in+rats+receiving+a+cocaine+challenge+at+various+time+points+after+cocaine+self-administration%3A+implications+for+cocaine-seeking+behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeisewander%26aufirst%3DJ.%2BL.%26aulast%3DFuchs%26aufirst%3DR.%2BA.%26aulast%3DTran-Nguyen%26aufirst%3DL.%2BT.%26aulast%3DWeber%26aufirst%3DS.%2BM.%26aulast%3DCoffey%26aufirst%3DG.%2BP.%26aulast%3DJoyce%26aufirst%3DJ.%2BN.%26atitle%3DIncreases%2520in%2520dopamine%2520D3%2520receptor%2520binding%2520in%2520rats%2520receiving%2520a%2520cocaine%2520challenge%2520at%2520various%2520time%2520points%2520after%2520cocaine%2520self-administration%253A%2520implications%2520for%2520cocaine-seeking%2520behavior%26jtitle%3DNeuropsychopharmacology%26date%3D2004%26volume%3D29%26spage%3D1479%26epage%3D1487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Huang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hufeisen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Identification of human Ether-a-go-go related gene modulators by three screening platforms in an academic drug-discovery setting</span> <span class="citation_source-journal">Assay Drug Dev. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">742</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=727-742&author=X.+P.+Huangauthor=T.+Manganoauthor=S.+Hufeisenauthor=V.+Setolaauthor=B.+L.+Roth&title=Identification+of+human+Ether-a-go-go+related+gene+modulators+by+three+screening+platforms+in+an+academic+drug-discovery+setting"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DMangano%26aufirst%3DT.%26aulast%3DHufeisen%26aufirst%3DS.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DIdentification%2520of%2520human%2520Ether-a-go-go%2520related%2520gene%2520modulators%2520by%2520three%2520screening%2520platforms%2520in%2520an%2520academic%2520drug-discovery%2520setting%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2010%26volume%3D8%26spage%3D727%26epage%3D742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Keck, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z. X.</span><span> </span><span class="NLM_article-title">Fenobam sulfate inhibits cocaine-taking and cocaine-seeking behavior in rats: implications for addiction treatment in humans</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">229</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=2013&pages=253-265&author=T.+M.+Keckauthor=H.+J.+Yangauthor=G.+H.+Biauthor=Y.+Huangauthor=H.+Y.+Zhangauthor=R.+Srivastavaauthor=E.+L.+Gardnerauthor=A.+H.+Newmanauthor=Z.+X.+Xi&title=Fenobam+sulfate+inhibits+cocaine-taking+and+cocaine-seeking+behavior+in+rats%3A+implications+for+addiction+treatment+in+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DYang%26aufirst%3DH.%2BJ.%26aulast%3DBi%26aufirst%3DG.%2BH.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%2BY.%26aulast%3DSrivastava%26aufirst%3DR.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DXi%26aufirst%3DZ.%2BX.%26atitle%3DFenobam%2520sulfate%2520inhibits%2520cocaine-taking%2520and%2520cocaine-seeking%2520behavior%2520in%2520rats%253A%2520implications%2520for%2520addiction%2520treatment%2520in%2520humans%26jtitle%3DPsychopharmacology%26date%3D2013%26volume%3D229%26spage%3D253%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Keck, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats</span> <span class="citation_source-journal">Addict. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1111%2Fadb.12086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24001208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjt1Slu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=195-209&author=T.+M.+Keckauthor=M.+F.+Zouauthor=G.+H.+Biauthor=H.+Y.+Zhangauthor=X.+F.+Wangauthor=H.+J.+Yangauthor=R.+Srivastavaauthor=E.+L.+Gardnerauthor=Z.+X.+Xiauthor=A.+H.+Newman&title=A+novel+mGluR5+antagonist%2C+MFZ+10-7%2C+inhibits+cocaine-taking+and+cocaine-seeking+behavior+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats</span></div><div class="casAuthors">Keck, Thomas M.; Zou, Mu-Fa; Bi, Guo-Hua; Zhang, Hai-Ying; Wang, Xiao-Fei; Yang, Hong-Ju; Srivastava, Ratika; Gardner, Eliot L.; Xi, Zheng-Xiong; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Addiction Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-209</span>CODEN:
                <span class="NLM_cas:coden">ADBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1369-1600</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Pre-clin. studies suggest that neg. allosteric modulators (NAMs) of the metabotropic glutamate receptor subtype 5 (mGluR5), including 2-methyl-6-(phenylethynyl)pyridine (MPEP), 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) and fenobam are highly effective in attenuating drug-taking and drug-seeking behaviors.  However, both MPEP and MTEP have no translational potential for use in humans because of their off-target effects and short half-lives.  Here, we report that 3-fluoro-5-[(6-methylpyridin-2-yl)ethynyl]benzonitrile (MFZ 10-7), a novel mGluR5 NAM, is more potent and selective than MPEP, MTEP and fenobam in both in vitro binding and functional assays.  Similar to MTEP, i.p. administration of MFZ 10-7 inhibited i.v. cocaine self-administration, cocaine-induced reinstatement of drug-seeking behavior and cocaine-assocd. cue-induced cocaine-seeking behavior in rats.  Although MFZ 10-7 and MTEP lowered the rate of oral sucrose self-administration, they did not alter total sucrose intake.  Further, MFZ 10-7 appeared to be more potent than MTEP in inducing downward shifts in the cocaine dose-response curve, but less effective than MTEP in attenuating sucrose-induced reinstatement of sucrose-seeking behavior.  MFZ 10-7 and MTEP had no effect on basal locomotor behavior.  These findings not only provide addnl. evidence supporting an important role for mGluR5 in cocaine reward and addiction, but also introduce a new tool for both in vitro and in vivo investigations with which to further characterize this role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZjsn6PiPda7Vg90H21EOLACvtfcHk0lgqRbwkymRzWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjt1Slu7w%253D&md5=660cc3bc341aff74ec5c8e89d1ddb23d</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1111%2Fadb.12086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fadb.12086%26sid%3Dliteratum%253Aachs%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DZou%26aufirst%3DM.%2BF.%26aulast%3DBi%26aufirst%3DG.%2BH.%26aulast%3DZhang%26aufirst%3DH.%2BY.%26aulast%3DWang%26aufirst%3DX.%2BF.%26aulast%3DYang%26aufirst%3DH.%2BJ.%26aulast%3DSrivastava%26aufirst%3DR.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26aulast%3DXi%26aufirst%3DZ.%2BX.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DA%2520novel%2520mGluR5%2520antagonist%252C%2520MFZ%252010-7%252C%2520inhibits%2520cocaine-taking%2520and%2520cocaine-seeking%2520behavior%2520in%2520rats%26jtitle%3DAddict.%2520Biol.%26date%3D2014%26volume%3D19%26spage%3D195%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Richardson, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, D. C.</span><span> </span><span class="NLM_article-title">Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2F0165-0270%2895%2900153-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=8794935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaK28Xkt1Olsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1996&pages=1-11&author=N.+R.+Richardsonauthor=D.+C.+Roberts&title=Progressive+ratio+schedules+in+drug+self-administration+studies+in+rats%3A+a+method+to+evaluate+reinforcing+efficacy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy</span></div><div class="casAuthors">Richardson, Nicole R.; Roberts, David C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 71 refs. Drug self-administration studies have recently employed progressive ratio (PR) schedules to examine psychostimulant and opiate reinforcement.  This review addresses the tech., statistical, and theor. issues related to the use of the PR schedule in self-administration studies in rats.  Session parameters adopted for use in in the authors' lab. and the considerations relevant to them are described.  The strengths and weaknesses of the PR schedule are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVG8KHfw02R7Vg90H21EOLACvtfcHk0lj9ZP3Mr8extg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xkt1Olsb4%253D&md5=e60158742a40dd8bf90046e9b56a0a69</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2F0165-0270%2895%2900153-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-0270%252895%252900153-0%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DN.%2BR.%26aulast%3DRoberts%26aufirst%3DD.%2BC.%26atitle%3DProgressive%2520ratio%2520schedules%2520in%2520drug%2520self-administration%2520studies%2520in%2520rats%253A%2520a%2520method%2520to%2520evaluate%2520reinforcing%2520efficacy%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D1996%26volume%3D66%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Arnold, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, D. C.</span><span> </span><span class="NLM_article-title">A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=441-447&author=J.+M.+Arnoldauthor=D.+C.+Roberts&title=A+critique+of+fixed+and+progressive+ratio+schedules+used+to+examine+the+neural+substrates+of+drug+reinforcement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DJ.%2BM.%26aulast%3DRoberts%26aufirst%3DD.%2BC.%26atitle%3DA%2520critique%2520of%2520fixed%2520and%2520progressive%2520ratio%2520schedules%2520used%2520to%2520examine%2520the%2520neural%2520substrates%2520of%2520drug%2520reinforcement%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1997%26volume%3D57%26spage%3D441%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Roberts, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span> </span><span class="NLM_article-title">How to make a rat addicted to cocaine</span> <span class="citation_source-journal">Prog. Neuropsychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1614</span><span class="NLM_x">–</span> <span class="NLM_lpage">1624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.pnpbp.2007.08.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=17888555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BD2snktFKgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2007&pages=1614-1624&author=D.+C.+Robertsauthor=D.+Morganauthor=Y.+Liu&title=How+to+make+a+rat+addicted+to+cocaine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">How to make a rat addicted to cocaine</span></div><div class="casAuthors">Roberts David C S; Morgan Drake; Liu Yu</div><div class="citationInfo"><span class="NLM_cas:title">Progress in neuro-psychopharmacology & biological psychiatry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1614-24</span>
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    </div><div class="casAbstract">Procedures have been developed which provide extremely stable patterns of cocaine self-administration in rats and these have been useful in lesion and drug pretreatment studies aimed at understanding the neurobiology of cocaine reinforcement.  The issue now is whether studying the neurobiology of reinforcement is the same as studying the neurobiology of addiction.  If the goal is to understand a progressive and deteriorating disorder, then the self-administration procedures should model specific aspects of the progressive stages of the addiction process.  Here we review theoretical strategies for modeling the addiction process and present data from a series of experiments from our laboratory showing conditions which produce a progressive change in the motivation to self-administer cocaine in rats.  This phenomenon is revealed by an escalation in breakpoints on a progressive ratio schedule.  The effect, which is robust and persistent, depends on dose and speed of injection.  Interestingly, high drug intake can retard the development of this effect, which we argue indicates that the addiction process has a developmental sequence.  Finally, we suggest that specific parameters (dose, price and availability) can be used to examine the transition from recreational use to binge-like intake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRUN2-8jIzYQG52AMpI4GK2fW6udTcc2eaPWeYgmwJcV7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snktFKgtw%253D%253D&md5=2a277388b2a0ec836ef0ce8e4bc681f7</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2007.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2007.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DD.%2BC.%26aulast%3DMorgan%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DHow%2520to%2520make%2520a%2520rat%2520addicted%2520to%2520cocaine%26jtitle%3DProg.%2520Neuropsychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2007%26volume%3D31%26spage%3D1614%26epage%3D1624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Roane, H. S.</span><span> </span><span class="NLM_article-title">On the applied use of progressive-ratio schedules of reinforcement</span> <span class="citation_source-journal">J. Appl. Behav. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1901%2Fjaba.2008.41-155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=18595280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BD1cvislSmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=155-161&author=H.+S.+Roane&title=On+the+applied+use+of+progressive-ratio+schedules+of+reinforcement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">On the applied use of progressive-ratio schedules of reinforcement</span></div><div class="casAuthors">Roane Henry S</div><div class="citationInfo"><span class="NLM_cas:title">Journal of applied behavior analysis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-61</span>
        ISSN:<span class="NLM_cas:issn">0021-8855</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTiWpqJRewCZpQHPYJuLg8TfW6udTcc2eaPWeYgmwJcV7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvislSmsg%253D%253D&md5=59222e2eeb65da771fcb5b7648a8f562</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1901%2Fjaba.2008.41-155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1901%252Fjaba.2008.41-155%26sid%3Dliteratum%253Aachs%26aulast%3DRoane%26aufirst%3DH.%2BS.%26atitle%3DOn%2520the%2520applied%2520use%2520of%2520progressive-ratio%2520schedules%2520of%2520reinforcement%26jtitle%3DJ.%2520Appl.%2520Behav.%2520Anal.%26date%3D2008%26volume%3D41%26spage%3D155%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Comer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vosburg, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalczyk, W. J.</span><span> </span><span class="NLM_article-title">Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1179</span><span class="NLM_x">–</span> <span class="NLM_lpage">1191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=1179-1191&author=S.+D.+Comerauthor=M.+A.+Sullivanauthor=R.+A.+Whittingtonauthor=S.+K.+Vosburgauthor=W.+J.+Kowalczyk&title=Abuse+liability+of+prescription+opioids+compared+to+heroin+in+morphine-maintained+heroin+abusers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DComer%26aufirst%3DS.%2BD.%26aulast%3DSullivan%26aufirst%3DM.%2BA.%26aulast%3DWhittington%26aufirst%3DR.%2BA.%26aulast%3DVosburg%26aufirst%3DS.%2BK.%26aulast%3DKowalczyk%26aufirst%3DW.%2BJ.%26atitle%3DAbuse%2520liability%2520of%2520prescription%2520opioids%2520compared%2520to%2520heroin%2520in%2520morphine-maintained%2520heroin%2520abusers%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26spage%3D1179%26epage%3D1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Jones, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, S. D.</span><span> </span><span class="NLM_article-title">A review of human drug self-administration procedures</span> <span class="citation_source-journal">Behav. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=384-395&author=J.+D.+Jonesauthor=S.+D.+Comer&title=A+review+of+human+drug+self-administration+procedures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DJ.%2BD.%26aulast%3DComer%26aufirst%3DS.%2BD.%26atitle%3DA%2520review%2520of%2520human%2520drug%2520self-administration%2520procedures%26jtitle%3DBehav.%2520Pharmacol.%26date%3D2013%26volume%3D24%26spage%3D384%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Stoops, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hays, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, C. R.</span><span> </span><span class="NLM_article-title">Intranasal cocaine functions as reinforcer on a progressive ratio schedule in humans</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">644</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.ejphar.2010.06.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=20638380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVejs7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=644&publication_year=2010&pages=101-105&author=W.+W.+Stoopsauthor=J.+A.+Lileauthor=P.+E.+Glaserauthor=L.+R.+Haysauthor=C.+R.+Rush&title=Intranasal+cocaine+functions+as+reinforcer+on+a+progressive+ratio+schedule+in+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Intranasal cocaine functions as reinforcer on a progressive ratio schedule in humans</span></div><div class="casAuthors">Stoops, William W.; Lile, Joshua A.; Glaser, Paul E. A.; Hays, Lon R.; Rush, Craig R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">644</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">101-105</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cocaine dependence continues to be a worldwide public health concern.  Although the majority of individuals reporting cocaine use do so via the intranasal route, relatively few lab. expts. have examd. the reinforcing effects of cocaine administered intranasally.  The purpose of this expt. was to measure the reinforcing effects of intranasal cocaine using a progressive ratio schedule in which eight cocaine-using subjects chose between doses of cocaine (4 [placebo], 15, 30 and 45 mg) and an alternative reinforcer (0.25).  During each session, subjects first sampled the dose of cocaine available that day and then made six choices between that dose and money, which were available on concurrent progressive ratio schedules of responding.  Break points for active cocaine doses were higher than those for placebo but no statistically significant active vs. placebo dose effects were obsd. on subject-rated or physiol. measures.  These data demonstrate that intranasal cocaine functions as a reinforcer under a progressive ratio schedule in humans.  Future research should test higher cocaine doses and larger values of the alternative reinforcer.  These procedures may be useful for examg. the influence of putative pharmacol. and behavioral interventions on intranasal cocaine self-administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxjRMUo-XoG7Vg90H21EOLACvtfcHk0liI6L6KJPvvpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVejs7jJ&md5=21ab997b2f5267a094990ef341b01a6a</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2010.06.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2010.06.055%26sid%3Dliteratum%253Aachs%26aulast%3DStoops%26aufirst%3DW.%2BW.%26aulast%3DLile%26aufirst%3DJ.%2BA.%26aulast%3DGlaser%26aufirst%3DP.%2BE.%26aulast%3DHays%26aufirst%3DL.%2BR.%26aulast%3DRush%26aufirst%3DC.%2BR.%26atitle%3DIntranasal%2520cocaine%2520functions%2520as%2520reinforcer%2520on%2520a%2520progressive%2520ratio%2520schedule%2520in%2520humans%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D644%26spage%3D101%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Epstein, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preston, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaham, Y.</span><span> </span><span class="NLM_article-title">Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">189</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2006&pages=1-16&author=D.+H.+Epsteinauthor=K.+L.+Prestonauthor=J.+Stewartauthor=Y.+Shaham&title=Toward+a+model+of+drug+relapse%3A+an+assessment+of+the+validity+of+the+reinstatement+procedure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEpstein%26aufirst%3DD.%2BH.%26aulast%3DPreston%26aufirst%3DK.%2BL.%26aulast%3DStewart%26aufirst%3DJ.%26aulast%3DShaham%26aufirst%3DY.%26atitle%3DToward%2520a%2520model%2520of%2520drug%2520relapse%253A%2520an%2520assessment%2520of%2520the%2520validity%2520of%2520the%2520reinstatement%2520procedure%26jtitle%3DPsychopharmacology%26date%3D2006%26volume%3D189%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Shaham, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalev, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Wit, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, J.</span><span> </span><span class="NLM_article-title">The reinstatement model of drug relapse: history, methodology and major findings</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2003&pages=3-20&author=Y.+Shahamauthor=U.+Shalevauthor=L.+Luauthor=H.+De+Witauthor=J.+Stewart&title=The+reinstatement+model+of+drug+relapse%3A+history%2C+methodology+and+major+findings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaham%26aufirst%3DY.%26aulast%3DShalev%26aufirst%3DU.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DDe%2BWit%26aufirst%3DH.%26aulast%3DStewart%26aufirst%3DJ.%26atitle%3DThe%2520reinstatement%2520model%2520of%2520drug%2520relapse%253A%2520history%252C%2520methodology%2520and%2520major%2520findings%26jtitle%3DPsychopharmacology%26date%3D2003%26volume%3D168%26spage%3D3%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Bossert, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchant, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calu, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaham, Y.</span><span> </span><span class="NLM_article-title">The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">229</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=2013&pages=453-476&author=J.+M.+Bossertauthor=N.+J.+Marchantauthor=D.+J.+Caluauthor=Y.+Shaham&title=The+reinstatement+model+of+drug+relapse%3A+recent+neurobiological+findings%2C+emerging+research+topics%2C+and+translational+research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBossert%26aufirst%3DJ.%2BM.%26aulast%3DMarchant%26aufirst%3DN.%2BJ.%26aulast%3DCalu%26aufirst%3DD.%2BJ.%26aulast%3DShaham%26aufirst%3DY.%26atitle%3DThe%2520reinstatement%2520model%2520of%2520drug%2520relapse%253A%2520recent%2520neurobiological%2520findings%252C%2520emerging%2520research%2520topics%252C%2520and%2520translational%2520research%26jtitle%3DPsychopharmacology%26date%3D2013%26volume%3D229%26spage%3D453%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, S. T.</span><span> </span><span class="NLM_article-title">The validity of the reinstatement model of craving and relapse to drug use</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2003&pages=21-30&author=J.+L.+Katzauthor=S.+T.+Higgins&title=The+validity+of+the+reinstatement+model+of+craving+and+relapse+to+drug+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DHiggins%26aufirst%3DS.%2BT.%26atitle%3DThe%2520validity%2520of%2520the%2520reinstatement%2520model%2520of%2520craving%2520and%2520relapse%2520to%2520drug%2520use%26jtitle%3DPsychopharmacology%26date%3D2003%26volume%3D168%26spage%3D21%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Koob, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenneth Lloyd, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, B. J.</span><span> </span><span class="NLM_article-title">Development of pharmacotherapies for drug addiction: a Rosetta stone approach</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="NLM_x">–</span> <span class="NLM_lpage">515</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=500-515&author=G.+F.+Koobauthor=G.+Kenneth+Lloydauthor=B.+J.+Mason&title=Development+of+pharmacotherapies+for+drug+addiction%3A+a+Rosetta+stone+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoob%26aufirst%3DG.%2BF.%26aulast%3DKenneth%2BLloyd%26aufirst%3DG.%26aulast%3DMason%26aufirst%3DB.%2BJ.%26atitle%3DDevelopment%2520of%2520pharmacotherapies%2520for%2520drug%2520addiction%253A%2520a%2520Rosetta%2520stone%2520approach%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D500%26epage%3D515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Woolverton, W. L.; Nader, M. A.</span><span> </span><span class="NLM_article-title">Experimental evaluation of the reinforcing effects of drugs</span>. In  <span class="citation_source-book">Testing and Evaluation of Drugs of Abuse</span>; <span class="NLM_contrib-group">Adler, M. W.; Cowan, A.</span>, Eds.; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">Oxford, England</span>,<span class="NLM_x"> </span><span class="NLM_year">1990</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&pages=165-192&author=W.+L.+Woolverton&author=M.+A.+Naderauthor=M.+W.+Adler&author=A.+Cowan&title=Testing+and+Evaluation+of+Drugs+of+Abuse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWoolverton%26aufirst%3DW.%2BL.%26atitle%3DExperimental%2520evaluation%2520of%2520the%2520reinforcing%2520effects%2520of%2520drugs%26btitle%3DTesting%2520and%2520Evaluation%2520of%2520Drugs%2520of%2520Abuse%26aulast%3DAdler%26aufirst%3DM.%2BW.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D1990%26spage%3D165%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Lile, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birmingham, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolverton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">The reinforcing efficacy of the dopamine reuptake inhibitor 2beta-propanoyl-3beta-(4-tolyl)-tropane (PTT) as measured by a progressive-ratio schedule and a choice procedure in rhesus monkeys</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">640</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1124%2Fjpet.102.039180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=12388646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD38XotlCnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=640-648&author=J.+A.+Lileauthor=D.+Morganauthor=A.+M.+Birminghamauthor=Z.+Wangauthor=W.+L.+Woolvertonauthor=H.+M.+Daviesauthor=M.+A.+Nader&title=The+reinforcing+efficacy+of+the+dopamine+reuptake+inhibitor+2beta-propanoyl-3beta-%284-tolyl%29-tropane+%28PTT%29+as+measured+by+a+progressive-ratio+schedule+and+a+choice+procedure+in+rhesus+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">The reinforcing efficacy of the dopamine reuptake inhibitor 2β-propanoyl-3β-(4-tolyl)-tropane (PTT) as measured by a progressive-ratio schedule and a choice procedure in rhesus monkeys</span></div><div class="casAuthors">Lile, Joshua A.; Morgan, Drake; Birmingham, Anne M.; Wang, Zhixia; Woolverton, William L.; Davies, Huw M. L.; Nader, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">640-648</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The present series of expts. was undertaken to investigate the variables that influence the reinforcing efficacy of psychostimulants.  The time of onset for dopamine transporter (DAT) occupancy of the long-acting, high-affinity DAT blocker 2β-propanoyl-3β-(4-tolyl)-tropane (PTT) was measured using an ex vivo binding assay in rodents and was detd. to be significantly longer than for cocaine (30 min vs. 2 min).  To assess the reinforcing efficacy of PTT relative to cocaine, a discrete-trials drug-drug choice procedure (n = 3) and a progressive-ratio (PR) schedule (n = 4) were used in rhesus monkeys.  Cocaine (0.003-0.56 mg/kg/injection) and PTT (0.003 - 0.03 mg/kg/injection) maintained responding greater than saline under the PR schedule.  Maximal breaking points were significantly higher for cocaine compared with PTT.  A sep. group of monkeys prepd. with double-lumen catheters was allowed to choose between cocaine (saline and 0.03 - 0.3 mg/kg/injection) and PTT (saline, and 0.01 and 0.03 mg/kg/injection).  Under these conditions, PTT was not preferred over saline.  When saline or 0.01 mg/kg/injection PTT was available as alternatives to cocaine, the highest dose of cocaine maintained greater than 80% choice.  When 0.03 mg/kg/injection PTT was the alternative to cocaine, cocaine choice declined to approx. 50%, and total cocaine intake was decreased by ∼70% at the highest cocaine dose.  These results suggest that the reinforcing efficacy of PTT is less than cocaine in nonhuman primates.  Data from studies with PTT indicate that slow-onset, long-acting DAT inhibitors can decrease cocaine self-administration while not functioning robustly as reinforcers, and support the further investigation of these drugs as treatment for cocaine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz98P3Fox5TrVg90H21EOLACvtfcHk0lgbhQ_OTX5n6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotlCnsr8%253D&md5=08f152ed0aa6c2973cf1a0cab12a9a2e</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.039180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.039180%26sid%3Dliteratum%253Aachs%26aulast%3DLile%26aufirst%3DJ.%2BA.%26aulast%3DMorgan%26aufirst%3DD.%26aulast%3DBirmingham%26aufirst%3DA.%2BM.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWoolverton%26aufirst%3DW.%2BL.%26aulast%3DDavies%26aufirst%3DH.%2BM.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DThe%2520reinforcing%2520efficacy%2520of%2520the%2520dopamine%2520reuptake%2520inhibitor%25202beta-propanoyl-3beta-%25284-tolyl%2529-tropane%2520%2528PTT%2529%2520as%2520measured%2520by%2520a%2520progressive-ratio%2520schedule%2520and%2520a%2520choice%2520procedure%2520in%2520rhesus%2520monkeys%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D640%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Woolverton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balster, R. L.</span><span> </span><span class="NLM_article-title">Effects of antipsychotic compounds in rhesus monkeys given a choice between cocaine and food</span> <span class="citation_source-journal">Drug Alcohol Depend.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2F0376-8716%2881%2990088-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=7297414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaL3MXmtFGisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1981&pages=69-78&author=W.+L.+Woolvertonauthor=R.+L.+Balster&title=Effects+of+antipsychotic+compounds+in+rhesus+monkeys+given+a+choice+between+cocaine+and+food"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of antipsychotic compounds in rhesus monkeys given a choice between cocaine and food</span></div><div class="casAuthors">Woolverton, William L.; Balster, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-78</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    </div><div class="casAbstract">Rhesus monkeys were trained in a preference procedure to choose between i.v. injections of cocaine  [50-36-2] or food presentation.  Frequency of cocaine choice increased as unit dose of cocaine was increased.  Continuous infusions of low or intermediate doses of chlorpromazine (CPZ)  [50-53-3] or haloperidol (H)  [52-86-8] either did not affect or increased the frequency of cocaine choice.  Higher doses of CPZ or H completely suppressed responding for both reinforcers.  Although there appears to be a mutual antagonism of some of the effects of cocaine and these antipsychotic compds., the results of the present expt. fail to support the hypothesis that the reinforcing effects of cocaine can be antagonized with CPZ or H.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnEw82QKhCZ7Vg90H21EOLACvtfcHk0lgbhQ_OTX5n6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXmtFGisL0%253D&md5=4297ae04eb320bfce8ad634372f5da34</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1016%2F0376-8716%2881%2990088-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0376-8716%252881%252990088-0%26sid%3Dliteratum%253Aachs%26aulast%3DWoolverton%26aufirst%3DW.%2BL.%26aulast%3DBalster%26aufirst%3DR.%2BL.%26atitle%3DEffects%2520of%2520antipsychotic%2520compounds%2520in%2520rhesus%2520monkeys%2520given%2520a%2520choice%2520between%2520cocaine%2520and%2520food%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D1981%26volume%3D8%26spage%3D69%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Negus, S. S.</span><span> </span><span class="NLM_article-title">Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with <i>d</i>-amphetamine and flupenthixol</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">919</span><span class="NLM_x">–</span> <span class="NLM_lpage">931</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=919-931&author=S.+S.+Negus&title=Rapid+assessment+of+choice+between+cocaine+and+food+in+rhesus+monkeys%3A+effects+of+environmental+manipulations+and+treatment+with+d-amphetamine+and+flupenthixol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNegus%26aufirst%3DS.%2BS.%26atitle%3DRapid%2520assessment%2520of%2520choice%2520between%2520cocaine%2520and%2520food%2520in%2520rhesus%2520monkeys%253A%2520effects%2520of%2520environmental%2520manipulations%2520and%2520treatment%2520with%2520d-amphetamine%2520and%2520flupenthixol%26jtitle%3DNeuropsychopharmacology%26date%3D2003%26volume%3D28%26spage%3D919%26epage%3D931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Levant, B.</span><span> </span><span class="NLM_article-title">Differential distribution of D3 dopamine receptors in the brains of several mammalian species</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">800</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2FS0006-8993%2898%2900529-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=9685676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADyaK1cXks1KrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=800&publication_year=1998&pages=269-274&author=B.+Levant&title=Differential+distribution+of+D3+dopamine+receptors+in+the+brains+of+several+mammalian+species"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Differential distribution of D3 dopamine receptors in the brains of several mammalian species</span></div><div class="casAuthors">Levant, Beth</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">800</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-274</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The D3 dopamine receptor has been proposed as a potential target for the treatment of schizophrenia and drug abuse.  This study compares the distribution of D3 sites in mouse, rat, guinea pig, and rabbit brain, and dog and human cerebellum using quant. autoradiog. with the putatively selective D3 receptor radioligand [3H]PD 128907.  In the mouse, rat, guinea pig, and rabbit, specific [3H]PD 128907 binding was heterogeneously distributed with highest densities obsd. in the islands of Calleja, followed by the nucleus accumbens.  Moderate densities of [3H]PD 128907 binding were obsd. in the anteroventral and dorsomedial caudate nucleus.  Dense [3H]PD 128907-labeled sites were obsd. in the dorsal thalamus, posterior mammillary nucleus, and dorsomedial interpeduncular nucleus of the rabbit that were not detected in the other species studied.  Moderately dense [3H]PD 128907 binding was also obsd. in the mol. layer of cerebellar lobule X of the rat but not in the mouse, guinea pig, rabbit, dog, or human.  These observations indicate significant inter-species differences in the distribution of D3 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf6KxmvddebLVg90H21EOLACvtfcHk0ljFR9_o2QDuIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXks1KrtLs%253D&md5=4a37b801934dd04773d416e9dd63545e</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2898%2900529-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252898%252900529-0%26sid%3Dliteratum%253Aachs%26aulast%3DLevant%26aufirst%3DB.%26atitle%3DDifferential%2520distribution%2520of%2520D3%2520dopamine%2520receptors%2520in%2520the%2520brains%2520of%2520several%2520mammalian%2520species%26jtitle%3DBrain%2520Res.%26date%3D1998%26volume%3D800%26spage%3D269%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derdeyn, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintun, M. A.</span><span> </span><span class="NLM_article-title">Endogenous dopamine (DA) competes with the binding of a radiolabeled D(3) receptor partial agonist in vivo: a positron emission tomography study</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">724</span><span class="NLM_x">–</span> <span class="NLM_lpage">732</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2011&pages=724-732&author=R.+H.+Machauthor=Z.+Tuauthor=J.+Xuauthor=S.+Liauthor=L.+A.+Jonesauthor=M.+Taylorauthor=R.+R.+Luedtkeauthor=C.+P.+Derdeynauthor=J.+S.+Perlmutterauthor=M.+A.+Mintun&title=Endogenous+dopamine+%28DA%29+competes+with+the+binding+of+a+radiolabeled+D%283%29+receptor+partial+agonist+in+vivo%3A+a+positron+emission+tomography+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DL.%2BA.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DDerdeyn%26aufirst%3DC.%2BP.%26aulast%3DPerlmutter%26aufirst%3DJ.%2BS.%26aulast%3DMintun%26aufirst%3DM.%2BA.%26atitle%3DEndogenous%2520dopamine%2520%2528DA%2529%2520competes%2520with%2520the%2520binding%2520of%2520a%2520radiolabeled%2520D%25283%2529%2520receptor%2520partial%2520agonist%2520in%2520vivo%253A%2520a%2520positron%2520emission%2520tomography%2520study%26jtitle%3DSynapse%26date%3D2011%26volume%3D65%26spage%3D724%26epage%3D732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Di Ciano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underwood, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everitt, B. J.</span><span> </span><span class="NLM_article-title">Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=329-338&author=P.+Di+Cianoauthor=R.+J.+Underwoodauthor=J.+J.+Haganauthor=B.+J.+Everitt&title=Attenuation+of+cue-controlled+cocaine-seeking+by+a+selective+D3+dopamine+receptor+antagonist+SB-277011-A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BCiano%26aufirst%3DP.%26aulast%3DUnderwood%26aufirst%3DR.%2BJ.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DEveritt%26aufirst%3DB.%2BJ.%26atitle%3DAttenuation%2520of%2520cue-controlled%2520cocaine-seeking%2520by%2520a%2520selective%2520D3%2520dopamine%2520receptor%2520antagonist%2520SB-277011-A%26jtitle%3DNeuropsychopharmacology%26date%3D2003%26volume%3D28%26spage%3D329%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Xi, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidbreder, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span> </span><span class="NLM_article-title">Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3427</span><span class="NLM_x">–</span> <span class="NLM_lpage">3438</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1111%2Fj.1460-9568.2005.04159.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=16026480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BD2MzmvFKgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2005&pages=3427-3438&author=Z.+X.+Xiauthor=J.+G.+Gilbertauthor=A.+C.+Pakauthor=C.+R.+Ashbyauthor=C.+A.+Heidbrederauthor=E.+L.+Gardner&title=Selective+dopamine+D3+receptor+antagonism+by+SB-277011A+attenuates+cocaine+reinforcement+as+assessed+by+progressive-ratio+and+variable-cost-variable-payoff+fixed-ratio+cocaine+self-administration+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats</span></div><div class="casAuthors">Xi Zheng-Xiong; Gilbert Jeremy G; Pak Arlene C; Ashby Charles R Jr; Heidbreder Christian A; Gardner Eliot L</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3427-38</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">In rats, acute administration of SB-277011A, a highly selective dopamine (DA) D(3) receptor antagonist, blocks cocaine-enhanced brain stimulation reward, cocaine-seeking behaviour and reinstatement of cocaine-seeking behaviour.  Here, we investigated whether SB-277011A attenuates cocaine reinforcement as assessed by cocaine self-administration under variable-cost-variable-payoff fixed-ratio (FR) and progressive-ratio (PR) reinforcement schedules.  Acute i.p. administration of SB-277011A (3-24 mg/kg) did not significantly alter cocaine (0.75 mg/kg/infusion) self-administration reinforced under FR1 (one lever press for one cocaine infusion) conditions.  However, acute administration of SB-277011A (24 mg/kg, i.p.) progressively attenuated cocaine self-administration when: (a) the unit dose of self-administered cocaine was lowered from 0.75 to 0.125-0.5 mg/kg, and (b) the work demand for cocaine reinforcement was increased from FR1 to FR10.  Under PR (increasing number of lever presses for each successive cocaine infusion) cocaine reinforcement, acute administration of SB-277011A (6-24 mg/kg i.p.) lowered the PR break point for cocaine self-administration in a dose-dependent manner.  The reduction in the cocaine (0.25-1.0 mg/kg) dose-response break-point curve produced by 24 mg/kg SB-277011A is consistent with a reduction in cocaine's reinforcing efficacy.  When substituted for cocaine, SB-277011A alone did not sustain self-administration behaviour.  In contrast with the mixed DA D(2)/D(3) receptor antagonist haloperidol (1 mg/kg), SB-277011A (3, 12 or 24 mg/kg) failed to impede locomotor activity, failed to impair rearing behaviour, failed to produce catalepsy and failed to impair rotarod performance.  These results show that SB-277011A significantly inhibits acute cocaine-induced reinforcement except at high cocaine doses and low work requirement for cocaine.  If these results extrapolate to humans, SB-277011A or similar selective DA D(3) receptor antagonists may be useful in the treatment of cocaine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSGuXqkPgxMy252AMpI4GK2fW6udTcc2eYwwP8XXpFi0Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzmvFKgtw%253D%253D&md5=5cd50cb9043a38f7739e04f1996af73e</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.2005.04159.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.2005.04159.x%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DZ.%2BX.%26aulast%3DGilbert%26aufirst%3DJ.%2BG.%26aulast%3DPak%26aufirst%3DA.%2BC.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DHeidbreder%26aufirst%3DC.%2BA.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26atitle%3DSelective%2520dopamine%2520D3%2520receptor%2520antagonism%2520by%2520SB-277011A%2520attenuates%2520cocaine%2520reinforcement%2520as%2520assessed%2520by%2520progressive-ratio%2520and%2520variable-cost-variable-payoff%2520fixed-ratio%2520cocaine%2520self-administration%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2005%26volume%3D21%26spage%3D3427%26epage%3D3438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Gyertyan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laszlovszky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gemesi, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasztor, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Csongor, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domany, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tihanyi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szombathelyi, Z.</span><span> </span><span class="NLM_article-title">Effects of RGH-237 [<i>N</i>-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D(3) receptor partial agonist in animal models of cocaine abuse</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">1268</span><span class="NLM_x">–</span> <span class="NLM_lpage">1278</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1124%2Fjpet.106.107920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=17170312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1Wgu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=1268-1278&author=I.+Gyertyanauthor=B.+Kissauthor=K.+Galauthor=I.+Laszlovszkyauthor=A.+Horvathauthor=L.+I.+Gemesiauthor=K.+Saghyauthor=G.+Pasztorauthor=M.+Zajerauthor=M.+Kapasauthor=E.+A.+Csongorauthor=G.+Domanyauthor=K.+Tihanyiauthor=Z.+Szombathelyi&title=Effects+of+RGH-237+%5BN-%7B4-%5B4-%283-aminocarbonyl-phenyl%29-piperazin-1-yl%5D-butyl%7D-4-bromo-benzamide%5D%2C+an+orally+active%2C+selective+dopamine+D%283%29+receptor+partial+agonist+in+animal+models+of+cocaine+abuse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D3 receptor partial agonist in animal models of cocaine abuse</span></div><div class="casAuthors">Gyertyan, Istvan; Kiss, Bela; Gal, Krisztina; Laszlovszky, Istvan; Horvath, Attila; Gemesi, Larisza I.; Saghy, Katalin; Pasztor, Gabriella; Zajer, Maria; Kapas, Margit; Csongor, Eva Agai; Domany, Gyorgy; Tihanyi, Karoly; Szombathelyi, Zsolt</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1268-1278</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dopamine D3 receptor partial agonism has been suggested as a potential therapeutic intervention in cocaine addiction.  RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide] was identified as a novel selective dopamine D3 receptor partial agonist and used for testing this hypothesis in animal models.  The compd. showed nanomolar affinity to human (Ki = 6.7 nM) and rat (Ki = 1.6 nM) D3 receptors with an intrinsic activity of approx. 50%.  It possessed several hundredfold selectivity over the D2 receptor.  The mol. bound with moderate (100-250 nM) affinity to 5-hydroxytryptamine 1A (5-HT1A) and nonselectively labeled opiate receptors.  RGH-237 proved to be practically inactive on more than 40 other targets, including monoaminergic, cholinergic, GABAergic, and glutamatergic receptors.  In rats orally administered RGH-237 was well and rapidly absorbed yielding 41% oral bioavailability.  At its pharmacol. active dose (10 mg/kg p.o.), the brain concn. of RGH-237 reached 110 ng/g.  Its blood and brain levels were sustained for 3 h.  RGH-237 at the oral dose of 10 mg/kg moderately but significantly inhibited the acquisition of cocaine-induced place preference, although by itself, it had no place-conditioning effect.  The compd. did not affect fixed ratio 1 cocaine self-administration.  In a reinstatement paradigm of cocaine self-administration, the compd. potently and dose-dependently blocked the cue-induced cocaine-seeking behavior of rats at 10 and 30 mg/kg oral doses.  RGH-237 did not affect seeking activity for natural rewards, such as sucrose and water.  It did not exert notable effect on spontaneous motor activity of rats.  Our results demonstrate that selective D3 partial agonists may be an effective therapeutic means in the treatment of cocaine abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfWOX5gEQ1DbVg90H21EOLACvtfcHk0lgQ48pnQGcqgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1Wgu74%253D&md5=a670d6e9d14b24332cc31f8a36708cd0</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.107920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.107920%26sid%3Dliteratum%253Aachs%26aulast%3DGyertyan%26aufirst%3DI.%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DGal%26aufirst%3DK.%26aulast%3DLaszlovszky%26aufirst%3DI.%26aulast%3DHorvath%26aufirst%3DA.%26aulast%3DGemesi%26aufirst%3DL.%2BI.%26aulast%3DSaghy%26aufirst%3DK.%26aulast%3DPasztor%26aufirst%3DG.%26aulast%3DZajer%26aufirst%3DM.%26aulast%3DKapas%26aufirst%3DM.%26aulast%3DCsongor%26aufirst%3DE.%2BA.%26aulast%3DDomany%26aufirst%3DG.%26aulast%3DTihanyi%26aufirst%3DK.%26aulast%3DSzombathelyi%26aufirst%3DZ.%26atitle%3DEffects%2520of%2520RGH-237%2520%255BN-%257B4-%255B4-%25283-aminocarbonyl-phenyl%2529-piperazin-1-yl%255D-butyl%257D-4-bromo-benzamide%255D%252C%2520an%2520orally%2520active%252C%2520selective%2520dopamine%2520D%25283%2529%2520receptor%2520partial%2520agonist%2520in%2520animal%2520models%2520of%2520cocaine%2520abuse%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D1268%26epage%3D1278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Di Ciano, P.</span><span> </span><span class="NLM_article-title">Drug seeking under a second-order schedule of reinforcement depends on dopamine D3 receptors in the basolateral amygdala</span> <span class="citation_source-journal">Behav. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2008&pages=129-139&author=P.+Di+Ciano&title=Drug+seeking+under+a+second-order+schedule+of+reinforcement+depends+on+dopamine+D3+receptors+in+the+basolateral+amygdala"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BCiano%26aufirst%3DP.%26atitle%3DDrug%2520seeking%2520under%2520a%2520second-order%2520schedule%2520of%2520reinforcement%2520depends%2520on%2520dopamine%2520D3%2520receptors%2520in%2520the%2520basolateral%2520amygdala%26jtitle%3DBehav.%2520Neurosci.%26date%3D2008%26volume%3D122%26spage%3D129%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Vorel, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span> </span><span class="NLM_article-title">Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">9595</span><span class="NLM_x">–</span> <span class="NLM_lpage">9603</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1523%2FJNEUROSCI.22-21-09595.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=12417684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVGmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=9595-9603&author=S.+R.+Vorelauthor=C.+R.+Ashbyauthor=M.+Paulauthor=X.+Liuauthor=R.+Hayesauthor=J.+J.+Haganauthor=D.+N.+Middlemissauthor=G.+Stempauthor=E.+L.+Gardner&title=Dopamine+D3+receptor+antagonism+inhibits+cocaine-seeking+and+cocaine-enhanced+brain+reward+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats</span></div><div class="casAuthors">Vorel, Stanislav R.; Ashby, Charles R., Jr.; Paul, Mousumi; Liu, Xinhe; Hayes, Robert; Hagan, Jim J.; Middlemiss, Derek N.; Stemp, Geoffrey; Gardner, Eliot L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9595-9603</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The dopamine D3 receptor is preferentially localized to the mesocorticolimbic dopaminergic system and has been hypothesized to play a role in cocaine addiction.  To study the involvement of the D3 receptor in brain mechanisms and behaviors commonly assumed to be involved in the addicting properties of cocaine, the potent and selective D3 receptor antagonist SB-277011-A was administered to lab. rats, and the following measures were assessed: (1) cocaine-enhanced elec. brain-stimulation reward, (2) cocaine-induced conditioned place preference, and (3) cocaine-triggered reinstatement of cocaine seeking behavior.  Systemic injections of SB-277011-A were found to (1) block enhancement of elec. brain stimulation reward by cocaine, (2) dose-dependently attenuate cocaine-induced conditioned place preference, and (3) dose-dependently attenuate cocaine-triggered reinstatement of cocaine seeking behavior.  Thus, D3 receptor blockade attenuates both the rewarding effects of cocaine and cocaine-induced drug-seeking behavior.  These data suggest an important role for D3 receptors in mediating the addictive properties of cocaine and suggest that blockade of dopamine D3 receptors may constitute a new and useful target for prospective pharmacotherapies for cocaine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbTQ6RyNaVH7Vg90H21EOLACvtfcHk0lgQ48pnQGcqgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVGmtr8%253D&md5=fafad91654fc4c174b1f0fe431b206cc</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.22-21-09595.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.22-21-09595.2002%26sid%3Dliteratum%253Aachs%26aulast%3DVorel%26aufirst%3DS.%2BR.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DPaul%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DHayes%26aufirst%3DR.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26atitle%3DDopamine%2520D3%2520receptor%2520antagonism%2520inhibits%2520cocaine-seeking%2520and%2520cocaine-enhanced%2520brain%2520reward%2520in%2520rats%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D9595%26epage%3D9603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Czoty, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">Effects of repeated treatment with the dopamine D2/D3 receptor partial agonist aripiprazole on striatal D2/D3 receptor availability in monkeys</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=2014&pages=613-619&author=P.+W.+Czotyauthor=H.+D.+Gageauthor=P.+K.+Gargauthor=S.+Gargauthor=M.+A.+Nader&title=Effects+of+repeated+treatment+with+the+dopamine+D2%2FD3+receptor+partial+agonist+aripiprazole+on+striatal+D2%2FD3+receptor+availability+in+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCzoty%26aufirst%3DP.%2BW.%26aulast%3DGage%26aufirst%3DH.%2BD.%26aulast%3DGarg%26aufirst%3DP.%2BK.%26aulast%3DGarg%26aufirst%3DS.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DEffects%2520of%2520repeated%2520treatment%2520with%2520the%2520dopamine%2520D2%252FD3%2520receptor%2520partial%2520agonist%2520aripiprazole%2520on%2520striatal%2520D2%252FD3%2520receptor%2520availability%2520in%2520monkeys%26jtitle%3DPsychopharmacology%26date%3D2014%26volume%3D231%26spage%3D613%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Garcia-Ladona, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B. F.</span><span> </span><span class="NLM_article-title">BP 897, a selective dopamine D3 receptor ligand with therapeutic potential for the treatment of cocaine-addiction</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=141-158&author=F.+J.+Garcia-Ladonaauthor=B.+F.+Cox&title=BP+897%2C+a+selective+dopamine+D3+receptor+ligand+with+therapeutic+potential+for+the+treatment+of+cocaine-addiction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Ladona%26aufirst%3DF.%2BJ.%26aulast%3DCox%26aufirst%3DB.%2BF.%26atitle%3DBP%2520897%252C%2520a%2520selective%2520dopamine%2520D3%2520receptor%2520ligand%2520with%2520therapeutic%2520potential%2520for%2520the%2520treatment%2520of%2520cocaine-addiction%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2003%26volume%3D9%26spage%3D141%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Preti, A.</span><span> </span><span class="NLM_article-title">New developments in the pharmacotherapy of cocaine abuse</span> <span class="citation_source-journal">Addict. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1111%2Fj.1369-1600.2007.00061.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=17508985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOqur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=133-151&author=A.+Preti&title=New+developments+in+the+pharmacotherapy+of+cocaine+abuse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">New developments in the pharmacotherapy of cocaine abuse</span></div><div class="casAuthors">Preti, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Addiction Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-151</span>CODEN:
                <span class="NLM_cas:coden">ADBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1355-6215</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite huge advances in the neuroscience of substance abuse and dependence in the past 20 years, no approved pharmacol. treatment exists for cocaine abuse.  The available drugs for the treatment of cocaine abuse are poorly effective, hence the need for new compds. to be screened and tested for efficacy: targeting symptoms might improve the effectiveness of the treatment of cocaine abuse and dependence.  On the basis of the known neurochem. of cocaine, some target compds. have been studied: among others.  BP-897, a D3 partial agonist: vanoxerine, a highly selective inhibitor of dopamine uptake: aripiprazole, a partial mixed-action agonist approved for the treatment of schizophrenia.  Recently modafinil, approved for the treatment of narcolepsy, proved effective in favoring cocaine abstinence in cocaine-abusing people.  Some placebo-controlled studies also reported the effectiveness of topiramate, a licensed antiepileptic drug, and of tiagabine, a gamma-aminobutyric acid (GABA) re-uptake inhibitor also approved as an anticonvulsant: both compds. increased cocaine abstinence with no serious adverse events.  Promising results came from two more compds. acting on the GABA circuits, baclofen and valproic acid.  Finally disulfiram, prescribed with active psychosocial therapy, was found to favor higher retention rates and longer abstinence periods from both alc. and cocaine in polydrug-abusing patients.  An alternative approach rests on the use of vaccines, to date in the exptl. stage still.  Psychosocial treatments are a useful companion in the pharmacotherapy of cocaine abuse, with group therapy and contingency management therapies improving motivation and social functioning, particularly in patients abusing alc. as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBg9wU-hybkLVg90H21EOLACvtfcHk0lgCBIesW3W0MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOqur3N&md5=93b4725efc304ddaee04534fa1ecfa8c</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1111%2Fj.1369-1600.2007.00061.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1369-1600.2007.00061.x%26sid%3Dliteratum%253Aachs%26aulast%3DPreti%26aufirst%3DA.%26atitle%3DNew%2520developments%2520in%2520the%2520pharmacotherapy%2520of%2520cocaine%2520abuse%26jtitle%3DAddict.%2520Biol.%26date%3D2007%26volume%3D12%26spage%3D133%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Pierce, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderschuren, L. J.</span><span> </span><span class="NLM_article-title">Rational development of addiction pharmacotherapies: successes, failures, and prospects</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">a012880</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=a012880&author=R.+C.+Pierceauthor=C.+P.+O%E2%80%99Brienauthor=P.+J.+Kennyauthor=L.+J.+Vanderschuren&title=Rational+development+of+addiction+pharmacotherapies%3A+successes%2C+failures%2C+and+prospects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DR.%2BC.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DC.%2BP.%26aulast%3DKenny%26aufirst%3DP.%2BJ.%26aulast%3DVanderschuren%26aufirst%3DL.%2BJ.%26atitle%3DRational%2520development%2520of%2520addiction%2520pharmacotherapies%253A%2520successes%252C%2520failures%252C%2520and%2520prospects%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2012%26volume%3D2%26spage%3Da012880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Ahmed, S. H.</span><span> </span><span class="NLM_article-title">Validation crisis in animal models of drug addiction: beyond non-disordered drug use toward drug addiction</span> <span class="citation_source-journal">Neurosci. Biobehav. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=172-184&author=S.+H.+Ahmed&title=Validation+crisis+in+animal+models+of+drug+addiction%3A+beyond+non-disordered+drug+use+toward+drug+addiction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DS.%2BH.%26atitle%3DValidation%2520crisis%2520in%2520animal%2520models%2520of%2520drug%2520addiction%253A%2520beyond%2520non-disordered%2520drug%2520use%2520toward%2520drug%2520addiction%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2010%26volume%3D35%26spage%3D172%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">John, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span> </span><span class="NLM_article-title">Differential effects of the dopamine D3 receptor antagonist PG01037 on cocaine and methamphetamine self-administration in rhesus monkeys</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2015&pages=34-43&author=W.+S.+Johnauthor=A.+H.+Newmanauthor=M.+A.+Nader&title=Differential+effects+of+the+dopamine+D3+receptor+antagonist+PG01037+on+cocaine+and+methamphetamine+self-administration+in+rhesus+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohn%26aufirst%3DW.%2BS.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DNader%26aufirst%3DM.%2BA.%26atitle%3DDifferential%2520effects%2520of%2520the%2520dopamine%2520D3%2520receptor%2520antagonist%2520PG01037%2520on%2520cocaine%2520and%2520methamphetamine%2520self-administration%2520in%2520rhesus%2520monkeys%26jtitle%3DNeuropharmacology%26date%3D2015%26volume%3D92%26spage%3D34%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">Searle, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaver, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tziortzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comley, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghibellini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo-Pich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabiner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R. N.</span><span> </span><span class="NLM_article-title">Mathematical modelling of [<sup>11</sup>C]-(+)-PHNO human competition studies</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=119-132&author=G.+E.+Searleauthor=J.+D.+Beaverauthor=A.+Tziortziauthor=R.+A.+Comleyauthor=M.+Baniauthor=G.+Ghibelliniauthor=E.+Merlo-Pichauthor=E.+A.+Rabinerauthor=M.+Laruelleauthor=R.+N.+Gunn&title=Mathematical+modelling+of+%5B11C%5D-%28%2B%29-PHNO+human+competition+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSearle%26aufirst%3DG.%2BE.%26aulast%3DBeaver%26aufirst%3DJ.%2BD.%26aulast%3DTziortzi%26aufirst%3DA.%26aulast%3DComley%26aufirst%3DR.%2BA.%26aulast%3DBani%26aufirst%3DM.%26aulast%3DGhibellini%26aufirst%3DG.%26aulast%3DMerlo-Pich%26aufirst%3DE.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26atitle%3DMathematical%2520modelling%2520of%2520%255B11C%255D-%2528%252B%2529-PHNO%2520human%2520competition%2520studies%26jtitle%3DNeuroImage%26date%3D2013%26volume%3D68%26spage%3D119%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Matuskey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallezot, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pittman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanyiri, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaiser, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannestad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, M. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labaree, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potenza, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malison, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y. S.</span><span> </span><span class="NLM_article-title">Dopamine D(3) receptor alterations in cocaine-dependent humans imaged with [<sup>11</sup>C](+)PHNO</span> <span class="citation_source-journal">Drug Alcohol Depend.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.drugalcdep.2014.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24717909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1Onur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2014&pages=100-105&author=D.+Matuskeyauthor=J.+D.+Gallezotauthor=B.+Pittmanauthor=W.+Williamsauthor=J.+Wanyiriauthor=E.+Gaiserauthor=D.+E.+Leeauthor=J.+Hannestadauthor=K.+Limauthor=M.+Q.+Zhengauthor=S.+F.+Linauthor=D.+Labareeauthor=M.+N.+Potenzaauthor=R.+E.+Carsonauthor=R.+T.+Malisonauthor=Y.+S.+Ding&title=Dopamine+D%283%29+receptor+alterations+in+cocaine-dependent+humans+imaged+with+%5B11C%5D%28%2B%29PHNO"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D3 receptor alterations in cocaine-dependent humans imaged with [11C](+)PHNO</span></div><div class="casAuthors">Matuskey, David; Gallezot, Jean-Dominique; Pittman, Brian; Williams, Wendol; Wanyiri, Jane; Gaiser, Edward; Lee, Dianne E.; Hannestad, Jonas; Lim, Keunpoong; Zheng, Minq-Qiang; Lin, Shu-fei; Labaree, David; Potenza, Marc N.; Carson, Richard E.; Malison, Robert T.; Ding, Yu-Shin</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">100-105</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Evidence from animal models and postmortem human studies points to the importance of the dopamine D3 receptor (D3R) in cocaine dependence (CD).  The objective of this pilot study was to use the D3R-preferring radioligand [11C](+)PHNO to compare receptor availability in groups with and without CD.  Ten medically healthy, non-treatment seeking CD subjects (mean age 41 ± 8) in early abstinence were compared to 10 healthy control (HC) subjects (mean age 41 ± 6) with no history of cocaine or illicit substance abuse.  Binding potential (BPND), a measure of available receptors, was detd. with parametric images, computed using the simplified ref. tissue model (SRTM2) with the cerebellum as the ref. region.  BPND in CD subjects was higher in D3R-rich areas including the substantia nigra ((SN) 29%; P = 0.03), hypothalamus (28%; P = 0.02) and amygdala (35%; P = 0.03).  No between-group differences were obsd. in the striatum or pallidum.  BPND values in the SN (r = +0.83; P = 0.008) and pallidum (r = +0.67; P = 0.03) correlated with years of cocaine use.  Between-group differences suggest an important role for dopaminergic transmission in the SN, hypothalamus and amygdala in CD.  Such findings also highlight the potential relevance of D3R as a medication development target in CD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLL7Wj9mkgx7Vg90H21EOLACvtfcHk0li4g5GqhhoFzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1Onur0%253D&md5=017147b027fee82196209cdaff86829d</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1016%2Fj.drugalcdep.2014.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drugalcdep.2014.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DMatuskey%26aufirst%3DD.%26aulast%3DGallezot%26aufirst%3DJ.%2BD.%26aulast%3DPittman%26aufirst%3DB.%26aulast%3DWilliams%26aufirst%3DW.%26aulast%3DWanyiri%26aufirst%3DJ.%26aulast%3DGaiser%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DD.%2BE.%26aulast%3DHannestad%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DK.%26aulast%3DZheng%26aufirst%3DM.%2BQ.%26aulast%3DLin%26aufirst%3DS.%2BF.%26aulast%3DLabaree%26aufirst%3DD.%26aulast%3DPotenza%26aufirst%3DM.%2BN.%26aulast%3DCarson%26aufirst%3DR.%2BE.%26aulast%3DMalison%26aufirst%3DR.%2BT.%26aulast%3DDing%26aufirst%3DY.%2BS.%26atitle%3DDopamine%2520D%25283%2529%2520receptor%2520alterations%2520in%2520cocaine-dependent%2520humans%2520imaged%2520with%2520%255B11C%255D%2528%252B%2529PHNO%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D2014%26volume%3D139%26spage%3D100%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Collins, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J. H.</span><span> </span><span class="NLM_article-title">Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">215</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2011&pages=609-620&author=G.+T.+Collinsauthor=Y.+N.+Truongauthor=B.+Levantauthor=J.+Chenauthor=S.+Wangauthor=J.+H.+Woods&title=Behavioral+sensitization+to+cocaine+in+rats%3A+evidence+for+temporal+differences+in+dopamine+D3+and+D2+receptor+sensitivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DG.%2BT.%26aulast%3DTruong%26aufirst%3DY.%2BN.%26aulast%3DLevant%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWoods%26aufirst%3DJ.%2BH.%26atitle%3DBehavioral%2520sensitization%2520to%2520cocaine%2520in%2520rats%253A%2520evidence%2520for%2520temporal%2520differences%2520in%2520dopamine%2520D3%2520and%2520D2%2520receptor%2520sensitivity%26jtitle%3DPsychopharmacology%26date%3D2011%26volume%3D215%26spage%3D609%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group">Conrad, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, M. E.</span><span> </span><span class="NLM_article-title">Dopamine receptor expression and distribution dynamically change in the rat nucleus accumbens after withdrawal from cocaine self-administration</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2010&pages=182-194&author=K.+L.+Conradauthor=K.+Fordauthor=M.+Marinelliauthor=M.+E.+Wolf&title=Dopamine+receptor+expression+and+distribution+dynamically+change+in+the+rat+nucleus+accumbens+after+withdrawal+from+cocaine+self-administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConrad%26aufirst%3DK.%2BL.%26aulast%3DFord%26aufirst%3DK.%26aulast%3DMarinelli%26aufirst%3DM.%26aulast%3DWolf%26aufirst%3DM.%2BE.%26atitle%3DDopamine%2520receptor%2520expression%2520and%2520distribution%2520dynamically%2520change%2520in%2520the%2520rat%2520nucleus%2520accumbens%2520after%2520withdrawal%2520from%2520cocaine%2520self-administration%26jtitle%3DNeuroscience%26date%3D2010%26volume%3D169%26spage%3D182%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group">Brady, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verduin, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolliver, B. K.</span><span> </span><span class="NLM_article-title">Treatment of patients comorbid for addiction and other psychiatric disorders</span> <span class="citation_source-journal">Curr. Psychiatry Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">374</span><span class="NLM_x">–</span> <span class="NLM_lpage">380</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1007%2Fs11920-007-0048-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=17915076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BD2srptlaktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=374-380&author=K.+T.+Bradyauthor=M.+L.+Verduinauthor=B.+K.+Tolliver&title=Treatment+of+patients+comorbid+for+addiction+and+other+psychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of patients comorbid for addiction and other psychiatric disorders</span></div><div class="casAuthors">Brady Kathleen T; Verduin Marcia L; Tolliver Bryan K</div><div class="citationInfo"><span class="NLM_cas:title">Current psychiatry reports</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">374-80</span>
        ISSN:<span class="NLM_cas:issn">1523-3812</span>.
    </div><div class="casAbstract">Psychiatric disorders and drug and alcohol use disorders commonly co-occur.  A growing literature has documented the epidemiology and effects on the course of illness of comorbid psychiatric and substance use disorders (SUDs).  Advances in treatment of co-occurring illnesses have progressed more slowly.  The current article reviews recent developments in the diagnosis and treatment of co-occurring psychiatric disorders and SUDs with particular focus on psychotic disorders, affective disorders, anxiety disorders, personality disorders, and attention-deficit/hyperactivity disorder.  Current treatment options and implications for future research are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOGdJ16j6YIEBuFdjgVNKSfW6udTcc2eZ85k-Pc4rGyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srptlaktA%253D%253D&md5=255a95cfc2dcd68d07426314387df70f</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1007%2Fs11920-007-0048-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11920-007-0048-0%26sid%3Dliteratum%253Aachs%26aulast%3DBrady%26aufirst%3DK.%2BT.%26aulast%3DVerduin%26aufirst%3DM.%2BL.%26aulast%3DTolliver%26aufirst%3DB.%2BK.%26atitle%3DTreatment%2520of%2520patients%2520comorbid%2520for%2520addiction%2520and%2520other%2520psychiatric%2520disorders%26jtitle%3DCurr.%2520Psychiatry%2520Rep.%26date%3D2007%26volume%3D9%26spage%3D374%26epage%3D380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">Schuckit, M. A.</span><span> </span><span class="NLM_article-title">Comorbidity between substance use disorders and psychiatric conditions</span> <span class="citation_source-journal">Addiction</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2006&pages=76-88&author=M.+A.+Schuckit&title=Comorbidity+between+substance+use+disorders+and+psychiatric+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchuckit%26aufirst%3DM.%2BA.%26atitle%3DComorbidity%2520between%2520substance%2520use%2520disorders%2520and%2520psychiatric%2520conditions%26jtitle%3DAddiction%26date%3D2006%26volume%3D101%26spage%3D76%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group">Urbanoski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenaszchuk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veldhuizen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, B.</span><span> </span><span class="NLM_article-title">The clustering of psychopathology among adults seeking treatment for alcohol and drug addiction</span> <span class="citation_source-journal">J. Subst. Abuse Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.jsat.2014.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=25124260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FhslCqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2015&pages=21-26&author=K.+Urbanoskiauthor=C.+Kenaszchukauthor=S.+Veldhuizenauthor=B.+Rush&title=The+clustering+of+psychopathology+among+adults+seeking+treatment+for+alcohol+and+drug+addiction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">The clustering of psychopathology among adults seeking treatment for alcohol and drug addiction</span></div><div class="casAuthors">Urbanoski Karen; Kenaszchuk Chris; Veldhuizen Scott; Rush Brian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of substance abuse treatment</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Beyond the high prevalence of co-occurring mental and substance use disorders, little is known about more complex patterns of psychopathology and multimorbidity, particularly in treatment populations.  We sought to identify a parsimonious set of latent classes to describe the structure of mental disorder comorbidity among adults entering outpatient addiction treatment, and explore differences in the structure and prevalence of classes across sociodemographic characteristics.  Participants (N=544) completed the Psychiatric Diagnostic Screening Questionnaire at treatment admission.  We used latent class analysis to identify classes of clients with specific patterns of co-occurring mental disorders.  The best-fitting solution identified 3 classes, characterized by no comorbidity (i.e., substance use disorders only), co-occurring major depression, and multimorbidity or a high degree of psychopathology.  Older age was associated with lower probability of being in the class with co-occurring major depression, women were more likely than men to be in the multimorbid class, and being married or partnered was associated with a lower probability of being in either of the comorbid classes.  These results are consistent with general population research on the patterning of psychiatric disorders, implying that while clients in addiction treatment may have extraordinarily high levels of psychopathology, the patterns of symptoms and the groups most affected are not markedly different than in other settings.  By capturing the complexity of interrelationships among the many factors that are known to influence prognosis and outcomes, latent class analysis offers a useful way to examine and represent case-mix in clinical populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ69rwS04o_OFQKX3ooHxWjfW6udTcc2eZabjd742LDs7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FhslCqtQ%253D%253D&md5=833d8cfa15751a2b3aae40940ead5144</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.jsat.2014.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsat.2014.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DUrbanoski%26aufirst%3DK.%26aulast%3DKenaszchuk%26aufirst%3DC.%26aulast%3DVeldhuizen%26aufirst%3DS.%26aulast%3DRush%26aufirst%3DB.%26atitle%3DThe%2520clustering%2520of%2520psychopathology%2520among%2520adults%2520seeking%2520treatment%2520for%2520alcohol%2520and%2520drug%2520addiction%26jtitle%3DJ.%2520Subst.%2520Abuse%2520Treat.%26date%3D2015%26volume%3D49%26spage%3D21%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group">Compton, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaslow, N. J.</span><span> </span><span class="NLM_article-title">The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems</span> <span class="citation_source-journal">Soc. Psychiatry Psychiatr. Epidemiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">939</span><span class="NLM_x">–</span> <span class="NLM_lpage">946</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1007%2Fs00127-005-0964-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=16247563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FivVensw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2005&pages=939-946&author=M.+T.+Comptonauthor=P.+S.+Weissauthor=J.+C.+Westauthor=N.+J.+Kaslow&title=The+associations+between+substance+use+disorders%2C+schizophrenia-spectrum+disorders%2C+and+Axis+IV+psychosocial+problems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems</span></div><div class="casAuthors">Compton Michael T; Weiss Paul S; West Joyce C; Kaslow Nadine J</div><div class="citationInfo"><span class="NLM_cas:title">Social psychiatry and psychiatric epidemiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">939-46</span>
        ISSN:<span class="NLM_cas:issn">0933-7954</span>.
    </div><div class="casAbstract">BACKGROUND:  Substance abuse among individuals with schizophrenia-spectrum disorders (SSDs) is associated with a range of adverse psychosocial outcomes in the areas of occupational functioning, housing stability, economic independence, access to health care, and involvement with the legal system.  The aim of this study was to estimate the effects of substance use disorders (SUDs), SSDS, and dual diagnosis with both disorders on the risk for six important Axis IV psychosocial problems.  This was accomplished using a large dataset of patients who are representative of individuals in routine US psychiatric practice.  METHOD:  Weighted data from the 1999 Study of Psychiatric Patients and Treatments from a practice-based research network of the American Psychiatric Institute for Research and Education were analyzed.  Some 615 US psychiatrists provided detailed clinical, psychosocial, and health services information on 1,843 patients, including 285 patients with one or more SUDs without an SSD, 180 patients with a diagnosis of an SSD without substance abuse comorbidity, and 68 dually diagnosed patients.  Logistic regression models were used to determine effect estimates (adjusted odds ratios), and corresponding 95% confidence intervals were calculated.  RESULTS:  After adjusting for sociodemographic variables and for SSD diagnosis, SUD diagnosis was independently associated with increased risk for five of the Axis IV psychosocial problems of interest (occupational problems, housing problems, economic problems, problems with access to health care services, and problems related to interaction with the legal system/crime) when compared to all other psychiatric patients (n=1,310).  After adjusting for the sociodemographic variables and for SUD diagnosis, SSD diagnosis (compared to all other psychiatric diagnoses) was associated with Axis IV economic problems, but not with the other five psychosocial problems of interest.  The presence of both an SUD and an SSD diagnosis (dual diagnosis) was associated with a greater risk for four of the six Axis IV psychosocial problems studied, compared to the risks associated with either diagnosis alone.  Limiting the substance of abuse to alcohol resulted in similar findings.  CONCLUSIONS:  Although SUDs are associated with increased risk for poor social adjustment, the comorbidity of SUDs and SSDs is associated with greatly compounded psychosocial burdens.  These findings, from a large sample of representative US psychiatric patients, demonstrate the ongoing need for improved services and policies for those specially burdened patients with the dual diagnosis of both an SSD and substance abuse or dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRm5th7kqzWsEQ0lWbKiCflfW6udTcc2eZabjd742LDs7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FivVensw%253D%253D&md5=764a38c70d8115475fbe8a287ba7d4a9</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1007%2Fs00127-005-0964-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00127-005-0964-4%26sid%3Dliteratum%253Aachs%26aulast%3DCompton%26aufirst%3DM.%2BT.%26aulast%3DWeiss%26aufirst%3DP.%2BS.%26aulast%3DWest%26aufirst%3DJ.%2BC.%26aulast%3DKaslow%26aufirst%3DN.%2BJ.%26atitle%3DThe%2520associations%2520between%2520substance%2520use%2520disorders%252C%2520schizophrenia-spectrum%2520disorders%252C%2520and%2520Axis%2520IV%2520psychosocial%2520problems%26jtitle%3DSoc.%2520Psychiatry%2520Psychiatr.%2520Epidemiol.%26date%3D2005%26volume%3D40%26spage%3D939%26epage%3D946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span> </span><span class="NLM_article-title">Dopamine D1 and D3 receptors mediate reconsolidation of cocaine memories in mouse models of drug self-administration</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2014&pages=154-164&author=Y.+Yanauthor=A.+H.+Newmanauthor=M.+Xu&title=Dopamine+D1+and+D3+receptors+mediate+reconsolidation+of+cocaine+memories+in+mouse+models+of+drug+self-administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DY.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DXu%26aufirst%3DM.%26atitle%3DDopamine%2520D1%2520and%2520D3%2520receptors%2520mediate%2520reconsolidation%2520of%2520cocaine%2520memories%2520in%2520mouse%2520models%2520of%2520drug%2520self-administration%26jtitle%3DNeuroscience%26date%3D2014%26volume%3D278%26spage%3D154%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group">Savitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgkinson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Soelch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szczepanik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nugent, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herscovitch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drevets, W. C.</span><span> </span><span class="NLM_article-title">The functional DRD3 Ser9Gly polymorphism (rs6280) is pleiotropic, affecting reward as well as movement</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e54108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e54108&author=J.+Savitzauthor=C.+A.+Hodgkinsonauthor=C.+Martin-Soelchauthor=P.+H.+Shenauthor=J.+Szczepanikauthor=A.+Nugentauthor=P.+Herscovitchauthor=A.+A.+Graceauthor=D.+Goldmanauthor=W.+C.+Drevets&title=The+functional+DRD3+Ser9Gly+polymorphism+%28rs6280%29+is+pleiotropic%2C+affecting+reward+as+well+as+movement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSavitz%26aufirst%3DJ.%26aulast%3DHodgkinson%26aufirst%3DC.%2BA.%26aulast%3DMartin-Soelch%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DP.%2BH.%26aulast%3DSzczepanik%26aufirst%3DJ.%26aulast%3DNugent%26aufirst%3DA.%26aulast%3DHerscovitch%26aufirst%3DP.%26aulast%3DGrace%26aufirst%3DA.%2BA.%26aulast%3DGoldman%26aufirst%3DD.%26aulast%3DDrevets%26aufirst%3DW.%2BC.%26atitle%3DThe%2520functional%2520DRD3%2520Ser9Gly%2520polymorphism%2520%2528rs6280%2529%2520is%2520pleiotropic%252C%2520affecting%2520reward%2520as%2520well%2520as%2520movement%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De54108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M. D.</span><span> </span><span class="NLM_article-title">A functional polymorphism, rs6280, in DRD3 is significantly associated with nicotine dependence in European-American smokers</span> <span class="citation_source-journal">Am. J. Med. Genet., Part B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">1109</span><span class="NLM_x">–</span> <span class="NLM_lpage">1115</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1002%2Fajmg.b.30731" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht12ru7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2008&pages=1109-1115&author=W.+Huangauthor=T.+J.+Payneauthor=J.+Z.+Maauthor=M.+D.+Li&title=A+functional+polymorphism%2C+rs6280%2C+in+DRD3+is+significantly+associated+with+nicotine+dependence+in+European-American+smokers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">A functional polymorphism, rs6280, in DRD3 is significantly associated with nicotine dependence in European-American smokers</span></div><div class="casAuthors">Huang, Weihua; Payne, Thomas J.; Ma, Jennie Z.; Li, Ming D.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">147B</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1109-1115</span>CODEN:
                <span class="NLM_cas:coden">AJMGC9</span>;
        ISSN:<span class="NLM_cas:issn">1552-4841</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Nicotine enhances reward functions in the mesocorticolimbic dopamine system in general and the nucleus accumbens in particular.  The genes encoding dopamine receptors are thus plausible candidates for involvement in nicotine dependence (ND).  We investigated 13 single nucleotide polymorphisms (SNPs) spanning a region of the dopamine D3 receptor gene (DRD3) to det. whether DRD3 is assocd. with ND.  We studied a set of 2,037 subjects in 602 nuclear families representing two distinct American populations using three ND measures, namely, smoking quantity (SQ), the Heaviness of Smoking Index (HSI), and the Fagerstrom Test for ND (FTND).  In the family based assocn. study, we found that SNP rs6280 showed a strong assocn. with ND in European-Americans (EAs) and the pooled sample, whereas SNPs rs1486012 and rs963468 had weak assocns. with ND in African-Americans (AAs) and the pooled sample.  Further haplotype anal. with all contiguous 3-SNP groups revealed relatively weak evidence for assocn. of DRD3 with ND in the EA and pooled samples.  The results indicate that DRD3 is significantly assocd. with ND in EAs, and that rs6280, a functional polymorphism causing an amino acid change of serine to glycine (Ser9Gly) in the N-terminal extracellular domain of the D3 receptor, likely is causative of the assocn. between DRD3 and ND.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQBxlbD4Lev7Vg90H21EOLACvtfcHk0lgfqCO9D6A9kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht12ru7rE&md5=7684e31a70946a544f14a575da99df63</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1002%2Fajmg.b.30731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fajmg.b.30731%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DPayne%26aufirst%3DT.%2BJ.%26aulast%3DMa%26aufirst%3DJ.%2BZ.%26aulast%3DLi%26aufirst%3DM.%2BD.%26atitle%3DA%2520functional%2520polymorphism%252C%2520rs6280%252C%2520in%2520DRD3%2520is%2520significantly%2520associated%2520with%2520nicotine%2520dependence%2520in%2520European-American%2520smokers%26jtitle%3DAm.%2520J.%2520Med.%2520Genet.%252C%2520Part%2520B%26date%3D2008%26volume%3D147%26spage%3D1109%26epage%3D1115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group">Kang, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, H. E.</span><span> </span><span class="NLM_article-title">DRD3 Gene rs6280 polymorphism may be associated with alcohol dependence overall and with Lesch type I alcohol dependence in Koreans</span> <span class="citation_source-journal">Neuropsychobiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=140-146&author=S.+G.+Kangauthor=B.+H.+Leeauthor=J.+S.+Leeauthor=Y.+G.+Chaiauthor=K.+P.+Koauthor=H.+J.+Leeauthor=D.+M.+Hanauthor=H.+Jiauthor=G.+H.+Jangauthor=H.+E.+Shin&title=DRD3+Gene+rs6280+polymorphism+may+be+associated+with+alcohol+dependence+overall+and+with+Lesch+type+I+alcohol+dependence+in+Koreans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DS.%2BG.%26aulast%3DLee%26aufirst%3DB.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DChai%26aufirst%3DY.%2BG.%26aulast%3DKo%26aufirst%3DK.%2BP.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DHan%26aufirst%3DD.%2BM.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DJang%26aufirst%3DG.%2BH.%26aulast%3DShin%26aufirst%3DH.%2BE.%26atitle%3DDRD3%2520Gene%2520rs6280%2520polymorphism%2520may%2520be%2520associated%2520with%2520alcohol%2520dependence%2520overall%2520and%2520with%2520Lesch%2520type%2520I%2520alcohol%2520dependence%2520in%2520Koreans%26jtitle%3DNeuropsychobiology%26date%3D2014%26volume%3D69%26spage%3D140%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. Y.</span><span> </span><span class="NLM_article-title">DRD3 variation associates with early-onset heroin dependence, but not specific personality traits</span> <span class="citation_source-journal">Prog. Neuropsychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Fjm501512b&amp;key=10.1016%2Fj.pnpbp.2013.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Fjm501512b&amp;key=24398431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Fjm501512b&amp;key=1%3ACAS%3A280%3ADC%252BC2czivF2gsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2014&pages=1-8&author=S.+C.+Kuoauthor=Y.+W.+Yehauthor=C.+Y.+Chenauthor=C.+C.+Huangauthor=H.+A.+Changauthor=C.+H.+Yenauthor=P.+S.+Hoauthor=C.+S.+Liangauthor=H.+W.+Chouauthor=R.+B.+Luauthor=S.+Y.+Huang&title=DRD3+variation+associates+with+early-onset+heroin+dependence%2C+but+not+specific+personality+traits"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">DRD3 variation associates with early-onset heroin dependence, but not specific personality traits</span></div><div class="casAuthors">Kuo Shin-Chang; Yeh Yi-Wei; Chen Chun-Yen; Huang Chang-Chih; Chang Hsin-An; Yen Che-Hung; Ho Pei-Shen; Chou Han-Wei; Liang Chih-Sung; Lu Ru-Band; Huang San-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">Progress in neuro-psychopharmacology & biological psychiatry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dopamine D3 receptor-mediated pathways are involved in the mechanism of addiction, and genetic factors play a role in the vulnerability to heroin dependence.  The aim of this study was to examine whether the corresponding gene, DRD3, is associated with the development of heroin dependence and specific personality traits in HD patients.  Eight polymorphisms in DRD3 were analyzed in 1067 unrelated Han Chinese subjects (566 heroin dependence patients and 501 controls).  All participants were screened using the same assessment tool and all patients met the criteria for heroin dependence.  A Tridimensional Personality Questionnaire was used to assess personality traits in 276 heroin dependence patients.  In addition, heroin dependence patients were divided into 4 clinical subgroups based on age-of-onset and family history of substance abuse, to reduce the clinical heterogeneity.  The rs6280 and rs9825563 variants showed association with the development of early-onset heroin dependence.  The GTA haplotype frequency in the block (rs324029, rs6280, rs9825563) was significantly associated with early-onset heroin dependence (p=0.003).  However, these significant associations were weaker after Bonferroni's correction.  In addition, these DRD3 polymorphisms did not influence novelty seeking and harm avoidance scores in HD patients.  DRD3 is possibly a genetic factor in the development of early-onset heroin dependence, but is not associated with specific personality traits in these patients among the Han Chinese population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_J0wMANoO-N1QT_1O5WBYfW6udTcc2ebGtjRBhmxmmrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czivF2gsQ%253D%253D&md5=8308255d9f5b17e7dea50e21f26f9351</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2013.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2013.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DYeh%26aufirst%3DY.%2BW.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DChang%26aufirst%3DH.%2BA.%26aulast%3DYen%26aufirst%3DC.%2BH.%26aulast%3DHo%26aufirst%3DP.%2BS.%26aulast%3DLiang%26aufirst%3DC.%2BS.%26aulast%3DChou%26aufirst%3DH.%2BW.%26aulast%3DLu%26aufirst%3DR.%2BB.%26aulast%3DHuang%26aufirst%3DS.%2BY.%26atitle%3DDRD3%2520variation%2520associates%2520with%2520early-onset%2520heroin%2520dependence%252C%2520but%2520not%2520specific%2520personality%2520traits%26jtitle%3DProg.%2520Neuropsychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2014%26volume%3D51%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i24"><a href="/doi/suppl/10.1021/jm501512b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_48738"></div></div></div></div></div><hr /></hr><p class="last">Detailed methods.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm501512b/suppl_file/jm501512b_si_001.pdf">jm501512b_si_001.pdf (362.25 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm501512b&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm501512b%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-14" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm501512b" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679930b78c7c1991","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
